
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitroaniline
C6H6N2O2
100-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)formamide
C7H6N2O3
16135-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-01-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16135-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37946251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isocyanides as Catalytic Electron Acceptors in the Visible Light Promoted
Oxidative Formation of Benzyl and Acyl Radicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Russo, Camilla; Donati, Greta; Giustiniano, Francesco; Amato, Jussara;
Marinelli, Luciana; Whitby, Richard John; Giustiniano, Mariateresa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(60), e202301852

$RFMT $RIREG SCHEME2 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Phenylthio)ethanamine
C8H11NS
2014-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-5-phenyl-1,4-benzothiazepine-4(5H)-carboxaldehyde
C16H15NOS
2173584-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9222 4.3281 0.0 0
M  V30 2 O 8.3559 4.8906 0.0 0
M  V30 3 C 4.3307 4.6201 0.0 0
M  V30 4 C 2.9433 5.2883 0.0 0
M  V30 5 N 5.7183 5.2883 0.0 0
M  V30 6 C 2.6005 6.7896 0.0 0
M  V30 7 C 1.8143 4.2408 0.0 0
M  V30 8 C 6.0609 6.7896 0.0 0
M  V30 9 S 3.5607 7.9936 0.0 0
M  V30 10 C 1.1290 7.2435 0.0 0
M  V30 11 C 0.3427 4.6946 0.0 0
M  V30 12 C 5.1007 7.9936 0.0 0
M  V30 13 C 0.0000 6.1961 0.0 0
M  V30 14 C 4.3307 3.0800 0.0 0
M  V30 15 C 2.9970 2.3100 0.0 0
M  V30 16 C 5.6644 2.3100 0.0 0
M  V30 17 C 2.9970 0.7700 0.0 0
M  V30 18 C 5.6644 0.7700 0.0 0
M  V30 19 C 4.3307 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2014-75-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173584-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-18393283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1493-13-6
$DTYPE RXN:VAR(1):NOTES
$DATUM modified Pictet-Spengler reaction, alternate reaction conditions gave
lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Short synthesis of
5-substituted-2,3,4,5-tetrahydro-benzo[f][1,4]thiazepines by using a
modified Pictet-Spengler reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Kitabatake, Michikazu; Sugihara, Yuuko; Ono, Yuuki;
Horiguchi, Yoshie; Mohri, Kunihiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2017), 94(6), 1063-1073

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(2-Amino-1-methyl-1H-imidazol-5-yl)-2-propyn-1-yl]-4,5-dibromo-1H-pyrrol...
C12H11Br2N5O
1006055-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 N 6.6365 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9701 1.5400 0.0 0
M  V30 5 C 9.3038 2.3101 0.0 0
M  V30 6 C 10.6376 3.0801 0.0 0
M  V30 7 Br 1.6752 5.5688 0.0 0
M  V30 8 Br 0.0000 2.6672 0.0 0
M  V30 9 C 13.6983 1.7173 0.0 0
M  V30 10 N 15.9403 4.2072 0.0 0
M  V30 11 C 3.9690 2.3101 0.0 0
M  V30 12 C 3.8080 3.8416 0.0 0
M  V30 13 N 2.5622 1.6836 0.0 0
M  V30 14 C 2.3016 4.1618 0.0 0
M  V30 15 C 1.5316 2.8281 0.0 0
M  V30 16 C 11.9713 3.8501 0.0 0
M  V30 17 N 13.3781 3.2236 0.0 0
M  V30 18 C 12.1322 5.3816 0.0 0
M  V30 19 C 14.4087 4.3682 0.0 0
M  V30 20 N 13.6387 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 1 6 16
M  V30 8 1 7 14
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 1 10 19
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[3-(2-amino-1-methyl-1H-imidazol-5-yl)-2-propyn-1-...
C12H11Br2N5O.CH2O2
1006055-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.8501 0.0 0
M  V30 2 N 6.6365 4.6201 0.0 0
M  V30 3 O 5.3026 2.3100 0.0 0
M  V30 4 C 7.9701 3.8501 0.0 0
M  V30 5 C 9.3038 4.6201 0.0 0
M  V30 6 C 10.6376 5.3901 0.0 0
M  V30 7 Br 1.6752 7.8788 0.0 0
M  V30 8 Br 0.0000 4.9772 0.0 0
M  V30 9 C 13.6983 4.0273 0.0 0
M  V30 10 N 15.9403 6.5172 0.0 0
M  V30 11 C 3.9690 4.6201 0.0 0
M  V30 12 C 3.8080 6.1516 0.0 0
M  V30 13 N 2.5622 3.9936 0.0 0
M  V30 14 C 2.3016 6.4718 0.0 0
M  V30 15 C 1.5316 5.1381 0.0 0
M  V30 16 C 11.9713 6.1601 0.0 0
M  V30 17 N 13.3781 5.5336 0.0 0
M  V30 18 C 12.1322 7.6917 0.0 0
M  V30 19 C 14.4087 6.6782 0.0 0
M  V30 20 N 13.6387 8.0118 0.0 0
M  V30 21 C 7.9701 0.0000 0.0 0
M  V30 22 O 6.6365 0.7700 0.0 0
M  V30 23 O 9.3038 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 1 6 16
M  V30 8 1 7 14
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 1 10 19
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1006055-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1006055-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30052796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 2: Alcohol 14 (320 mg, 0.50 mmol) was
heated with HCO2H-H2O (5:1, 10 mL) under reflux for 24 h (monitored by
TLC). The mixture was concentrated in vacuo and MeOH (5 mL) and H2O (20
mL) were added. The resulting suspension was filtered and the residue was
diluted with MeOH (5 mL) and H2O (20 mL) once again. The filtrate was
purified by RP-chromatography (RP-18, MeOH-H2O + 0.5% HCO2H, 1:4) to give
16-HCO2H. Compound 24. Quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 4(5)-acyl-2-aminoimidazoles and vinylogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Poeverlein, Christoph; Jacobi, Nicolas; Mayer, Peter; Lindel, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2007), (23), 3620-3626

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-[2,6-dichloro-4-[(phenylamino)carbonyl]phenoxy]ethyl]c...
C20H22Cl2N2O4
1006584-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5500 5.5411 0.0 0
M  V30 2 C 12.3200 4.2074 0.0 0
M  V30 3 C 13.8600 4.2074 0.0 0
M  V30 4 N 14.6300 2.8738 0.0 0
M  V30 5 C 16.1700 2.8738 0.0 0
M  V30 6 O 16.9400 1.5400 0.0 0
M  V30 7 O 16.9400 4.2074 0.0 0
M  V30 8 C 18.4800 1.5400 0.0 0
M  V30 9 C 18.4800 0.0000 0.0 0
M  V30 10 C 20.0200 1.5400 0.0 0
M  V30 11 C 18.4800 3.0800 0.0 0
M  V30 12 Cl 10.0100 2.8738 0.0 0
M  V30 13 Cl 10.0100 8.2085 0.0 0
M  V30 14 C 5.3900 5.5411 0.0 0
M  V30 15 N 4.6200 6.8747 0.0 0
M  V30 16 O 4.6200 4.2074 0.0 0
M  V30 17 C 10.0100 5.5411 0.0 0
M  V30 18 C 9.2400 4.2074 0.0 0
M  V30 19 C 9.2400 6.8747 0.0 0
M  V30 20 C 7.7000 4.2074 0.0 0
M  V30 21 C 7.7000 6.8747 0.0 0
M  V30 22 C 6.9300 5.5411 0.0 0
M  V30 23 C 3.0800 6.8747 0.0 0
M  V30 24 C 2.3100 5.5411 0.0 0
M  V30 25 C 2.3100 8.2085 0.0 0
M  V30 26 C 0.7700 5.5411 0.0 0
M  V30 27 C 0.7700 8.2085 0.0 0
M  V30 28 C 0.0000 6.8747 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 18
M  V30 13 1 13 19
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 22
M  V30 17 1 15 23
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-(2-aminoethoxy)-3,5-dichloro-N-phenylbenzamide (1:1)
C15H14Cl2N2O2.CH2O2
1032434-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.9301 0.0 0
M  V30 2 N 4.0010 6.1601 0.0 0
M  V30 3 O 5.3348 8.4702 0.0 0
M  V30 4 Cl 8.0022 2.3100 0.0 0
M  V30 5 Cl 10.6697 6.9301 0.0 0
M  V30 6 O 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 N 14.6707 4.6201 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 6.9301 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 9.3358 6.1601 0.0 0
M  V30 15 C 9.3358 4.6201 0.0 0
M  V30 16 C 2.6673 6.9301 0.0 0
M  V30 17 C 1.3337 6.1601 0.0 0
M  V30 18 C 2.6673 8.4702 0.0 0
M  V30 19 C 0.0000 6.9301 0.0 0
M  V30 20 C 1.3337 9.2402 0.0 0
M  V30 21 C 0.0000 8.4702 0.0 0
M  V30 22 C 7.3353 0.0000 0.0 0
M  V30 23 O 6.0017 0.7700 0.0 0
M  V30 24 O 8.6690 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 13
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1006584-00-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032434-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-8656354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The N-(butyloxycarbonyl) derivative was dissolved in either a saturated
solution of hydrogen chloride in diethyl ether (5-10 ml per mmol of
substrate) or in 4 M hydrogen chloride in 1,4- dioxane (5-10 ml per mmol
of substrate) and the resulting solution was stirred at room temperature
for 4-16 hours until the reaction was shown to be complete as evidenced
by HPLC/MS analysis. The solvent was then removed in vacuo to yield
amines 7-16 (80-100% yield). If necessary the final products were further
purified by HPLC/MS. Compounds were isolated as mono- or di-hydrochloride
salts, or if purified by HPLC/MS as a formate salt as indicated below.
N-Phenyl 4-[(2-amino)ethoxy]-3,5-dichlorobenzamide formate (7). From
intermediate A and aniline. Colourless solid. 1H NMR (400 MHz, MeOH-d4):
δ 3.45 (t, J = 7, 2H), 4.35 (t, J = 7, 2H), 7.15 (t, J = 8, 1H), 7.35 (t,
J = 8, 2H), 7.70 (d, J = 7, 2H), 8.05 (s, 2H), 8.35 (s, 1H). MS (+ES):
m/e 325 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternately 1,4-dioxane may be used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable
Inhibitors of Urokinase-Type Plasminogen Activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frederickson, Martyn; Callaghan, Owen; Chessari, Gianni; Congreve, Miles;
Cowan, Suzanna R.; Matthews, Julia E.; McMenamin, Rachel; Smith,
Donna-Michelle; Vinkovic, Mladen; Wallis, Nicola G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(2), 183-186

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-[2,6-dichloro-4-[[(2-methoxyphenyl)amino]carbonyl]phen...
C21H24Cl2N2O5
1006584-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 6.6684 0.0 0
M  V30 4 Cl 10.0100 8.0021 0.0 0
M  V30 5 Cl 10.0100 2.6674 0.0 0
M  V30 6 O 11.5500 5.3347 0.0 0
M  V30 7 C 12.3200 6.6684 0.0 0
M  V30 8 C 13.8600 6.6684 0.0 0
M  V30 9 N 14.6300 8.0021 0.0 0
M  V30 10 C 16.1700 8.0021 0.0 0
M  V30 11 O 16.9400 9.3358 0.0 0
M  V30 12 O 16.9400 6.6684 0.0 0
M  V30 13 C 18.4800 9.3358 0.0 0
M  V30 14 C 18.4800 7.7958 0.0 0
M  V30 15 C 20.0200 9.3358 0.0 0
M  V30 16 C 18.4800 10.8758 0.0 0
M  V30 17 O 3.0800 1.3336 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 9.2400 6.6684 0.0 0
M  V30 23 C 9.2400 4.0011 0.0 0
M  V30 24 C 10.0100 5.3347 0.0 0
M  V30 25 C 3.0800 4.0011 0.0 0
M  V30 26 C 2.3100 2.6674 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 0.7700 2.6674 0.0 0
M  V30 29 C 0.7700 5.3347 0.0 0
M  V30 30 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 25
M  V30 5 1 4 22
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 26
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-(2-aminoethoxy)-3,5-dichloro-N-(2-methoxyphenyl)be...
C16H16Cl2N2O3.CH2O2
1032434-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 6.1601 0.0 0
M  V30 2 C 5.3348 6.9301 0.0 0
M  V30 3 O 5.3348 8.4702 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 Cl 8.0022 2.3100 0.0 0
M  V30 7 Cl 10.6697 6.9301 0.0 0
M  V30 8 O 10.6697 3.8501 0.0 0
M  V30 9 C 12.0033 4.6201 0.0 0
M  V30 10 C 13.3370 3.8501 0.0 0
M  V30 11 N 14.6707 4.6201 0.0 0
M  V30 12 C 2.6673 6.9301 0.0 0
M  V30 13 C 1.3337 6.1601 0.0 0
M  V30 14 C 2.6673 8.4702 0.0 0
M  V30 15 C 0.0000 6.9301 0.0 0
M  V30 16 C 1.3337 9.2402 0.0 0
M  V30 17 C 0.0000 8.4702 0.0 0
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 6.6685 4.6201 0.0 0
M  V30 20 C 8.0022 6.9301 0.0 0
M  V30 21 C 8.0022 3.8501 0.0 0
M  V30 22 C 9.3358 6.1601 0.0 0
M  V30 23 C 9.3358 4.6201 0.0 0
M  V30 24 C 7.3353 0.0000 0.0 0
M  V30 25 O 6.0017 0.7700 0.0 0
M  V30 26 O 8.6690 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 6 21
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1006584-01-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032434-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10786496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The N-(butyloxycarbonyl) derivative was
dissolved in either a saturated solution of hydrogen chloride in diethyl
ether (5-10 ml per mmol of substrate) or in 4 M hydrogen chloride in 1,4-
dioxane (5-10 ml per mmol of substrate) and the resulting solution was
stirred at room temperature for 4-16 hours until the reaction was shown
to be complete as evidenced by HPLC/MS analysis. The solvent was then
removed in vacuo to yield amines 7-16 (80-100% yield). If necessary the
final products were further purified by HPLC/MS. Compounds were isolated
as mono- or di-hydrochloride salts, or if purified by HPLC/MS as a
formate salt as indicated below. N-(2-Methoxyphenyl)
4-[(2-amino)ethoxy]-3,5-dichlorobenzamide formate (8). From intermediate
A and 2-methoxyaniline. Colourless solid. 1H NMR (400 MHz, MeOH-d4): δ
3.45 (t, J = 7, 2H), 3.90 (s, 3H), 4.35 (t, J = 7, 2H), 7.00 (t, J = 7.5,
1H), 7.12 (t, J = 7.5, 1H), 7.21 (t, J = 7.5, 1H), 7.85 (d, J = 7.5, 1H),
8.00 (s, 2H), 8.45 (s, 1H). MS (+ES): m/e 355 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternately 1,4-dioxane may be used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable
Inhibitors of Urokinase-Type Plasminogen Activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frederickson, Martyn; Callaghan, Owen; Chessari, Gianni; Congreve, Miles;
Cowan, Suzanna R.; Matthews, Julia E.; McMenamin, Rachel; Smith,
Donna-Michelle; Vinkovic, Mladen; Wallis, Nicola G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(2), 183-186

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-[2,6-dichloro-4-[[[3-(1-methylethoxy)phenyl]amino]carb...
C23H28Cl2N2O5
1006584-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 2.3101 0.0 0
M  V30 2 N 8.0022 3.0801 0.0 0
M  V30 3 O 9.3358 0.7700 0.0 0
M  V30 4 Cl 14.6708 2.3101 0.0 0
M  V30 5 Cl 12.0033 6.9302 0.0 0
M  V30 6 O 14.6708 5.3901 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 C 17.3382 5.3901 0.0 0
M  V30 9 N 18.6718 4.6201 0.0 0
M  V30 10 C 20.0057 5.3901 0.0 0
M  V30 11 O 21.3393 4.6201 0.0 0
M  V30 12 O 20.0057 6.9302 0.0 0
M  V30 13 C 22.6730 5.3901 0.0 0
M  V30 14 C 21.9030 6.7238 0.0 0
M  V30 15 C 24.0067 6.1601 0.0 0
M  V30 16 C 23.4430 4.0564 0.0 0
M  V30 17 O 2.6673 3.0801 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 1.3337 0.7700 0.0 0
M  V30 20 C 0.0000 3.0801 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 12.0033 2.3101 0.0 0
M  V30 23 C 10.6697 4.6201 0.0 0
M  V30 24 C 13.3370 3.0801 0.0 0
M  V30 25 C 12.0033 5.3901 0.0 0
M  V30 26 C 13.3370 4.6201 0.0 0
M  V30 27 C 6.6685 2.3101 0.0 0
M  V30 28 C 5.3348 3.0801 0.0 0
M  V30 29 C 6.6685 0.7700 0.0 0
M  V30 30 C 4.0010 2.3101 0.0 0
M  V30 31 C 5.3348 0.0000 0.0 0
M  V30 32 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 27
M  V30 5 1 4 24
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 30
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-(2-aminoethoxy)-3,5-dichloro-N-[3-(1-methylethoxy)...
C18H20Cl2N2O3.CH2O2
1032434-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 6.9301 0.0 0
M  V30 2 N 8.0023 6.1601 0.0 0
M  V30 3 O 9.3360 8.4702 0.0 0
M  V30 4 Cl 14.6708 6.9301 0.0 0
M  V30 5 Cl 12.0035 2.3100 0.0 0
M  V30 6 O 14.6708 3.8501 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 C 17.3383 3.8501 0.0 0
M  V30 9 N 18.6720 4.6201 0.0 0
M  V30 10 O 2.6675 6.1601 0.0 0
M  V30 11 C 1.3337 6.9301 0.0 0
M  V30 12 C 1.3337 8.4702 0.0 0
M  V30 13 C 0.0000 6.1601 0.0 0
M  V30 14 C 10.6697 6.1601 0.0 0
M  V30 15 C 12.0035 6.9301 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 13.3372 6.1601 0.0 0
M  V30 18 C 12.0035 3.8501 0.0 0
M  V30 19 C 13.3372 4.6201 0.0 0
M  V30 20 C 6.6685 6.9301 0.0 0
M  V30 21 C 5.3348 6.1601 0.0 0
M  V30 22 C 6.6685 8.4702 0.0 0
M  V30 23 C 4.0012 6.9301 0.0 0
M  V30 24 C 5.3348 9.2402 0.0 0
M  V30 25 C 4.0012 8.4702 0.0 0
M  V30 26 C 9.3360 0.0000 0.0 0
M  V30 27 O 8.0023 0.7700 0.0 0
M  V30 28 O 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 20
M  V30 5 1 4 17
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1006584-02-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032434-40-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-12913157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The N-(butyloxycarbonyl) derivative was
dissolved in either a saturated solution of hydrogen chloride in diethyl
ether (5-10 ml per mmol of substrate) or in 4 M hydrogen chloride in 1,4-
dioxane (5-10 ml per mmol of substrate) and the resulting solution was
stirred at room temperature for 4-16 hours until the reaction was shown
to be complete as evidenced by HPLC/MS analysis. The solvent was then
removed in vacuo to yield amines 7-16 (80-100% yield). If necessary the
final products were further purified by HPLC/MS. Compounds were isolated
as mono- or di-hydrochloride salts, or if purified by HPLC/MS as a
formate salt as indicated below. N-[3-(isopropyloxy)phenyl]
4-[(2-amino)ethoxy]-3,5-dichlorobenzamide formate (9). From intermediate
A and 3-(isopropyloxy)aniline. Tan foam. 1H NMR (400 MHz, MeOHd 4): δ
1.35 (d, J = 7, 6H), 3.45 (t, J = 7, 2H), 4.35 (t, J = 7, 2H), 4.60 (m,
1H), 6.75 (dd, J = 7, 2.5, 1H), 7.25 (m, 2H), 7.40 (s, 1H), 8.05 (s, 2H),
8.42 (s, 1H). MS (+ES): m/e 383 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternately 1,4-dioxane may be used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable
Inhibitors of Urokinase-Type Plasminogen Activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frederickson, Martyn; Callaghan, Owen; Chessari, Gianni; Congreve, Miles;
Cowan, Suzanna R.; Matthews, Julia E.; McMenamin, Rachel; Smith,
Donna-Michelle; Vinkovic, Mladen; Wallis, Nicola G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(2), 183-186

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazolium, 2-carboxy-3-ethyl-1-methyl-, inner salt
C7H10N2O2
1017847-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7104 0.7700 0.0 0
M  V30 2 O 4.0442 0.0000 0.0 0 CHG=-1
M  V30 3 O 1.3768 0.0000 0.0 0
M  V30 4 C 5.4210 2.7392 0.0 0
M  V30 5 C 6.5654 3.7698 0.0 0
M  V30 6 C 0.0000 2.7392 0.0 0
M  V30 7 C 2.7104 2.3100 0.0 0
M  V30 8 N 3.9563 3.2152 0.0 0 CHG=1
M  V30 9 N 1.4645 3.2152 0.0 0
M  V30 10 C 3.4804 4.6798 0.0 0
M  V30 11 C 1.9404 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazolium, 3-ethyl-1-methyl-, formate (1:1)
C6H11N2.CHO2
865627-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.9318 0.0 0
M  V30 2 C 6.6363 4.1618 0.0 0
M  V30 3 C 0.0000 3.8046 0.0 0
M  V30 4 N 3.9690 4.1618 0.0 0 CHG=1
M  V30 5 C 2.5620 4.7882 0.0 0
M  V30 6 C 3.8079 2.6302 0.0 0
M  V30 7 N 1.5316 3.6437 0.0 0
M  V30 8 C 2.3016 2.3100 0.0 0
M  V30 9 C 3.3182 0.0000 0.0 0
M  V30 10 O 1.9845 0.7700 0.0 0 CHG=-1
M  V30 11 O 4.6518 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1017847-51-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 865627-65-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-109-CAS-22211618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses and applications of ionic liquids as solvents and reactants:
natural substances dissolution, esterification & ionic tagging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2013), (D0730-5), No pp.

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-pyridinamine
C6H8N2O
10201-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 N 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 N 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-2-pyridinyl)formamide
C7H8N2O2
2675448-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10201-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2675448-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24200176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed microwave vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Substituted 2-isocyanopyridines as versatile convertible isocyanides
for peptidomimetic design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollanders, Charlie; Elsocht, Mathias; Van der Poorten, Olivier; Jida,
Mouhamad; Renders, Evelien; Maes, Bert U. W.; Ballet, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(56),
6863-6866

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,4R)-2-(Phenylmethyl)-5-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diazabicyclo...
C18H18F3N3
1024011-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2296 2.4282 0.0 0
M  V30 2 C 13.3560 2.8498 0.0 0
M  V30 3 F 12.5860 1.5162 0.0 0
M  V30 4 F 14.6897 2.0798 0.0 0
M  V30 5 F 14.1260 4.1836 0.0 0
M  V30 6 N 8.0212 2.8498 0.0 0
M  V30 7 C 6.5739 2.5203 0.0 0 CFG=1
M  V30 8 C 7.1439 1.9036 0.0 0
M  V30 9 C 5.8276 0.0000 0.0 0
M  V30 10 C 5.5134 3.4344 0.0 0
M  V30 11 C 5.8966 1.4190 0.0 0 CFG=2
M  V30 12 N 4.7670 2.5175 0.0 0
M  V30 13 C 9.3549 3.6198 0.0 0
M  V30 14 C 10.6885 2.8498 0.0 0
M  V30 15 N 9.3549 5.1599 0.0 0
M  V30 16 C 12.0224 3.6198 0.0 0
M  V30 17 C 10.6885 5.9299 0.0 0
M  V30 18 C 12.0224 5.1599 0.0 0
M  V30 19 C 2.3835 3.7148 0.0 0
M  V30 20 C 3.0748 5.0910 0.0 0
M  V30 21 C 0.8461 3.6255 0.0 0
M  V30 22 C 2.2287 6.3779 0.0 0
M  V30 23 C 0.0000 4.9124 0.0 0
M  V30 24 C 0.6913 6.2885 0.0 0
M  V30 25 H 6.9455 4.0147 0.0 0
M  V30 26 H 4.4638 0.8543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 13
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 25 CFG=1
M  V30 13 1 8 11
M  V30 14 1 9 11
M  V30 15 1 10 12
M  V30 16 1 11 12
M  V30 17 1 11 26 CFG=3
M  V30 18 2 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (1R,4R)-2-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diaz...
C11H12F3N3.CH2O2
1024011-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8922 5.1600 0.0 0
M  V30 2 F 8.1221 3.8262 0.0 0
M  V30 3 F 10.2258 4.3900 0.0 0
M  V30 4 F 9.6622 6.4937 0.0 0
M  V30 5 N 3.5573 5.1600 0.0 0
M  V30 6 C 2.1100 4.8303 0.0 0 CFG=1
M  V30 7 C 2.6801 4.2137 0.0 0
M  V30 8 C 1.3639 2.3100 0.0 0
M  V30 9 C 1.0495 5.7444 0.0 0
M  V30 10 C 1.4327 3.7290 0.0 0 CFG=2
M  V30 11 N 0.3031 4.8275 0.0 0
M  V30 12 C 4.8910 5.9300 0.0 0
M  V30 13 C 6.2248 5.1600 0.0 0
M  V30 14 N 4.8910 7.4701 0.0 0
M  V30 15 C 7.5585 5.9300 0.0 0
M  V30 16 C 6.2248 8.2401 0.0 0
M  V30 17 C 7.5585 7.4701 0.0 0
M  V30 18 H 2.4818 6.3247 0.0 0
M  V30 19 H 0.0000 3.1644 0.0 0
M  V30 20 C 5.1129 0.0000 0.0 0
M  V30 21 O 3.7792 0.7700 0.0 0
M  V30 22 O 6.4466 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 18 CFG=1
M  V30 11 1 7 10
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 15 1 10 19 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024011-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024011-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-15303594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 5: ethyl
4-((1R.4R)-2.5-diazabicyclo[2.2.1]heptan-2-yl)benzoate formate (208) Step
8:
(1R,4R)-2-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptane
formate (242) Using Procedure H-2 (Table 3) with compound 241 the title
compound 242 was obtained (0.30 g, 100%) as clear oil. LRMS(ESI): (calc.)
243.10 (found) 244.2 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclo[2.2.1]heptan-2-yl compounds as HDAC inhibitors
and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Shapiro, Gideon; Chantigny, Yves; Mancuso, John;
Deziel, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137503 A1 2009-11-12

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,4R)-2-(Phenylmethyl)-5-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diazabicyclo...
C18H18F3N3
1024011-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2296 2.4282 0.0 0
M  V30 2 C 13.3560 2.8498 0.0 0
M  V30 3 F 12.5860 1.5162 0.0 0
M  V30 4 F 14.6897 2.0798 0.0 0
M  V30 5 F 14.1260 4.1836 0.0 0
M  V30 6 N 8.0212 2.8498 0.0 0
M  V30 7 C 6.5739 2.5203 0.0 0 CFG=1
M  V30 8 C 7.1439 1.9036 0.0 0
M  V30 9 C 5.8276 0.0000 0.0 0
M  V30 10 C 5.5134 3.4344 0.0 0
M  V30 11 C 5.8966 1.4190 0.0 0 CFG=2
M  V30 12 N 4.7670 2.5175 0.0 0
M  V30 13 C 9.3549 3.6198 0.0 0
M  V30 14 C 10.6885 2.8498 0.0 0
M  V30 15 N 9.3549 5.1599 0.0 0
M  V30 16 C 12.0224 3.6198 0.0 0
M  V30 17 C 10.6885 5.9299 0.0 0
M  V30 18 C 12.0224 5.1599 0.0 0
M  V30 19 C 2.3835 3.7148 0.0 0
M  V30 20 C 3.0748 5.0910 0.0 0
M  V30 21 C 0.8461 3.6255 0.0 0
M  V30 22 C 2.2287 6.3779 0.0 0
M  V30 23 C 0.0000 4.9124 0.0 0
M  V30 24 C 0.6913 6.2885 0.0 0
M  V30 25 H 6.9455 4.0147 0.0 0
M  V30 26 H 4.4638 0.8543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 13
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 25 CFG=1
M  V30 13 1 8 11
M  V30 14 1 9 11
M  V30 15 1 10 12
M  V30 16 1 11 12
M  V30 17 1 11 26 CFG=3
M  V30 18 2 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (1R,4R)-2-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diaz...
C11H12F3N3.CH2O2
1024011-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8922 5.1600 0.0 0
M  V30 2 F 8.1221 3.8262 0.0 0
M  V30 3 F 10.2258 4.3900 0.0 0
M  V30 4 F 9.6622 6.4937 0.0 0
M  V30 5 N 3.5573 5.1600 0.0 0
M  V30 6 C 2.1100 4.8303 0.0 0 CFG=1
M  V30 7 C 2.6801 4.2137 0.0 0
M  V30 8 C 1.3639 2.3100 0.0 0
M  V30 9 C 1.0495 5.7444 0.0 0
M  V30 10 C 1.4327 3.7290 0.0 0 CFG=2
M  V30 11 N 0.3031 4.8275 0.0 0
M  V30 12 C 4.8910 5.9300 0.0 0
M  V30 13 C 6.2248 5.1600 0.0 0
M  V30 14 N 4.8910 7.4701 0.0 0
M  V30 15 C 7.5585 5.9300 0.0 0
M  V30 16 C 6.2248 8.2401 0.0 0
M  V30 17 C 7.5585 7.4701 0.0 0
M  V30 18 H 2.4818 6.3247 0.0 0
M  V30 19 H 0.0000 3.1644 0.0 0
M  V30 20 C 5.1129 0.0000 0.0 0
M  V30 21 O 3.7792 0.7700 0.0 0
M  V30 22 O 6.4466 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 18 CFG=1
M  V30 11 1 7 10
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 15 1 10 19 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024011-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024011-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-12471237
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 5: ethyl
4-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzoate formate (208).
Title compound 207 (0.32 g, 0.878 mmol) and Pd/C (0.093 g, 0.088 mmol)
were combined in methanol (16.73 mL) and formic acid (0.836 mL). The
reaction mixture was stirred at reflux for 2h. The mixture was filtered
and concentrated to afford title compound 208 (0.278 g, 99%) as a clear
oil.
(1R,4R)-2-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptane
formate (242). Using Procedure H-2 (Table 3) with compound 241 the title
compound 242 was obtained (0.30 g, 100%) as clear oil. LRMS(ESI): (calc.)
243.10 (found) 244.2 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzo-fused 7-membered heterocyclic compounds and methods
for treating cognitive disorders using inhibitors of histone deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rogers, Kathryn; Patzke, Holger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137462 A2 2009-11-12

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,4R)-2-(Phenylmethyl)-5-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diazabicyclo...
C18H18F3N3
1024011-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2296 2.4282 0.0 0
M  V30 2 C 13.3560 2.8498 0.0 0
M  V30 3 F 12.5860 1.5162 0.0 0
M  V30 4 F 14.6897 2.0798 0.0 0
M  V30 5 F 14.1260 4.1836 0.0 0
M  V30 6 N 8.0212 2.8498 0.0 0
M  V30 7 C 6.5739 2.5203 0.0 0 CFG=1
M  V30 8 C 7.1439 1.9036 0.0 0
M  V30 9 C 5.8276 0.0000 0.0 0
M  V30 10 C 5.5134 3.4344 0.0 0
M  V30 11 C 5.8966 1.4190 0.0 0 CFG=2
M  V30 12 N 4.7670 2.5175 0.0 0
M  V30 13 C 9.3549 3.6198 0.0 0
M  V30 14 C 10.6885 2.8498 0.0 0
M  V30 15 N 9.3549 5.1599 0.0 0
M  V30 16 C 12.0224 3.6198 0.0 0
M  V30 17 C 10.6885 5.9299 0.0 0
M  V30 18 C 12.0224 5.1599 0.0 0
M  V30 19 C 2.3835 3.7148 0.0 0
M  V30 20 C 3.0748 5.0910 0.0 0
M  V30 21 C 0.8461 3.6255 0.0 0
M  V30 22 C 2.2287 6.3779 0.0 0
M  V30 23 C 0.0000 4.9124 0.0 0
M  V30 24 C 0.6913 6.2885 0.0 0
M  V30 25 H 6.9455 4.0147 0.0 0
M  V30 26 H 4.4638 0.8543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 13
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 25 CFG=1
M  V30 13 1 8 11
M  V30 14 1 9 11
M  V30 15 1 10 12
M  V30 16 1 11 12
M  V30 17 1 11 26 CFG=3
M  V30 18 2 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (1R,4R)-2-[4-(trifluoromethyl)-2-pyridinyl]-2,5-diaz...
C11H12F3N3.CH2O2
1024011-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8922 5.1600 0.0 0
M  V30 2 F 8.1221 3.8262 0.0 0
M  V30 3 F 10.2258 4.3900 0.0 0
M  V30 4 F 9.6622 6.4937 0.0 0
M  V30 5 N 3.5573 5.1600 0.0 0
M  V30 6 C 2.1100 4.8303 0.0 0 CFG=1
M  V30 7 C 2.6801 4.2137 0.0 0
M  V30 8 C 1.3639 2.3100 0.0 0
M  V30 9 C 1.0495 5.7444 0.0 0
M  V30 10 C 1.4327 3.7290 0.0 0 CFG=2
M  V30 11 N 0.3031 4.8275 0.0 0
M  V30 12 C 4.8910 5.9300 0.0 0
M  V30 13 C 6.2248 5.1600 0.0 0
M  V30 14 N 4.8910 7.4701 0.0 0
M  V30 15 C 7.5585 5.9300 0.0 0
M  V30 16 C 6.2248 8.2401 0.0 0
M  V30 17 C 7.5585 7.4701 0.0 0
M  V30 18 H 2.4818 6.3247 0.0 0
M  V30 19 H 0.0000 3.1644 0.0 0
M  V30 20 C 5.1129 0.0000 0.0 0
M  V30 21 O 3.7792 0.7700 0.0 0
M  V30 22 O 6.4466 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 18 CFG=1
M  V30 11 1 7 10
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 15 1 10 19 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024011-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024011-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-8146622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 5: ethyl
4-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzoate formate (208)
Title compound 207 (0.32 g, 0.878 mmol) and Pd/C (0.093 g, 0.088 mmol)
were combined in methanol (16.73 mL) and formic acid (0.836 mL). The
reaction mixture was stirred at reflux for 2h. The mixture was filtered
and concentrated to afford title compound 208 (0.278 g, 99%) as a clear
oil. Step 8:
(1R,4R)-2-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptane
formate (242) Using Procedure H-2 (Table 3) with compound 241 the title
compound 242 was obtained (0.30 g, 100%) as clear oil. LRMS(ESI): (calc.)
243.10 (found) 244.2 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic hydroxamic acids as inhibitors of histone
deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shapiro, Gideon; Moncuso, John; Pierre, Tessier; Leit, Silvana; Deziel,
Robert; David, Smil; Richard, Chesworth; Chantigny, Yves Andre; Patrick,
Beaulieu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008055068 A2 2008-05-08

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3α,5α,7α,25R)-Spirostan-3,7-diamine
C27H46N2O2
1036286-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4737 5.8136 0.0 0
M  V30 2 C 9.7922 5.4388 0.0 0
M  V30 3 C 17.7788 3.6457 0.0 0
M  V30 4 N 6.9302 0.0000 0.0 0
M  V30 5 C 4.7544 5.5352 0.0 0
M  V30 6 N 0.0000 4.0012 0.0 0
M  V30 7 C 13.1839 3.1628 0.0 0 CFG=1
M  V30 8 C 12.1535 4.3073 0.0 0 CFG=1
M  V30 9 O 12.4139 1.8291 0.0 0
M  V30 10 C 13.8104 4.5697 0.0 0
M  V30 11 O 14.0892 1.9169 0.0 0
M  V30 12 C 10.7467 3.6808 0.0 0 CFG=2
M  V30 13 C 10.9076 2.1493 0.0 0 CFG=1
M  V30 14 C 15.3420 4.7307 0.0 0
M  V30 15 C 15.6207 2.0778 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0 CFG=2
M  V30 17 C 9.5006 1.5229 0.0 0
M  V30 18 C 16.2472 3.4848 0.0 0 CFG=1
M  V30 19 C 8.4702 2.6673 0.0 0 CFG=2
M  V30 20 C 8.4702 5.3348 0.0 0
M  V30 21 C 6.9302 2.6673 0.0 0 CFG=2
M  V30 22 C 6.9302 5.3348 0.0 0
M  V30 23 C 6.1601 4.0012 0.0 0 CFG=1
M  V30 24 C 6.1601 1.3337 0.0 0 CFG=2
M  V30 25 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.8501 2.6673 0.0 0 CFG=2
M  V30 28 C 3.8501 5.3348 0.0 0
M  V30 29 C 2.3101 2.6673 0.0 0
M  V30 30 C 2.3101 5.3348 0.0 0
M  V30 31 C 1.5400 4.0012 0.0 0 CFG=2
M  V30 32 H 10.9875 5.2019 0.0 0
M  V30 33 H 11.0685 0.6177 0.0 0
M  V30 34 H 8.4971 1.1276 0.0 0
M  V30 35 H 7.3287 1.1798 0.0 0
M  V30 36 H 6.0258 5.5352 0.0 0
M  V30 37 H 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 16 2 CFG=1
M  V30 3 1 18 3 CFG=1
M  V30 4 1 24 4 CFG=3
M  V30 5 1 25 5 CFG=1
M  V30 6 1 31 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9 CFG=1
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 12 16
M  V30 17 1 12 32 CFG=3
M  V30 18 1 13 17
M  V30 19 1 13 33 CFG=3
M  V30 20 1 14 18
M  V30 21 1 15 18
M  V30 22 1 16 19
M  V30 23 1 16 20
M  V30 24 1 17 19
M  V30 25 1 19 21
M  V30 26 1 19 34 CFG=3
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 1 21 24
M  V30 30 1 21 35 CFG=1
M  V30 31 1 22 23
M  V30 32 1 23 25
M  V30 33 1 23 36 CFG=3
M  V30 34 1 24 26
M  V30 35 1 25 27
M  V30 36 1 25 28
M  V30 37 1 26 27
M  V30 38 1 27 29
M  V30 39 1 27 37 CFG=3
M  V30 40 1 28 30
M  V30 41 1 29 31
M  V30 42 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(13 7 8 12 13 16 18 19 21 23 24 25 27 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N,N′-(3α,5α,7α,25R)-Spirostan-3,7-diylbis[formamide]
C29H46N2O4
1443438-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2447 8.1801 0.0 0
M  V30 2 C 5.3051 8.4809 0.0 0
M  V30 3 N 10.8485 2.6673 0.0 0
M  V30 4 C 11.6186 1.3337 0.0 0
M  V30 5 O 10.8485 0.0000 0.0 0
M  V30 6 C 13.0243 8.2026 0.0 0
M  V30 7 C 0.0000 6.3130 0.0 0
M  V30 8 N 17.7787 6.6685 0.0 0
M  V30 9 C 18.5487 8.0021 0.0 0
M  V30 10 O 20.0887 8.0021 0.0 0
M  V30 11 C 7.0321 6.3483 0.0 0 CFG=1
M  V30 12 C 8.5385 6.6685 0.0 0 CFG=2
M  V30 13 C 6.8711 4.8166 0.0 0 CFG=2
M  V30 14 C 5.6252 6.9746 0.0 0 CFG=2
M  V30 15 C 9.3085 5.3348 0.0 0 CFG=2
M  V30 16 C 9.3085 8.0021 0.0 0
M  V30 17 O 5.3648 4.4964 0.0 0
M  V30 18 C 8.2781 4.1903 0.0 0
M  V30 19 C 4.5948 5.8302 0.0 0 CFG=1
M  V30 20 C 10.8485 5.3348 0.0 0 CFG=2
M  V30 21 C 10.8485 8.0021 0.0 0
M  V30 22 C 3.9683 7.2370 0.0 0
M  V30 23 O 3.6896 4.5842 0.0 0
M  V30 24 C 11.6186 6.6685 0.0 0 CFG=1
M  V30 25 C 11.6186 4.0010 0.0 0 CFG=2
M  V30 26 C 2.4368 7.3980 0.0 0
M  V30 27 C 2.1580 4.7453 0.0 0
M  V30 28 C 13.1586 6.6685 0.0 0 CFG=2
M  V30 29 C 13.1586 4.0010 0.0 0
M  V30 30 C 1.5316 6.1521 0.0 0 CFG=1
M  V30 31 C 13.9286 5.3348 0.0 0 CFG=2
M  V30 32 C 13.9286 8.0021 0.0 0
M  V30 33 C 15.4686 5.3348 0.0 0
M  V30 34 C 15.4686 8.0021 0.0 0
M  V30 35 C 16.2386 6.6685 0.0 0 CFG=2
M  V30 36 H 6.5308 7.8044 0.0 0
M  V30 37 H 6.7102 3.2850 0.0 0
M  V30 38 H 9.5494 3.8137 0.0 0
M  V30 39 H 10.4500 3.8471 0.0 0
M  V30 40 H 12.0171 8.1560 0.0 0
M  V30 41 H 14.6986 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 14 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 25 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 28 6 CFG=3
M  V30 7 1 30 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 35 8 CFG=1
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 36 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 37 CFG=1
M  V30 20 1 14 19
M  V30 21 1 15 18
M  V30 22 1 15 20
M  V30 23 1 15 38 CFG=1
M  V30 24 1 16 21
M  V30 25 1 19 17 CFG=3
M  V30 26 1 19 22
M  V30 27 1 19 23
M  V30 28 1 20 24
M  V30 29 1 20 25
M  V30 30 1 20 39 CFG=3
M  V30 31 1 21 24
M  V30 32 1 22 26
M  V30 33 1 23 27
M  V30 34 1 24 28
M  V30 35 1 24 40 CFG=1
M  V30 36 1 25 29
M  V30 37 1 26 30
M  V30 38 1 27 30
M  V30 39 1 28 31
M  V30 40 1 28 32
M  V30 41 1 29 31
M  V30 42 1 31 33
M  V30 43 1 31 41 CFG=1
M  V30 44 1 32 34
M  V30 45 1 33 35
M  V30 46 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(13 11 12 13 14 15 19 20 24 25 28 30 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1036286-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443438-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11184882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solution of stage 1 added dropwise to solution of stage 2 in stage 3, see
experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Multiple Multicomponent Approach to Chimeric Peptide-Peptoid Podands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rivera, Daniel G.; Leon, Fredy; Concepcion, Odette; Morales, Fidel E.;
Wessjohann, Ludger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(20), 6417-6428

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azido-3-methylbutanoic acid
C5H9N3O2
105090-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 4.0010 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 4.7710 2.8737 0.0 0
M  V30 5 C 3.2310 0.2064 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 N 6.3111 2.8737 0.0 0 CHG=1 VAL=4
M  V30 10 N 7.8511 2.8737 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanoic acid, 3-amino-3-methyl-, formate (1:1)
C5H11NO2.CH2O2
1037832-96-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.8500 0.0 0
M  V30 2 C 1.5400 3.8500 0.0 0
M  V30 3 C 3.8500 5.1837 0.0 0
M  V30 4 C 1.5400 2.3100 0.0 0
M  V30 5 C 0.0000 3.8500 0.0 0
M  V30 6 N 1.5400 5.3900 0.0 0
M  V30 7 O 3.0800 6.5173 0.0 0
M  V30 8 O 5.3900 5.1837 0.0 0
M  V30 9 C 2.6950 0.0000 0.0 0
M  V30 10 O 1.3613 0.7700 0.0 0
M  V30 11 O 4.0287 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 9 10
M  V30 9 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105090-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037832-96-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-527-CAS-4729821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) 1-Carboxy-2-methylpropan-2-ammonium formate. To an ice cold solution
of crude 3-azido-3-methylbutanoic acid (14.00 g, 97.2 mmol) in formic
acid (100 mL) was added 10% Pd/C (0.500 g) under a nitrogen atmosphere.
The flask was sealed with a septum and the suspension was degassed with
applied vacuum and a hydrogen flush (3 times). An oil bubbler was
attached to the flask and the reaction was removed from the ice bath.
After approximately 15 min, the flask became warm and hydrogen was
liberated. After hydrogen ceased to be liberated from the reaction, the
flask was fitted with a balloon filed with hydrogen and left to stir for
17 h. The suspension was filtered through a pad of Celite and the solid
was washed with water (2× 50 mL). The filtrate was concentrated to a
light green oil. The residue was dissolved into water (200 mL) and
extracted with ethyl acetate (2× 200 mL). The aqueous layer was
concentrated to a pale yellow oil (16.0 g, quantitative). This oil was
used without further purification.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-halogenated amino compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Najafi, Ramin; Jain, Rakesh K.; Shiau, Timothy P.; Low, Eddy; Nair,
Satheesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008083347 A1 2008-07-10

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12499745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM water separator used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of Spirocyclic Oxindole-Butenolides by Using Three-Component
Cycloadditions of Isocyanides, Allenoates, and Isatins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Jian; Liu, Yuejin; Li, Chunju; Jia, Xueshun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2011), 17(27), 7409-7413,
S7409/1-S7409/46

$RFMT $RIREG SCHEME13 STEP1
$RXN



  3  1
$MOL
1-(1-Methylethyl)-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pi...
C19H31BN2O2
1073354-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2114 4.5526 0.0 0
M  V30 2 C 0.0000 2.8854 0.0 0
M  V30 3 C 0.0000 1.6672 0.0 0
M  V30 4 C 1.2114 0.0000 0.0 0
M  V30 5 C 14.6818 2.2763 0.0 0
M  V30 6 C 15.4518 3.6100 0.0 0
M  V30 7 C 15.4518 0.9427 0.0 0
M  V30 8 C 5.4416 2.2763 0.0 0
M  V30 9 C 6.2116 0.9427 0.0 0
M  V30 10 C 6.2116 3.6100 0.0 0
M  V30 11 C 7.7516 0.9427 0.0 0
M  V30 12 C 7.7516 3.6100 0.0 0
M  V30 13 C 8.5216 2.2763 0.0 0
M  V30 14 B 3.9015 2.2763 0.0 0
M  V30 15 O 2.9963 3.5222 0.0 0
M  V30 16 O 2.9963 1.0304 0.0 0
M  V30 17 C 1.5316 3.0463 0.0 0
M  V30 18 C 1.5316 1.5063 0.0 0
M  V30 19 N 10.0617 2.2763 0.0 0
M  V30 20 C 10.8317 0.9427 0.0 0
M  V30 21 C 10.8317 3.6100 0.0 0
M  V30 22 C 12.3717 0.9427 0.0 0
M  V30 23 C 12.3717 3.6100 0.0 0
M  V30 24 N 13.1417 2.2763 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 17
M  V30 3 1 3 18
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 24
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 13 19
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[(3R)-1-[5-chloro-2-[[(trifluoromethyl)sulfonyl]oxy]phenyl]-3-piperid...
C19H18ClF6N3O5S
2787591-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.4394 9.3790 0.0 0
M  V30 2 F 8.9747 8.9031 0.0 0
M  V30 3 F 9.9635 10.8435 0.0 0
M  V30 4 F 11.9040 9.8548 0.0 0
M  V30 5 C 13.6258 8.3436 0.0 0
M  V30 6 O 15.0326 7.7171 0.0 0
M  V30 7 O 13.4648 9.8751 0.0 0
M  V30 8 C 16.2785 8.6223 0.0 0
M  V30 9 C 17.6854 7.9960 0.0 0
M  V30 10 O 3.0800 5.3347 0.0 0
M  V30 11 S 1.5400 5.3347 0.0 0 VAL=6
M  V30 12 C 1.5400 6.8747 0.0 0
M  V30 13 O 0.0000 5.3347 0.0 0
M  V30 14 O 1.5400 3.7947 0.0 0
M  V30 15 F 2.8737 7.6448 0.0 0
M  V30 16 F 1.5400 8.4148 0.0 0
M  V30 17 F 0.2064 7.6448 0.0 0
M  V30 18 Cl 6.1600 0.0000 0.0 0
M  V30 19 N 10.0101 6.6684 0.0 0
M  V30 20 C 10.9153 7.9143 0.0 0
M  V30 21 N 10.9153 5.4225 0.0 0
M  V30 22 C 12.3800 7.4384 0.0 0
M  V30 23 C 12.3800 5.8984 0.0 0
M  V30 24 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 25 C 7.7000 5.3347 0.0 0
M  V30 26 C 7.7000 8.0020 0.0 0
M  V30 27 N 6.1600 5.3347 0.0 0
M  V30 28 C 6.1600 8.0020 0.0 0
M  V30 29 C 5.3900 6.6684 0.0 0
M  V30 30 C 5.3900 4.0009 0.0 0
M  V30 31 C 3.8500 4.0009 0.0 0
M  V30 32 C 6.1600 2.6673 0.0 0
M  V30 33 C 3.0800 2.6673 0.0 0
M  V30 34 C 5.3900 1.3336 0.0 0
M  V30 35 C 3.8500 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 31
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 18 34
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 24 19 CFG=1
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 27 30
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C31H37ClF3N5O2.xCH2O2
2787591-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.5194 11.6890 0.0 0
M  V30 2 F 14.9840 12.1648 0.0 0
M  V30 3 F 13.0436 13.1535 0.0 0
M  V30 4 F 12.0547 11.2130 0.0 0
M  V30 5 C 16.7059 10.6536 0.0 0
M  V30 6 O 18.1127 10.0272 0.0 0
M  V30 7 O 16.5448 12.1852 0.0 0
M  V30 8 C 19.3585 10.9324 0.0 0
M  V30 9 C 20.7655 10.3060 0.0 0
M  V30 10 Cl 9.2400 2.3100 0.0 0
M  V30 11 C 1.5400 15.6468 0.0 0
M  V30 12 C 2.3100 16.9804 0.0 0
M  V30 13 C 0.0000 15.6468 0.0 0
M  V30 14 N 13.0901 8.9784 0.0 0
M  V30 15 C 13.9953 10.2243 0.0 0
M  V30 16 N 13.9953 7.7325 0.0 0
M  V30 17 C 15.4600 9.7484 0.0 0
M  V30 18 C 15.4600 8.2084 0.0 0
M  V30 19 C 11.5501 8.9784 0.0 0
M  V30 20 C 10.7801 7.6448 0.0 0
M  V30 21 C 10.7801 10.3121 0.0 0
M  V30 22 N 9.2400 7.6448 0.0 0
M  V30 23 C 9.2400 10.3121 0.0 0
M  V30 24 C 8.4700 8.9784 0.0 0
M  V30 25 C 8.4700 6.3110 0.0 0
M  V30 26 C 6.9300 6.3110 0.0 0
M  V30 27 C 9.2400 4.9773 0.0 0
M  V30 28 C 6.1600 4.9773 0.0 0
M  V30 29 C 8.4700 3.6437 0.0 0
M  V30 30 C 6.9300 3.6437 0.0 0
M  V30 31 C 6.1600 7.6448 0.0 0
M  V30 32 C 6.9300 8.9784 0.0 0
M  V30 33 C 4.6200 7.6448 0.0 0
M  V30 34 C 6.1600 10.3121 0.0 0
M  V30 35 C 3.8500 8.9784 0.0 0
M  V30 36 C 4.6200 10.3121 0.0 0
M  V30 37 N 3.8500 11.6457 0.0 0
M  V30 38 C 4.6200 12.9795 0.0 0
M  V30 39 C 2.3100 11.6457 0.0 0
M  V30 40 C 3.8500 14.3131 0.0 0
M  V30 41 C 1.5400 12.9795 0.0 0
M  V30 42 N 2.3100 14.3131 0.0 0
M  V30 43 C 10.3827 0.0000 0.0 0
M  V30 44 O 9.0491 0.7700 0.0 0
M  V30 45 O 11.7164 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 29
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 42
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 26 31
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 36 37
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 47 1 43 44
M  V30 48 2 43 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1073354-18-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787591-58-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787591-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33336173
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Suzuki coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolo piperidine carboxylic acids for
treating cardiovascular and cardiac diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakalopoulos, Alexandros; Collin-Kroepelin, Marie-Pierre; Ortega
Hernandez, Nuria; Dieskau, Andre; Boultadakis-Arapinis, Melissa; Candish,
Lisa; Stellfeld, Timo; Mathar, Ilka; Hofmeister, Lucas Hudson; Sandner,
Peter; Wunder, Frank; Dietz, Lisa; Webster, Robert Alan; Schmeck, Carsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022122916 A1 2022-06-16

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-chloro-3-hydrazinylpyridazine-4-carboxylate
C7H9ClN4O2
1073488-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 O 6.1600 5.3347 0.0 0
M  V30 3 O 3.8500 6.6685 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0
M  V30 5 C 8.4700 6.6685 0.0 0
M  V30 6 N 1.5400 5.3347 0.0 0
M  V30 7 N 0.0000 5.3347 0.0 0
M  V30 8 Cl 4.6200 0.0000 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 N 1.5400 2.6674 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 N 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 10 CFG=2
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-chloro-1,2,4-triazolo[4,3-b]pyridazine-8-carboxylate
C8H7ClN4O2
1263425-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 4.6201 0.0 0
M  V30 2 O 6.4792 3.8501 0.0 0
M  V30 3 O 5.1456 6.1601 0.0 0
M  V30 4 C 7.8129 4.6201 0.0 0
M  V30 5 C 9.1466 3.8501 0.0 0
M  V30 6 Cl 2.4781 0.0000 0.0 0
M  V30 7 C 2.4781 4.6201 0.0 0
M  V30 8 C 3.8117 3.8501 0.0 0
M  V30 9 N 1.1444 3.8501 0.0 0
M  V30 10 N 2.1579 6.1264 0.0 0
M  V30 11 C 3.8117 2.3101 0.0 0
M  V30 12 N 1.1444 2.3101 0.0 0
M  V30 13 C 0.0000 4.8805 0.0 0
M  V30 14 N 0.6263 6.2873 0.0 0
M  V30 15 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1073488-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1263425-78-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-9326241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3: Ethyl 6-chloro-[1,2,4]triazolo[4,3-b]pyridazine-8-carboxylate. To
a toluene (20 mL) solution of ethyl
6-chloro-3-hydrazinylpyridazine-4-carboxylate (1.99 g, 9.19 mmol), formic
acid (1.76 mL, 45.9 mmol) was added and stirred at 70°C. for 2 hours. The
reaction solution was concentrated under reduced pressure to obtain the
titled compound. Yield 2.10 g, 9.25 mmol, 100%, skin-color solid
substance. 1H-NMR (400 MHz, CDCl3) δ 1.38 (t, J=7.1 Hz, 3H), 4.47 (q,
J=7.1 Hz, 2H), 7.89 (s, 1H), 9.79 (s, 1H). MS (ESI) m/z = 227 (M+H)+.
LC/MS tR = 1.06 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminoimidazolpyrazinylbenzamide derivatives and analogs
for use as TTK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kusakabe, Ken-Ichi; Yoshida, Hiroshi; Nozu, Kohei; Hashizume, Hiroshi;
Tadano, Genta; Sato, Jun; Tamura, Yuusuke; Mitsuoka, Yasunori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120059162 A1 2012-03-08

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine
C3H7NO2
107-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 N 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-β-alanine
C4H7NO3
14565-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14565-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14722632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metabolic Glycan Imaging by Isonitrile-Tetrazine Click Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stairs, Shaun; Neves, Andre A.; Stoeckmann, Henning; Wainman, Yelena A.;
Ireland-Zecchini, Heather; Brindle, Kevin M.; Leeper, Finian J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemBioChem (2013), 14(9), 1063-1067

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine
C3H7NO2
107-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 N 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-β-alanine
C4H7NO3
14565-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14565-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11953454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thioester-isocyanides: versatile reagents for the synthesis of cycle-tail
peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rotstein, Benjamin H.; Winternheimer, David J.; Yin, Lois M.; Deber,
Charles M.; Yudin, Andrei K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(31),
3775-3777

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Dimethylamino)ethanol
C4H11NO
108-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 O 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(dimethylamino)ethanol (1:1)
C4H11NO.CH2O2
59101-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 N 1.3338 3.8500 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 O 5.3349 4.6200 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 O 1.3338 0.7700 0.0 0
M  V30 9 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 7 8
M  V30 7 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59101-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29907959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM ionic liquid (product)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Distillable Protic Ionic Liquids for Keratin Dissolution and Recovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Idris, Azila; Vijayaraghavan, R.; Patti, A. F.; MacFarlane, D. R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2014), 2(7), 1888-1894

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fumagillol
C16H26O4
108102-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1840 2.0425 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 7.1478 3.3233 0.0 0
M  V30 5 C 8.3274 4.3132 0.0 0
M  V30 6 C 9.7745 3.7864 0.0 0
M  V30 7 C 10.9543 4.7763 0.0 0
M  V30 8 C 10.0420 2.2698 0.0 0
M  V30 9 O 1.3338 0.0000 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 11 C 1.3338 4.6200 0.0 0 CFG=1
M  V30 12 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 13 C 0.5638 5.9536 0.0 0
M  V30 14 O 2.1038 5.9536 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 4.1840 3.5825 0.0 0 CFG=2
M  V30 19 C 5.7006 3.8500 0.0 0 CFG=1
M  V30 20 O 4.7107 5.0296 0.0 0
M  V30 21 H 3.1941 5.2971 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 12 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 16 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 18
M  V30 13 1 10 21 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14 CFG=1
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20 CFG=3
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 11 12 16 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Oxaspiro[2.5]octan-6-ol, 5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-...
C17H26O5
1399361-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 5.1973 0.0 0
M  V30 2 O 5.3900 5.5411 0.0 0
M  V30 3 C 4.6200 6.8747 0.0 0
M  V30 4 C 9.0068 5.5700 0.0 0
M  V30 5 C 10.5234 5.3025 0.0 0
M  V30 6 C 11.5133 6.4823 0.0 0
M  V30 7 C 13.0299 6.2148 0.0 0
M  V30 8 C 10.9865 7.9295 0.0 0
M  V30 9 O 2.3100 5.5411 0.0 0
M  V30 10 C 0.7700 5.5411 0.0 0
M  V30 11 O 0.0000 6.8747 0.0 0
M  V30 12 C 4.6200 1.5400 0.0 0 CFG=1
M  V30 13 C 5.3900 2.8736 0.0 0 CFG=1
M  V30 14 C 5.9538 0.7700 0.0 0
M  V30 15 O 4.6200 0.0000 0.0 0
M  V30 16 C 3.0800 1.5400 0.0 0
M  V30 17 C 4.6200 4.2074 0.0 0 CFG=2
M  V30 18 C 2.3100 2.8736 0.0 0
M  V30 19 C 3.0800 4.2074 0.0 0 CFG=2
M  V30 20 C 6.5698 3.8636 0.0 0 CFG=2
M  V30 21 C 8.0169 4.3902 0.0 0 CFG=1
M  V30 22 O 7.7494 2.8736 0.0 0
M  V30 23 H 6.5698 1.8839 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 1 4 5
M  V30 5 1 21 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 19 9 CFG=1
M  V30 11 2 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15 CFG=3
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 13 20
M  V30 18 1 13 23 CFG=1
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22 CFG=1
M  V30 25 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 12 13 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108102-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1399361-16-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-11475195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1972-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 14 [0141] 1g (3.5 mmol) of fumagillol, 2.8g (10.7 mmol) of
triphenylphosphine and 0.4 mL of formic acid are dissolved in 15 mL of
dry THF and cooled to 0 °C. Then DEAD (1.7 mL, 13.7 mmol) is added drop
wise. The reaction is allowed to warm to room temperature overnight and
diluted with 50 mL of EtOAc. The mixture is then washed with 3x 30 mL of
water, 30 mL of brine; dried over Na2SO4 and condensed in vacuo.
Purification by biotage flash chromatography (SiO2, EtOAc/Hexanes
gradient) affords Intermediate E. 1.1 g (100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of oxaspiro[2.5]octane derivatives and
analogs for use as antiobesity agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vath, James E.; Chaffee, Stuart
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012122264 A1 2012-09-13

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6aS,8R,9S,10S,10aS)-8-Chloro-9-ethenyl-5,6,6a,7,8,9,10,10a-octahydro-6,6,9-t...
C20H25ClN2
1093389-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 6.4791 0.0 0
M  V30 2 C 5.6504 0.0000 0.0 0
M  V30 3 C 3.6346 0.4284 0.0 0
M  V30 4 C 0.8629 5.6721 0.0 0
M  V30 5 C 0.5955 7.1887 0.0 0
M  V30 6 C 2.5775 6.6620 0.0 0
M  V30 7 Cl 0.0000 3.8118 0.0 0
M  V30 8 C 6.1264 3.4916 0.0 0
M  V30 9 C 4.6200 3.8118 0.0 0 CFG=1
M  V30 10 C 6.2874 1.9600 0.0 0
M  V30 11 C 7.5332 4.1180 0.0 0
M  V30 12 C 3.8500 2.4780 0.0 0 CFG=2
M  V30 13 C 3.8500 5.1454 0.0 0 CFG=2
M  V30 14 C 4.8804 1.3336 0.0 0
M  V30 15 N 7.7936 1.6398 0.0 0
M  V30 16 C 8.5636 2.9736 0.0 0
M  V30 17 C 8.0091 5.5827 0.0 0
M  V30 18 C 2.3100 2.4780 0.0 0
M  V30 19 C 2.3100 5.1454 0.0 0 CFG=2
M  V30 20 C 10.0701 3.2938 0.0 0
M  V30 21 C 9.5155 5.9028 0.0 0
M  V30 22 C 1.5400 3.8118 0.0 0 CFG=1
M  V30 23 C 10.5459 4.7583 0.0 0
M  V30 24 H 5.5252 5.0577 0.0 0
M  V30 25 H 3.2237 1.0712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 14
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 19 4 CFG=1
M  V30 6 1 19 6 CFG=3
M  V30 7 1 22 7 CFG=1
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 24 CFG=1
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 14
M  V30 19 1 12 18
M  V30 20 1 12 25 CFG=3
M  V30 21 1 13 19
M  V30 22 1 15 16
M  V30 23 2 16 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 12 13 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(6aS,8R,9S,10S,10aS)-8-Chloro-9-ethenyl-5,6,6a,7,8,9,10,10a-octahydro-6,6,...
C21H25ClN2O
1093615-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6673 0.0 0
M  V30 2 C 3.8500 1.3337 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 5.6505 9.1465 0.0 0
M  V30 5 C 3.6346 8.7180 0.0 0
M  V30 6 C 0.8629 3.4743 0.0 0
M  V30 7 C 0.5955 1.9577 0.0 0
M  V30 8 C 2.5775 2.4844 0.0 0
M  V30 9 Cl 0.0000 5.3348 0.0 0
M  V30 10 C 6.1265 5.6549 0.0 0
M  V30 11 C 4.6200 5.3348 0.0 0 CFG=1
M  V30 12 C 6.2874 7.1865 0.0 0
M  V30 13 C 7.5333 5.0285 0.0 0
M  V30 14 C 3.8500 6.6684 0.0 0 CFG=2
M  V30 15 C 3.8500 4.0010 0.0 0 CFG=2
M  V30 16 C 4.8805 7.8128 0.0 0
M  V30 17 N 7.7937 7.5067 0.0 0
M  V30 18 C 8.5637 6.1730 0.0 0
M  V30 19 C 8.0092 3.5639 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 2.3100 4.0010 0.0 0 CFG=2
M  V30 22 C 10.0702 5.8528 0.0 0
M  V30 23 C 9.5156 3.2437 0.0 0
M  V30 24 C 1.5400 5.3348 0.0 0 CFG=1
M  V30 25 C 10.5460 4.3881 0.0 0
M  V30 26 H 5.5253 4.0887 0.0 0
M  V30 27 H 3.2237 8.0752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 16
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 21 8 CFG=1
M  V30 9 1 24 9 CFG=3
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 11 26 CFG=3
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 2 13 19
M  V30 20 1 14 16
M  V30 21 1 14 20
M  V30 22 1 14 27 CFG=1
M  V30 23 1 15 21
M  V30 24 1 17 18
M  V30 25 2 18 22
M  V30 26 1 19 23
M  V30 27 1 20 24
M  V30 28 1 21 24
M  V30 29 1 22 25
M  V30 30 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 14 15 21 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1093389-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1093615-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4301055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 3140-73-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 71: To compound 70 (1.83 g, 5.59 mmol, 1.0 equiv.) was added
sequentially formic acid (422 μL, 11.2 mmol, 2.0 equiv.),
2-chloro-4,6-dimethoxy-1,3,5-triazine (2.16 g, 12.3 mmol, 2.2 equiv.),
DMAP (68.3 mg, 0.56 mmol, 0.1 equiv.), N-methylmorpholine (1.35 mL, 12.3
mmol, 2.2 equiv.), and DCM (14.7 mL, 0.38 M). The resulting suspension
was stirred rapidly at room temperature for 30 minutes. The reaction was
then diluted with DCM (100 mL) and washed sequentially with 1N HCl (2 x
75 mL), sat. NaHCO3 (75 mL), and brine (75 mL), dried (MgSO4), and the
solvent was removed in vacuo. It was found that the intermediate
formamide (71), once fully dried, crystallized into a polymorph that was
completely insoluble in most organic solvents. It was therefore necessary
to leave ca 5.0 mL of DCM in the flask after removing from the rotary
evaporator and use the material crude in the next step. As such, it was
also impossible to obtain full characterization of this compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and
Welwitindolinones via a Redox Economic Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richter, Jeremy M.; Ishihara, Yoshihiro; Masuda, Takeshi; Whitefield,
Brandon W.; Llamas, Tomas; Pohjakallio, Antti; Baran, Phil S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(52), 17938-17954

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexanoic acid, 6-[[2-[[(2R)-2-amino-3-mercapto-1-oxopropyl]amino]ethyl]methyl...
C12H25N3O3S.2C2HF3O2
1100364-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.7238 0.0 0
M  V30 2 C 6.6685 7.4938 0.0 0
M  V30 3 C 4.0012 7.4938 0.0 0
M  V30 4 C 8.0023 6.7238 0.0 0
M  V30 5 C 2.6675 6.7238 0.0 0 CFG=1
M  V30 6 O 4.0012 9.0338 0.0 0
M  V30 7 N 9.3360 7.4938 0.0 0
M  V30 8 C 1.3337 7.4938 0.0 0
M  V30 9 N 2.6675 5.1837 0.0 0
M  V30 10 C 10.6697 6.7238 0.0 0
M  V30 11 C 9.3360 9.0338 0.0 0
M  V30 12 S 0.0000 6.7238 0.0 0
M  V30 13 C 12.0035 7.4938 0.0 0
M  V30 14 C 13.3372 6.7238 0.0 0
M  V30 15 C 14.6708 7.4938 0.0 0
M  V30 16 C 16.0045 6.7238 0.0 0
M  V30 17 C 17.3383 7.4938 0.0 0
M  V30 18 O 17.3383 9.0338 0.0 0
M  V30 19 O 18.6720 6.7238 0.0 0
M  V30 20 C 8.6692 2.3101 0.0 0
M  V30 21 C 10.0028 1.5400 0.0 0
M  V30 22 F 9.4392 3.6437 0.0 0
M  V30 23 F 7.3355 3.0801 0.0 0
M  V30 24 F 7.8991 0.9764 0.0 0
M  V30 25 O 11.3365 2.3101 0.0 0
M  V30 26 O 10.0028 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9 CFG=1
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 10 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 20 21
M  V30 20 1 20 22
M  V30 21 1 20 23
M  V30 22 1 20 24
M  V30 23 1 21 25
M  V30 24 2 21 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Hexanoic acid, 6-[[2-[[(2R)-2-amino-1-oxo-3-sulfopropyl]amino]ethyl]methylami...
C12H25N3O6S.CH2O2
1100364-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0 CFG=1
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 2.6675 4.6201 0.0 0
M  V30 7 N 4.0012 2.3100 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 S 1.3337 3.8501 0.0 0 VAL=6
M  V30 10 N 10.6697 4.6201 0.0 0
M  V30 11 O 2.1037 2.5164 0.0 0
M  V30 12 O 0.5637 5.1837 0.0 0
M  V30 13 O 0.0000 3.0800 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 C 10.6697 6.1601 0.0 0
M  V30 16 C 13.3372 4.6201 0.0 0
M  V30 17 C 14.6708 3.8501 0.0 0
M  V30 18 C 16.0045 4.6201 0.0 0
M  V30 19 C 17.3382 3.8501 0.0 0
M  V30 20 C 18.6720 4.6201 0.0 0
M  V30 21 O 18.6720 6.1601 0.0 0
M  V30 22 O 20.0057 3.8501 0.0 0
M  V30 23 C 10.0028 0.0000 0.0 0
M  V30 24 O 8.6692 0.7700 0.0 0
M  V30 25 O 11.3365 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 14 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 23 24
M  V30 23 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1100364-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1100364-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-507-CAS-13910645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-(N-methyl-N-(2-(2-amino-3-sulfonate-propionamido)ethyl)amino)hexanoic
acid, hydroformate (19): A mixture of 30% hydrogen peroxide (5 mL) and
99% formic acid (50 mL) was allowed to stand at room temperature for 1
hour prior to use (J. Am. Chem. Soc. 1960, 82, 896-903). The performic
acid reagent solution (55 mL) was added at 0 °C to a flask containing
6-(N-methyl-N-(2-(2-amino-3-mercapto-propionamido)ethyl)amino)hexanoic
acid, bishydrotrifluoroacetate (1.5 g, 2.89 mmol). The mixture was
stirred at 0 °C for 1 hour. The solvent was removed in vacuo. Water was
added and removed in vacuo again. The residue was dried under vacuum to
yield a white crystalline solid (1.10 g, 2.89 mmol, 100%). 1H NMR (500
MHz, D2O δ ) 1.41 (p, 2H, J = 7.5 Hz), 1.65 (p, 2H, J = 7.5 Hz), 1.75 (m,
2H), 2.41 (t, 2H, J = 7.5 Hz), 2.91 (d, 3H, J = 5 Hz), 3.07-3.18 (m, 1H),
3.21-3.34 (m, 2H), 3.38-3.62 (m, 2H), 3.49 (t, 2H, J = 6 Hz), 3.78-3.92
(m, 1H), 4.43 (t, 1H, J = 6 Hz); 13C NMR (125 MHz, D2O δ ) 24.11, 24.72,
26.15, 34.48, 35.62, 35.68, 40.96, 41.03, 50.98, 51.14, 55.81, 57.29,
57.63, 169.37, 179.60; HRMS-ES (m/z): [M] calcd for C12H26N3O6S+ 340.1542
found 340.1514.
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reagent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel optical labeling molecules having a fluorophore in
proteomics and other biological analyses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dratz, Edward; Grieco, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009005871 A2 2009-01-08

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(aminophenylmethyl)phosphonate
C9H14NO3P
110470-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 5.3900 2.6674 0.0 0 VAL=5
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.1600 1.3338 0.0 0
M  V30 4 O 6.7236 3.4374 0.0 0
M  V30 5 O 4.0562 1.8974 0.0 0
M  V30 6 N 5.3900 5.3349 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 C 8.0573 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 9
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, P-[(formylamino)phenylmethyl]-, dimethyl ester
C10H14NO4P
2055461-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4374 4.0012 0.0 0
M  V30 2 P 2.6673 5.3348 0.0 0 VAL=5
M  V30 3 N 2.6673 2.6675 0.0 0
M  V30 4 O 1.8973 6.6687 0.0 0
M  V30 5 O 1.3337 4.5648 0.0 0
M  V30 6 O 4.0012 6.1048 0.0 0
M  V30 7 C 3.4374 1.3337 0.0 0
M  V30 8 C 2.6673 8.0023 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 O 2.6673 0.0000 0.0 0
M  V30 11 C 4.9774 4.0012 0.0 0
M  V30 12 C 5.7474 2.6675 0.0 0
M  V30 13 C 5.7474 5.3348 0.0 0
M  V30 14 C 7.2874 2.6675 0.0 0
M  V30 15 C 7.2874 5.3348 0.0 0
M  V30 16 C 8.0575 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110470-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055461-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16450197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective Synthesis of Pyrroles from Alkyne-Isocyanide Click
Reactions: An Angle Strain-Induced Bond Migration Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM George, Jimil; Kim, Hun Young; Oh, Kyungsoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(23), 3714-3718

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentylamine
C5H13N
110-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 N 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1-pentanamine (1:1)
C5H13N.CH2O2
221271-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 C 4.0012 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 N 6.6687 2.3100 0.0 0
M  V30 7 C 3.3343 0.0000 0.0 0
M  V30 8 O 2.0007 0.7700 0.0 0
M  V30 9 O 4.6680 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 7 8
M  V30 7 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-58-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 221271-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39083440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Redox-Mediated Amination of Pyrogallol-Based Polyphenols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashirbaev, Salavat S.; Bras, Natercia F.; Frei, Patricia; Liu, Kuangjie;
Moser, Simone; Zipse, Hendrik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2024), 30(12), e202303783

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexene
C6H10
110-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 C 0.7700 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxylic acid
C7H12O2
98-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-992256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7790-45-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction run in autoclave, 190 0C for 2.5 h, optimized on temp.,
hydroxycarbonylation method avoids handling of toxic CO gas
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iridium-formic acid based system for hydroxycarbonylation without CO gas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Simonato, J.-P.; Walter, T.; Metivier, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2001), 171(1-2), 91-94

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16482408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst, no
solvent, sealed tube used, recyclable catalyst, silica supported catalyst
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallophytes for organic synthesis: towards new bio-based selective
protection/deprotection procedures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grison, Claire M.; Velati, Alicia; Escande, Vincent; Grison, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Environmental Science and Pollution Research (2015), 22(8), 5686-5698

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-943289
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1428443-59-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave similar results
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and convenient N-formylation protocol in water-containing solvents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aleiwi, Bilal A.; Mitachi, Katsuhiko; Kurosu, Michio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(16), 2077-2081

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [amino(4-methoxyphenyl)methyl]-, diethyl ester
C12H20NO4P
112564-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0009 4.0011 0.0 0 VAL=5
M  V30 2 C 4.7709 5.3347 0.0 0
M  V30 3 O 3.2309 2.6674 0.0 0
M  V30 4 O 2.6673 4.7711 0.0 0
M  V30 5 O 5.3347 3.2311 0.0 0
M  V30 6 N 4.0009 6.6685 0.0 0
M  V30 7 C 4.0009 1.3338 0.0 0
M  V30 8 C 1.3336 4.0011 0.0 0
M  V30 9 C 3.2309 0.0000 0.0 0
M  V30 10 C 0.0000 4.7711 0.0 0
M  V30 11 O 10.9309 5.3347 0.0 0
M  V30 12 C 11.7009 6.6685 0.0 0
M  V30 13 C 6.3109 5.3347 0.0 0
M  V30 14 C 7.0809 4.0011 0.0 0
M  V30 15 C 7.0809 6.6685 0.0 0
M  V30 16 C 8.6209 4.0011 0.0 0
M  V30 17 C 8.6209 6.6685 0.0 0
M  V30 18 C 9.3909 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 13
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [(formylamino)(4-methoxyphenyl)methyl]-, diethyl ester
C13H20NO5P
155267-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7710 5.3348 0.0 0
M  V30 2 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 3 N 4.0010 6.6685 0.0 0
M  V30 4 O 3.2310 2.6675 0.0 0
M  V30 5 O 2.6673 4.7712 0.0 0
M  V30 6 O 5.3348 3.2311 0.0 0
M  V30 7 C 4.7710 8.0023 0.0 0
M  V30 8 C 4.0010 1.3337 0.0 0
M  V30 9 C 1.3337 4.0012 0.0 0
M  V30 10 O 4.0010 9.3360 0.0 0
M  V30 11 C 3.2310 0.0000 0.0 0
M  V30 12 C 0.0000 4.7712 0.0 0
M  V30 13 O 10.9312 5.3348 0.0 0
M  V30 14 C 11.7012 6.6685 0.0 0
M  V30 15 C 6.3111 5.3348 0.0 0
M  V30 16 C 7.0811 4.0012 0.0 0
M  V30 17 C 7.0811 6.6685 0.0 0
M  V30 18 C 8.6211 4.0012 0.0 0
M  V30 19 C 8.6211 6.6685 0.0 0
M  V30 20 C 9.3911 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112564-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 155267-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21768487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also acts as a solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor
Ligands for Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abas, Sonia; Rodriguez-Arevalo, Sergio; Bagan, Andrea; Grinan-Ferre,
Christian; Vasilopoulou, Foteini; Brocos-Mosquera, Iria; Muguruza,
Carolina; Perez, Belen; Molins, Elies; Luque, F. Javier; Perez-Lozano,
Pilar; de Jonghe, Steven; Daelemans, Dirk; Naesens, Lieve; Brea, Jose;
Loza, M. Isabel; Hernandez-Hernandez, Elena; Garcia-Sevilla, Jesus A.;
Garcia-Fuster, M. Julia; Radan, Milica; Djikic, Teodora; Nikolic,
Katarina; Pallas, Merce; Callado, Luis F.; Escolano, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(7), 3610-3633

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-glycero-α-L-talo-Heptofuranuronic acid, 6-[(3-aminopropyl)amino]-1,6-dideox...
C36H59N5O13
1146698-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.9054 0.0 0 CFG=1
M  V30 2 C 5.3900 6.9054 0.0 0 CFG=2
M  V30 3 O 7.7000 5.5717 0.0 0
M  V30 4 C 4.6200 5.5717 0.0 0
M  V30 5 N 4.6200 8.2392 0.0 0
M  V30 6 O 3.0800 5.5717 0.0 0
M  V30 7 O 5.3900 4.2381 0.0 0
M  V30 8 C 3.0800 8.2392 0.0 0
M  V30 9 C 2.3100 4.2381 0.0 0
M  V30 10 C 2.3100 9.5728 0.0 0
M  V30 11 C 0.9764 5.0081 0.0 0
M  V30 12 C 1.5400 2.9045 0.0 0
M  V30 13 C 3.6437 3.4681 0.0 0
M  V30 14 C 0.7700 9.5728 0.0 0
M  V30 15 N 0.0000 10.9065 0.0 0
M  V30 16 C 11.9043 10.9151 0.0 0
M  V30 17 C 10.8737 12.7000 0.0 0
M  V30 18 O 7.0945 13.4098 0.0 0
M  V30 19 C 12.8558 7.2470 0.0 0
M  V30 20 N 14.2626 6.6206 0.0 0
M  V30 21 C 15.5085 7.5257 0.0 0
M  V30 22 O 16.9154 6.8994 0.0 0
M  V30 23 O 15.3476 9.0574 0.0 0
M  V30 24 C 18.1613 7.8046 0.0 0
M  V30 25 C 19.0665 6.5587 0.0 0
M  V30 26 C 19.4072 8.7098 0.0 0
M  V30 27 C 17.2561 9.0505 0.0 0
M  V30 28 C 10.9835 0.9031 0.0 0
M  V30 29 C 9.4520 0.7421 0.0 0
M  V30 30 C 12.9436 1.5400 0.0 0
M  V30 31 C 12.9436 0.0000 0.0 0
M  V30 32 O 1.8763 14.5189 0.0 0
M  V30 33 C 7.7000 8.2392 0.0 0 CFG=1
M  V30 34 C 8.7305 9.3836 0.0 0 CFG=1
M  V30 35 O 6.2932 8.8655 0.0 0
M  V30 36 C 7.9605 10.7172 0.0 0 CFG=1
M  V30 37 O 10.2369 9.7037 0.0 0
M  V30 38 C 6.4542 10.3971 0.0 0 CFG=1
M  V30 39 O 8.9910 11.8618 0.0 0
M  V30 40 C 10.3978 11.2353 0.0 0
M  V30 41 C 9.2400 5.5717 0.0 0 CFG=2
M  V30 42 C 10.1453 4.3259 0.0 0 CFG=2
M  V30 43 O 10.1453 6.8176 0.0 0
M  V30 44 C 11.6098 4.8017 0.0 0 CFG=2
M  V30 45 O 10.1453 2.7859 0.0 0
M  V30 46 C 11.6098 6.3418 0.0 0 CFG=2
M  V30 47 O 12.5150 3.5559 0.0 0
M  V30 48 C 11.6098 2.3100 0.0 0
M  V30 49 N 5.3096 11.4275 0.0 0
M  V30 50 C 5.6298 12.9339 0.0 0
M  V30 51 C 3.8451 10.9516 0.0 0
M  V30 52 N 4.4854 13.9643 0.0 0
M  V30 53 C 2.7006 11.9822 0.0 0
M  V30 54 C 3.0207 13.4885 0.0 0
M  V30 55 H 8.9459 7.3340 0.0 0
M  V30 56 H 9.5005 8.0499 0.0 0
M  V30 57 H 7.1905 12.0509 0.0 0
M  V30 58 H 8.6806 3.8500 0.0 0
M  V30 59 H 13.0745 5.2776 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 33
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 41 3 CFG=3
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 14 15
M  V30 17 1 16 40
M  V30 18 1 17 40
M  V30 19 2 18 50
M  V30 20 1 19 20
M  V30 21 1 46 19 CFG=3
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 28 29
M  V30 30 1 28 48
M  V30 31 1 30 31
M  V30 32 1 30 48
M  V30 33 2 32 54
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 33 55 CFG=3
M  V30 37 1 34 36
M  V30 38 1 34 37
M  V30 39 1 34 56 CFG=1
M  V30 40 1 35 38
M  V30 41 1 36 38
M  V30 42 1 36 39
M  V30 43 1 36 57 CFG=1
M  V30 44 1 37 40
M  V30 45 1 38 49 CFG=1
M  V30 46 1 39 40
M  V30 47 1 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 42 45
M  V30 51 1 42 58 CFG=3
M  V30 52 1 43 46
M  V30 53 1 44 46
M  V30 54 1 44 47
M  V30 55 1 44 59 CFG=3
M  V30 56 1 45 48
M  V30 57 1 47 48
M  V30 58 1 49 50
M  V30 59 1 49 51
M  V30 60 1 50 52
M  V30 61 2 51 53
M  V30 62 1 52 54
M  V30 63 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 2 33 34 36 38 41 42 44 46)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-glycero-α-L-talo-Heptofuranuronic acid, 1,6-dideoxy-5-O-[5-deoxy-5-[[(1,1-d...
C37H59N5O14
1146698-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.9054 0.0 0 CFG=2
M  V30 2 O 10.0101 5.5717 0.0 0
M  V30 3 C 7.7000 6.9054 0.0 0 CFG=1
M  V30 4 N 6.9300 8.2392 0.0 0
M  V30 5 C 6.9300 5.5717 0.0 0
M  V30 6 C 5.3900 8.2392 0.0 0
M  V30 7 O 5.3900 5.5717 0.0 0
M  V30 8 O 7.7000 4.2381 0.0 0
M  V30 9 C 4.6200 9.5728 0.0 0
M  V30 10 C 4.6200 4.2381 0.0 0
M  V30 11 C 3.0800 9.5728 0.0 0
M  V30 12 C 5.9537 3.4681 0.0 0
M  V30 13 C 3.8500 2.9045 0.0 0
M  V30 14 C 3.2864 5.0081 0.0 0
M  V30 15 N 2.3100 10.9065 0.0 0
M  V30 16 C 0.7700 10.9065 0.0 0
M  V30 17 O 0.0000 12.2401 0.0 0
M  V30 18 C 14.2143 10.9151 0.0 0
M  V30 19 C 13.1837 12.7000 0.0 0
M  V30 20 O 9.4045 13.4098 0.0 0
M  V30 21 C 15.1658 7.2470 0.0 0
M  V30 22 N 16.5726 6.6205 0.0 0
M  V30 23 C 17.8185 7.5257 0.0 0
M  V30 24 O 19.2255 6.8994 0.0 0
M  V30 25 O 17.6576 9.0574 0.0 0
M  V30 26 C 20.4713 7.8046 0.0 0
M  V30 27 C 19.5661 9.0505 0.0 0
M  V30 28 C 21.7172 8.7098 0.0 0
M  V30 29 C 21.3765 6.5587 0.0 0
M  V30 30 C 13.2935 0.9031 0.0 0
M  V30 31 C 11.7620 0.7421 0.0 0
M  V30 32 C 15.2536 1.5400 0.0 0
M  V30 33 C 15.2536 0.0000 0.0 0
M  V30 34 O 4.1864 14.5189 0.0 0
M  V30 35 C 10.0101 8.2392 0.0 0 CFG=1
M  V30 36 C 11.0405 9.3836 0.0 0 CFG=1
M  V30 37 O 8.6033 8.8655 0.0 0
M  V30 38 C 10.2705 10.7172 0.0 0 CFG=1
M  V30 39 O 12.5469 9.7037 0.0 0
M  V30 40 C 8.7642 10.3971 0.0 0 CFG=1
M  V30 41 O 11.3010 11.8618 0.0 0
M  V30 42 C 12.7078 11.2353 0.0 0
M  V30 43 C 11.5501 5.5717 0.0 0 CFG=2
M  V30 44 C 12.4553 4.3259 0.0 0 CFG=2
M  V30 45 O 12.4553 6.8176 0.0 0
M  V30 46 C 13.9198 4.8017 0.0 0 CFG=2
M  V30 47 O 12.4553 2.7859 0.0 0
M  V30 48 C 13.9198 6.3418 0.0 0 CFG=2
M  V30 49 O 14.8250 3.5559 0.0 0
M  V30 50 C 13.9198 2.3100 0.0 0
M  V30 51 N 7.6197 11.4275 0.0 0
M  V30 52 C 7.9398 12.9339 0.0 0
M  V30 53 C 6.1551 10.9516 0.0 0
M  V30 54 N 6.7954 13.9643 0.0 0
M  V30 55 C 5.0106 11.9822 0.0 0
M  V30 56 C 5.3307 13.4885 0.0 0
M  V30 57 H 11.2559 7.3340 0.0 0
M  V30 58 H 11.8105 8.0499 0.0 0
M  V30 59 H 9.5005 12.0509 0.0 0
M  V30 60 H 10.9906 3.8500 0.0 0
M  V30 61 H 15.3845 5.2776 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 35
M  V30 4 1 43 2 CFG=3
M  V30 5 1 3 4 CFG=1
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 15 16
M  V30 18 2 16 17
M  V30 19 1 18 42
M  V30 20 1 19 42
M  V30 21 2 20 52
M  V30 22 1 21 22
M  V30 23 1 48 21 CFG=3
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 26 29
M  V30 31 1 30 31
M  V30 32 1 30 50
M  V30 33 1 32 33
M  V30 34 1 32 50
M  V30 35 2 34 56
M  V30 36 1 35 36
M  V30 37 1 35 37
M  V30 38 1 35 57 CFG=3
M  V30 39 1 36 38
M  V30 40 1 36 39
M  V30 41 1 36 58 CFG=1
M  V30 42 1 37 40
M  V30 43 1 38 40
M  V30 44 1 38 41
M  V30 45 1 38 59 CFG=1
M  V30 46 1 39 42
M  V30 47 1 40 51 CFG=1
M  V30 48 1 41 42
M  V30 49 1 43 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 1 44 47
M  V30 53 1 44 60 CFG=3
M  V30 54 1 45 48
M  V30 55 1 46 48
M  V30 56 1 46 49
M  V30 57 1 46 61 CFG=3
M  V30 58 1 47 50
M  V30 59 1 49 50
M  V30 60 1 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 2 53 55
M  V30 64 1 54 56
M  V30 65 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 3 35 36 38 40 43 44 46 48)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1146698-90-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1146698-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13319207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic study of muraymycins using Ugi-four component reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanino, Tetsuya; Hirano, Shinpei; Ichikawa, Satoshi; Matsuda, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Symposium Series (2008), 52(1), 557-558

$RFMT $RIREG SCHEME26 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]dihydro-2-thioxo-4...
C19H11N3O4S
2178914-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 8.0022 0.0 0
M  V30 2 O 2.3100 2.6675 0.0 0
M  V30 3 N 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 2.6675 0.0 0
M  V30 5 O 11.5501 0.0000 0.0 0
M  V30 6 O 11.5501 5.3348 0.0 0
M  V30 7 S 16.1702 2.6675 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 4.6201 6.6686 0.0 0
M  V30 11 C 6.9301 5.3348 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 3.0800 6.6686 0.0 0
M  V30 15 C 7.7001 4.0011 0.0 0
M  V30 16 C 2.3100 5.3348 0.0 0
M  V30 17 C 6.9301 2.6675 0.0 0
M  V30 18 C 2.3100 8.0022 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.7700 8.0022 0.0 0
M  V30 21 C 0.0000 6.6686 0.0 0
M  V30 22 C 11.5501 2.6675 0.0 0
M  V30 23 C 12.3201 1.3337 0.0 0
M  V30 24 C 12.3201 4.0011 0.0 0
M  V30 25 N 13.8602 1.3338 0.0 0
M  V30 26 N 13.8602 4.0011 0.0 0
M  V30 27 C 14.6302 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 22
M  V30 6 2 5 23
M  V30 7 2 6 24
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 2 15 17
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27728354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME27 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylamine
C10H9N
134-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-5-[(1-naphthalenylamino)methylene]-2-thioxo-4,6(1H,5H)-pyrimidinedione
C15H11N3O2S
380652-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 9.3360 0.7700 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 S 12.0033 5.3901 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 N 10.6697 3.0801 0.0 0
M  V30 20 N 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 16
M  V30 4 2 3 17
M  V30 5 2 4 18
M  V30 6 2 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-32-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 380652-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29511161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME28 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthracene
C14H11N
613-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 8.0023 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Anthracenylamino)methylene]dihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione
C19H13N3O2S
2178914-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 10.0100 2.6674 0.0 0
M  V30 3 O 11.5500 0.0000 0.0 0
M  V30 4 O 11.5500 5.3347 0.0 0
M  V30 5 S 16.1700 2.6674 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 6.6685 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 12.3200 1.3336 0.0 0
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 23 N 13.8600 1.3336 0.0 0
M  V30 24 N 13.8600 4.0011 0.0 0
M  V30 25 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 20
M  V30 4 2 3 21
M  V30 5 2 4 22
M  V30 6 2 5 25
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 613-13-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28639892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME29 STEP1
$RXN



  3  1
$MOL
Aniline
C6H7N
62-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-5-[(phenylamino)methylene]-2-thioxo-4,6(1H,5H)-pyrimidinedione
C11H9N3O2S
69791-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 O 6.9300 5.3349 0.0 0
M  V30 5 S 11.5500 2.6674 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 N 9.2400 1.3338 0.0 0
M  V30 10 N 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 2 12
M  V30 4 2 3 7
M  V30 5 2 4 8
M  V30 6 2 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-53-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69791-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27463265
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME30 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminoanthraquinone
C14H9NO2
82-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 6.1600 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-1-anthracenyl)amino]methylene]dihydro-2-thioxo-4...
C19H11N3O4S
2178915-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 O 0.0000 5.3901 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 10.6697 6.9302 0.0 0
M  V30 7 S 13.3370 2.3101 0.0 0
M  V30 8 C 4.0010 4.6201 0.0 0
M  V30 9 C 2.6673 5.3901 0.0 0
M  V30 10 C 5.3348 5.3901 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 4.0010 7.7002 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 0.0000 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 9.3360 3.0801 0.0 0
M  V30 24 C 10.6697 5.3901 0.0 0
M  V30 25 N 10.6697 2.3101 0.0 0
M  V30 26 N 12.0033 4.6201 0.0 0
M  V30 27 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 22
M  V30 4 2 3 11
M  V30 5 2 4 12
M  V30 6 2 5 23
M  V30 7 2 6 24
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 16
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-45-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-04-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30235311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME31 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthylamine
C10H9N
91-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-5-[(2-naphthalenylamino)methylene]-2-thioxo-4,6(1H,5H)-pyrimidinedione
C15H11N3O2S
710295-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 5.3347 0.0 0
M  V30 5 S 13.8600 2.6674 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 10.0100 1.3338 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 N 11.5500 1.3338 0.0 0
M  V30 20 N 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 16
M  V30 4 2 3 17
M  V30 5 2 4 18
M  V30 6 2 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-59-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 710295-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25437937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME32 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobiphenyl
C12H11N
92-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 2.6673 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-2-thioxo-4,5,6(1H)-pyrimidinetrione
C4H2N2O3S
114753-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[([1,1′-Biphenyl]-4-ylamino)methylene]dihydro-2-thioxo-4,6(1H,5H)-pyrimidin...
C17H13N3O2S
2178914-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 10.0100 2.6674 0.0 0
M  V30 3 O 11.5500 5.3349 0.0 0
M  V30 4 O 11.5500 0.0000 0.0 0
M  V30 5 S 16.1700 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 6.9300 5.3349 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 20 C 12.3200 1.3338 0.0 0
M  V30 21 N 13.8600 4.0011 0.0 0
M  V30 22 N 13.8600 1.3338 0.0 0
M  V30 23 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 18
M  V30 4 2 3 19
M  V30 5 2 4 20
M  V30 6 2 5 23
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92-67-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 114753-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30678165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-4-nitro-N-(phenylmethyl)-1H-pyrazol-5-amine
C12H14N4O2
1153247-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 3.3320 0.0 0
M  V30 2 C 6.6364 2.5620 0.0 0
M  V30 3 N 2.2420 4.6948 0.0 0 VAL=5
M  V30 4 O 3.3864 5.7252 0.0 0
M  V30 5 O 0.7773 5.1706 0.0 0
M  V30 6 C 4.9526 0.0000 0.0 0
M  V30 7 C 0.0000 2.2049 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 N 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 N 2.3017 0.7103 0.0 0
M  V30 13 C 7.9701 3.3320 0.0 0
M  V30 14 C 7.9701 4.8720 0.0 0
M  V30 15 C 9.3037 2.5620 0.0 0
M  V30 16 C 9.3037 5.6420 0.0 0
M  V30 17 C 10.6376 3.3320 0.0 0
M  V30 18 C 10.6376 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 10
M  V30 8 1 7 11
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1,3-Dimethyl-5-[(phenylmethyl)amino]-1H-pyrazol-4-yl]formamide
C13H16N4O
1262887-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3027 3.3450 0.0 0
M  V30 2 C 6.6363 4.1150 0.0 0
M  V30 3 N 2.2419 1.9823 0.0 0
M  V30 4 C 0.7772 1.5064 0.0 0
M  V30 5 O 0.4571 0.0000 0.0 0
M  V30 6 C 4.9525 6.6771 0.0 0
M  V30 7 C 0.0000 4.4722 0.0 0
M  V30 8 C 3.9689 4.1150 0.0 0
M  V30 9 C 2.5621 3.4887 0.0 0
M  V30 10 N 3.8080 5.6466 0.0 0
M  V30 11 C 1.5317 4.6331 0.0 0
M  V30 12 N 2.3017 5.9667 0.0 0
M  V30 13 C 7.9700 3.3450 0.0 0
M  V30 14 C 9.3036 4.1150 0.0 0
M  V30 15 C 7.9700 1.8050 0.0 0
M  V30 16 C 10.6374 3.3450 0.0 0
M  V30 17 C 9.3036 1.0350 0.0 0
M  V30 18 C 10.6374 1.8050 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 2 4 5
M  V30 7 1 6 10
M  V30 8 1 7 11
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1153247-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262887-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-6436866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Experimental Procedure
1H-Benzo[d]imidazole15 (1): A 40 mL glass vial was charged with
o-nitroaniline (0.138 g, 1.00 mmol), iron powder 325 mesh (0.558 g, 10.0
mmol), NH4Cl (0.535 g, 10.0 mmol), and a magnetic stir bar. 2-PrOH (5.0
mL) and formic acid (5.0 mL) were added, and the reaction vial was sealed
with a Teflon-lined cap. The reaction mixture was stirred at 80 °C for 1
h at which time LC-MS analysis indicated that conversion into the product
was complete. The reaction mixture was diluted with 2-PrOH (10 mL) and
filtered to remove insoluble materials. The filtrate was concentrated to
dryness, and the resulting residue partitioned between CH2Cl2 (20 mL) and
(5 mL) sat. aq NaHCO3. The aqueous layer was extracted with additional
CH2Cl2 (5 x 20 mL). The combined organic extracts were dried over MgSO4,
filtered, and concentrated. Yield 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and general one-pot reduction and cyclization of aromatic and
heteroaromatic 2-nitroamines to bicyclic 2H-imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanan, Emily J.; Chan, Bryan K.; Estrada, Anthony A.; Shore, Daniel G.;
Lyssikatos, Joseph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (18), 2759-2764

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(6-Methoxy-3′-nitro[1,1′-biphenyl]-3-yl)methyl]benzenemethanamine
C21H20N2O3
1158229-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 9.3358 0.0 0
M  V30 2 C 6.9300 10.6694 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 N 12.3200 4.0011 0.0 0 VAL=5
M  V30 5 O 11.5500 2.6673 0.0 0
M  V30 6 O 13.8600 4.0011 0.0 0
M  V30 7 C 3.0800 1.3336 0.0 0
M  V30 8 N 2.3100 0.0000 0.0 0
M  V30 9 C 7.7000 6.6684 0.0 0
M  V30 10 C 6.9300 8.0021 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 5.3900 8.0021 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 14 C 4.6200 6.6684 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 12.3200 6.6684 0.0 0
M  V30 21 C 3.0800 4.0011 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 0.7700 2.6673 0.0 0
M  V30 25 C 0.7700 5.3347 0.0 0
M  V30 26 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 3 21
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-[(6-Methoxy-3′-nitro[1,1′-biphenyl]-3-yl)methyl]phenyl]methyl]formamide
C22H20N2O4
1158229-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 8.0020 0.0 0
M  V30 2 C 0.0000 9.3358 0.0 0
M  V30 3 C 6.9300 8.0020 0.0 0
M  V30 4 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 4.6200 1.3336 0.0 0
M  V30 7 C 10.0100 8.0020 0.0 0
M  V30 8 N 11.5500 8.0020 0.0 0
M  V30 9 C 12.3200 6.6684 0.0 0
M  V30 10 O 13.8600 6.6684 0.0 0
M  V30 11 C 3.0800 6.6684 0.0 0
M  V30 12 C 2.3100 8.0020 0.0 0
M  V30 13 C 4.6200 6.6684 0.0 0
M  V30 14 C 3.0800 9.3358 0.0 0
M  V30 15 C 5.3900 8.0020 0.0 0
M  V30 16 C 4.6200 9.3358 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 2.6673 0.0 0
M  V30 21 C 0.0000 4.0011 0.0 0
M  V30 22 C 0.7700 2.6673 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 6.9300 10.6694 0.0 0
M  V30 26 C 10.0100 10.6694 0.0 0
M  V30 27 C 7.7000 12.0031 0.0 0
M  V30 28 C 9.2400 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 15
M  V30 4 1 3 23
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1158229-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1158229-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-469218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 356. Preparation of P-158 Synthesis of
N-[2-(6-Methoxy-3'-nitro-biphenyl-3-ylmethyl)-benzyl]-formamide (P-158).
Formic acid (0.18mL, 4.57mmol) was added to acetic anhydride (0.42mL,
4.57mmol) at 0 °C. Then reaction mixture was heated at 50 °C for 2 hours.
0.3mL of the above mixture was added dropwise into the DCM (1mL) solution
of P-133 (50mg, 0.14 mmol) at -30 °C and then stirred at -10°C 30 minutes
then room temperature 20 hours. The reaction mixture was diluted with
ethyl acetate, washed with water, brine and dried over Na2SO4 After
removal of solvent, the residue was purified by 2g silica gel column
chromatography with ethyl acetate /hexane as eluent to give 53 mg of
product P-158. Yield: 100 %.
N-[2-(6-Methoxy-3'-nitro-biphenyl-3-ylmethyl)-benzyl]-formamide (P-158),
yield 53 mg, 100 % 1H NMR (400 MHz, CDCl3) ppm 3.81 (s, 3 H) 4.05 (s, 2
H) 4.50 (d, J = 5.77 Hz, 2 H) 5.50 (br. s., 1 H) 6.93 (d, J = 8.99 Hz, 1
H) 7.03 - 7.14 (m, 2 H) 7.16 - 7.35 (m, 4 H) 7.54 (t, J = 7.98 Hz, 1 H)
7.80 (d, J = 7.51 Hz, 1 H) 8.13 - 8.19 (m, 2 H) 8.37 (s, 1 H) LC-MS
(APCI+): 349.1 (M+1) 98.2 %.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryls as PDE4 inhibitors for treating inflammation and their
preparation and pharmaceutical compositions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Jasbir; Gurney, Mark E.; Burgin, Alex; Sandanayaka, Vincent;
Kiselyov, Alexander; Motta, Adalie; Schultz, Gary; Hategan, Georgeta;
Hagen, Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009067600 A2 2009-05-28

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(aminomethyl)-5-fluoro-2-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-...
C17H21F2N3O2Si
1168091-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 O 0.7700 6.6684 0.0 0
M  V30 4 O 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 N 4.6200 0.0000 0.0 0
M  V30 8 F 2.3100 1.3336 0.0 0
M  V30 9 F 6.9300 9.3358 0.0 0
M  V30 10 Si 11.5500 6.6684 0.0 0
M  V30 11 C 13.0900 6.6684 0.0 0
M  V30 12 C 11.5500 8.2084 0.0 0
M  V30 13 C 11.5500 5.1284 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 N 5.3900 4.0011 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 6.9300 6.6684 0.0 0
M  V30 21 C 7.7000 8.0021 0.0 0
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 24 C 9.2400 5.3347 0.0 0
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 19
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-fluoro-2-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-6-[(formylamino)...
C18H21F2N3O3Si
1168091-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 9.3358 0.0 0
M  V30 2 C 2.3100 9.3358 0.0 0
M  V30 3 O 0.7700 9.3358 0.0 0
M  V30 4 O 3.0800 10.6694 0.0 0
M  V30 5 C 0.0000 10.6694 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 N 4.6200 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 F 2.3100 4.0011 0.0 0
M  V30 11 F 6.9300 12.0031 0.0 0
M  V30 12 Si 11.5500 9.3358 0.0 0
M  V30 13 C 13.0900 9.3358 0.0 0
M  V30 14 C 11.5500 10.8758 0.0 0
M  V30 15 C 11.5500 7.7958 0.0 0
M  V30 16 C 4.6200 8.0020 0.0 0
M  V30 17 C 3.0800 8.0020 0.0 0
M  V30 18 N 5.3900 6.6684 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 3.0800 5.3347 0.0 0
M  V30 22 C 6.9300 9.3358 0.0 0
M  V30 23 C 7.7000 10.6694 0.0 0
M  V30 24 C 7.7000 8.0020 0.0 0
M  V30 25 C 9.2400 10.6694 0.0 0
M  V30 26 C 9.2400 8.0020 0.0 0
M  V30 27 C 10.0100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 10 21
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1168091-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1168091-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3117303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5:
5-Fluoro-2-(2-fluoro-4-trimethylsilanyl-phenylamino)-6-formylaminomethyl-nicotinic
acid methyl ester To a solution of
6-aminomethyl-5-fluoro-2-(2-fluoro-4-trimethylsilanyl-phenylamino)-nicotinic
acid methyl ester (2.0 g, 5.5 mmol) in formic acid (30 mL) at 0°C. was
added acetic anhydride (6 mL). The reaction mixture was stirred at
ambient temperature for 2 hours. The reaction mixture was concentrated in
vacuo and the resultant residue azeotroped with toluene, then dissolved
in dichloromethane. This organic layer was washed with a saturated
aqueous solution of sodium bicarbonate, followed by brine, dried
(Na2SO4), filtered and concentrated in vacuo to afford the title compound
as a dark brown solid (2.1 g, 100%).
5-Fluoro-2-(2-fluoro-4-trimethylsilanyl-phenylamino)-6-formylaminomethyl-nicotinic
acid methyl ester, yield (2.1 g, 100%). LCMS (method B): RT=4.36 min,
[M+H]+=394.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-anilinoimidazopyridines and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Price, Stephen; Heald, Robert; Lee, Wendy; Zak, Mark E.; Hewitt, Joanne
Frances Mary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100004269 A1 2010-01-07

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(aminomethyl)-5-fluoro-2-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-...
C17H21F2N3O2Si
1168091-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 O 0.7700 6.6684 0.0 0
M  V30 4 O 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 N 4.6200 0.0000 0.0 0
M  V30 8 F 2.3100 1.3336 0.0 0
M  V30 9 F 6.9300 9.3358 0.0 0
M  V30 10 Si 11.5500 6.6684 0.0 0
M  V30 11 C 13.0900 6.6684 0.0 0
M  V30 12 C 11.5500 8.2084 0.0 0
M  V30 13 C 11.5500 5.1284 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 N 5.3900 4.0011 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 6.9300 6.6684 0.0 0
M  V30 21 C 7.7000 8.0021 0.0 0
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 24 C 9.2400 5.3347 0.0 0
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 19
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-fluoro-2-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-6-[(formylamino)...
C18H21F2N3O3Si
1168091-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 9.3358 0.0 0
M  V30 2 C 2.3100 9.3358 0.0 0
M  V30 3 O 0.7700 9.3358 0.0 0
M  V30 4 O 3.0800 10.6694 0.0 0
M  V30 5 C 0.0000 10.6694 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 N 4.6200 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 F 2.3100 4.0011 0.0 0
M  V30 11 F 6.9300 12.0031 0.0 0
M  V30 12 Si 11.5500 9.3358 0.0 0
M  V30 13 C 13.0900 9.3358 0.0 0
M  V30 14 C 11.5500 10.8758 0.0 0
M  V30 15 C 11.5500 7.7958 0.0 0
M  V30 16 C 4.6200 8.0020 0.0 0
M  V30 17 C 3.0800 8.0020 0.0 0
M  V30 18 N 5.3900 6.6684 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 3.0800 5.3347 0.0 0
M  V30 22 C 6.9300 9.3358 0.0 0
M  V30 23 C 7.7000 10.6694 0.0 0
M  V30 24 C 7.7000 8.0020 0.0 0
M  V30 25 C 9.2400 10.6694 0.0 0
M  V30 26 C 9.2400 8.0020 0.0 0
M  V30 27 C 10.0100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 10 21
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1168091-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1168091-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13736028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5:
5-Fluoro-2-(2-fluoro-4-trimethylsilanyl-phenylamino)-6-formylaminomethyl-nicotinic
acid methyl ester To a solution of
6-aminomethyl-5-fluoro-2-(2-fluoro-4-trimethylsilanylphenylamino)-nicotinic
acid methyl ester (2.0 g, 5.5 mmol) in formic acid (30 mL) at 0°C was
added acetic anhydride (6 mL). The reaction mixture was stirred at
ambient temperature for 2 hours. The reaction mixture was concentrated in
vacuo and the resultant residue azeotroped with toluene, then dissolved
in dichloromethane. This organic layer was washed with a saturated
aqueous solution of sodium bicarbonate, followed by brine, dried
(Na2SO4), filtered and concentrated in vacuo to afford the title compound
as a dark brown solid (2.1 g, 100%).
5-Fluoro-2-(2-fluoro-4-trimethylsilanyl-phenylamino)-6-formylaminomethyl-nicotinic
acid methyl ester, yield (2.1 g, 100%) LCMS (method B): RT = 4.36 min,
[M+H]+ = 394.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-anilinoimidazopyridines and their use as anti-cancer
and/or anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Price, Stephen; Heald, Robert; Lee, Wendy; Zak, Mark E.; Hewitt, Joanne
Frances Mary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009085983 A1 2009-07-09

$RFMT $RIREG SCHEME36 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C10H8N2O3
15018-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 5.3349 0.0 0
M  V30 2 O 4.6201 0.0000 0.0 0
M  V30 3 O 9.2401 2.6675 0.0 0
M  V30 4 N 4.6201 2.6675 0.0 0
M  V30 5 C 5.3901 4.0011 0.0 0
M  V30 6 C 5.3901 1.3338 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 N 6.9301 1.3338 0.0 0
M  V30 9 C 7.7001 2.6675 0.0 0
M  V30 10 C 3.0800 2.6675 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 1.3338 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]-1-phenyl-2,4,6(1H...
C25H15N3O5
2178914-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 10.6694 3.8500 0.0 0
M  V30 5 O 13.3369 2.3100 0.0 0
M  V30 6 O 10.6694 6.9300 0.0 0
M  V30 7 O 16.0041 6.9300 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 0.0000 2.3100 0.0 0
M  V30 22 C 12.0032 4.6200 0.0 0
M  V30 23 C 13.3369 3.8500 0.0 0
M  V30 24 C 12.0032 6.1600 0.0 0
M  V30 25 N 14.6705 4.6200 0.0 0
M  V30 26 N 13.3369 6.9300 0.0 0
M  V30 27 C 14.6705 6.1600 0.0 0
M  V30 28 C 16.0041 3.8500 0.0 0
M  V30 29 C 16.0041 2.3100 0.0 0
M  V30 30 C 17.3379 4.6200 0.0 0
M  V30 31 C 17.3379 1.5400 0.0 0
M  V30 32 C 18.6716 3.8500 0.0 0
M  V30 33 C 18.6716 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 22 CFG=2
M  V30 6 2 5 23
M  V30 7 2 6 24
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 2 15 17
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15018-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22143724
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME37 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]-1-methyl-2,4,6(1H...
C20H13N3O5
2178914-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 8.0021 0.0 0
M  V30 2 O 2.3100 2.6674 0.0 0
M  V30 3 N 9.2400 4.0011 0.0 0
M  V30 4 C 10.0100 2.6674 0.0 0
M  V30 5 O 11.5500 0.0000 0.0 0
M  V30 6 O 11.5500 5.3347 0.0 0
M  V30 7 C 14.6300 0.0000 0.0 0
M  V30 8 O 16.1700 2.6674 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 4.6200 6.6685 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 0.0000 6.6685 0.0 0
M  V30 23 C 11.5500 2.6674 0.0 0
M  V30 24 C 12.3200 1.3336 0.0 0
M  V30 25 C 12.3200 4.0011 0.0 0
M  V30 26 N 13.8600 1.3338 0.0 0
M  V30 27 N 13.8600 4.0011 0.0 0
M  V30 28 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 2 4 23 CFG=2
M  V30 6 2 5 24
M  V30 7 2 6 25
M  V30 8 1 7 26
M  V30 9 2 8 28
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 2 16 18
M  V30 22 2 17 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22142470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME38 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Nitrophenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
C10H7N3O5
27425-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 0.0000 0.0 0
M  V30 2 O 6.9302 5.3350 0.0 0
M  V30 3 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 4 O 0.0000 1.3338 0.0 0
M  V30 5 O 0.0000 4.0012 0.0 0
M  V30 6 O 11.5503 2.6675 0.0 0
M  V30 7 C 5.3901 2.6675 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 4.6201 1.3338 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 C 3.0801 1.3338 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 N 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 1.3338 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 9.2402 1.3338 0.0 0
M  V30 17 N 9.2402 4.0012 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 15
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 6 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]-1-(4-nitrophenyl)...
C25H14N4O7
2178915-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 N 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 13.3370 2.3101 0.0 0
M  V30 6 O 10.6697 6.9302 0.0 0
M  V30 7 O 16.0045 6.9302 0.0 0
M  V30 8 N 20.0057 1.5400 0.0 0 VAL=5
M  V30 9 O 20.0057 0.0000 0.0 0
M  V30 10 O 21.3393 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 8.0022 2.3101 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 1.5400 0.0 0
M  V30 23 C 0.0000 3.8501 0.0 0
M  V30 24 C 0.0000 2.3101 0.0 0
M  V30 25 C 12.0033 4.6201 0.0 0
M  V30 26 C 13.3370 3.8501 0.0 0
M  V30 27 C 12.0033 6.1601 0.0 0
M  V30 28 N 14.6708 4.6201 0.0 0
M  V30 29 N 13.3370 6.9302 0.0 0
M  V30 30 C 14.6708 6.1601 0.0 0
M  V30 31 C 16.0045 3.8501 0.0 0
M  V30 32 C 17.3382 4.6201 0.0 0
M  V30 33 C 16.0045 2.3101 0.0 0
M  V30 34 C 18.6720 3.8501 0.0 0
M  V30 35 C 17.3382 1.5400 0.0 0
M  V30 36 C 18.6720 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 2 4 25 CFG=2
M  V30 6 2 5 26
M  V30 7 2 6 27
M  V30 8 2 7 30
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 36
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 2 17 21
M  V30 23 2 18 20
M  V30 24 2 19 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 27425-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-00-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22143608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME39 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]-2,4,6(1H,3H,5H)-p...
C19H11N3O5
2178914-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 8.0022 0.0 0
M  V30 2 O 2.3100 2.6675 0.0 0
M  V30 3 N 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 2.6675 0.0 0
M  V30 5 O 11.5501 0.0000 0.0 0
M  V30 6 O 11.5501 5.3348 0.0 0
M  V30 7 O 16.1702 2.6675 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 4.6201 6.6686 0.0 0
M  V30 11 C 6.9301 5.3348 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 3.0800 6.6686 0.0 0
M  V30 15 C 7.7001 4.0011 0.0 0
M  V30 16 C 2.3100 5.3348 0.0 0
M  V30 17 C 6.9301 2.6675 0.0 0
M  V30 18 C 2.3100 8.0022 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.7700 8.0022 0.0 0
M  V30 21 C 0.0000 6.6686 0.0 0
M  V30 22 C 11.5501 2.6675 0.0 0
M  V30 23 C 12.3201 1.3337 0.0 0
M  V30 24 C 12.3201 4.0011 0.0 0
M  V30 25 N 13.8602 1.3338 0.0 0
M  V30 26 N 13.8602 4.0011 0.0 0
M  V30 27 C 14.6302 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 22
M  V30 6 2 5 23
M  V30 7 2 6 24
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 2 15 17
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-94-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22142380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME40 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthraquinone
C14H9NO2
117-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-2-anthracenyl)amino]methylene]-1,3-dimethyl-2,4,...
C21H15N3O5
2178914-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 8.0022 0.0 0
M  V30 2 O 2.3100 2.6675 0.0 0
M  V30 3 N 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 2.6675 0.0 0
M  V30 5 O 11.5501 0.0000 0.0 0
M  V30 6 O 11.5501 5.3348 0.0 0
M  V30 7 C 14.6302 0.0000 0.0 0
M  V30 8 C 14.6302 5.3348 0.0 0
M  V30 9 O 16.1702 2.6675 0.0 0
M  V30 10 C 5.3901 5.3348 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 4.6201 6.6686 0.0 0
M  V30 13 C 6.9301 5.3348 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 5.3901 2.6675 0.0 0
M  V30 16 C 3.0800 6.6686 0.0 0
M  V30 17 C 7.7001 4.0011 0.0 0
M  V30 18 C 2.3100 5.3348 0.0 0
M  V30 19 C 6.9301 2.6675 0.0 0
M  V30 20 C 2.3100 8.0022 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 0.7700 8.0022 0.0 0
M  V30 23 C 0.0000 6.6686 0.0 0
M  V30 24 C 11.5501 2.6675 0.0 0
M  V30 25 C 12.3201 1.3337 0.0 0
M  V30 26 C 12.3201 4.0011 0.0 0
M  V30 27 N 13.8602 1.3338 0.0 0
M  V30 28 N 13.8602 4.0011 0.0 0
M  V30 29 C 14.6302 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 24
M  V30 6 2 5 25
M  V30 7 2 6 26
M  V30 8 1 7 27
M  V30 9 1 8 28
M  V30 10 2 9 29
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 16 20
M  V30 22 2 17 19
M  V30 23 2 18 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-96-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22142200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6,7-dimethoxyisoquinoline
C11H13NO2
3382-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 C 2.3100 6.6685 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 0.7700 6.6685 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 N 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3382-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27587572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Bischler-Napieralski reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Phenethylamino)demethyl(oxy)aaptamine as an anti-dormant mycobacterial
substance: Isolation, evaluation and total synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sumii, Yuji; Kotoku, Naoyuki; Han, Chisu; Kamiya, Kentaro; Setiawan,
Andi; Vilcheze, Catherine; Jacobs, William R. Jr.; Arai, Masayoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2020), 61(22), 151924

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(4-Methoxyphenyl)methyl]thio]-2,6-dimethyl-3-pyridinamine
C15H18N2OS
1208988-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 N 2.6673 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 12.0033 6.9302 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3337 2.3101 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 9.3360 6.9302 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 9
M  V30 5 1 4 11
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dimethylthiazolo[4,5-c]pyridine
C8H8N2S
1208988-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7036 0.0000 0.0 0
M  V30 2 C 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 3.7036 4.6200 0.0 0
M  V30 6 S 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1208988-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208988-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30519610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14104-20-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of 4- and 6-substituted thiazolo[4,5-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yuhua; Bennett, Frank; Girijavallabhan, Vinay; Alvarez, Carmen;
Chan, Tze-Ming; Osterman, Rebecca; Senior, Mary; Kwong, Cecil; Bansal,
Namita; George Njoroge, F.; MacCoss, Malcolm
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2010), 51(21), 2800-2802

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Nitroacetophenone
C8H7NO3
121-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Acetylphenyl)formamide
C9H9NO2
72801-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 1.5400 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-89-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72801-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-15755296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1604839-72-6
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated iron oxide-bound
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, regioselective, solid-supported
catalyst, ionic liquid functionalized magnetic nanoparticle supported
palladium catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Water-Dispersible/Magnetically Separable Palladium Catalyst:
Selective Transfer Hydrogenation or Direct Reductive N-Formylation of
Nitroarenes in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Babak; Mansouri, Fariborz; Vali, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemPlusChem (2015), 80(12), 1750-1759

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl α-aminobenzeneacetate
C12H17NO2
124619-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 4.0012 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3348 3.8501 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 7.2323 3.6437 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 8.7723 0.9764 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl α-(formylamino)benzeneacetate
C13H17NO3
2055461-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 N 4.0012 2.3101 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 O 5.3348 6.1601 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 8.0023 4.6201 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 C 8.7723 3.2864 0.0 0
M  V30 10 C 9.3360 5.3901 0.0 0
M  V30 11 C 7.2323 5.9538 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 1.3337 6.9302 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124619-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055461-02-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16450196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective Synthesis of Pyrroles from Alkyne-Isocyanide Click
Reactions: An Angle Strain-Induced Bond Migration Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM George, Jimil; Kim, Hun Young; Oh, Kyungsoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(23), 3714-3718

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]benzenamine
C17H28N4O
1254058-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 C 15.4000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 N 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 N 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 N 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 10
M  V30 4 1 4 22
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]formamide
C18H28N4O2
2766157-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.7800 1.3338 0.0 0
M  V30 2 C 11.5500 0.0000 0.0 0
M  V30 3 N 15.4000 4.0011 0.0 0
M  V30 4 C 16.1700 5.3349 0.0 0
M  V30 5 O 17.7100 5.3349 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 10.7800 4.0011 0.0 0
M  V30 8 C 11.5500 2.6674 0.0 0
M  V30 9 C 11.5500 5.3349 0.0 0
M  V30 10 C 13.0900 2.6674 0.0 0
M  V30 11 C 13.0900 5.3349 0.0 0
M  V30 12 C 13.8600 4.0011 0.0 0
M  V30 13 N 9.2400 4.0011 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 6.9300 5.3349 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 N 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 5.3349 0.0 0
M  V30 21 C 3.8500 2.6674 0.0 0
M  V30 22 C 2.3100 5.3349 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 2 4 5
M  V30 6 1 6 24
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1254058-34-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766157-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-4-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]benzenamine
C17H28N4
1254059-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 C 15.4003 2.6673 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 C 3.8501 1.3337 0.0 0
M  V30 6 C 3.8501 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 1.5400 2.6673 0.0 0
M  V30 10 N 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 C 6.9302 1.3337 0.0 0
M  V30 13 C 8.4702 4.0010 0.0 0
M  V30 14 C 8.4702 1.3337 0.0 0
M  V30 15 N 9.2402 2.6673 0.0 0
M  V30 16 C 10.7802 2.6673 0.0 0
M  V30 17 C 11.5503 4.0010 0.0 0
M  V30 18 C 11.5503 1.3337 0.0 0
M  V30 19 C 13.0903 4.0010 0.0 0
M  V30 20 C 13.0903 1.3337 0.0 0
M  V30 21 N 13.8603 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 21
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methyl-4-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]phenyl]formamide
C18H28N4O
2766157-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7802 0.0000 0.0 0
M  V30 2 N 15.4003 2.6673 0.0 0
M  V30 3 C 16.1704 4.0010 0.0 0
M  V30 4 O 17.7104 4.0010 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 N 9.2402 2.6673 0.0 0
M  V30 7 C 8.4702 1.3337 0.0 0
M  V30 8 C 8.4702 4.0010 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 N 6.1601 2.6673 0.0 0
M  V30 12 C 10.7802 2.6673 0.0 0
M  V30 13 C 11.5503 1.3337 0.0 0
M  V30 14 C 11.5503 4.0010 0.0 0
M  V30 15 C 13.0903 1.3337 0.0 0
M  V30 16 C 13.0903 4.0010 0.0 0
M  V30 17 C 13.8603 2.6673 0.0 0
M  V30 18 C 4.6201 2.6673 0.0 0
M  V30 19 C 3.8501 4.0010 0.0 0
M  V30 20 C 3.8501 1.3337 0.0 0
M  V30 21 C 2.3101 4.0010 0.0 0
M  V30 22 C 2.3101 1.3337 0.0 0
M  V30 23 N 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 2 3 4
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 11 18
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1254059-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766157-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979897
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-[3-(4-chlorophenoxy)phenoxy]ethyl]-1-azetidinecarboxylate
C22H26ClNO4
1257857-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 4.1692 0.0 0
M  V30 2 C 12.0035 3.3992 0.0 0
M  V30 3 O 10.6697 4.1692 0.0 0
M  V30 4 C 17.8907 1.5400 0.0 0
M  V30 5 O 19.2244 2.3101 0.0 0
M  V30 6 O 17.8907 0.0000 0.0 0
M  V30 7 C 20.5581 1.5400 0.0 0
M  V30 8 C 19.7880 0.2064 0.0 0
M  V30 9 C 21.8919 0.7700 0.0 0
M  V30 10 C 21.3281 2.8739 0.0 0
M  V30 11 O 5.3348 4.1692 0.0 0
M  V30 12 Cl 0.0000 1.0891 0.0 0
M  V30 13 C 14.6708 3.3992 0.0 0
M  V30 14 C 15.0694 1.9115 0.0 0
M  V30 15 C 16.1583 3.7977 0.0 0
M  V30 16 N 16.5571 2.3101 0.0 0
M  V30 17 C 9.3360 3.3992 0.0 0
M  V30 18 C 8.0023 4.1692 0.0 0
M  V30 19 C 9.3360 1.8591 0.0 0
M  V30 20 C 6.6687 3.3992 0.0 0
M  V30 21 C 8.0023 1.0891 0.0 0
M  V30 22 C 6.6687 1.8591 0.0 0
M  V30 23 C 4.0012 3.3992 0.0 0
M  V30 24 C 4.0012 1.8591 0.0 0
M  V30 25 C 2.6675 4.1692 0.0 0
M  V30 26 C 2.6675 1.0891 0.0 0
M  V30 27 C 1.3338 3.3992 0.0 0
M  V30 28 C 1.3338 1.8591 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 20
M  V30 13 1 11 23
M  V30 14 1 12 28
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3-[2-[3-(4-chlorophenoxy)phenoxy]ethyl]azetidine (1:1)
C17H18ClNO2.CH2O2
1257857-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.3901 0.0 0
M  V30 2 O 10.6697 5.3901 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 C 13.3370 5.3901 0.0 0
M  V30 5 Cl 0.0000 2.3100 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 C 8.0022 5.3901 0.0 0
M  V30 8 C 6.6685 3.0800 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 8.0022 2.3100 0.0 0
M  V30 11 C 9.3360 3.0800 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 3.0800 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 C 14.6708 4.6201 0.0 0
M  V30 19 C 15.0694 3.1325 0.0 0
M  V30 20 C 16.1583 5.0186 0.0 0
M  V30 21 N 16.5569 3.5311 0.0 0
M  V30 22 C 8.2785 0.0000 0.0 0
M  V30 23 O 6.9448 0.7700 0.0 0
M  V30 24 O 9.6121 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 4 18
M  V30 7 1 5 17
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1257857-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257857-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-11468927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-{2-[3-(4-Chloro-phenoxy)-phenoxy]-ethyl}-azetidine-1-carboxylic acid
tert-butyl ester (545 mg, 1.35 mmol) was dissolved in formic acid (5.0
mL) and stirred for 4 h at room temperature.
3-{2-[3-(4-Chloro-phenoxy)-phenoxy]-ethyl}-azetidine,formic acid salt.
Yellow oil (460 mg, 100%). MS (ESI++): calcd. for C17H18ClNO2, 303.10;
m/z found, 304.1 (M+H)+. 1H NMR (d6- DMSO): 8.41 (s, 1H), 7.43 (d, J= 8.8
Hz, 2H), 7.28 (t, J= 8.1 Hz, 1H), 7.03 (d, J= 8.8 Hz, 2H), 6.72 (dd, J=
8.2, 2.2 Hz, 1H), 6.60-6.53 (m, 2H), 3.94 (t, J = 6.2 Hz, 2H), 3.88 (t,
J= 9.2 Hz, 2H), 3.67-3.59 (m, 2H), 2.95-2.85 (m, 1H), 2.03-1.96 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-substituted heterocyclic urea modulators of fatty
acid amide hydrolase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breitenbucher, Guy J.; Tichenor, Mark S.; Merit, Jeffrey E.; Hawryluk,
Natalie A.; Chambers, Alison L.; Keith, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010141809 A1 2010-12-09

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanine 2-propen-1-yl ester
C12H21NO4
127043-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 2.8737 0.0 0
M  V30 2 C 6.1601 4.2073 0.0 0
M  V30 3 C 3.8500 2.8737 0.0 0
M  V30 4 C 7.4939 3.4373 0.0 0
M  V30 5 C 4.8264 4.9773 0.0 0
M  V30 6 C 6.9301 5.5410 0.0 0
M  V30 7 O 3.0800 1.5400 0.0 0
M  V30 8 O 3.0800 4.2073 0.0 0
M  V30 9 O 8.8275 4.2073 0.0 0
M  V30 10 O 7.4939 1.8973 0.0 0
M  V30 11 C 1.5400 1.5400 0.0 0
M  V30 12 C 10.1612 3.4373 0.0 0
M  V30 13 C 1.5400 0.0000 0.0 0
M  V30 14 C 0.0000 1.5400 0.0 0
M  V30 15 C 1.5400 3.0800 0.0 0
M  V30 16 C 11.4948 4.2073 0.0 0
M  V30 17 C 12.8286 3.4373 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Alanine, 2-methyl-, 2-propenyl ester, formate
C7H13NO2.CH2O2
127043-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 O 2.6675 2.3100 0.0 0
M  V30 5 C 2.1037 5.9537 0.0 0
M  V30 6 C 0.0000 5.3901 0.0 0
M  V30 7 N 0.5637 3.2864 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 C 8.0023 3.8501 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 O 2.6675 0.7700 0.0 0
M  V30 13 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 8 9
M  V30 9 2 9 10
M  V30 10 1 11 12
M  V30 11 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 127043-33-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127043-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23925326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Functionalized Oxaziridines as Topological
Analogs of Penicillins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marchand-Brynaert, Jacqueline; Bounkhala-Khrouz, Zoubida; van Keulen,
Berend Jan; Vanlierde, Huguette; Ghosez, LEOn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Israel Journal of Chemistry (2013), 29(2-3), 247-255

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenyl-N-[1-(1-methylethyl)-2-propen-1-yl]benzenamine
C14H19N
1273298-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.6674 0.0 0
M  V30 2 C 2.3100 2.6674 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 C 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 8.4700 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 4.6200 6.6685 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Ethenylphenyl)-N-[1-(1-methylethyl)-2-propen-1-yl]formamide
C15H19NO
1273298-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 C 1.5400 5.3347 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 O 3.8500 6.6685 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 C 2.3100 6.6685 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 8.4700 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0
M  V30 15 C 6.9300 1.3338 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 2 5 9
M  V30 10 2 10 11
M  V30 11 1 10 13
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1273298-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1273298-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11571348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkene isomerization/enamide-ene and diene metathesis for the
construction of indoles, quinolines, benzofurans and chromenes with a
chiral cyclopropane substituent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Takaaki; Arisawa, Mitsuhiro; Shuto, Satoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(4), 1219-1224

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7,11-Trioxa-2,18-diaza-6-phosphanonadecanedioic acid, 6-(2-cyanoethoxy)-3-[...
C38H60N3O14P
1277177-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 10.0100 10.6694 0.0 0 CFG=3 VAL=5
M  V30 2 O 8.4700 10.6694 0.0 0
M  V30 3 O 11.5500 10.6694 0.0 0
M  V30 4 O 10.0100 12.2094 0.0 0
M  V30 5 O 10.0100 9.1294 0.0 0
M  V30 6 C 7.7000 9.3358 0.0 0
M  V30 7 C 12.3200 9.3358 0.0 0
M  V30 8 C 8.6764 12.9794 0.0 0
M  V30 9 C 6.1600 9.3358 0.0 0 CFG=1
M  V30 10 C 13.8600 9.3358 0.0 0 CFG=2
M  V30 11 C 8.6764 14.5194 0.0 0
M  V30 12 N 5.3900 10.6694 0.0 0
M  V30 13 C 5.3900 8.0020 0.0 0
M  V30 14 C 14.6300 10.6694 0.0 0
M  V30 15 O 14.6300 8.0020 0.0 0
M  V30 16 C 7.3427 15.2894 0.0 0
M  V30 17 C 3.8500 10.6694 0.0 0
M  V30 18 O 6.1600 6.6684 0.0 0
M  V30 19 O 3.8500 8.0020 0.0 0
M  V30 20 O 16.1700 10.6694 0.0 0
M  V30 21 C 13.8600 6.6684 0.0 0
M  V30 22 N 6.0089 16.0594 0.0 0
M  V30 23 O 3.0800 12.0031 0.0 0
M  V30 24 O 3.0800 9.3358 0.0 0
M  V30 25 C 5.3900 5.3347 0.0 0
M  V30 26 C 16.9400 12.0031 0.0 0
M  V30 27 C 14.6300 5.3347 0.0 0
M  V30 28 O 12.3200 6.6684 0.0 0
M  V30 29 C 1.5400 12.0031 0.0 0
M  V30 30 C 4.0564 6.1047 0.0 0
M  V30 31 C 4.6200 4.0011 0.0 0
M  V30 32 C 6.7236 4.5647 0.0 0
M  V30 33 C 18.4800 12.0031 0.0 0
M  V30 34 O 16.1700 13.3369 0.0 0
M  V30 35 C 13.8600 4.0011 0.0 0
M  V30 36 C 1.5400 10.4631 0.0 0
M  V30 37 C 0.0000 12.0031 0.0 0
M  V30 38 C 1.5400 13.5431 0.0 0
M  V30 39 C 19.2500 13.3369 0.0 0
M  V30 40 C 14.6300 2.6673 0.0 0
M  V30 41 C 20.7900 13.3369 0.0 0
M  V30 42 C 13.8600 1.3336 0.0 0
M  V30 43 C 21.5600 14.6705 0.0 0
M  V30 44 C 14.6300 0.0000 0.0 0
M  V30 45 C 23.1000 14.6705 0.0 0
M  V30 46 N 23.8700 16.0041 0.0 0
M  V30 47 C 25.4100 16.0041 0.0 0
M  V30 48 O 26.1800 17.3378 0.0 0
M  V30 49 O 26.1800 14.6705 0.0 0
M  V30 50 C 27.7200 17.3378 0.0 0
M  V30 51 C 28.4900 18.6716 0.0 0
M  V30 52 C 27.7200 20.0052 0.0 0
M  V30 53 C 30.0300 18.6716 0.0 0
M  V30 54 C 28.4900 21.3389 0.0 0
M  V30 55 C 30.8000 20.0052 0.0 0
M  V30 56 C 30.0300 21.3389 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15 CFG=1
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 3 16 22
M  V30 22 1 17 23
M  V30 23 2 17 24
M  V30 24 1 18 25
M  V30 25 1 20 26
M  V30 26 1 21 27
M  V30 27 2 21 28
M  V30 28 1 23 29
M  V30 29 1 25 30
M  V30 30 1 25 31
M  V30 31 1 25 32
M  V30 32 1 26 33
M  V30 33 2 26 34
M  V30 34 1 27 35
M  V30 35 1 29 36
M  V30 36 1 29 37
M  V30 37 1 29 38
M  V30 38 1 33 39
M  V30 39 1 35 40
M  V30 40 1 39 41
M  V30 41 1 40 42
M  V30 42 1 41 43
M  V30 43 1 42 44
M  V30 44 1 43 45
M  V30 45 1 45 46
M  V30 46 1 46 47
M  V30 47 1 47 48
M  V30 48 2 47 49
M  V30 49 1 48 50
M  V30 50 1 50 51
M  V30 51 2 51 52
M  V30 52 1 51 53
M  V30 53 1 52 54
M  V30 54 2 53 55
M  V30 55 2 54 56
M  V30 56 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5,7,10-Trioxa-2-aza-6-phosphahexadecanoic acid, 9-[[(6-amino-1-oxohexyl)oxy]m...
C30H54N3O12P.CH2O2
1335285-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 16.9805 0.0 0 CFG=1
M  V30 2 C 6.1600 15.6469 0.0 0
M  V30 3 N 6.1600 18.3142 0.0 0
M  V30 4 C 3.8500 16.9805 0.0 0
M  V30 5 O 7.7000 15.6469 0.0 0
M  V30 6 C 5.3900 19.6478 0.0 0
M  V30 7 O 3.0800 15.6469 0.0 0
M  V30 8 O 3.0800 18.3142 0.0 0
M  V30 9 P 8.4700 14.3131 0.0 0 CFG=3 VAL=5
M  V30 10 O 6.1600 20.9816 0.0 0
M  V30 11 O 3.8500 19.6478 0.0 0
M  V30 12 C 1.5400 15.6469 0.0 0
M  V30 13 O 9.2400 12.9794 0.0 0
M  V30 14 O 7.1364 13.5431 0.0 0
M  V30 15 O 9.8036 15.0831 0.0 0
M  V30 16 C 5.3900 22.3152 0.0 0
M  V30 17 C 1.5400 14.1069 0.0 0
M  V30 18 C 0.0000 15.6469 0.0 0
M  V30 19 C 1.5400 17.1869 0.0 0
M  V30 20 C 10.7800 12.9794 0.0 0
M  V30 21 C 7.1364 12.0031 0.0 0
M  V30 22 C 6.7236 23.0852 0.0 0
M  V30 23 C 4.6200 23.6489 0.0 0
M  V30 24 C 4.0564 21.5452 0.0 0
M  V30 25 C 11.5500 11.6458 0.0 0 CFG=1
M  V30 26 C 5.8027 11.2331 0.0 0
M  V30 27 O 10.7800 10.3120 0.0 0
M  V30 28 C 13.0900 11.6458 0.0 0
M  V30 29 C 5.8027 9.6931 0.0 0
M  V30 30 C 11.5500 8.9784 0.0 0
M  V30 31 O 13.8600 12.9794 0.0 0
M  V30 32 N 5.8027 8.1531 0.0 0
M  V30 33 C 10.7800 7.6447 0.0 0
M  V30 34 O 13.0900 8.9784 0.0 0
M  V30 35 C 15.4000 12.9794 0.0 0
M  V30 36 C 11.5500 6.3111 0.0 0
M  V30 37 C 16.1700 14.3131 0.0 0
M  V30 38 O 16.1700 11.6458 0.0 0
M  V30 39 C 10.7800 4.9773 0.0 0
M  V30 40 C 17.7100 14.3131 0.0 0
M  V30 41 C 11.5500 3.6437 0.0 0
M  V30 42 C 18.4800 15.6469 0.0 0
M  V30 43 C 10.7800 2.3100 0.0 0
M  V30 44 C 20.0200 15.6467 0.0 0
M  V30 45 C 20.7900 16.9805 0.0 0
M  V30 46 N 22.3300 16.9805 0.0 0
M  V30 47 C 11.1650 0.0000 0.0 0
M  V30 48 O 9.8313 0.7700 0.0 0
M  V30 49 O 12.4987 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 13 20
M  V30 20 1 14 21
M  V30 21 1 16 22
M  V30 22 1 16 23
M  V30 23 1 16 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 25 27 CFG=1
M  V30 27 1 25 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 3 29 32
M  V30 32 1 30 33
M  V30 33 2 30 34
M  V30 34 1 31 35
M  V30 35 1 33 36
M  V30 36 1 35 37
M  V30 37 2 35 38
M  V30 38 1 36 39
M  V30 39 1 37 40
M  V30 40 1 39 41
M  V30 41 1 40 42
M  V30 42 1 41 43
M  V30 43 1 42 44
M  V30 44 1 44 45
M  V30 45 1 45 46
M  V30 46 1 47 48
M  V30 47 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1277177-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1335285-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-12473400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Trifunctional Phosphatidylserine Probes for Identification
of Lipid-Binding Proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bandyopadhyay, Saibal; Bong, Dennis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), (4), 751-758,
S751/1-S751/66

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitro-1,8-naphthalenediamine
C10H9N3O2
128094-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 5.3900 0.0 0
M  V30 2 N 0.0000 3.0800 0.0 0
M  V30 3 N 6.6684 5.3900 0.0 0 VAL=5
M  V30 4 O 8.0021 4.6200 0.0 0
M  V30 5 O 6.6685 6.9300 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 5.3347 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Nitro-1H-perimidine
C11H7N3O2
314729-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 5.3900 0.0 0 VAL=5
M  V30 2 O 8.0021 4.6200 0.0 0
M  V30 3 O 6.6685 6.9300 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 5.3347 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 N 1.3336 5.3900 0.0 0
M  V30 12 N 0.0000 3.0800 0.0 0
M  V30 13 C 1.3336 0.7700 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 2.6674 0.0000 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 2 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 16
M  V30 18 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 128094-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 314729-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12097816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peri-naphthylenediamines 29. 1,8-bis(dimethylamino)-3-nitro- and
-3,6-dinitronaphthalenes and 5,6-bis(dimethylamino)-3-nitro- and
-3,8-dinitroacenaphthenes as the first representatives of "proton
sponges" meta-substituted relative to NMe2 groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ozeryanskii, V. A.; Pozharskii, A. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2000), 49(8), 1399-1405

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[6-(Phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl]cyclo...
C20H21N5O2S
1315495-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.6660 3.6952 0.0 0 VAL=6
M  V30 2 O 9.6660 2.1552 0.0 0
M  V30 3 O 9.6660 5.2352 0.0 0
M  V30 4 N 0.0000 0.0000 0.0 0
M  V30 5 C 4.6117 5.4956 0.0 0
M  V30 6 C 5.7561 4.4652 0.0 0
M  V30 7 N 3.0800 5.3347 0.0 0
M  V30 8 C 4.9318 7.0021 0.0 0
M  V30 9 C 7.2208 4.9411 0.0 0
M  V30 10 C 5.7561 2.9252 0.0 0
M  V30 11 C 2.4537 6.7417 0.0 0
M  V30 12 C 6.3964 7.4779 0.0 0
M  V30 13 N 3.5982 7.7721 0.0 0
M  V30 14 N 8.1260 3.6952 0.0 0
M  V30 15 N 7.5409 6.4475 0.0 0
M  V30 16 C 7.2208 2.4494 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 22 C 0.7700 1.3336 0.0 0 CFG=1
M  V30 23 C 11.2060 3.6952 0.0 0
M  V30 24 C 11.9760 2.3616 0.0 0
M  V30 25 C 11.9760 5.0289 0.0 0
M  V30 26 C 13.5160 2.3616 0.0 0
M  V30 27 C 13.5160 5.0289 0.0 0
M  V30 28 C 14.2860 3.6952 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 23
M  V30 5 1 22 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 17 7 CFG=3
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 1 9 15
M  V30 17 2 10 16
M  V30 18 2 11 13
M  V30 19 2 12 15
M  V30 20 1 14 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[6-(Phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl]cy...
C21H21N5O3S
1315496-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0010 3.0801 0.0 0 VAL=6
M  V30 2 O 4.7710 1.7462 0.0 0
M  V30 3 O 3.2310 4.4137 0.0 0
M  V30 4 N 14.2197 4.7128 0.0 0
M  V30 5 C 15.5534 5.4828 0.0 0
M  V30 6 O 16.8871 4.7128 0.0 0
M  V30 7 C 7.4779 7.1665 0.0 0
M  V30 8 C 7.0021 5.7018 0.0 0
M  V30 9 N 8.8849 7.7929 0.0 0
M  V30 10 C 6.4475 8.3109 0.0 0
M  V30 11 C 5.4958 5.3816 0.0 0
M  V30 12 C 7.7721 4.3682 0.0 0
M  V30 13 C 8.7240 9.3244 0.0 0
M  V30 14 C 4.9412 7.9908 0.0 0
M  V30 15 N 7.2175 9.6446 0.0 0
M  V30 16 N 5.3348 3.8501 0.0 0
M  V30 17 N 4.4653 6.5260 0.0 0
M  V30 18 C 6.7417 3.2236 0.0 0
M  V30 19 C 10.2186 7.0229 0.0 0 CFG=1
M  V30 20 C 10.2186 5.4828 0.0 0
M  V30 21 C 11.5523 7.7929 0.0 0
M  V30 22 C 11.5523 4.7128 0.0 0
M  V30 23 C 12.8861 7.0229 0.0 0
M  V30 24 C 12.8861 5.4828 0.0 0 CFG=1
M  V30 25 C 2.6673 2.3101 0.0 0
M  V30 26 C 1.3337 3.0801 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 0.0000 2.3101 0.0 0
M  V30 29 C 1.3337 0.0000 0.0 0
M  V30 30 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 24 4 CFG=3
M  V30 7 2 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 19 9 CFG=1
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 2 12 18
M  V30 20 2 13 15
M  V30 21 2 14 17
M  V30 22 1 16 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315495-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315496-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3615192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM trans-N-[4-(6-Phenylsulfonyl-imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-cyclohexyl]-formamide.
A mixture of acetic anhydride (359 μL, 3.78 mmol) and formic acid (713
μL, 18.9 mmol) was heated to 50 °C for 5 min then cooled to 0 °C. 62 (500
mg, 1.26 mmol) and THF (2 mL) was added and the resulting mixture stirred
for 30 min, then quenched with saturated aqueous sodium bicarbonate and
extracted with DCM. The combined organic layers were dried over sodium
sulfate and concentrated under vacuum. The aqueous layer was filtered and
an insoluble solid collected and washed with water. This was combined
with the concentrated organic layers to afford
trans-N-[4-(6-phenylsulfonyl-imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-cyclohexyl]-formamide.
Yield 550 mg, quant. LCMS (Method 2, ESI): RT = 2.79 min, m+H = 424.3; 1H
NMR (400 MHz, DMSO-d6) δ: 8.73 (s, 1 H), 8.48 (s, 1 H), 8.11-8.10 (m, 3
H), 7.98-7.97 (m, 2 H), 7.69-7.66 (m, 1 H), 7.61-7.60 (m, 2 H), 7.23 (d,
J= 4.1 Hz, 1 H), 4.70-4.58 (m, 1 H), 3.82-3.69 (m, 1 H), 2.00 (m, 6 H),
1.67-1.53 (m, 2 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine;
Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico;
Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya;
Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir
Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray,
Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar,
Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz,
Bohdan; Zak, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(12), 5901-5921

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[6-(Phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl]cyclo...
C20H21N5O2S
1315495-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.6660 3.6952 0.0 0 VAL=6
M  V30 2 O 9.6660 2.1552 0.0 0
M  V30 3 O 9.6660 5.2352 0.0 0
M  V30 4 N 0.0000 0.0000 0.0 0
M  V30 5 C 4.6117 5.4956 0.0 0
M  V30 6 C 5.7561 4.4652 0.0 0
M  V30 7 N 3.0800 5.3347 0.0 0
M  V30 8 C 4.9318 7.0021 0.0 0
M  V30 9 C 7.2208 4.9411 0.0 0
M  V30 10 C 5.7561 2.9252 0.0 0
M  V30 11 C 2.4537 6.7417 0.0 0
M  V30 12 C 6.3964 7.4779 0.0 0
M  V30 13 N 3.5982 7.7721 0.0 0
M  V30 14 N 8.1260 3.6952 0.0 0
M  V30 15 N 7.5409 6.4475 0.0 0
M  V30 16 C 7.2208 2.4494 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 22 C 0.7700 1.3336 0.0 0 CFG=1
M  V30 23 C 11.2060 3.6952 0.0 0
M  V30 24 C 11.9760 2.3616 0.0 0
M  V30 25 C 11.9760 5.0289 0.0 0
M  V30 26 C 13.5160 2.3616 0.0 0
M  V30 27 C 13.5160 5.0289 0.0 0
M  V30 28 C 14.2860 3.6952 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 23
M  V30 5 1 22 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 17 7 CFG=3
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 1 9 15
M  V30 17 2 10 16
M  V30 18 2 11 13
M  V30 19 2 12 15
M  V30 20 1 14 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[6-(Phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl]cy...
C21H21N5O3S
1315496-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0010 3.0801 0.0 0 VAL=6
M  V30 2 O 4.7710 1.7462 0.0 0
M  V30 3 O 3.2310 4.4137 0.0 0
M  V30 4 N 14.2197 4.7128 0.0 0
M  V30 5 C 15.5534 5.4828 0.0 0
M  V30 6 O 16.8871 4.7128 0.0 0
M  V30 7 C 7.4779 7.1665 0.0 0
M  V30 8 C 7.0021 5.7018 0.0 0
M  V30 9 N 8.8849 7.7929 0.0 0
M  V30 10 C 6.4475 8.3109 0.0 0
M  V30 11 C 5.4958 5.3816 0.0 0
M  V30 12 C 7.7721 4.3682 0.0 0
M  V30 13 C 8.7240 9.3244 0.0 0
M  V30 14 C 4.9412 7.9908 0.0 0
M  V30 15 N 7.2175 9.6446 0.0 0
M  V30 16 N 5.3348 3.8501 0.0 0
M  V30 17 N 4.4653 6.5260 0.0 0
M  V30 18 C 6.7417 3.2236 0.0 0
M  V30 19 C 10.2186 7.0229 0.0 0 CFG=1
M  V30 20 C 10.2186 5.4828 0.0 0
M  V30 21 C 11.5523 7.7929 0.0 0
M  V30 22 C 11.5523 4.7128 0.0 0
M  V30 23 C 12.8861 7.0229 0.0 0
M  V30 24 C 12.8861 5.4828 0.0 0 CFG=1
M  V30 25 C 2.6673 2.3101 0.0 0
M  V30 26 C 1.3337 3.0801 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 0.0000 2.3101 0.0 0
M  V30 29 C 1.3337 0.0000 0.0 0
M  V30 30 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 24 4 CFG=3
M  V30 7 2 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 19 9 CFG=1
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 2 12 18
M  V30 20 2 13 15
M  V30 21 2 14 17
M  V30 22 1 16 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315495-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315496-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7647767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Trans
N-[4-(6-Benzenesulfonyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexyl]-formamide
A mixture of acetic anhydride (359 μL, 3.78 mmol) and formic acid (713
μ1,18.9 mmol) was heated to 50 °C for 5 minutes then cooled to 0 °C
before trans
4-(6-benzenesulfonyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexylamine
(500 mg, 1.26 mmol) and THF (2 mL) were added and the resulting mixture
stirred for 30 minutes. The reaction mixture was quenched with saturated
aqueous sodium bicarbonate and extracted with DCM. The combined organic
layers were dried over sodium sulfate and concentrated under vacuum. The
aqueous layer was filtered and an insoluble solid collected and washed
with water. This was combined with the concentrated organic layers to
afford of trans
N-[4-(6-benzenesulfonyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexyl]-formamide.
Yield 550 mg (quant.) LCMS (Method B, ESI): RT = 2.79 min, m+H = 424.3;
1H NMR (400 MHz, DMSO) δ: 8.73 (s, 1 H), 8.48 (s, 1 H), 8.11-8.10 (m, 3
H), 7.98-7.97 (m, 2 H), 7.69-7.66 (m, 1 H), 7.61-7.60 (m, 2 H), 7.23 (d,
1 H), 4.70-4.58 (m, 1 H), 3.82-3.69 (m, 1 H), 2.02-1.99 (m, 6 H)
1.67-1.53 (m, 2 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic heterocyclic compounds as JAK1 inhibitors, and their
preparation, compositions and use in the treatment of immunological and
hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babu, Srinivasan; Bergeron, Phillippe; Dragovich, Peter; Dyke, Hazel
Joan; Gibbons, Paul; Gradl, Stefan; Hanan, Emily; Hurley, Christopher;
Johnson, Tony; Koehler, Michael; Kulagowski, Janusz Josef; Labadie,
Sharada Shenvi; Lyssikatos, Joseph P.; Mendonca, Rohan; Pulk, Rebecca;
Ward, Stuard; Waszkowycz, Bohdan; Zak, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011086053 A1 2011-07-21

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2aR,4R,7S,8S)-8-Amino-6-chloro-7-ethenyl-1,2a,3,4,7,8-hexahydro-1,3,3,7-tetr...
C21H23ClN2O2
1326216-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.0388 1.4932 0.0 0
M  V30 2 C 2.0915 1.6780 0.0 0
M  V30 3 C 0.7577 0.9080 0.0 0
M  V30 4 C 0.5800 2.9229 0.0 0
M  V30 5 O 2.9218 4.3884 0.0 0
M  V30 6 Cl 0.0000 4.8847 0.0 0
M  V30 7 C 5.3937 7.3707 0.0 0
M  V30 8 C 7.2453 6.3952 0.0 0
M  V30 9 O 8.4532 6.2886 0.0 0
M  V30 10 C 10.2161 3.4274 0.0 0
M  V30 11 C 3.6193 2.9196 0.0 0 CFG=2
M  V30 12 C 5.0748 1.9659 0.0 0
M  V30 13 C 2.0915 3.2181 0.0 0 CFG=2
M  V30 14 C 4.4401 4.1307 0.0 0
M  V30 15 C 6.2759 3.0094 0.0 0
M  V30 16 C 5.3471 0.5119 0.0 0
M  V30 17 C 1.5186 4.6288 0.0 0
M  V30 18 C 4.0611 5.5582 0.0 0 CFG=1
M  V30 19 C 6.4237 4.4540 0.0 0 CFG=2
M  V30 20 C 7.6859 2.4253 0.0 0
M  V30 21 C 6.7642 0.0000 0.0 0
M  V30 22 C 2.5224 5.7740 0.0 0
M  V30 23 C 5.7929 5.8831 0.0 0
M  V30 24 C 7.8871 4.8566 0.0 0
M  V30 25 N 8.6816 3.5591 0.0 0
M  V30 26 C 7.9290 0.9525 0.0 0
M  V30 27 H 4.0255 7.0978 0.0 0
M  V30 28 H 7.0844 5.8451 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 2 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 13 4 CFG=1
M  V30 5 2 5 14
M  V30 6 1 6 17
M  V30 7 1 7 23
M  V30 8 1 8 23
M  V30 9 2 9 24
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 21
M  V30 21 2 17 22
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 27 CFG=1
M  V30 25 1 19 23
M  V30 26 1 19 24
M  V30 27 1 19 28 CFG=3
M  V30 28 1 20 25
M  V30 29 1 20 26
M  V30 30 2 21 26
M  V30 31 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 13 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2aR,4R,7S,8S)-6-Chloro-7-ethenyl-1,2a,3,4,7,8-hexahydro-8-isocyano-1,3,3,7-t...
C22H21ClN2O2
159189-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0930 1.5400 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0930 0.0000 0.0 0 CHG=-1
M  V30 3 C 3.1458 1.3542 0.0 0
M  V30 4 C 2.2009 0.1381 0.0 0
M  V30 5 C 1.2767 1.9375 0.0 0
M  V30 6 O 2.8934 4.1775 0.0 0
M  V30 7 Cl 0.0000 3.5361 0.0 0
M  V30 8 C 4.0589 7.8716 0.0 0
M  V30 9 C 6.1417 7.6660 0.0 0
M  V30 10 O 7.3006 8.0227 0.0 0
M  V30 11 C 10.0118 6.0370 0.0 0
M  V30 12 C 4.0930 3.0801 0.0 0 CFG=2
M  V30 13 C 5.8006 2.7453 0.0 0
M  V30 14 C 2.5654 2.7805 0.0 0 CFG=2
M  V30 15 C 4.3968 4.5112 0.0 0
M  V30 16 C 6.5198 4.1644 0.0 0
M  V30 17 C 6.6008 1.5012 0.0 0
M  V30 18 C 1.5031 3.8714 0.0 0
M  V30 19 C 3.5078 5.6906 0.0 0 CFG=1
M  V30 20 C 6.1123 5.5583 0.0 0 CFG=2
M  V30 21 C 8.0461 4.1550 0.0 0
M  V30 22 C 8.1063 1.5613 0.0 0
M  V30 23 C 2.0011 5.3104 0.0 0
M  V30 24 C 4.9893 6.6444 0.0 0
M  V30 25 C 7.3160 6.4826 0.0 0
M  V30 26 N 8.5409 5.5805 0.0 0
M  V30 27 C 8.8261 2.8825 0.0 0
M  V30 28 H 2.8944 7.1033 0.0 0
M  V30 29 H 6.1999 7.0959 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 3 4
M  V30 4 1 14 3 CFG=3
M  V30 5 1 14 5 CFG=1
M  V30 6 2 6 15
M  V30 7 1 7 18
M  V30 8 1 8 24
M  V30 9 1 9 24
M  V30 10 2 10 25
M  V30 11 1 11 26
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 16 21
M  V30 21 1 17 22
M  V30 22 2 18 23
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 19 28 CFG=1
M  V30 26 1 20 24
M  V30 27 1 20 25
M  V30 28 1 20 29 CFG=3
M  V30 29 1 21 26
M  V30 30 1 21 27
M  V30 31 2 22 27
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 14 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1326216-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159189-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29121663
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29684-56-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (-)-N-Methylwelwitindolinone Isonitrile (2). A 1-dram vial was charged
with 96% formic acid (0.100 mL) and acetic anhydride (0.100 mL), and then
stirred at 60 °C for 1 h. The reaction vessel was cooled to room
temperature and 68 μL of the 96% formic acid/acetic anhydride mixture was
added to a solution of aminoketone 12 (7.5 mg, 0.0203 mmol, 1 equiv) in
THF (450 μL) at 0 °C. The reaction was stirred at 0 °C for 5 minutes, and
then warmed to room temperature. After stirring for an additional 30
minutes, the reaction mixture was then transferred to a test tube
containing EtOAc (1 mL) and a saturated solution of aqueous NaHCO3 (1
mL). The resulting biphasic mixture was extracted with EtOAc (3 x 3 mL).
The organic layers were combined, dried over MgSO4, and evaporated under
reduced pressure to afford the crude product, which was used directly in
the subsequent reaction. To the crude residue was added THF (1 mL) and
benzene (1 mL), followed by the addition of Burgess reagent (12 mg,
0.0406 mmol, 2 equiv). The vial was flushed with N2 and allowed to stir
at room temperature for 1 h. The reaction was then filtered through a
plug of silica gel (EtOAc eluent, 20 mL). The filtrate was evaporated
under reduced pressure, and the resulting residue was purified by prep
TLC (1:1 hexanes:EtOAc) to afford (-)-2. Yield 7.8 mg, quant., amorphous
solid. Spectral data for synthetic 2 was consistent with literature
reports4: Rf 0.60 (1:1 hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.33
(ddd, J = 8.5, 7.7, 0.9, 1H), 7.27 (dd, J = 8.5, 0.9, 1H), 6.81 (dd, J =
7.7, 0.9, 1H), 6.18 (d, J = 4.4, 1H), 5.37-5.30 (m, 3H), 3.73 (s, 1H),
3.23 (d, J = 4.4, 1H), 3.18 (s, 3H), 1.68 (s, 3H), 1.53 (s, 3H), 0.79 (s,
3H); 13C NMR (125 MHz, CDCl3): δ 193.4, 173.9, 163.5, 144.5, 138.3,
136.2, 128.7, 127.7, 124.6, 123.3, 122.8, 118.3, 108.8, 81.9, 61.6, 55.6,
53.2, 40.7, 26.4, 25.6, 22.6, 21.3; IR (film): 2969, 2141, 1735, 1711,
1609, 1587, 1460, 1341 cm-1; HRMS-ESI (m/z) [M + Na]+ calcd for
C22H21N2O2ClNa, 403.1189; found 403.1178; [α ]24.2 D -90.4° (c = 0.25,
CH2Cl2).5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Oxidized Welwitindolinones and
(-)-N-Methylwelwitindolinone C Isonitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quasdorf, Kyle W.; Huters, Alexander D.; Lodewyk, Michael W.; Tantillo,
Dean J.; Garg, Neil K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2012), 134(3), 1396-1399

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(aminomethyl)-5-chloro-2-(3-fluorophenyl)-3-pyridinecarboxylate
C14H12ClFN2O2
1341231-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.9300 0.0 0
M  V30 2 O 1.3336 7.7000 0.0 0
M  V30 3 O 4.0011 7.7000 0.0 0
M  V30 4 C 1.3336 9.2400 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 N 4.0011 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.3100 0.0 0
M  V30 8 F 9.3358 4.6200 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 N 4.0011 3.0800 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 1.3336 3.0800 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 5.3347 6.9300 0.0 0
M  V30 18 C 8.0021 5.3900 0.0 0
M  V30 19 C 6.6684 7.7000 0.0 0
M  V30 20 C 8.0021 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 14
M  V30 8 1 8 18
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-(3-fluorophenyl)-6-[(formylamino)methyl]-3-pyridinecarboxylate
C15H12ClFN2O3
1341231-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 O 2.6673 3.0801 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 8.0022 7.7002 0.0 0
M  V30 6 N 9.3360 6.9302 0.0 0
M  V30 7 C 10.6697 7.7002 0.0 0
M  V30 8 O 12.0033 6.9302 0.0 0
M  V30 9 Cl 5.3348 9.2402 0.0 0
M  V30 10 F 8.0022 0.0000 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 N 6.6685 5.3901 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 15 C 6.6685 6.9302 0.0 0
M  V30 16 C 5.3348 7.7002 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0012 0.7700 0.0 0
M  V30 22 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 16
M  V30 10 1 10 20
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1341231-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1341231-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13497515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step F: Methyl
5-chloro-2-(3-fluorophenyl)-6-[formylamino)methyl]nicotinate Methyl
6-(aminomethyl)-5-chloro-2-(3-fluorophenyl)nicotinate (1.1 g, 3.7
mmol)was stirred in formic acid (10 mL) and heated to 90 °C for 10 hours.
Evaporation gave the crude material which was contaminated with the
corresponding dechlorinated byproduct. Yield (1.1 g, quantitative). LCMS
calculated for C15H13ClFN2O3 (M+H)+: m/z = 323.1; found: 322.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridinylethylpurinamine derivatives and analogs
for use as PI3K inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Combs, Andrew P.; Sparks, Richard B.; Yue, Eddy W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011130342 A1 2011-10-20

$RFMT $RIREG SCHEME55 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylamine
C10H9N
134-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-[(1-naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C16H13N3O3
2178914-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 9.3360 0.7700 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 O 12.0033 5.3901 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 8.0022 3.0801 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 N 10.6697 3.0801 0.0 0
M  V30 21 N 9.3360 5.3901 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 17 CFG=2
M  V30 4 2 3 18
M  V30 5 2 4 19
M  V30 6 1 5 20
M  V30 7 2 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-32-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22150339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME56 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylamine
C10H9N
134-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1-Naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C15H11N3O3
337341-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 9.3360 0.7700 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 O 12.0033 5.3901 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 N 10.6697 3.0801 0.0 0
M  V30 20 N 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 16
M  V30 4 2 3 17
M  V30 5 2 4 18
M  V30 6 2 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 134-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 337341-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21331377
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME57 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylamine
C10H9N
134-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-5-[(1-naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C17H15N3O3
294852-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 6.6685 1.5400 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 O 12.0033 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 6.1601 0.0 0
M  V30 13 C 1.3337 6.1601 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 6.9302 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 N 9.3360 1.5400 0.0 0
M  V30 22 N 10.6697 3.8501 0.0 0
M  V30 23 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 18
M  V30 4 2 3 19
M  V30 5 2 4 20
M  V30 6 1 5 21
M  V30 7 1 6 22
M  V30 8 2 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 15 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-32-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 294852-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21333318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Azidomethyl)benzenemethanamine
C8H10N4
134557-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 4.0011 0.0000 0.0 0
M  V30 4 N 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0 CHG=1 VAL=4
M  V30 6 N 9.3359 3.0800 0.0 0 CHG=-1
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R)-2-Azido-1-phenylethyl]formamide
C9H10N4O
910488-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 N 6.6684 3.8500 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 8.0022 4.6201 0.0 0 CHG=1 VAL=4
M  V30 7 O 5.3348 0.0000 0.0 0
M  V30 8 N 9.3359 5.3901 0.0 0 CHG=-1
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3337 3.8500 0.0 0
M  V30 11 C 2.6675 6.1601 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 1.3337 6.9301 0.0 0
M  V30 14 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134557-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910488-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5384118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (R)-2-Azido-N-formylamino-1-phenylethylamine (14) (a) Formylation of 13.
To a solution of 13 (1.71 g, 10.5 mmol) in formic acid (5.9 mL, 156 mmol)
was added dropwise acetic anhydride (14.8 mL, 157 mmol) at 0°C and then
the whole was stirred at room temperature for 2 h. The solvent was
removed under reduced pressure to give 14. Pale yellow oil, yield (2.01
g, quant.). [α]23 D -119.8 (c 2.27, MeOH); 1H NMR δ: δ 3.72 (2H, d, J =
5.20 Hz), 5.32-5.27 (1H, m), 6.16 (1H, br), 7.29-7.43 (5H, m), 8.27 (1H,
s); 13C NMR δ: 51.2, 55.0, 126.6, 128.3, 129.0, 138.1, 160.7; IR (neat)
λmax cm-1: 3276 (NH), 2104 (N=N=N), 1663 (C=O); FABMS m/z: 191 ([M + 1]+,
100%), 134 (80%), 91 (39%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported and polymeric chiral guanidines: Preparation and
application to the asymmetric Michael reaction of iminoacetate with
methyl vinyl ketone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wannaporn, Disadee; Ishikawa, Tsutomu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2005), 9(4), 321-331

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-bromopyridine
C5H5BrN2
13534-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 Br 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-3-pyridinyl)formamide
C6H5BrN2O
1350901-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 N 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13534-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350901-10-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23300304
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Continuous-flow synthesis of thioureas, enabled by aqueous polysulfide
solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nemeth, Andras Gy.; Szabo, Renata; Orsy, Gyorgy; Mandity, Istvan M.;
Keseru, Gyorgy M.; Abranyi-Balogh, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(2), 303

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-bromopyridine
C5H5BrN2
13534-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 N 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Bromo-2-pyridinyl)formamide
C6H5BrN2O
1465456-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13534-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1465456-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24200177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed microwave vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Substituted 2-isocyanopyridines as versatile convertible isocyanides
for peptidomimetic design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollanders, Charlie; Elsocht, Mathias; Van der Poorten, Olivier; Jida,
Mouhamad; Renders, Evelien; Maes, Bert U. W.; Ballet, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(56),
6863-6866

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4E)-6-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-4-hexen-1-amine
C12H27NOSi
1353722-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 2.6673 2.1037 0.0 0
M  V30 2 O 4.0010 2.8737 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 1.8973 3.4374 0.0 0
M  V30 5 C 3.4374 0.7700 0.0 0
M  V30 6 C 5.3348 2.1037 0.0 0
M  V30 7 C 2.1037 0.0000 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 C 0.5637 2.6673 0.0 0
M  V30 10 C 6.6685 2.8737 0.0 0
M  V30 11 C 8.0022 2.1037 0.0 0
M  V30 12 C 9.3360 2.8737 0.0 0
M  V30 13 C 10.6697 2.1037 0.0 0
M  V30 14 C 12.0033 2.8737 0.0 0
M  V30 15 N 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4E)-6-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-4-hexen-1-yl]formamide
C13H27NO2Si
1353722-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 2.6675 2.1037 0.0 0
M  V30 2 O 4.0012 2.8737 0.0 0
M  V30 3 C 1.3338 1.3337 0.0 0
M  V30 4 C 1.8975 3.4374 0.0 0
M  V30 5 C 3.4375 0.7700 0.0 0
M  V30 6 C 5.3348 2.1037 0.0 0
M  V30 7 C 0.5638 2.6673 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 C 2.1038 0.0000 0.0 0
M  V30 10 C 6.6687 2.8737 0.0 0
M  V30 11 C 8.0023 2.1037 0.0 0
M  V30 12 C 9.3360 2.8737 0.0 0
M  V30 13 C 10.6698 2.1037 0.0 0
M  V30 14 C 12.0035 2.8737 0.0 0
M  V30 15 N 13.3372 2.1037 0.0 0
M  V30 16 C 14.6708 2.8737 0.0 0
M  V30 17 O 16.0046 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353722-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353722-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2201684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3945-69-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Process (i):
(E)-6-Amino-1-((tert-butyldimethylsilyl)oxy)hex-2-ene (1.51 g, 6.59 mmol)
(Scheme S3) and acrylic acid (843 mg, 11.7 mmol) were dissolved in THF
(30 mL). To this was added DMT-MM (4.82 g, 17.5 mmol) at rt. The white
suspension was stirred at rt for 5 h, and concentrated in vacuo. The
residue was partitioned between EtOAc (15 mL) and 1 M aq HCl (15 mL). The
aq layer was extracted with EtOAc (5 mL x 2), and the combined organic
layers were washed with sat aq NaHCO3 (15 mL) and brine (15 mL). Dryness
over Na2SO4 (5 g)/filtration/concentration process gave crude product (2
g). This was purified by SiO2-chromatography (50 g, 1:1 hexane-EtOAc
eluent) to give (E)-6-(acryloylamino)-1-((tertbutyldimethylsilyl)
oxy)hex-2-ene. Process (i): For the procedure, see Scheme S7-(i).
Reaction: (E)-6-amino-1-((tert-butyldimethylsilyl)oxy)hex-2-ene (1.00 g,
4.37 mmol) (Scheme S3); HCOOH (165 μL, 4.37 mmol); DMT-MM (1.80 g, 6.55
mmol); THF (8.7 mL); rt; 5 h. Workup: concentration/partition of the
residue between EtOAc (20 mL) and 1 M aq HCl (20 mL)/extraction with
EtOAc (10 mL x 2)/washing with sat aq NaHCO3 (15 mL) and brine (15 mL).
Dryness over Na2SO4 (5 g)/filtration/concentration process gave crude
product (1.27 g). Purification: SiO2-chromatography (100 g, EtOAc
eluent); (E)-1-((tert-butyldimethylsilyl)oxy)-6-(formylamino)hex-2-ene
(1.15 g). This intermediate exists as ca. 4:1 rotamers. 1H NMR (CDCl3),
major δ 0.07 (6H, s, Si(CH3)2), 0.91 (9H, s, SiC(CH3)3), 1.63 (2H, tt, J
= 6.87, 6.87 Hz, CH2CH2CH2), 2.10 (2H, dt, J = 6.87, 6.87 Hz, CH2CH2CH=),
3.32 (2H, dt, J = 6.87, 6.87 Hz, NHCH2), 4.12 (2H, d, J = 5.50 Hz,
CHCH2O), 5.49 (1H, br, NH), 5.58 (1H, dt, J = 16.5, 5.50 Hz, CH=CH), 5.64
(1H, dt, J = 15.1, 6.87 Hz, CH=CH), 8.17 (s, 1H, CHO); minor δ 0.07 (6H,
s, Si(CH3)2), 0.91 (9H, s, SiC(CH3)3), 1.63 (2H, tt, J = 6.87, 6.87 Hz,
CH2CH2CH2), 2.10 (2H, dt, J = 6.87, 6.87 Hz, CH2CH2CH=), 3.23 (2H, dt, J
= 6.87, 6.87 Hz, NHCH2), 4.12 (2H, d, J = 5.50 Hz, CHCH2O), 5.49 (1H, br,
NH), 5.58 (1H, dt, J = 16.5, 5.50 Hz, CH=CH), 5.64 (1H, dt, J = 15.1,
6.87 Hz, CH=CH), 8.02 (1H, d, J = 11.68 Hz, CHO).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Synthesis of Pyrrolidine-, Piperidine-, and Azepane-Type
N-Heterocycles with α-Alkenyl Substitution: The CpRu-Catalyzed
Dehydrative Intramolecular N-Allylation Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seki, Tomoaki; Tanaka, Shinji; Kitamura, Masato
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(2), 608-611

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[amino(4-fluorophenyl)methyl]phosphonate
C11H17FNO3P
135473-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0009 4.0011 0.0 0 VAL=5
M  V30 2 C 4.7709 5.3347 0.0 0
M  V30 3 O 3.2309 2.6674 0.0 0
M  V30 4 O 2.6673 4.7711 0.0 0
M  V30 5 O 5.3347 3.2311 0.0 0
M  V30 6 N 4.0009 6.6685 0.0 0
M  V30 7 C 4.0009 1.3338 0.0 0
M  V30 8 C 1.3336 4.0011 0.0 0
M  V30 9 C 3.2309 0.0000 0.0 0
M  V30 10 C 0.0000 4.7711 0.0 0
M  V30 11 F 10.9309 5.3347 0.0 0
M  V30 12 C 6.3109 5.3347 0.0 0
M  V30 13 C 7.0809 4.0011 0.0 0
M  V30 14 C 7.0809 6.6685 0.0 0
M  V30 15 C 8.6209 4.0011 0.0 0
M  V30 16 C 8.6209 6.6685 0.0 0
M  V30 17 C 9.3909 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 12
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H17FNO4P
2412201-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7710 5.3348 0.0 0
M  V30 2 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 3 N 4.0010 6.6685 0.0 0
M  V30 4 O 3.2310 2.6675 0.0 0
M  V30 5 O 2.6673 4.7712 0.0 0
M  V30 6 O 5.3348 3.2311 0.0 0
M  V30 7 C 4.7710 8.0023 0.0 0
M  V30 8 C 4.0010 1.3337 0.0 0
M  V30 9 C 1.3337 4.0012 0.0 0
M  V30 10 O 4.0010 9.3360 0.0 0
M  V30 11 C 3.2310 0.0000 0.0 0
M  V30 12 C 0.0000 4.7712 0.0 0
M  V30 13 F 10.9312 5.3348 0.0 0
M  V30 14 C 6.3111 5.3348 0.0 0
M  V30 15 C 7.0811 4.0012 0.0 0
M  V30 16 C 7.0811 6.6685 0.0 0
M  V30 17 C 8.6211 4.0012 0.0 0
M  V30 18 C 8.6211 6.6685 0.0 0
M  V30 19 C 9.3911 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135473-59-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412201-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21768486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also acts as a solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor
Ligands for Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abas, Sonia; Rodriguez-Arevalo, Sergio; Bagan, Andrea; Grinan-Ferre,
Christian; Vasilopoulou, Foteini; Brocos-Mosquera, Iria; Muguruza,
Carolina; Perez, Belen; Molins, Elies; Luque, F. Javier; Perez-Lozano,
Pilar; de Jonghe, Steven; Daelemans, Dirk; Naesens, Lieve; Brea, Jose;
Loza, M. Isabel; Hernandez-Hernandez, Elena; Garcia-Sevilla, Jesus A.;
Garcia-Fuster, M. Julia; Radan, Milica; Djikic, Teodora; Nikolic,
Katarina; Pallas, Merce; Callado, Luis F.; Escolano, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(7), 3610-3633

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[3-[3-[[[5-(2-amino-3,4-dihydro-4-oxo-3-phenyl-6-quinazol...
C34H36N6O7S
1383990-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 N 2.6673 6.9302 0.0 0
M  V30 3 S 14.6708 4.6201 0.0 0 VAL=6
M  V30 4 N 16.0045 5.3901 0.0 0
M  V30 5 O 15.4408 3.2864 0.0 0
M  V30 6 O 13.9008 5.9538 0.0 0
M  V30 7 O 14.6708 1.5400 0.0 0
M  V30 8 C 14.6708 0.0000 0.0 0
M  V30 9 O 21.3393 5.3901 0.0 0
M  V30 10 C 22.6730 4.6201 0.0 0
M  V30 11 C 24.0068 5.3901 0.0 0
M  V30 12 C 25.3405 4.6201 0.0 0
M  V30 13 N 26.6742 5.3901 0.0 0
M  V30 14 C 28.0078 4.6201 0.0 0
M  V30 15 O 29.3416 5.3901 0.0 0
M  V30 16 O 28.0078 3.0801 0.0 0
M  V30 17 C 30.6753 4.6201 0.0 0
M  V30 18 C 31.4453 5.9538 0.0 0
M  V30 19 C 32.0090 3.8501 0.0 0
M  V30 20 C 29.9053 3.2864 0.0 0
M  V30 21 C 6.6685 4.6201 0.0 0
M  V30 22 C 6.6685 6.1601 0.0 0
M  V30 23 C 5.3348 3.8501 0.0 0
M  V30 24 C 8.0022 3.8501 0.0 0
M  V30 25 N 5.3348 6.9302 0.0 0
M  V30 26 C 8.0022 6.9302 0.0 0
M  V30 27 N 4.0012 4.6201 0.0 0
M  V30 28 C 9.3360 4.6201 0.0 0
M  V30 29 C 4.0012 6.1601 0.0 0
M  V30 30 C 9.3360 6.1601 0.0 0
M  V30 31 C 2.6673 3.8501 0.0 0
M  V30 32 C 2.6673 2.3101 0.0 0
M  V30 33 C 1.3337 4.6201 0.0 0
M  V30 34 C 1.3337 1.5400 0.0 0
M  V30 35 C 0.0000 3.8501 0.0 0
M  V30 36 C 0.0000 2.3101 0.0 0
M  V30 37 C 10.6697 3.8501 0.0 0
M  V30 38 C 12.0033 4.6201 0.0 0
M  V30 39 C 10.6697 2.3101 0.0 0
M  V30 40 C 13.3370 3.8501 0.0 0
M  V30 41 N 12.0033 1.5400 0.0 0
M  V30 42 C 13.3370 2.3101 0.0 0
M  V30 43 C 17.3382 4.6201 0.0 0
M  V30 44 C 18.6720 5.3901 0.0 0
M  V30 45 C 17.3382 3.0801 0.0 0
M  V30 46 C 20.0057 4.6201 0.0 0
M  V30 47 C 18.6720 2.3101 0.0 0
M  V30 48 C 20.0057 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 29
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 40
M  V30 7 1 4 43
M  V30 8 1 7 8
M  V30 9 1 7 42
M  V30 10 1 9 10
M  V30 11 1 9 46
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 29
M  V30 32 1 27 31
M  V30 33 2 28 30
M  V30 34 1 28 37
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-(2-amino-3,4-dihydro-4-oxo-3-phenyl-6-quinazolinyl...
C29H28N6O5S.CH2O2
1383990-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6201 0.0 0
M  V30 2 N 2.6675 9.2402 0.0 0
M  V30 3 S 14.6708 6.9301 0.0 0 VAL=6
M  V30 4 N 16.0046 7.7001 0.0 0
M  V30 5 O 15.4408 5.5964 0.0 0
M  V30 6 O 13.9008 8.2638 0.0 0
M  V30 7 O 14.6708 3.8501 0.0 0
M  V30 8 C 14.6708 2.3100 0.0 0
M  V30 9 O 21.3395 7.7001 0.0 0
M  V30 10 C 22.6731 6.9301 0.0 0
M  V30 11 C 24.0068 7.7001 0.0 0
M  V30 12 C 25.3405 6.9301 0.0 0
M  V30 13 N 26.6743 7.7001 0.0 0
M  V30 14 C 6.6687 6.9301 0.0 0
M  V30 15 C 6.6687 8.4702 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 8.0023 6.1601 0.0 0
M  V30 18 N 5.3348 9.2402 0.0 0
M  V30 19 C 8.0023 9.2402 0.0 0
M  V30 20 N 4.0012 6.9301 0.0 0
M  V30 21 C 9.3360 6.9301 0.0 0
M  V30 22 C 4.0012 8.4702 0.0 0
M  V30 23 C 9.3360 8.4702 0.0 0
M  V30 24 C 2.6675 6.1601 0.0 0
M  V30 25 C 1.3338 6.9301 0.0 0
M  V30 26 C 2.6675 4.6201 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 1.3338 3.8501 0.0 0
M  V30 29 C 0.0000 4.6201 0.0 0
M  V30 30 C 10.6697 6.1601 0.0 0
M  V30 31 C 12.0035 6.9301 0.0 0
M  V30 32 C 10.6697 4.6201 0.0 0
M  V30 33 C 13.3372 6.1601 0.0 0
M  V30 34 N 12.0035 3.8501 0.0 0
M  V30 35 C 13.3372 4.6201 0.0 0
M  V30 36 C 17.3383 6.9301 0.0 0
M  V30 37 C 18.6720 7.7001 0.0 0
M  V30 38 C 17.3383 5.3901 0.0 0
M  V30 39 C 20.0057 6.9301 0.0 0
M  V30 40 C 18.6720 4.6201 0.0 0
M  V30 41 C 20.0057 5.3901 0.0 0
M  V30 42 C 13.3372 0.0000 0.0 0
M  V30 43 O 12.0035 0.7700 0.0 0
M  V30 44 O 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 33
M  V30 7 1 4 36
M  V30 8 1 7 8
M  V30 9 1 7 35
M  V30 10 1 9 10
M  V30 11 1 9 39
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 20 24
M  V30 26 2 21 23
M  V30 27 1 21 30
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 1 42 43
M  V30 47 2 42 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1383990-99-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383990-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-3345676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-(2-Amino-4-oxo-3-phenyl-3,4-dihydroquinazolin-6-yl)-N-(3-(3-aminopropoxy)phenyl)-2-methoxypyridine-3-sulfonamide
tert-Butyl
(3-(3-(5-(2-amino-4-oxo-3-phenyl-3,4-dihydroquinazolin-6-yl)-2-methoxypyridine-3-sulfonamido)phenoxy)propyl)carbamate
(88.5 mg, 0.132 mmol) was stirred in trifluoroacetic acid (4 mL, 51.9
mmol) at room temperature. After 30 minutes, the solvent was removed
under reduced pressure and purified by preparative RP-HPLC [5-90% ACN
gradient, 0.1% formic acid] to give
5-(2-amino-4-oxo-3-phenyl-3,4-dihydroquinazolin-6-yl)-N-(3-(3-aminopropoxy)phenyl)-2-methoxypyridine-3-sulfonamide,
0.47 formic acid salt. white powder, yield (79 mg, 0.132 mmol, 100 %). 1H
NMR (400 MHz, DMSO-d6) δ ppm 1.92 (quin, 2 H), 2.89 (t, J= 7.3 Hz, 2 H),
3.92 (t, J=6.0 Hz, 2 H), 4.01 (s, 3 H), 6.44 (br. s., 2 H), 6.57 (dd,
J=8.3, 1.7 Hz, 1 H), 6.69 - 6.75 (m, 2 H), 7.08 - 7.16 (m, 1 H), 7.32 -
7.41 (m, 3 H), 7.49 - 7.64 (m, 3 H), 7.93 (dd, J=8.6, 2.3 Hz, 1 H), 8.05
(d, J=2.2 Hz, 1 H), 8.20 (s, 0.47 H, formic acid), 8.32 (d, J=2.5 Hz, 1
H), 8.71 (d, J=2.4 Hz, 1 H); LCMS (m/z) ES- 571.3 (M-1).
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out using RP-HPLC, TFA also used as a solvent in
stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinone derivatives as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banka, Anna Lindsey; Botyanszki, Janos; Duan, Maosheng; Leivers, Martin
Robert; Shotwell, John Bradford; Tallant, Matthew David; Dickerson, Scott
Howard; Tai, Vincent W.-F.; McFadyen, Robert Blount; Redman, Aniko Maria;
Yu, Jianjun; Li, Xiofei; Garrido, Dulce Maria; Catalano, John George;
Adjabeng, George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012087938 A1 2012-06-28

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Ethyl-2-methoxyphenoxy)benzenamine
C15H17NO2
1403681-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0801 4.0012 0.0 0
M  V30 2 O 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 0.0000 0.0 0
M  V30 4 C 9.2402 4.0012 0.0 0
M  V30 5 C 10.0102 5.3348 0.0 0
M  V30 6 N 0.0000 4.0012 0.0 0
M  V30 7 C 4.6201 4.0012 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 5.3901 5.3348 0.0 0
M  V30 10 C 6.9302 2.6675 0.0 0
M  V30 11 C 6.9302 5.3348 0.0 0
M  V30 12 C 7.7002 4.0012 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 0.7700 5.3348 0.0 0
M  V30 15 C 3.0801 6.6687 0.0 0
M  V30 16 C 0.0000 6.6687 0.0 0
M  V30 17 C 2.3101 8.0023 0.0 0
M  V30 18 C 0.7700 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Ethyl-2-methoxyphenoxy)phenyl]formamide
C16H17NO3
1403681-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 4.0012 0.0 0
M  V30 2 O 6.9302 1.3337 0.0 0
M  V30 3 C 7.7002 0.0000 0.0 0
M  V30 4 C 11.5503 4.0012 0.0 0
M  V30 5 C 12.3203 5.3348 0.0 0
M  V30 6 N 2.3101 4.0012 0.0 0
M  V30 7 C 0.7700 4.0012 0.0 0
M  V30 8 O 0.0000 2.6675 0.0 0
M  V30 9 C 6.9302 4.0012 0.0 0
M  V30 10 C 7.7002 2.6675 0.0 0
M  V30 11 C 7.7002 5.3348 0.0 0
M  V30 12 C 9.2402 2.6675 0.0 0
M  V30 13 C 9.2402 5.3348 0.0 0
M  V30 14 C 10.0102 4.0012 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 5.3901 6.6687 0.0 0
M  V30 18 C 2.3101 6.6687 0.0 0
M  V30 19 C 4.6201 8.0023 0.0 0
M  V30 20 C 3.0801 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403681-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403681-94-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9451180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) N-[2-(4-ethyl-2-methoxyphenoxy)phenyl]formamide To acetic anhydride
(0.53 mmol; 51 PL) under argon, at 0°C, was added formic acid (0.66 mmol;
25 PL). The reaction was stirred 2 hours at 60°C. After cooling to 0°C,
the mixture was diluted with 1 mL of dry THF, followed by a solution of
2-(4-ethyl-2-methoxyphenoxy)aniline (0.21 mmol; 50 mg) in dry THF (1 mL).
The reaction was stirred 2 hours at room temperature. The mixture was
concentrated in vacuo to give the title compound used without further
purification. Brown oil, yield 72 mg; quantitative. MS (ES) m/e 272
(M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From Triclosan toward the Clinic: Discovery of Nonbiocidal, Potent FabI
Inhibitors for the Treatment of Resistant Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gerusz, Vincent; Denis, Alexis; Faivre, Fabien; Bonvin, Yannick; Oxoby,
Mayalen; Briet, Sophia; LeFralliec, Geraldine; Oliveira, Chrystelle;
Desroy, Nicolas; Raymond, Cedric; Peltier, Laetitia; Moreau, Francois;
Escaich, Sonia; Vongsouthi, Vanida; Floquet, Stephanie; Drocourt, Elodie;
Walton, Armelle; Prouvensier, Laure; Saccomani, Marc; Durant, Lionel;
Genevard, Jean-Marie; Sam-Sambo, Vanessa; Soulama-Mouze, Coralie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(22), 9914-9928

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
N-(2-Methoxyphenyl)-2,4-dinitrobenzenamine
C13H11N3O5
14038-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 4.0011 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0 VAL=5
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9301 1.3337 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3348 0.0 0
M  V30 7 O 0.0000 2.6675 0.0 0
M  V30 8 O 10.0101 4.0011 0.0 0
M  V30 9 C 11.5501 4.0011 0.0 0
M  V30 10 C 5.3901 4.0011 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 3.0800 2.6675 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 9.2401 5.3348 0.0 0
M  V30 18 C 6.9301 6.6686 0.0 0
M  V30 19 C 10.0101 6.6686 0.0 0
M  V30 20 C 7.7001 8.0022 0.0 0
M  V30 21 C 9.2401 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 8 9
M  V30 10 1 8 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Methoxyphenyl)-1H-benzimidazol-5-amine
C14H13N3O
380641-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 4.0011 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 N 10.5454 5.5898 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0
M  V30 5 C 6.1516 4.1620 0.0 0
M  V30 6 C 3.9936 5.4079 0.0 0
M  V30 7 C 6.4717 5.6685 0.0 0
M  V30 8 C 7.2960 3.1316 0.0 0
M  V30 9 N 5.1381 6.4385 0.0 0
M  V30 10 C 7.9363 6.1443 0.0 0
M  V30 11 C 8.7607 3.6075 0.0 0
M  V30 12 C 9.0808 5.1139 0.0 0
M  V30 13 C 3.8500 2.6675 0.0 0
M  V30 14 C 2.3100 2.6675 0.0 0
M  V30 15 C 4.6200 1.3337 0.0 0
M  V30 16 C 1.5400 1.3337 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14038-08-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 380641-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-11929870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Amino-1-(2-methoxyphenyl)benzimidazole (3). To a solution of
2,4-dinitro-N-(2-methoxyphenyl)benzamine (2) (2.72 g, 9.4 mmol) in ethyl
acetate (95 mL) is added 10% Pd/C (325 mg). The reaction mixture is
stirred under H2 for 91 h and then filtered through Celite (Ethyl acetate
rinse). After solvent removal at reduced pressure, the residue is used in
the next step without further purification. The solution of the residue
and formic acid (1.5 mL, 38 mmol) in 4 N HCl (32 mL) is heated at 110 °C
under argon for 2.75 h. The reaction mixture is cooled to room
temperature, brought to pH 12 with NaOH pellets, and extracted with ethyl
acetate (150 mL, 100 mL, and 50 mL). The extract is washed (brine) and
dried. After solvent removal at reduced pressure, the residue is purified
on silica gel (1% to 6% methanol/ethyl acetate) to give 2.3 g (100%) of 3
as a red-brown solid. 5-Amino-1-(2-methoxyphenyl)benzimidazole (3), yield
2.3 g (100%) mp 48-50 °C. IR 3323, 2951, 1510, 1260 cm-1; 1H NMR (CDCl3)
δ 2.98 (bs, 2H, NH2, 3.83 (s, 3H, CH3), 6.74 (dd, J = 8.4 Hz, 1.8 Hz, 1H,
6-BenzimidH), 7.10-7.20 (m, 4H, 4,7-BenzimidH, 3,5-PhH), 7.40-7.49 (m,
2H, 4,6-PhH), 8.00 ppm(s, 1H, 2-BenzimidH). HRMS calcd C14H13N3O [M + H]+
240.1131, found 240.1133.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted azaheteroaryl derivatives and analogs for use
as stem cell differentiators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mercola, Mark; Dawson, Marcia I.; Cashman, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010033643 A2 2010-03-25

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxyethylammonium formate
C2H7NO.CH2O2
53226-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 C 2.6673 3.0800 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 O 4.0010 2.3100 0.0 0
M  V30 5 C 2.0005 0.0000 0.0 0
M  V30 6 O 0.6668 0.7700 0.0 0
M  V30 7 O 3.3342 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53226-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26442518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM unspecified solvent used, ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct extraction of genomic DNA from maize with aqueous ionic liquid
buffer systems for applications in genetically modified organisms
analysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gonzalez Garcia, Eric; Ressmann, Anna K.; Gaertner, Peter; Zirbs, Ronald;
Mach, Robert L.; Krska, Rudolf; Bica, Katharina; Brunner, Kurt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical and Bioanalytical Chemistry (2014), 406(30), 7773-7784

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxyethylammonium formate
C2H7NO.CH2O2
53226-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 C 2.6673 3.0800 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 O 4.0010 2.3100 0.0 0
M  V30 5 C 2.0005 0.0000 0.0 0
M  V30 6 O 0.6668 0.7700 0.0 0
M  V30 7 O 3.3342 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53226-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26088329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrophilic ionic liquids in the synthesis of Hantzsch ester
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pavlovica, S.; Gzibovska, E.; Zicmanis, A.; Mekss, P.; Klavins, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Latvijas Kimijas Zurnals (2011), 50(3/4), 277-283

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxyethylammonium formate
C2H7NO.CH2O2
53226-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 C 2.6673 3.0800 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 O 4.0010 2.3100 0.0 0
M  V30 5 C 2.0005 0.0000 0.0 0
M  V30 6 O 0.6668 0.7700 0.0 0
M  V30 7 O 3.3342 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53226-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30800871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid prepd.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Hydroxyethylammonium carboxylates - highly biodegradable and slightly
toxic ionic liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zicmanis, A.; Pavlovica, S.; Gzibovska, E.; Mekss, P.; Klavins, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Latvijas Kimijas Zurnals (2010), (3/4), 269-276

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-ethyl-4-nitrobenzamide
C9H11N3O3
1414781-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 N 8.0021 3.8500 0.0 0
M  V30 3 O 6.6684 6.1600 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 C 10.6694 3.8500 0.0 0
M  V30 6 N 4.0011 6.1600 0.0 0
M  V30 7 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 O 1.3336 0.0000 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethyl-7-nitro-4(3H)-quinazolinone
C10H9N3O3
695199-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.0000 0.0 0
M  V30 2 C 9.3358 1.5400 0.0 0
M  V30 3 C 10.6694 2.3100 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 N 6.6684 4.6200 0.0 0
M  V30 13 N 8.0021 2.3100 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1414781-99-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 695199-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12190691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Ethyl-7-nitroquinazolin-4(3H)-one (13a). A mixture of 12a (1.13 g, 5.4
mmol) and formic acid (2.2 mL, 57 mmol) was heated under reflux for 3 h.
After cooling to 25 °C, the mixture was poured into water, and the
solution was alkalinized with NaOH and extracted with chloroform. The
organic phase was dried over Na2SO4 and evaporated under reduced pressure
to afford pure 13a. Light-yellow solid, quantitative yield. mp (ethyl
acetate/n-hexane) 148-150 °C. 1H NMR (300 MHz, CDCl3) δ 8.54 (d, J = 2.2
Hz, 1H), 8.47 (d, J = 8.8 Hz, 1H), 8.25 (dd, J = 8.8, 2.2 Hz, 1H), 8.16
(s, 1H), 4.10 (q, J = 7.2 Hz, 2H), 1.45 (t, J = 7.2 Hz, 3H). MS (ESI) m/z
220 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological
Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as
Potential Antimalarial Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gemma, Sandra; Camodeca, Caterina; Brindisi, Margherita; Brogi, Simone;
Kukreja, Gagan; Kunjir, Sanil; Gabellieri, Emanuele; Lucantoni, Leonardo;
Habluetzel, Annette; Taramelli, Donatella; Basilico, Nicoletta; Gualdani,
Roberta; Tadini-Buoninsegni, Francesco; Bartolommei, Gianluca; Moncelli,
Maria Rosa; Martin, Rowena E.; Summers, Robert L.; Lamponi, Stefania;
Savini, Luisa; Fiorini, Isabella; Valoti, Massimo; Novellino, Ettore;
Campiani, Giuseppe; Butini, Stefania
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(23), 10387-10404

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitro-N-propylbenzamide
C10H13N3O3
1414782-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0021 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 C 12.0032 4.6201 0.0 0
M  V30 7 N 4.0011 6.1601 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-3-propyl-4(3H)-quinazolinone
C11H11N3O3
1414782-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.1601 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 N 6.6685 1.5400 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 N 8.0022 3.8501 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1414782-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1414782-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-14319725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3-Ethyl-7-nitroquinazolin-4(3H)-one (13a). A
mixture of 12a (1.13 g, 5.4 mmol) and formic acid (2.2 mL, 57 mmol) was
heated under reflux for 3 h. After cooling to 25 °C, the mixture was
poured into water, and the solution was alkalinized with NaOH and
extracted with chloroform. The organic phase was dried over Na2SO4 and
evaporated under reduced pressure to afford pure 13a.
7-Nitro-3-propylquinazolin-4(3H)-one (13b). Starting from 12b (1.33 g,
6.0 mmol) and formic acid (2.4 mL, 62 mmol), the title compound was
obtained following the procedure reported for 13a in quantitative yield
as a light-yellow solid. mp (ethyl acetate/n-hexane) 122-124 °C. 1H NMR
(300 MHz, CDCl3) δ 8.55 (d, J = 2.2 Hz, 1H), 8.47 (d, J = 8.8 Hz, 1H),
8.26 (dd, J = 8.8, 2.2 Hz, 1H), 8.13 (s, 1H), 4.04-3.96 (m, 2H),
1.94-1.77 (m, 2H), 1.02 (t, J = 7.4 Hz, 3H). MS (ESI) m/z 234 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological
Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as
Potential Antimalarial Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gemma, Sandra; Camodeca, Caterina; Brindisi, Margherita; Brogi, Simone;
Kukreja, Gagan; Kunjir, Sanil; Gabellieri, Emanuele; Lucantoni, Leonardo;
Habluetzel, Annette; Taramelli, Donatella; Basilico, Nicoletta; Gualdani,
Roberta; Tadini-Buoninsegni, Francesco; Bartolommei, Gianluca; Moncelli,
Maria Rosa; Martin, Rowena E.; Summers, Robert L.; Lamponi, Stefania;
Savini, Luisa; Fiorini, Isabella; Valoti, Massimo; Novellino, Ettore;
Campiani, Giuseppe; Butini, Stefania
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(23), 10387-10404

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzodioxol-5-amine
C7H7NO2
14268-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 O 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1,3-Benzodioxol-5-ylformamide
C8H7NO3
117889-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14268-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117889-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21873468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Outstandingly robust anodic dehydrogenative aniline coupling reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, Lara; Husmann, Jan-Ake; Waldvogel, Siegfried R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Electrochimica Acta (2020), 337135786

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzodioxol-5-amine
C7H7NO2
14268-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 O 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1,3-Benzodioxol-5-ylformamide
C8H7NO3
117889-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14268-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117889-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19189584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Anodic Dehydrogenative Cross- and Homo-Coupling of Formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, Lara; Franke, Robert; Waldvogel, Siegfried R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemElectroChem (2018), 5(15), 2069-2072

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Triphenylphosphoranylidene)-2-propanone
C21H19OP
1439-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.4626 3.8500 0.0 0 VAL=5
M  V30 2 C 4.4626 2.3100 0.0 0
M  V30 3 C 3.1290 1.5400 0.0 0
M  V30 4 C 1.7952 2.3100 0.0 0
M  V30 5 O 3.1290 0.0000 0.0 0
M  V30 6 C 6.0026 3.8500 0.0 0
M  V30 7 C 6.7726 2.5164 0.0 0
M  V30 8 C 6.7726 5.1837 0.0 0
M  V30 9 C 8.3126 2.5164 0.0 0
M  V30 10 C 8.3126 5.1837 0.0 0
M  V30 11 C 9.0826 3.8500 0.0 0
M  V30 12 C 2.9751 4.2486 0.0 0
M  V30 13 C 1.8862 3.1596 0.0 0
M  V30 14 C 2.5764 5.7361 0.0 0
M  V30 15 C 0.3986 3.5582 0.0 0
M  V30 16 C 1.0889 6.1348 0.0 0
M  V30 17 C 0.0000 5.0458 0.0 0
M  V30 18 C 4.4626 5.3900 0.0 0
M  V30 19 C 5.7963 6.1600 0.0 0
M  V30 20 C 3.1290 6.1600 0.0 0
M  V30 21 C 5.7963 7.7000 0.0 0
M  V30 22 C 3.1290 7.7000 0.0 0
M  V30 23 C 4.4626 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonium, (2-oxopropyl)triphenyl-, formate (1:1)
C21H20OP.CHO2
311808-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.4626 6.1600 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.4626 4.6200 0.0 0
M  V30 3 C 3.1290 3.8500 0.0 0
M  V30 4 C 1.7952 4.6200 0.0 0
M  V30 5 O 3.1290 2.3100 0.0 0
M  V30 6 C 6.0026 6.1600 0.0 0
M  V30 7 C 6.7726 4.8264 0.0 0
M  V30 8 C 6.7726 7.4937 0.0 0
M  V30 9 C 8.3126 4.8264 0.0 0
M  V30 10 C 8.3126 7.4937 0.0 0
M  V30 11 C 9.0826 6.1600 0.0 0
M  V30 12 C 2.9751 6.5586 0.0 0
M  V30 13 C 1.8862 5.4696 0.0 0
M  V30 14 C 2.5764 8.0461 0.0 0
M  V30 15 C 0.3986 5.8682 0.0 0
M  V30 16 C 1.0889 8.4448 0.0 0
M  V30 17 C 0.0000 7.3558 0.0 0
M  V30 18 C 4.4626 7.7000 0.0 0
M  V30 19 C 5.7963 8.4700 0.0 0
M  V30 20 C 3.1290 8.4700 0.0 0
M  V30 21 C 5.7963 10.0100 0.0 0
M  V30 22 C 3.1290 10.0100 0.0 0
M  V30 23 C 4.4626 10.7801 0.0 0
M  V30 24 C 4.5413 0.0000 0.0 0
M  V30 25 O 3.2077 0.7700 0.0 0 CHG=-1
M  V30 26 O 5.8750 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1439-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 311808-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30129999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Reaction of Triphenylphosphonium or Triphenylarsonium Salts with
Aldehyde: Effect of the Counteranion on their Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hon, Y.-S.; Lee, C.-F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(40), 7893-7902

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetyloxy)-3-aminobenzoic acid
C9H9NO4
1440548-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 4.0011 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 C 0.0000 5.3349 0.0 0
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 O 4.6200 5.3349 0.0 0
M  V30 8 N 0.7700 1.3338 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetyloxy)-3-(formylamino)benzoic acid
C10H9NO5
2546051-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 N 6.6685 3.8501 0.0 0
M  V30 6 C 8.0023 4.6201 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 1.3337 3.8501 0.0 0
M  V30 9 O 0.0000 4.6201 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 5.3348 6.1601 0.0 0
M  V30 15 C 2.6675 6.1601 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1440548-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2546051-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23478659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino esters of heterocyclic compounds with fungicidal
activity, agronomic compositions containing them and use thereof for
control of phytopathogenic fungi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gusmeroli, Marilena; Mormile, Silvia; Elmini, Alexia; Bellandi, Paolo;
Vazzola, Matteo; Venturini, Giovanni; Badaracco, Christian; Liguori,
Riccardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020225700 A1 2020-11-12

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tributyltin chloride
C12H27ClSn
1461-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 4.6201 5.3348 0.0 0
M  V30 2 C 3.8501 6.6687 0.0 0
M  V30 3 C 5.3901 4.0012 0.0 0
M  V30 4 C 5.9539 6.1048 0.0 0
M  V30 5 Cl 3.2864 4.5648 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0
M  V30 8 C 7.2876 5.3348 0.0 0
M  V30 9 C 1.5400 8.0023 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 11 C 8.6213 6.1048 0.0 0
M  V30 12 C 0.0000 8.0023 0.0 0
M  V30 13 C 4.6201 0.0000 0.0 0
M  V30 14 C 9.9551 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tributylstannyl formate
C13H28O2Sn
5847-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 5.3348 5.3348 0.0 0
M  V30 2 C 6.6685 4.5648 0.0 0
M  V30 3 C 4.0012 6.1048 0.0 0
M  V30 4 C 4.5648 4.0012 0.0 0
M  V30 5 O 6.1048 6.6685 0.0 0
M  V30 6 C 8.0023 5.3348 0.0 0
M  V30 7 C 2.6673 5.3348 0.0 0
M  V30 8 C 5.3348 2.6675 0.0 0
M  V30 9 C 5.3348 8.0023 0.0 0
M  V30 10 C 9.3360 4.5648 0.0 0
M  V30 11 C 1.3337 6.1048 0.0 0
M  V30 12 C 4.5648 1.3337 0.0 0
M  V30 13 O 6.1048 9.3360 0.0 0
M  V30 14 C 10.6697 5.3348 0.0 0
M  V30 15 C 0.0000 5.3348 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1461-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5847-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-11225853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recycle of tin thiolate compounds relevant to ammonia borane regeneration
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutton, Andrew D.; Davis, Benjamin L.; Bhattacharyya, Koyel X.; Ellis,
Bobby D.; Gordon, John C.; Power, Philip P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2010), 46(1),
148-149

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 2-amino-, methyl ester
C7H8N2O2
14667-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 N 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 N 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(formylamino)-3-pyridinecarboxylate
C8H8N2O3
338990-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 7.7000 5.3349 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 O 3.0800 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 N 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14667-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338990-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24200178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed microwave vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Substituted 2-isocyanopyridines as versatile convertible isocyanides
for peptidomimetic design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollanders, Charlie; Elsocht, Mathias; Van der Poorten, Olivier; Jida,
Mouhamad; Renders, Evelien; Maes, Bert U. W.; Ballet, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(56),
6863-6866

$RFMT $RIREG SCHEME74 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[[4-(aminomethyl)phenyl]iminomethyl]carbamate
C16H17N3O2
147291-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 1.5400 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 N 9.3359 0.0000 0.0 0
M  V30 4 C 6.6686 1.5400 0.0 0
M  V30 5 O 5.3348 2.3100 0.0 0
M  V30 6 O 6.6686 0.0000 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 14.6707 4.6201 0.0 0
M  V30 9 N 16.0045 3.8500 0.0 0
M  V30 10 C 10.6697 2.3100 0.0 0
M  V30 11 C 10.6697 3.8500 0.0 0
M  V30 12 C 12.0034 1.5400 0.0 0
M  V30 13 C 12.0034 4.6201 0.0 0
M  V30 14 C 13.3370 2.3100 0.0 0
M  V30 15 C 13.3370 3.8500 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 1.3338 1.5400 0.0 0
M  V30 18 C 2.6675 3.8500 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R,3S,6S,8S,8aS)-3-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]m...
C37H54N2O5Si
494836-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6845 8.9859 0.0 0
M  V30 2 C 12.2094 9.2003 0.0 0
M  V30 3 O 13.1576 7.9867 0.0 0
M  V30 4 O 12.7863 10.6282 0.0 0
M  V30 5 C 14.6827 8.2010 0.0 0
M  V30 6 C 14.8969 6.6761 0.0 0
M  V30 7 C 16.2076 8.4153 0.0 0
M  V30 8 C 14.4683 9.7260 0.0 0
M  V30 9 C 11.0960 10.9224 0.0 0
M  V30 10 C 11.1498 12.4615 0.0 0
M  V30 11 C 9.8438 13.2776 0.0 0
M  V30 12 C 12.5096 13.1846 0.0 0
M  V30 13 O 9.1818 7.5904 0.0 0
M  V30 14 O 7.2782 13.4488 0.0 0
M  V30 15 C 8.3086 14.5933 0.0 0
M  V30 16 C 5.9536 6.9300 0.0 0
M  V30 17 O 4.6200 6.1600 0.0 0
M  V30 18 Si 4.6200 4.6200 0.0 0
M  V30 19 C 6.1600 4.6200 0.0 0
M  V30 20 C 6.1600 3.0800 0.0 0
M  V30 21 C 7.7000 4.6200 0.0 0
M  V30 22 C 6.1600 6.1600 0.0 0
M  V30 23 C 4.2784 12.0858 0.0 0
M  V30 24 C 2.7469 11.9247 0.0 0
M  V30 25 C 9.7363 10.1994 0.0 0 CFG=1
M  V30 26 C 8.7059 9.0550 0.0 0
M  V30 27 C 9.2605 11.6641 0.0 0
M  V30 28 N 7.1995 9.3752 0.0 0
M  V30 29 C 7.7541 11.9843 0.0 0 CFG=2
M  V30 30 C 6.7236 10.8398 0.0 0 CFG=1
M  V30 31 C 5.9536 8.4700 0.0 0 CFG=2
M  V30 32 C 5.1836 10.8398 0.0 0 CFG=2
M  V30 33 C 4.7078 9.3752 0.0 0
M  V30 34 C 4.6200 3.0800 0.0 0
M  V30 35 C 3.2864 2.3100 0.0 0
M  V30 36 C 5.9536 2.3100 0.0 0
M  V30 37 C 3.2864 0.7700 0.0 0
M  V30 38 C 5.9536 0.7700 0.0 0
M  V30 39 C 4.6200 0.0000 0.0 0
M  V30 40 C 3.0800 4.6200 0.0 0
M  V30 41 C 2.3100 3.2864 0.0 0
M  V30 42 C 2.3100 5.9536 0.0 0
M  V30 43 C 0.7700 3.2864 0.0 0
M  V30 44 C 0.7700 5.9536 0.0 0
M  V30 45 C 0.0000 4.6200 0.0 0
M  V30 46 H 6.0973 12.2467 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 25 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 13 26
M  V30 14 1 14 15
M  V30 15 1 29 14 CFG=1
M  V30 16 1 16 17
M  V30 17 1 31 16 CFG=3
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 34
M  V30 21 1 18 40
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 23 24
M  V30 26 1 32 23 CFG=1
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31
M  V30 33 1 29 30
M  V30 34 1 30 32
M  V30 35 1 30 46 CFG=3
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 25 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, (1R,3S,6S,8S,8aS)-compd. with 6-amino-N-[[4-(aminoiminomethyl)ph...
C24H35N5O3.2CH2O2
494836-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7662 8.2389 0.0 0
M  V30 2 N 9.3062 8.2389 0.0 0
M  V30 3 O 6.9962 9.5727 0.0 0
M  V30 4 C 10.0762 9.5727 0.0 0
M  V30 5 O 4.6405 9.2811 0.0 0
M  V30 6 C 6.6392 2.9363 0.0 0
M  V30 7 C 8.0460 2.3100 0.0 0
M  V30 8 O 3.3597 3.2557 0.0 0
M  V30 9 C 1.8951 2.7797 0.0 0
M  V30 10 C 2.6413 8.8239 0.0 0
M  V30 11 C 1.2135 9.4008 0.0 0
M  V30 12 C 0.0000 8.4526 0.0 0
M  V30 13 C 0.9992 10.9257 0.0 0
M  V30 14 N 1.3165 7.3526 0.0 0
M  V30 15 C 16.2362 9.5727 0.0 0
M  V30 16 N 17.0062 8.2389 0.0 0
M  V30 17 N 17.0062 10.9063 0.0 0
M  V30 18 N 5.4647 6.7443 0.0 0
M  V30 19 C 5.1445 5.2379 0.0 0 CFG=2
M  V30 20 C 6.9962 6.9052 0.0 0 CFG=2
M  V30 21 C 4.3203 7.7747 0.0 0
M  V30 22 C 6.4782 4.4679 0.0 0 CFG=2
M  V30 23 C 3.6800 4.7620 0.0 0 CFG=1
M  V30 24 C 7.6227 5.4984 0.0 0
M  V30 25 C 2.8556 7.2988 0.0 0 CFG=2
M  V30 26 C 2.5355 5.7924 0.0 0
M  V30 27 C 11.6162 9.5727 0.0 0
M  V30 28 C 12.3862 8.2389 0.0 0
M  V30 29 C 12.3862 10.9063 0.0 0
M  V30 30 C 13.9262 8.2389 0.0 0
M  V30 31 C 13.9262 10.9063 0.0 0
M  V30 32 C 14.6962 9.5727 0.0 0
M  V30 33 H 4.9836 3.7063 0.0 0
M  V30 34 C 8.5031 0.0000 0.0 0
M  V30 35 O 7.1694 0.7700 0.0 0
M  V30 36 O 9.8368 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 20 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 27
M  V30 6 2 5 21
M  V30 7 1 6 7
M  V30 8 1 22 6 CFG=1
M  V30 9 1 8 9
M  V30 10 1 23 8 CFG=1
M  V30 11 1 10 11
M  V30 12 1 25 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 25 14 CFG=3
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 19 33 CFG=3
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 24
M  V30 28 1 23 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 19 20 22 23 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147291-50-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 494836-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 494836-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-1394863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeting thrombin and factor VIIa: design, synthesis, and inhibitory
activity of functionally relevant indolizidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanessian, Stephen; Therrien, Eric; Granberg, Kenneth; Nilsson, Ingemar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(20), 2907-2911

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzenediamine, 3-bromo-4-methyl-
C7H9BrN2
1482389-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 N 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-6-methyl-1H-benzimidazole
C8H7BrN2
1360963-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.7036 0.0000 0.0 0
M  V30 2 C 6.3710 1.5400 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0
M  V30 5 C 3.7036 1.5400 0.0 0
M  V30 6 N 0.9052 1.8341 0.0 0
M  V30 7 C 3.7036 4.6200 0.0 0
M  V30 8 N 0.9052 4.3259 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1482389-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360963-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23221248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused tricyclic compounds useful as anticancer agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason Grant; Simpson, Iain; Phillips, Christopher; Boyd, Scott;
Steward, Oliver Ross; Bodnarchuk, Michael Steven; Cassar, Doyle Joseph;
Pike, Kurt Gordon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020178282 A1 2020-09-10

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzenediamine, 3-bromo-4-methyl-
C7H9BrN2
1482389-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 N 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-6-methyl-1H-benzimidazole
C8H7BrN2
1360963-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.7036 0.0000 0.0 0
M  V30 2 C 6.3710 1.5400 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0
M  V30 5 C 3.7036 1.5400 0.0 0
M  V30 6 N 0.9052 1.8341 0.0 0
M  V30 7 C 3.7036 4.6200 0.0 0
M  V30 8 N 0.9052 4.3259 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1482389-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360963-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-20965393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetracyclic compounds as inhibitors of G12C mutant RAS
protein, for use as anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason Grant; Bagal, Sharanjeet Kaur; Robb, Graeme Richard; Smith,
James; Goldberg, Frederick Woolf; Cassar, Doyle Joseph; Feron, James
Lyman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019110751 A1 2019-06-13

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-7-Amino-2-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3,4-dihydro-3-methyl-...
C18H15F6N3O2
1493798-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 7.7002 0.0 0
M  V30 2 O 12.0033 1.5400 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 N 14.6707 3.0801 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 F 2.1037 7.4938 0.0 0
M  V30 8 F 0.0000 6.9302 0.0 0
M  V30 9 F 0.5637 4.8265 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 F 2.4610 1.5400 0.0 0
M  V30 12 F 4.0010 0.0000 0.0 0
M  V30 13 F 5.5410 1.5400 0.0 0
M  V30 14 C 10.6697 5.3901 0.0 0
M  V30 15 N 10.6697 3.8501 0.0 0
M  V30 16 C 9.3358 6.1601 0.0 0
M  V30 17 C 12.0033 6.1601 0.0 0
M  V30 18 C 9.3358 3.0801 0.0 0
M  V30 19 C 12.0033 3.0801 0.0 0
M  V30 20 N 8.0022 5.3901 0.0 0
M  V30 21 C 13.3370 5.3901 0.0 0
M  V30 22 C 8.0022 3.8501 0.0 0 CFG=1
M  V30 23 C 13.3370 3.8501 0.0 0
M  V30 24 C 5.3348 5.3901 0.0 0
M  V30 25 C 4.0010 6.1601 0.0 0
M  V30 26 C 5.3348 3.8501 0.0 0
M  V30 27 C 2.6673 5.3901 0.0 0
M  V30 28 C 4.0010 3.0801 0.0 0
M  V30 29 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 2 2 19
M  V30 3 1 3 20
M  V30 4 1 3 24
M  V30 5 1 22 4 CFG=1
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 27
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 28
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(3R)-2-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-1,3,4,6-tetrahydro-3-methy...
C19H15F6N3O3
1493798-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.0035 1.5400 0.0 0
M  V30 2 O 9.3360 7.7002 0.0 0
M  V30 3 N 14.6708 3.0801 0.0 0
M  V30 4 C 16.0045 3.8501 0.0 0
M  V30 5 O 17.3383 3.0801 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 C 6.6687 6.1601 0.0 0
M  V30 8 C 1.3338 6.1601 0.0 0
M  V30 9 F 2.1038 7.4938 0.0 0
M  V30 10 F 0.0000 6.9302 0.0 0
M  V30 11 F 0.5638 4.8265 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 F 2.4611 1.5400 0.0 0
M  V30 14 F 4.0012 0.0000 0.0 0
M  V30 15 F 5.5412 1.5400 0.0 0
M  V30 16 N 10.6697 3.8501 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 12.0035 3.0801 0.0 0
M  V30 19 C 9.3360 3.0801 0.0 0
M  V30 20 C 9.3360 6.1601 0.0 0
M  V30 21 C 12.0035 6.1601 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 24 N 8.0023 5.3901 0.0 0
M  V30 25 C 13.3372 5.3901 0.0 0
M  V30 26 C 5.3348 5.3901 0.0 0
M  V30 27 C 4.0012 6.1601 0.0 0
M  V30 28 C 5.3348 3.8501 0.0 0
M  V30 29 C 2.6675 5.3901 0.0 0
M  V30 30 C 4.0012 3.0801 0.0 0
M  V30 31 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 2 4 5
M  V30 6 1 23 6 CFG=1
M  V30 7 1 7 24
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 24
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493798-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493798-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6359120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM m) Preparation of Intermediate 18. Acetic anhydride (0.614 mL, 6.50 mmol)
was added dropwise to formic acid (0.967 mL, 25.65 mmol) at r.t. and
stirred for 30 min at the same temperature. To this solution was added
dropwise intermediate 17 (1.71 mmol, crude material) in THF (10 mL). The
r.m. was then stirred 16 h at 60° C. After this time the reaction was
partitioned between water and EtOAc, the phases were separated, the aq.
phase extracted once more with EtOAc, and the combined organic phases
were dried (MgSO4), filtered and evaporated. The crude intermediate 18
was used as such in the next reaction step (quantitative yield;
R-enantiomer).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-dione
derivatives useful for the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rombouts, Frederik Jan Rita; Trabanco-Suarez, Andres Avelino; Gijsen,
Henricus Jacobus Maria; Macdonald, Gregor James; Bischoff, Francois Paul;
Alonso-De Diego, Sergio-Alvar; Velter, Adriana Ingrid; Van Roosbroeck,
Yves Emiel Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013171712 A1 2013-11-21

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-7-Amino-3,4-dihydro-2-[(4-methoxyphenyl)methyl]-3-methyl-2H-pyrido[1,2-a...
C17H19N3O3
1493798-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 O 2.6673 6.1601 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 3.8501 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 N 4.0010 3.8501 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 9.3358 2.3101 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 20 C 9.3358 3.8501 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 13
M  V30 3 1 3 14
M  V30 4 1 3 18
M  V30 5 1 16 4 CFG=1
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(3R)-1,3,4,6-Tetrahydro-2-[(4-methoxyphenyl)methyl]-3-methyl-1,6-dioxo-2H-...
C18H19N3O4
1493798-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 O 12.0035 6.1601 0.0 0
M  V30 3 C 6.6687 1.5400 0.0 0
M  V30 4 N 14.6708 4.6201 0.0 0
M  V30 5 C 16.0045 3.8501 0.0 0
M  V30 6 O 17.3383 4.6201 0.0 0
M  V30 7 C 6.6687 4.6201 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 N 10.6697 3.8501 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 N 8.0023 2.3101 0.0 0
M  V30 17 C 13.3372 2.3101 0.0 0
M  V30 18 C 13.3372 3.8501 0.0 0
M  V30 19 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 4.0012 1.5400 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 16
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 2 5 6
M  V30 8 1 19 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493798-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493798-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14448016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted pyrido-piperazinone derivatives as gamma
secretase modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bischoff, Francois Paul; Velter, Adriana Ingrid; Rombouts, Frederik Jan
Rita; De Cleyn, Michel Anna Jozef; Van Brandt, Sven Franciscus Anna;
Gijsen, Henricus Jacobus Maria; Zavattaro, Chiara; Van den Keybus, Frans
Alfons Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014111457 A1 2014-07-24

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-7-Amino-3,4-dihydro-2-[(4-methoxyphenyl)methyl]-3-methyl-2H-pyrido[1,2-a...
C17H19N3O3
1493798-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 O 2.6673 6.1601 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 3.8501 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 N 4.0010 3.8501 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 9.3358 2.3101 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 20 C 9.3358 3.8501 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 13
M  V30 3 1 3 14
M  V30 4 1 3 18
M  V30 5 1 16 4 CFG=1
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(3R)-1,3,4,6-Tetrahydro-2-[(4-methoxyphenyl)methyl]-3-methyl-1,6-dioxo-2H-...
C18H19N3O4
1493798-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 O 12.0035 6.1601 0.0 0
M  V30 3 C 6.6687 1.5400 0.0 0
M  V30 4 N 14.6708 4.6201 0.0 0
M  V30 5 C 16.0045 3.8501 0.0 0
M  V30 6 O 17.3383 4.6201 0.0 0
M  V30 7 C 6.6687 4.6201 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 N 10.6697 3.8501 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 N 8.0023 2.3101 0.0 0
M  V30 17 C 13.3372 2.3101 0.0 0
M  V30 18 C 13.3372 3.8501 0.0 0
M  V30 19 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 4.0012 1.5400 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 16
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 2 5 6
M  V30 8 1 19 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493798-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493798-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2918508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) Preparation of Intermediate 37. Acetic anhydride (0.339 mL, 3.58 mmol)
was added dropwise to formic acid (0.533 mL, 14.13 mmol) at r.t. and
stirred for 30 min at the same temperature. To this solution was added
dropwise intermediate 36 (crude material, 0.94 mmol) in THF (6 mL). The
r.m. was stirred 16 h at 60° C., then water and EtOAc were added. The
phases were separated and the aqueous phase was extracted once more. The
combined organics were dried over MgSO4, filtered and evaporated. The
crude intermediate 37 was used as such in the next reaction step
(quantitative yield; R-enantiomer).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-dione
derivatives useful for the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rombouts, Frederik Jan Rita; Trabanco-Suarez, Andres Avelino; Gijsen,
Henricus Jacobus Maria; Macdonald, Gregor James; Bischoff, Francois Paul;
Alonso-De Diego, Sergio-Alvar; Velter, Adriana Ingrid; Van Roosbroeck,
Yves Emiel Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013171712 A1 2013-11-21

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2,4,5-pyrimidinetriamine-2,4,5,6-13C4
C4H6ClN5
1499168-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 1.5400 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0 MASS=13
M  V30 6 C 2.3100 1.3338 0.0 0 MASS=13
M  V30 7 C 2.3100 4.0011 0.0 0 MASS=13
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0 MASS=13
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9H-purin-2-amine-2,4,5,6-13C4
C5H4ClN5
1499168-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 N 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0 MASS=13
M  V30 4 C 2.3699 2.3100 0.0 0 MASS=13
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0 MASS=13
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0 MASS=13
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1499168-56-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1499168-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-15408329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 122-51-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An alternative and robust synthesis of [13C4]-Baraclude (entecavir)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Easter, John A.; Burrell, Richard C.; Bonacorsi, Samuel J. Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Labelled Compounds and Radiopharmaceuticals (2013), 56(12),
632-636

$RFMT $RIREG SCHEME79 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminoanthraquinone
C14H9NO2
82-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 6.1600 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C10H8N2O3
15018-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 5.3349 0.0 0
M  V30 2 O 4.6201 0.0000 0.0 0
M  V30 3 O 9.2401 2.6675 0.0 0
M  V30 4 N 4.6201 2.6675 0.0 0
M  V30 5 C 5.3901 4.0011 0.0 0
M  V30 6 C 5.3901 1.3338 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 N 6.9301 1.3338 0.0 0
M  V30 9 C 7.7001 2.6675 0.0 0
M  V30 10 C 3.0800 2.6675 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 1.3338 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-1-anthracenyl)amino]methylene]-1-phenyl-2,4,6(1H...
C25H15N3O5
2178915-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 O 5.3900 4.0011 0.0 0
M  V30 4 O 2.3100 9.3358 0.0 0
M  V30 5 O 12.3200 5.3347 0.0 0
M  V30 6 O 7.7000 2.6674 0.0 0
M  V30 7 O 12.3200 0.0000 0.0 0
M  V30 8 C 5.3900 6.6684 0.0 0
M  V30 9 C 4.6200 8.0021 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.0800 8.0021 0.0 0
M  V30 13 C 5.3900 9.3358 0.0 0
M  V30 14 C 7.7000 8.0021 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 22 C 10.0100 4.0011 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 9.2400 2.6674 0.0 0
M  V30 25 N 12.3200 2.6674 0.0 0
M  V30 26 N 10.0100 1.3336 0.0 0
M  V30 27 C 11.5500 1.3336 0.0 0
M  V30 28 C 13.8600 2.6674 0.0 0
M  V30 29 C 14.6300 4.0011 0.0 0
M  V30 30 C 14.6300 1.3336 0.0 0
M  V30 31 C 16.1700 4.0011 0.0 0
M  V30 32 C 16.1700 1.3336 0.0 0
M  V30 33 C 16.9400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 22 CFG=2
M  V30 4 2 3 11
M  V30 5 2 4 12
M  V30 6 2 5 23
M  V30 7 2 6 24
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 16
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-45-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15018-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22131693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
DL-Phenylalanine
C9H11NO2
150-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0
M  V30 3 C 1.3338 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3338 6.9300 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylphenylalanine
C10H11NO3
4289-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 4.6200 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4289-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42621226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Csp3-Csp2 Coupling of Isonitriles and (Hetero)arenes through a
Photoredox-Catalyzed Double Decyanation Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martin, Maria; Romero, Rafael Martin; Portolani, Chiara; Tortosa, Mariola
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2024), 14(23), 17286-17292

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (S)-α-[[(1,1-dimethylethoxy)carbonyl]amino][1,1′-biphenyl]-4-pro...
C27H29NO4
153037-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9536 8.0020 0.0 0 CFG=2
M  V30 2 C 6.7236 9.3358 0.0 0
M  V30 3 C 6.7236 6.6684 0.0 0
M  V30 4 N 4.4136 8.0020 0.0 0
M  V30 5 O 5.9536 5.3347 0.0 0
M  V30 6 O 8.2636 6.6684 0.0 0
M  V30 7 C 3.6436 9.3358 0.0 0
M  V30 8 C 6.7236 4.0011 0.0 0
M  V30 9 O 2.1036 9.3358 0.0 0
M  V30 10 O 4.4136 10.6694 0.0 0
M  V30 11 C 1.3336 10.6694 0.0 0
M  V30 12 C 0.0000 9.8994 0.0 0
M  V30 13 C 0.5636 12.0031 0.0 0
M  V30 14 C 2.6673 11.4394 0.0 0
M  V30 15 C 8.2636 9.3358 0.0 0
M  V30 16 C 9.0336 8.0020 0.0 0
M  V30 17 C 9.0336 10.6694 0.0 0
M  V30 18 C 10.5736 8.0020 0.0 0
M  V30 19 C 10.5736 10.6694 0.0 0
M  V30 20 C 11.3436 9.3358 0.0 0
M  V30 21 C 5.9536 2.6673 0.0 0
M  V30 22 C 4.4136 2.6673 0.0 0
M  V30 23 C 6.7236 1.3336 0.0 0
M  V30 24 C 3.6436 1.3336 0.0 0
M  V30 25 C 5.9536 0.0000 0.0 0
M  V30 26 C 4.4136 0.0000 0.0 0
M  V30 27 C 12.8836 9.3358 0.0 0
M  V30 28 C 13.6536 10.6694 0.0 0
M  V30 29 C 13.6536 8.0020 0.0 0
M  V30 30 C 15.1936 10.6694 0.0 0
M  V30 31 C 15.1936 8.0020 0.0 0
M  V30 32 C 15.9636 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 20 27
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-propanoic acid, α-amino-, phenylmethyl ester, (αS)-, format...
C22H21NO2.CH2O2
1345219-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 7.7000 0.0 0
M  V30 2 C 9.3358 6.9300 0.0 0 CFG=2
M  V30 3 C 10.6694 7.7000 0.0 0
M  V30 4 N 9.3358 5.3900 0.0 0
M  V30 5 O 12.0032 6.9300 0.0 0
M  V30 6 O 10.6694 9.2400 0.0 0
M  V30 7 C 13.3369 7.7000 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 C 4.0011 6.9300 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 C 6.6685 5.3900 0.0 0
M  V30 13 C 6.6685 6.9300 0.0 0
M  V30 14 C 2.6674 4.6200 0.0 0
M  V30 15 C 1.3338 5.3900 0.0 0
M  V30 16 C 2.6674 3.0800 0.0 0
M  V30 17 C 0.0000 4.6200 0.0 0
M  V30 18 C 1.3338 2.3100 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 20 C 14.6705 6.9300 0.0 0
M  V30 21 C 16.0041 7.7000 0.0 0
M  V30 22 C 14.6705 5.3900 0.0 0
M  V30 23 C 17.3379 6.9300 0.0 0
M  V30 24 C 16.0041 4.6200 0.0 0
M  V30 25 C 17.3379 5.3900 0.0 0
M  V30 26 C 8.6690 0.0000 0.0 0
M  V30 27 O 7.3353 0.7700 0.0 0
M  V30 28 O 10.0026 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 20
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 153037-45-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345219-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-4222706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design of dipeptide derivatives for the human neutral
endopeptidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Misawa, Kensuke; Suzuki, Yasuto; Takahashi, Satoshi; Yoshimori, Atsushi;
Takasawa, Ryoko; Shibuya, Yusuke; Tanuma, Sei-Ichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(20), 5935-5947

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,2-benzenediamine
C6H7BrN2
1575-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1H-benzimidazole
C7H5BrN2
4887-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1575-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1462602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM step 1: A mixture of 4-bromobenzene-1,2-diamine (4.0 g, 21.5 mmol) and
formic acid (95%, 100 mL) was stirred at 100 °C overnight. The reaction
mixture was cooled to RT and concentrated in vacuo to afford a dark oil.
The crude oil was partitioned between EtOAc (500 mL) and NH3/H2O (50 mL).
The EtOAc layer was separated and concentrated in vacuo to afford
5-bromo-1H-benzo[d] imidazole (78). Brown solid, yield 4.5 g (100%). MS
(ESI) m/z = 197.0 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazolylmethylpyrimidinediamine derivatives and
analogs for use as serine/threonine PAK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aliagas-Martin, Ignacio; Crawford, James; Lee, Wendy; Mathieu, Simon;
Rudolph, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013026914 A1 2013-02-28

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenylmethyl)alanine methyl ester
C11H15NO2
159721-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-N-(phenylmethyl)alanine methyl ester
C12H15NO3
2211040-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.6674 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 7.7000 4.0011 0.0 0
M  V30 6 C 7.7000 1.3338 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 O 9.2400 4.0011 0.0 0
M  V30 9 O 6.9300 5.3349 0.0 0
M  V30 10 C 10.0100 5.3349 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 11
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159721-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211040-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19113107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methylpiperazino)aniline
C11H17N3
16153-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 C 10.7802 1.3337 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 1.5400 1.3337 0.0 0
M  V30 9 N 6.1601 1.3337 0.0 0
M  V30 10 C 6.9302 0.0000 0.0 0
M  V30 11 C 6.9302 2.6673 0.0 0
M  V30 12 C 8.4702 0.0000 0.0 0
M  V30 13 C 8.4702 2.6673 0.0 0
M  V30 14 N 9.2402 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 14
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(4-Methyl-1-piperazinyl)phenyl]formamide
C12H17N3O
2314032-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7802 1.3337 0.0 0
M  V30 2 C 11.5503 2.6673 0.0 0
M  V30 3 O 13.0903 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 6.1601 1.3337 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 6.9302 0.0000 0.0 0
M  V30 8 C 8.4702 2.6673 0.0 0
M  V30 9 C 8.4702 0.0000 0.0 0
M  V30 10 C 9.2402 1.3337 0.0 0
M  V30 11 N 4.6201 1.3337 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 C 3.8501 2.6673 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 15 C 2.3101 2.6673 0.0 0
M  V30 16 N 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 16
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16153-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2314032-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[[(3S,6S,7R,9aS)-6-[[(2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-oxobut...
C37H49N5O8
1620196-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.8782 5.4839 0.0 0
M  V30 2 N 16.4182 5.4839 0.0 0
M  V30 3 O 14.1082 6.8176 0.0 0
M  V30 4 C 17.1882 6.8176 0.0 0
M  V30 5 O 12.2459 6.5761 0.0 0
M  V30 6 N 9.3700 6.5330 0.0 0
M  V30 7 C 7.8327 6.6251 0.0 0
M  V30 8 C 7.1439 8.0025 0.0 0 CFG=2
M  V30 9 O 6.9844 5.3399 0.0 0
M  V30 10 N 5.6065 8.0945 0.0 0
M  V30 11 C 7.9923 9.2877 0.0 0
M  V30 12 C 4.9177 9.4719 0.0 0
M  V30 13 C 9.5295 9.1956 0.0 0
M  V30 14 O 3.3805 9.5640 0.0 0
M  V30 15 O 5.7661 10.7572 0.0 0
M  V30 16 C 2.6916 10.9414 0.0 0
M  V30 17 C 1.3142 10.2526 0.0 0
M  V30 18 C 2.0028 12.3188 0.0 0
M  V30 19 C 4.0690 11.6302 0.0 0
M  V30 20 C 7.6104 4.2576 0.0 0
M  V30 21 N 6.5800 3.1133 0.0 0
M  V30 22 C 5.0735 3.4334 0.0 0
M  V30 23 C 4.0431 2.2889 0.0 0
M  V30 24 O 4.5977 4.8980 0.0 0
M  V30 25 C 2.5368 2.6091 0.0 0
M  V30 26 C 1.5063 1.4647 0.0 0
M  V30 27 O 0.0000 1.7849 0.0 0
M  V30 28 O 1.9823 0.0000 0.0 0
M  V30 29 N 12.5767 3.9892 0.0 0
M  V30 30 C 14.1082 4.1501 0.0 0 CFG=2
M  V30 31 C 12.2566 2.4829 0.0 0 CFG=1
M  V30 32 C 11.5987 5.1787 0.0 0
M  V30 33 C 14.7347 2.7434 0.0 0
M  V30 34 C 13.5902 1.7129 0.0 0
M  V30 35 C 10.8792 1.7939 0.0 0
M  V30 36 C 10.0588 5.1558 0.0 0 CFG=1
M  V30 37 C 9.4818 2.4414 0.0 0
M  V30 38 C 9.1168 3.9375 0.0 0 CFG=1
M  V30 39 C 16.4182 8.1512 0.0 0
M  V30 40 C 17.1882 9.4849 0.0 0
M  V30 41 C 14.8782 8.1512 0.0 0
M  V30 42 C 16.4182 10.8187 0.0 0
M  V30 43 C 14.1082 9.4849 0.0 0
M  V30 44 C 14.8782 10.8187 0.0 0
M  V30 45 C 18.7282 6.8176 0.0 0
M  V30 46 C 19.4982 8.1512 0.0 0
M  V30 47 C 19.4982 5.4839 0.0 0
M  V30 48 C 21.0382 8.1512 0.0 0
M  V30 49 C 21.0382 5.4839 0.0 0
M  V30 50 C 21.8082 6.8176 0.0 0
M  V30 51 H 12.2105 0.9436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 30 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 39
M  V30 6 1 4 45
M  V30 7 2 5 32
M  V30 8 1 6 7
M  V30 9 1 36 6 CFG=3
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11 CFG=1
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 20 21
M  V30 23 1 38 20 CFG=3
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 29 32
M  V30 34 1 30 33
M  V30 35 1 31 34
M  V30 36 1 31 35
M  V30 37 1 31 51 CFG=1
M  V30 38 1 32 36
M  V30 39 1 33 34
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 49 2 45 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 49
M  V30 53 2 48 50
M  V30 54 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 30 31 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Butanoic acid, 4-[[[(3S,6S,7R,9aS)-6-[[(2S)-2-amino-1-oxobutyl]amino]-3-[[(di...
C32H41N5O6.CH2O2
1609252-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 7.7938 0.0 0
M  V30 2 N 5.3900 7.7938 0.0 0
M  V30 3 O 7.7000 9.1274 0.0 0
M  V30 4 C 4.6200 9.1274 0.0 0
M  V30 5 O 9.5623 8.8860 0.0 0
M  V30 6 N 12.4383 8.8430 0.0 0
M  V30 7 C 13.9755 8.9351 0.0 0
M  V30 8 C 14.6643 10.3125 0.0 0 CFG=1
M  V30 9 O 14.8239 7.6498 0.0 0
M  V30 10 C 16.2017 10.4046 0.0 0
M  V30 11 N 13.8160 11.5976 0.0 0
M  V30 12 C 16.8906 11.7819 0.0 0
M  V30 13 C 14.1979 6.5677 0.0 0
M  V30 14 N 15.2283 5.4231 0.0 0
M  V30 15 C 16.7347 5.7433 0.0 0
M  V30 16 C 17.7651 4.5989 0.0 0
M  V30 17 O 17.2106 7.2080 0.0 0
M  V30 18 C 19.2714 4.9191 0.0 0
M  V30 19 C 20.3020 3.7746 0.0 0
M  V30 20 O 21.8082 4.0949 0.0 0
M  V30 21 O 19.8261 2.3100 0.0 0
M  V30 22 N 9.2315 6.2992 0.0 0
M  V30 23 C 7.7000 6.4602 0.0 0 CFG=2
M  V30 24 C 9.5517 4.7928 0.0 0 CFG=1
M  V30 25 C 10.2096 7.4887 0.0 0
M  V30 26 C 7.0735 5.0532 0.0 0
M  V30 27 C 8.2181 4.0228 0.0 0
M  V30 28 C 10.9291 4.1040 0.0 0
M  V30 29 C 11.7494 7.4656 0.0 0 CFG=1
M  V30 30 C 12.3265 4.7514 0.0 0
M  V30 31 C 12.6914 6.2473 0.0 0 CFG=1
M  V30 32 C 5.3900 10.4612 0.0 0
M  V30 33 C 6.9300 10.4612 0.0 0
M  V30 34 C 4.6200 11.7949 0.0 0
M  V30 35 C 7.7000 11.7949 0.0 0
M  V30 36 C 5.3900 13.1285 0.0 0
M  V30 37 C 6.9300 13.1285 0.0 0
M  V30 38 C 3.0800 9.1274 0.0 0
M  V30 39 C 2.3100 7.7938 0.0 0
M  V30 40 C 2.3100 10.4612 0.0 0
M  V30 41 C 0.7700 7.7938 0.0 0
M  V30 42 C 0.7700 10.4612 0.0 0
M  V30 43 C 0.0000 9.1274 0.0 0
M  V30 44 H 9.5977 3.2536 0.0 0
M  V30 45 C 10.9041 0.0000 0.0 0
M  V30 46 O 9.5705 0.7700 0.0 0
M  V30 47 O 12.2378 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 32
M  V30 6 1 4 38
M  V30 7 2 5 25
M  V30 8 1 6 7
M  V30 9 1 29 6 CFG=1
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11 CFG=1
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 31 13 CFG=1
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 24 44 CFG=3
M  V30 31 1 25 29
M  V30 32 1 26 27
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 48 1 45 46
M  V30 49 2 45 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 23 24 29 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620196-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609252-33-6
$DTYPE RXN:PRO(1):AMD
$DATUM SPION conjugates
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-14746739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SPION-Smac mimetic nano-conjugates: Putative pro-apoptotic agents in
oncology
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seneci, Pierfausto; Rizzi, Mattia; Ballabio, Luigi; Lecis, Daniele;
Conti, Annalisa; Carrara, Claudio; Licandro, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(10), 2374-2378

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2-aminophenyl)methyl]carbamate
C12H18N2O2
162046-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 7.7000 5.3349 0.0 0
M  V30 5 O 7.7000 2.6674 0.0 0
M  V30 6 C 9.2400 5.3349 0.0 0
M  V30 7 C 9.2400 6.8749 0.0 0
M  V30 8 C 10.7800 5.3349 0.0 0
M  V30 9 C 9.2400 3.7949 0.0 0
M  V30 10 N 3.0800 0.0000 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 1.3338 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 12
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H18N2O3
2770273-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 4.0011 0.0 0
M  V30 2 N 4.4137 4.0011 0.0 0
M  V30 3 C 3.6437 5.3348 0.0 0
M  V30 4 O 2.1037 5.3348 0.0 0
M  V30 5 O 4.4137 6.6686 0.0 0
M  V30 6 C 1.3337 6.6686 0.0 0
M  V30 7 C 2.6673 7.4386 0.0 0
M  V30 8 C 0.5636 8.0022 0.0 0
M  V30 9 C 0.0000 5.8986 0.0 0
M  V30 10 N 9.0337 4.0011 0.0 0
M  V30 11 C 10.5738 4.0011 0.0 0
M  V30 12 O 11.3438 5.3348 0.0 0
M  V30 13 C 6.7237 2.6675 0.0 0
M  V30 14 C 8.2637 2.6675 0.0 0
M  V30 15 C 5.9537 1.3337 0.0 0
M  V30 16 C 9.0337 1.3337 0.0 0
M  V30 17 C 6.7237 0.0000 0.0 0
M  V30 18 C 8.2637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 14
M  V30 12 2 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 162046-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2770273-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32012164
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light photocatalytic metal-free multicomponent Ugi-like chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Russo, Camilla; Graziani, Giulia; Cannalire, Rolando; Tron, Gian Cesare;
Giustiniano, Mariateresa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2022), 24(10), 3993-4003

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Bromo-2-oxopropyl)-N-(trans-4-hydroxycyclohexyl)-2-methoxybenzenesulfona...
C16H22BrNO5S
1620777-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 2 N 6.6685 7.7002 0.0 0
M  V30 3 O 4.5648 8.2638 0.0 0
M  V30 4 O 6.1048 5.5965 0.0 0
M  V30 5 O 2.6673 8.4702 0.0 0
M  V30 6 C 1.3337 9.2402 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0 CFG=3
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 Br 4.0012 1.5400 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 O 12.0033 4.6201 0.0 0
M  V30 13 C 4.0012 6.1601 0.0 0
M  V30 14 C 2.6673 6.9302 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0 CFG=2
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 9.3360 7.7002 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 10.6697 6.9302 0.0 0
M  V30 24 C 10.6697 5.3901 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 19 2 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 24 12 CFG=1
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[1-(Formyloxy)-2-oxopropyl]-N-(trans-4-hydroxycyclohexyl)-2-methoxybenzenes...
C17H23NO7S
1620777-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 7.7002 0.0 0 VAL=6
M  V30 2 N 6.6685 8.4702 0.0 0
M  V30 3 O 6.1048 6.3665 0.0 0
M  V30 4 O 4.5648 9.0338 0.0 0
M  V30 5 O 2.6673 9.2402 0.0 0
M  V30 6 C 1.3337 10.0102 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0 CFG=3
M  V30 8 O 4.0012 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 O 1.3337 0.7700 0.0 0
M  V30 13 O 5.3348 0.0000 0.0 0
M  V30 14 O 12.0033 5.3901 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 16 C 2.6673 7.7002 0.0 0
M  V30 17 C 4.0012 5.3901 0.0 0
M  V30 18 C 1.3337 6.9302 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 8.0022 7.7002 0.0 0 CFG=2
M  V30 22 C 8.0022 6.1601 0.0 0
M  V30 23 C 9.3360 8.4702 0.0 0
M  V30 24 C 9.3360 5.3901 0.0 0
M  V30 25 C 10.6697 7.7002 0.0 0
M  V30 26 C 10.6697 6.1601 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 21 2 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 26 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620777-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620777-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-15418981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating
inhibition of HCV replication
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keaney, Erin P.; Connolly, Michael; Dobler, Markus; Karki, Rajeshri;
Honda, Ayako; Sokup, Samantha; Karur, Subramanian; Britt, Shawn; Patnaik,
Anup; Raman, Prakash; Hamann, Lawrence G.; Wiedmann, Brigitte; LaMarche,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(16), 3714-3718

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[[(6-Nitro-1,3-benzodioxol-5-yl)methyl]amino]ethyl]phenol
C16H16N2O5
1629339-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7472 1.3336 0.0 0 VAL=5
M  V30 2 O 6.2872 1.3336 0.0 0
M  V30 3 O 3.9772 0.0000 0.0 0
M  V30 4 C 6.2872 4.0011 0.0 0
M  V30 5 N 7.0572 5.3347 0.0 0
M  V30 6 C 8.5972 5.3347 0.0 0
M  V30 7 C 9.3672 6.6684 0.0 0
M  V30 8 O 15.5272 6.6685 0.0 0
M  V30 9 C 1.6672 4.0011 0.0 0
M  V30 10 C 2.4372 5.3347 0.0 0
M  V30 11 C 2.4372 2.6674 0.0 0
M  V30 12 O 0.1609 4.3212 0.0 0
M  V30 13 C 3.9772 5.3347 0.0 0
M  V30 14 O 1.4068 6.4792 0.0 0
M  V30 15 C 3.9772 2.6674 0.0 0
M  V30 16 C 0.0000 5.8528 0.0 0
M  V30 17 C 4.7472 4.0011 0.0 0
M  V30 18 C 10.9072 6.6685 0.0 0
M  V30 19 C 11.6772 5.3347 0.0 0
M  V30 20 C 11.6772 8.0021 0.0 0
M  V30 21 C 13.2172 5.3347 0.0 0
M  V30 22 C 13.2172 8.0021 0.0 0
M  V30 23 C 13.9872 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 18
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Hydroxyphenyl)ethyl]-N-[(6-nitro-1,3-benzodioxol-5-yl)methyl]formamide
C17H16N2O6
1629485-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2872 4.0011 0.0 0
M  V30 2 N 7.0572 5.3347 0.0 0
M  V30 3 C 8.5972 5.3347 0.0 0
M  V30 4 C 6.2872 6.6685 0.0 0
M  V30 5 C 9.3672 6.6685 0.0 0
M  V30 6 O 7.0572 8.0021 0.0 0
M  V30 7 N 4.7472 1.3336 0.0 0 VAL=5
M  V30 8 O 3.9772 0.0000 0.0 0
M  V30 9 O 6.2872 1.3336 0.0 0
M  V30 10 O 15.5272 6.6685 0.0 0
M  V30 11 C 4.7472 4.0011 0.0 0
M  V30 12 C 3.9772 2.6674 0.0 0
M  V30 13 C 3.9772 5.3347 0.0 0
M  V30 14 C 2.4372 2.6674 0.0 0
M  V30 15 C 2.4372 5.3347 0.0 0
M  V30 16 C 1.6672 4.0011 0.0 0
M  V30 17 O 1.4068 6.4792 0.0 0
M  V30 18 O 0.1609 4.3212 0.0 0
M  V30 19 C 0.0000 5.8528 0.0 0
M  V30 20 C 10.9072 6.6685 0.0 0
M  V30 21 C 11.6772 8.0021 0.0 0
M  V30 22 C 11.6772 5.3347 0.0 0
M  V30 23 C 13.2172 8.0021 0.0 0
M  V30 24 C 13.2172 5.3347 0.0 0
M  V30 25 C 13.9872 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 20
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 12
M  V30 11 1 10 25
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629339-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629485-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9086616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[2-(4-Hydroxy-phenyl)-ethyl]-N-(6-nitro-benzo[1,3]dioxol-5-ylmethyl)-formamide
159: Formic acid (954 microL, 25.3 mmol) was added dropwise to a solution
of carbonyl diimidazole (4.10 g, 25.3 mmol) in THF (20 mL) at 0 degC and
allowed to warm to 25 degC over 2 hours. The resultant colourless
solution was then added to a stirred suspension of
4-{2-[(6-nitro-benzo[1,3]dioxol-5-ylmethyl)-amino]-ethyl}-phenol 157
(5.00 g, 15.8 mmol) via cannula and the mixture stirred at 25 degC for 1
hour. The reaction was quenched by addition of silica (50 g), filtered,
eluting with EtOAc (500 mL), and the resultant solution condensed in
vacuo to afford
N-[2-(4-hydroxy-phenyl)-ethyl]-N-(6-nitro-benzo[1,3]dioxol-5-ylmethyl)-formamide
159 (5.45 g, 15.8 mmol, 100 %) as an amorphous pale yellow solid. mp
114-120 degC.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-Step Organic Synthesis using Solid-Supported Reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bream, R. N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2003), (20140701), No pp.

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(6′-Chloro-3-fluoro[2,4′-bipyridin]-2′-yl)-4-(1-methyl-1H-pyrazol-4-yl)-1,...
C20H16ClFN6
1630834-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.0800 8.0021 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 Cl 7.7000 8.0021 0.0 0
M  V30 4 N 9.2400 0.0000 0.0 0
M  V30 5 C 17.4756 0.9922 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 N 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 10.0100 1.3336 0.0 0
M  V30 20 C 10.0100 4.0011 0.0 0
M  V30 21 C 11.5500 1.3336 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 12.3200 2.6674 0.0 0
M  V30 24 C 13.8600 2.6674 0.0 0
M  V30 25 C 14.7652 1.4216 0.0 0
M  V30 26 C 14.7652 3.9133 0.0 0
M  V30 27 N 16.2298 1.8974 0.0 0
M  V30 28 N 16.2298 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 15
M  V30 3 1 2 18
M  V30 4 1 3 16
M  V30 5 1 4 19
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6′-Chloro-3-fluoro[2,4′-bipyridin]-2′-yl)-5-(1-methyl-1H-pyrazol-4-yl)-1H-...
C21H14ClFN6
1630834-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 F 1.3337 2.3101 0.0 0
M  V30 3 C 17.8133 3.9200 0.0 0
M  V30 4 C 9.4091 3.9938 0.0 0
M  V30 5 N 8.0022 4.6201 0.0 0
M  V30 6 C 10.4396 5.1382 0.0 0
M  V30 7 C 9.8850 2.5290 0.0 0
M  V30 8 C 8.1633 6.1517 0.0 0
M  V30 9 C 11.9459 4.8180 0.0 0
M  V30 10 N 9.6696 6.4718 0.0 0
M  V30 11 C 11.3913 2.2089 0.0 0
M  V30 12 C 12.4219 3.3533 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 19 C 13.9282 3.0331 0.0 0
M  V30 20 C 14.5545 1.6263 0.0 0
M  V30 21 C 15.0728 4.0637 0.0 0
M  V30 22 N 16.0863 1.7872 0.0 0
M  V30 23 N 16.4064 3.2937 0.0 0
M  V30 24 C 2.6673 4.6201 0.0 0
M  V30 25 C 1.3337 3.8501 0.0 0
M  V30 26 N 2.6673 6.1601 0.0 0
M  V30 27 C 0.0000 4.6201 0.0 0
M  V30 28 C 1.3337 6.9302 0.0 0
M  V30 29 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 25
M  V30 3 1 3 23
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 1 12 19
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 16 24
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18615240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2013KO00382 A 2014-10-10

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(6′-Chloro-3-fluoro[2,4′-bipyridin]-2′-yl)-4-(1-methyl-1H-pyrazol-4-yl)-1,...
C20H16ClFN6
1630834-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.0800 8.0021 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 Cl 7.7000 8.0021 0.0 0
M  V30 4 N 9.2400 0.0000 0.0 0
M  V30 5 C 17.4756 0.9922 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 N 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 10.0100 1.3336 0.0 0
M  V30 20 C 10.0100 4.0011 0.0 0
M  V30 21 C 11.5500 1.3336 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 12.3200 2.6674 0.0 0
M  V30 24 C 13.8600 2.6674 0.0 0
M  V30 25 C 14.7652 1.4216 0.0 0
M  V30 26 C 14.7652 3.9133 0.0 0
M  V30 27 N 16.2298 1.8974 0.0 0
M  V30 28 N 16.2298 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 15
M  V30 3 1 2 18
M  V30 4 1 3 16
M  V30 5 1 4 19
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6′-Chloro-3-fluoro[2,4′-bipyridin]-2′-yl)-5-(1-methyl-1H-pyrazol-4-yl)-1H-...
C21H14ClFN6
1630834-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 F 1.3337 2.3101 0.0 0
M  V30 3 C 17.8133 3.9200 0.0 0
M  V30 4 C 9.4091 3.9938 0.0 0
M  V30 5 N 8.0022 4.6201 0.0 0
M  V30 6 C 10.4396 5.1382 0.0 0
M  V30 7 C 9.8850 2.5290 0.0 0
M  V30 8 C 8.1633 6.1517 0.0 0
M  V30 9 C 11.9459 4.8180 0.0 0
M  V30 10 N 9.6696 6.4718 0.0 0
M  V30 11 C 11.3913 2.2089 0.0 0
M  V30 12 C 12.4219 3.3533 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 19 C 13.9282 3.0331 0.0 0
M  V30 20 C 14.5545 1.6263 0.0 0
M  V30 21 C 15.0728 4.0637 0.0 0
M  V30 22 N 16.0863 1.7872 0.0 0
M  V30 23 N 16.4064 3.2937 0.0 0
M  V30 24 C 2.6673 4.6201 0.0 0
M  V30 25 C 1.3337 3.8501 0.0 0
M  V30 26 N 2.6673 6.1601 0.0 0
M  V30 27 C 0.0000 4.6201 0.0 0
M  V30 28 C 1.3337 6.9302 0.0 0
M  V30 29 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 25
M  V30 3 1 3 23
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 1 12 19
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 16 24
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-8243886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla; Linnanen,
Tero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014162039 A1 2014-10-09

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,1′′,1′′′-[Hexahydro-4,7-bis(phenylmethyl)-5,2,6-(iminomethenimino)-1H-im...
C28H32N6O4
166046-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0965 8.6938 0.0 0
M  V30 2 C 4.5802 8.9638 0.0 0
M  V30 3 O 7.0883 9.8719 0.0 0
M  V30 4 C 3.5829 9.2579 0.0 0
M  V30 5 C 2.0459 9.3542 0.0 0
M  V30 6 O 4.4348 10.5409 0.0 0
M  V30 7 C 3.5231 1.5100 0.0 0
M  V30 8 C 2.3667 2.5270 0.0 0
M  V30 9 O 3.2204 0.0000 0.0 0
M  V30 10 C 8.4280 1.5667 0.0 0
M  V30 11 C 8.7656 0.0642 0.0 0
M  V30 12 O 9.5605 2.6104 0.0 0
M  V30 13 C 8.7477 4.2819 0.0 0
M  V30 14 C 3.1407 4.2174 0.0 0
M  V30 15 C 5.9102 7.1958 0.0 0
M  V30 16 C 5.9784 1.2964 0.0 0
M  V30 17 N 6.8830 6.5219 0.0 0
M  V30 18 N 4.9532 6.4996 0.0 0
M  V30 19 N 4.9822 2.0028 0.0 0
M  V30 20 N 6.9580 2.0258 0.0 0
M  V30 21 C 6.5672 5.3813 0.0 0
M  V30 22 C 5.2953 5.3666 0.0 0
M  V30 23 C 5.3459 3.1688 0.0 0
M  V30 24 C 6.5673 3.1826 0.0 0
M  V30 25 N 7.2077 4.2819 0.0 0
M  V30 26 N 4.6805 4.2528 0.0 0
M  V30 27 C 9.5177 5.6157 0.0 0
M  V30 28 C 8.7477 6.9494 0.0 0
M  V30 29 C 11.0578 5.6157 0.0 0
M  V30 30 C 9.5177 8.2831 0.0 0
M  V30 31 C 11.8278 6.9494 0.0 0
M  V30 32 C 11.0578 8.2831 0.0 0
M  V30 33 C 2.3402 5.5330 0.0 0
M  V30 34 C 0.8007 5.4975 0.0 0
M  V30 35 C 3.0793 6.8841 0.0 0
M  V30 36 C 0.0000 6.8131 0.0 0
M  V30 37 C 2.2788 8.1998 0.0 0
M  V30 38 C 0.7391 8.1642 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 20
M  V30 13 1 13 25
M  V30 14 1 13 27
M  V30 15 1 14 26
M  V30 16 1 14 33
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 24
M  V30 30 1 23 26
M  V30 31 1 24 25
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,3,8,10-tetraacetyloctahydro-5,2,6-(iminomethenimin...
C14H20N6O4.2CH2O2
245730-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5938 8.2864 0.0 0
M  V30 2 C 1.5535 6.4229 0.0 0
M  V30 3 O 0.0000 9.2533 0.0 0
M  V30 4 C 5.5117 12.6385 0.0 0
M  V30 5 C 7.3609 12.8738 0.0 0
M  V30 6 O 4.3834 14.1223 0.0 0
M  V30 7 C 10.4690 8.2305 0.0 0
M  V30 8 C 10.4690 10.0946 0.0 0
M  V30 9 O 12.0833 7.2985 0.0 0
M  V30 10 C 6.4963 3.8181 0.0 0
M  V30 11 C 7.5920 2.3100 0.0 0
M  V30 12 O 4.6425 3.6231 0.0 0
M  V30 13 C 3.3932 10.6063 0.0 0
M  V30 14 C 8.7002 5.8283 0.0 0
M  V30 15 N 3.2278 9.1834 0.0 0
M  V30 16 N 4.7909 10.9195 0.0 0
M  V30 17 N 8.8546 7.2985 0.0 0
M  V30 18 N 7.2544 5.5209 0.0 0
M  V30 19 C 4.5169 8.5586 0.0 0
M  V30 20 C 5.5473 9.7030 0.0 0
M  V30 21 C 7.5042 7.8998 0.0 0
M  V30 22 C 6.5151 6.8010 0.0 0
M  V30 23 N 5.0041 7.0977 0.0 0
M  V30 24 N 7.0509 9.3713 0.0 0
M  V30 25 C 6.0417 0.0000 0.0 0
M  V30 26 O 4.7080 0.7700 0.0 0
M  V30 27 O 7.3753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 21 24
M  V30 27 1 22 23
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 166046-53-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 245730-67-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-9539484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 3 To a stirred slurry of 10.09 (19.36 mmol) of TADB in 200 ml of
formic acid were added 10.0 g of 5% Pd/C. After 18 hours, the Pd/C was
removed by filtration and the formic acid was removed under reduced
pressure to afford 8.78 g (104%) of the desired bis salt. 1H NMR (DMSO):
1.9-2.2 (multiplet, 12H, CHICO), 6.1-6.8 (multiplet, 6H, CH), 8.1-8.4
(multiplet, 6+H, NH, HCO2H). Upon heating to 150° C., the multiplet at
1.9-2.2 collapses to a singlet and the other 2 multiplets begin to
collapse.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polycyclic, polyamides as precursors for energetic polycyclic
polynitramine oxidizers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wardle, Robert B.; Hinshaw, Jerald C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7129348 B1 2006-10-31

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-ethylbenzonitrile
C9H10N2
170230-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 N 7.7000 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyano-2-ethylphenyl)formamide
C10H10N2O
216063-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 C 3.8500 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 N 10.0100 4.0011 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 6.1600 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170230-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 216063-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13621565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Acetic anhydride (235 mL, 2.5 mol, 2.6 equiv.) was added to formic acid
(118 mL 3.1 mol, 3.2 equiv.) and the resulting solution was heated at
60°C. for 2 h. After the reaction had cooled to room temp., a solution of
4-amino-3-ethylbenzonitrile (140 g, 0.96 mol) in anh. THE (700 mL) was
added at such a rate that the reaction temp. did not exceed 45°C.
(approximately 20 min.). When the resulting solution had cooled to room
temp. it was concentrated under reduced pressure, treated with EtOH (600
mL), and concentrated again under reduced pressure to afford
4-cyano-2-ethylformanilide. Light tan solid, yield 167 g, 100%. 1H NMR
(CDCl3) 81.13 (t, J=7.3 Hz, 3H), 2.48 (q, J=7.3 Hz, 2H), 7.65 (d, J=8.5
Hz, 1H), 8.35 (d, J8.5 Hz, 1H), 8.37 (s, 1H), 9.89 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and use of, e.g., 2-arylimino-1,3-thiazolidines as
progesterone receptor binding ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Brian R.; Bagi, Cedo M.; Brennan, Catherine R.; Brittelli, David
R.; Bullock, William H.; Chen, Jinshan; Collibee, William L.; Dally,
Robert; Johnson, Jeffrey S.; Kluender, Harold C. E.; Lathrop, William F.;
Liu, Peiying; Mase, Carol Ann; Redman, Aniko M.; Scott, William J.;
Urbahns, Klaus; Wolanin, Donald J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6353006 B1 2002-03-05

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-ethylbenzonitrile
C9H10N2
170230-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 N 7.7000 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyano-2-ethylphenyl)formamide
C10H10N2O
216063-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 C 3.8500 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 N 10.0100 4.0011 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 6.1600 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170230-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 216063-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-30192079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aryliminothiazolidines and related compounds
progesterone receptor binding agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Brian R.; Bagi, Cedo M.; Brennan, Catherine R.; Brittelli, David
R.; Bullock, William H.; Chen, Jinshan; Collibee, William L.; Dally,
Robert; Johnson, Jeffrey S.; Kluender, Harold C. E.; Lathrop, William F.;
Liu, Peiying; Mase, Carol Ann; Redman, Aniko M.; Scott, William J.;
Urbahns, Klaus; Wolanin, John J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000042031 A2 2000-07-20

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-trifluoromethoxyaniline
C7H5BrF3NO
175278-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 2.6674 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 F 2.3100 5.3349 0.0 0
M  V30 4 F 0.7700 5.3349 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 Br 6.9300 0.0000 0.0 0
M  V30 7 N 8.4700 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 6.1600 1.3338 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Bromo-4-(trifluoromethoxy)phenyl]formamide
C8H5BrF3NO2
941294-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 O 10.7800 4.0011 0.0 0
M  V30 4 Br 6.9300 0.0000 0.0 0
M  V30 5 O 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 F 2.3100 5.3349 0.0 0
M  V30 8 F 0.7700 5.3349 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 6.1600 1.3338 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 175278-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 941294-53-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16979127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh2(II)-Catalyzed Ring Expansion of Cyclobutanol-Substituted Aryl Azides
To Access Medium-Sized N-Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mazumdar, Wrickban; Jana, Navendu; Thurman, Bryant T.; Wink, Donald J.;
Driver, Tom G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(14), 5031-5034

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(1-methylethyl)tricyclo[3.3.1.13,7]decan-1-ol
C16H28O
176537-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4023 1.9513 0.0 0
M  V30 2 C 7.7360 2.7214 0.0 0
M  V30 3 C 6.4023 0.4112 0.0 0
M  V30 4 C 1.4888 1.4864 0.0 0
M  V30 5 C 0.0000 1.8800 0.0 0
M  V30 6 C 1.8923 0.0000 0.0 0
M  V30 7 O 5.0302 6.0451 0.0 0
M  V30 8 C 5.0685 2.7214 0.0 0
M  V30 9 C 3.7802 1.8826 0.0 0
M  V30 10 C 5.1506 4.2563 0.0 0
M  V30 11 C 4.2121 4.1828 0.0 0
M  V30 12 C 2.5745 2.5789 0.0 0
M  V30 13 C 3.9449 4.9524 0.0 0
M  V30 14 C 3.0063 4.8790 0.0 0
M  V30 15 C 2.6567 4.1138 0.0 0
M  V30 16 C 1.7180 4.0402 0.0 0
M  V30 17 C 3.0883 6.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(1-methylethyl)tricyclo[3.3.1.13,7]decane-1-carboxylic acid
C17H28O2
337908-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6460 3.4654 0.0 0
M  V30 2 C 7.9798 4.2354 0.0 0
M  V30 3 C 6.6460 1.9254 0.0 0
M  V30 4 C 3.0393 1.0925 0.0 0
M  V30 5 C 4.1247 0.0000 0.0 0
M  V30 6 C 1.5504 0.6987 0.0 0
M  V30 7 C 1.3338 5.7234 0.0 0
M  V30 8 O 0.0000 4.9535 0.0 0
M  V30 9 O 1.3338 7.2634 0.0 0
M  V30 10 C 5.3123 4.2354 0.0 0
M  V30 11 C 4.9477 2.8916 0.0 0
M  V30 12 C 4.1723 5.2661 0.0 0
M  V30 13 C 6.5060 5.4369 0.0 0
M  V30 14 C 3.4427 2.5788 0.0 0
M  V30 15 C 2.6675 4.9534 0.0 0
M  V30 16 C 5.0014 5.1238 0.0 0
M  V30 17 C 2.3027 3.6097 0.0 0
M  V30 18 C 4.6367 3.7802 0.0 0
M  V30 19 C 3.8613 6.1549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176537-33-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 337908-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-075-CAS-9742752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3,5-Diisopropyl-1-adamantanecarboxylic Acid (3b-CO2H). To a mixture of
CCl4 (80 mL) and H2SO4 (100 mL) was added with stirring a solution of
3,5-diisopropyl-1-adamantanol11 (3bOH) (4.92 g, 20.8 mmol) in formic acid
(70 mL, 1.8 mol) over 210 min at 8-17 °C by cooling in an ice-water bath.
The reaction mixture was poured into ice-water and extracted with CCl4.
The aqueous layer was extracted with CCl4, and the organic layer was
dried (MgSO4). Evaporation of solvent gave 3bCO2H as a colorless solid
(5.55 g) in 100% yield: 3,5-Diisopropyl-1-adamantanecarboxylic Acid
(3b-CO2H), (5.55 g) in 100% yield. mp 81.0-82.0 °C (from hexane). Anal.
Calcd for C17H28O2: C, 77.22; H, 10.67. Found: C, 76.96; H, 10.58. 1H NMR
(CDCl3, 270MHz) δ 0.83 (d, 12H, J= 6.9 Hz), 1.19 (s, 2H), 1.29 (sept, 2H,
J= 6.9 Hz), 1.36 (br d, 2H, J= 11.6 Hz), 1.41 (br d, 2H, J= 11.6 Hz),
1.53 (d, 2H, J= 12.5 Hz), 1.58 (d, 2H, J= 12.5 Hz), 1.75 (d, 2H, J= 2
Hz), 2.16 (sept, 111, J= 2 Hz), 11.2 (br s, 1H); 13C NMR (CDCl3, 67.5
MHz) δ 16.4(CH3), 28.7 (CH), 35.3 (C), 37.5 (CH), 37.8 (CH2), 38.1 (CH2),
40.1 (CH2), 40.4 (CH2), 42.1 (C), 185.0 (C).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of Alkyl Substitution on the Gas-Phase Stability of 1-Adamantyl
Cation and on the Solvent Effects in the Solvolysis of 1-Bromoadamantane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takeuchi, Ken'ichi; Okazaki, Takao; Kitagawa, Toshikazu; Ushino,
Takuhiro; Ueda, Kenji; Endo, Tadasuke; Notario, Rafael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(6), 2034-2043

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N5-(phenylmethoxy)-D-ornithine phenylmethyl...
C24H32N2O5
1788880-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0 CFG=1
M  V30 2 C 6.9300 8.0020 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 O 5.3900 8.0020 0.0 0
M  V30 6 O 7.7000 9.3358 0.0 0
M  V30 7 C 7.7000 4.0011 0.0 0
M  V30 8 C 10.0100 8.0020 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 6.9300 2.6673 0.0 0
M  V30 11 O 9.2400 4.0011 0.0 0
M  V30 12 C 11.5500 8.0020 0.0 0
M  V30 13 C 7.7000 1.3336 0.0 0
M  V30 14 N 12.3200 9.3358 0.0 0
M  V30 15 C 9.0336 2.1036 0.0 0
M  V30 16 C 8.4700 0.0000 0.0 0
M  V30 17 C 6.3664 0.5636 0.0 0
M  V30 18 O 13.8600 9.3358 0.0 0
M  V30 19 C 14.6300 10.6694 0.0 0
M  V30 20 C 3.0800 9.3358 0.0 0
M  V30 21 C 2.3100 10.6694 0.0 0
M  V30 22 C 2.3100 8.0020 0.0 0
M  V30 23 C 0.7700 10.6694 0.0 0
M  V30 24 C 0.7700 8.0020 0.0 0
M  V30 25 C 0.0000 9.3358 0.0 0
M  V30 26 C 16.1700 10.6694 0.0 0
M  V30 27 C 16.9400 12.0031 0.0 0
M  V30 28 C 16.9400 9.3358 0.0 0
M  V30 29 C 18.4800 12.0031 0.0 0
M  V30 30 C 18.4800 9.3358 0.0 0
M  V30 31 C 19.2500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 20
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 18 19
M  V30 20 1 19 26
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N5-formyl-N5-(phenylmethoxy)-D-ornithine ph...
C25H32N2O6
1788880-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0020 0.0 0 CFG=2
M  V30 2 C 5.3900 6.6684 0.0 0
M  V30 3 C 7.7000 8.0020 0.0 0
M  V30 4 N 5.3900 9.3358 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 O 3.8500 6.6684 0.0 0
M  V30 7 C 8.4700 9.3358 0.0 0
M  V30 8 C 3.8500 9.3358 0.0 0
M  V30 9 C 5.3900 4.0009 0.0 0
M  V30 10 C 10.0100 9.3358 0.0 0
M  V30 11 O 3.0800 10.6694 0.0 0
M  V30 12 O 3.0800 8.0020 0.0 0
M  V30 13 N 10.7800 10.6694 0.0 0
M  V30 14 C 1.5400 10.6694 0.0 0
M  V30 15 O 12.3200 10.6694 0.0 0
M  V30 16 C 10.0100 12.0031 0.0 0
M  V30 17 C 1.5400 12.2094 0.0 0
M  V30 18 C 0.0000 10.6694 0.0 0
M  V30 19 C 1.5400 9.1294 0.0 0
M  V30 20 C 13.0900 12.0031 0.0 0
M  V30 21 O 10.7800 13.3367 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 7.7000 2.6673 0.0 0
M  V30 24 C 5.3900 1.3336 0.0 0
M  V30 25 C 8.4700 1.3336 0.0 0
M  V30 26 C 6.1600 0.0000 0.0 0
M  V30 27 C 7.7000 0.0000 0.0 0
M  V30 28 C 14.6300 12.0031 0.0 0
M  V30 29 C 15.4000 10.6694 0.0 0
M  V30 30 C 15.4000 13.3367 0.0 0
M  V30 31 C 16.9400 10.6694 0.0 0
M  V30 32 C 16.9400 13.3367 0.0 0
M  V30 33 C 17.7100 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 22
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 2 16 21
M  V30 22 1 20 28
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1788880-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1788880-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10148318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis and Antimicrobial Activity of Chlorocatechelin A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kishimoto, Shinji; Nishimura, Shinichi; Hatano, Masaki; Igarashi,
Masayuki; Kakeya, Hideaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(12), 6076-6082

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N1,3-dimethyl-1,2-benzenediamine
C8H11BrN2
1799973-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 4.6201 0.0000 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,4-dimethyl-1H-benzimidazole
C9H9BrN2
2411638-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 0.0000 0.0 0
M  V30 2 C 0.0000 3.3776 0.0 0
M  V30 3 Br 7.2708 2.6673 0.0 0
M  V30 4 C 3.4207 1.3337 0.0 0
M  V30 5 C 2.6507 2.6673 0.0 0
M  V30 6 C 4.9608 1.3337 0.0 0
M  V30 7 N 2.3903 0.1891 0.0 0
M  V30 8 N 1.1444 2.3472 0.0 0
M  V30 9 C 3.4207 4.0010 0.0 0
M  V30 10 C 5.7308 2.6673 0.0 0
M  V30 11 C 0.9835 0.8156 0.0 0
M  V30 12 C 4.9608 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1799973-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411638-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23223543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective Copper-Mediated Conjugate Addition of Functionalized
Magnesiates for the Preparation of Bisaryl Nrf2 Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glogowski, Michal P.; Matthews, Jay M.; Lawhorn, Brian G.; Minbiole,
Kevin P. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(4), 3120-3137

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-1-[6-Amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-5-nitro-2-pyridinyl]-3-...
C23H28N6O3
1807697-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.3311 1.5400 0.0 0 VAL=5
M  V30 2 O 6.9974 2.3100 0.0 0
M  V30 3 O 8.3311 0.0000 0.0 0
M  V30 4 N 10.9984 0.0000 0.0 0
M  V30 5 C 17.6349 4.9771 0.0 0
M  V30 6 O 18.5401 6.2231 0.0 0
M  V30 7 C 9.6648 3.8501 0.0 0
M  V30 8 C 9.6648 2.3100 0.0 0
M  V30 9 C 10.9984 4.6201 0.0 0
M  V30 10 C 10.9984 1.5400 0.0 0
M  V30 11 C 12.3322 3.8501 0.0 0
M  V30 12 N 12.3322 2.3100 0.0 0
M  V30 13 C 8.3311 4.6201 0.0 0
M  V30 14 C 8.3311 6.1601 0.0 0
M  V30 15 C 6.9974 3.8501 0.0 0
M  V30 16 C 6.9974 6.9301 0.0 0
M  V30 17 C 5.6636 4.6201 0.0 0
M  V30 18 C 5.6636 6.1601 0.0 0
M  V30 19 N 6.6771 8.4364 0.0 0
M  V30 20 N 4.5192 7.1905 0.0 0
M  V30 21 C 5.1455 8.5974 0.0 0
M  V30 22 N 13.6659 4.6201 0.0 0
M  V30 23 C 15.0727 3.9936 0.0 0
M  V30 24 C 13.8268 6.1516 0.0 0
M  V30 25 C 16.1033 5.1382 0.0 0 CFG=1
M  V30 26 C 15.3333 6.4718 0.0 0
M  V30 27 C 3.0128 6.8704 0.0 0
M  V30 28 C 2.5369 5.4057 0.0 0
M  V30 29 C 1.9823 8.0148 0.0 0
M  V30 30 C 1.0306 5.0855 0.0 0
M  V30 31 C 0.4760 7.6946 0.0 0
M  V30 32 C 0.0000 6.2300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 25 5 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 11 22
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 20 27
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyrrolidinemethanol, 1-[7-(1-cyclohexyl-1H-benzimidazol-5-yl)-3H-imidazo[4,...
C25H28N6O2
1807697-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.6347 5.1046 0.0 0
M  V30 2 O 18.5399 6.3505 0.0 0
M  V30 3 C 20.0715 6.1895 0.0 0
M  V30 4 O 20.9767 7.4354 0.0 0
M  V30 5 C 9.6646 3.9774 0.0 0
M  V30 6 C 9.6646 2.4374 0.0 0
M  V30 7 C 10.9984 4.7474 0.0 0
M  V30 8 C 10.9984 1.6674 0.0 0
M  V30 9 N 8.5202 1.4070 0.0 0
M  V30 10 C 12.3321 3.9774 0.0 0
M  V30 11 N 12.3321 2.4374 0.0 0
M  V30 12 N 10.6782 0.1611 0.0 0
M  V30 13 C 9.1465 0.0000 0.0 0
M  V30 14 C 8.3309 4.7474 0.0 0
M  V30 15 C 8.3309 6.2875 0.0 0
M  V30 16 C 6.9973 3.9774 0.0 0
M  V30 17 C 6.9973 7.0575 0.0 0
M  V30 18 C 5.6636 4.7474 0.0 0
M  V30 19 C 5.6636 6.2875 0.0 0
M  V30 20 N 6.6771 8.5638 0.0 0
M  V30 21 N 4.5191 7.3179 0.0 0
M  V30 22 C 5.1455 8.7249 0.0 0
M  V30 23 N 13.6657 4.7474 0.0 0
M  V30 24 C 15.0727 4.1211 0.0 0
M  V30 25 C 13.8268 6.2790 0.0 0
M  V30 26 C 16.1031 5.2655 0.0 0 CFG=1
M  V30 27 C 15.3331 6.5992 0.0 0
M  V30 28 C 3.0128 6.9977 0.0 0
M  V30 29 C 2.5369 5.5332 0.0 0
M  V30 30 C 1.9822 8.1423 0.0 0
M  V30 31 C 1.0304 5.2128 0.0 0
M  V30 32 C 0.4759 7.8221 0.0 0
M  V30 33 C 0.0000 6.3574 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 23
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 19
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 21 28
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807697-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807697-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31215676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128333 A1 2015-09-03

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-1-[6-Amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-5-nitro-2-pyridinyl]-3-...
C23H28N6O3
1807697-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.3311 1.5400 0.0 0 VAL=5
M  V30 2 O 6.9974 2.3100 0.0 0
M  V30 3 O 8.3311 0.0000 0.0 0
M  V30 4 N 10.9984 0.0000 0.0 0
M  V30 5 C 17.6349 4.9771 0.0 0
M  V30 6 O 18.5401 6.2231 0.0 0
M  V30 7 C 9.6648 3.8501 0.0 0
M  V30 8 C 9.6648 2.3100 0.0 0
M  V30 9 C 10.9984 4.6201 0.0 0
M  V30 10 C 10.9984 1.5400 0.0 0
M  V30 11 C 12.3322 3.8501 0.0 0
M  V30 12 N 12.3322 2.3100 0.0 0
M  V30 13 C 8.3311 4.6201 0.0 0
M  V30 14 C 8.3311 6.1601 0.0 0
M  V30 15 C 6.9974 3.8501 0.0 0
M  V30 16 C 6.9974 6.9301 0.0 0
M  V30 17 C 5.6636 4.6201 0.0 0
M  V30 18 C 5.6636 6.1601 0.0 0
M  V30 19 N 6.6771 8.4364 0.0 0
M  V30 20 N 4.5192 7.1905 0.0 0
M  V30 21 C 5.1455 8.5974 0.0 0
M  V30 22 N 13.6659 4.6201 0.0 0
M  V30 23 C 15.0727 3.9936 0.0 0
M  V30 24 C 13.8268 6.1516 0.0 0
M  V30 25 C 16.1033 5.1382 0.0 0 CFG=1
M  V30 26 C 15.3333 6.4718 0.0 0
M  V30 27 C 3.0128 6.8704 0.0 0
M  V30 28 C 2.5369 5.4057 0.0 0
M  V30 29 C 1.9823 8.0148 0.0 0
M  V30 30 C 1.0306 5.0855 0.0 0
M  V30 31 C 0.4760 7.6946 0.0 0
M  V30 32 C 0.0000 6.2300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 25 5 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 11 22
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 20 27
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyrrolidinemethanol, 1-[7-(1-cyclohexyl-1H-benzimidazol-5-yl)-3H-imidazo[4,...
C25H28N6O2
1807697-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.6347 5.1046 0.0 0
M  V30 2 O 18.5399 6.3505 0.0 0
M  V30 3 C 20.0715 6.1895 0.0 0
M  V30 4 O 20.9767 7.4354 0.0 0
M  V30 5 C 9.6646 3.9774 0.0 0
M  V30 6 C 9.6646 2.4374 0.0 0
M  V30 7 C 10.9984 4.7474 0.0 0
M  V30 8 C 10.9984 1.6674 0.0 0
M  V30 9 N 8.5202 1.4070 0.0 0
M  V30 10 C 12.3321 3.9774 0.0 0
M  V30 11 N 12.3321 2.4374 0.0 0
M  V30 12 N 10.6782 0.1611 0.0 0
M  V30 13 C 9.1465 0.0000 0.0 0
M  V30 14 C 8.3309 4.7474 0.0 0
M  V30 15 C 8.3309 6.2875 0.0 0
M  V30 16 C 6.9973 3.9774 0.0 0
M  V30 17 C 6.9973 7.0575 0.0 0
M  V30 18 C 5.6636 4.7474 0.0 0
M  V30 19 C 5.6636 6.2875 0.0 0
M  V30 20 N 6.6771 8.5638 0.0 0
M  V30 21 N 4.5191 7.3179 0.0 0
M  V30 22 C 5.1455 8.7249 0.0 0
M  V30 23 N 13.6657 4.7474 0.0 0
M  V30 24 C 15.0727 4.1211 0.0 0
M  V30 25 C 13.8268 6.2790 0.0 0
M  V30 26 C 16.1031 5.2655 0.0 0 CFG=1
M  V30 27 C 15.3331 6.5992 0.0 0
M  V30 28 C 3.0128 6.9977 0.0 0
M  V30 29 C 2.5369 5.5332 0.0 0
M  V30 30 C 1.9822 8.1423 0.0 0
M  V30 31 C 1.0304 5.2128 0.0 0
M  V30 32 C 0.4759 7.8221 0.0 0
M  V30 33 C 0.0000 6.3574 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 23
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 19
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 21 28
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807697-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807697-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27985379
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2913330 A1 2015-09-02

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[(2-hydroxyethyl)methy...
C24H29N5O5
1807698-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 9.3358 0.0 0 VAL=5
M  V30 2 O 8.4700 9.3358 0.0 0
M  V30 3 O 6.1600 10.6694 0.0 0
M  V30 4 N 3.8500 9.3358 0.0 0
M  V30 5 N 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 2.6673 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 C 2.3100 6.6684 0.0 0
M  V30 11 O 1.5400 8.0021 0.0 0
M  V30 12 O 1.5400 5.3347 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 3.8500 6.6684 0.0 0
M  V30 20 C 8.4700 6.6684 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 10.7800 8.0021 0.0 0
M  V30 25 C 11.5500 6.6684 0.0 0
M  V30 26 N 11.8104 4.1903 0.0 0
M  V30 27 N 13.0563 6.3482 0.0 0
M  V30 28 C 13.2172 4.8167 0.0 0
M  V30 29 C 14.2006 7.3786 0.0 0
M  V30 30 C 15.6653 6.9027 0.0 0
M  V30 31 C 13.8805 8.8850 0.0 0
M  V30 32 C 16.8097 7.9333 0.0 0
M  V30 33 C 15.0250 9.9154 0.0 0
M  V30 34 C 16.4895 9.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 2 24 25
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1-Cyclohexyl-1H-benzimidazol-5-yl)-1,6,7,8-tetrahydro-6-methyl-10H-imidazo...
C24H25N5O2
1807698-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5124 0.0000 0.0 0
M  V30 2 C 2.5124 6.4632 0.0 0
M  V30 3 C 4.7074 1.6916 0.0 0
M  V30 4 C 6.0410 2.4616 0.0 0
M  V30 5 C 3.3737 2.4616 0.0 0
M  V30 6 N 5.0275 0.1851 0.0 0
M  V30 7 C 6.0410 4.0016 0.0 0
M  V30 8 N 7.1856 1.4310 0.0 0
M  V30 9 C 3.3737 4.0016 0.0 0
M  V30 10 C 2.1696 1.5014 0.0 0
M  V30 11 C 6.5591 0.0242 0.0 0
M  V30 12 C 4.7074 4.7716 0.0 0
M  V30 13 N 2.1696 4.9618 0.0 0
M  V30 14 O 0.6682 1.8440 0.0 0
M  V30 15 C 0.6682 4.6190 0.0 0
M  V30 16 C 0.0000 3.2316 0.0 0
M  V30 17 C 7.3747 4.7716 0.0 0
M  V30 18 C 7.3747 6.3116 0.0 0
M  V30 19 C 8.7085 4.0016 0.0 0
M  V30 20 C 8.7085 7.0816 0.0 0
M  V30 21 C 10.0422 4.7716 0.0 0
M  V30 22 C 10.0422 6.3116 0.0 0
M  V30 23 N 9.0287 8.5879 0.0 0
M  V30 24 N 11.1865 7.3420 0.0 0
M  V30 25 C 10.5602 8.7489 0.0 0
M  V30 26 C 12.6930 7.0219 0.0 0
M  V30 27 C 13.7234 8.1663 0.0 0
M  V30 28 C 13.1689 5.5572 0.0 0
M  V30 29 C 15.2299 7.8461 0.0 0
M  V30 30 C 14.6752 5.2370 0.0 0
M  V30 31 C 15.7057 6.3815 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 7 17
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 9 13
M  V30 16 1 10 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 22
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-108348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128333 A1 2015-09-03

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[(2-hydroxyethyl)methy...
C24H29N5O5
1807698-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 9.3358 0.0 0 VAL=5
M  V30 2 O 8.4700 9.3358 0.0 0
M  V30 3 O 6.1600 10.6694 0.0 0
M  V30 4 N 3.8500 9.3358 0.0 0
M  V30 5 N 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 2.6673 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 C 2.3100 6.6684 0.0 0
M  V30 11 O 1.5400 8.0021 0.0 0
M  V30 12 O 1.5400 5.3347 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 3.8500 6.6684 0.0 0
M  V30 20 C 8.4700 6.6684 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 10.7800 8.0021 0.0 0
M  V30 25 C 11.5500 6.6684 0.0 0
M  V30 26 N 11.8104 4.1903 0.0 0
M  V30 27 N 13.0563 6.3482 0.0 0
M  V30 28 C 13.2172 4.8167 0.0 0
M  V30 29 C 14.2006 7.3786 0.0 0
M  V30 30 C 15.6653 6.9027 0.0 0
M  V30 31 C 13.8805 8.8850 0.0 0
M  V30 32 C 16.8097 7.9333 0.0 0
M  V30 33 C 15.0250 9.9154 0.0 0
M  V30 34 C 16.4895 9.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 2 24 25
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1-Cyclohexyl-1H-benzimidazol-5-yl)-1,6,7,8-tetrahydro-6-methyl-10H-imidazo...
C24H25N5O2
1807698-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5124 0.0000 0.0 0
M  V30 2 C 2.5124 6.4632 0.0 0
M  V30 3 C 4.7074 1.6916 0.0 0
M  V30 4 C 6.0410 2.4616 0.0 0
M  V30 5 C 3.3737 2.4616 0.0 0
M  V30 6 N 5.0275 0.1851 0.0 0
M  V30 7 C 6.0410 4.0016 0.0 0
M  V30 8 N 7.1856 1.4310 0.0 0
M  V30 9 C 3.3737 4.0016 0.0 0
M  V30 10 C 2.1696 1.5014 0.0 0
M  V30 11 C 6.5591 0.0242 0.0 0
M  V30 12 C 4.7074 4.7716 0.0 0
M  V30 13 N 2.1696 4.9618 0.0 0
M  V30 14 O 0.6682 1.8440 0.0 0
M  V30 15 C 0.6682 4.6190 0.0 0
M  V30 16 C 0.0000 3.2316 0.0 0
M  V30 17 C 7.3747 4.7716 0.0 0
M  V30 18 C 7.3747 6.3116 0.0 0
M  V30 19 C 8.7085 4.0016 0.0 0
M  V30 20 C 8.7085 7.0816 0.0 0
M  V30 21 C 10.0422 4.7716 0.0 0
M  V30 22 C 10.0422 6.3116 0.0 0
M  V30 23 N 9.0287 8.5879 0.0 0
M  V30 24 N 11.1865 7.3420 0.0 0
M  V30 25 C 10.5602 8.7489 0.0 0
M  V30 26 C 12.6930 7.0219 0.0 0
M  V30 27 C 13.7234 8.1663 0.0 0
M  V30 28 C 13.1689 5.5572 0.0 0
M  V30 29 C 15.2299 7.8461 0.0 0
M  V30 30 C 14.6752 5.2370 0.0 0
M  V30 31 C 15.7057 6.3815 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 7 17
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 9 13
M  V30 16 1 10 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 22
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-19302084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2913330 A1 2015-09-02

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[2-[(dimethylamino)met...
C28H36N6O4
1807698-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 7.0036 0.0 0
M  V30 2 O 1.5400 8.3373 0.0 0
M  V30 3 O 1.5400 5.6699 0.0 0
M  V30 4 C 0.0000 8.3373 0.0 0
M  V30 5 C 5.9827 2.6091 0.0 0
M  V30 6 N 6.4587 1.1446 0.0 0
M  V30 7 C 7.9651 0.8242 0.0 0
M  V30 8 C 5.4282 0.0000 0.0 0
M  V30 9 N 3.8501 9.6711 0.0 0
M  V30 10 N 6.9302 9.6711 0.0 0 VAL=5
M  V30 11 O 8.4702 9.6711 0.0 0
M  V30 12 O 6.1601 11.0048 0.0 0
M  V30 13 C 4.6201 5.6699 0.0 0
M  V30 14 C 3.8501 7.0036 0.0 0
M  V30 15 C 6.1601 5.6699 0.0 0
M  V30 16 C 4.6201 8.3373 0.0 0
M  V30 17 C 6.9302 7.0036 0.0 0
M  V30 18 C 6.1601 8.3373 0.0 0
M  V30 19 N 3.8501 4.3363 0.0 0
M  V30 20 C 4.4764 2.9293 0.0 0
M  V30 21 C 2.3184 4.1752 0.0 0
M  V30 22 C 3.3319 1.8989 0.0 0
M  V30 23 C 1.9982 2.6689 0.0 0
M  V30 24 C 8.4702 7.0036 0.0 0
M  V30 25 C 9.2402 5.6699 0.0 0
M  V30 26 C 9.2402 8.3373 0.0 0
M  V30 27 C 10.7802 5.6699 0.0 0
M  V30 28 C 10.7802 8.3373 0.0 0
M  V30 29 C 11.5503 7.0036 0.0 0
M  V30 30 N 11.8107 4.5254 0.0 0
M  V30 31 N 13.0566 6.6834 0.0 0
M  V30 32 C 13.2175 5.1519 0.0 0
M  V30 33 C 14.2010 7.7139 0.0 0
M  V30 34 C 13.8808 9.2203 0.0 0
M  V30 35 C 15.6657 7.2380 0.0 0
M  V30 36 C 15.0253 10.2508 0.0 0
M  V30 37 C 16.8101 8.2684 0.0 0
M  V30 38 C 16.4899 9.7749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 16
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 17 24
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 2 28 29
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1′-cyclohexyl-6-[2-[(dimethylamino)methyl]-1-pyrrolidinyl][4,5′-bi-1H-...
C29H36N6O2
1807698-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 7.0036 0.0 0
M  V30 2 O 1.5400 8.3373 0.0 0
M  V30 3 O 1.5400 5.6699 0.0 0
M  V30 4 C 0.0000 8.3373 0.0 0
M  V30 5 C 5.9827 2.6091 0.0 0
M  V30 6 N 6.4587 1.1446 0.0 0
M  V30 7 C 7.9651 0.8242 0.0 0
M  V30 8 C 5.4282 0.0000 0.0 0
M  V30 9 C 6.9302 7.0036 0.0 0
M  V30 10 C 6.1601 8.3373 0.0 0
M  V30 11 C 6.1601 5.6699 0.0 0
M  V30 12 C 4.6201 8.3373 0.0 0
M  V30 13 N 6.6360 9.8020 0.0 0
M  V30 14 C 4.6201 5.6699 0.0 0
M  V30 15 C 3.8501 7.0036 0.0 0
M  V30 16 N 4.1441 9.8020 0.0 0
M  V30 17 C 5.3901 10.7072 0.0 0
M  V30 18 C 8.4702 7.0036 0.0 0
M  V30 19 C 9.2402 8.3373 0.0 0
M  V30 20 C 9.2402 5.6699 0.0 0
M  V30 21 C 10.7802 8.3373 0.0 0
M  V30 22 C 10.7802 5.6699 0.0 0
M  V30 23 C 11.5503 7.0036 0.0 0
M  V30 24 N 11.8107 9.4818 0.0 0
M  V30 25 N 13.0566 7.3238 0.0 0
M  V30 26 C 13.2175 8.8555 0.0 0
M  V30 27 N 3.8501 4.3363 0.0 0
M  V30 28 C 4.4764 2.9293 0.0 0
M  V30 29 C 2.3184 4.1752 0.0 0
M  V30 30 C 3.3319 1.8989 0.0 0
M  V30 31 C 1.9982 2.6689 0.0 0
M  V30 32 C 14.2010 6.2933 0.0 0
M  V30 33 C 15.6657 6.7692 0.0 0
M  V30 34 C 13.8808 4.7870 0.0 0
M  V30 35 C 16.8101 5.7388 0.0 0
M  V30 36 C 15.0253 3.7565 0.0 0
M  V30 37 C 16.4899 4.2323 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 14 27
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 23
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 25 32
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-6666024
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128333 A1 2015-09-03

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[2-[(dimethylamino)met...
C28H36N6O4
1807698-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 7.0036 0.0 0
M  V30 2 O 1.5400 8.3373 0.0 0
M  V30 3 O 1.5400 5.6699 0.0 0
M  V30 4 C 0.0000 8.3373 0.0 0
M  V30 5 C 5.9827 2.6091 0.0 0
M  V30 6 N 6.4587 1.1446 0.0 0
M  V30 7 C 7.9651 0.8242 0.0 0
M  V30 8 C 5.4282 0.0000 0.0 0
M  V30 9 N 3.8501 9.6711 0.0 0
M  V30 10 N 6.9302 9.6711 0.0 0 VAL=5
M  V30 11 O 8.4702 9.6711 0.0 0
M  V30 12 O 6.1601 11.0048 0.0 0
M  V30 13 C 4.6201 5.6699 0.0 0
M  V30 14 C 3.8501 7.0036 0.0 0
M  V30 15 C 6.1601 5.6699 0.0 0
M  V30 16 C 4.6201 8.3373 0.0 0
M  V30 17 C 6.9302 7.0036 0.0 0
M  V30 18 C 6.1601 8.3373 0.0 0
M  V30 19 N 3.8501 4.3363 0.0 0
M  V30 20 C 4.4764 2.9293 0.0 0
M  V30 21 C 2.3184 4.1752 0.0 0
M  V30 22 C 3.3319 1.8989 0.0 0
M  V30 23 C 1.9982 2.6689 0.0 0
M  V30 24 C 8.4702 7.0036 0.0 0
M  V30 25 C 9.2402 5.6699 0.0 0
M  V30 26 C 9.2402 8.3373 0.0 0
M  V30 27 C 10.7802 5.6699 0.0 0
M  V30 28 C 10.7802 8.3373 0.0 0
M  V30 29 C 11.5503 7.0036 0.0 0
M  V30 30 N 11.8107 4.5254 0.0 0
M  V30 31 N 13.0566 6.6834 0.0 0
M  V30 32 C 13.2175 5.1519 0.0 0
M  V30 33 C 14.2010 7.7139 0.0 0
M  V30 34 C 13.8808 9.2203 0.0 0
M  V30 35 C 15.6657 7.2380 0.0 0
M  V30 36 C 15.0253 10.2508 0.0 0
M  V30 37 C 16.8101 8.2684 0.0 0
M  V30 38 C 16.4899 9.7749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 16
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 17 24
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 2 28 29
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1′-cyclohexyl-6-[2-[(dimethylamino)methyl]-1-pyrrolidinyl][4,5′-bi-1H-...
C29H36N6O2
1807698-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 7.0036 0.0 0
M  V30 2 O 1.5400 8.3373 0.0 0
M  V30 3 O 1.5400 5.6699 0.0 0
M  V30 4 C 0.0000 8.3373 0.0 0
M  V30 5 C 5.9827 2.6091 0.0 0
M  V30 6 N 6.4587 1.1446 0.0 0
M  V30 7 C 7.9651 0.8242 0.0 0
M  V30 8 C 5.4282 0.0000 0.0 0
M  V30 9 C 6.9302 7.0036 0.0 0
M  V30 10 C 6.1601 8.3373 0.0 0
M  V30 11 C 6.1601 5.6699 0.0 0
M  V30 12 C 4.6201 8.3373 0.0 0
M  V30 13 N 6.6360 9.8020 0.0 0
M  V30 14 C 4.6201 5.6699 0.0 0
M  V30 15 C 3.8501 7.0036 0.0 0
M  V30 16 N 4.1441 9.8020 0.0 0
M  V30 17 C 5.3901 10.7072 0.0 0
M  V30 18 C 8.4702 7.0036 0.0 0
M  V30 19 C 9.2402 8.3373 0.0 0
M  V30 20 C 9.2402 5.6699 0.0 0
M  V30 21 C 10.7802 8.3373 0.0 0
M  V30 22 C 10.7802 5.6699 0.0 0
M  V30 23 C 11.5503 7.0036 0.0 0
M  V30 24 N 11.8107 9.4818 0.0 0
M  V30 25 N 13.0566 7.3238 0.0 0
M  V30 26 C 13.2175 8.8555 0.0 0
M  V30 27 N 3.8501 4.3363 0.0 0
M  V30 28 C 4.4764 2.9293 0.0 0
M  V30 29 C 2.3184 4.1752 0.0 0
M  V30 30 C 3.3319 1.8989 0.0 0
M  V30 31 C 1.9982 2.6689 0.0 0
M  V30 32 C 14.2010 6.2933 0.0 0
M  V30 33 C 15.6657 6.7692 0.0 0
M  V30 34 C 13.8808 4.7870 0.0 0
M  V30 35 C 16.8101 5.7388 0.0 0
M  V30 36 C 15.0253 3.7565 0.0 0
M  V30 37 C 16.4899 4.2323 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 14 27
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 23
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 25 32
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19302114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2913330 A1 2015-09-02

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[[2-(dimethylami...
C33H40N6O5
1807699-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0101 10.6695 0.0 0 VAL=5
M  V30 2 O 11.5501 10.6695 0.0 0
M  V30 3 O 9.2401 12.0032 0.0 0
M  V30 4 N 6.9301 10.6695 0.0 0
M  V30 5 N 6.9301 5.3348 0.0 0
M  V30 6 C 7.7001 4.0010 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 6.9301 2.6673 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 N 7.7001 1.3337 0.0 0
M  V30 11 O 3.0800 4.0010 0.0 0
M  V30 12 C 6.9301 0.0000 0.0 0
M  V30 13 C 9.2401 1.3337 0.0 0
M  V30 14 C 5.3901 8.0021 0.0 0
M  V30 15 O 4.6201 9.3359 0.0 0
M  V30 16 O 4.6201 6.6684 0.0 0
M  V30 17 C 3.0800 9.3359 0.0 0
M  V30 18 C 10.0101 8.0021 0.0 0
M  V30 19 C 9.2401 9.3359 0.0 0
M  V30 20 C 9.2401 6.6684 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 7.7001 6.6684 0.0 0
M  V30 23 C 6.9301 8.0021 0.0 0
M  V30 24 C 11.5501 8.0021 0.0 0
M  V30 25 C 12.3201 6.6684 0.0 0
M  V30 26 C 12.3201 9.3359 0.0 0
M  V30 27 C 13.8602 6.6684 0.0 0
M  V30 28 C 13.8602 9.3359 0.0 0
M  V30 29 C 14.6302 8.0021 0.0 0
M  V30 30 N 14.8906 5.5240 0.0 0
M  V30 31 N 16.1365 7.6819 0.0 0
M  V30 32 C 16.2974 6.1504 0.0 0
M  V30 33 C 17.2808 8.7123 0.0 0
M  V30 34 C 16.9607 10.2188 0.0 0
M  V30 35 C 18.7455 8.2365 0.0 0
M  V30 36 C 18.1052 11.2492 0.0 0
M  V30 37 C 19.8899 9.2671 0.0 0
M  V30 38 C 19.5698 10.7733 0.0 0
M  V30 39 C 2.3100 10.6695 0.0 0
M  V30 40 C 0.7700 10.6695 0.0 0
M  V30 41 C 3.0800 12.0032 0.0 0
M  V30 42 C 0.0000 12.0032 0.0 0
M  V30 43 C 2.3100 13.3369 0.0 0
M  V30 44 C 0.7700 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 17 39
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 2 28 29
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 1′-cyclohexyl-6-[[2-(dimethylamino)ethyl][2-(formyloxy)ethyl]ami...
C35H40N6O4
1807699-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 10.0102 0.0 0
M  V30 2 C 5.3348 9.2402 0.0 0
M  V30 3 C 6.6685 11.5503 0.0 0
M  V30 4 C 4.0010 10.0102 0.0 0
M  V30 5 C 5.3348 12.3203 0.0 0
M  V30 6 O 2.6673 9.2402 0.0 0
M  V30 7 N 5.3348 13.8603 0.0 0
M  V30 8 C 1.3337 10.0102 0.0 0
M  V30 9 C 4.0010 14.6303 0.0 0
M  V30 10 C 6.6685 14.6303 0.0 0
M  V30 11 O 0.0000 9.2402 0.0 0
M  V30 12 C 6.6685 6.9302 0.0 0
M  V30 13 O 6.6685 5.3901 0.0 0
M  V30 14 O 5.3348 7.7002 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 10.6697 9.2402 0.0 0
M  V30 17 C 10.6697 7.7002 0.0 0
M  V30 18 C 9.3358 10.0102 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 N 11.8141 6.6697 0.0 0
M  V30 21 C 8.0022 9.2402 0.0 0
M  V30 22 C 8.0022 7.7002 0.0 0
M  V30 23 N 9.6562 5.4238 0.0 0
M  V30 24 C 11.1877 5.2628 0.0 0
M  V30 25 C 12.0033 10.0102 0.0 0
M  V30 26 C 12.0033 11.5503 0.0 0
M  V30 27 C 13.3370 9.2402 0.0 0
M  V30 28 C 13.3370 12.3203 0.0 0
M  V30 29 C 14.6707 10.0102 0.0 0
M  V30 30 C 14.6707 11.5503 0.0 0
M  V30 31 N 13.6572 13.8266 0.0 0
M  V30 32 N 15.8152 12.5807 0.0 0
M  V30 33 C 15.1889 13.9877 0.0 0
M  V30 34 C 17.3215 12.2605 0.0 0
M  V30 35 C 17.7976 10.7959 0.0 0
M  V30 36 C 18.3521 13.4051 0.0 0
M  V30 37 C 19.3039 10.4758 0.0 0
M  V30 38 C 19.8584 13.0849 0.0 0
M  V30 39 C 20.3343 11.6202 0.0 0
M  V30 40 C 5.3348 3.0801 0.0 0
M  V30 41 C 6.6685 2.3101 0.0 0
M  V30 42 C 4.0010 2.3101 0.0 0
M  V30 43 C 6.6685 0.7700 0.0 0
M  V30 44 C 4.0010 0.7700 0.0 0
M  V30 45 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 22
M  V30 15 1 13 15
M  V30 16 1 15 40
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 25
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 2 19 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807699-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807699-02-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31215680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128333 A1 2015-09-03

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-[[2-(dimethylami...
C33H40N6O5
1807699-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0101 10.6695 0.0 0 VAL=5
M  V30 2 O 11.5501 10.6695 0.0 0
M  V30 3 O 9.2401 12.0032 0.0 0
M  V30 4 N 6.9301 10.6695 0.0 0
M  V30 5 N 6.9301 5.3348 0.0 0
M  V30 6 C 7.7001 4.0010 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 6.9301 2.6673 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 N 7.7001 1.3337 0.0 0
M  V30 11 O 3.0800 4.0010 0.0 0
M  V30 12 C 6.9301 0.0000 0.0 0
M  V30 13 C 9.2401 1.3337 0.0 0
M  V30 14 C 5.3901 8.0021 0.0 0
M  V30 15 O 4.6201 9.3359 0.0 0
M  V30 16 O 4.6201 6.6684 0.0 0
M  V30 17 C 3.0800 9.3359 0.0 0
M  V30 18 C 10.0101 8.0021 0.0 0
M  V30 19 C 9.2401 9.3359 0.0 0
M  V30 20 C 9.2401 6.6684 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 7.7001 6.6684 0.0 0
M  V30 23 C 6.9301 8.0021 0.0 0
M  V30 24 C 11.5501 8.0021 0.0 0
M  V30 25 C 12.3201 6.6684 0.0 0
M  V30 26 C 12.3201 9.3359 0.0 0
M  V30 27 C 13.8602 6.6684 0.0 0
M  V30 28 C 13.8602 9.3359 0.0 0
M  V30 29 C 14.6302 8.0021 0.0 0
M  V30 30 N 14.8906 5.5240 0.0 0
M  V30 31 N 16.1365 7.6819 0.0 0
M  V30 32 C 16.2974 6.1504 0.0 0
M  V30 33 C 17.2808 8.7123 0.0 0
M  V30 34 C 16.9607 10.2188 0.0 0
M  V30 35 C 18.7455 8.2365 0.0 0
M  V30 36 C 18.1052 11.2492 0.0 0
M  V30 37 C 19.8899 9.2671 0.0 0
M  V30 38 C 19.5698 10.7733 0.0 0
M  V30 39 C 2.3100 10.6695 0.0 0
M  V30 40 C 0.7700 10.6695 0.0 0
M  V30 41 C 3.0800 12.0032 0.0 0
M  V30 42 C 0.0000 12.0032 0.0 0
M  V30 43 C 2.3100 13.3369 0.0 0
M  V30 44 C 0.7700 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 17 39
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 2 28 29
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 1′-cyclohexyl-6-[[2-(dimethylamino)ethyl][2-(formyloxy)ethyl]ami...
C35H40N6O4
1807699-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 10.0102 0.0 0
M  V30 2 C 5.3348 9.2402 0.0 0
M  V30 3 C 6.6685 11.5503 0.0 0
M  V30 4 C 4.0010 10.0102 0.0 0
M  V30 5 C 5.3348 12.3203 0.0 0
M  V30 6 O 2.6673 9.2402 0.0 0
M  V30 7 N 5.3348 13.8603 0.0 0
M  V30 8 C 1.3337 10.0102 0.0 0
M  V30 9 C 4.0010 14.6303 0.0 0
M  V30 10 C 6.6685 14.6303 0.0 0
M  V30 11 O 0.0000 9.2402 0.0 0
M  V30 12 C 6.6685 6.9302 0.0 0
M  V30 13 O 6.6685 5.3901 0.0 0
M  V30 14 O 5.3348 7.7002 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 10.6697 9.2402 0.0 0
M  V30 17 C 10.6697 7.7002 0.0 0
M  V30 18 C 9.3358 10.0102 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 N 11.8141 6.6697 0.0 0
M  V30 21 C 8.0022 9.2402 0.0 0
M  V30 22 C 8.0022 7.7002 0.0 0
M  V30 23 N 9.6562 5.4238 0.0 0
M  V30 24 C 11.1877 5.2628 0.0 0
M  V30 25 C 12.0033 10.0102 0.0 0
M  V30 26 C 12.0033 11.5503 0.0 0
M  V30 27 C 13.3370 9.2402 0.0 0
M  V30 28 C 13.3370 12.3203 0.0 0
M  V30 29 C 14.6707 10.0102 0.0 0
M  V30 30 C 14.6707 11.5503 0.0 0
M  V30 31 N 13.6572 13.8266 0.0 0
M  V30 32 N 15.8152 12.5807 0.0 0
M  V30 33 C 15.1889 13.9877 0.0 0
M  V30 34 C 17.3215 12.2605 0.0 0
M  V30 35 C 17.7976 10.7959 0.0 0
M  V30 36 C 18.3521 13.4051 0.0 0
M  V30 37 C 19.3039 10.4758 0.0 0
M  V30 38 C 19.8584 13.0849 0.0 0
M  V30 39 C 20.3343 11.6202 0.0 0
M  V30 40 C 5.3348 3.0801 0.0 0
M  V30 41 C 6.6685 2.3101 0.0 0
M  V30 42 C 4.0010 2.3101 0.0 0
M  V30 43 C 6.6685 0.7700 0.0 0
M  V30 44 C 4.0010 0.7700 0.0 0
M  V30 45 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 22
M  V30 15 1 13 15
M  V30 16 1 15 40
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 25
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 2 19 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807699-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807699-02-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29996411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2913330 A1 2015-09-02

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Gold, [4,4′′-bis(1,1-dimethylethyl)-5′-(3-methyl-2-pyridinyl-κN)[1,1′:3′,1′′-...
C32H33AuFN
1817799-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.1804 3.4550 0.0 0 CHG=-1 VAL=1
M  V30 2 C 1.5394 6.5923 0.0 0
M  V30 3 C 0.7330 7.9044 0.0 0
M  V30 4 C 0.0000 6.5501 0.0 0
M  V30 5 C 0.8062 5.2380 0.0 0
M  V30 6 C 10.7664 1.2674 0.0 0
M  V30 7 C 15.7413 9.5431 0.0 0
M  V30 8 C 14.9723 10.8773 0.0 0
M  V30 9 C 17.0755 10.3121 0.0 0
M  V30 10 C 16.5103 8.2088 0.0 0
M  V30 11 Au 6.5140 4.2250 0.0 0 CHG=3 VAL=4
M  V30 12 C 7.7795 4.9543 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.4245 5.3647 0.0 0 CHG=-1 VAL=4
M  V30 14 N 6.9566 2.7107 0.0 0 VAL=4
M  V30 15 C 9.0312 4.1452 0.0 0
M  V30 16 C 7.7069 6.4429 0.0 0
M  V30 17 C 6.1577 6.7190 0.0 0
M  V30 18 C 3.8851 5.3225 0.0 0
M  V30 19 C 8.4936 2.6662 0.0 0
M  V30 20 C 6.1484 1.3999 0.0 0
M  V30 21 C 10.3821 4.9280 0.0 0
M  V30 22 C 9.0614 7.2194 0.0 0
M  V30 23 C 5.3513 8.0311 0.0 0
M  V30 24 C 3.0788 6.6346 0.0 0
M  V30 25 C 9.2271 1.3108 0.0 0
M  V30 26 C 6.8795 0.0445 0.0 0
M  V30 27 C 10.4042 6.4671 0.0 0
M  V30 28 C 3.8120 7.9889 0.0 0
M  V30 29 C 8.4189 0.0000 0.0 0
M  V30 30 C 11.7385 7.2361 0.0 0
M  V30 31 C 13.0717 6.4651 0.0 0
M  V30 32 C 11.7397 8.7761 0.0 0
M  V30 33 C 14.4059 7.2341 0.0 0
M  V30 34 C 13.0740 9.5451 0.0 0
M  V30 35 C 14.4070 8.7741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 24
M  V30 6 1 6 25
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 35
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 2 14 20
M  V30 20 1 15 19
M  V30 21 2 15 21
M  V30 22 1 16 17
M  V30 23 1 16 22
M  V30 24 2 17 23
M  V30 25 1 18 24
M  V30 26 2 19 25
M  V30 27 1 20 26
M  V30 28 1 21 27
M  V30 29 2 22 27
M  V30 30 1 23 28
M  V30 31 2 24 28
M  V30 32 1 25 29
M  V30 33 2 26 29
M  V30 34 1 27 30
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C33H34AuNO2
2205889-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1804 3.4550 0.0 0 CHG=-1 VAL=2
M  V30 2 C 5.1804 1.9150 0.0 0
M  V30 3 O 3.8468 1.1450 0.0 0
M  V30 4 C 1.5394 6.5923 0.0 0
M  V30 5 C 0.8062 5.2380 0.0 0
M  V30 6 C 0.0000 6.5501 0.0 0
M  V30 7 C 0.7330 7.9044 0.0 0
M  V30 8 C 10.7664 1.2674 0.0 0
M  V30 9 C 15.7413 9.5431 0.0 0
M  V30 10 C 14.9723 10.8773 0.0 0
M  V30 11 C 17.0755 10.3121 0.0 0
M  V30 12 C 16.5103 8.2088 0.0 0
M  V30 13 Au 6.5140 4.2250 0.0 0 CHG=3 VAL=4
M  V30 14 C 7.7795 4.9543 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.4245 5.3647 0.0 0 CHG=-1 VAL=4
M  V30 16 N 6.9566 2.7107 0.0 0 VAL=4
M  V30 17 C 9.0312 4.1452 0.0 0
M  V30 18 C 7.7069 6.4429 0.0 0
M  V30 19 C 6.1577 6.7190 0.0 0
M  V30 20 C 3.8851 5.3225 0.0 0
M  V30 21 C 8.4936 2.6662 0.0 0
M  V30 22 C 6.1484 1.3999 0.0 0
M  V30 23 C 10.3821 4.9280 0.0 0
M  V30 24 C 9.0614 7.2194 0.0 0
M  V30 25 C 5.3513 8.0311 0.0 0
M  V30 26 C 3.0788 6.6346 0.0 0
M  V30 27 C 9.2271 1.3108 0.0 0
M  V30 28 C 6.8795 0.0445 0.0 0
M  V30 29 C 10.4042 6.4671 0.0 0
M  V30 30 C 3.8120 7.9889 0.0 0
M  V30 31 C 8.4189 0.0000 0.0 0
M  V30 32 C 11.7385 7.2362 0.0 0
M  V30 33 C 13.0717 6.4651 0.0 0
M  V30 34 C 11.7397 8.7762 0.0 0
M  V30 35 C 14.4059 7.2341 0.0 0
M  V30 36 C 13.0740 9.5451 0.0 0
M  V30 37 C 14.4070 8.7741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 26
M  V30 8 1 8 27
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 37
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 21
M  V30 21 2 16 22
M  V30 22 1 17 21
M  V30 23 2 17 23
M  V30 24 1 18 19
M  V30 25 1 18 24
M  V30 26 2 19 25
M  V30 27 1 20 26
M  V30 28 2 21 27
M  V30 29 1 22 28
M  V30 30 1 23 29
M  V30 31 2 24 29
M  V30 32 1 25 30
M  V30 33 2 26 30
M  V30 34 1 27 31
M  V30 35 2 28 31
M  V30 36 1 29 32
M  V30 37 2 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1817799-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2205889-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-18622449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The First Gold(III) Formate: Evidence for β-Hydride Elimination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Roopender; Krieger, Jean-Philippe; Gomez-Bengoa, Enrique; Fox,
Thomas; Linden, Anthony; Nevado, Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(42), 12862-12865

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Formic-d acid
CHDO2
917-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 H 1.3337 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Gold, [4,4′′-bis(1,1-dimethylethyl)-5′-(3-methyl-2-pyridinyl-κN)[1,1′:3′,1′′-...
C32H33AuFN
1817799-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.1804 3.4550 0.0 0 CHG=-1 VAL=1
M  V30 2 C 1.5394 6.5923 0.0 0
M  V30 3 C 0.7330 7.9044 0.0 0
M  V30 4 C 0.0000 6.5501 0.0 0
M  V30 5 C 0.8062 5.2380 0.0 0
M  V30 6 C 10.7664 1.2674 0.0 0
M  V30 7 C 15.7413 9.5431 0.0 0
M  V30 8 C 14.9723 10.8773 0.0 0
M  V30 9 C 17.0755 10.3121 0.0 0
M  V30 10 C 16.5103 8.2088 0.0 0
M  V30 11 Au 6.5140 4.2250 0.0 0 CHG=3 VAL=4
M  V30 12 C 7.7795 4.9543 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.4245 5.3647 0.0 0 CHG=-1 VAL=4
M  V30 14 N 6.9566 2.7107 0.0 0 VAL=4
M  V30 15 C 9.0312 4.1452 0.0 0
M  V30 16 C 7.7069 6.4429 0.0 0
M  V30 17 C 6.1577 6.7190 0.0 0
M  V30 18 C 3.8851 5.3225 0.0 0
M  V30 19 C 8.4936 2.6662 0.0 0
M  V30 20 C 6.1484 1.3999 0.0 0
M  V30 21 C 10.3821 4.9280 0.0 0
M  V30 22 C 9.0614 7.2194 0.0 0
M  V30 23 C 5.3513 8.0311 0.0 0
M  V30 24 C 3.0788 6.6346 0.0 0
M  V30 25 C 9.2271 1.3108 0.0 0
M  V30 26 C 6.8795 0.0445 0.0 0
M  V30 27 C 10.4042 6.4671 0.0 0
M  V30 28 C 3.8120 7.9889 0.0 0
M  V30 29 C 8.4189 0.0000 0.0 0
M  V30 30 C 11.7385 7.2361 0.0 0
M  V30 31 C 13.0717 6.4651 0.0 0
M  V30 32 C 11.7397 8.7761 0.0 0
M  V30 33 C 14.4059 7.2341 0.0 0
M  V30 34 C 13.0740 9.5451 0.0 0
M  V30 35 C 14.4070 8.7741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 24
M  V30 6 1 6 25
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 35
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 2 14 20
M  V30 20 1 15 19
M  V30 21 2 15 21
M  V30 22 1 16 17
M  V30 23 1 16 22
M  V30 24 2 17 23
M  V30 25 1 18 24
M  V30 26 2 19 25
M  V30 27 1 20 26
M  V30 28 1 21 27
M  V30 29 2 22 27
M  V30 30 1 23 28
M  V30 31 2 24 28
M  V30 32 1 25 29
M  V30 33 2 26 29
M  V30 34 1 27 30
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C33H33AuDNO2
2205889-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6335 2.9614 0.0 0 CHG=-1 VAL=2
M  V30 2 C 4.0992 3.0945 0.0 0
M  V30 3 O 3.4473 4.4897 0.0 0
M  V30 4 C 1.5394 6.5872 0.0 0
M  V30 5 C 0.7321 7.8987 0.0 0
M  V30 6 C 0.0000 6.5439 0.0 0
M  V30 7 C 0.8073 5.2325 0.0 0
M  V30 8 C 10.7705 1.2691 0.0 0
M  V30 9 C 15.7391 9.5486 0.0 0
M  V30 10 C 14.9691 10.8823 0.0 0
M  V30 11 C 17.0728 10.3186 0.0 0
M  V30 12 C 16.5091 8.2150 0.0 0
M  V30 13 Au 6.5158 4.2236 0.0 0 CHG=3 VAL=4
M  V30 14 C 7.7807 4.9539 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.4254 5.3626 0.0 0 CHG=-1 VAL=4
M  V30 16 N 6.9594 2.7096 0.0 0 VAL=4
M  V30 17 C 9.0330 4.1458 0.0 0
M  V30 18 C 7.7071 6.4425 0.0 0
M  V30 19 C 6.1576 6.7173 0.0 0
M  V30 20 C 3.8860 5.3192 0.0 0
M  V30 21 C 8.4964 2.6664 0.0 0
M  V30 22 C 6.1522 1.3982 0.0 0
M  V30 23 C 10.3833 4.9294 0.0 0
M  V30 24 C 9.0609 7.2200 0.0 0
M  V30 25 C 5.3503 8.0288 0.0 0
M  V30 26 C 3.0788 6.6306 0.0 0
M  V30 27 C 9.2311 1.3115 0.0 0
M  V30 28 C 6.8844 0.0433 0.0 0
M  V30 29 C 10.4044 6.4686 0.0 0
M  V30 30 C 3.8109 7.9855 0.0 0
M  V30 31 C 8.4238 0.0000 0.0 0
M  V30 32 C 11.7381 7.2386 0.0 0
M  V30 33 C 11.7381 8.7786 0.0 0
M  V30 34 C 13.0717 6.4686 0.0 0
M  V30 35 C 13.0717 9.5486 0.0 0
M  V30 36 C 14.4055 7.2386 0.0 0
M  V30 37 C 14.4055 8.7786 0.0 0
M  V30 38 H 3.2168 1.8323 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 38
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 26
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 37
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 21
M  V30 24 2 17 23
M  V30 25 1 18 19
M  V30 26 1 18 24
M  V30 27 2 19 25
M  V30 28 1 20 26
M  V30 29 2 21 27
M  V30 30 1 22 28
M  V30 31 1 23 29
M  V30 32 2 24 29
M  V30 33 1 25 30
M  V30 34 2 26 30
M  V30 35 1 27 31
M  V30 36 2 28 31
M  V30 37 1 29 32
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 917-71-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1817799-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2205889-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-18622450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The First Gold(III) Formate: Evidence for β-Hydride Elimination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Roopender; Krieger, Jean-Philippe; Gomez-Bengoa, Enrique; Fox,
Thomas; Linden, Anthony; Nevado, Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(42), 12862-12865

$RFMT $RIREG SCHEME102 STEP1
$RXN



  3  1
$MOL
Vinylmagnesium bromide
C2H3BrMg
1826-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 Mg 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azabicyclo[3.1.0]hexane-6-carboxamide, 3-[7-(8-chloro-1-naphthalenyl)-5,6,7...
C31H37ClN6O3
2925475-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.8768 11.9216 0.0 0
M  V30 2 N 15.2104 11.1516 0.0 0
M  V30 3 O 13.8768 13.4616 0.0 0
M  V30 4 O 16.5442 11.9216 0.0 0
M  V30 5 C 15.2104 9.6116 0.0 0
M  V30 6 C 17.8779 11.1516 0.0 0
M  V30 7 O 6.6685 4.6798 0.0 0
M  V30 8 C 5.3347 3.9098 0.0 0
M  V30 9 C 2.6242 1.9406 0.0 0
M  V30 10 Cl 5.3347 13.1498 0.0 0
M  V30 11 C 11.0031 11.1516 0.0 0 CFG=2
M  V30 12 C 11.7731 9.8178 0.0 0 CFG=1
M  V30 13 C 12.5431 11.1516 0.0 0 CFG=2
M  V30 14 C 9.4967 10.8313 0.0 0
M  V30 15 C 10.7426 8.6734 0.0 0
M  V30 16 N 9.3358 9.2998 0.0 0
M  V30 17 C 8.0021 8.5298 0.0 0
M  V30 18 C 6.6684 9.2998 0.0 0
M  V30 19 N 8.0021 6.9898 0.0 0
M  V30 20 C 5.3347 8.5298 0.0 0
M  V30 21 C 6.6684 10.8398 0.0 0
M  V30 22 C 6.6684 6.2198 0.0 0
M  V30 23 C 4.0011 9.2998 0.0 0
M  V30 24 N 5.3347 6.9898 0.0 0
M  V30 25 C 5.3347 11.6098 0.0 0
M  V30 26 N 4.0011 10.8398 0.0 0
M  V30 27 C 2.6674 11.6098 0.0 0
M  V30 28 C 2.6674 13.1498 0.0 0
M  V30 29 C 1.3336 10.8398 0.0 0
M  V30 30 C 1.3336 13.9198 0.0 0
M  V30 31 C 4.0011 13.9198 0.0 0
M  V30 32 C 0.0000 11.6098 0.0 0
M  V30 33 C 0.0000 13.1498 0.0 0
M  V30 34 C 1.3336 15.4598 0.0 0
M  V30 35 C 4.0011 15.4598 0.0 0
M  V30 36 C 2.6674 16.2298 0.0 0
M  V30 37 C 5.3347 2.3698 0.0 0 CFG=2
M  V30 38 N 4.0889 1.4645 0.0 0
M  V30 39 C 6.5806 1.4645 0.0 0
M  V30 40 C 4.5647 0.0000 0.0 0
M  V30 41 C 6.1047 0.0000 0.0 0
M  V30 42 H 10.8421 12.6831 0.0 0
M  V30 43 H 13.0190 8.9126 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 37 8 CFG=3
M  V30 10 1 9 38
M  V30 11 1 10 31
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 42 CFG=1
M  V30 16 1 12 13
M  V30 17 1 12 15
M  V30 18 1 12 43 CFG=1
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 21 1 16 17
M  V30 22 2 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 2 19 22
M  V30 27 1 20 23
M  V30 28 2 20 24
M  V30 29 1 21 25
M  V30 30 1 22 24
M  V30 31 1 23 26
M  V30 32 1 25 26
M  V30 33 1 26 27
M  V30 34 1 27 28
M  V30 35 2 27 29
M  V30 36 2 28 30
M  V30 37 1 28 31
M  V30 38 1 29 32
M  V30 39 1 30 33
M  V30 40 1 30 34
M  V30 41 2 31 35
M  V30 42 2 32 33
M  V30 43 2 34 36
M  V30 44 1 35 36
M  V30 45 1 37 38
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 41
M  V30 49 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 13 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1-[(1α,5α,6-endo,6β)-3-[7-(8-chloro-1-naphthalenyl)-...
C31H34ClN5O2.CH2O2
2925466-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.7357 11.6459 0.0 0
M  V30 2 C 15.5057 12.9795 0.0 0
M  V30 3 O 15.5057 10.3122 0.0 0
M  V30 4 C 17.0457 12.9795 0.0 0
M  V30 5 O 4.8721 14.3133 0.0 0
M  V30 6 C 3.3321 14.3133 0.0 0
M  V30 7 C 0.0000 14.6635 0.0 0
M  V30 8 Cl 7.9521 6.3111 0.0 0
M  V30 9 C 11.8619 10.8758 0.0 0 CFG=2
M  V30 10 C 11.8619 12.4159 0.0 0 CFG=1
M  V30 11 C 13.1957 11.6459 0.0 0 CFG=2
M  V30 12 C 10.3974 10.4000 0.0 0
M  V30 13 C 10.3974 12.8917 0.0 0
M  V30 14 N 9.4921 11.6459 0.0 0
M  V30 15 C 7.9521 11.6459 0.0 0
M  V30 16 C 7.1821 10.3122 0.0 0
M  V30 17 N 7.1821 12.9795 0.0 0
M  V30 18 C 5.6421 10.3122 0.0 0
M  V30 19 C 7.9521 8.9786 0.0 0
M  V30 20 C 5.6421 12.9795 0.0 0
M  V30 21 C 4.8721 8.9786 0.0 0
M  V30 22 N 4.8721 11.6459 0.0 0
M  V30 23 C 7.1821 7.6448 0.0 0
M  V30 24 N 5.6421 7.6448 0.0 0
M  V30 25 C 4.8721 6.3111 0.0 0
M  V30 26 C 5.6421 4.9775 0.0 0
M  V30 27 C 3.3321 6.3111 0.0 0
M  V30 28 C 4.8721 3.6438 0.0 0
M  V30 29 C 7.1821 4.9775 0.0 0
M  V30 30 C 2.5621 4.9775 0.0 0
M  V30 31 C 3.3321 3.6438 0.0 0
M  V30 32 C 5.6421 2.3100 0.0 0
M  V30 33 C 7.9521 3.6438 0.0 0
M  V30 34 C 7.1821 2.3100 0.0 0
M  V30 35 C 2.5621 15.6469 0.0 0 CFG=2
M  V30 36 N 1.0306 15.8079 0.0 0
M  V30 37 C 3.1884 17.0537 0.0 0
M  V30 38 C 0.7104 17.3143 0.0 0
M  V30 39 C 2.0441 18.0843 0.0 0
M  V30 40 H 12.4884 9.4691 0.0 0
M  V30 41 H 12.4884 13.8228 0.0 0
M  V30 42 C 8.5229 0.0000 0.0 0
M  V30 43 O 7.1892 0.7700 0.0 0
M  V30 44 O 9.8565 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 35 6 CFG=1
M  V30 8 1 7 36
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 40 CFG=3
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 16 1 10 41 CFG=3
M  V30 17 1 12 14
M  V30 18 1 13 14
M  V30 19 1 14 15
M  V30 20 2 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 16 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 2 18 22
M  V30 27 1 19 23
M  V30 28 1 20 22
M  V30 29 1 21 24
M  V30 30 1 23 24
M  V30 31 1 24 25
M  V30 32 1 25 26
M  V30 33 2 25 27
M  V30 34 2 26 28
M  V30 35 1 26 29
M  V30 36 1 27 30
M  V30 37 1 28 31
M  V30 38 1 28 32
M  V30 39 2 29 33
M  V30 40 2 30 31
M  V30 41 2 32 34
M  V30 42 1 33 34
M  V30 43 1 35 36
M  V30 44 1 35 37
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 1 38 39
M  V30 48 1 42 43
M  V30 49 2 42 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 11 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1826-67-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925475-01-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925466-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36881891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM Grignard reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridinopyrimidines and piperidinopyrimidines as KRAS G12C inhibitors and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Snahel; Tanaka, Hiroko; Erlanson, Daniel A.; Gerken, Philip A.;
Widen, John C.; Williams, Monika Jane; Dotsenko, Irina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023081840 A1 2023-05-11

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-5-methyl-, methyl ester
C9H11NO2
18595-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 N 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(formylamino)-5-methylbenzoate
C10H11NO3
2279975-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 3.8501 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18595-15-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279975-65-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Hydroxyphenylmethyl)-1-methyl-6-[3-(1-methylethyl)phenoxy]-3-[3-[(tetrahyd...
C32H37N3O6
1878199-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 O 10.6697 2.3101 0.0 0
M  V30 3 O 12.0033 3.0801 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 12.0033 9.2402 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 C 16.0045 5.3901 0.0 0
M  V30 8 C 17.3382 4.6201 0.0 0
M  V30 9 O 18.6718 5.3901 0.0 0
M  V30 10 O 14.6708 7.7002 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 0.0000 5.3901 0.0 0
M  V30 14 C 10.6697 5.3901 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 6.9302 0.0 0
M  V30 17 C 12.0033 4.6201 0.0 0
M  V30 18 C 8.0022 5.3901 0.0 0
M  V30 19 N 12.0033 7.7002 0.0 0
M  V30 20 N 9.3360 7.7002 0.0 0
M  V30 21 N 13.3370 5.3901 0.0 0
M  V30 22 C 8.0022 6.9302 0.0 0
M  V30 23 C 13.3370 6.9302 0.0 0
M  V30 24 C 8.0022 2.3101 0.0 0
M  V30 25 C 8.0022 0.7700 0.0 0
M  V30 26 C 6.6685 3.0801 0.0 0
M  V30 27 C 6.6685 0.0000 0.0 0
M  V30 28 C 5.3348 2.3101 0.0 0
M  V30 29 C 5.3348 0.7700 0.0 0
M  V30 30 C 5.3348 5.3901 0.0 0
M  V30 31 C 4.0012 4.6201 0.0 0
M  V30 32 C 5.3348 6.9302 0.0 0
M  V30 33 C 2.6673 5.3901 0.0 0
M  V30 34 C 4.0012 7.7002 0.0 0
M  V30 35 C 2.6673 6.9302 0.0 0
M  V30 36 C 20.0057 4.6201 0.0 0
M  V30 37 C 20.0057 3.0801 0.0 0
M  V30 38 O 21.3393 5.3901 0.0 0
M  V30 39 C 21.3393 2.3101 0.0 0
M  V30 40 C 22.6730 4.6201 0.0 0
M  V30 41 C 22.6730 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 24
M  V30 4 2 3 17
M  V30 5 1 4 18
M  V30 6 1 4 30
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 1 6 21
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 36
M  V30 13 2 10 23
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 33
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 1 17 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-(Formyloxy)propyl]-1-methyl-6-[3-(1-methylethyl)phenoxy]-5-(phenylmethyl...
C28H29N3O5
1878199-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 O 12.0033 3.0801 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 12.0033 9.2402 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 C 16.0045 5.3901 0.0 0
M  V30 7 C 17.3382 4.6201 0.0 0
M  V30 8 O 18.6720 5.3901 0.0 0
M  V30 9 C 20.0057 4.6201 0.0 0
M  V30 10 O 21.3393 5.3901 0.0 0
M  V30 11 O 14.6708 7.7002 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 10.6697 5.3901 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 6.9302 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 20 N 12.0033 7.7002 0.0 0
M  V30 21 N 9.3360 7.7002 0.0 0
M  V30 22 N 13.3372 5.3901 0.0 0
M  V30 23 C 8.0022 6.9302 0.0 0
M  V30 24 C 13.3372 6.9302 0.0 0
M  V30 25 C 8.0022 2.3101 0.0 0
M  V30 26 C 6.6685 3.0801 0.0 0
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 5.3348 2.3101 0.0 0
M  V30 29 C 6.6685 0.0000 0.0 0
M  V30 30 C 5.3348 0.7700 0.0 0
M  V30 31 C 5.3348 5.3901 0.0 0
M  V30 32 C 4.0012 4.6201 0.0 0
M  V30 33 C 5.3348 6.9302 0.0 0
M  V30 34 C 2.6673 5.3901 0.0 0
M  V30 35 C 4.0012 7.7002 0.0 0
M  V30 36 C 2.6673 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 25
M  V30 3 2 2 18
M  V30 4 1 3 19
M  V30 5 1 3 31
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 1 5 22
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 2 11 24
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 34
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1878199-12-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878199-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-15649209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as TRPC5 modulators
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chenard, Bertrand L.; Gallaschun, Randall J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016023830 A1 2016-02-18

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenoxy)-5-[(4-fluorophenyl)hydroxymethyl]-1-methyl-3-[3-[(tetrahy...
C29H29ClFN3O6
1878199-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 9.3360 2.3101 0.0 0
M  V30 3 O 10.6697 3.0801 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 10.6697 9.2402 0.0 0
M  V30 6 C 13.3372 4.6201 0.0 0
M  V30 7 C 14.6708 5.3901 0.0 0
M  V30 8 C 16.0045 4.6201 0.0 0
M  V30 9 O 17.3382 5.3901 0.0 0
M  V30 10 O 13.3372 7.7002 0.0 0
M  V30 11 F 2.6673 0.0000 0.0 0
M  V30 12 Cl 0.0000 7.7002 0.0 0
M  V30 13 C 9.3360 5.3901 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 9.3360 6.9302 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 N 10.6697 7.7002 0.0 0
M  V30 19 N 8.0022 7.7002 0.0 0
M  V30 20 N 12.0033 5.3901 0.0 0
M  V30 21 C 6.6685 6.9302 0.0 0
M  V30 22 C 12.0033 6.9302 0.0 0
M  V30 23 C 6.6685 2.3101 0.0 0
M  V30 24 C 5.3348 3.0801 0.0 0
M  V30 25 C 6.6685 0.7700 0.0 0
M  V30 26 C 4.0012 2.3101 0.0 0
M  V30 27 C 5.3348 0.0000 0.0 0
M  V30 28 C 4.0012 0.7700 0.0 0
M  V30 29 C 4.0012 5.3901 0.0 0
M  V30 30 C 2.6673 4.6201 0.0 0
M  V30 31 C 4.0012 6.9302 0.0 0
M  V30 32 C 1.3337 5.3901 0.0 0
M  V30 33 C 2.6673 7.7002 0.0 0
M  V30 34 C 1.3337 6.9302 0.0 0
M  V30 35 C 18.6720 4.6201 0.0 0
M  V30 36 C 18.6720 3.0801 0.0 0
M  V30 37 O 20.0057 5.3901 0.0 0
M  V30 38 C 20.0057 2.3101 0.0 0
M  V30 39 C 21.3393 4.6201 0.0 0
M  V30 40 C 21.3393 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 2 3 16
M  V30 5 1 4 17
M  V30 6 1 4 29
M  V30 7 1 5 18
M  V30 8 1 6 7
M  V30 9 1 6 20
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 35
M  V30 13 2 10 22
M  V30 14 1 11 28
M  V30 15 1 12 34
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenoxy)-5-[(4-fluorophenyl)methyl]-3-[3-(formyloxy)propyl]-1-meth...
C25H21ClFN3O5
1878199-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 O 10.6697 3.0801 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 10.6697 9.2402 0.0 0
M  V30 5 C 13.3372 4.6201 0.0 0
M  V30 6 C 14.6708 5.3901 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 O 17.3382 5.3901 0.0 0
M  V30 9 C 18.6720 4.6201 0.0 0
M  V30 10 O 20.0057 5.3901 0.0 0
M  V30 11 O 13.3372 7.7002 0.0 0
M  V30 12 F 2.6675 0.0000 0.0 0
M  V30 13 Cl 0.0000 7.7002 0.0 0
M  V30 14 C 9.3360 5.3901 0.0 0
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 C 9.3360 6.9302 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 6.6685 5.3901 0.0 0
M  V30 19 N 10.6697 7.7002 0.0 0
M  V30 20 N 8.0023 7.7002 0.0 0
M  V30 21 N 12.0033 5.3901 0.0 0
M  V30 22 C 6.6685 6.9302 0.0 0
M  V30 23 C 12.0033 6.9302 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 6.6685 0.7700 0.0 0
M  V30 26 C 5.3348 3.0801 0.0 0
M  V30 27 C 5.3348 0.0000 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 4.0012 0.7700 0.0 0
M  V30 30 C 4.0012 5.3901 0.0 0
M  V30 31 C 4.0012 6.9302 0.0 0
M  V30 32 C 2.6675 4.6201 0.0 0
M  V30 33 C 2.6675 7.7002 0.0 0
M  V30 34 C 1.3337 5.3901 0.0 0
M  V30 35 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 24
M  V30 3 2 2 17
M  V30 4 1 3 18
M  V30 5 1 3 30
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 5 21
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 2 11 23
M  V30 14 1 12 29
M  V30 15 1 13 35
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1878199-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878199-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-15643797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as TRPC5 modulators
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chenard, Bertrand L.; Gallaschun, Randall J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016023830 A1 2016-02-18

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,3-Dioxolan-2-yl)benzenamine
C9H11NO2
19073-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 C 4.6798 2.6673 0.0 0
M  V30 4 C 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 C 2.3698 1.3336 0.0 0
M  V30 9 O 1.4645 2.5795 0.0 0
M  V30 10 O 1.4645 0.0878 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(1,3-Dioxolan-2-yl)phenyl]formamide
C10H11NO3
1696254-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 1.3336 0.0 0
M  V30 2 C 9.2998 2.6673 0.0 0
M  V30 3 O 10.8398 2.6673 0.0 0
M  V30 4 C 3.9098 1.3336 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 4.6798 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.2198 2.6673 0.0 0
M  V30 9 C 6.9898 1.3336 0.0 0
M  V30 10 C 2.3698 1.3336 0.0 0
M  V30 11 O 1.4645 2.5795 0.0 0
M  V30 12 O 1.4645 0.0878 0.0 0
M  V30 13 C 0.0000 2.1037 0.0 0
M  V30 14 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19073-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1696254-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35865059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazine-2-carboxamides as HPK1 inhibitors for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nilsson Lill, Sten; Giblin, Kathryn; Kettle, Jason Grant; Goldberg,
Frederick Woolf; Grimster, Neil Patrick; Morrill, Lucas; Escobar,
Randolph; Metrano, Anthony; Song, Kun; Sheppeck, James; Ziegler, Robert
Evans; Wu, Ye; Sha, Li; Wu, Dedong; Grebe, Tyler; Mfuh, Adelphe; Balazs,
Amber; Shields, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023001794 A1 2023-01-26

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-amino-3,4-dihydro-2H-1-benzopyran-2-carboxylate
C12H15NO3
195453-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 9.3360 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 10.6697 1.5400 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 O 5.3348 1.5400 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-(formylamino)-3,4-dihydro-2H-1-benzopyran-2-carboxylate
C13H15NO4
507277-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 N 12.0033 1.5400 0.0 0
M  V30 7 C 13.3370 2.3101 0.0 0
M  V30 8 O 14.6707 1.5400 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 O 6.6685 1.5400 0.0 0
M  V30 12 C 9.3358 1.5400 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3358 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 195453-70-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 507277-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7648949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(aminoalkyl)chromans as 5-hydroxytryptamine-6 ligands
for treatment of CNS disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenblatt, Lynne Padilla; Kelly, Michael Gerard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003029238 A1 2003-04-10

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dichloro-N-[[1-(methylamino)cyclohexyl]methyl]benzamide
C15H20Cl2N2O
1984845-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 1.5400 0.0 0
M  V30 2 N 6.6684 2.3100 0.0 0
M  V30 3 C 5.3347 1.5400 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 N 8.3459 3.4898 0.0 0
M  V30 6 C 8.8726 4.9369 0.0 0
M  V30 7 Cl 0.0000 1.5400 0.0 0
M  V30 8 Cl 0.0000 4.6200 0.0 0
M  V30 9 C 9.3358 2.3100 0.0 0
M  V30 10 C 9.8625 0.8629 0.0 0
M  V30 11 C 10.3257 3.4898 0.0 0
M  V30 12 C 11.3791 0.5955 0.0 0
M  V30 13 C 11.8423 3.2223 0.0 0
M  V30 14 C 12.3690 1.7752 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6674 1.5400 0.0 0
M  V30 17 C 4.0011 3.8500 0.0 0
M  V30 18 C 1.3336 2.3100 0.0 0
M  V30 19 C 2.6674 4.6200 0.0 0
M  V30 20 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 9
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dichloro-N-[[1-(formylmethylamino)cyclohexyl]methyl]benzamide
C16H20Cl2N2O2
2241768-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5766 4.3670 0.0 0
M  V30 2 N 6.1166 4.3670 0.0 0
M  V30 3 C 6.8866 5.7006 0.0 0
M  V30 4 O 6.1166 7.0343 0.0 0
M  V30 5 N 2.6268 4.0231 0.0 0
M  V30 6 C 1.1798 3.4964 0.0 0
M  V30 7 C 2.8943 5.5398 0.0 0
M  V30 8 O 0.0000 4.4863 0.0 0
M  V30 9 Cl 11.5066 8.3681 0.0 0
M  V30 10 Cl 13.0466 5.7006 0.0 0
M  V30 11 C 3.8066 3.0333 0.0 0
M  V30 12 C 5.2537 2.5065 0.0 0
M  V30 13 C 2.6268 2.0434 0.0 0
M  V30 14 C 5.5211 0.9899 0.0 0
M  V30 15 C 2.8943 0.5268 0.0 0
M  V30 16 C 4.3414 0.0000 0.0 0
M  V30 17 C 8.4266 5.7006 0.0 0
M  V30 18 C 9.1966 7.0343 0.0 0
M  V30 19 C 9.1966 4.3670 0.0 0
M  V30 20 C 10.7366 7.0343 0.0 0
M  V30 21 C 10.7366 4.3670 0.0 0
M  V30 22 C 11.5066 5.7006 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1984845-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241768-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19081383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an Unconventional Amine Protecting Group for PET
Radiochemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jakobsson, Jimmy Erik; Gronnevik, Gaute; Rafique, Waqas; Hartvig,
Karoline; Riss, Patrick Johannes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2018), 2018(27-28), 3701-3704

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
25,26,27,28-Tetrapropoxypentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,...
C40H49NO4
199923-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4055 8.2986 0.0 0
M  V30 2 C 5.8844 7.9024 0.0 0
M  V30 3 C 6.9670 8.9850 0.0 0
M  V30 4 C 8.4458 8.5888 0.0 0
M  V30 5 N 0.0000 12.0921 0.0 0
M  V30 6 O 6.3977 6.7790 0.0 0
M  V30 7 C 6.7940 8.2578 0.0 0
M  V30 8 C 5.7114 9.3403 0.0 0
M  V30 9 C 6.1076 10.8193 0.0 0
M  V30 10 O 10.0558 9.1561 0.0 0
M  V30 11 C 11.3816 9.9216 0.0 0
M  V30 12 C 12.7076 9.1561 0.0 0
M  V30 13 C 14.0335 9.9216 0.0 0
M  V30 14 O 6.3999 3.9777 0.0 0
M  V30 15 C 7.1654 2.6517 0.0 0
M  V30 16 C 6.3999 1.3258 0.0 0
M  V30 17 C 7.1654 0.0000 0.0 0
M  V30 18 C 4.0092 9.7774 0.0 0
M  V30 19 C 2.6748 9.0087 0.0 0
M  V30 20 C 4.0077 11.3175 0.0 0
M  V30 21 C 2.4637 7.5442 0.0 0
M  V30 22 C 1.3243 9.7756 0.0 0
M  V30 23 C 5.1706 12.2327 0.0 0
M  V30 24 C 2.6684 12.1036 0.0 0
M  V30 25 C 3.3788 6.3812 0.0 0
M  V30 26 C 1.3258 11.3266 0.0 0
M  V30 27 C 6.6354 12.0216 0.0 0
M  V30 28 C 4.9188 6.3827 0.0 0
M  V30 29 C 2.5926 5.0419 0.0 0
M  V30 30 C 7.4041 10.6871 0.0 0
M  V30 31 C 7.4021 13.3721 0.0 0
M  V30 32 C 5.6875 5.0482 0.0 0
M  V30 33 C 3.3696 3.6994 0.0 0
M  V30 34 C 8.9441 10.6887 0.0 0
M  V30 35 C 8.9533 13.3704 0.0 0
M  V30 36 C 7.1522 4.8372 0.0 0
M  V30 37 C 4.9208 3.6977 0.0 0
M  V30 38 C 9.8592 9.5257 0.0 0
M  V30 39 C 9.7303 12.0280 0.0 0
M  V30 40 C 8.3152 5.7523 0.0 0
M  V30 41 C 9.6481 8.0610 0.0 0
M  V30 42 C 8.3136 7.2923 0.0 0
M  V30 43 C 9.6545 4.9661 0.0 0
M  V30 44 C 10.9986 7.2943 0.0 0
M  V30 45 C 10.9970 5.7431 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 26
M  V30 6 1 6 7
M  V30 7 1 6 28
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 30
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 42
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 2 24 26
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 27 30
M  V30 31 2 27 31
M  V30 32 2 28 32
M  V30 33 1 29 33
M  V30 34 2 30 34
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 1 32 37
M  V30 38 2 33 37
M  V30 39 1 34 38
M  V30 40 1 34 39
M  V30 41 2 35 39
M  V30 42 1 36 40
M  V30 43 1 38 41
M  V30 44 1 40 42
M  V30 45 2 40 43
M  V30 46 2 41 42
M  V30 47 1 41 44
M  V30 48 1 43 45
M  V30 49 2 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(25,26,27,28-Tetrapropoxypentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25)...
C41H49NO5
375813-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8261 7.4717 0.0 0
M  V30 2 C 8.4298 8.9505 0.0 0
M  V30 3 C 6.9510 9.3468 0.0 0
M  V30 4 C 6.5548 10.8256 0.0 0
M  V30 5 N 2.6517 2.9919 0.0 0
M  V30 6 C 1.3258 3.7574 0.0 0
M  V30 7 O 0.0000 2.9919 0.0 0
M  V30 8 O 13.3704 6.3106 0.0 0
M  V30 9 C 14.6964 5.5451 0.0 0
M  V30 10 C 16.0222 6.3106 0.0 0
M  V30 11 C 17.3481 5.5451 0.0 0
M  V30 12 O 8.3631 5.7437 0.0 0
M  V30 13 C 7.2805 4.6610 0.0 0
M  V30 14 C 5.8017 5.0574 0.0 0
M  V30 15 C 4.7192 3.9748 0.0 0
M  V30 16 O 8.3309 4.0293 0.0 0
M  V30 17 C 8.9779 2.6417 0.0 0
M  V30 18 C 8.0998 1.3877 0.0 0
M  V30 19 C 8.7468 0.0000 0.0 0
M  V30 20 C 6.6594 3.7664 0.0 0
M  V30 21 C 6.6609 5.3066 0.0 0
M  V30 22 C 7.8223 2.8513 0.0 0
M  V30 23 C 5.3201 2.9802 0.0 0
M  V30 24 C 5.3265 6.0752 0.0 0
M  V30 25 C 9.2870 3.0625 0.0 0
M  V30 26 C 3.9777 3.7574 0.0 0
M  V30 27 C 5.1154 7.5399 0.0 0
M  V30 28 C 3.9760 5.3084 0.0 0
M  V30 29 C 10.0558 4.3969 0.0 0
M  V30 30 C 10.0538 1.7120 0.0 0
M  V30 31 C 6.0305 8.7028 0.0 0
M  V30 32 C 11.5958 4.3953 0.0 0
M  V30 33 C 11.6050 1.7136 0.0 0
M  V30 34 C 7.5706 8.7013 0.0 0
M  V30 35 C 5.2444 10.0421 0.0 0
M  V30 36 C 12.5109 5.5583 0.0 0
M  V30 37 C 12.3820 3.0560 0.0 0
M  V30 38 C 8.3394 10.0357 0.0 0
M  V30 39 C 6.0214 11.3847 0.0 0
M  V30 40 C 12.2999 7.0230 0.0 0
M  V30 41 C 9.8039 10.2468 0.0 0
M  V30 42 C 7.5725 11.3864 0.0 0
M  V30 43 C 10.9653 7.7917 0.0 0
M  V30 44 C 13.6504 7.7897 0.0 0
M  V30 45 C 10.9669 9.3318 0.0 0
M  V30 46 C 13.6487 9.3409 0.0 0
M  V30 47 C 12.3062 10.1179 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 26
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 34
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 43
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 2 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 24 27
M  V30 27 1 24 28
M  V30 28 1 25 29
M  V30 29 2 25 30
M  V30 30 2 26 28
M  V30 31 1 27 31
M  V30 32 2 29 32
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 2 31 35
M  V30 36 1 32 36
M  V30 37 1 32 37
M  V30 38 2 33 37
M  V30 39 2 34 38
M  V30 40 1 35 39
M  V30 41 1 36 40
M  V30 42 1 38 41
M  V30 43 1 38 42
M  V30 44 2 39 42
M  V30 45 1 40 43
M  V30 46 2 40 44
M  V30 47 1 41 45
M  V30 48 2 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199923-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 375813-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1491611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-N-Formamyl-25,26,27,28-tetra-n-propoxycalix[4]arene (10). A solution
containing compound 9 (0.42 g, 0.69 mmol) in formic acid (20 mL) and
toluene (100 mL) was refluxed several hours. The excess of formic acid
and water was eliminated using a Dean-Stark apparatus, prior to evaporate
the solution to dryness. The white solid was purified by column
chromatography using CH2Cl2: yield 100% (0.44 g);
5-N-Formamyl-25,26,27,28-tetra-n-propoxycalix[4]arene (10), yield 100%
(0.44 g); Tm = 171 °C; IR solid ν (cm-1) 1690 (C=O); 1H NMR (CDCl3)
8.156- 8.159 (2 s, 1H, CHO), 7.94 (br s, 0.5H, NHCHO), 7.91 (br s, 0.5H,
NHCHO), 6.2-7.05 (m, 9H, Ph), 5.85 (s, 2H, Ph) 4.44 (d, 4H, J = 13.5,
CH2), 3.75-4.01 (m, 4H, OCH2), 3.70 (t, 4H, J = 7.0, OCH2), 3.16 (d, 2H,
J = 14.0, CH2), 3.11 (d, 2H, J = 14.0, CH2), 1.82-1.98 (m, 8H, CH2CH3),
0.87-1.11 ppm (m, 12H, CH3); 13C NMR (CDCl3) 163.1, 158.5, 157.2, 156.6,
155.6, 153.6, 136.4, 135.7, 135.4, 134.8, 133.8, 130.3, 128.9, 128.4,
128.1, 127.8, 127.4, 121.9, 121.5, 120.0, 119.0, 77.0, 76.7, 76.4, 30.8,
23.3, 23.0, 22.9, 10.5, 10.1, 9.8 ppm; MS (EI) m/e 635 (M+). Anal. Calcd
for C41H49O5N: C, 77.45; H, 7.77; N, 2.20. Found: C, 77.42; H, 8.10; N,
2.26.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Upper-Rim Functionalization of Calix[4]arene by Chloro(isocyanide)gold(I)
Groups: An Entry to Polymetallic Architecture
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gagnon, Jonathan; Drouin, Marc; Harvey, Pierre D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2001), 40(23), 6052-6056

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3R,4R)-3-[([1,1′-biphenyl]-4-ylcarbonyl)amino]-4-fluor...
C22H25FN2O3
2018361-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8243 4.0442 0.0 0
M  V30 2 N 9.0543 2.7106 0.0 0
M  V30 3 O 9.0543 5.3779 0.0 0
M  V30 4 F 7.0851 0.0000 0.0 0
M  V30 5 C 3.8987 4.3858 0.0 0
M  V30 6 O 2.4917 3.7593 0.0 0
M  V30 7 O 4.0596 5.9173 0.0 0
M  V30 8 C 1.2459 4.6645 0.0 0
M  V30 9 C 0.3406 3.4187 0.0 0
M  V30 10 C 0.0000 5.5697 0.0 0
M  V30 11 C 2.1511 5.9104 0.0 0
M  V30 12 C 14.4443 4.0442 0.0 0
M  V30 13 C 13.6743 5.3779 0.0 0
M  V30 14 C 13.6743 2.7106 0.0 0
M  V30 15 C 12.1343 5.3779 0.0 0
M  V30 16 C 12.1343 2.7106 0.0 0
M  V30 17 C 11.3643 4.0442 0.0 0
M  V30 18 C 15.9844 4.0442 0.0 0
M  V30 19 C 16.7544 5.3779 0.0 0
M  V30 20 C 16.7544 2.7106 0.0 0
M  V30 21 C 18.2944 5.3779 0.0 0
M  V30 22 C 18.2944 2.7106 0.0 0
M  V30 23 C 19.0644 4.0442 0.0 0
M  V30 24 C 7.5143 2.7106 0.0 0 CFG=1
M  V30 25 C 6.6091 3.9564 0.0 0
M  V30 26 C 6.6091 1.4647 0.0 0 CFG=2
M  V30 27 N 5.1446 3.4806 0.0 0
M  V30 28 C 5.1446 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 24 2 CFG=1
M  V30 5 1 26 4 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[(3R,4R)-4-fluoro-3-pyrrolidinyl][1,1′-biphenyl]-4...
C17H17FN2O.CH2O2
2018361-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 6.3542 0.0 0
M  V30 2 N 3.9098 5.0206 0.0 0
M  V30 3 O 3.9098 7.6880 0.0 0
M  V30 4 F 1.9406 2.3100 0.0 0
M  V30 5 C 9.2998 6.3542 0.0 0
M  V30 6 C 8.5298 5.0206 0.0 0
M  V30 7 C 8.5298 7.6880 0.0 0
M  V30 8 C 6.9898 5.0206 0.0 0
M  V30 9 C 6.9898 7.6880 0.0 0
M  V30 10 C 6.2198 6.3542 0.0 0
M  V30 11 C 10.8398 6.3542 0.0 0
M  V30 12 C 11.6098 5.0206 0.0 0
M  V30 13 C 11.6098 7.6880 0.0 0
M  V30 14 C 13.1498 5.0206 0.0 0
M  V30 15 C 13.1498 7.6880 0.0 0
M  V30 16 C 13.9198 6.3542 0.0 0
M  V30 17 C 2.3698 5.0206 0.0 0 CFG=2
M  V30 18 C 1.4645 3.7747 0.0 0 CFG=2
M  V30 19 C 1.4645 6.2664 0.0 0
M  V30 20 C 0.0000 4.2506 0.0 0
M  V30 21 N 0.0000 5.7906 0.0 0
M  V30 22 C 6.9599 0.0000 0.0 0
M  V30 23 O 5.6262 0.7700 0.0 0
M  V30 24 O 8.2935 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 17 2 CFG=1
M  V30 5 1 18 4 CFG=3
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2018361-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2018361-76-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-16834544
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Cyanopyrrolidine compounds as USP30 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Alison; Kemp, Mark; Stockley, Martin; Gibson, Karl; Whitlock,
Gavin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016156816 A1 2016-10-06

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-fluoro-4-methylbenzenamine
C7H7BrFN
202865-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6674 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 F 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-5-fluoro-4-methylphenyl)formamide
C8H7BrFNO
2090133-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 F 1.5400 5.3349 0.0 0
M  V30 6 C 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 202865-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2090133-63-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16979131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh2(II)-Catalyzed Ring Expansion of Cyclobutanol-Substituted Aryl Azides
To Access Medium-Sized N-Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mazumdar, Wrickban; Jana, Navendu; Thurman, Bryant T.; Wink, Donald J.;
Driver, Tom G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(14), 5031-5034

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrabutylammonium hydroxide
C16H36N.HO
2052-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.8748 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0012 6.1048 0.0 0
M  V30 3 C 6.6685 7.6448 0.0 0
M  V30 4 C 4.5648 8.2085 0.0 0
M  V30 5 C 6.1048 5.5412 0.0 0
M  V30 6 C 2.6673 6.8748 0.0 0
M  V30 7 C 8.0023 6.8748 0.0 0
M  V30 8 C 5.3348 9.5423 0.0 0
M  V30 9 C 5.3348 4.2073 0.0 0
M  V30 10 C 1.3337 6.1048 0.0 0
M  V30 11 C 9.3360 7.6448 0.0 0
M  V30 12 C 4.5648 10.8760 0.0 0
M  V30 13 C 6.1048 2.8737 0.0 0
M  V30 14 C 0.0000 6.8748 0.0 0
M  V30 15 C 10.6697 6.8748 0.0 0
M  V30 16 C 5.3348 12.2097 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 O 5.3348 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butanaminium, N,N,N-tributyl-, formate, compd. with formic acid (1:1:1)
C16H36N.CH2O2.CHO2
1321626-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 14.5197 0.0 0
M  V30 2 O 4.0012 15.2897 0.0 0
M  V30 3 O 6.6685 15.2897 0.0 0
M  V30 4 N 5.3348 7.6448 0.0 0 CHG=1 VAL=4
M  V30 5 C 4.0012 6.8748 0.0 0
M  V30 6 C 6.6685 8.4149 0.0 0
M  V30 7 C 4.5648 8.9785 0.0 0
M  V30 8 C 6.1048 6.3112 0.0 0
M  V30 9 C 2.6673 7.6448 0.0 0
M  V30 10 C 8.0023 7.6448 0.0 0
M  V30 11 C 5.3348 10.3123 0.0 0
M  V30 12 C 5.3348 4.9774 0.0 0
M  V30 13 C 1.3337 6.8748 0.0 0
M  V30 14 C 9.3360 8.4149 0.0 0
M  V30 15 C 4.5648 11.6460 0.0 0
M  V30 16 C 6.1048 3.6437 0.0 0
M  V30 17 C 0.0000 7.6448 0.0 0
M  V30 18 C 10.6697 7.6448 0.0 0
M  V30 19 C 5.3348 12.9797 0.0 0
M  V30 20 C 5.3348 2.3100 0.0 0
M  V30 21 C 5.3348 0.0000 0.0 0
M  V30 22 O 4.0012 0.7700 0.0 0 CHG=-1
M  V30 23 O 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 1 4 7
M  V30 6 1 4 8
M  V30 7 1 5 9
M  V30 8 1 6 10
M  V30 9 1 7 11
M  V30 10 1 8 12
M  V30 11 1 9 13
M  V30 12 1 10 14
M  V30 13 1 11 15
M  V30 14 1 12 16
M  V30 15 1 13 17
M  V30 16 1 14 18
M  V30 17 1 15 19
M  V30 18 1 16 20
M  V30 19 1 21 22
M  V30 20 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2052-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1321626-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-21067467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Reinvestigation of the Ionic Liquid Diisopropylethylammonium Formate by
NMR and DFT Methods
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hansen, Poul Erik; Lund, Torben; Krake, Jacob; Spanget-Larsen, Jens;
Hvidt, Soeren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2016), 120(43), 11279-11286

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrabutylammonium hydroxide
C16H36N.HO
2052-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.8748 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0012 6.1048 0.0 0
M  V30 3 C 6.6685 7.6448 0.0 0
M  V30 4 C 4.5648 8.2085 0.0 0
M  V30 5 C 6.1048 5.5412 0.0 0
M  V30 6 C 2.6673 6.8748 0.0 0
M  V30 7 C 8.0023 6.8748 0.0 0
M  V30 8 C 5.3348 9.5423 0.0 0
M  V30 9 C 5.3348 4.2073 0.0 0
M  V30 10 C 1.3337 6.1048 0.0 0
M  V30 11 C 9.3360 7.6448 0.0 0
M  V30 12 C 4.5648 10.8760 0.0 0
M  V30 13 C 6.1048 2.8737 0.0 0
M  V30 14 C 0.0000 6.8748 0.0 0
M  V30 15 C 10.6697 6.8748 0.0 0
M  V30 16 C 5.3348 12.2097 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 O 5.3348 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrabutylammonium formate
C16H36N.CHO2
35733-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 7.6448 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0012 6.8748 0.0 0
M  V30 3 C 6.6685 8.4149 0.0 0
M  V30 4 C 4.5648 8.9785 0.0 0
M  V30 5 C 6.1048 6.3112 0.0 0
M  V30 6 C 2.6673 7.6448 0.0 0
M  V30 7 C 8.0023 7.6448 0.0 0
M  V30 8 C 5.3348 10.3123 0.0 0
M  V30 9 C 5.3348 4.9774 0.0 0
M  V30 10 C 1.3337 6.8748 0.0 0
M  V30 11 C 9.3360 8.4149 0.0 0
M  V30 12 C 4.5648 11.6460 0.0 0
M  V30 13 C 6.1048 3.6437 0.0 0
M  V30 14 C 0.0000 7.6448 0.0 0
M  V30 15 C 10.6697 7.6448 0.0 0
M  V30 16 C 5.3348 12.9797 0.0 0
M  V30 17 C 5.3348 2.3100 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 O 4.0012 0.7700 0.0 0 CHG=-1
M  V30 20 O 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 18 19
M  V30 18 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2052-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35733-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-21251248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mapping the Intricate Reactivity of Nanojars toward Molecules of Varying
Acidity and Their Conjugate Bases Leading To Exchange of Pyrazolate
Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartman, Christian K.; Mezei, Gellert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2017), 56(17), 10609-10624

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrabutylammonium hydroxide
C16H36N.HO
2052-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.8748 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0012 6.1048 0.0 0
M  V30 3 C 6.6685 7.6448 0.0 0
M  V30 4 C 4.5648 8.2085 0.0 0
M  V30 5 C 6.1048 5.5412 0.0 0
M  V30 6 C 2.6673 6.8748 0.0 0
M  V30 7 C 8.0023 6.8748 0.0 0
M  V30 8 C 5.3348 9.5423 0.0 0
M  V30 9 C 5.3348 4.2073 0.0 0
M  V30 10 C 1.3337 6.1048 0.0 0
M  V30 11 C 9.3360 7.6448 0.0 0
M  V30 12 C 4.5648 10.8760 0.0 0
M  V30 13 C 6.1048 2.8737 0.0 0
M  V30 14 C 0.0000 6.8748 0.0 0
M  V30 15 C 10.6697 6.8748 0.0 0
M  V30 16 C 5.3348 12.2097 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 O 5.3348 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrabutylammonium formate
C16H36N.CHO2
35733-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 7.6448 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.0012 6.8748 0.0 0
M  V30 3 C 6.6685 8.4149 0.0 0
M  V30 4 C 4.5648 8.9785 0.0 0
M  V30 5 C 6.1048 6.3112 0.0 0
M  V30 6 C 2.6673 7.6448 0.0 0
M  V30 7 C 8.0023 7.6448 0.0 0
M  V30 8 C 5.3348 10.3123 0.0 0
M  V30 9 C 5.3348 4.9774 0.0 0
M  V30 10 C 1.3337 6.8748 0.0 0
M  V30 11 C 9.3360 8.4149 0.0 0
M  V30 12 C 4.5648 11.6460 0.0 0
M  V30 13 C 6.1048 3.6437 0.0 0
M  V30 14 C 0.0000 7.6448 0.0 0
M  V30 15 C 10.6697 7.6448 0.0 0
M  V30 16 C 5.3348 12.9797 0.0 0
M  V30 17 C 5.3348 2.3100 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 O 4.0012 0.7700 0.0 0 CHG=-1
M  V30 20 O 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 18 19
M  V30 18 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2052-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35733-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26133536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of silyl formates, formamides, and aldehydes via solvent-free
organocatalytic hydrosilylation of CO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murata, Takumi; Hiyoshi, Mahoko; Ratanasak, Manussada; Hasegawa, Jun-ya;
Ema, Tadashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2020), 56(43),
5783-5786

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(aminocarbonyl)amino]-1,4-dihydro-6-methyl-4-phenyl-5-pyrimidinecarb...
C15H18N4O3
2087929-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 O 2.3100 6.6685 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 0.7700 6.6685 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 4.6200 8.0021 0.0 0
M  V30 7 N 9.2400 5.3347 0.0 0
M  V30 8 C 10.0100 6.6685 0.0 0
M  V30 9 N 11.5500 6.6685 0.0 0
M  V30 10 O 9.2400 8.0021 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 5.3900 6.6685 0.0 0
M  V30 14 N 6.9300 4.0011 0.0 0
M  V30 15 N 6.9300 6.6685 0.0 0
M  V30 16 C 7.7000 5.3347 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 5.3900 1.3336 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-phenyl-, formic a...
C14H17N3O2.CH2O2
2087929-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0
M  V30 2 O 6.6684 7.7000 0.0 0
M  V30 3 O 5.3347 5.3900 0.0 0
M  V30 4 C 8.0021 6.9300 0.0 0
M  V30 5 C 9.3358 7.7000 0.0 0
M  V30 6 C 5.3347 10.0100 0.0 0
M  V30 7 N 0.0000 10.0100 0.0 0
M  V30 8 C 4.0011 7.7000 0.0 0
M  V30 9 C 2.6674 6.9300 0.0 0
M  V30 10 C 4.0011 9.2400 0.0 0
M  V30 11 N 1.3336 7.7000 0.0 0
M  V30 12 N 2.6674 10.0100 0.0 0
M  V30 13 C 1.3336 9.2400 0.0 0
M  V30 14 C 2.6674 5.3900 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 4.0011 3.0800 0.0 0
M  V30 18 C 1.3336 3.0800 0.0 0
M  V30 19 C 2.6674 2.3100 0.0 0
M  V30 20 C 4.6679 0.0000 0.0 0
M  V30 21 O 3.3342 0.7700 0.0 0
M  V30 22 O 6.0016 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2087929-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2087929-48-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-16722573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, alternative preparation shown, Biginelli reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the synthesis of deceptively simple Biginelli products through
N-CN bond cleavage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fidencio, Juan Jesus Nolasco; Rios-Guerra, Hulme; Gonzalez-Villanueva,
Gilberto; Penieres-Carrillo, Jose Guillermo; Balcazar, Gustavo Guevara;
Nicolas-Vazquez, Ma. Ines; Delgado, Francisco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2016), 92(10), 1803-1809

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-6-methyl-1,6-naphthyridin-3-amine
C9H13N3
216966-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0021 3.0800 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.3347 0.0000 0.0 0
M  V30 7 C 5.3347 3.0800 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5,6,7,8-Tetrahydro-6-methyl-1,6-naphthyridin-3-yl)formamide
C10H13N3O
2766157-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 O 10.6697 3.0801 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 N 5.3348 0.0000 0.0 0
M  V30 10 C 2.6673 0.0000 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 N 1.3337 2.3101 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216966-37-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766157-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-4-methyl-2,3-benzoxazin-1-one
C9H8N2O2
217196-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 0.0000 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 3.0800 5.3349 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 O 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methyl-1-oxo-1H-2,3-benzoxazin-6-yl)formamide
C10H8N2O3
745784-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 N 6.6684 4.6201 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 O 9.3359 4.6201 0.0 0
M  V30 6 C 2.6675 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 O 0.0000 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 217196-94-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745784-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2040862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formic acid (20.4 mL) was added dropwise over 5 min to chilled (0°C)
acetic anhydride (41.8 mL).The mixture was warmed to 55 °C and stirred
for 2 h. A suspension of benzoxazin (22.0 g, 0.125 mol) in THF (500 mL)
under N2 was prepared.To this was added the first solution. The mixture
was stirred under N2 at room temperature for 72 h, at which point the
solvent was removed in vacuo to give formamido product, yield 25.7 g,
100%. white solid; LC/MS: tR = 2.17 min; MH+ = 205.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dissociated Nonsteroidal Glucocorticoid Receptor Modulators; Discovery of
the Agonist Trigger in a Tetrahydronaphthalene-Benzoxazine Series
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barker, Mike; Clackers, Margaret; Copley, Royston; Demaine, Derek A.;
Humphreys, Davina; Inglis, Graham G. A.; Johnston, Michael J.; Jones,
Haydn T.; Haase, Michael V.; House, David; Loiseau, Richard; Nisbet,
Lesley; Pacquet, Francois; Skone, Philip A.; Shanahan, Stephen E.; Tape,
Dan; Vinader, Victoria M.; Washington, Melanie; Uings, Iain; Upton,
Richard; McLay, Iain M.; Macdonald, Simon J. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(14), 4216-4231

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-4-methyl-2,3-benzoxazin-1-one
C9H8N2O2
217196-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 0.0000 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 3.0800 5.3349 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 O 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methyl-1-oxo-1H-2,3-benzoxazin-6-yl)formamide
C10H8N2O3
745784-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 N 6.6684 4.6201 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 O 9.3359 4.6201 0.0 0
M  V30 6 C 2.6675 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 O 0.0000 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 217196-94-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745784-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8398745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-methyl-1-oxo-2,3-benzoxazin-6-ylformamide: Formic acid (20.4mL) was
added dropwise over 5 minutes to chilled (0°C) acetic anhydride (41.8mL).
The mixture was warmed to 55°C and stirred for 2 hours. A suspension of
6-amino-4-methyl-2,3-benzoxazin-1-one (22.0g, 0.125 mol) in THF (500mL)
under N2 was prepared. To this, the first solution was added. The mixture
was stirred under N2 at RT for 72 hours, at which point the solvent was
removed in vacuo to afford 4-methyl-1-oxo-2,3-benzoxazin-6-ylformamide as
a white solid, yield 25.7g, 100%. LCMS = 205 (M + 1)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of New Nonsteroidal Glucocorticoid Modulators
through Application of an "Agreement Docking" Method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barker, Mike; Clackers, Margaret; Demaine, Derek A.; Humphreys, Davina;
Johnston, Michael J.; Jones, Haydn T.; Pacquet, Francois; Pritchard, John
M.; Salter, Mark; Shanahan, Stephen E.; Skone, Philip A.; Vinader,
Victoria M.; Uings, Iain; McLay, Iain M.; Macdonald, Simon J. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(14), 4507-4510

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)-2-phenylacetyl]oxy]methy...
C28H29NO6
2173078-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.0010 0.0 0 CFG=1
M  V30 2 C 6.6685 3.2310 0.0 0
M  V30 3 O 6.1048 5.3348 0.0 0
M  V30 4 O 8.0022 4.0010 0.0 0
M  V30 5 O 6.6685 1.6910 0.0 0
M  V30 6 C 9.3360 3.2310 0.0 0
M  V30 7 O 0.0000 7.0811 0.0 0
M  V30 8 C 14.6708 6.3111 0.0 0
M  V30 9 O 16.0045 5.5410 0.0 0
M  V30 10 O 14.6708 7.8511 0.0 0
M  V30 11 C 17.3382 6.3111 0.0 0
M  V30 12 C 4.0012 4.7710 0.0 0
M  V30 13 C 4.0012 6.3111 0.0 0
M  V30 14 C 2.6673 4.0010 0.0 0
M  V30 15 C 2.6673 7.0811 0.0 0
M  V30 16 C 1.3337 4.7710 0.0 0
M  V30 17 C 1.3337 6.3111 0.0 0
M  V30 18 C 4.5648 2.6673 0.0 0
M  V30 19 C 5.3348 1.3337 0.0 0
M  V30 20 C 3.0248 2.6673 0.0 0
M  V30 21 C 4.5648 0.0000 0.0 0
M  V30 22 C 2.2548 1.3337 0.0 0
M  V30 23 C 3.0248 0.0000 0.0 0
M  V30 24 C 10.6697 4.0010 0.0 0
M  V30 25 C 10.6697 5.5410 0.0 0
M  V30 26 C 12.0033 3.2310 0.0 0
M  V30 27 C 12.0033 6.3111 0.0 0
M  V30 28 C 13.3370 4.0010 0.0 0
M  V30 29 N 13.3372 5.5410 0.0 0
M  V30 30 C 18.6720 5.5410 0.0 0
M  V30 31 C 18.6720 4.0010 0.0 0
M  V30 32 C 20.0057 6.3111 0.0 0
M  V30 33 C 20.0057 3.2310 0.0 0
M  V30 34 C 21.3393 5.5410 0.0 0
M  V30 35 C 21.3393 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12 CFG=1
M  V30 4 1 1 18 CFG=3
M  V30 5 1 2 4
M  V30 6 2 2 5
M  V30 7 1 4 6
M  V30 8 1 6 24
M  V30 9 1 7 17
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 29
M  V30 13 1 9 11
M  V30 14 1 11 30
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (αR)-4-piperidinylmethyl α,4-dihydroxy-α-phenylbenze...
C20H23NO4.CH2O2
2173079-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.3110 0.0 0 CFG=1
M  V30 2 C 6.6685 5.5410 0.0 0
M  V30 3 O 6.1048 7.6448 0.0 0
M  V30 4 O 8.0022 6.3110 0.0 0
M  V30 5 O 6.6685 4.0010 0.0 0
M  V30 6 C 9.3360 5.5410 0.0 0
M  V30 7 O 0.0000 9.3911 0.0 0
M  V30 8 C 4.0010 7.0810 0.0 0
M  V30 9 C 2.6673 6.3110 0.0 0
M  V30 10 C 4.0010 8.6211 0.0 0
M  V30 11 C 1.3337 7.0810 0.0 0
M  V30 12 C 2.6673 9.3911 0.0 0
M  V30 13 C 1.3337 8.6211 0.0 0
M  V30 14 C 4.5648 4.9774 0.0 0
M  V30 15 C 3.0248 4.9774 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 17 C 2.2548 3.6437 0.0 0
M  V30 18 C 4.5648 2.3100 0.0 0
M  V30 19 C 3.0248 2.3100 0.0 0
M  V30 20 C 10.6697 6.3110 0.0 0
M  V30 21 C 10.6697 7.8511 0.0 0
M  V30 22 C 12.0033 5.5410 0.0 0
M  V30 23 C 12.0033 8.6211 0.0 0
M  V30 24 C 13.3370 6.3110 0.0 0
M  V30 25 N 13.3370 7.8511 0.0 0
M  V30 26 C 6.6685 0.0000 0.0 0
M  V30 27 O 5.3348 0.7700 0.0 0
M  V30 28 O 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 2 4
M  V30 6 2 2 5
M  V30 7 1 4 6
M  V30 8 1 6 20
M  V30 9 1 7 13
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173078-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173079-02-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-19910716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyquinolinone compounds as muscarinic receptor antagonists and beta2
adrenergic receptor agonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rancati, Fabio; Rizzi, Andrea; Carzaniga, Laura; Linney, Ian; Knight,
Chris; Schmidt, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018011090 A1 2018-01-18

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-1,2-phenylenediamine
C6H7ClN2
21745-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 N 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1H-benzimidazole
C7H5ClN2
16931-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 N 2.1579 4.5864 0.0 0
M  V30 6 C 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 C 3.8119 0.7700 0.0 0
M  V30 9 C 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21745-41-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16931-35-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-4251585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of Compounds 29, 38, 43. To a
suspension of 3-chlorobenzene-1,2-diamine,41 27 or 28 (9.8mmol) in water
(14mL), formic acid (1.2mL, 29mmol) was added and the mixture was heated
at 100°C for 3 h. After the complete disappearance of the starting
material (tlc), the reaction was poured on ice and 1M KOH was added until
pH9-10. The resulting solid was filtrated, dried, and recrystallized;
otherwise, the aqueous solution was extracted with CH2Cl2 (3 50 mL), the
organic layers were dried (Na2SO4), and evaporated to dryness. The
residue was purified by column chromatography using the appropriate
eluent, to afford pure benzimidazoles 29, 38, 43.
4-Chloro-1H-benzimidazole (29). Obtained from 3-chlorobenzene-1,2-diamine
in quantitative yield; mp 167-169°C (lit.42 170-171°C) (EtOAc). IR (KBr)
3424, 1631, 1587, 1481, 1458. 1H NMR (CDCl3) δ 7.23 (t, J = 7.8, 1H),
7.33 (dd, J= 7.8, 1.5, 1H), 7.59 (dd, J = 7.8, 1.1, 1H), 8.23 (s, 1H).
13C NMR (CDCl3) δ 114.4, 120.3, 122.8, 123.6, 135.7, 138.8, 141.0. MS
(ESI), 152.8 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole Derivatives as New Serotonin 5-HT6 Receptor Antagonists.
Molecular Mechanisms of Receptor Inactivation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de la Fuente, Tania; Martin-Fontecha, Mar; Sallander, Jessica; Benhamu,
Bellinda; Campillo, Mercedes; Medina, Rocio A.; Pellissier, Lucie P.;
Claeysen, Sylvie; Dumuis, Aline; Pardo, Leonardo; Lopez-Rodriguez, Maria
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(3), 1357-1369

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-3-nitro-2-pyridinamine
C6H7N3O2
21901-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Methyl-3-nitro-2-pyridinyl)formamide
C7H7N3O3
2199501-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 6.6685 0.0 0
M  V30 4 N 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 6.6685 0.0 0
M  V30 11 N 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21901-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2199501-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18697636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine
Adenylyltransferase from Gram-Negative Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moreau, Robert J.; Skepper, Colin K.; Appleton, Brent A.; Blechschmidt,
Anke; Balibar, Carl J.; Benton, Bret M.; Drumm, Joseph E.; Feng, Brian
Y.; Geng, Mei; Li, Cindy; Lindvall, Mika K.; Lingel, Andreas; Lu, Yipin;
Mamo, Mulugeta; Mergo, Wosenu; Polyakov, Valery; Smith, Thomas M.;
Takeoka, Kenneth; Uehara, Kyoko; Wang, Lisha; Wei, Jun-Rong; Weiss,
Andrew H.; Xie, Lili; Xu, Wenjian; Zhang, Qiong; de Vicente, Javier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(8), 3309-3324

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[(4aS,5S,7aS)-2-(Benzoylamino)-5,7-dihydro-5-[(triphenylmethoxy)methyl]-...
C45H38FN5O5S
2205016-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7446 4.6200 0.0 0
M  V30 2 O 10.7446 6.1600 0.0 0
M  V30 3 C 9.4108 6.9300 0.0 0
M  V30 4 F 6.8306 13.3317 0.0 0
M  V30 5 N 5.0736 12.8086 0.0 0
M  V30 6 C 3.5673 12.4884 0.0 0
M  V30 7 O 3.0914 11.0238 0.0 0
M  V30 8 N 12.9569 13.9756 0.0 0
M  V30 9 C 13.5832 15.3824 0.0 0
M  V30 10 O 12.6780 16.6284 0.0 0
M  V30 11 O 19.7095 16.0264 0.0 0
M  V30 12 C 20.3358 17.4332 0.0 0
M  V30 13 C 12.2846 4.6200 0.0 0
M  V30 14 C 13.0546 5.9537 0.0 0
M  V30 15 C 13.0546 3.2864 0.0 0
M  V30 16 C 14.5947 5.9537 0.0 0
M  V30 17 C 14.5947 3.2864 0.0 0
M  V30 18 C 15.3647 4.6200 0.0 0
M  V30 19 C 10.7446 3.0800 0.0 0
M  V30 20 C 12.0783 2.3100 0.0 0
M  V30 21 C 9.4108 2.3100 0.0 0
M  V30 22 C 12.0783 0.7700 0.0 0
M  V30 23 C 9.4108 0.7700 0.0 0
M  V30 24 C 10.7446 0.0000 0.0 0
M  V30 25 C 9.2046 4.6200 0.0 0
M  V30 26 C 8.4346 5.9537 0.0 0
M  V30 27 C 8.4346 3.2864 0.0 0
M  V30 28 C 6.8946 5.9537 0.0 0
M  V30 29 C 6.8946 3.2864 0.0 0
M  V30 30 C 6.1246 4.6200 0.0 0
M  V30 31 C 9.4108 8.4700 0.0 0 CFG=1
M  V30 32 C 8.1650 9.3753 0.0 0 CFG=1
M  V30 33 O 10.6569 9.3753 0.0 0
M  V30 34 C 8.6408 10.8398 0.0 0 CFG=1
M  V30 35 C 6.6587 9.0551 0.0 0
M  V30 36 C 10.1808 10.8398 0.0 0
M  V30 37 N 7.6104 11.9843 0.0 0
M  V30 38 S 5.6281 10.1995 0.0 0
M  V30 39 C 6.1041 11.6642 0.0 0
M  V30 40 C 9.2673 12.2468 0.0 0
M  V30 41 C 10.7988 12.4077 0.0 0
M  V30 42 C 8.3621 13.4926 0.0 0
M  V30 43 C 11.4252 13.8146 0.0 0
M  V30 44 C 8.9884 14.8996 0.0 0
M  V30 45 C 10.5201 15.0605 0.0 0
M  V30 46 C 2.5369 13.6329 0.0 0
M  V30 47 C 1.0304 13.3126 0.0 0
M  V30 48 C 3.0127 15.0975 0.0 0
M  V30 49 C 0.0000 14.4571 0.0 0
M  V30 50 C 1.9821 16.2420 0.0 0
M  V30 51 C 0.4759 15.9217 0.0 0
M  V30 52 C 15.1147 15.5435 0.0 0
M  V30 53 C 16.0199 14.2974 0.0 0
M  V30 54 N 15.7412 16.9502 0.0 0
M  V30 55 N 17.5515 14.4585 0.0 0
M  V30 56 C 17.2727 17.1112 0.0 0
M  V30 57 C 18.1779 15.8653 0.0 0
M  V30 58 H 7.8448 7.8688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 3
M  V30 6 1 31 3 CFG=3
M  V30 7 1 4 42
M  V30 8 1 5 6
M  V30 9 1 5 39
M  V30 10 2 6 7
M  V30 11 1 6 46
M  V30 12 1 8 9
M  V30 13 1 8 43
M  V30 14 2 9 10
M  V30 15 1 9 52
M  V30 16 1 11 12
M  V30 17 1 11 57
M  V30 18 2 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 32 58 CFG=3
M  V30 41 1 33 36
M  V30 42 1 34 36
M  V30 43 1 34 37
M  V30 44 1 34 40 CFG=3
M  V30 45 1 35 38
M  V30 46 2 37 39
M  V30 47 1 38 39
M  V30 48 2 40 41
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 2 42 44
M  V30 52 2 43 45
M  V30 53 1 44 45
M  V30 54 2 46 47
M  V30 55 1 46 48
M  V30 56 1 47 49
M  V30 57 2 48 50
M  V30 58 2 49 51
M  V30 59 1 50 51
M  V30 60 1 52 53
M  V30 61 2 52 54
M  V30 62 2 53 55
M  V30 63 1 54 56
M  V30 64 1 55 57
M  V30 65 2 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 31 32 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Pyrazinecarboxamide, N-[3-[(4aS,5S,7aS)-2-(benzoylamino)-5-[(formyloxy)meth...
C27H24FN5O6S
2205017-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5726 3.3420 0.0 0
M  V30 2 O 9.8186 2.4368 0.0 0
M  V30 3 C 9.6575 0.9052 0.0 0
M  V30 4 O 10.9034 0.0000 0.0 0
M  V30 5 F 6.6756 9.9782 0.0 0
M  V30 6 N 4.8737 9.6417 0.0 0
M  V30 7 C 3.3420 9.4806 0.0 0
M  V30 8 O 2.7156 8.0738 0.0 0
M  V30 9 N 12.8357 9.9782 0.0 0
M  V30 10 C 13.6057 11.3118 0.0 0
M  V30 11 O 12.8357 12.6456 0.0 0
M  V30 12 O 19.7657 11.3118 0.0 0
M  V30 13 C 20.5357 12.6456 0.0 0
M  V30 14 C 8.2156 7.3109 0.0 0 CFG=2
M  V30 15 C 7.5892 5.9039 0.0 0 CFG=2
M  V30 16 N 7.3104 8.5567 0.0 0
M  V30 17 C 9.7472 7.1498 0.0 0
M  V30 18 C 8.7337 4.8735 0.0 0 CFG=1
M  V30 19 C 6.0576 5.7430 0.0 0
M  V30 20 C 5.7787 8.3958 0.0 0
M  V30 21 O 10.0673 5.6435 0.0 0
M  V30 22 S 5.1524 6.9889 0.0 0
M  V30 23 C 8.9856 8.6445 0.0 0
M  V30 24 C 10.5256 8.6445 0.0 0
M  V30 25 C 8.2156 9.9782 0.0 0
M  V30 26 C 11.2956 9.9782 0.0 0
M  V30 27 C 8.9856 11.3118 0.0 0
M  V30 28 C 10.5256 11.3118 0.0 0
M  V30 29 C 2.4369 10.7266 0.0 0
M  V30 30 C 3.0632 12.1334 0.0 0
M  V30 31 C 0.9052 10.5655 0.0 0
M  V30 32 C 2.1580 13.3793 0.0 0
M  V30 33 C 0.0000 11.8114 0.0 0
M  V30 34 C 0.6265 13.2183 0.0 0
M  V30 35 C 15.1457 11.3118 0.0 0
M  V30 36 C 15.9157 9.9782 0.0 0
M  V30 37 N 15.9157 12.6456 0.0 0
M  V30 38 N 17.4557 9.9782 0.0 0
M  V30 39 C 17.4557 12.6456 0.0 0
M  V30 40 C 18.2257 11.3120 0.0 0
M  V30 41 H 7.1133 4.4394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 2 7 8
M  V30 9 1 7 29
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 2 10 11
M  V30 13 1 10 35
M  V30 14 1 12 13
M  V30 15 1 12 40
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 23 CFG=3
M  V30 20 1 15 18
M  V30 21 1 15 19
M  V30 22 1 15 41 CFG=3
M  V30 23 2 16 20
M  V30 24 1 17 21
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 1 20 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2205016-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2205017-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-22174371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of a Novel Positron Emission Tomography (PET) Ligand for
Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in
Brain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Lei; Chen, Laigao; Dutra, Jason K.; Beck, Elizabeth M.; Nag,
Sangram; Takano, Akihiro; Amini, Nahid; Arakawa, Ryosuke; Brodney,
Michael A.; Buzon, Leanne M.; Doran, Shawn D.; Lanyon, Lorraine F.;
McCarthy, Timothy J.; Bales, Kelly R.; Nolan, Charles E.; O'Neill, Brian
T.; Schildknegt, Klaas; Halldin, Christer; Villalobos, Anabella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(8), 3296-3308

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C76H114N24O17
2207573-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  117 132 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.5323 11.6504 0.0 0
M  V30 2 O 15.7623 10.3168 0.0 0
M  V30 3 C 18.5017 8.9398 0.0 0
M  V30 4 O 16.9952 8.6197 0.0 0
M  V30 5 C 13.2001 12.0006 0.0 0
M  V30 6 O 13.6762 10.5361 0.0 0
M  V30 7 C 17.8050 5.6627 0.0 0
M  V30 8 O 16.5591 6.5679 0.0 0
M  V30 9 C 10.7104 9.7588 0.0 0
M  V30 10 O 9.4645 8.8536 0.0 0
M  V30 11 C 20.2949 3.4209 0.0 0
M  V30 12 O 20.7707 4.8854 0.0 0
M  V30 13 C 11.4069 6.4816 0.0 0
M  V30 14 O 9.9006 6.8018 0.0 0
M  V30 15 C 23.6270 3.7711 0.0 0
M  V30 16 O 22.8570 5.1047 0.0 0
M  V30 17 C 9.4376 3.7711 0.0 0
M  V30 18 O 8.6676 5.1047 0.0 0
M  V30 19 C 25.5962 6.4816 0.0 0
M  V30 20 O 24.0899 6.8018 0.0 0
M  V30 21 C 6.1056 3.4209 0.0 0
M  V30 22 O 6.5814 4.8854 0.0 0
M  V30 23 C 24.8997 9.7588 0.0 0
M  V30 24 O 23.6538 8.8536 0.0 0
M  V30 25 C 3.6157 5.6627 0.0 0
M  V30 26 O 5.0226 6.2891 0.0 0
M  V30 27 C 27.3896 12.0006 0.0 0
M  V30 28 O 27.8655 10.5361 0.0 0
M  V30 29 C 3.6157 9.0131 0.0 0
M  V30 30 O 5.0226 8.3867 0.0 0
M  V30 31 C 30.7216 11.6504 0.0 0
M  V30 32 O 32.2616 11.6504 0.0 0
M  V30 33 O 29.9516 10.3168 0.0 0
M  V30 34 C 33.0316 10.3168 0.0 0
M  V30 35 C 34.3653 11.0868 0.0 0
M  V30 36 C 33.8016 8.9831 0.0 0
M  V30 37 C 31.6980 9.5467 0.0 0
M  V30 38 N 18.0723 11.6504 0.0 0
M  V30 39 N 18.9775 10.4045 0.0 0
M  V30 40 C 18.9775 12.8963 0.0 0
M  V30 41 C 20.4421 10.8804 0.0 0
M  V30 42 C 20.4421 12.4204 0.0 0
M  V30 43 C 15.7623 12.9841 0.0 0 CFG=2
M  V30 44 N 14.2307 13.1452 0.0 0
M  V30 45 C 16.3886 14.3910 0.0 0
M  V30 46 C 13.9106 14.6515 0.0 0
M  V30 47 C 15.2442 15.4215 0.0 0
M  V30 48 N 19.5321 7.7954 0.0 0
M  V30 49 C 19.2119 6.2890 0.0 0 CFG=2
M  V30 50 C 21.0636 7.9564 0.0 0
M  V30 51 C 20.5456 5.5190 0.0 0
M  V30 52 C 21.6900 6.5496 0.0 0
M  V30 53 N 11.6938 12.3208 0.0 0
M  V30 54 N 10.5493 11.2904 0.0 0
M  V30 55 C 11.0675 13.7278 0.0 0
M  V30 56 C 9.2156 12.0604 0.0 0
M  V30 57 C 9.5358 13.5668 0.0 0
M  V30 58 N 17.6440 4.1311 0.0 0
M  V30 59 N 18.7886 3.1007 0.0 0
M  V30 60 C 16.3104 3.3611 0.0 0
M  V30 61 C 18.1621 1.6937 0.0 0
M  V30 62 C 16.6305 1.8546 0.0 0
M  V30 63 C 12.1172 9.1323 0.0 0 CFG=2
M  V30 64 N 12.4374 7.6260 0.0 0
M  V30 65 C 13.4509 9.9023 0.0 0
M  V30 66 C 13.9691 7.4651 0.0 0
M  V30 67 C 14.5954 8.8719 0.0 0
M  V30 68 N 21.3253 2.2763 0.0 0
M  V30 69 C 22.8570 2.4374 0.0 0 CFG=2
M  V30 70 C 21.0051 0.7700 0.0 0
M  V30 71 C 23.4833 1.0304 0.0 0
M  V30 72 C 22.3388 0.0000 0.0 0
M  V30 73 N 11.8828 5.0169 0.0 0
M  V30 74 N 10.9776 3.7711 0.0 0
M  V30 75 C 13.3475 4.5411 0.0 0
M  V30 76 C 11.8828 2.5252 0.0 0
M  V30 77 C 13.3475 3.0010 0.0 0
M  V30 78 N 25.1669 3.7711 0.0 0
M  V30 79 N 26.0721 5.0169 0.0 0
M  V30 80 C 26.0721 2.5252 0.0 0
M  V30 81 C 27.5368 4.5411 0.0 0
M  V30 82 C 27.5368 3.0010 0.0 0
M  V30 83 C 8.6676 2.4374 0.0 0 CFG=2
M  V30 84 N 7.1360 2.2763 0.0 0
M  V30 85 C 9.2940 1.0304 0.0 0
M  V30 86 C 6.8158 0.7700 0.0 0
M  V30 87 C 8.1495 0.0000 0.0 0
M  V30 88 N 26.6267 7.6260 0.0 0
M  V30 89 C 26.3065 9.1323 0.0 0 CFG=2
M  V30 90 C 28.1584 7.4651 0.0 0
M  V30 91 C 27.6403 9.9023 0.0 0
M  V30 92 C 28.7847 8.8719 0.0 0
M  V30 93 N 4.5991 3.1007 0.0 0
M  V30 94 N 3.4547 4.1311 0.0 0
M  V30 95 C 3.9728 1.6937 0.0 0
M  V30 96 C 2.1211 3.3611 0.0 0
M  V30 97 C 2.4412 1.8546 0.0 0
M  V30 98 N 24.7388 11.2904 0.0 0
M  V30 99 N 25.8831 12.3208 0.0 0
M  V30 100 C 23.4049 12.0604 0.0 0
M  V30 101 C 25.2568 13.7278 0.0 0
M  V30 102 C 23.7251 13.5668 0.0 0
M  V30 103 C 2.3698 6.5679 0.0 0 CFG=2
M  V30 104 N 2.3698 8.1079 0.0 0
M  V30 105 C 0.9051 6.0920 0.0 0
M  V30 106 C 0.9051 8.5838 0.0 0
M  V30 107 C 0.0000 7.3379 0.0 0
M  V30 108 N 28.4200 13.1452 0.0 0
M  V30 109 C 29.9516 12.9841 0.0 0 CFG=2
M  V30 110 C 28.0999 14.6515 0.0 0
M  V30 111 C 30.5779 14.3910 0.0 0
M  V30 112 C 29.4335 15.4215 0.0 0
M  V30 113 N 3.4547 10.5447 0.0 0
M  V30 114 C 2.1211 11.3147 0.0 0
M  V30 115 N 4.5991 11.5751 0.0 0
M  V30 116 C 2.4412 12.8211 0.0 0
M  V30 117 C 3.9728 12.9821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 38
M  V30 3 1 43 1 CFG=1
M  V30 4 2 3 4
M  V30 5 1 3 39
M  V30 6 1 3 48
M  V30 7 2 5 6
M  V30 8 1 5 44
M  V30 9 1 5 53
M  V30 10 2 7 8
M  V30 11 1 49 7 CFG=1
M  V30 12 1 7 58
M  V30 13 2 9 10
M  V30 14 1 9 54
M  V30 15 1 63 9 CFG=3
M  V30 16 2 11 12
M  V30 17 1 11 59
M  V30 18 1 11 68
M  V30 19 2 13 14
M  V30 20 1 13 64
M  V30 21 1 13 73
M  V30 22 2 15 16
M  V30 23 1 69 15 CFG=3
M  V30 24 1 15 78
M  V30 25 2 17 18
M  V30 26 1 17 74
M  V30 27 1 83 17 CFG=3
M  V30 28 2 19 20
M  V30 29 1 19 79
M  V30 30 1 19 88
M  V30 31 2 21 22
M  V30 32 1 21 84
M  V30 33 1 21 93
M  V30 34 2 23 24
M  V30 35 1 89 23 CFG=3
M  V30 36 1 23 98
M  V30 37 2 25 26
M  V30 38 1 25 94
M  V30 39 1 103 25 CFG=3
M  V30 40 2 27 28
M  V30 41 1 27 99
M  V30 42 1 27 108
M  V30 43 2 29 30
M  V30 44 1 29 104
M  V30 45 1 29 113
M  V30 46 1 31 32
M  V30 47 2 31 33
M  V30 48 1 109 31 CFG=1
M  V30 49 1 32 34
M  V30 50 1 34 35
M  V30 51 1 34 36
M  V30 52 1 34 37
M  V30 53 1 38 39
M  V30 54 1 38 40
M  V30 55 1 39 41
M  V30 56 1 40 42
M  V30 57 1 41 42
M  V30 58 1 43 44
M  V30 59 1 43 45
M  V30 60 1 44 46
M  V30 61 1 45 47
M  V30 62 1 46 47
M  V30 63 1 48 49
M  V30 64 1 48 50
M  V30 65 1 49 51
M  V30 66 1 50 52
M  V30 67 1 51 52
M  V30 68 1 53 54
M  V30 69 1 53 55
M  V30 70 1 54 56
M  V30 71 1 55 57
M  V30 72 1 56 57
M  V30 73 1 58 59
M  V30 74 1 58 60
M  V30 75 1 59 61
M  V30 76 1 60 62
M  V30 77 1 61 62
M  V30 78 1 63 64
M  V30 79 1 63 65
M  V30 80 1 64 66
M  V30 81 1 65 67
M  V30 82 1 66 67
M  V30 83 1 68 69
M  V30 84 1 68 70
M  V30 85 1 69 71
M  V30 86 1 70 72
M  V30 87 1 71 72
M  V30 88 1 73 74
M  V30 89 1 73 75
M  V30 90 1 74 76
M  V30 91 1 75 77
M  V30 92 1 76 77
M  V30 93 1 78 79
M  V30 94 1 78 80
M  V30 95 1 79 81
M  V30 96 1 80 82
M  V30 97 1 81 82
M  V30 98 1 83 84
M  V30 99 1 83 85
M  V30 100 1 84 86
M  V30 101 1 85 87
M  V30 102 1 86 87
M  V30 103 1 88 89
M  V30 104 1 88 90
M  V30 105 1 89 91
M  V30 106 1 90 92
M  V30 107 1 91 92
M  V30 108 1 93 94
M  V30 109 1 93 95
M  V30 110 1 94 96
M  V30 111 1 95 97
M  V30 112 1 96 97
M  V30 113 1 98 99
M  V30 114 1 98 100
M  V30 115 1 99 101
M  V30 116 1 100 102
M  V30 117 1 101 102
M  V30 118 1 103 104
M  V30 119 1 103 105
M  V30 120 1 104 106
M  V30 121 1 105 107
M  V30 122 1 106 107
M  V30 123 1 108 109
M  V30 124 1 108 110
M  V30 125 1 109 111
M  V30 126 1 110 112
M  V30 127 1 111 112
M  V30 128 1 113 114
M  V30 129 1 113 115
M  V30 130 1 114 116
M  V30 131 1 115 117
M  V30 132 1 116 117
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 43 49 63 69 83 89 103 109)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C77H114N24O18
2207573-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  119 134 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6738 16.6111 0.0 0
M  V30 2 O 15.9198 15.7061 0.0 0
M  V30 3 C 17.5753 18.2864 0.0 0
M  V30 4 O 17.7364 16.7548 0.0 0
M  V30 5 C 13.3970 13.0058 0.0 0
M  V30 6 O 14.8976 12.6593 0.0 0
M  V30 7 C 20.7618 17.2510 0.0 0
M  V30 8 O 19.7314 16.1066 0.0 0
M  V30 9 C 9.9448 11.3591 0.0 0
M  V30 10 O 8.9345 10.1969 0.0 0
M  V30 11 C 22.1245 14.1904 0.0 0
M  V30 12 O 22.8945 12.8566 0.0 0
M  V30 13 C 6.7408 12.3387 0.0 0
M  V30 14 O 6.9285 10.8101 0.0 0
M  V30 15 C 20.1552 11.4798 0.0 0
M  V30 16 O 21.6616 11.1597 0.0 0
M  V30 17 C 3.8690 10.6131 0.0 0
M  V30 18 O 5.1305 9.7298 0.0 0
M  V30 19 C 20.8519 8.2027 0.0 0
M  V30 20 O 22.0977 9.1078 0.0 0
M  V30 21 C 3.2297 7.3243 0.0 0
M  V30 22 O 4.7303 7.6706 0.0 0
M  V30 23 C 23.7534 6.5275 0.0 0
M  V30 24 O 23.9143 8.0590 0.0 0
M  V30 25 C 5.2460 4.6485 0.0 0
M  V30 26 O 5.9926 5.9954 0.0 0
M  V30 27 C 26.9398 7.5628 0.0 0
M  V30 28 O 25.9092 8.7072 0.0 0
M  V30 29 C 8.5837 4.3565 0.0 0
M  V30 30 O 8.0823 5.8126 0.0 0
M  V30 31 C 28.3024 10.6234 0.0 0
M  V30 32 O 29.0724 11.9572 0.0 0
M  V30 33 O 26.7624 10.6234 0.0 0
M  V30 34 C 28.3024 13.2909 0.0 0
M  V30 35 C 26.9688 12.5209 0.0 0
M  V30 36 C 27.5324 14.6245 0.0 0
M  V30 37 C 29.6362 14.0609 0.0 0
M  V30 38 C 9.9996 1.3199 0.0 0
M  V30 39 O 10.7927 0.0000 0.0 0
M  V30 40 N 14.8349 18.1428 0.0 0
M  V30 41 N 16.1685 18.9128 0.0 0
M  V30 42 C 13.6904 19.1733 0.0 0
M  V30 43 C 15.8484 20.4191 0.0 0
M  V30 44 C 14.3168 20.5800 0.0 0
M  V30 45 C 13.2670 15.9848 0.0 0 CFG=2
M  V30 46 N 12.9468 14.4785 0.0 0
M  V30 47 C 11.9334 16.7548 0.0 0
M  V30 48 C 11.4153 14.3175 0.0 0
M  V30 49 C 10.7888 15.7244 0.0 0
M  V30 50 N 18.8212 19.1916 0.0 0
M  V30 51 C 20.2859 18.7157 0.0 0 CFG=2
M  V30 52 C 18.8214 20.7316 0.0 0
M  V30 53 C 21.1911 19.9616 0.0 0
M  V30 54 C 20.2859 21.2074 0.0 0
M  V30 55 N 12.9211 11.5411 0.0 0
M  V30 56 N 11.4566 11.0653 0.0 0
M  V30 57 C 13.8263 10.2953 0.0 0
M  V30 58 C 11.4566 9.5253 0.0 0
M  V30 59 C 12.9211 9.0494 0.0 0
M  V30 60 N 22.2682 16.9308 0.0 0
M  V30 61 N 22.8945 15.5240 0.0 0
M  V30 62 C 23.4126 17.9614 0.0 0
M  V30 63 C 24.4261 15.6850 0.0 0
M  V30 64 C 24.7462 17.1914 0.0 0
M  V30 65 C 9.4435 12.8152 0.0 0 CFG=2
M  V30 66 N 7.9708 13.2655 0.0 0
M  V30 67 C 10.3268 14.0767 0.0 0
M  V30 68 C 7.9438 14.8052 0.0 0
M  V30 69 C 9.3999 15.3066 0.0 0
M  V30 70 N 20.5845 14.1904 0.0 0
M  V30 71 C 19.6793 12.9444 0.0 0 CFG=2
M  V30 72 C 19.6793 15.4363 0.0 0
M  V30 73 C 18.2148 13.4204 0.0 0
M  V30 74 C 18.2148 14.9604 0.0 0
M  V30 75 N 5.3232 12.9404 0.0 0
M  V30 76 N 4.0033 12.1473 0.0 0
M  V30 77 C 4.9768 14.4410 0.0 0
M  V30 78 C 2.8410 13.1575 0.0 0
M  V30 79 C 3.4427 14.5751 0.0 0
M  V30 80 N 19.1247 10.3353 0.0 0
M  V30 81 N 19.4449 8.8290 0.0 0
M  V30 82 C 17.5932 10.4964 0.0 0
M  V30 83 C 18.1113 8.0590 0.0 0
M  V30 84 C 16.9667 9.0894 0.0 0
M  V30 85 C 2.4733 9.9623 0.0 0 CFG=2
M  V30 86 N 2.1794 8.4505 0.0 0
M  V30 87 C 1.1264 10.7089 0.0 0
M  V30 88 C 0.6508 8.2629 0.0 0
M  V30 89 C 0.0000 9.6586 0.0 0
M  V30 90 N 21.0128 6.6710 0.0 0
M  V30 91 C 22.3464 5.9010 0.0 0 CFG=2
M  V30 92 C 19.8683 5.6406 0.0 0
M  V30 93 C 22.0263 4.3947 0.0 0
M  V30 94 C 20.4947 4.2338 0.0 0
M  V30 95 N 2.7794 5.8516 0.0 0
M  V30 96 N 3.7062 4.6216 0.0 0
M  V30 97 C 1.3233 5.3501 0.0 0
M  V30 98 C 2.8230 3.3601 0.0 0
M  V30 99 C 1.3501 3.8104 0.0 0
M  V30 100 N 24.9993 5.6223 0.0 0
M  V30 101 N 26.4638 6.0981 0.0 0
M  V30 102 C 24.9993 4.0823 0.0 0
M  V30 103 C 27.3690 4.8523 0.0 0
M  V30 104 C 26.4638 3.6064 0.0 0
M  V30 105 C 6.0391 3.3284 0.0 0 CFG=2
M  V30 106 N 7.5733 3.1943 0.0 0
M  V30 107 C 5.4375 1.9108 0.0 0
M  V30 108 C 7.9198 1.6937 0.0 0
M  V30 109 C 6.5997 0.9006 0.0 0
M  V30 110 N 28.4461 7.8830 0.0 0
M  V30 111 C 29.0724 9.2898 0.0 0 CFG=2
M  V30 112 C 29.5905 6.8524 0.0 0
M  V30 113 C 30.6041 9.1289 0.0 0
M  V30 114 C 30.9243 7.6224 0.0 0
M  V30 115 N 10.0954 4.0627 0.0 0
M  V30 116 N 10.7462 2.6670 0.0 0
M  V30 117 C 11.2217 5.1130 0.0 0
M  V30 118 C 12.2748 2.8546 0.0 0
M  V30 119 C 12.5686 4.3664 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 40
M  V30 3 1 45 1 CFG=1
M  V30 4 2 3 4
M  V30 5 1 3 41
M  V30 6 1 3 50
M  V30 7 2 5 6
M  V30 8 1 5 46
M  V30 9 1 5 55
M  V30 10 2 7 8
M  V30 11 1 51 7 CFG=1
M  V30 12 1 7 60
M  V30 13 2 9 10
M  V30 14 1 9 56
M  V30 15 1 65 9 CFG=1
M  V30 16 2 11 12
M  V30 17 1 11 61
M  V30 18 1 11 70
M  V30 19 2 13 14
M  V30 20 1 13 66
M  V30 21 1 13 75
M  V30 22 2 15 16
M  V30 23 1 71 15 CFG=3
M  V30 24 1 15 80
M  V30 25 2 17 18
M  V30 26 1 17 76
M  V30 27 1 85 17 CFG=1
M  V30 28 2 19 20
M  V30 29 1 19 81
M  V30 30 1 19 90
M  V30 31 2 21 22
M  V30 32 1 21 86
M  V30 33 1 21 95
M  V30 34 2 23 24
M  V30 35 1 91 23 CFG=3
M  V30 36 1 23 100
M  V30 37 2 25 26
M  V30 38 1 25 96
M  V30 39 1 105 25 CFG=1
M  V30 40 2 27 28
M  V30 41 1 27 101
M  V30 42 1 27 110
M  V30 43 2 29 30
M  V30 44 1 29 106
M  V30 45 1 29 115
M  V30 46 1 31 32
M  V30 47 2 31 33
M  V30 48 1 111 31 CFG=3
M  V30 49 1 32 34
M  V30 50 1 34 35
M  V30 51 1 34 36
M  V30 52 1 34 37
M  V30 53 2 38 39
M  V30 54 1 38 116
M  V30 55 1 40 41
M  V30 56 1 40 42
M  V30 57 1 41 43
M  V30 58 1 42 44
M  V30 59 1 43 44
M  V30 60 1 45 46
M  V30 61 1 45 47
M  V30 62 1 46 48
M  V30 63 1 47 49
M  V30 64 1 48 49
M  V30 65 1 50 51
M  V30 66 1 50 52
M  V30 67 1 51 53
M  V30 68 1 52 54
M  V30 69 1 53 54
M  V30 70 1 55 56
M  V30 71 1 55 57
M  V30 72 1 56 58
M  V30 73 1 57 59
M  V30 74 1 58 59
M  V30 75 1 60 61
M  V30 76 1 60 62
M  V30 77 1 61 63
M  V30 78 1 62 64
M  V30 79 1 63 64
M  V30 80 1 65 66
M  V30 81 1 65 67
M  V30 82 1 66 68
M  V30 83 1 67 69
M  V30 84 1 68 69
M  V30 85 1 70 71
M  V30 86 1 70 72
M  V30 87 1 71 73
M  V30 88 1 72 74
M  V30 89 1 73 74
M  V30 90 1 75 76
M  V30 91 1 75 77
M  V30 92 1 76 78
M  V30 93 1 77 79
M  V30 94 1 78 79
M  V30 95 1 80 81
M  V30 96 1 80 82
M  V30 97 1 81 83
M  V30 98 1 82 84
M  V30 99 1 83 84
M  V30 100 1 85 86
M  V30 101 1 85 87
M  V30 102 1 86 88
M  V30 103 1 87 89
M  V30 104 1 88 89
M  V30 105 1 90 91
M  V30 106 1 90 92
M  V30 107 1 91 93
M  V30 108 1 92 94
M  V30 109 1 93 94
M  V30 110 1 95 96
M  V30 111 1 95 97
M  V30 112 1 96 98
M  V30 113 1 97 99
M  V30 114 1 98 99
M  V30 115 1 100 101
M  V30 116 1 100 102
M  V30 117 1 101 103
M  V30 118 1 102 104
M  V30 119 1 103 104
M  V30 120 1 105 106
M  V30 121 1 105 107
M  V30 122 1 106 108
M  V30 123 1 107 109
M  V30 124 1 108 109
M  V30 125 1 110 111
M  V30 126 1 110 112
M  V30 127 1 111 113
M  V30 128 1 112 114
M  V30 129 1 113 114
M  V30 130 1 115 116
M  V30 131 1 115 117
M  V30 132 1 116 118
M  V30 133 1 117 119
M  V30 134 1 118 119
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 45 51 65 71 85 91 105 111)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2207573-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2207573-76-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19084563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of stable β6.3-Helices:
Discovery of non-hemolytic antibacterial peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, Damodara N.; Singh, Sukrit; Ho, Chris M. W.; Patel, Janki;
Schlesinger, Paul; Rodgers, Stephen; Doctor, Allan; Marshall, Garland R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 149193-210

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(4-amino-2-fluorophenyl)carbamate
C11H15FN2O2
220913-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0023 1.5400 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.1060 0.9764 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 8.5660 3.6437 0.0 0
M  V30 9 F 2.6673 0.0000 0.0 0
M  V30 10 N 0.0000 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 12
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-fluoro-4-(formylamino)phenyl]-, 1,1-dimethylethyl ester
C12H15FN2O3
275824-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 F 8.0022 0.0000 0.0 0
M  V30 10 N 10.6697 4.6201 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 O 13.3370 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 8.0022 1.5400 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 2 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 220913-43-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 275824-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17136935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for preparation of camptothecin analogs having antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Curran, Dennis P.; Josien, Hubert; Bom, David; Burke, Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6136978 A 2000-10-24

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(4-amino-2-fluorophenyl)carbamate
C11H15FN2O2
220913-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0023 1.5400 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.1060 0.9764 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 8.5660 3.6437 0.0 0
M  V30 9 F 2.6673 0.0000 0.0 0
M  V30 10 N 0.0000 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 12
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-fluoro-4-(formylamino)phenyl]-, 1,1-dimethylethyl ester
C12H15FN2O3
275824-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 F 8.0022 0.0000 0.0 0
M  V30 10 N 10.6697 4.6201 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 O 13.3370 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 8.0022 1.5400 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 2 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 220913-43-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 275824-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9189665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of camptothecin analogs for use as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Curran, Dennis P.; Josien, Hubert; Bom, David; Burke, Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000035924 A1 2000-06-22

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methyl]-2-hydroxy-3-[(2-methoxyphenyl)amino]-3-methylbutan...
C19H23ClN2O3
2211037-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3349 0.0 0
M  V30 3 C 6.7236 4.5649 0.0 0
M  V30 4 C 6.1600 6.6685 0.0 0
M  V30 5 C 4.0564 6.1049 0.0 0
M  V30 6 C 8.0573 5.3349 0.0 0
M  V30 7 O 6.7236 3.0249 0.0 0
M  V30 8 N 9.3911 4.5649 0.0 0
M  V30 9 O 8.0573 6.8749 0.0 0
M  V30 10 C 10.7247 5.3349 0.0 0
M  V30 11 O 3.0800 1.3338 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 Cl 16.0594 5.3349 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.7700 5.3349 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 C 12.0584 4.5649 0.0 0
M  V30 21 C 13.3921 5.3349 0.0 0
M  V30 22 C 12.0584 3.0249 0.0 0
M  V30 23 C 14.7258 4.5649 0.0 0
M  V30 24 C 13.3921 2.2549 0.0 0
M  V30 25 C 14.7258 3.0249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 20
M  V30 12 1 11 12
M  V30 13 1 11 15
M  V30 14 1 13 23
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methyl]-3-[formyl(2-methoxyphenyl)amino]-2-hydroxy-3-methy...
C20H23ClN2O4
2211038-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0011 0.0 0
M  V30 2 C 5.3901 5.3349 0.0 0
M  V30 3 C 5.3901 2.6675 0.0 0
M  V30 4 C 6.7237 4.5649 0.0 0
M  V30 5 C 6.1601 6.6686 0.0 0
M  V30 6 C 4.0564 6.1049 0.0 0
M  V30 7 O 4.6201 1.3338 0.0 0
M  V30 8 C 8.0574 5.3349 0.0 0
M  V30 9 O 6.7237 3.0249 0.0 0
M  V30 10 N 9.3912 4.5649 0.0 0
M  V30 11 O 8.0574 6.8749 0.0 0
M  V30 12 C 10.7248 5.3349 0.0 0
M  V30 13 O 3.0800 1.3338 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 Cl 16.0596 5.3349 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 2.3100 2.6675 0.0 0
M  V30 18 C 2.3100 5.3349 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.7700 5.3349 0.0 0
M  V30 21 C 0.0000 4.0011 0.0 0
M  V30 22 C 12.0585 4.5649 0.0 0
M  V30 23 C 13.3923 5.3349 0.0 0
M  V30 24 C 12.0585 3.0249 0.0 0
M  V30 25 C 14.7259 4.5649 0.0 0
M  V30 26 C 13.3923 2.2549 0.0 0
M  V30 27 C 14.7259 3.0249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 22
M  V30 14 1 13 14
M  V30 15 1 13 17
M  V30 16 1 15 25
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211037-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211038-60-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1,reaction in a sealed vial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methyl]-α-hydroxy-β-[(2-methoxyphenyl)amino]benzenepropana...
C23H23ClN2O3
2211037-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 4.0011 5.3900 0.0 0
M  V30 3 C 6.6685 5.3900 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 O 6.6685 6.9300 0.0 0
M  V30 6 N 9.3358 5.3900 0.0 0
M  V30 7 O 8.0021 3.0800 0.0 0
M  V30 8 C 10.6696 4.6200 0.0 0
M  V30 9 O 1.3338 6.9300 0.0 0
M  V30 10 C 0.0000 7.7000 0.0 0
M  V30 11 Cl 16.0043 4.6200 0.0 0
M  V30 12 C 5.3347 3.0800 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6685 2.3100 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 5.3347 0.0000 0.0 0
M  V30 18 C 4.0011 6.9300 0.0 0
M  V30 19 C 2.6674 7.7000 0.0 0
M  V30 20 C 5.3347 7.7000 0.0 0
M  V30 21 C 2.6674 9.2400 0.0 0
M  V30 22 C 5.3347 9.2400 0.0 0
M  V30 23 C 4.0011 10.0100 0.0 0
M  V30 24 C 12.0032 5.3900 0.0 0
M  V30 25 C 13.3369 4.6200 0.0 0
M  V30 26 C 12.0032 6.9300 0.0 0
M  V30 27 C 14.6705 5.3900 0.0 0
M  V30 28 C 13.3369 7.7000 0.0 0
M  V30 29 C 14.6705 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 9 19
M  V30 13 1 11 27
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methyl]-β-[formyl(2-methoxyphenyl)amino]-α-hydroxybenzenep...
C24H23ClN2O4
2211038-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 8.4700 5.3347 0.0 0
M  V30 6 O 6.1600 6.6685 0.0 0
M  V30 7 O 2.3100 2.6674 0.0 0
M  V30 8 N 9.2400 4.0011 0.0 0
M  V30 9 O 9.2400 6.6685 0.0 0
M  V30 10 C 10.7800 4.0011 0.0 0
M  V30 11 O 1.5400 4.0011 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 Cl 15.4000 6.6685 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 6.1600 1.3336 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 6.9300 0.0000 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 C 8.4700 0.0000 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 22 C 4.6200 6.6685 0.0 0
M  V30 23 C 1.5400 6.6685 0.0 0
M  V30 24 C 3.8500 8.0021 0.0 0
M  V30 25 C 2.3100 8.0021 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 13.0900 5.3347 0.0 0
M  V30 28 C 10.7800 6.6685 0.0 0
M  V30 29 C 13.8600 6.6685 0.0 0
M  V30 30 C 11.5500 8.0021 0.0 0
M  V30 31 C 13.0900 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 20
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 2 5 9
M  V30 11 1 8 10
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 1 11 21
M  V30 15 1 13 29
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211037-24-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211038-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1,reaction in a sealed vial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-2-hydroxy-5-methyl-3-[[(tetrahydro-2H-pyran-4-yl)methyl...
C17H32N2O3
2211038-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 4.6200 5.3347 0.0 0
M  V30 6 C 9.2400 5.3347 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 N 10.0100 6.6685 0.0 0
M  V30 10 O 10.0100 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 7.7000 0.0000 0.0 0
M  V30 13 C 11.5500 6.6685 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 O 0.0000 5.3347 0.0 0
M  V30 20 C 12.3200 8.0021 0.0 0
M  V30 21 C 12.3200 9.5421 0.0 0
M  V30 22 C 13.6536 8.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 20
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-3-[formyl[(tetrahydro-2H-pyran-4-yl)methyl]amino]-2-hyd...
C18H32N2O4
2211039-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 N 5.3348 4.6201 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 4.0010 3.8501 0.0 0
M  V30 6 C 5.3348 6.1601 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 8.0022 6.1601 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 O 6.6685 6.9302 0.0 0
M  V30 11 N 10.6697 4.6201 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 12.0033 3.8501 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 21 O 0.0000 6.1601 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 14.8770 4.6201 0.0 0
M  V30 24 C 14.1070 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 16
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 1 15 22
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-2-hydroxy-3-[(3-methoxypropyl)amino]-5-methylhexanamide
C15H30N2O3
2211038-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1036 6.6685 0.0 0
M  V30 2 N 3.6436 6.6685 0.0 0
M  V30 3 C 4.4136 5.3347 0.0 0
M  V30 4 C 5.9536 5.3347 0.0 0
M  V30 5 O 3.6436 4.0011 0.0 0
M  V30 6 C 6.7236 4.0011 0.0 0
M  V30 7 O 6.7236 6.6685 0.0 0
M  V30 8 N 8.2636 4.0011 0.0 0
M  V30 9 C 5.9536 2.6674 0.0 0
M  V30 10 C 9.0336 5.3347 0.0 0
M  V30 11 C 6.7236 1.3336 0.0 0
M  V30 12 C 10.5736 5.3347 0.0 0
M  V30 13 C 5.9536 0.0000 0.0 0
M  V30 14 C 8.2636 1.3336 0.0 0
M  V30 15 C 11.3436 6.6685 0.0 0
M  V30 16 O 12.8836 6.6685 0.0 0
M  V30 17 C 13.6536 8.0021 0.0 0
M  V30 18 C 1.3336 8.0021 0.0 0
M  V30 19 C 1.3336 9.5421 0.0 0
M  V30 20 C 0.0000 8.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-3-[formyl(3-methoxypropyl)amino]-2-hydroxy-5-methylhexa...
C16H30N2O4
2211039-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 4.0011 0.0 0
M  V30 2 N 8.2636 4.0011 0.0 0
M  V30 3 C 5.9536 5.3347 0.0 0
M  V30 4 C 5.9536 2.6674 0.0 0
M  V30 5 C 9.0336 5.3347 0.0 0
M  V30 6 C 9.0336 2.6674 0.0 0
M  V30 7 C 4.4136 5.3347 0.0 0
M  V30 8 O 6.7236 6.6685 0.0 0
M  V30 9 C 6.7236 1.3336 0.0 0
M  V30 10 C 10.5736 5.3347 0.0 0
M  V30 11 O 10.5736 2.6674 0.0 0
M  V30 12 N 3.6436 6.6685 0.0 0
M  V30 13 O 3.6436 4.0011 0.0 0
M  V30 14 C 5.9536 0.0000 0.0 0
M  V30 15 C 8.2636 1.3336 0.0 0
M  V30 16 C 11.3436 6.6685 0.0 0
M  V30 17 C 2.1036 6.6685 0.0 0
M  V30 18 O 12.8836 6.6685 0.0 0
M  V30 19 C 13.6536 8.0021 0.0 0
M  V30 20 C 1.3336 8.0021 0.0 0
M  V30 21 C 0.0000 8.7721 0.0 0
M  V30 22 C 1.3336 9.5421 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 12 17
M  V30 17 1 16 18
M  V30 18 1 17 20
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112842
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-2-hydroxy-5-methyl-3-[[(tetrahydro-3-furanyl)methyl]ami...
C16H30N2O3
2211038-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1047 3.8501 0.0 0
M  V30 2 N 3.7711 4.6201 0.0 0
M  V30 3 C 6.4384 4.6201 0.0 0
M  V30 4 C 5.1047 2.3100 0.0 0
M  V30 5 C 3.7711 6.1601 0.0 0
M  V30 6 C 7.7722 3.8501 0.0 0
M  V30 7 O 6.4384 6.1601 0.0 0
M  V30 8 C 3.7711 1.5400 0.0 0
M  V30 9 N 9.1059 4.6201 0.0 0
M  V30 10 O 7.7722 2.3100 0.0 0
M  V30 11 C 2.4372 2.3100 0.0 0
M  V30 12 C 3.7711 0.0000 0.0 0
M  V30 13 C 10.4395 3.8501 0.0 0
M  V30 14 C 2.4372 6.9301 0.0 0
M  V30 15 C 1.0304 6.3036 0.0 0
M  V30 16 C 2.2763 8.4617 0.0 0
M  V30 17 C 0.0000 7.4482 0.0 0
M  V30 18 O 0.7700 8.7819 0.0 0
M  V30 19 C 11.7732 4.6201 0.0 0
M  V30 20 C 13.3132 4.6201 0.0 0
M  V30 21 C 12.5432 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 19
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylmethyl)-3-[formyl[(tetrahydro-3-furanyl)methyl]amino]-2-hydroxy...
C17H30N2O4
2211039-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1047 3.8501 0.0 0
M  V30 2 N 3.7711 4.6201 0.0 0
M  V30 3 C 6.4384 4.6201 0.0 0
M  V30 4 C 5.1047 2.3100 0.0 0
M  V30 5 C 3.7711 6.1601 0.0 0
M  V30 6 C 2.4372 3.8501 0.0 0
M  V30 7 C 7.7722 3.8501 0.0 0
M  V30 8 O 6.4384 6.1601 0.0 0
M  V30 9 C 3.7711 1.5400 0.0 0
M  V30 10 O 1.1036 4.6201 0.0 0
M  V30 11 N 9.1059 4.6201 0.0 0
M  V30 12 O 7.7722 2.3100 0.0 0
M  V30 13 C 2.4372 2.3100 0.0 0
M  V30 14 C 3.7711 0.0000 0.0 0
M  V30 15 C 10.4395 3.8501 0.0 0
M  V30 16 C 2.4372 6.9301 0.0 0
M  V30 17 C 1.0304 6.3036 0.0 0
M  V30 18 C 2.2763 8.4617 0.0 0
M  V30 19 C 0.0000 7.4482 0.0 0
M  V30 20 O 0.7700 8.7819 0.0 0
M  V30 21 C 11.7732 4.6201 0.0 0
M  V30 22 C 12.5432 5.9538 0.0 0
M  V30 23 C 13.3132 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 16
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 1 15 21
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H32N2O3
2211038-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 6.6687 0.0 0
M  V30 2 C 5.9538 8.0023 0.0 0
M  V30 3 C 8.2638 6.6687 0.0 0
M  V30 4 N 5.9538 5.3348 0.0 0
M  V30 5 C 4.4137 8.0023 0.0 0
M  V30 6 O 6.7238 9.3360 0.0 0
M  V30 7 C 9.0338 8.0023 0.0 0
M  V30 8 C 6.7238 4.0012 0.0 0
M  V30 9 N 3.6437 6.6687 0.0 0
M  V30 10 O 3.6437 9.3360 0.0 0
M  V30 11 C 2.1037 6.6687 0.0 0
M  V30 12 C 10.5739 8.0023 0.0 0
M  V30 13 C 11.3439 9.3360 0.0 0
M  V30 14 C 11.3439 6.6687 0.0 0
M  V30 15 C 12.8839 9.3360 0.0 0
M  V30 16 C 12.8839 6.6687 0.0 0
M  V30 17 C 13.6539 8.0023 0.0 0
M  V30 18 C 5.9538 2.6675 0.0 0
M  V30 19 C 6.7238 1.3337 0.0 0
M  V30 20 C 4.4137 2.6675 0.0 0
M  V30 21 C 5.9538 0.0000 0.0 0
M  V30 22 C 3.6437 1.3337 0.0 0
M  V30 23 O 4.4137 0.0000 0.0 0
M  V30 24 C 1.3337 8.0023 0.0 0
M  V30 25 C 1.3337 9.5424 0.0 0
M  V30 26 C 0.0000 8.7723 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 7 12
M  V30 11 1 8 18
M  V30 12 1 9 11
M  V30 13 1 11 24
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H32N2O4
2211039-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7237 6.6686 0.0 0
M  V30 2 N 8.2637 6.6686 0.0 0
M  V30 3 C 5.9537 5.3348 0.0 0
M  V30 4 C 5.9537 8.0022 0.0 0
M  V30 5 C 9.0337 5.3348 0.0 0
M  V30 6 C 9.0337 8.0022 0.0 0
M  V30 7 C 6.7237 4.0011 0.0 0
M  V30 8 C 4.4137 8.0022 0.0 0
M  V30 9 O 6.7237 9.3359 0.0 0
M  V30 10 O 8.2637 9.3359 0.0 0
M  V30 11 N 3.6437 6.6686 0.0 0
M  V30 12 O 3.6437 9.3359 0.0 0
M  V30 13 C 2.1037 6.6686 0.0 0
M  V30 14 C 10.5738 5.3348 0.0 0
M  V30 15 C 11.3438 4.0011 0.0 0
M  V30 16 C 11.3438 6.6686 0.0 0
M  V30 17 C 12.8838 4.0011 0.0 0
M  V30 18 C 12.8838 6.6686 0.0 0
M  V30 19 O 13.6538 5.3348 0.0 0
M  V30 20 C 5.9537 2.6675 0.0 0
M  V30 21 C 6.7237 1.3337 0.0 0
M  V30 22 C 4.4137 2.6675 0.0 0
M  V30 23 C 5.9537 0.0000 0.0 0
M  V30 24 C 3.6437 1.3337 0.0 0
M  V30 25 C 4.4137 0.0000 0.0 0
M  V30 26 C 1.3337 8.0022 0.0 0
M  V30 27 C 0.0000 8.7722 0.0 0
M  V30 28 C 1.3337 9.5423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 14
M  V30 10 2 6 10
M  V30 11 1 7 20
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 11 13
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-43-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, 5-chloro-N-[(2,4-dimethoxyphenyl)methyl]-4-[[(1S,2S)-2-(d...
C26H30ClF3N4O4S2
2222539-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 12.3200 3.7710 0.0 0
M  V30 2 S 10.7800 3.7710 0.0 0 VAL=6
M  V30 3 C 13.0900 5.1046 0.0 0
M  V30 4 O 10.7800 5.3110 0.0 0
M  V30 5 O 10.7800 2.2310 0.0 0
M  V30 6 F 9.2400 6.4384 0.0 0
M  V30 7 O 14.6300 7.7721 0.0 0
M  V30 8 C 15.4000 9.1057 0.0 0
M  V30 9 Cl 6.1600 1.1037 0.0 0
M  V30 10 N 4.6200 3.7710 0.0 0
M  V30 11 O 19.2500 5.1046 0.0 0
M  V30 12 C 20.0200 6.4384 0.0 0
M  V30 13 N 1.5400 3.7710 0.0 0
M  V30 14 C 0.0000 3.7710 0.0 0
M  V30 15 C 2.3100 2.4374 0.0 0
M  V30 16 F 2.5773 9.2887 0.0 0
M  V30 17 F 0.8629 8.2988 0.0 0
M  V30 18 C 13.0900 2.4374 0.0 0
M  V30 19 N 14.6215 2.2764 0.0 0
M  V30 20 S 12.4637 1.0304 0.0 0
M  V30 21 C 14.9417 0.7700 0.0 0
M  V30 22 C 13.6081 0.0000 0.0 0
M  V30 23 C 9.2400 3.7710 0.0 0
M  V30 24 C 8.4700 5.1046 0.0 0
M  V30 25 C 8.4700 2.4374 0.0 0
M  V30 26 C 6.9300 5.1046 0.0 0
M  V30 27 C 6.9300 2.4374 0.0 0
M  V30 28 C 6.1600 3.7710 0.0 0
M  V30 29 C 14.6300 5.1046 0.0 0
M  V30 30 C 15.4000 6.4384 0.0 0
M  V30 31 C 15.4000 3.7710 0.0 0
M  V30 32 C 16.9400 6.4384 0.0 0
M  V30 33 C 16.9400 3.7710 0.0 0
M  V30 34 C 17.7100 5.1046 0.0 0
M  V30 35 C 3.8500 5.1046 0.0 0 CFG=1
M  V30 36 C 2.3100 5.1046 0.0 0 CFG=1
M  V30 37 C 4.6200 6.4384 0.0 0
M  V30 38 C 1.5400 6.4384 0.0 0
M  V30 39 C 3.8500 7.7721 0.0 0
M  V30 40 C 2.3100 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 23
M  V30 7 1 3 29
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 30
M  V30 11 1 9 27
M  V30 12 1 10 28
M  V30 13 1 35 10 CFG=3
M  V30 14 1 11 12
M  V30 15 1 11 34
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 36 13 CFG=1
M  V30 19 1 16 40
M  V30 20 1 17 40
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 35 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-chloro-4-[[(1S,2S)-2-(dimethylamino)-4,4-difluoroc...
C17H20ClF3N4O2S2.CH2O2
2222537-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5178 4.6201 0.0 0
M  V30 2 N 2.8504 3.0800 0.0 0
M  V30 3 C 1.5168 2.3100 0.0 0
M  V30 4 C 4.1841 2.3100 0.0 0
M  V30 5 F 0.9899 8.3773 0.0 0
M  V30 6 F 0.0000 6.6628 0.0 0
M  V30 7 Cl 8.1853 3.0800 0.0 0
M  V30 8 F 8.1853 9.2402 0.0 0
M  V30 9 S 10.8526 7.7001 0.0 0 VAL=6
M  V30 10 N 12.1864 8.4702 0.0 0
M  V30 11 O 10.0826 9.0338 0.0 0
M  V30 12 O 11.6226 6.3665 0.0 0
M  V30 13 C 4.1841 5.3901 0.0 0 CFG=1
M  V30 14 C 2.8504 4.6201 0.0 0 CFG=1
M  V30 15 C 4.1841 6.9301 0.0 0
M  V30 16 C 1.5168 5.3901 0.0 0
M  V30 17 C 2.8504 7.7001 0.0 0
M  V30 18 C 1.5168 6.9301 0.0 0
M  V30 19 C 6.8516 5.3901 0.0 0
M  V30 20 C 8.1853 4.6201 0.0 0
M  V30 21 C 6.8516 6.9301 0.0 0
M  V30 22 C 9.5189 5.3901 0.0 0
M  V30 23 C 8.1853 7.7001 0.0 0
M  V30 24 C 9.5189 6.9301 0.0 0
M  V30 25 C 13.5201 7.7001 0.0 0
M  V30 26 N 13.6810 6.1686 0.0 0
M  V30 27 S 14.9269 8.3265 0.0 0
M  V30 28 C 15.1875 5.8484 0.0 0
M  V30 29 C 15.9575 7.1821 0.0 0
M  V30 30 C 7.9788 0.0000 0.0 0
M  V30 31 O 6.6451 0.7700 0.0 0
M  V30 32 O 9.3124 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 14 2 CFG=1
M  V30 6 1 5 18
M  V30 7 1 6 18
M  V30 8 1 7 20
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 9 12
M  V30 13 1 9 24
M  V30 14 1 10 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222539-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222537-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-20681607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Heteroaryl benzenesulfonamides as voltage-dependent sodium channel
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutherlin, Daniel; McKerrall, Steven; Wilson, Michael Scott; Lai, Kwong
Wah; Bergeron, Philippe; Zhang, Birong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180105504 A1 2018-04-19

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminobenzonitrile
C7H6N2
2237-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Cyanophenyl)formamide
C8H6N2O
70531-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 0.0000 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2237-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70531-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37946224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isocyanides as Catalytic Electron Acceptors in the Visible Light Promoted
Oxidative Formation of Benzyl and Acyl Radicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Russo, Camilla; Donati, Greta; Giustiniano, Francesco; Amato, Jussara;
Marinelli, Luciana; Whitby, Richard John; Giustiniano, Mariateresa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(60), e202301852

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-5-[(2-cyclopropyl-2-oxoethyl)amino]-2-fluorobenzoate
C13H13BrFNO3
2243009-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 6.9302 0.0 0
M  V30 5 F 1.3337 1.5400 0.0 0
M  V30 6 Br 4.0012 0.0000 0.0 0
M  V30 7 N 6.6685 4.6201 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 O 9.3360 6.1601 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 11.4397 2.5164 0.0 0
M  V30 19 C 12.2097 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-5-[(2-cyclopropyl-2-oxoethyl)formylamino]-2-fluorobenzoate
C14H13BrFNO4
2243009-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 2.6675 0.0 0
M  V30 2 C 7.7001 4.0011 0.0 0
M  V30 3 C 7.7001 1.3338 0.0 0
M  V30 4 C 9.2401 4.0011 0.0 0
M  V30 5 O 6.9301 0.0000 0.0 0
M  V30 6 O 10.0101 2.6675 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 O 0.7700 5.3349 0.0 0
M  V30 9 O 3.0800 6.6686 0.0 0
M  V30 10 C 0.0000 6.6686 0.0 0
M  V30 11 Br 2.3100 0.0000 0.0 0
M  V30 12 F 0.7700 2.6675 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 4.6201 4.0011 0.0 0
M  V30 15 C 4.6201 1.3338 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 2.3100 2.6675 0.0 0
M  V30 19 C 10.0101 5.3349 0.0 0
M  V30 20 C 11.3438 6.1049 0.0 0
M  V30 21 C 10.0101 6.8749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 1 11 17
M  V30 13 1 12 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243009-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243009-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20428519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinyl based apoptosis signal-regulation kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Bohan; Dong, Qing; Hung, Gene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018151830 A1 2018-08-23

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[(2-cyclopropyl-2-oxoethyl)amino]-2,2-difluoro-1,3-benzodioxole-4-ca...
C14H13F2NO5
2243009-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.2538 0.0 0
M  V30 2 O 1.3337 7.7938 0.0 0
M  V30 3 O 0.0000 5.4838 0.0 0
M  V30 4 C 0.0000 8.5638 0.0 0
M  V30 5 F 2.4696 0.0000 0.0 0
M  V30 6 F 0.6847 1.0304 0.0 0
M  V30 7 N 6.6685 6.2538 0.0 0
M  V30 8 C 8.0023 5.4838 0.0 0
M  V30 9 C 9.3360 6.2538 0.0 0
M  V30 10 O 9.3360 7.7938 0.0 0
M  V30 11 C 2.6673 3.9437 0.0 0
M  V30 12 C 4.0012 3.1737 0.0 0
M  V30 13 C 2.6673 5.4838 0.0 0
M  V30 14 O 1.5229 2.9133 0.0 0
M  V30 15 C 5.3348 3.9437 0.0 0
M  V30 16 O 3.6810 1.6674 0.0 0
M  V30 17 C 4.0012 6.2538 0.0 0
M  V30 18 C 2.1493 1.5063 0.0 0
M  V30 19 C 5.3348 5.4838 0.0 0
M  V30 20 C 10.6697 5.4838 0.0 0
M  V30 21 C 11.4397 4.1501 0.0 0
M  V30 22 C 12.2097 5.4838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 18
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[(2-cyclopropyl-2-oxoethyl)formylamino]-2,2-difluoro-1,3-benzodioxol...
C15H13F2NO6
2243009-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8479 2.3100 0.0 0
M  V30 2 O 6.1817 1.5400 0.0 0
M  V30 3 O 3.5143 1.5400 0.0 0
M  V30 4 C 6.1817 0.0000 0.0 0
M  V30 5 F 0.0000 6.4204 0.0 0
M  V30 6 F 0.0000 4.3596 0.0 0
M  V30 7 N 7.5154 6.9300 0.0 0
M  V30 8 C 8.8490 6.1600 0.0 0
M  V30 9 C 7.5154 8.4700 0.0 0
M  V30 10 C 10.1827 6.9300 0.0 0
M  V30 11 O 6.1817 9.2400 0.0 0
M  V30 12 O 10.1827 8.4700 0.0 0
M  V30 13 C 3.5143 4.6200 0.0 0
M  V30 14 C 3.5143 6.1600 0.0 0
M  V30 15 C 4.8479 3.8500 0.0 0
M  V30 16 O 2.0497 4.1442 0.0 0
M  V30 17 C 4.8479 6.9300 0.0 0
M  V30 18 O 2.0497 6.6359 0.0 0
M  V30 19 C 6.1817 4.6200 0.0 0
M  V30 20 C 1.1445 5.3900 0.0 0
M  V30 21 C 6.1817 6.1600 0.0 0
M  V30 22 C 11.5165 6.1600 0.0 0
M  V30 23 C 12.2865 4.8264 0.0 0
M  V30 24 C 13.0565 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 21
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 10 22
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243009-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243009-49-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20428541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinyl based apoptosis signal-regulation kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Bohan; Dong, Qing; Hung, Gene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018151830 A1 2018-08-23

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-4-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-2H-pyran-4-amine
C17H27NO4
2243413-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1669 6.6685 0.0 0
M  V30 2 O 8.7869 4.0011 0.0 0
M  V30 3 C 9.5569 5.3347 0.0 0
M  V30 4 C 11.0969 5.3347 0.0 0
M  V30 5 C 11.8669 6.6685 0.0 0
M  V30 6 O 13.4069 6.6685 0.0 0
M  V30 7 C 14.1769 8.0021 0.0 0
M  V30 8 N 2.8943 5.1519 0.0 0
M  V30 9 O 7.2469 1.3338 0.0 0
M  V30 10 C 6.4769 0.0000 0.0 0
M  V30 11 C 4.9369 5.3347 0.0 0
M  V30 12 C 6.4769 5.3347 0.0 0
M  V30 13 C 4.1669 4.0011 0.0 0
M  V30 14 C 7.2469 4.0011 0.0 0
M  V30 15 C 4.9369 2.6674 0.0 0
M  V30 16 C 6.4769 2.6674 0.0 0
M  V30 17 C 2.6269 6.6685 0.0 0
M  V30 18 C 2.8943 8.1851 0.0 0
M  V30 19 C 1.1798 6.1417 0.0 0
M  V30 20 C 1.7146 9.1750 0.0 0
M  V30 21 C 0.0000 7.1316 0.0 0
M  V30 22 O 0.2675 8.6482 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[Tetrahydro-4-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-2H-pyran-4-yl]...
C18H27NO5
2243413-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1669 6.6685 0.0 0
M  V30 2 N 2.8943 8.1851 0.0 0
M  V30 3 C 1.7146 9.1750 0.0 0
M  V30 4 O 1.9820 10.6916 0.0 0
M  V30 5 O 8.7869 4.0011 0.0 0
M  V30 6 C 9.5569 5.3347 0.0 0
M  V30 7 C 11.0969 5.3347 0.0 0
M  V30 8 C 11.8669 6.6685 0.0 0
M  V30 9 O 13.4069 6.6685 0.0 0
M  V30 10 C 14.1769 8.0021 0.0 0
M  V30 11 O 7.2469 1.3338 0.0 0
M  V30 12 C 6.4769 0.0000 0.0 0
M  V30 13 C 2.6269 6.6685 0.0 0
M  V30 14 C 2.8943 5.1519 0.0 0
M  V30 15 C 1.1798 7.1952 0.0 0
M  V30 16 C 1.7146 4.1620 0.0 0
M  V30 17 C 0.0000 6.2053 0.0 0
M  V30 18 O 0.2675 4.6887 0.0 0
M  V30 19 C 4.9369 5.3347 0.0 0
M  V30 20 C 6.4769 5.3347 0.0 0
M  V30 21 C 4.1669 4.0011 0.0 0
M  V30 22 C 7.2469 4.0011 0.0 0
M  V30 23 C 4.9369 2.6674 0.0 0
M  V30 24 C 6.4769 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 2 3 4
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243413-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243413-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20474032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolizinones as antivirals for inhibition of HBe and HBs
antigens and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catalano, John G.; Dickson, Hamilton D.; Kazmierski, Wieslaw Mieczyslaw;
Leivers, Martin R.; Weatherhead, John Gordon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018154466 A1 2018-08-30

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[4-Methoxy-3-(phenylmethoxy)phenyl]methyl]-3,3-dimethylcyclobutanamine
C21H27NO2
2243416-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 N 3.0800 5.1285 0.0 0
M  V30 3 O 9.2400 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 C 0.0000 8.2085 0.0 0
M  V30 6 C 1.5400 9.7485 0.0 0
M  V30 7 O 7.7000 1.3338 0.0 0
M  V30 8 C 6.9300 0.0000 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 3.0800 8.2085 0.0 0
M  V30 17 C 1.5400 6.6685 0.0 0
M  V30 18 C 1.5400 8.2085 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 12.3200 4.0011 0.0 0
M  V30 21 C 12.3200 6.6685 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 23 C 13.8600 6.6685 0.0 0
M  V30 24 C 14.6300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 19
M  V30 7 1 5 18
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 7 14
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-Methoxy-3-(phenylmethoxy)phenyl]methyl]-3,3-dimethylcyclobutyl]forma...
C22H27NO3
2243416-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.8500 0.0 0
M  V30 2 N 3.0800 2.3100 0.0 0
M  V30 3 C 1.7464 1.5400 0.0 0
M  V30 4 O 1.7464 0.0000 0.0 0
M  V30 5 C 1.5400 6.9300 0.0 0
M  V30 6 C 0.0000 5.3900 0.0 0
M  V30 7 O 9.2400 6.5174 0.0 0
M  V30 8 C 10.0100 5.1838 0.0 0
M  V30 9 O 7.7000 9.1847 0.0 0
M  V30 10 C 6.9300 10.5185 0.0 0
M  V30 11 C 3.0800 3.8500 0.0 0
M  V30 12 C 1.5400 3.8500 0.0 0
M  V30 13 C 3.0800 5.3900 0.0 0
M  V30 14 C 1.5400 5.3900 0.0 0
M  V30 15 C 5.3900 5.1838 0.0 0
M  V30 16 C 6.9300 5.1838 0.0 0
M  V30 17 C 4.6200 6.5174 0.0 0
M  V30 18 C 7.7000 6.5174 0.0 0
M  V30 19 C 5.3900 7.8511 0.0 0
M  V30 20 C 6.9300 7.8511 0.0 0
M  V30 21 C 11.5500 5.1838 0.0 0
M  V30 22 C 12.3200 6.5174 0.0 0
M  V30 23 C 12.3200 3.8500 0.0 0
M  V30 24 C 13.8600 6.5174 0.0 0
M  V30 25 C 13.8600 3.8500 0.0 0
M  V30 26 C 14.6300 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 2 3 4
M  V30 6 1 5 14
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 21
M  V30 11 1 9 10
M  V30 12 1 9 20
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243416-51-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243416-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20474305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolizinones as antivirals for inhibition of HBe and HBs
antigens and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catalano, John G.; Dickson, Hamilton D.; Kazmierski, Wieslaw Mieczyslaw;
Leivers, Martin R.; Weatherhead, John Gordon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018154466 A1 2018-08-30

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-amino-3-methylbutyl)-2-(3-methoxypropoxy)benzoate
C17H27NO4
2253886-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 5.3347 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 10.7800 6.6684 0.0 0
M  V30 4 C 11.5500 8.0021 0.0 0
M  V30 5 O 13.0900 8.0021 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 O 6.1600 1.3336 0.0 0
M  V30 9 O 8.4700 2.6673 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 C 3.8500 8.0021 0.0 0
M  V30 12 C 2.3100 8.0021 0.0 0
M  V30 13 C 1.5400 9.3358 0.0 0
M  V30 14 N 1.5400 6.6684 0.0 0
M  V30 15 C 0.0000 9.3358 0.0 0
M  V30 16 C 2.3100 10.6694 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 3.8500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(3-methoxypropoxy)benzoate
C18H27NO5
2253886-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 O 4.0010 1.5400 0.0 0
M  V30 3 O 6.6684 1.5400 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 C 9.3357 4.6201 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0
M  V30 8 C 12.0032 4.6201 0.0 0
M  V30 9 O 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6201 0.0 0
M  V30 11 C 5.3348 8.4701 0.0 0
M  V30 12 C 4.0010 9.2401 0.0 0
M  V30 13 N 2.6673 8.4701 0.0 0
M  V30 14 C 4.0010 10.7801 0.0 0
M  V30 15 C 1.3337 9.2401 0.0 0
M  V30 16 C 5.3348 11.5501 0.0 0
M  V30 17 C 2.6673 11.5501 0.0 0
M  V30 18 O 0.0000 8.4701 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 6.6684 4.6201 0.0 0
M  V30 21 C 4.0010 4.6201 0.0 0
M  V30 22 C 6.6684 6.1601 0.0 0
M  V30 23 C 4.0010 6.1601 0.0 0
M  V30 24 C 5.3348 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24132053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of DHQ-based chemical biology probe to profile cellular
targets for HBV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Qing; Huang, Jianzhou; Chow, Hoi Yee; Wang, Jinzheng; Zhang,
Yingjun; Fung, Yi Man Eva; Ren, Qingyun; Li, Xuechen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(23), 127615

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-amino-3-methylbutyl)-2-(3-methoxypropoxy)benzoate
C17H27NO4
2253886-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 5.3347 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 10.7800 6.6684 0.0 0
M  V30 4 C 11.5500 8.0021 0.0 0
M  V30 5 O 13.0900 8.0021 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 O 6.1600 1.3336 0.0 0
M  V30 9 O 8.4700 2.6673 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 C 3.8500 8.0021 0.0 0
M  V30 12 C 2.3100 8.0021 0.0 0
M  V30 13 C 1.5400 9.3358 0.0 0
M  V30 14 N 1.5400 6.6684 0.0 0
M  V30 15 C 0.0000 9.3358 0.0 0
M  V30 16 C 2.3100 10.6694 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 3.8500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(3-methoxypropoxy)benzoate
C18H27NO5
2253886-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 O 4.0010 1.5400 0.0 0
M  V30 3 O 6.6684 1.5400 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 C 9.3357 4.6201 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0
M  V30 8 C 12.0032 4.6201 0.0 0
M  V30 9 O 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6201 0.0 0
M  V30 11 C 5.3348 8.4701 0.0 0
M  V30 12 C 4.0010 9.2401 0.0 0
M  V30 13 N 2.6673 8.4701 0.0 0
M  V30 14 C 4.0010 10.7801 0.0 0
M  V30 15 C 1.3337 9.2401 0.0 0
M  V30 16 C 5.3348 11.5501 0.0 0
M  V30 17 C 2.6673 11.5501 0.0 0
M  V30 18 O 0.0000 8.4701 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 6.6684 4.6201 0.0 0
M  V30 21 C 4.0010 4.6201 0.0 0
M  V30 22 C 6.6684 6.1601 0.0 0
M  V30 23 C 4.0010 6.1601 0.0 0
M  V30 24 C 5.3348 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-amino-3-methylbutyl)-2-(3-methoxypropoxy)benzoate
C17H27NO4
2253886-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 5.3347 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 10.7800 6.6684 0.0 0
M  V30 4 C 11.5500 8.0021 0.0 0
M  V30 5 O 13.0900 8.0021 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 O 6.1600 1.3336 0.0 0
M  V30 9 O 8.4700 2.6673 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 C 3.8500 8.0021 0.0 0
M  V30 12 C 2.3100 8.0021 0.0 0
M  V30 13 C 1.5400 9.3358 0.0 0
M  V30 14 N 1.5400 6.6684 0.0 0
M  V30 15 C 0.0000 9.3358 0.0 0
M  V30 16 C 2.3100 10.6694 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 3.8500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(3-methoxypropoxy)benzoate
C18H27NO5
2253886-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 O 4.0010 1.5400 0.0 0
M  V30 3 O 6.6684 1.5400 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 C 9.3357 4.6201 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0
M  V30 8 C 12.0032 4.6201 0.0 0
M  V30 9 O 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6201 0.0 0
M  V30 11 C 5.3348 8.4701 0.0 0
M  V30 12 C 4.0010 9.2401 0.0 0
M  V30 13 N 2.6673 8.4701 0.0 0
M  V30 14 C 4.0010 10.7801 0.0 0
M  V30 15 C 1.3337 9.2401 0.0 0
M  V30 16 C 5.3348 11.5501 0.0 0
M  V30 17 C 2.6673 11.5501 0.0 0
M  V30 18 O 0.0000 8.4701 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 6.6684 4.6201 0.0 0
M  V30 21 C 4.0010 4.6201 0.0 0
M  V30 22 C 6.6684 6.1601 0.0 0
M  V30 23 C 4.0010 6.1601 0.0 0
M  V30 24 C 5.3348 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-(2-amino-3-methylbutyl)-2-(3-methoxypropoxy)benzoate
C23H31NO4
2253886-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 9.3360 0.0 0
M  V30 2 C 11.5503 9.3360 0.0 0
M  V30 3 C 12.3203 10.6697 0.0 0
M  V30 4 C 13.8603 10.6697 0.0 0
M  V30 5 O 14.6303 12.0033 0.0 0
M  V30 6 C 16.1704 12.0033 0.0 0
M  V30 7 C 6.9302 9.3360 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 7.7002 10.6697 0.0 0
M  V30 10 C 4.6201 10.6697 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 C 10.0102 1.3337 0.0 0
M  V30 14 N 7.7002 2.6673 0.0 0
M  V30 15 C 11.5503 1.3337 0.0 0
M  V30 16 C 9.2402 0.0000 0.0 0
M  V30 17 C 9.2402 8.0022 0.0 0
M  V30 18 C 7.7002 8.0022 0.0 0
M  V30 19 C 10.0102 6.6685 0.0 0
M  V30 20 C 6.9302 6.6685 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 7.7002 5.3348 0.0 0
M  V30 23 C 3.0801 10.6697 0.0 0
M  V30 24 C 2.3101 9.3360 0.0 0
M  V30 25 C 2.3101 12.0033 0.0 0
M  V30 26 C 0.7700 9.3360 0.0 0
M  V30 27 C 0.7700 12.0033 0.0 0
M  V30 28 C 0.0000 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 1 11 21
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[2-(formylamino)-3-methylbutyl]-2-(3-methoxypropoxy)benzoate
C24H31NO5
2253886-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 9.3360 0.0 0
M  V30 2 C 11.5503 9.3360 0.0 0
M  V30 3 C 12.3203 10.6697 0.0 0
M  V30 4 C 13.8603 10.6697 0.0 0
M  V30 5 O 14.6303 12.0033 0.0 0
M  V30 6 C 16.1704 12.0033 0.0 0
M  V30 7 C 6.9302 9.3360 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 7.7002 10.6697 0.0 0
M  V30 10 C 4.6201 10.6697 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 N 7.7002 2.6673 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 C 11.5503 1.3337 0.0 0
M  V30 17 C 9.2402 0.0000 0.0 0
M  V30 18 O 5.3901 1.3337 0.0 0
M  V30 19 C 9.2402 8.0022 0.0 0
M  V30 20 C 7.7002 8.0022 0.0 0
M  V30 21 C 10.0102 6.6685 0.0 0
M  V30 22 C 6.9302 6.6685 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 7.7002 5.3348 0.0 0
M  V30 25 C 3.0801 10.6697 0.0 0
M  V30 26 C 2.3101 9.3360 0.0 0
M  V30 27 C 2.3101 12.0033 0.0 0
M  V30 28 C 0.7700 9.3360 0.0 0
M  V30 29 C 0.7700 12.0033 0.0 0
M  V30 30 C 0.0000 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-(2-amino-3-methylbutyl)-2-(3-methoxypropoxy)benzoate
C23H31NO4
2253886-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 9.3360 0.0 0
M  V30 2 C 11.5503 9.3360 0.0 0
M  V30 3 C 12.3203 10.6697 0.0 0
M  V30 4 C 13.8603 10.6697 0.0 0
M  V30 5 O 14.6303 12.0033 0.0 0
M  V30 6 C 16.1704 12.0033 0.0 0
M  V30 7 C 6.9302 9.3360 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 7.7002 10.6697 0.0 0
M  V30 10 C 4.6201 10.6697 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 C 10.0102 1.3337 0.0 0
M  V30 14 N 7.7002 2.6673 0.0 0
M  V30 15 C 11.5503 1.3337 0.0 0
M  V30 16 C 9.2402 0.0000 0.0 0
M  V30 17 C 9.2402 8.0022 0.0 0
M  V30 18 C 7.7002 8.0022 0.0 0
M  V30 19 C 10.0102 6.6685 0.0 0
M  V30 20 C 6.9302 6.6685 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 7.7002 5.3348 0.0 0
M  V30 23 C 3.0801 10.6697 0.0 0
M  V30 24 C 2.3101 9.3360 0.0 0
M  V30 25 C 2.3101 12.0033 0.0 0
M  V30 26 C 0.7700 9.3360 0.0 0
M  V30 27 C 0.7700 12.0033 0.0 0
M  V30 28 C 0.0000 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 1 11 21
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[2-(formylamino)-3-methylbutyl]-2-(3-methoxypropoxy)benzoate
C24H31NO5
2253886-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 9.3360 0.0 0
M  V30 2 C 11.5503 9.3360 0.0 0
M  V30 3 C 12.3203 10.6697 0.0 0
M  V30 4 C 13.8603 10.6697 0.0 0
M  V30 5 O 14.6303 12.0033 0.0 0
M  V30 6 C 16.1704 12.0033 0.0 0
M  V30 7 C 6.9302 9.3360 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 7.7002 10.6697 0.0 0
M  V30 10 C 4.6201 10.6697 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 N 7.7002 2.6673 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 C 11.5503 1.3337 0.0 0
M  V30 17 C 9.2402 0.0000 0.0 0
M  V30 18 O 5.3901 1.3337 0.0 0
M  V30 19 C 9.2402 8.0022 0.0 0
M  V30 20 C 7.7002 8.0022 0.0 0
M  V30 21 C 10.0102 6.6685 0.0 0
M  V30 22 C 6.9302 6.6685 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 7.7002 5.3348 0.0 0
M  V30 25 C 3.0801 10.6697 0.0 0
M  V30 26 C 2.3101 9.3360 0.0 0
M  V30 27 C 2.3101 12.0033 0.0 0
M  V30 28 C 0.7700 9.3360 0.0 0
M  V30 29 C 0.7700 12.0033 0.0 0
M  V30 30 C 0.0000 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[Bis(phenylmethyl)amino]-3-(3-methoxypropoxy)-α-(1-methylethyl)benzeneethan...
C29H38N2O2
2253886-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 9.2402 0.0 0
M  V30 2 C 4.0010 8.4702 0.0 0
M  V30 3 C 5.3348 10.7802 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 O 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 10.6697 6.1601 0.0 0
M  V30 11 C 12.0033 6.9302 0.0 0
M  V30 12 C 13.3370 6.1601 0.0 0
M  V30 13 N 12.0033 8.4702 0.0 0
M  V30 14 C 14.6707 6.9302 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 6.6685 8.4702 0.0 0
M  V30 17 C 6.6685 6.9302 0.0 0
M  V30 18 C 8.0022 9.2402 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 9.3358 8.4702 0.0 0
M  V30 21 C 9.3358 6.9302 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 2.6673 10.7802 0.0 0
M  V30 24 C 1.3337 8.4702 0.0 0
M  V30 25 C 1.3337 11.5503 0.0 0
M  V30 26 C 0.0000 9.2402 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 6.6685 11.5503 0.0 0
M  V30 29 C 8.0022 10.7802 0.0 0
M  V30 30 C 6.6685 13.0903 0.0 0
M  V30 31 C 9.3358 11.5503 0.0 0
M  V30 32 C 8.0022 13.8603 0.0 0
M  V30 33 C 9.3358 13.0903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 28
M  V30 6 1 4 5
M  V30 7 1 4 17
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 21
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-[Bis(phenylmethyl)amino]-3-(3-methoxypropoxy)phenyl]methyl]-2-methyl...
C30H38N2O3
2253886-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 9.2402 0.0 0
M  V30 2 C 4.0010 8.4702 0.0 0
M  V30 3 C 5.3348 10.7802 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 O 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 10.6697 6.1601 0.0 0
M  V30 11 C 12.0033 6.9302 0.0 0
M  V30 12 N 12.0033 8.4702 0.0 0
M  V30 13 C 13.3370 6.1601 0.0 0
M  V30 14 C 13.3370 9.2402 0.0 0
M  V30 15 C 14.6707 6.9302 0.0 0
M  V30 16 C 13.3370 4.6201 0.0 0
M  V30 17 O 13.3370 10.7802 0.0 0
M  V30 18 C 6.6685 8.4702 0.0 0
M  V30 19 C 6.6685 6.9302 0.0 0
M  V30 20 C 8.0022 9.2402 0.0 0
M  V30 21 C 8.0022 6.1601 0.0 0
M  V30 22 C 9.3358 8.4702 0.0 0
M  V30 23 C 9.3358 6.9302 0.0 0
M  V30 24 C 2.6673 9.2402 0.0 0
M  V30 25 C 2.6673 10.7802 0.0 0
M  V30 26 C 1.3337 8.4702 0.0 0
M  V30 27 C 1.3337 11.5503 0.0 0
M  V30 28 C 0.0000 9.2402 0.0 0
M  V30 29 C 0.0000 10.7802 0.0 0
M  V30 30 C 6.6685 11.5503 0.0 0
M  V30 31 C 8.0022 10.7802 0.0 0
M  V30 32 C 6.6685 13.0903 0.0 0
M  V30 33 C 9.3358 11.5503 0.0 0
M  V30 34 C 8.0022 13.8603 0.0 0
M  V30 35 C 9.3358 13.0903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 24
M  V30 5 1 3 30
M  V30 6 1 4 5
M  V30 7 1 4 19
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 23
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-85-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[Bis(phenylmethyl)amino]-3-(3-methoxypropoxy)-α-(1-methylethyl)benzeneethan...
C29H38N2O2
2253886-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 9.2402 0.0 0
M  V30 2 C 4.0010 8.4702 0.0 0
M  V30 3 C 5.3348 10.7802 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 O 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 10.6697 6.1601 0.0 0
M  V30 11 C 12.0033 6.9302 0.0 0
M  V30 12 C 13.3370 6.1601 0.0 0
M  V30 13 N 12.0033 8.4702 0.0 0
M  V30 14 C 14.6707 6.9302 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 6.6685 8.4702 0.0 0
M  V30 17 C 6.6685 6.9302 0.0 0
M  V30 18 C 8.0022 9.2402 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 9.3358 8.4702 0.0 0
M  V30 21 C 9.3358 6.9302 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 2.6673 10.7802 0.0 0
M  V30 24 C 1.3337 8.4702 0.0 0
M  V30 25 C 1.3337 11.5503 0.0 0
M  V30 26 C 0.0000 9.2402 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 6.6685 11.5503 0.0 0
M  V30 29 C 8.0022 10.7802 0.0 0
M  V30 30 C 6.6685 13.0903 0.0 0
M  V30 31 C 9.3358 11.5503 0.0 0
M  V30 32 C 8.0022 13.8603 0.0 0
M  V30 33 C 9.3358 13.0903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 28
M  V30 6 1 4 5
M  V30 7 1 4 17
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 21
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-[Bis(phenylmethyl)amino]-3-(3-methoxypropoxy)phenyl]methyl]-2-methyl...
C30H38N2O3
2253886-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 9.2402 0.0 0
M  V30 2 C 4.0010 8.4702 0.0 0
M  V30 3 C 5.3348 10.7802 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 O 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 10.6697 6.1601 0.0 0
M  V30 11 C 12.0033 6.9302 0.0 0
M  V30 12 N 12.0033 8.4702 0.0 0
M  V30 13 C 13.3370 6.1601 0.0 0
M  V30 14 C 13.3370 9.2402 0.0 0
M  V30 15 C 14.6707 6.9302 0.0 0
M  V30 16 C 13.3370 4.6201 0.0 0
M  V30 17 O 13.3370 10.7802 0.0 0
M  V30 18 C 6.6685 8.4702 0.0 0
M  V30 19 C 6.6685 6.9302 0.0 0
M  V30 20 C 8.0022 9.2402 0.0 0
M  V30 21 C 8.0022 6.1601 0.0 0
M  V30 22 C 9.3358 8.4702 0.0 0
M  V30 23 C 9.3358 6.9302 0.0 0
M  V30 24 C 2.6673 9.2402 0.0 0
M  V30 25 C 2.6673 10.7802 0.0 0
M  V30 26 C 1.3337 8.4702 0.0 0
M  V30 27 C 1.3337 11.5503 0.0 0
M  V30 28 C 0.0000 9.2402 0.0 0
M  V30 29 C 0.0000 10.7802 0.0 0
M  V30 30 C 6.6685 11.5503 0.0 0
M  V30 31 C 8.0022 10.7802 0.0 0
M  V30 32 C 6.6685 13.0903 0.0 0
M  V30 33 C 9.3358 11.5503 0.0 0
M  V30 34 C 8.0022 13.8603 0.0 0
M  V30 35 C 9.3358 13.0903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 24
M  V30 5 1 3 30
M  V30 6 1 4 5
M  V30 7 1 4 19
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 23
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253886-85-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253886-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methoxypropoxy)-α-(1-methylethyl)-4-(2-thiazolyl)benzeneethanamine
C18H26N2O2S
2253887-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 5.1047 0.0 0
M  V30 2 C 9.2402 6.4384 0.0 0
M  V30 3 C 10.7802 6.4384 0.0 0
M  V30 4 C 11.5502 7.7722 0.0 0
M  V30 5 O 13.0902 7.7722 0.0 0
M  V30 6 C 13.8603 9.1059 0.0 0
M  V30 7 C 3.8501 7.7722 0.0 0
M  V30 8 C 2.3100 7.7722 0.0 0
M  V30 9 C 1.5400 9.1059 0.0 0
M  V30 10 N 1.5400 6.4384 0.0 0
M  V30 11 C 0.0000 9.1059 0.0 0
M  V30 12 C 2.3100 10.4395 0.0 0
M  V30 13 C 6.1601 3.7711 0.0 0
M  V30 14 C 6.9301 5.1047 0.0 0
M  V30 15 C 4.6201 3.7711 0.0 0
M  V30 16 C 6.1601 6.4384 0.0 0
M  V30 17 C 3.8501 5.1047 0.0 0
M  V30 18 C 4.6201 6.4384 0.0 0
M  V30 19 C 6.9301 2.4374 0.0 0
M  V30 20 N 6.3038 1.0304 0.0 0
M  V30 21 S 8.4617 2.2763 0.0 0
M  V30 22 C 7.4482 0.0000 0.0 0
M  V30 23 C 8.7819 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[3-(3-Methoxypropoxy)-4-(2-thiazolyl)phenyl]methyl]-2-methylpropyl]form...
C19H26N2O3S
2253887-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 7.7001 0.0 0
M  V30 2 C 9.3358 6.9301 0.0 0
M  V30 3 C 10.6696 7.7001 0.0 0
M  V30 4 C 12.0032 6.9301 0.0 0
M  V30 5 O 13.3369 7.7001 0.0 0
M  V30 6 C 14.6705 6.9301 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 4.0010 2.3100 0.0 0
M  V30 9 N 2.6673 3.0800 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 O 0.0000 3.0800 0.0 0
M  V30 15 C 5.3348 7.7001 0.0 0
M  V30 16 C 6.6684 6.9301 0.0 0
M  V30 17 C 4.0010 6.9301 0.0 0
M  V30 18 C 6.6684 5.3901 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 5.3348 9.2401 0.0 0
M  V30 22 N 4.0888 10.1453 0.0 0
M  V30 23 S 6.5807 10.1453 0.0 0
M  V30 24 C 4.5648 11.6099 0.0 0
M  V30 25 C 6.1048 11.6099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methoxypropoxy)-α-(1-methylethyl)-4-(2-thiazolyl)benzeneethanamine
C18H26N2O2S
2253887-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 5.1047 0.0 0
M  V30 2 C 9.2402 6.4384 0.0 0
M  V30 3 C 10.7802 6.4384 0.0 0
M  V30 4 C 11.5502 7.7722 0.0 0
M  V30 5 O 13.0902 7.7722 0.0 0
M  V30 6 C 13.8603 9.1059 0.0 0
M  V30 7 C 3.8501 7.7722 0.0 0
M  V30 8 C 2.3100 7.7722 0.0 0
M  V30 9 C 1.5400 9.1059 0.0 0
M  V30 10 N 1.5400 6.4384 0.0 0
M  V30 11 C 0.0000 9.1059 0.0 0
M  V30 12 C 2.3100 10.4395 0.0 0
M  V30 13 C 6.1601 3.7711 0.0 0
M  V30 14 C 6.9301 5.1047 0.0 0
M  V30 15 C 4.6201 3.7711 0.0 0
M  V30 16 C 6.1601 6.4384 0.0 0
M  V30 17 C 3.8501 5.1047 0.0 0
M  V30 18 C 4.6201 6.4384 0.0 0
M  V30 19 C 6.9301 2.4374 0.0 0
M  V30 20 N 6.3038 1.0304 0.0 0
M  V30 21 S 8.4617 2.2763 0.0 0
M  V30 22 C 7.4482 0.0000 0.0 0
M  V30 23 C 8.7819 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[3-(3-Methoxypropoxy)-4-(2-thiazolyl)phenyl]methyl]-2-methylpropyl]form...
C19H26N2O3S
2253887-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 7.7001 0.0 0
M  V30 2 C 9.3358 6.9301 0.0 0
M  V30 3 C 10.6696 7.7001 0.0 0
M  V30 4 C 12.0032 6.9301 0.0 0
M  V30 5 O 13.3369 7.7001 0.0 0
M  V30 6 C 14.6705 6.9301 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 4.0010 2.3100 0.0 0
M  V30 9 N 2.6673 3.0800 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 O 0.0000 3.0800 0.0 0
M  V30 15 C 5.3348 7.7001 0.0 0
M  V30 16 C 6.6684 6.9301 0.0 0
M  V30 17 C 4.0010 6.9301 0.0 0
M  V30 18 C 6.6684 5.3901 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 5.3348 9.2401 0.0 0
M  V30 22 N 4.0888 10.1453 0.0 0
M  V30 23 S 6.5807 10.1453 0.0 0
M  V30 24 C 4.5648 11.6099 0.0 0
M  V30 25 C 6.1048 11.6099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(2-amino-3-methylbutyl)-2-(1-pyrrolidinyl)-, methyl ester
C17H26N2O2
2253887-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 C 10.4396 5.3901 0.0 0
M  V30 8 N 9.1059 3.0801 0.0 0
M  V30 9 C 11.7733 4.6201 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 3.7711 4.6201 0.0 0
M  V30 12 C 3.7711 3.0801 0.0 0
M  V30 13 C 5.1047 5.3901 0.0 0
M  V30 14 C 5.1047 2.3101 0.0 0
M  V30 15 C 6.4384 4.6201 0.0 0
M  V30 16 C 6.4384 3.0801 0.0 0
M  V30 17 N 2.4373 5.3901 0.0 0
M  V30 18 C 2.2763 6.9217 0.0 0
M  V30 19 C 1.0304 4.7636 0.0 0
M  V30 20 C 0.7700 7.2419 0.0 0
M  V30 21 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(1-pyrrolidinyl)benzoate
C18H26N2O3
2253887-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 N 9.1059 3.0801 0.0 0
M  V30 8 C 10.4396 5.3901 0.0 0
M  V30 9 C 10.4396 2.3101 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 11.7733 4.6201 0.0 0
M  V30 12 O 10.4396 0.7700 0.0 0
M  V30 13 C 3.7711 4.6201 0.0 0
M  V30 14 C 3.7711 3.0801 0.0 0
M  V30 15 C 5.1047 5.3901 0.0 0
M  V30 16 C 5.1047 2.3101 0.0 0
M  V30 17 C 6.4384 4.6201 0.0 0
M  V30 18 C 6.4384 3.0801 0.0 0
M  V30 19 N 2.4373 5.3901 0.0 0
M  V30 20 C 2.2763 6.9217 0.0 0
M  V30 21 C 1.0304 4.7636 0.0 0
M  V30 22 C 0.7700 7.2419 0.0 0
M  V30 23 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24132483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of DHQ-based chemical biology probe to profile cellular
targets for HBV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Qing; Huang, Jianzhou; Chow, Hoi Yee; Wang, Jinzheng; Zhang,
Yingjun; Fung, Yi Man Eva; Ren, Qingyun; Li, Xuechen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(23), 127615

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(2-amino-3-methylbutyl)-2-(1-pyrrolidinyl)-, methyl ester
C17H26N2O2
2253887-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 C 10.4396 5.3901 0.0 0
M  V30 8 N 9.1059 3.0801 0.0 0
M  V30 9 C 11.7733 4.6201 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 3.7711 4.6201 0.0 0
M  V30 12 C 3.7711 3.0801 0.0 0
M  V30 13 C 5.1047 5.3901 0.0 0
M  V30 14 C 5.1047 2.3101 0.0 0
M  V30 15 C 6.4384 4.6201 0.0 0
M  V30 16 C 6.4384 3.0801 0.0 0
M  V30 17 N 2.4373 5.3901 0.0 0
M  V30 18 C 2.2763 6.9217 0.0 0
M  V30 19 C 1.0304 4.7636 0.0 0
M  V30 20 C 0.7700 7.2419 0.0 0
M  V30 21 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(1-pyrrolidinyl)benzoate
C18H26N2O3
2253887-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 N 9.1059 3.0801 0.0 0
M  V30 8 C 10.4396 5.3901 0.0 0
M  V30 9 C 10.4396 2.3101 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 11.7733 4.6201 0.0 0
M  V30 12 O 10.4396 0.7700 0.0 0
M  V30 13 C 3.7711 4.6201 0.0 0
M  V30 14 C 3.7711 3.0801 0.0 0
M  V30 15 C 5.1047 5.3901 0.0 0
M  V30 16 C 5.1047 2.3101 0.0 0
M  V30 17 C 6.4384 4.6201 0.0 0
M  V30 18 C 6.4384 3.0801 0.0 0
M  V30 19 N 2.4373 5.3901 0.0 0
M  V30 20 C 2.2763 6.9217 0.0 0
M  V30 21 C 1.0304 4.7636 0.0 0
M  V30 22 C 0.7700 7.2419 0.0 0
M  V30 23 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786375
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(2-amino-3-methylbutyl)-2-(1-pyrrolidinyl)-, methyl ester
C17H26N2O2
2253887-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 C 10.4396 5.3901 0.0 0
M  V30 8 N 9.1059 3.0801 0.0 0
M  V30 9 C 11.7733 4.6201 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 3.7711 4.6201 0.0 0
M  V30 12 C 3.7711 3.0801 0.0 0
M  V30 13 C 5.1047 5.3901 0.0 0
M  V30 14 C 5.1047 2.3101 0.0 0
M  V30 15 C 6.4384 4.6201 0.0 0
M  V30 16 C 6.4384 3.0801 0.0 0
M  V30 17 N 2.4373 5.3901 0.0 0
M  V30 18 C 2.2763 6.9217 0.0 0
M  V30 19 C 1.0304 4.7636 0.0 0
M  V30 20 C 0.7700 7.2419 0.0 0
M  V30 21 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-(formylamino)-3-methylbutyl]-2-(1-pyrrolidinyl)benzoate
C18H26N2O3
2253887-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4373 2.3101 0.0 0
M  V30 2 O 2.4373 0.7700 0.0 0
M  V30 3 O 1.1036 3.0801 0.0 0
M  V30 4 C 1.1036 0.0000 0.0 0
M  V30 5 C 7.7722 5.3901 0.0 0
M  V30 6 C 9.1059 4.6201 0.0 0
M  V30 7 N 9.1059 3.0801 0.0 0
M  V30 8 C 10.4396 5.3901 0.0 0
M  V30 9 C 10.4396 2.3101 0.0 0
M  V30 10 C 10.4396 6.9302 0.0 0
M  V30 11 C 11.7733 4.6201 0.0 0
M  V30 12 O 10.4396 0.7700 0.0 0
M  V30 13 C 3.7711 4.6201 0.0 0
M  V30 14 C 3.7711 3.0801 0.0 0
M  V30 15 C 5.1047 5.3901 0.0 0
M  V30 16 C 5.1047 2.3101 0.0 0
M  V30 17 C 6.4384 4.6201 0.0 0
M  V30 18 C 6.4384 3.0801 0.0 0
M  V30 19 N 2.4373 5.3901 0.0 0
M  V30 20 C 2.2763 6.9217 0.0 0
M  V30 21 C 1.0304 4.7636 0.0 0
M  V30 22 C 0.7700 7.2419 0.0 0
M  V30 23 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[3-[[[(1α,1′′R,3′′S,4α)-4-[4-[2-(4-morpholinyl)ethoxy]phe...
C37H55N3O8
2260870-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 22.4250 3.0893 0.0 0
M  V30 2 N 23.8753 3.6074 0.0 0
M  V30 3 O 22.1486 1.5742 0.0 0
M  V30 4 C 25.0491 2.6104 0.0 0
M  V30 5 C 26.4994 3.1284 0.0 0
M  V30 6 C 27.6732 2.1316 0.0 0
M  V30 7 N 29.1234 2.6496 0.0 0
M  V30 8 C 30.2972 1.6528 0.0 0
M  V30 9 O 31.7475 2.1708 0.0 0
M  V30 10 O 30.0208 0.1377 0.0 0
M  V30 11 C 32.9213 1.1738 0.0 0
M  V30 12 C 31.9244 0.0000 0.0 0
M  V30 13 C 34.0951 0.1770 0.0 0
M  V30 14 C 33.9183 2.3476 0.0 0
M  V30 15 O 6.6685 9.8470 0.0 0
M  V30 16 C 5.3348 9.0770 0.0 0
M  V30 17 C 4.0010 9.8470 0.0 0
M  V30 18 C 17.1081 4.7088 0.0 0
M  V30 19 C 18.7722 4.3937 0.0 0 CFG=2
M  V30 20 C 18.5257 5.3023 0.0 0 CFG=1
M  V30 21 O 16.0776 5.8532 0.0 0
M  V30 22 O 16.3381 3.3750 0.0 0
M  V30 23 C 19.8335 3.4925 0.0 0
M  V30 24 C 19.1288 5.8888 0.0 0
M  V30 25 C 19.5869 4.4010 0.0 0
M  V30 26 C 18.8822 6.7976 0.0 0
M  V30 27 C 14.6708 5.2269 0.0 0 CFG=1
M  V30 28 O 14.8318 3.6953 0.0 0
M  V30 29 C 21.2512 4.0862 0.0 0
M  V30 30 C 20.5464 6.4826 0.0 0
M  V30 31 C 14.6708 6.7669 0.0 0
M  V30 32 C 13.3370 4.4569 0.0 0
M  V30 33 C 21.6076 5.5814 0.0 0
M  V30 34 C 13.3370 7.5369 0.0 0
M  V30 35 C 12.0033 5.2269 0.0 0
M  V30 36 C 12.0033 6.7669 0.0 0 CFG=1
M  V30 37 C 10.6697 7.5369 0.0 0
M  V30 38 C 10.6697 9.0770 0.0 0
M  V30 39 C 9.3358 6.7669 0.0 0
M  V30 40 C 9.3358 9.8470 0.0 0
M  V30 41 C 8.0022 7.5369 0.0 0
M  V30 42 C 8.0022 9.0770 0.0 0
M  V30 43 N 2.6673 9.0770 0.0 0
M  V30 44 C 1.3337 9.8470 0.0 0
M  V30 45 C 2.6673 7.5369 0.0 0
M  V30 46 C 0.0000 9.0770 0.0 0
M  V30 47 C 1.3337 6.7669 0.0 0
M  V30 48 O 0.0000 7.5369 0.0 0
M  V30 49 H 18.1085 3.0041 0.0 0
M  V30 50 H 17.3519 6.2992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 42
M  V30 17 1 16 17
M  V30 18 1 17 43
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 19 49 CFG=1
M  V30 26 1 20 25
M  V30 27 1 20 26
M  V30 28 1 20 50 CFG=3
M  V30 29 1 21 27
M  V30 30 1 22 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 29
M  V30 34 1 26 30
M  V30 35 1 27 28 CFG=3
M  V30 36 1 27 31
M  V30 37 1 27 32
M  V30 38 1 29 33
M  V30 39 1 30 33
M  V30 40 1 31 34
M  V30 41 1 32 35
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 44 1 36 37 CFG=3
M  V30 45 2 37 38
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 2 39 41
M  V30 49 2 40 42
M  V30 50 1 41 42
M  V30 51 1 43 44
M  V30 52 1 43 45
M  V30 53 1 44 46
M  V30 54 1 45 47
M  V30 55 1 46 48
M  V30 56 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 20 27 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (1α,1′′R,3′′S,4α)-N-(3-aminopropyl)-4-[4-[2-(4-morph...
C32H47N3O6.CH2O2
2260870-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 22.4250 3.8251 0.0 0
M  V30 2 N 23.8754 4.3432 0.0 0
M  V30 3 O 22.1486 2.3100 0.0 0
M  V30 4 C 25.0491 3.3462 0.0 0
M  V30 5 C 26.4995 3.8642 0.0 0
M  V30 6 C 27.6733 2.8674 0.0 0
M  V30 7 N 29.1236 3.3854 0.0 0
M  V30 8 O 6.6687 10.5828 0.0 0
M  V30 9 C 5.3348 9.8128 0.0 0
M  V30 10 C 4.0012 10.5828 0.0 0
M  V30 11 C 17.1082 5.4446 0.0 0
M  V30 12 C 18.7722 5.1295 0.0 0 CFG=2
M  V30 13 C 18.5257 6.0381 0.0 0 CFG=1
M  V30 14 O 16.0776 6.5890 0.0 0
M  V30 15 O 16.3382 4.1108 0.0 0
M  V30 16 C 19.8335 4.2283 0.0 0
M  V30 17 C 19.1288 6.6246 0.0 0
M  V30 18 C 19.5871 5.1367 0.0 0
M  V30 19 C 18.8822 7.5333 0.0 0
M  V30 20 C 14.6708 5.9627 0.0 0 CFG=1
M  V30 21 O 14.8318 4.4311 0.0 0
M  V30 22 C 21.2512 4.8220 0.0 0
M  V30 23 C 20.5465 7.2184 0.0 0
M  V30 24 C 14.6708 7.5027 0.0 0
M  V30 25 C 13.3372 5.1927 0.0 0
M  V30 26 C 21.6077 6.3172 0.0 0
M  V30 27 C 13.3372 8.2727 0.0 0
M  V30 28 C 12.0035 5.9627 0.0 0
M  V30 29 C 12.0035 7.5027 0.0 0 CFG=1
M  V30 30 C 10.6697 8.2727 0.0 0
M  V30 31 C 9.3360 7.5027 0.0 0
M  V30 32 C 10.6697 9.8128 0.0 0
M  V30 33 C 8.0023 8.2727 0.0 0
M  V30 34 C 9.3360 10.5828 0.0 0
M  V30 35 C 8.0023 9.8128 0.0 0
M  V30 36 N 2.6675 9.8128 0.0 0
M  V30 37 C 2.6675 8.2727 0.0 0
M  V30 38 C 1.3338 10.5828 0.0 0
M  V30 39 C 1.3338 7.5027 0.0 0
M  V30 40 C 0.0000 9.8128 0.0 0
M  V30 41 O 0.0000 8.2727 0.0 0
M  V30 42 H 18.1086 3.7399 0.0 0
M  V30 43 H 17.3520 7.0351 0.0 0
M  V30 44 C 14.5618 0.0000 0.0 0
M  V30 45 O 13.2281 0.7700 0.0 0
M  V30 46 O 15.8955 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 35
M  V30 10 1 9 10
M  V30 11 1 10 36
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 42 CFG=1
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 1 13 43 CFG=3
M  V30 22 1 20 14 CFG=1
M  V30 23 1 15 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 22
M  V30 27 1 19 23
M  V30 28 1 20 21
M  V30 29 1 20 24
M  V30 30 1 20 25
M  V30 31 1 22 26
M  V30 32 1 23 26
M  V30 33 1 24 27
M  V30 34 1 25 28
M  V30 35 1 27 29
M  V30 36 1 28 29
M  V30 37 1 29 30 CFG=3
M  V30 38 2 30 31
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 2 32 34
M  V30 42 2 33 35
M  V30 43 1 34 35
M  V30 44 1 36 37
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 41
M  V30 49 1 40 41
M  V30 50 1 44 45
M  V30 51 2 44 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 20 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2260870-28-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260870-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-19734775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of isomer
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of trioxolane derivatives for use as antimalarials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Talukder, Poulami; Renslo, Adam Robert; Blank, Brian Richard; Muir, Ryan
Keith; Evans, Michael John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019005977 A1 2019-01-03

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
9H-Fluoren-9-ylmethyl N-[2-[[2-[(1α,1′′R,3′′S,4α)-5′′-[[[3-[[(1,1-dimethyleth...
C46H62N4O9
2260870-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 68 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 26.9412 3.9731 0.0 0
M  V30 2 N 28.3916 4.4912 0.0 0
M  V30 3 O 26.6648 2.4582 0.0 0
M  V30 4 C 29.5654 3.4943 0.0 0
M  V30 5 C 31.0157 4.0124 0.0 0
M  V30 6 C 32.1895 3.0155 0.0 0
M  V30 7 N 33.6397 3.5336 0.0 0
M  V30 8 C 34.8135 2.5366 0.0 0
M  V30 9 O 36.2638 3.0547 0.0 0
M  V30 10 O 34.5371 1.0217 0.0 0
M  V30 11 C 37.4376 2.0578 0.0 0
M  V30 12 C 36.4407 0.8840 0.0 0
M  V30 13 C 38.6114 1.0608 0.0 0
M  V30 14 C 38.4345 3.2316 0.0 0
M  V30 15 C 15.1858 8.4207 0.0 0
M  V30 16 C 13.8521 7.6507 0.0 0
M  V30 17 N 12.5185 8.4207 0.0 0
M  V30 18 O 13.8521 6.1107 0.0 0
M  V30 19 C 11.1848 7.6507 0.0 0
M  V30 20 C 9.8510 8.4207 0.0 0
M  V30 21 N 9.0810 7.0871 0.0 0
M  V30 22 C 10.6210 9.7546 0.0 0
M  V30 23 C 8.5173 9.1908 0.0 0
M  V30 24 C 7.5409 7.0871 0.0 0
M  V30 25 O 6.7709 5.7534 0.0 0
M  V30 26 O 6.7709 8.4207 0.0 0
M  V30 27 C 5.2309 5.7534 0.0 0
M  V30 28 C 21.6244 5.5926 0.0 0
M  V30 29 C 23.2884 5.2777 0.0 0 CFG=2
M  V30 30 C 23.0420 6.1862 0.0 0 CFG=1
M  V30 31 O 20.5939 6.7372 0.0 0
M  V30 32 O 20.8544 4.2590 0.0 0
M  V30 33 C 24.3498 4.3763 0.0 0
M  V30 34 C 23.6449 6.7728 0.0 0
M  V30 35 C 24.1032 5.2849 0.0 0
M  V30 36 C 23.3983 7.6815 0.0 0
M  V30 37 C 19.1870 6.1107 0.0 0 CFG=1
M  V30 38 O 19.3479 4.5791 0.0 0
M  V30 39 C 25.7674 4.9702 0.0 0
M  V30 40 C 25.0627 7.3666 0.0 0
M  V30 41 C 19.1870 7.6507 0.0 0
M  V30 42 C 17.8533 5.3407 0.0 0
M  V30 43 C 26.1239 6.4652 0.0 0
M  V30 44 C 17.8533 8.4207 0.0 0
M  V30 45 C 16.5196 6.1107 0.0 0
M  V30 46 C 16.5196 7.6507 0.0 0 CFG=1
M  V30 47 C 4.4609 4.4197 0.0 0
M  V30 48 C 5.0873 3.0128 0.0 0
M  V30 49 C 2.9293 4.2587 0.0 0
M  V30 50 C 3.9428 1.9823 0.0 0
M  V30 51 C 6.5519 2.5369 0.0 0
M  V30 52 C 2.6091 2.7523 0.0 0
M  V30 53 C 1.7849 5.2892 0.0 0
M  V30 54 C 4.2630 0.4759 0.0 0
M  V30 55 C 6.8721 1.0306 0.0 0
M  V30 56 C 1.1444 2.2765 0.0 0
M  V30 57 C 0.3202 4.8134 0.0 0
M  V30 58 C 5.7277 0.0000 0.0 0
M  V30 59 C 0.0000 3.3069 0.0 0
M  V30 60 H 22.6248 3.8880 0.0 0
M  V30 61 H 21.8682 7.1832 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 39
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 46 15 CFG=3
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 27 47
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 1 29 34
M  V30 35 1 29 60 CFG=1
M  V30 36 1 30 35
M  V30 37 1 30 36
M  V30 38 1 30 61 CFG=3
M  V30 39 1 31 37
M  V30 40 1 32 38
M  V30 41 1 33 39
M  V30 42 1 34 40
M  V30 43 1 35 39
M  V30 44 1 36 40
M  V30 45 1 37 38 CFG=3
M  V30 46 1 37 41
M  V30 47 1 37 42
M  V30 48 1 39 43
M  V30 49 1 40 43
M  V30 50 1 41 44
M  V30 51 1 42 45
M  V30 52 1 44 46
M  V30 53 1 45 46
M  V30 54 1 47 48
M  V30 55 1 47 49
M  V30 56 1 48 50
M  V30 57 2 48 51
M  V30 58 1 49 52
M  V30 59 2 49 53
M  V30 60 1 50 52
M  V30 61 2 50 54
M  V30 62 1 51 55
M  V30 63 2 52 56
M  V30 64 1 53 57
M  V30 65 1 54 58
M  V30 66 2 55 58
M  V30 67 1 56 59
M  V30 68 2 57 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 29 30 37 46)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[2-[[2-[(1α,1′′R,3′′S,4α)-5′′-[[(3-aminopropyl)amino]carbony...
C41H54N4O7.CH2O2
2260870-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 26.4882 10.5922 0.0 0
M  V30 2 N 28.0144 10.3870 0.0 0
M  V30 3 O 25.9027 12.0166 0.0 0
M  V30 4 C 28.9553 11.6062 0.0 0
M  V30 5 C 30.4816 11.4009 0.0 0
M  V30 6 C 31.4224 12.6201 0.0 0
M  V30 7 N 32.9487 12.4149 0.0 0
M  V30 8 C 15.1857 10.7307 0.0 0
M  V30 9 C 13.8520 9.9607 0.0 0
M  V30 10 N 12.5184 10.7307 0.0 0
M  V30 11 O 13.8520 8.4207 0.0 0
M  V30 12 C 11.1847 9.9607 0.0 0
M  V30 13 C 9.8509 10.7307 0.0 0
M  V30 14 N 9.0809 9.3970 0.0 0
M  V30 15 C 10.6209 12.0645 0.0 0
M  V30 16 C 8.5172 11.5007 0.0 0
M  V30 17 C 7.5409 9.3970 0.0 0
M  V30 18 O 6.7709 8.0634 0.0 0
M  V30 19 O 6.7709 10.7307 0.0 0
M  V30 20 C 5.2308 8.0634 0.0 0
M  V30 21 C 21.6242 7.9026 0.0 0
M  V30 22 C 23.1864 8.5568 0.0 0 CFG=2
M  V30 23 C 23.1342 7.6168 0.0 0 CFG=1
M  V30 24 O 20.5938 9.0471 0.0 0
M  V30 25 O 20.8542 6.5689 0.0 0
M  V30 26 C 24.0371 9.6590 0.0 0
M  V30 27 C 23.8460 7.1685 0.0 0
M  V30 28 C 23.9847 8.7191 0.0 0
M  V30 29 C 23.7938 6.2284 0.0 0
M  V30 30 C 19.1868 8.4207 0.0 0 CFG=1
M  V30 31 O 19.3477 6.8891 0.0 0
M  V30 32 C 25.5472 9.3730 0.0 0
M  V30 33 C 25.3561 6.8823 0.0 0
M  V30 34 C 19.1868 9.9607 0.0 0
M  V30 35 C 17.8532 7.6507 0.0 0
M  V30 36 C 26.2067 7.9847 0.0 0
M  V30 37 C 17.8532 10.7307 0.0 0
M  V30 38 C 16.5195 8.4207 0.0 0
M  V30 39 C 16.5195 9.9607 0.0 0 CFG=1
M  V30 40 C 4.4608 6.7297 0.0 0
M  V30 41 C 2.9293 6.5686 0.0 0
M  V30 42 C 5.0873 5.3228 0.0 0
M  V30 43 C 2.6091 5.0623 0.0 0
M  V30 44 C 1.7849 7.5992 0.0 0
M  V30 45 C 3.9428 4.2923 0.0 0
M  V30 46 C 6.5519 4.8469 0.0 0
M  V30 47 C 1.1444 4.5865 0.0 0
M  V30 48 C 0.3202 7.1234 0.0 0
M  V30 49 C 4.2629 2.7859 0.0 0
M  V30 50 C 6.8720 3.3406 0.0 0
M  V30 51 C 0.0000 5.6169 0.0 0
M  V30 52 C 5.7276 2.3100 0.0 0
M  V30 53 H 22.2482 9.7780 0.0 0
M  V30 54 H 22.1934 6.3975 0.0 0
M  V30 55 C 16.4744 0.0000 0.0 0
M  V30 56 O 15.1407 0.7700 0.0 0
M  V30 57 O 17.8080 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 32
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 39 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 40
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 22 27
M  V30 28 1 22 53 CFG=3
M  V30 29 1 23 28
M  V30 30 1 23 29
M  V30 31 1 23 54 CFG=1
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 26 32
M  V30 35 1 27 33
M  V30 36 1 28 32
M  V30 37 1 29 33
M  V30 38 1 30 31 CFG=3
M  V30 39 1 30 34
M  V30 40 1 30 35
M  V30 41 1 32 36
M  V30 42 1 33 36
M  V30 43 1 34 37
M  V30 44 1 35 38
M  V30 45 1 37 39
M  V30 46 1 38 39
M  V30 47 1 40 41
M  V30 48 1 40 42
M  V30 49 1 41 43
M  V30 50 2 41 44
M  V30 51 1 42 45
M  V30 52 2 42 46
M  V30 53 1 43 45
M  V30 54 2 43 47
M  V30 55 1 44 48
M  V30 56 2 45 49
M  V30 57 1 46 50
M  V30 58 1 47 51
M  V30 59 2 48 51
M  V30 60 1 49 52
M  V30 61 2 50 52
M  V30 62 1 55 56
M  V30 63 2 55 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 22 23 30 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2260870-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260870-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-19734786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of trioxolane derivatives for use as antimalarials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Talukder, Poulami; Renslo, Adam Robert; Blank, Brian Richard; Muir, Ryan
Keith; Evans, Michael John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019005977 A1 2019-01-03

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cobaltocenium, 1,1′-dicarboxy-, inner salt
C12H9CoO4
232598-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1063 5.1421 0.0 0
M  V30 2 O 3.5770 4.8708 0.0 0 CHG=-1
M  V30 3 O 3.1063 5.6863 0.0 0
M  V30 4 C 3.0778 0.5682 0.0 0
M  V30 5 O 3.5485 0.8395 0.0 0
M  V30 6 O 3.0778 0.0240 0.0 0
M  V30 7 Co 1.3208 2.8424 0.0 0 CHG=3 VAL=10
M  V30 8 C 2.6355 4.8708 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.6070 0.8395 0.0 0 CHG=-1 VAL=4
M  V30 10 C 1.7795 1.3178 0.0 0 VAL=5
M  V30 11 C 1.2923 0.0000 0.0 0 VAL=5
M  V30 12 C 1.8095 4.3925 0.0 0 VAL=5
M  V30 13 C 1.3208 5.7088 0.0 0 VAL=5
M  V30 14 C 0.0300 4.8708 0.0 0 VAL=5
M  V30 15 C 0.8545 4.3925 0.0 0 VAL=5
M  V30 16 C 0.0000 0.8395 0.0 0 VAL=5
M  V30 17 C 0.8230 1.3178 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 12
M  V30 18 1 8 13
M  V30 19 1 9 10
M  V30 20 1 9 11
M  V30 21 2 10 17
M  V30 22 2 11 16
M  V30 23 2 12 15
M  V30 24 2 13 14
M  V30 25 1 14 15
M  V30 26 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cobaltocenium, 1,1′-dicarboxy-, inner salt, compd. with formic acid (1:1)
C12H9CoO4.CH2O2
499771-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1063 7.4521 0.0 0
M  V30 2 O 3.5770 7.1808 0.0 0 CHG=-1
M  V30 3 O 3.1063 7.9963 0.0 0
M  V30 4 C 3.0778 2.8782 0.0 0
M  V30 5 O 3.5485 3.1495 0.0 0
M  V30 6 O 3.0778 2.3340 0.0 0
M  V30 7 Co 1.3208 5.1524 0.0 0 CHG=3 VAL=10
M  V30 8 C 2.6355 7.1808 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.6070 3.1495 0.0 0 CHG=-1 VAL=4
M  V30 10 C 1.7795 3.6278 0.0 0 VAL=5
M  V30 11 C 1.2923 2.3100 0.0 0 VAL=5
M  V30 12 C 1.8095 6.7026 0.0 0 VAL=5
M  V30 13 C 1.3208 8.0188 0.0 0 VAL=5
M  V30 14 C 0.0300 7.1808 0.0 0 VAL=5
M  V30 15 C 0.8545 6.7026 0.0 0 VAL=5
M  V30 16 C 0.0000 3.1495 0.0 0 VAL=5
M  V30 17 C 0.8230 3.6278 0.0 0 VAL=5
M  V30 18 C 1.7885 0.0000 0.0 0
M  V30 19 O 0.4548 0.7700 0.0 0
M  V30 20 O 3.1222 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 12
M  V30 18 1 8 13
M  V30 19 1 9 10
M  V30 20 1 9 11
M  V30 21 2 10 17
M  V30 22 2 11 16
M  V30 23 2 12 15
M  V30 24 2 13 14
M  V30 25 1 14 15
M  V30 26 1 16 17
M  V30 27 1 18 19
M  V30 28 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 232598-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 499771-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27103497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Supramolecular gas-solid reaction between formic acid vapors and solid
[CoIII(η5-C5H4COOH)(η5-C5H4COO)]
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Braga, Dario; Maini, Lucia; Mazzotti, Michele; Rubini, Katia; Masic,
Admir; Gobetto, Roberto; Grepioni, Fabrizia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2002), (20),
2296-2297

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL

C37H55N3O8
2363744-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 56 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 22.4250 3.0893 0.0 0
M  V30 2 N 23.8753 3.6074 0.0 0
M  V30 3 O 22.1486 1.5742 0.0 0
M  V30 4 C 25.0491 2.6104 0.0 0
M  V30 5 C 26.4994 3.1284 0.0 0
M  V30 6 C 27.6732 2.1316 0.0 0
M  V30 7 N 29.1234 2.6496 0.0 0
M  V30 8 C 30.2972 1.6528 0.0 0
M  V30 9 O 31.7475 2.1708 0.0 0
M  V30 10 O 30.0208 0.1377 0.0 0
M  V30 11 C 32.9213 1.1738 0.0 0
M  V30 12 C 33.9183 2.3476 0.0 0
M  V30 13 C 34.0951 0.1770 0.0 0
M  V30 14 C 31.9244 0.0000 0.0 0
M  V30 15 O 6.6685 9.8470 0.0 0
M  V30 16 C 5.3348 9.0770 0.0 0
M  V30 17 C 4.0010 9.8470 0.0 0
M  V30 18 C 17.1081 4.7088 0.0 0
M  V30 19 C 18.7722 4.3937 0.0 0 CFG=3
M  V30 20 C 18.5257 5.3023 0.0 0 CFG=3
M  V30 21 O 16.0776 5.8532 0.0 0
M  V30 22 O 16.3381 3.3750 0.0 0
M  V30 23 C 19.8335 3.4925 0.0 0
M  V30 24 C 19.1288 5.8888 0.0 0
M  V30 25 C 19.5869 4.4010 0.0 0
M  V30 26 C 18.8822 6.7976 0.0 0
M  V30 27 C 14.6708 5.2269 0.0 0 CFG=2
M  V30 28 O 14.8318 3.6953 0.0 0
M  V30 29 C 21.2512 4.0862 0.0 0
M  V30 30 C 20.5464 6.4826 0.0 0
M  V30 31 C 13.3370 4.4569 0.0 0
M  V30 32 C 14.6708 6.7669 0.0 0
M  V30 33 C 21.6076 5.5814 0.0 0
M  V30 34 C 12.0033 5.2269 0.0 0
M  V30 35 C 13.3370 7.5369 0.0 0
M  V30 36 C 12.0033 6.7669 0.0 0 CFG=2
M  V30 37 C 10.6697 7.5369 0.0 0
M  V30 38 C 9.3360 6.7669 0.0 0
M  V30 39 C 10.6697 9.0770 0.0 0
M  V30 40 C 8.0022 7.5369 0.0 0
M  V30 41 C 9.3360 9.8470 0.0 0
M  V30 42 C 8.0022 9.0770 0.0 0
M  V30 43 N 2.6673 9.0770 0.0 0
M  V30 44 C 2.6673 7.5369 0.0 0
M  V30 45 C 1.3337 9.8470 0.0 0
M  V30 46 C 1.3337 6.7669 0.0 0
M  V30 47 C 0.0000 9.0770 0.0 0
M  V30 48 O 0.0000 7.5369 0.0 0
M  V30 49 H 18.1085 3.0041 0.0 0
M  V30 50 H 17.3519 6.2992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 42
M  V30 17 1 16 17
M  V30 18 1 17 43
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 19 49
M  V30 26 1 20 25
M  V30 27 1 20 26
M  V30 28 1 20 50
M  V30 29 1 27 21 CFG=1
M  V30 30 1 22 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 29
M  V30 34 1 26 30
M  V30 35 1 27 28
M  V30 36 1 27 31
M  V30 37 1 27 32
M  V30 38 1 29 33
M  V30 39 1 30 33
M  V30 40 1 31 34
M  V30 41 1 32 35
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 44 1 36 37 CFG=3
M  V30 45 2 37 38
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 2 39 41
M  V30 49 2 40 42
M  V30 50 1 41 42
M  V30 51 1 43 44
M  V30 52 1 43 45
M  V30 53 1 44 46
M  V30 54 1 45 47
M  V30 55 1 46 48
M  V30 56 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 27 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H47N3O6.CH2O2
2363744-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 22.4250 3.8251 0.0 0
M  V30 2 N 23.8753 4.3432 0.0 0
M  V30 3 O 22.1486 2.3100 0.0 0
M  V30 4 C 25.0491 3.3462 0.0 0
M  V30 5 C 26.4995 3.8642 0.0 0
M  V30 6 C 27.6733 2.8674 0.0 0
M  V30 7 N 29.1236 3.3854 0.0 0
M  V30 8 O 6.6687 10.5828 0.0 0
M  V30 9 C 5.3348 9.8128 0.0 0
M  V30 10 C 4.0012 10.5828 0.0 0
M  V30 11 C 17.1082 5.4446 0.0 0
M  V30 12 C 18.7722 5.1295 0.0 0 CFG=3
M  V30 13 C 18.5257 6.0381 0.0 0 CFG=3
M  V30 14 O 16.0778 6.5890 0.0 0
M  V30 15 O 16.3382 4.1108 0.0 0
M  V30 16 C 19.8335 4.2283 0.0 0
M  V30 17 C 19.1288 6.6246 0.0 0
M  V30 18 C 19.5871 5.1367 0.0 0
M  V30 19 C 18.8822 7.5333 0.0 0
M  V30 20 C 14.6708 5.9627 0.0 0 CFG=1
M  V30 21 O 14.8318 4.4311 0.0 0
M  V30 22 C 21.2512 4.8220 0.0 0
M  V30 23 C 20.5465 7.2184 0.0 0
M  V30 24 C 14.6708 7.5027 0.0 0
M  V30 25 C 13.3372 5.1927 0.0 0
M  V30 26 C 21.6077 6.3172 0.0 0
M  V30 27 C 13.3372 8.2727 0.0 0
M  V30 28 C 12.0035 5.9627 0.0 0
M  V30 29 C 12.0035 7.5027 0.0 0 CFG=1
M  V30 30 C 10.6697 8.2727 0.0 0
M  V30 31 C 10.6697 9.8128 0.0 0
M  V30 32 C 9.3360 7.5027 0.0 0
M  V30 33 C 9.3360 10.5828 0.0 0
M  V30 34 C 8.0023 8.2727 0.0 0
M  V30 35 C 8.0023 9.8128 0.0 0
M  V30 36 N 2.6675 9.8128 0.0 0
M  V30 37 C 1.3338 10.5828 0.0 0
M  V30 38 C 2.6675 8.2727 0.0 0
M  V30 39 C 0.0000 9.8128 0.0 0
M  V30 40 C 1.3338 7.5027 0.0 0
M  V30 41 O 0.0000 8.2727 0.0 0
M  V30 42 H 18.1086 3.7399 0.0 0
M  V30 43 H 17.3520 7.0351 0.0 0
M  V30 44 C 14.5618 0.0000 0.0 0
M  V30 45 O 13.2281 0.7700 0.0 0
M  V30 46 O 15.8955 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 35
M  V30 10 1 9 10
M  V30 11 1 10 36
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 42
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 1 13 43
M  V30 22 1 20 14 CFG=1
M  V30 23 1 15 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 22
M  V30 27 1 19 23
M  V30 28 1 20 21
M  V30 29 1 20 24
M  V30 30 1 20 25
M  V30 31 1 22 26
M  V30 32 1 23 26
M  V30 33 1 24 27
M  V30 34 1 25 28
M  V30 35 1 27 29
M  V30 36 1 28 29
M  V30 37 1 29 30 CFG=3
M  V30 38 2 30 31
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 2 32 34
M  V30 42 2 33 35
M  V30 43 1 34 35
M  V30 44 1 36 37
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 41
M  V30 49 1 40 41
M  V30 50 1 44 45
M  V30 51 2 44 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 20 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2363744-26-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2363744-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-20421218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a
Reactivity-Based Probe for Positron Emission Tomography
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muir, Ryan K.; Zhao, Ning; Wei, Junnian; Wang, Yung-hua; Moroz, Anna;
Huang, Yangjie; Chen, Ying-Chu; Sriram, Renuka; Kurhanewicz, John;
Ruggero, Davide; Renslo, Adam R.; Evans, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Central Science (2019), 5(4), 727-736

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Muricholic acid
C24H40O5
2393-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.3502 5.2458 0.0 0
M  V30 2 O 8.0021 1.5400 0.0 0
M  V30 3 C 8.1630 7.6916 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 10.8005 7.4060 0.0 0 CFG=2
M  V30 6 C 10.8005 8.9460 0.0 0
M  V30 7 C 12.1341 6.6360 0.0 0
M  V30 8 C 12.1341 9.7160 0.0 0
M  V30 9 C 12.1341 11.2560 0.0 0
M  V30 10 O 13.4678 12.0260 0.0 0
M  V30 11 O 10.8005 12.0260 0.0 0
M  V30 12 O 0.0000 1.5400 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0 CFG=2
M  V30 14 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 15 C 4.0010 3.8501 0.0 0 CFG=2
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 8.0021 4.6201 0.0 0 CFG=2
M  V30 18 C 6.6685 2.3100 0.0 0 CFG=1
M  V30 19 C 4.0010 2.3100 0.0 0 CFG=1
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 6.6685 6.9301 0.0 0
M  V30 22 C 8.0021 6.1601 0.0 0 CFG=2
M  V30 23 C 9.4668 4.1442 0.0 0
M  V30 24 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6673 1.5400 0.0 0
M  V30 26 C 1.3337 3.8501 0.0 0
M  V30 27 C 9.4668 6.6360 0.0 0 CFG=1
M  V30 28 C 10.3721 5.3901 0.0 0
M  V30 29 C 1.3337 2.3100 0.0 0 CFG=2
M  V30 30 H 4.4514 5.8815 0.0 0
M  V30 31 H 7.5518 2.5885 0.0 0
M  V30 32 H 8.7952 3.3000 0.0 0
M  V30 33 H 4.0010 0.7700 0.0 0
M  V30 34 H 8.8403 8.0429 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 22 3 CFG=1
M  V30 4 1 24 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=1
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 32 CFG=3
M  V30 26 1 18 24
M  V30 27 1 19 24
M  V30 28 1 19 25
M  V30 29 1 19 33 CFG=1
M  V30 30 1 20 26
M  V30 31 1 21 22
M  V30 32 1 22 27
M  V30 33 1 23 28
M  V30 34 1 25 29
M  V30 35 1 26 29
M  V30 36 1 27 28
M  V30 37 1 27 34 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 5 13 14 15 17 18 19 22 24 27 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cholan-24-oic acid, 3,6,7-tris(formyloxy)-, (3α,5β,6β,7β)-
C27H40O8
700862-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 3.8500 0.0 0
M  V30 2 C 10.6695 2.3100 0.0 0
M  V30 3 O 12.0032 1.5400 0.0 0
M  V30 4 C 6.0176 7.5558 0.0 0
M  V30 5 C 10.8305 10.0016 0.0 0
M  V30 6 O 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 O 6.6684 0.0000 0.0 0
M  V30 9 C 11.5078 10.3527 0.0 0 CFG=2
M  V30 10 C 12.4130 11.5986 0.0 0
M  V30 11 C 9.9762 10.5137 0.0 0
M  V30 12 C 11.7865 13.0056 0.0 0
M  V30 13 C 12.6917 14.2515 0.0 0
M  V30 14 O 12.0654 15.6583 0.0 0
M  V30 15 O 14.2233 14.0905 0.0 0
M  V30 16 O 2.6673 3.8500 0.0 0
M  V30 17 C 1.3337 4.6200 0.0 0
M  V30 18 O 0.0000 3.8500 0.0 0
M  V30 19 C 9.3357 6.1601 0.0 0 CFG=1
M  V30 20 C 8.0021 6.9301 0.0 0 CFG=2
M  V30 21 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 22 C 9.3357 4.6200 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1601 0.0 0 CFG=2
M  V30 24 C 8.0021 8.4701 0.0 0
M  V30 25 C 10.6695 8.4701 0.0 0 CFG=2
M  V30 26 C 12.1341 6.4540 0.0 0
M  V30 27 C 8.0021 3.8500 0.0 0 CFG=1
M  V30 28 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 29 C 5.3348 6.9301 0.0 0
M  V30 30 C 9.3357 9.2401 0.0 0
M  V30 31 C 12.1341 8.9459 0.0 0 CFG=1
M  V30 32 C 13.0393 7.7001 0.0 0
M  V30 33 C 5.3348 3.8500 0.0 0
M  V30 34 C 4.0010 6.1601 0.0 0
M  V30 35 C 4.0010 4.6200 0.0 0 CFG=2
M  V30 36 H 10.4247 5.0710 0.0 0
M  V30 37 H 6.9131 8.0190 0.0 0
M  V30 38 H 11.2213 5.4923 0.0 0
M  V30 39 H 6.6684 3.0800 0.0 0
M  V30 40 H 13.4677 9.7160 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 27 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 31
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 30
M  V30 34 1 25 31
M  V30 35 1 26 32
M  V30 36 1 27 28
M  V30 37 1 28 33
M  V30 38 1 28 39 CFG=1
M  V30 39 1 29 34
M  V30 40 1 31 32
M  V30 41 1 31 40 CFG=3
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 27 28 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2393-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 700862-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-9825081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical synthesis of (22E)-3α,6β,7β-trihydroxy-5β-chol-22-en-24-oic acid
and its taurine and glycine conjugates: a major bile acid in the rat
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kakiyama, Genta; Iida, Takashi; Yoshimoto, Atsushi; Goto, Takaaki; Mano,
Nariyasu; Goto, Junichi; Nambara, Toshio; Hagey, Lee R.; Hofmann, Alan F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Lipid Research (2004), 45(3), 567-573

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N-[[(3R,3aS,6R,7S,7aS)-2,3,3a,6,7,7a-Hexahydro-1-(2-methylpropyl)-7-(phen...
C27H39N3O3
2411661-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6270 5.8641 0.0 0
M  V30 2 N 9.9606 6.6342 0.0 0
M  V30 3 O 8.6270 4.3241 0.0 0
M  V30 4 C 11.2945 5.8641 0.0 0
M  V30 5 C 12.6281 6.6342 0.0 0
M  V30 6 C 13.9618 5.8641 0.0 0
M  V30 7 O 15.2955 6.6342 0.0 0
M  V30 8 O 13.9618 4.3241 0.0 0
M  V30 9 C 16.6293 5.8641 0.0 0
M  V30 10 C 15.8593 4.5305 0.0 0
M  V30 11 C 17.9630 5.0941 0.0 0
M  V30 12 C 17.3993 7.1980 0.0 0
M  V30 13 C 6.7514 4.5499 0.0 0
M  V30 14 C 2.5521 5.0897 0.0 0
M  V30 15 C 1.0522 5.4385 0.0 0
M  V30 16 C 0.6042 6.9120 0.0 0
M  V30 17 C 0.0000 4.3139 0.0 0
M  V30 18 C 7.2933 6.6342 0.0 0 CFG=2
M  V30 19 C 6.1005 5.9456 0.0 0 CFG=2
M  V30 20 C 5.9675 8.5979 0.0 0
M  V30 21 N 7.2933 8.0117 0.0 0
M  V30 22 C 4.9076 6.6343 0.0 0 CFG=1
M  V30 23 C 3.6040 8.4314 0.0 0 CFG=2
M  V30 24 C 6.1004 8.7003 0.0 0
M  V30 25 C 4.9073 8.0116 0.0 0 CFG=2
M  V30 26 N 3.6043 6.2143 0.0 0
M  V30 27 C 2.8002 7.3227 0.0 0
M  V30 28 C 6.4838 3.0333 0.0 0
M  V30 29 C 5.0368 2.5064 0.0 0
M  V30 30 C 7.6637 2.0433 0.0 0
M  V30 31 C 4.7693 0.9898 0.0 0
M  V30 32 C 7.3963 0.5267 0.0 0
M  V30 33 C 5.9491 0.0000 0.0 0
M  V30 34 H 4.7447 5.1029 0.0 0
M  V30 35 H 2.8565 9.7777 0.0 0
M  V30 36 H 4.7444 9.5430 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 19 13 CFG=3
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 1 14 26
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20 CFG=1
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 23 20 CFG=1
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 22 26
M  V30 27 1 22 34 CFG=3
M  V30 28 1 23 25
M  V30 29 1 23 27
M  V30 30 1 23 35 CFG=3
M  V30 31 1 24 25
M  V30 32 1 25 36 CFG=3
M  V30 33 1 26 27
M  V30 34 2 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 32
M  V30 38 2 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 18 19 22 23 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-[[(3R,3aS,6R,7S,7aS)-2,3,3a,6,7,7a-hexahydro-1-(2-methylpropyl)-...
C23H31N3O3.CH2O2
2411660-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6269 8.1741 0.0 0
M  V30 2 N 9.9607 8.9441 0.0 0
M  V30 3 O 8.6269 6.6341 0.0 0
M  V30 4 C 11.2944 8.1741 0.0 0
M  V30 5 C 12.6280 8.9441 0.0 0
M  V30 6 C 13.9617 8.1741 0.0 0
M  V30 7 O 13.9617 6.6341 0.0 0
M  V30 8 O 15.2955 8.9441 0.0 0
M  V30 9 C 6.7513 6.8599 0.0 0
M  V30 10 C 2.5521 7.3996 0.0 0
M  V30 11 C 1.0521 7.7485 0.0 0
M  V30 12 C 0.6043 9.2220 0.0 0
M  V30 13 C 0.0000 6.6239 0.0 0
M  V30 14 C 7.2932 8.9441 0.0 0 CFG=2
M  V30 15 C 6.1005 8.2556 0.0 0 CFG=2
M  V30 16 C 5.9674 10.9078 0.0 0
M  V30 17 N 7.2932 10.3217 0.0 0
M  V30 18 C 4.9076 8.9443 0.0 0 CFG=1
M  V30 19 C 3.6040 10.7413 0.0 0 CFG=2
M  V30 20 C 6.1003 11.0102 0.0 0
M  V30 21 C 4.9074 10.3215 0.0 0 CFG=2
M  V30 22 N 3.6043 8.5243 0.0 0
M  V30 23 C 2.8002 9.6327 0.0 0
M  V30 24 C 6.4840 5.3432 0.0 0
M  V30 25 C 5.0368 4.8164 0.0 0
M  V30 26 C 7.6636 4.3533 0.0 0
M  V30 27 C 4.7693 3.2998 0.0 0
M  V30 28 C 7.3963 2.8367 0.0 0
M  V30 29 C 5.9491 2.3100 0.0 0
M  V30 30 H 4.7448 7.4129 0.0 0
M  V30 31 H 2.8564 12.0876 0.0 0
M  V30 32 H 4.7445 11.8529 0.0 0
M  V30 33 C 7.6478 0.0000 0.0 0
M  V30 34 O 6.3141 0.7700 0.0 0
M  V30 35 O 8.9814 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 15 9 CFG=3
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=1
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 19 16 CFG=1
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 18 30 CFG=3
M  V30 24 1 19 21
M  V30 25 1 19 23
M  V30 26 1 19 31 CFG=3
M  V30 27 1 20 21
M  V30 28 1 21 32 CFG=3
M  V30 29 1 22 23
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 14 15 18 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411661-11-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411660-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24742533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of octahydro-3,6-methanopyrrolo[3,2-b]pyridine-3a-carboxamide
and octahydro-3,6-methanopyrrolo[3,2-c]pyridine-6-carboxamide derivatives
for treatment of rabies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kouji, Hiroyuki; Yamada, Kentaro; Kato, Akira; Ishizaki, Toshimasa;
Matsuoka, Shigeru; Nishizono, Akira; Mishina, Tadashi; Yoshimori, Atsushi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210214356 A1 2021-07-15

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Triphenylarsoranylidene)-2-propanone
C21H19AsO
24143-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 As 4.4626 3.8500 0.0 0 VAL=5
M  V30 2 C 4.4626 2.3100 0.0 0
M  V30 3 C 3.1290 1.5400 0.0 0
M  V30 4 C 1.7952 2.3100 0.0 0
M  V30 5 O 3.1290 0.0000 0.0 0
M  V30 6 C 6.0026 3.8500 0.0 0
M  V30 7 C 6.7726 2.5164 0.0 0
M  V30 8 C 6.7726 5.1837 0.0 0
M  V30 9 C 8.3126 2.5164 0.0 0
M  V30 10 C 8.3126 5.1837 0.0 0
M  V30 11 C 9.0826 3.8500 0.0 0
M  V30 12 C 2.9751 4.2486 0.0 0
M  V30 13 C 1.8862 3.1596 0.0 0
M  V30 14 C 2.5764 5.7361 0.0 0
M  V30 15 C 0.3986 3.5582 0.0 0
M  V30 16 C 1.0889 6.1348 0.0 0
M  V30 17 C 0.0000 5.0458 0.0 0
M  V30 18 C 4.4626 5.3900 0.0 0
M  V30 19 C 5.7963 6.1600 0.0 0
M  V30 20 C 3.1290 6.1600 0.0 0
M  V30 21 C 5.7963 7.7000 0.0 0
M  V30 22 C 3.1290 7.7000 0.0 0
M  V30 23 C 4.4626 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Arsonium, (2-oxopropyl)triphenyl-, formate (1:1)
C21H20AsO.CHO2
311808-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 As 4.4626 6.1600 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.4626 4.6200 0.0 0
M  V30 3 C 3.1290 3.8500 0.0 0
M  V30 4 C 1.7952 4.6200 0.0 0
M  V30 5 O 3.1290 2.3100 0.0 0
M  V30 6 C 6.0026 6.1600 0.0 0
M  V30 7 C 6.7726 4.8264 0.0 0
M  V30 8 C 6.7726 7.4937 0.0 0
M  V30 9 C 8.3126 4.8264 0.0 0
M  V30 10 C 8.3126 7.4937 0.0 0
M  V30 11 C 9.0826 6.1600 0.0 0
M  V30 12 C 2.9751 6.5586 0.0 0
M  V30 13 C 1.8862 5.4696 0.0 0
M  V30 14 C 2.5764 8.0461 0.0 0
M  V30 15 C 0.3986 5.8682 0.0 0
M  V30 16 C 1.0889 8.4448 0.0 0
M  V30 17 C 0.0000 7.3558 0.0 0
M  V30 18 C 4.4626 7.7000 0.0 0
M  V30 19 C 5.7963 8.4700 0.0 0
M  V30 20 C 3.1290 8.4700 0.0 0
M  V30 21 C 5.7963 10.0100 0.0 0
M  V30 22 C 3.1290 10.0100 0.0 0
M  V30 23 C 4.4626 10.7801 0.0 0
M  V30 24 C 4.5413 0.0000 0.0 0
M  V30 25 O 3.2077 0.7700 0.0 0 CHG=-1
M  V30 26 O 5.8750 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24143-92-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 311808-92-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28580524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Reaction of Triphenylphosphonium or Triphenylarsonium Salts with
Aldehyde: Effect of the Counteranion on their Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hon, Y.-S.; Lee, C.-F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(40), 7893-7902

$RFMT $RIREG SCHEME147 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)aniline
C7H6F3N
455-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-formyl-N-[4-(trifluoromethyl)phenyl]carbamate
C13H14F3NO3
1259119-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 4.0011 0.0 0
M  V30 2 C 3.6437 2.6675 0.0 0
M  V30 3 C 3.6437 5.3348 0.0 0
M  V30 4 O 2.1037 2.6675 0.0 0
M  V30 5 O 4.4137 1.3338 0.0 0
M  V30 6 O 4.4137 6.6686 0.0 0
M  V30 7 C 1.3337 1.3338 0.0 0
M  V30 8 C 0.0000 2.1038 0.0 0
M  V30 9 C 0.5636 0.0000 0.0 0
M  V30 10 C 2.6673 0.5638 0.0 0
M  V30 11 C 10.5738 4.0011 0.0 0
M  V30 12 F 10.5738 2.4611 0.0 0
M  V30 13 F 12.1138 4.0011 0.0 0
M  V30 14 F 10.5738 5.5411 0.0 0
M  V30 15 C 5.9537 4.0011 0.0 0
M  V30 16 C 6.7237 2.6675 0.0 0
M  V30 17 C 6.7237 5.3348 0.0 0
M  V30 18 C 8.2637 2.6675 0.0 0
M  V30 19 C 8.2637 5.3348 0.0 0
M  V30 20 C 9.0337 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-14-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259119-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-11565360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
tert-Butyl formylcarbamates and N-Formyl pivalamides A) Formylation
Acetic anhydride (102 mmol 3.3 equiv) was given into an oven-dried
round-bottomed flask and cooled down to 0 °C, formic acid (102 mmol, 3.3
equiv) was added dropwise and the mixture was warmed up to rt and then to
60 °C for 1.5 h subsequently. After cooling down to rt THF (56 mL) was
added and the solution was cooled down to 0 °C before the amine (30.9
mmol, 1.00 equiv) in THF (32 mL) was added dropwise. The mixture was
warmed up to rt and stirred for 1 h. The remaining acid was neutralized
with K2CO3 and solvent was removed under vacuum. The remaining residue
was extracted with DCM (2 x 50 mL), washed with water (2 x 50 mL) and
dried over MgSO4. The solvent was removed under vacuum and the isolated
product was used without further purification for the next step of the
reaction sequence. B) Boc Group Protection Boc2O (10.0 mmol, 1.00 equiv),
the amide (10.0 mmol, 1.00 equiv) and DMAP (0.5 mmol, 0.05 equiv) were
placed into round-bottomed flask and dissolved in acetonitrile (20 mL, 2
mL/mmol). The mixture was stirred at rt for 14 h. After removal of the
solvent the residue was redissolved in DCM and H2O was added for
extraction. The collected organic layers were washed with brine, dried
over MgSO4 and dried under vacuum. tert-Butyl formyl(phenyl)carbamate
(AA) tert-Butyl formyl(4-(trifluoromethyl)phenyl)carbamate (AC)
Synthesized according to the general procedure using
4-(trifluoromethyl)benzenamine (81 mg, 0.5 mmol). The crude product was
purified by column chromatography (10–25 % ethyl acetate in pentane) to
yield the product as white solid (145 mg, 100 %). M.P. 64–65 °C; 1H-NMR δ
(CDCl3, 300 MHz) 9.40 (s, 1H), 7.70 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 8.5
Hz, 2H), 1.58 (s, 9H); 13C-NMR δ (CDCl3, 100 MHz) 162.5, 151.6, 137.7 (q,
JCF = 1 Hz), 130.7 (q, J CF = 33 Hz), 128.9 (2C), 126.2 (q, 1 J CF = 4
Hz, 2C), 85.3, 27.9 (3C);IR νmax/cm-1 (CHCl3) 3410, 3086, 2982, 2936,
1744, 1709, 1327, 1285, 1238, 1153, 1126, 1069, 1018, 849; HRMS m/z (EI)
calcd. for C13H14F3NO3: 289.0926, found 289.0927.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-Oxazolones and α-Aminoketones via Palladium-Catalyzed
Reaction of β,β-Dibromoenamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chai, David I.; Hoffmeister, Laura; Lautens, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2011), 13(1), 106-109

$RFMT $RIREG SCHEME147 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)aniline
C7H6F3N
455-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-formyl-N-[4-(trifluoromethyl)phenyl]carbamate
C13H14F3NO3
1259119-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 4.0011 0.0 0
M  V30 2 C 3.6437 2.6675 0.0 0
M  V30 3 C 3.6437 5.3348 0.0 0
M  V30 4 O 2.1037 2.6675 0.0 0
M  V30 5 O 4.4137 1.3338 0.0 0
M  V30 6 O 4.4137 6.6686 0.0 0
M  V30 7 C 1.3337 1.3338 0.0 0
M  V30 8 C 0.0000 2.1038 0.0 0
M  V30 9 C 0.5636 0.0000 0.0 0
M  V30 10 C 2.6673 0.5638 0.0 0
M  V30 11 C 10.5738 4.0011 0.0 0
M  V30 12 F 10.5738 2.4611 0.0 0
M  V30 13 F 12.1138 4.0011 0.0 0
M  V30 14 F 10.5738 5.5411 0.0 0
M  V30 15 C 5.9537 4.0011 0.0 0
M  V30 16 C 6.7237 2.6675 0.0 0
M  V30 17 C 6.7237 5.3348 0.0 0
M  V30 18 C 8.2637 2.6675 0.0 0
M  V30 19 C 8.2637 5.3348 0.0 0
M  V30 20 C 9.0337 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-14-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259119-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-8690607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM t-Butyl formyl(4-(trifluoromethyl)phenyl)carbamate (AC): General
procedure for the synthesis of t-butyl formylcarbamates and N-formyl
pivalamides. A) Formylation: Acetic anhydride (102 mmol 3.3 equiv.) was
given into an oven-dried round-bottomed flask and cooled down to 0 degC,
formic acid (102 mmol, 3.3 equiv.) was added dropwise and the mixture was
warmed up to rt and then to 60 degC for 1.5 hr subsequently. After
cooling down to rt, THF (56 mL) was added and the solution was cooled
down to 0 degC before the amine (30.9 mmol, 1.00 equiv.) in THF (32 mL)
was added dropwise. The mixture was warmed up to rt and stirred for 1 hr.
The remaining acid was neutralized with K2CO3 and solvent was removed
under vacuum. The remaining residue was extracted with DCM (2 x 50 mL),
washed with water (2 x 50 mL) and dried over MgSO4. The solvent was
removed under vacuum and the isolated product was used without further
purification for the next step of the reaction sequence. B) Boc group
protection: BOC2O (10.0 mmol, 1.00 equiv.), the amide (10.0 mmol, 1.00
equiv.) and DMAP (0.5 mmol, 0.05 equiv.) were placed into round-bottomed
flask and dissolved in acetonitrile (20 mL, 2 mL/mmol). The mixture was
stirred at rt for 14 hr. After removal of the solvent the residue was
redissolved in DCM and H2O was added for extraction. The collected
organic layers were washed with brine, dried over MgSO4 and dried under
vacuum. Synthesized according to the general procedure using
4-(trifluoromethyl)benzenamine (81 mg, 0.5 mmol). The crude product was
purified by column chromatography (10-25 % ethyl acetate in pentane) to
yield the product as white solid (145 mg, 100 %). mp 64-65 degC.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocycles and carbocycles through tandem and domino
palladium-catalyzed reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chai, David Ingoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2011), 73(5), 605 pages

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 6-[[5-fluoro-2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimid...
C28H36FN7O3S2
2455425-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9747 3.5650 0.0 0
M  V30 2 O 2.8138 2.0333 0.0 0
M  V30 3 O 1.7288 4.4701 0.0 0
M  V30 4 C 1.4068 1.4070 0.0 0
M  V30 5 C 2.0332 0.0000 0.0 0
M  V30 6 C 0.0000 0.7806 0.0 0
M  V30 7 C 0.7805 2.8138 0.0 0
M  V30 8 C 8.9930 8.0782 0.0 0
M  V30 9 O 8.2230 9.4119 0.0 0
M  V30 10 F 10.5331 10.7457 0.0 0
M  V30 11 N 16.6142 5.4565 0.0 0
M  V30 12 C 17.9479 6.2265 0.0 0
M  V30 13 C 19.2817 5.4565 0.0 0 CFG=1
M  V30 14 C 20.6153 6.2265 0.0 0
M  V30 15 C 19.2817 3.9165 0.0 0
M  V30 16 N 21.9490 5.4565 0.0 0
M  V30 17 S 27.2838 8.5366 0.0 0
M  V30 18 C 28.6175 7.7665 0.0 0
M  V30 19 C 6.3713 5.0772 0.0 0
M  V30 20 C 5.8193 3.6394 0.0 0
M  V30 21 C 4.9335 5.6291 0.0 0
M  V30 22 C 6.6914 6.5835 0.0 0
M  V30 23 C 7.7049 4.3072 0.0 0
M  V30 24 N 4.3815 4.1914 0.0 0
M  V30 25 N 8.2230 6.7446 0.0 0
M  V30 26 C 8.8493 5.3376 0.0 0
M  V30 27 C 10.5331 8.0782 0.0 0
M  V30 28 C 11.3031 6.7446 0.0 0
M  V30 29 C 11.3031 9.4119 0.0 0
M  V30 30 C 12.8431 6.7446 0.0 0
M  V30 31 C 12.8431 9.4119 0.0 0
M  V30 32 C 13.6131 8.0782 0.0 0
M  V30 33 S 13.8735 5.6000 0.0 0
M  V30 34 N 15.1196 7.7581 0.0 0
M  V30 35 C 15.2805 6.2265 0.0 0
M  V30 36 C 23.2827 6.2265 0.0 0
M  V30 37 N 24.6165 5.4565 0.0 0
M  V30 38 N 23.2827 7.7665 0.0 0
M  V30 39 C 25.9502 6.2265 0.0 0
M  V30 40 C 24.6165 8.5366 0.0 0
M  V30 41 C 25.9502 7.7665 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 25
M  V30 10 1 8 27
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 35
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 13 15 CFG=3
M  V30 17 1 14 16
M  V30 18 1 16 36
M  V30 19 1 17 18
M  V30 20 1 17 41
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 36 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2,6-diazaspiro[3.4]oct-6-yl[5-fluoro-2-[[(2S)-2-meth...
C23H28FN7OS2.xCH2O2
2457408-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6114 4.9775 0.0 0
M  V30 2 O 3.8414 3.6438 0.0 0
M  V30 3 F 6.1514 2.3100 0.0 0
M  V30 4 N 12.2325 7.5992 0.0 0
M  V30 5 C 13.5663 6.8292 0.0 0
M  V30 6 C 14.8999 7.5992 0.0 0 CFG=1
M  V30 7 C 16.2336 6.8292 0.0 0
M  V30 8 C 14.8999 9.1392 0.0 0
M  V30 9 N 17.5672 7.5992 0.0 0
M  V30 10 S 22.9020 4.5192 0.0 0
M  V30 11 C 24.2358 5.2892 0.0 0
M  V30 12 C 1.9897 7.9785 0.0 0
M  V30 13 C 2.3099 6.4721 0.0 0
M  V30 14 C 3.3233 8.7485 0.0 0
M  V30 15 C 0.5519 7.4266 0.0 0
M  V30 16 C 1.4378 9.4162 0.0 0
M  V30 17 N 3.8414 6.3111 0.0 0
M  V30 18 C 4.4679 7.7181 0.0 0
M  V30 19 N 0.0000 8.8643 0.0 0
M  V30 20 C 6.1514 4.9775 0.0 0
M  V30 21 C 6.9214 6.3111 0.0 0
M  V30 22 C 6.9214 3.6438 0.0 0
M  V30 23 C 8.4614 6.3111 0.0 0
M  V30 24 C 8.4614 3.6438 0.0 0
M  V30 25 C 9.2314 4.9775 0.0 0
M  V30 26 S 9.4920 7.4557 0.0 0
M  V30 27 N 10.7379 5.2976 0.0 0
M  V30 28 C 10.8988 6.8292 0.0 0
M  V30 29 C 18.9010 6.8292 0.0 0
M  V30 30 N 18.9010 5.2892 0.0 0
M  V30 31 N 20.2347 7.5992 0.0 0
M  V30 32 C 20.2347 4.5192 0.0 0
M  V30 33 C 21.5683 6.8292 0.0 0
M  V30 34 C 21.5683 5.2892 0.0 0
M  V30 35 C 12.1179 0.0000 0.0 0
M  V30 36 O 10.7842 0.7700 0.0 0
M  V30 37 O 13.4516 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 20
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 10 34
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 24 25
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2455425-86-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2457408-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-22779763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
2-[[2-methyl-3-[[5-(methylthio)pyrimidin-2-yl]amino]propyl]amino]benzo[d]thiazoles
and analogs as PCSK9 inhibitors and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serrano-Wu, Michael H.; Hubbard, Brian K.; Kaushik, Virendar; Daniels,
Doug
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020150474 A1 2020-07-23

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 6-[[5-fluoro-2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimid...
C28H36FN7O3S2
2455425-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9747 3.5650 0.0 0
M  V30 2 O 2.8138 2.0333 0.0 0
M  V30 3 O 1.7288 4.4701 0.0 0
M  V30 4 C 1.4068 1.4070 0.0 0
M  V30 5 C 2.0332 0.0000 0.0 0
M  V30 6 C 0.0000 0.7806 0.0 0
M  V30 7 C 0.7805 2.8138 0.0 0
M  V30 8 C 8.9930 8.0782 0.0 0
M  V30 9 O 8.2230 9.4119 0.0 0
M  V30 10 F 10.5331 10.7457 0.0 0
M  V30 11 N 16.6142 5.4565 0.0 0
M  V30 12 C 17.9479 6.2265 0.0 0
M  V30 13 C 19.2817 5.4565 0.0 0 CFG=1
M  V30 14 C 20.6153 6.2265 0.0 0
M  V30 15 C 19.2817 3.9165 0.0 0
M  V30 16 N 21.9490 5.4565 0.0 0
M  V30 17 S 27.2838 8.5366 0.0 0
M  V30 18 C 28.6175 7.7665 0.0 0
M  V30 19 C 6.3713 5.0772 0.0 0
M  V30 20 C 5.8193 3.6394 0.0 0
M  V30 21 C 4.9335 5.6291 0.0 0
M  V30 22 C 6.6914 6.5835 0.0 0
M  V30 23 C 7.7049 4.3072 0.0 0
M  V30 24 N 4.3815 4.1914 0.0 0
M  V30 25 N 8.2230 6.7446 0.0 0
M  V30 26 C 8.8493 5.3376 0.0 0
M  V30 27 C 10.5331 8.0782 0.0 0
M  V30 28 C 11.3031 6.7446 0.0 0
M  V30 29 C 11.3031 9.4119 0.0 0
M  V30 30 C 12.8431 6.7446 0.0 0
M  V30 31 C 12.8431 9.4119 0.0 0
M  V30 32 C 13.6131 8.0782 0.0 0
M  V30 33 S 13.8735 5.6000 0.0 0
M  V30 34 N 15.1196 7.7581 0.0 0
M  V30 35 C 15.2805 6.2265 0.0 0
M  V30 36 C 23.2827 6.2265 0.0 0
M  V30 37 N 24.6165 5.4565 0.0 0
M  V30 38 N 23.2827 7.7665 0.0 0
M  V30 39 C 25.9502 6.2265 0.0 0
M  V30 40 C 24.6165 8.5366 0.0 0
M  V30 41 C 25.9502 7.7665 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 25
M  V30 10 1 8 27
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 35
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 13 15 CFG=3
M  V30 17 1 14 16
M  V30 18 1 16 36
M  V30 19 1 17 18
M  V30 20 1 17 41
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 36 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2,6-diazaspiro[3.4]oct-6-yl[5-fluoro-2-[[(2S)-2-meth...
C23H28FN7OS2.xCH2O2
2457408-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6114 4.9775 0.0 0
M  V30 2 O 3.8414 3.6438 0.0 0
M  V30 3 F 6.1514 2.3100 0.0 0
M  V30 4 N 12.2325 7.5992 0.0 0
M  V30 5 C 13.5663 6.8292 0.0 0
M  V30 6 C 14.8999 7.5992 0.0 0 CFG=1
M  V30 7 C 16.2336 6.8292 0.0 0
M  V30 8 C 14.8999 9.1392 0.0 0
M  V30 9 N 17.5672 7.5992 0.0 0
M  V30 10 S 22.9020 4.5192 0.0 0
M  V30 11 C 24.2358 5.2892 0.0 0
M  V30 12 C 1.9897 7.9785 0.0 0
M  V30 13 C 2.3099 6.4721 0.0 0
M  V30 14 C 3.3233 8.7485 0.0 0
M  V30 15 C 0.5519 7.4266 0.0 0
M  V30 16 C 1.4378 9.4162 0.0 0
M  V30 17 N 3.8414 6.3111 0.0 0
M  V30 18 C 4.4679 7.7181 0.0 0
M  V30 19 N 0.0000 8.8643 0.0 0
M  V30 20 C 6.1514 4.9775 0.0 0
M  V30 21 C 6.9214 6.3111 0.0 0
M  V30 22 C 6.9214 3.6438 0.0 0
M  V30 23 C 8.4614 6.3111 0.0 0
M  V30 24 C 8.4614 3.6438 0.0 0
M  V30 25 C 9.2314 4.9775 0.0 0
M  V30 26 S 9.4920 7.4557 0.0 0
M  V30 27 N 10.7379 5.2976 0.0 0
M  V30 28 C 10.8988 6.8292 0.0 0
M  V30 29 C 18.9010 6.8292 0.0 0
M  V30 30 N 18.9010 5.2892 0.0 0
M  V30 31 N 20.2347 7.5992 0.0 0
M  V30 32 C 20.2347 4.5192 0.0 0
M  V30 33 C 21.5683 6.8292 0.0 0
M  V30 34 C 21.5683 5.2892 0.0 0
M  V30 35 C 12.1179 0.0000 0.0 0
M  V30 36 O 10.7842 0.7700 0.0 0
M  V30 37 O 13.4516 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 20
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 10 34
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 24 25
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2455425-86-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2457408-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-22790523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
2-[[2-methyl-3-[[5-(methylthio)pyrimidin-2-yl]amino]propyl]amino]benzo[d]thiazoles
and analogs as PCSK9 inhibitors and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serrano-Wu, Michael H.; Chambers, Mark; Goldsmith, Erica; Tierney, Jason;
Jandu, Karamjit; Clark, David; Hinchliffe, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020150473 A2 2020-07-23

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Hydroxy-4-(phenylmethoxy)phenyl]-2-butanone
C17H18O3
2460598-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 11.5500 2.6674 0.0 0
M  V30 5 C 12.3200 4.0011 0.0 0
M  V30 6 C 13.8600 4.0011 0.0 0
M  V30 7 C 14.6300 5.3349 0.0 0
M  V30 8 O 14.6300 2.6674 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 C 7.7000 1.3338 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 9.2400 1.3338 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 2.3100 5.3349 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.7700 5.3349 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(Formyloxy)-4-(phenylmethoxy)phenyl]-2-butanone
C18H18O4
2460598-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 O 5.3900 5.3347 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 C 11.5500 5.3347 0.0 0
M  V30 7 C 12.3200 6.6685 0.0 0
M  V30 8 C 13.8600 6.6685 0.0 0
M  V30 9 C 14.6300 8.0021 0.0 0
M  V30 10 O 14.6300 5.3347 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2460598-39-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2460598-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24911008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic Modification of Zingerone Reveals Structural Requirements for
Attraction of Jarvis's Fruit Fly
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanssen, Benjamin L.; Park, Soo Jean; Royer, Jane E.; Jamie, Joanne F.;
Taylor, Phillip W.; Jamie, Ian M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2019), 9(1), 19332

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-4-methoxy-, methyl ester
C9H11NO3
24812-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 O 7.7002 4.0010 0.0 0
M  V30 3 O 7.7002 1.3337 0.0 0
M  V30 4 C 9.2402 4.0010 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 O 0.7700 2.6673 0.0 0
M  V30 7 C 0.0000 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 3.0801 1.3337 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(formylamino)-4-methoxybenzoate
C10H11NO4
2279976-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 6.9300 0.0 0
M  V30 4 O 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24812-90-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279976-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(aminomethyl)-4-methyl-3-pyridinecarboxylate
C9H12N2O2
2489461-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 O 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 C 8.4702 2.6673 0.0 0
M  V30 7 N 9.2402 4.0010 0.0 0
M  V30 8 C 3.8501 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 N 6.1601 4.0010 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[(formylamino)methyl]-4-methyl-3-pyridinecarboxylate
C10H12N2O3
2489461-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 O 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 8.4700 2.6674 0.0 0
M  V30 7 N 9.2400 4.0011 0.0 0
M  V30 8 C 10.7800 4.0011 0.0 0
M  V30 9 O 11.5500 5.3349 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 1.3338 0.0 0
M  V30 14 N 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2489461-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489461-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23279652
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indazole derivatives for use as LRRK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garofalo, Albert W.; De Lombaert, Stephane; Andreotti, Daniele;
Sabbatini, Fabio Maria; Serra, Elena; Bernardi, Silvia; Migliore, Marco;
Budassi, Federica; Beato, Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020191261 A1 2020-09-24

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL

C40H35NO8
2495074-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6641 7.9387 0.0 0
M  V30 2 C 1.2941 7.2353 0.0 0
M  V30 3 C 1.2183 5.6973 0.0 0
M  V30 4 O 0.0000 8.0701 0.0 0
M  V30 5 O 5.5493 4.2980 0.0 0
M  V30 6 C 4.7793 2.9644 0.0 0
M  V30 7 C 5.5493 1.6307 0.0 0
M  V30 8 O 3.2393 2.9644 0.0 0
M  V30 9 O 6.5152 2.6066 0.0 0
M  V30 10 C 6.9845 1.1399 0.0 0
M  V30 11 C 5.9489 0.0000 0.0 0
M  V30 12 O 8.4894 0.8130 0.0 0
M  V30 13 O 13.1617 6.8744 0.0 0
M  V30 14 C 14.5982 7.4295 0.0 0
M  V30 15 C 14.8358 8.9510 0.0 0
M  V30 16 O 15.7971 6.4629 0.0 0
M  V30 17 C 5.5493 9.6327 0.0 0
M  V30 18 C 4.1100 10.1802 0.0 0
M  V30 19 C 6.4405 10.7402 0.0 0
M  V30 20 C 6.0545 8.3043 0.0 0
M  V30 21 C 4.1857 11.7184 0.0 0
M  V30 22 C 2.7400 9.4769 0.0 0
M  V30 23 N 7.9891 10.6042 0.0 0
M  V30 24 C 5.6720 12.1215 0.0 0
M  V30 25 C 7.5694 7.9551 0.0 0
M  V30 26 C 2.8917 12.5532 0.0 0
M  V30 27 C 1.4458 10.3116 0.0 0
M  V30 28 C 8.4796 9.1687 0.0 0
M  V30 29 C 9.0047 11.9586 0.0 0
M  V30 30 C 8.1169 6.3531 0.0 0
M  V30 31 C 1.5217 11.8497 0.0 0
M  V30 32 C 10.6094 11.7972 0.0 0
M  V30 33 C 9.6218 6.0262 0.0 0
M  V30 34 C 7.0813 5.2132 0.0 0
M  V30 35 C 11.0882 10.2654 0.0 0
M  V30 36 C 10.6217 7.3197 0.0 0
M  V30 37 C 10.0912 4.5595 0.0 0
M  V30 38 C 7.5507 3.7465 0.0 0
M  V30 39 C 12.2026 9.3549 0.0 0
M  V30 40 C 9.6307 9.6725 0.0 0
M  V30 41 C 11.9628 7.8411 0.0 0
M  V30 42 C 9.4188 8.3339 0.0 0
M  V30 43 C 9.0555 3.4196 0.0 0
M  V30 44 C 4.7793 8.2991 0.0 0
M  V30 45 C 5.5493 6.9655 0.0 0
M  V30 46 C 3.2393 8.2991 0.0 0
M  V30 47 C 4.7793 5.6318 0.0 0
M  V30 48 C 2.4692 6.9655 0.0 0
M  V30 49 C 3.2393 5.6318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 47
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 38
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 41
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 44
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 2 20 25
M  V30 26 1 21 24
M  V30 27 2 21 26
M  V30 28 1 22 27
M  V30 29 1 23 28
M  V30 30 1 23 29
M  V30 31 1 25 28
M  V30 32 1 25 30
M  V30 33 1 26 31
M  V30 34 2 27 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 2 30 34
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 2 33 37
M  V30 41 1 34 38
M  V30 42 1 35 39
M  V30 43 2 35 40
M  V30 44 1 36 41
M  V30 45 2 36 42
M  V30 46 1 37 43
M  V30 47 2 38 43
M  V30 48 2 39 41
M  V30 49 1 40 42
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H27NO4.CH2O2
2546060-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.9449 5.0022 0.0 0
M  V30 2 O 1.9292 3.2919 0.0 0
M  V30 3 O 8.9460 2.3100 0.0 0
M  V30 4 O 12.5682 9.3293 0.0 0
M  V30 5 C 4.5966 7.9119 0.0 0
M  V30 6 C 4.8147 9.3164 0.0 0
M  V30 7 C 3.0763 7.6663 0.0 0
M  V30 8 C 5.6985 7.0139 0.0 0
M  V30 9 N 6.2238 9.9731 0.0 0
M  V30 10 C 3.4585 10.1286 0.0 0
M  V30 11 C 2.3728 9.0363 0.0 0
M  V30 12 C 2.2415 6.3722 0.0 0
M  V30 13 C 7.1850 7.4689 0.0 0
M  V30 14 C 7.3664 8.9751 0.0 0
M  V30 15 C 6.4261 11.6538 0.0 0
M  V30 16 C 0.8348 9.1120 0.0 0
M  V30 17 C 0.7035 6.4480 0.0 0
M  V30 18 C 8.4600 6.3554 0.0 0
M  V30 19 C 7.8967 12.3163 0.0 0
M  V30 20 C 0.0000 7.8180 0.0 0
M  V30 21 C 9.9267 6.8247 0.0 0
M  V30 22 C 8.1330 4.8504 0.0 0
M  V30 23 C 9.0771 11.2292 0.0 0
M  V30 24 C 10.1460 8.4448 0.0 0
M  V30 25 C 11.0666 5.7892 0.0 0
M  V30 26 C 9.2730 3.8149 0.0 0
M  V30 27 C 10.4974 10.9979 0.0 0
M  V30 28 C 8.1113 9.9869 0.0 0
M  V30 29 C 11.0467 9.5670 0.0 0
M  V30 30 C 8.5970 8.7217 0.0 0
M  V30 31 C 10.7397 4.2843 0.0 0
M  V30 32 C 4.5966 6.3719 0.0 0
M  V30 33 C 3.2630 5.6019 0.0 0
M  V30 34 C 5.9302 5.6019 0.0 0
M  V30 35 C 3.2630 4.0619 0.0 0
M  V30 36 C 5.9302 4.0619 0.0 0
M  V30 37 C 4.5966 3.2919 0.0 0
M  V30 38 C 6.2841 0.0000 0.0 0
M  V30 39 O 4.9505 0.7700 0.0 0
M  V30 40 O 7.6178 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 35
M  V30 3 1 3 26
M  V30 4 1 4 29
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 32
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 11
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 13 14
M  V30 20 1 13 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 2 18 22
M  V30 26 1 19 23
M  V30 27 1 21 24
M  V30 28 2 21 25
M  V30 29 1 22 26
M  V30 30 1 23 27
M  V30 31 2 23 28
M  V30 32 1 24 29
M  V30 33 2 24 30
M  V30 34 1 25 31
M  V30 35 2 26 31
M  V30 36 2 27 29
M  V30 37 1 28 30
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 44 1 38 39
M  V30 45 2 38 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2495074-61-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2546060-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-23031733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as HCO2H salt using preparative TLC eluting with 17%
MeOH/CHCl3 containing 5% HCO2H
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable Total Syntheses and Structure-Activity Relationships of
Haouamines A, B, and Their Derivatives as Stable Formate Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsukamoto, Hirokazu; Nakamura, Saki; Tomida, Akito; Doi, Takayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(55), 12528-12532

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL

C40H35NO8
2495094-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6072 7.7607 0.0 0
M  V30 2 C 1.1411 8.2319 0.0 0
M  V30 3 C 0.0000 7.1980 0.0 0
M  V30 4 O 0.8164 9.7373 0.0 0
M  V30 5 O 7.8879 3.8663 0.0 0
M  V30 6 C 7.1179 2.5325 0.0 0
M  V30 7 C 7.8879 1.1989 0.0 0
M  V30 8 O 5.5779 2.5325 0.0 0
M  V30 9 O 10.6394 2.6642 0.0 0
M  V30 10 C 11.4723 1.3689 0.0 0
M  V30 11 C 10.7671 0.0000 0.0 0
M  V30 12 O 13.0106 1.4427 0.0 0
M  V30 13 O 15.9549 8.5070 0.0 0
M  V30 14 C 17.1988 9.4148 0.0 0
M  V30 15 C 17.0345 10.9460 0.0 0
M  V30 16 O 18.6070 8.7914 0.0 0
M  V30 17 C 7.8879 9.2011 0.0 0
M  V30 18 C 8.4620 10.5013 0.0 0
M  V30 19 C 6.3559 9.3572 0.0 0
M  V30 20 C 8.7198 8.0485 0.0 0
M  V30 21 N 9.9931 10.7708 0.0 0
M  V30 22 C 7.3623 11.6367 0.0 0
M  V30 23 C 6.0311 10.8626 0.0 0
M  V30 24 C 5.2146 8.3233 0.0 0
M  V30 25 C 10.2735 8.1032 0.0 0
M  V30 26 C 10.8386 9.5112 0.0 0
M  V30 27 C 10.6237 12.3419 0.0 0
M  V30 28 C 4.5650 11.3340 0.0 0
M  V30 29 C 3.7485 8.7947 0.0 0
M  V30 30 C 11.2169 6.6976 0.0 0
M  V30 31 C 12.2155 12.6012 0.0 0
M  V30 32 C 3.4237 10.3000 0.0 0
M  V30 33 C 12.7551 6.7714 0.0 0
M  V30 34 C 10.5116 5.3286 0.0 0
M  V30 35 C 13.0743 11.2456 0.0 0
M  V30 36 C 13.3862 8.2794 0.0 0
M  V30 37 C 13.5881 5.4761 0.0 0
M  V30 38 C 11.3446 4.0333 0.0 0
M  V30 39 C 14.3864 10.6547 0.0 0
M  V30 40 C 11.8202 10.2957 0.0 0
M  V30 41 C 14.5466 9.1302 0.0 0
M  V30 42 C 11.9618 8.9479 0.0 0
M  V30 43 C 12.8829 4.1070 0.0 0
M  V30 44 C 7.1179 7.8673 0.0 0
M  V30 45 C 7.8879 6.5336 0.0 0
M  V30 46 C 5.5779 7.8673 0.0 0
M  V30 47 C 7.1179 5.2000 0.0 0
M  V30 48 C 4.8079 6.5336 0.0 0
M  V30 49 C 5.5779 5.2000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 47
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 38
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 41
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 44
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 19 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 1 21 27
M  V30 28 1 22 23
M  V30 29 2 23 28
M  V30 30 1 24 29
M  V30 31 1 25 26
M  V30 32 1 25 30
M  V30 33 1 27 31
M  V30 34 1 28 32
M  V30 35 2 29 32
M  V30 36 1 30 33
M  V30 37 2 30 34
M  V30 38 1 31 35
M  V30 39 1 33 36
M  V30 40 2 33 37
M  V30 41 1 34 38
M  V30 42 1 35 39
M  V30 43 2 35 40
M  V30 44 1 36 41
M  V30 45 2 36 42
M  V30 46 1 37 43
M  V30 47 2 38 43
M  V30 48 2 39 41
M  V30 49 1 40 42
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H27NO4.CH2O2
2495094-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 7.4063 0.0 0
M  V30 2 O 5.2807 3.5120 0.0 0
M  V30 3 O 8.0320 2.3100 0.0 0
M  V30 4 O 13.3475 8.1526 0.0 0
M  V30 5 C 5.2807 8.8467 0.0 0
M  V30 6 C 5.8548 10.1471 0.0 0
M  V30 7 C 3.7485 9.0030 0.0 0
M  V30 8 C 6.1126 7.6943 0.0 0
M  V30 9 N 7.3858 10.4166 0.0 0
M  V30 10 C 4.7551 11.2825 0.0 0
M  V30 11 C 3.4237 10.5084 0.0 0
M  V30 12 C 2.6074 7.9691 0.0 0
M  V30 13 C 7.6661 7.7490 0.0 0
M  V30 14 C 8.2313 9.1569 0.0 0
M  V30 15 C 8.0163 11.9877 0.0 0
M  V30 16 C 1.9576 10.9798 0.0 0
M  V30 17 C 1.1413 8.4403 0.0 0
M  V30 18 C 8.6095 6.3433 0.0 0
M  V30 19 C 9.6082 12.2470 0.0 0
M  V30 20 C 0.8164 9.9456 0.0 0
M  V30 21 C 10.1478 6.4170 0.0 0
M  V30 22 C 7.9044 4.9744 0.0 0
M  V30 23 C 10.4671 10.8914 0.0 0
M  V30 24 C 10.7788 7.9252 0.0 0
M  V30 25 C 10.9808 5.1217 0.0 0
M  V30 26 C 8.7373 3.6791 0.0 0
M  V30 27 C 11.7792 10.3005 0.0 0
M  V30 28 C 9.2127 9.9415 0.0 0
M  V30 29 C 11.9393 8.7760 0.0 0
M  V30 30 C 9.3544 8.5935 0.0 0
M  V30 31 C 10.2755 3.7528 0.0 0
M  V30 32 C 4.5107 7.5131 0.0 0
M  V30 33 C 5.2807 6.1794 0.0 0
M  V30 34 C 2.9707 7.5131 0.0 0
M  V30 35 C 4.5107 4.8458 0.0 0
M  V30 36 C 2.2007 6.1794 0.0 0
M  V30 37 C 2.9707 4.8458 0.0 0
M  V30 38 C 6.6737 0.0000 0.0 0
M  V30 39 O 5.3401 0.7700 0.0 0
M  V30 40 O 8.0074 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 35
M  V30 3 1 3 26
M  V30 4 1 4 29
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 32
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 11
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 13 14
M  V30 20 1 13 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 2 18 22
M  V30 26 1 19 23
M  V30 27 1 21 24
M  V30 28 2 21 25
M  V30 29 1 22 26
M  V30 30 1 23 27
M  V30 31 2 23 28
M  V30 32 1 24 29
M  V30 33 2 24 30
M  V30 34 1 25 31
M  V30 35 2 26 31
M  V30 36 2 27 29
M  V30 37 1 28 30
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 44 1 38 39
M  V30 45 2 38 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2495094-78-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2495094-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-23034596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as HCO2H salt using preparative TLC eluting with 17%
MeOH/CHCl3 containing 5% HCO2H
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable Total Syntheses and Structure-Activity Relationships of
Haouamines A, B, and Their Derivatives as Stable Formate Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsukamoto, Hirokazu; Nakamura, Saki; Tomida, Akito; Doi, Takayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(55), 12528-12532

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C42H39NO
2553219-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5951 5.0107 0.0 0
M  V30 2 C 11.3651 6.3443 0.0 0
M  V30 3 C 12.9051 6.3443 0.0 0
M  V30 4 C 13.6751 7.6779 0.0 0
M  V30 5 C 15.2151 7.6779 0.0 0
M  V30 6 C 15.9851 9.0116 0.0 0
M  V30 7 C 17.5251 9.0116 0.0 0
M  V30 8 C 18.2951 10.3454 0.0 0
M  V30 9 C 19.8351 10.3454 0.0 0
M  V30 10 N 3.4939 0.0000 0.0 0
M  V30 11 C 7.5235 3.9840 0.0 0
M  V30 12 C 6.9954 1.5743 0.0 0
M  V30 13 C 4.9760 4.8513 0.0 0
M  V30 14 C 7.5152 5.0107 0.0 0
M  V30 15 C 7.4411 1.9564 0.0 0
M  V30 16 C 4.4440 2.1056 0.0 0
M  V30 17 C 4.9388 5.4996 0.0 0
M  V30 18 C 4.2096 3.4348 0.0 0
M  V30 19 C 5.4414 5.0276 0.0 0
M  V30 20 C 6.6052 4.3302 0.0 0
M  V30 21 C 4.7935 2.9081 0.0 0
M  V30 22 C 3.7108 3.8166 0.0 0
M  V30 23 C 6.3134 6.1937 0.0 0
M  V30 24 C 3.9552 1.9161 0.0 0
M  V30 25 C 5.0527 7.3336 0.0 0
M  V30 26 C 6.8402 2.9942 0.0 0
M  V30 27 C 6.1410 3.1185 0.0 0
M  V30 28 C 1.6536 4.8536 0.0 0
M  V30 29 C 7.6019 5.3502 0.0 0
M  V30 30 C 5.1433 0.9363 0.0 0
M  V30 31 C 3.6797 7.9479 0.0 0
M  V30 32 C 2.7655 7.2033 0.0 0
M  V30 33 C 6.5858 1.4753 0.0 0
M  V30 34 C 7.5158 3.8127 0.0 0
M  V30 35 C 0.8752 5.9339 0.0 0
M  V30 36 C 2.4547 7.0145 0.0 0
M  V30 37 C 3.4838 9.4753 0.0 0
M  V30 38 C 2.6613 8.7398 0.0 0
M  V30 39 C 0.1044 7.0227 0.0 0
M  V30 40 C 1.0340 7.6086 0.0 0
M  V30 41 C 2.0631 10.0694 0.0 0
M  V30 42 C 1.2785 9.4177 0.0 0
M  V30 43 C 0.0000 8.5591 0.0 0
M  V30 44 C 0.8382 9.1362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 21
M  V30 23 2 17 23
M  V30 24 1 18 20
M  V30 25 2 18 24
M  V30 26 2 19 22
M  V30 27 1 19 25
M  V30 28 2 20 26
M  V30 29 2 21 27
M  V30 30 1 22 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 33
M  V30 36 1 27 34
M  V30 37 1 28 35
M  V30 38 1 28 36
M  V30 39 2 29 34
M  V30 40 2 30 33
M  V30 41 1 31 36
M  V30 42 2 31 37
M  V30 43 1 32 35
M  V30 44 2 32 38
M  V30 45 2 35 39
M  V30 46 2 36 40
M  V30 47 1 37 41
M  V30 48 1 38 42
M  V30 49 1 39 43
M  V30 50 1 40 44
M  V30 51 2 41 44
M  V30 52 2 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C43H39NO2
2605741-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.6269 9.0321 0.0 0
M  V30 2 C 12.9605 8.2621 0.0 0
M  V30 3 C 14.2941 9.0321 0.0 0
M  V30 4 C 15.6277 8.2621 0.0 0
M  V30 5 C 16.9615 9.0321 0.0 0
M  V30 6 C 18.2951 8.2621 0.0 0
M  V30 7 C 19.6287 9.0321 0.0 0
M  V30 8 C 20.9624 8.2621 0.0 0
M  V30 9 C 22.2961 9.0321 0.0 0
M  V30 10 N 2.5676 9.7410 0.0 0
M  V30 11 C 1.0752 9.3611 0.0 0
M  V30 12 O 0.0000 10.4636 0.0 0
M  V30 13 C 7.7866 8.0005 0.0 0
M  V30 14 C 6.1245 9.8231 0.0 0
M  V30 15 C 6.0141 5.9756 0.0 0
M  V30 16 C 8.2926 7.1072 0.0 0
M  V30 17 C 6.7014 9.7151 0.0 0
M  V30 18 C 4.1804 8.0872 0.0 0
M  V30 19 C 6.3059 5.3955 0.0 0
M  V30 20 C 4.6421 6.8190 0.0 0
M  V30 21 C 6.5053 6.0555 0.0 0
M  V30 22 C 7.1645 7.2415 0.0 0
M  V30 23 C 4.8845 7.5670 0.0 0
M  V30 24 C 4.4010 6.2391 0.0 0
M  V30 25 C 7.8434 5.4817 0.0 0
M  V30 26 C 3.6624 8.0071 0.0 0
M  V30 27 C 7.3217 3.8641 0.0 0
M  V30 28 C 6.7000 8.5159 0.0 0
M  V30 29 C 6.1567 8.0586 0.0 0
M  V30 30 C 3.1380 4.3124 0.0 0
M  V30 31 C 8.5377 6.8563 0.0 0
M  V30 32 C 4.2014 9.4496 0.0 0
M  V30 33 C 6.4397 2.6457 0.0 0
M  V30 34 C 5.2758 2.8334 0.0 0
M  V30 35 C 5.7203 9.7040 0.0 0
M  V30 36 C 7.6942 8.1448 0.0 0
M  V30 37 C 3.0040 2.9876 0.0 0
M  V30 38 C 4.9122 2.8416 0.0 0
M  V30 39 C 7.0339 1.2249 0.0 0
M  V30 40 C 5.9537 1.4507 0.0 0
M  V30 41 C 2.8808 1.6592 0.0 0
M  V30 42 C 3.9788 1.6167 0.0 0
M  V30 43 C 6.1005 0.0000 0.0 0
M  V30 44 C 5.0952 0.1722 0.0 0
M  V30 45 C 3.5587 0.2764 0.0 0
M  V30 46 C 4.5730 0.1959 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 1 19 23
M  V30 25 2 19 25
M  V30 26 1 20 22
M  V30 27 2 20 26
M  V30 28 2 21 24
M  V30 29 1 21 27
M  V30 30 2 22 28
M  V30 31 2 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 26 32
M  V30 35 1 27 33
M  V30 36 1 27 34
M  V30 37 1 28 35
M  V30 38 1 29 36
M  V30 39 1 30 37
M  V30 40 1 30 38
M  V30 41 2 31 36
M  V30 42 2 32 35
M  V30 43 1 33 38
M  V30 44 2 33 39
M  V30 45 1 34 37
M  V30 46 2 34 40
M  V30 47 2 37 41
M  V30 48 2 38 42
M  V30 49 1 39 43
M  V30 50 1 40 44
M  V30 51 1 41 45
M  V30 52 1 42 46
M  V30 53 2 43 46
M  V30 54 2 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2553219-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2605741-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23151345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A polymorphic pentiptycene-containing gold(I) isocyanide complex:
solvent- and conformation-dependent supramolecular luminescence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hsu, Ying-Feng; Chen, Ssu-Ying; Maity, Subhendu; Liu, Yi-Hung; Peng,
Shie-Ming; Yang, Jye-Shane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2020), 49(44), 15602-15606

$RFMT $RIREG SCHEME155 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthracene
C14H11N
613-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 8.0023 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Anthracenylamino)methylene]-1-methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C20H15N3O3
2178914-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 10.0100 2.6674 0.0 0
M  V30 3 O 11.5500 0.0000 0.0 0
M  V30 4 O 11.5500 5.3347 0.0 0
M  V30 5 C 14.6300 0.0000 0.0 0
M  V30 6 O 16.1700 2.6674 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 4.6200 6.6685 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 21 C 11.5500 2.6674 0.0 0
M  V30 22 C 12.3200 1.3336 0.0 0
M  V30 23 C 12.3200 4.0011 0.0 0
M  V30 24 N 13.8600 1.3336 0.0 0
M  V30 25 N 13.8600 4.0011 0.0 0
M  V30 26 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 21 CFG=2
M  V30 4 2 3 22
M  V30 5 2 4 23
M  V30 6 1 5 24
M  V30 7 2 6 26
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 13 17
M  V30 19 1 14 16
M  V30 20 1 15 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 613-13-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22139830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
Aniline
C6H7N
62-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-[(phenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C12H11N3O3
23069-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 4.6200 5.3349 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 2.3100 1.3338 0.0 0
M  V30 11 N 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.7800 2.6674 0.0 0
M  V30 17 C 10.7800 5.3349 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7 CFG=2
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 2 4 9
M  V30 6 1 5 10
M  V30 7 2 6 12
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-53-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23069-98-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21063684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME157 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminoanthraquinone
C14H9NO2
82-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 6.1600 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-1-anthracenyl)amino]methylene]-1-methyl-2,4,6(1H...
C20H13N3O5
2178915-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 O 5.3900 4.0011 0.0 0
M  V30 4 O 2.3100 9.3358 0.0 0
M  V30 5 O 12.3200 5.3347 0.0 0
M  V30 6 O 7.7000 2.6674 0.0 0
M  V30 7 C 13.8600 2.6674 0.0 0
M  V30 8 O 12.3200 0.0000 0.0 0
M  V30 9 C 5.3900 6.6684 0.0 0
M  V30 10 C 4.6200 8.0021 0.0 0
M  V30 11 C 6.9300 6.6684 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.0800 8.0021 0.0 0
M  V30 14 C 5.3900 9.3358 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6684 0.0 0
M  V30 18 C 6.9300 9.3358 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 5.3347 0.0 0
M  V30 23 C 10.0100 4.0011 0.0 0
M  V30 24 C 11.5500 4.0011 0.0 0
M  V30 25 C 9.2400 2.6674 0.0 0
M  V30 26 N 12.3200 2.6674 0.0 0
M  V30 27 N 10.0100 1.3336 0.0 0
M  V30 28 C 11.5500 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 23 CFG=2
M  V30 4 2 3 12
M  V30 5 2 4 13
M  V30 6 2 5 24
M  V30 7 2 6 25
M  V30 8 1 7 26
M  V30 9 2 8 28
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 17
M  V30 21 2 16 19
M  V30 22 2 17 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-45-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22132939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME158 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthylamine
C10H9N
91-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-[(2-naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C16H13N3O3
2178914-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 5.3347 0.0 0
M  V30 5 C 12.3200 0.0000 0.0 0
M  V30 6 O 13.8600 2.6674 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 5.3347 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.0100 1.3338 0.0 0
M  V30 19 C 10.0100 4.0011 0.0 0
M  V30 20 N 11.5500 1.3338 0.0 0
M  V30 21 N 11.5500 4.0011 0.0 0
M  V30 22 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 17 CFG=2
M  V30 4 2 3 18
M  V30 5 2 4 19
M  V30 6 1 5 20
M  V30 7 2 6 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-59-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22140331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobiphenyl
C12H11N
92-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 2.6673 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C5H6N2O3
2565-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[([1,1′-Biphenyl]-4-ylamino)methylene]-1-methyl-2,4,6(1H,3H,5H)-pyrimidinet...
C18H15N3O3
2178914-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 4.6200 5.3349 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 C 11.5500 4.0011 0.0 0
M  V30 8 C 10.7800 2.6674 0.0 0
M  V30 9 C 10.7800 5.3349 0.0 0
M  V30 10 C 9.2400 2.6674 0.0 0
M  V30 11 C 9.2400 5.3349 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 13.0900 4.0011 0.0 0
M  V30 14 C 13.8600 5.3349 0.0 0
M  V30 15 C 13.8600 2.6674 0.0 0
M  V30 16 C 15.4000 5.3349 0.0 0
M  V30 17 C 15.4000 2.6674 0.0 0
M  V30 18 C 16.1700 4.0011 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.8500 1.3338 0.0 0
M  V30 21 C 3.8500 4.0011 0.0 0
M  V30 22 N 2.3100 1.3338 0.0 0
M  V30 23 N 2.3100 4.0011 0.0 0
M  V30 24 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 19 CFG=2
M  V30 4 2 3 20
M  V30 5 2 4 21
M  V30 6 1 5 22
M  V30 7 2 6 24
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 13
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92-67-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2565-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22150046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (triphenylphosphoranylidene)acetate
C21H19O2P
2605-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0012 4.0010 0.0 0 VAL=5
M  V30 2 C 5.3348 3.2310 0.0 0
M  V30 3 C 6.6685 4.0010 0.0 0
M  V30 4 O 8.0023 3.2310 0.0 0
M  V30 5 O 6.6685 5.5410 0.0 0
M  V30 6 C 9.3360 4.0010 0.0 0
M  V30 7 C 3.2311 2.6673 0.0 0
M  V30 8 C 1.6911 2.6673 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 0.9211 1.3337 0.0 0
M  V30 11 C 3.2311 0.0000 0.0 0
M  V30 12 C 1.6911 0.0000 0.0 0
M  V30 13 C 4.3997 5.4887 0.0 0
M  V30 14 C 3.3108 6.5776 0.0 0
M  V30 15 C 5.8872 5.8872 0.0 0
M  V30 16 C 3.7093 8.0652 0.0 0
M  V30 17 C 6.2860 7.3748 0.0 0
M  V30 18 C 5.1968 8.4637 0.0 0
M  V30 19 C 2.6675 4.7710 0.0 0
M  V30 20 C 2.6675 6.3111 0.0 0
M  V30 21 C 1.3337 4.0010 0.0 0
M  V30 22 C 1.3337 7.0811 0.0 0
M  V30 23 C 0.0000 4.7710 0.0 0
M  V30 24 C 0.0000 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonium, (2-methoxy-2-oxoethyl)triphenyl-, formate (1:1)
C21H20O2P.CHO2
311808-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0012 6.3110 0.0 0 CHG=1 VAL=4
M  V30 2 C 5.3348 5.5410 0.0 0
M  V30 3 C 6.6685 6.3110 0.0 0
M  V30 4 O 8.0023 5.5410 0.0 0
M  V30 5 O 6.6685 7.8511 0.0 0
M  V30 6 C 9.3360 6.3110 0.0 0
M  V30 7 C 3.2311 4.9774 0.0 0
M  V30 8 C 1.6911 4.9774 0.0 0
M  V30 9 C 4.0012 3.6437 0.0 0
M  V30 10 C 0.9211 3.6437 0.0 0
M  V30 11 C 3.2311 2.3100 0.0 0
M  V30 12 C 1.6911 2.3100 0.0 0
M  V30 13 C 4.3997 7.7987 0.0 0
M  V30 14 C 3.3108 8.8877 0.0 0
M  V30 15 C 5.8872 8.1973 0.0 0
M  V30 16 C 3.7093 10.3752 0.0 0
M  V30 17 C 6.2860 9.6848 0.0 0
M  V30 18 C 5.1968 10.7737 0.0 0
M  V30 19 C 2.6675 7.0810 0.0 0
M  V30 20 C 2.6675 8.6211 0.0 0
M  V30 21 C 1.3337 6.3110 0.0 0
M  V30 22 C 1.3337 9.3911 0.0 0
M  V30 23 C 0.0000 7.0810 0.0 0
M  V30 24 C 0.0000 8.6211 0.0 0
M  V30 25 C 4.6680 0.0000 0.0 0
M  V30 26 O 3.3343 0.7700 0.0 0 CHG=-1
M  V30 27 O 6.0017 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2605-67-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 311808-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27037382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Reaction of Triphenylphosphonium or Triphenylarsonium Salts with
Aldehyde: Effect of the Counteranion on their Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hon, Y.-S.; Lee, C.-F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(40), 7893-7902

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H40O6Si
2605900-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0 CFG=2
M  V30 2 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 3 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 4 O 4.6200 8.0021 0.0 0
M  V30 5 C 7.7000 8.0021 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 O 5.3900 4.0011 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 Si 3.0800 8.0021 0.0 0
M  V30 10 O 9.2400 8.0021 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 O 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 8.0021 0.0 0
M  V30 15 C 3.0800 9.5421 0.0 0
M  V30 16 C 3.0800 6.4621 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 O 5.3900 1.3336 0.0 0
M  V30 19 C 1.5400 6.4621 0.0 0
M  V30 20 C 0.0000 8.0021 0.0 0
M  V30 21 C 1.5400 9.5421 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 O 9.2400 10.6694 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 11.5500 10.8758 0.0 0
M  V30 26 C 13.0900 9.3358 0.0 0
M  V30 27 C 11.5500 7.7958 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 10 17
M  V30 17 1 12 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 17 22
M  V30 22 2 17 23
M  V30 23 1 18 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C21H40O7Si
2605900-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6201 0.0 0 CFG=2
M  V30 3 C 8.0022 4.6201 0.0 0 CFG=1
M  V30 4 O 6.6685 6.9302 0.0 0
M  V30 5 C 4.0010 5.3901 0.0 0
M  V30 6 O 5.3348 3.0801 0.0 0
M  V30 7 C 9.3358 5.3901 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 Si 5.3348 7.7002 0.0 0
M  V30 10 O 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 O 10.6697 4.6201 0.0 0
M  V30 13 C 9.3358 2.3101 0.0 0
M  V30 14 C 4.0010 8.4702 0.0 0
M  V30 15 C 6.1048 9.0338 0.0 0
M  V30 16 C 4.5648 6.3665 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 O 4.0010 0.7700 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 3.2310 7.1365 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 4.7710 9.8039 0.0 0
M  V30 23 O 0.0000 4.6201 0.0 0
M  V30 24 C 2.6673 0.0000 0.0 0
M  V30 25 C 13.3370 4.6201 0.0 0
M  V30 26 O 12.0033 6.9302 0.0 0
M  V30 27 C 12.5670 3.2864 0.0 0
M  V30 28 C 14.6707 3.8501 0.0 0
M  V30 29 C 14.1070 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7 CFG=3
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 1 12 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 14 22
M  V30 22 2 17 23
M  V30 23 1 18 24
M  V30 24 1 19 25
M  V30 25 2 19 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2605900-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2605900-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29947513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-catalyzed Regio- and Stereoselective Hydrostannylation of an Alkyl
Ethynyl Ether/One-Pot Stille Coupling Enables the Synthesis of
14-Membered Macrolactone of Luminamicin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sugawara, Akihiro; Takada, Hirokazu; Hirose, Tomoyasu; Kimishima, Aoi;
Yamada, Takeshi; Toda, Masaki; Kojima, Toru; Matsumaru, Takanori;
Sunazuka, Toshiaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2021), 23(5), 1758-1763

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Pyridinyl)-1,2,4-benzenetriamine
C11H12N4
2658557-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 6.1600 0.0 0
M  V30 2 N 8.0021 4.6200 0.0 0
M  V30 3 N 5.3347 0.0000 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 5.3347 4.6200 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 6.6685 3.8500 0.0 0
M  V30 8 C 5.3347 1.5400 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 6.1600 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 1.3336 6.9300 0.0 0
M  V30 15 N 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[7-(4-Pyridinyl)-1H-benzimidazol-5-yl]formamide
C13H10N4O
2658557-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 4.7473 0.0 0
M  V30 2 C 9.3360 3.9773 0.0 0
M  V30 3 O 10.6697 4.7473 0.0 0
M  V30 4 C 4.0012 3.9773 0.0 0
M  V30 5 C 4.0012 2.4373 0.0 0
M  V30 6 C 5.3348 4.7473 0.0 0
M  V30 7 C 5.3348 1.6672 0.0 0
M  V30 8 N 2.8566 1.4068 0.0 0
M  V30 9 C 6.6685 3.9773 0.0 0
M  V30 10 C 6.6685 2.4373 0.0 0
M  V30 11 N 5.0147 0.1609 0.0 0
M  V30 12 C 3.4831 0.0000 0.0 0
M  V30 13 C 2.6673 4.7473 0.0 0
M  V30 14 C 2.6673 6.2873 0.0 0
M  V30 15 C 1.3337 3.9773 0.0 0
M  V30 16 C 1.3337 7.0574 0.0 0
M  V30 17 C 0.0000 4.7473 0.0 0
M  V30 18 N 0.0000 6.2873 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2658557-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2658557-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31539569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole compounds as HDAC6 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piscopio, Anthony D.; Zhang, Gan; Hunt, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021133957 A1 2021-07-01

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylglycine methyl ester
C9H11NO2
26682-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(formylamino)benzeneacetate
C10H11NO3
76570-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 7.7000 5.3349 0.0 0
M  V30 4 O 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 5.3349 0.0 0
M  V30 6 N 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 0.0000 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26682-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76570-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-080-CAS-2331734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antiplasmodial, β-hematin inhibition, antitrypanosomal and cytotoxic
activity in vitro of novel 4-aminoquinoline 2-imidazolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Musonda, Chitalu C.; Yardley, Vanessa; Carvalho de Souza, Renata C.;
Ncokazi, Kanyile; Egan, Timothy J.; Chibale, Kelly
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2008), 6(23), 4446-4451

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[3-(7,8-dihydro-7-oxo-6H-pyrimido[5,4-b][1,4]oxazin-2-...
C16H21N5O6
2713998-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3592 0.0000 0.0 0
M  V30 2 C 10.5457 4.3858 0.0 0
M  V30 3 C 11.9526 3.7593 0.0 0
M  V30 4 N 13.1985 4.6645 0.0 0
M  V30 5 C 14.6053 4.0382 0.0 0
M  V30 6 O 15.8511 4.9434 0.0 0
M  V30 7 O 14.7664 2.5067 0.0 0
M  V30 8 C 17.2581 4.3169 0.0 0
M  V30 9 C 16.6318 2.9102 0.0 0
M  V30 10 C 18.6649 3.6906 0.0 0
M  V30 11 C 17.8844 5.7239 0.0 0
M  V30 12 O 0.0000 6.7117 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 N 4.6200 4.0442 0.0 0
M  V30 15 N 4.6200 1.3769 0.0 0
M  V30 16 C 3.0800 4.0442 0.0 0
M  V30 17 C 3.0800 1.3769 0.0 0
M  V30 18 C 2.3100 2.7106 0.0 0
M  V30 19 N 2.3100 5.3779 0.0 0
M  V30 20 O 0.7700 2.7106 0.0 0
M  V30 21 C 0.7700 5.3779 0.0 0
M  V30 22 C 0.0000 4.0442 0.0 0
M  V30 23 N 6.9300 2.7106 0.0 0
M  V30 24 C 7.8351 3.9564 0.0 0
M  V30 25 C 7.8351 1.4647 0.0 0
M  V30 26 C 9.2998 3.4806 0.0 0
M  V30 27 O 9.2998 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 23
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-[5-(2-aminoethyl)-2-oxo-3-oxazolidinyl]-6H-pyrimid...
C11H13N5O4.CH2O2
2713998-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3594 9.0217 0.0 0
M  V30 2 C 10.5457 4.6359 0.0 0
M  V30 3 C 11.9526 5.2624 0.0 0
M  V30 4 N 13.1985 4.3571 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 N 6.9300 6.3111 0.0 0
M  V30 7 C 7.8353 5.0652 0.0 0
M  V30 8 C 7.8353 7.5570 0.0 0
M  V30 9 C 9.2998 5.5411 0.0 0
M  V30 10 O 9.2998 7.0811 0.0 0
M  V30 11 C 5.3900 6.3111 0.0 0
M  V30 12 N 4.6200 4.9775 0.0 0
M  V30 13 N 4.6200 7.6448 0.0 0
M  V30 14 C 3.0800 4.9775 0.0 0
M  V30 15 C 3.0800 7.6448 0.0 0
M  V30 16 C 2.3100 6.3111 0.0 0
M  V30 17 N 2.3100 3.6438 0.0 0
M  V30 18 O 0.7700 6.3111 0.0 0
M  V30 19 C 0.7700 3.6437 0.0 0
M  V30 20 C 0.0000 4.9775 0.0 0
M  V30 21 C 6.5992 0.0000 0.0 0
M  V30 22 O 5.2656 0.7700 0.0 0
M  V30 23 O 7.9329 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 3 4
M  V30 5 2 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713998-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713998-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24583917
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and their use in the treatment of
bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cumming, John G.; Kramer, Christian; Kreis, Lukas; Kuehne, Holger;
Schnider, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021190727 A1 2021-09-30

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H40O4
2715080-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 3.3501 4.4757 0.0 0
M  V30 3 C 6.6684 7.7000 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 13 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 16 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 19 C 9.4667 3.3740 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 22 C 2.6673 3.8500 0.0 0
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 25 C 10.3720 4.6200 0.0 0
M  V30 26 C 2.6673 0.7700 0.0 0
M  V30 27 C 1.3336 3.0800 0.0 0
M  V30 28 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 29 H 7.7573 1.9909 0.0 0
M  V30 30 H 4.2458 4.9390 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 8.1631 6.9216 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 34 H 10.8004 6.6359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 16 2 CFG=1
M  V30 3 1 23 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 23
M  V30 27 1 18 24
M  V30 28 1 18 32 CFG=1
M  V30 29 1 19 25
M  V30 30 1 20 21
M  V30 31 1 21 26
M  V30 32 1 21 33 CFG=1
M  V30 33 1 22 27
M  V30 34 1 24 25
M  V30 35 1 24 34 CFG=3
M  V30 36 1 26 28
M  V30 37 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 12 13 14 15 16 18 21 23 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H40O6
2715080-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 6.0176 6.0158 0.0 0
M  V30 5 C 9.3357 9.2401 0.0 0
M  V30 6 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 7 C 12.4130 10.0586 0.0 0
M  V30 8 C 9.9762 8.9737 0.0 0
M  V30 9 C 11.7865 11.4656 0.0 0
M  V30 10 C 12.6917 12.7114 0.0 0
M  V30 11 O 12.0654 14.1182 0.0 0
M  V30 12 O 14.2233 12.5505 0.0 0
M  V30 13 O 2.6673 2.3100 0.0 0
M  V30 14 C 1.3337 3.0800 0.0 0
M  V30 15 O 0.0000 2.3100 0.0 0
M  V30 16 C 9.3357 4.6200 0.0 0 CFG=1
M  V30 17 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 18 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 19 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 20 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 21 C 8.0021 6.9301 0.0 0
M  V30 22 C 10.6695 6.9301 0.0 0 CFG=1
M  V30 23 C 12.1341 4.9140 0.0 0
M  V30 24 C 8.0021 2.3100 0.0 0
M  V30 25 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 26 C 5.3348 5.3901 0.0 0
M  V30 27 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 28 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 29 C 13.0393 6.1601 0.0 0
M  V30 30 C 5.3348 2.3100 0.0 0
M  V30 31 C 4.0010 4.6200 0.0 0
M  V30 32 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 33 H 10.4247 3.5309 0.0 0
M  V30 34 H 6.9131 6.4790 0.0 0
M  V30 35 H 11.2213 3.9523 0.0 0
M  V30 36 H 10.8305 8.4616 0.0 0
M  V30 37 H 6.6684 1.5400 0.0 0
M  V30 38 H 13.4677 8.1759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 20 4 CFG=1
M  V30 5 1 27 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 28
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=1
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 34 CFG=3
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 1 18 35 CFG=3
M  V30 26 1 19 24
M  V30 27 1 20 25
M  V30 28 1 20 26
M  V30 29 1 21 27
M  V30 30 1 22 27
M  V30 31 1 22 28
M  V30 32 1 22 36 CFG=1
M  V30 33 1 23 29
M  V30 34 1 24 25
M  V30 35 1 25 30
M  V30 36 1 25 37 CFG=1
M  V30 37 1 26 31
M  V30 38 1 28 29
M  V30 39 1 28 38 CFG=3
M  V30 40 1 30 32
M  V30 41 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 6 16 17 18 19 20 22 25 27 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2715080-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2715080-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24577539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 12β-Methyl-18-nor-bile Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luxenburger, Andreas; Harris, Lawrence D.; Ure, Elizabeth M.; Landaeta
Aponte, Roselis A.; Woolhouse, Anthony D.; Cameron, Scott A.; Ling, Chris
D.; Piltz, Ross O.; Lewis, Andrew R.; Gainsford, Graeme J.;
Weymouth-Wilson, Alex; Furneaux, Richard H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(38), 25019-25039

$RFMT $RIREG SCHEME166 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminoanthraquinone
C14H9NO2
82-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 6.1600 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Nitrophenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
C10H7N3O5
27425-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 0.0000 0.0 0
M  V30 2 O 6.9302 5.3350 0.0 0
M  V30 3 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 4 O 0.0000 1.3338 0.0 0
M  V30 5 O 0.0000 4.0012 0.0 0
M  V30 6 O 11.5503 2.6675 0.0 0
M  V30 7 C 5.3901 2.6675 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 4.6201 1.3338 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 C 3.0801 1.3338 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 N 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 1.3338 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 9.2402 1.3338 0.0 0
M  V30 17 N 9.2402 4.0012 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 15
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 6 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-1-anthracenyl)amino]methylene]-1-(4-nitrophenyl)...
C25H14N4O7
2178915-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 4.0011 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 O 5.3900 5.3347 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 12.3200 4.0011 0.0 0
M  V30 6 O 7.7000 6.6684 0.0 0
M  V30 7 O 12.3200 9.3358 0.0 0
M  V30 8 N 18.4800 6.6684 0.0 0 VAL=5
M  V30 9 O 19.2500 8.0021 0.0 0
M  V30 10 O 19.2500 5.3347 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 5.3900 0.0000 0.0 0
M  V30 17 C 7.7000 1.3336 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 6.9300 0.0000 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 0.7700 5.3347 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 25 C 10.0100 5.3347 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 9.2400 6.6684 0.0 0
M  V30 28 N 12.3200 6.6684 0.0 0
M  V30 29 N 10.0100 8.0021 0.0 0
M  V30 30 C 11.5500 8.0021 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 32 C 14.6300 8.0021 0.0 0
M  V30 33 C 14.6300 5.3347 0.0 0
M  V30 34 C 16.1700 8.0021 0.0 0
M  V30 35 C 16.1700 5.3347 0.0 0
M  V30 36 C 16.9400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 25 CFG=2
M  V30 4 2 3 14
M  V30 5 2 4 15
M  V30 6 2 5 26
M  V30 7 2 6 27
M  V30 8 2 7 30
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 36
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 18 21
M  V30 24 2 19 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-45-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 27425-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22132023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminocyclohexanecarboxylic acid
C7H13NO2
2756-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2598 1.5166 0.0 0
M  V30 2 O 3.9923 0.0000 0.0 0
M  V30 3 O 5.7069 2.0433 0.0 0
M  V30 4 N 4.2598 3.4964 0.0 0
M  V30 5 C 3.0800 2.5065 0.0 0
M  V30 6 C 2.3100 1.1729 0.0 0
M  V30 7 C 2.3100 3.8401 0.0 0
M  V30 8 C 0.7700 1.1729 0.0 0
M  V30 9 C 0.7700 3.8401 0.0 0
M  V30 10 C 0.0000 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formylamino)cyclohexanecarboxylic acid
C8H13NO3
4507-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7571 1.9798 0.0 0
M  V30 2 C 4.9368 2.9696 0.0 0
M  V30 3 O 6.3839 2.4429 0.0 0
M  V30 4 C 2.0425 0.9899 0.0 0
M  V30 5 O 0.5954 0.4631 0.0 0
M  V30 6 O 3.2223 0.0000 0.0 0
M  V30 7 C 2.3100 2.5065 0.0 0
M  V30 8 C 3.0800 3.8401 0.0 0
M  V30 9 C 0.7700 2.5065 0.0 0
M  V30 10 C 2.3100 5.1738 0.0 0
M  V30 11 C 0.0000 3.8401 0.0 0
M  V30 12 C 0.7700 5.1738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4507-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18485690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The α-tertiary amine motif drives remarkable selectivity for Pd-catalyzed
carbonylation of β-methylene C-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogg, Kirsten F.; Trowbridge, Aaron; Alvarez-Perez, Andrea; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 8198-8203

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H14FNOS
2758815-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0010 4.6201 0.0 0
M  V30 2 N 6.6685 6.1601 0.0 0
M  V30 3 F 1.3337 6.1601 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 19 C 12.0033 1.5400 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 13.3370 2.3101 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 23 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 7
M  V30 4 1 3 13
M  V30 5 2 4 5
M  V30 6 1 4 11
M  V30 7 1 4 18
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-Benzoyl-2-[(2-fluorophenyl)thio]phenyl]formamide
C20H14FNO2S
2758815-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 C 5.3901 1.3337 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 9.2402 5.3348 0.0 0
M  V30 6 O 10.0102 4.0012 0.0 0
M  V30 7 F 0.0000 5.3348 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0
M  V30 10 C 5.3901 6.6685 0.0 0
M  V30 11 C 6.9302 4.0012 0.0 0
M  V30 12 C 6.9302 6.6685 0.0 0
M  V30 13 C 7.7002 5.3348 0.0 0
M  V30 14 C 2.3101 6.6685 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 3.0801 8.0023 0.0 0
M  V30 17 C 0.0000 8.0023 0.0 0
M  V30 18 C 2.3101 9.3360 0.0 0
M  V30 19 C 0.7700 9.3360 0.0 0
M  V30 20 C 10.0102 6.6685 0.0 0
M  V30 21 C 9.2402 8.0023 0.0 0
M  V30 22 C 11.5503 6.6685 0.0 0
M  V30 23 C 10.0102 9.3360 0.0 0
M  V30 24 C 12.3203 8.0023 0.0 0
M  V30 25 C 11.5503 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 2 3 4
M  V30 6 2 5 6
M  V30 7 1 5 13
M  V30 8 1 5 20
M  V30 9 1 7 15
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2758815-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2758815-59-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31420678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ubiquitin-specific peptidase 24 inhibitor, medicinal composition
including the same and method of delaying or reversing multidrug
resistance in cancers using the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hung, Chien-Chung; Young, Ming-Jer
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20220024887 A1 2022-01-27

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-[[8-[[(1,1-dimethylethoxy)carbonyl][(2-methoxyphenyl)meth...
C32H45N5O5S
2765335-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 4.6200 6.6684 0.0 0
M  V30 4 O 5.3900 8.0021 0.0 0
M  V30 5 O 3.0800 6.6684 0.0 0
M  V30 6 C 4.6200 9.3358 0.0 0
M  V30 7 C 5.9536 10.1058 0.0 0
M  V30 8 C 3.8500 10.6694 0.0 0
M  V30 9 C 3.2864 8.5658 0.0 0
M  V30 10 C 11.1806 2.0605 0.0 0
M  V30 11 C 11.5007 0.5542 0.0 0
M  V30 12 C 12.3249 3.0909 0.0 0
M  V30 13 S 10.0100 8.0021 0.0 0
M  V30 14 O 3.0800 1.3336 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 16.1700 8.0021 0.0 0
M  V30 17 O 16.9400 9.3358 0.0 0
M  V30 18 O 16.9400 6.6684 0.0 0
M  V30 19 C 18.4800 9.3358 0.0 0
M  V30 20 C 18.4800 7.7958 0.0 0
M  V30 21 C 20.0200 9.3358 0.0 0
M  V30 22 C 18.4800 10.8758 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 6.9300 5.3347 0.0 0
M  V30 25 N 9.2400 4.0011 0.0 0
M  V30 26 N 7.2241 2.5364 0.0 0
M  V30 27 N 7.7000 6.6684 0.0 0
M  V30 28 C 9.7159 2.5364 0.0 0
M  V30 29 C 10.0100 5.3347 0.0 0
M  V30 30 C 8.4700 1.6312 0.0 0
M  V30 31 C 9.2400 6.6684 0.0 0
M  V30 32 C 3.0800 4.0011 0.0 0
M  V30 33 C 2.3100 2.6674 0.0 0
M  V30 34 C 2.3100 5.3347 0.0 0
M  V30 35 C 0.7700 2.6674 0.0 0
M  V30 36 C 0.7700 5.3347 0.0 0
M  V30 37 C 0.0000 4.0011 0.0 0
M  V30 38 C 11.5500 8.0021 0.0 0
M  V30 39 C 12.3200 9.3358 0.0 0
M  V30 40 C 12.3200 6.6684 0.0 0
M  V30 41 C 13.8600 9.3358 0.0 0
M  V30 42 C 13.8600 6.6684 0.0 0
M  V30 43 N 14.6300 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 24
M  V30 4 1 2 32
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 28
M  V30 14 1 13 31
M  V30 15 1 13 38
M  V30 16 1 14 15
M  V30 17 1 14 33
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 16 43
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[(2-methoxyphenyl)methyl]-3-(1-methylethyl)-6-(4-p...
C22H29N5OS.CH2O2
2765334-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2401 7.0907 0.0 0
M  V30 2 C 10.0101 8.4244 0.0 0
M  V30 3 C 3.4495 3.8165 0.0 0
M  V30 4 C 3.1293 2.3100 0.0 0
M  V30 5 C 2.3051 4.8469 0.0 0
M  V30 6 S 4.6201 9.7580 0.0 0
M  V30 7 O 11.5502 11.0917 0.0 0
M  V30 8 C 12.3202 12.4255 0.0 0
M  V30 9 C 6.9301 5.7569 0.0 0
M  V30 10 N 5.3901 5.7569 0.0 0
M  V30 11 C 7.7001 7.0907 0.0 0
M  V30 12 N 7.4060 4.2923 0.0 0
M  V30 13 C 4.9142 4.2923 0.0 0
M  V30 14 C 4.6201 7.0907 0.0 0
M  V30 15 N 6.9301 8.4244 0.0 0
M  V30 16 C 6.1601 3.3871 0.0 0
M  V30 17 C 5.3901 8.4244 0.0 0
M  V30 18 C 11.5502 8.4244 0.0 0
M  V30 19 C 12.3202 9.7580 0.0 0
M  V30 20 C 12.3202 7.0907 0.0 0
M  V30 21 C 13.8602 9.7580 0.0 0
M  V30 22 C 13.8602 7.0907 0.0 0
M  V30 23 C 14.6302 8.4244 0.0 0
M  V30 24 C 3.0800 9.7580 0.0 0
M  V30 25 C 2.3100 11.0917 0.0 0
M  V30 26 C 2.3100 8.4244 0.0 0
M  V30 27 C 0.7700 11.0917 0.0 0
M  V30 28 C 0.7700 8.4244 0.0 0
M  V30 29 N 0.0000 9.7580 0.0 0
M  V30 30 C 7.3151 0.0000 0.0 0
M  V30 31 O 5.9814 0.7700 0.0 0
M  V30 32 O 8.6488 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 13
M  V30 7 1 6 17
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 19
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2765335-98-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765334-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31918258
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out by preparative HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridazine and imidazopyrazine compounds as
inhibitors of CDK7
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kasibhatla, Srinivas Rao; Sharma, Sunil; Kaadige, Mohan; Weston, Alexis;
Dana, Srikanta; Thode, Trason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022061155 A1 2022-03-24

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-(4-methyl-4,7-diazaspiro[2.5]oct-7-yl)benzenamine
C13H18FN3
2766158-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6673 0.0 0
M  V30 2 F 6.1601 0.0000 0.0 0
M  V30 3 N 10.7802 2.6673 0.0 0
M  V30 4 C 2.3101 4.0010 0.0 0
M  V30 5 C 3.8501 4.0010 0.0 0
M  V30 6 C 2.3101 5.5410 0.0 0
M  V30 7 C 0.9764 4.7710 0.0 0
M  V30 8 N 1.5400 2.6673 0.0 0
M  V30 9 N 4.6201 2.6673 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 3.8501 1.3337 0.0 0
M  V30 12 C 6.1601 2.6673 0.0 0
M  V30 13 C 6.9302 1.3337 0.0 0
M  V30 14 C 6.9302 4.0010 0.0 0
M  V30 15 C 8.4702 1.3337 0.0 0
M  V30 16 C 8.4702 4.0010 0.0 0
M  V30 17 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 13
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 7
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Fluoro-4-(4-methyl-4,7-diazaspiro[2.5]oct-7-yl)phenyl]formamide
C14H18FN3O
2766158-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6673 0.0 0
M  V30 2 F 6.1601 0.0000 0.0 0
M  V30 3 N 10.7802 2.6673 0.0 0
M  V30 4 C 11.5503 4.0010 0.0 0
M  V30 5 O 13.0903 4.0010 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 0.9764 4.7710 0.0 0
M  V30 9 C 2.3101 5.5410 0.0 0
M  V30 10 N 1.5400 2.6673 0.0 0
M  V30 11 N 4.6201 2.6673 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 3.8501 1.3337 0.0 0
M  V30 14 C 6.1601 2.6673 0.0 0
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 C 6.9302 4.0010 0.0 0
M  V30 17 C 8.4702 1.3337 0.0 0
M  V30 18 C 8.4702 4.0010 0.0 0
M  V30 19 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2766158-15-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766158-16-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dabco
C6H12N2
280-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.9240 1.6408 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 0.0000 1.3337 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 N 2.1560 1.5380 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,4-diazabicyclo[2.2.2]octane (1:1)
C6H12N2.CH2O2
75980-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.9240 3.9508 0.0 0
M  V30 2 C 2.3101 2.3100 0.0 0
M  V30 3 C 0.0000 3.6437 0.0 0
M  V30 4 C 0.7700 4.9774 0.0 0
M  V30 5 C 3.0801 3.6437 0.0 0
M  V30 6 C 0.7700 2.3100 0.0 0
M  V30 7 C 2.3101 4.9774 0.0 0
M  V30 8 N 2.1560 3.8480 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 O 0.2064 0.7700 0.0 0
M  V30 11 O 2.8737 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 280-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 75980-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35653999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-94-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DABCO-Catalysed [3+2] Cyclization/Deformylation Cascade of p-Quinols with
3-Formylchromones: Access to Benzopyrone-Fused Tetracyclic Ring Systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xiong-Wei; Lin, Xiao-Tong; Zhao, Cheng; Hu, Xiao-Wei; Xu, Yi-Bing;
Zheng, Yi-Lin; Liu, Xin-Ni; Chen, Guo-Shu; Chen, Long; Liu, Yun-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2023), 365(5), 715-721

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methyl 2-[(1α,5α,6α)-6-[[[2-(trifluoromethyl)-3-pyridinyl]oxy]methyl]-3-azabi...
C18H17F3N4O3
2860565-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5411 2.3100 0.0 0
M  V30 2 O 4.2074 3.0800 0.0 0
M  V30 3 C 1.5400 4.6200 0.0 0
M  V30 4 F 3.0800 4.6200 0.0 0
M  V30 5 F 1.5400 6.1600 0.0 0
M  V30 6 F 0.0000 4.6200 0.0 0
M  V30 7 C 15.4168 4.9317 0.0 0
M  V30 8 O 16.7504 5.7017 0.0 0
M  V30 9 O 15.4168 3.3917 0.0 0
M  V30 10 C 18.0842 4.9317 0.0 0
M  V30 11 C 8.4147 3.0800 0.0 0 CFG=2
M  V30 12 C 7.6447 4.4136 0.0 0 CFG=1
M  V30 13 C 6.8747 3.0800 0.0 0 CFG=1
M  V30 14 C 9.9211 3.4002 0.0 0
M  V30 15 C 8.6753 5.5582 0.0 0
M  V30 16 N 10.0821 4.9317 0.0 0
M  V30 17 C 11.4157 5.7017 0.0 0
M  V30 18 N 12.7495 4.9317 0.0 0
M  V30 19 N 11.4157 7.2417 0.0 0
M  V30 20 C 14.0831 5.7017 0.0 0
M  V30 21 C 12.7495 8.0117 0.0 0
M  V30 22 C 14.0831 7.2417 0.0 0
M  V30 23 C 2.8738 2.3100 0.0 0
M  V30 24 C 1.5400 3.0800 0.0 0
M  V30 25 C 2.8738 0.7700 0.0 0
M  V30 26 N 0.2064 2.3100 0.0 0
M  V30 27 C 1.5400 0.0000 0.0 0
M  V30 28 C 0.2064 0.7700 0.0 0
M  V30 29 H 8.5758 1.5485 0.0 0
M  V30 30 H 6.3989 5.3189 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 29 CFG=1
M  V30 16 1 12 13
M  V30 17 1 12 15
M  V30 18 1 12 30 CFG=1
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 21 1 16 17
M  V30 22 1 17 18
M  V30 23 2 17 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1α,5α,6α)-6-[[[2-(Trifluoromethyl)-3-pyridinyl]oxy]methyl]-3-azabicyclo[3...
C18H17F3N6O3
2860565-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5411 2.3100 0.0 0
M  V30 2 O 4.2075 3.0800 0.0 0
M  V30 3 C 1.5400 4.6200 0.0 0
M  V30 4 F 3.0800 4.6200 0.0 0
M  V30 5 F 1.5400 6.1600 0.0 0
M  V30 6 F 0.0000 4.6200 0.0 0
M  V30 7 C 15.4169 4.9317 0.0 0
M  V30 8 N 16.7505 5.7017 0.0 0
M  V30 9 O 15.4169 3.3917 0.0 0
M  V30 10 N 18.0842 4.9317 0.0 0
M  V30 11 C 19.4180 5.7017 0.0 0
M  V30 12 O 20.7516 4.9317 0.0 0
M  V30 13 C 8.4148 3.0800 0.0 0 CFG=1
M  V30 14 C 7.6448 4.4137 0.0 0 CFG=2
M  V30 15 C 6.8747 3.0800 0.0 0 CFG=2
M  V30 16 C 9.9212 3.4002 0.0 0
M  V30 17 C 8.6752 5.5582 0.0 0
M  V30 18 N 10.0821 4.9317 0.0 0
M  V30 19 C 11.4158 5.7017 0.0 0
M  V30 20 N 12.7494 4.9317 0.0 0
M  V30 21 N 11.4158 7.2417 0.0 0
M  V30 22 C 14.0832 5.7017 0.0 0
M  V30 23 C 12.7494 8.0117 0.0 0
M  V30 24 C 14.0832 7.2417 0.0 0
M  V30 25 C 2.8737 2.3100 0.0 0
M  V30 26 C 1.5400 3.0800 0.0 0
M  V30 27 C 2.8737 0.7700 0.0 0
M  V30 28 N 0.2064 2.3100 0.0 0
M  V30 29 C 1.5400 0.0000 0.0 0
M  V30 30 C 0.2064 0.7700 0.0 0
M  V30 31 H 8.5757 1.5485 0.0 0
M  V30 32 H 6.3989 5.3189 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 31 CFG=3
M  V30 18 1 14 15
M  V30 19 1 14 17
M  V30 20 1 14 32 CFG=3
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 23 1 18 19
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2860565-03-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2860565-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36038578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7803-57-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of small molecule modulators of glucocerebrosidase activity
and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hunt, Kevin; Zheng, Jianbin; Shen, Sida
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022232383 A1 2022-11-03

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Formic-d acid
CHDO2
917-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 H 1.3337 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R)-7-(4-Fluorophenyl)-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-7-amine
C17H24FNO2
2886760-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.2596 4.1840 0.0 0
M  V30 2 C 1.7145 6.8515 0.0 0
M  V30 3 C 0.0000 5.8615 0.0 0
M  V30 4 F 10.3155 4.7743 0.0 0
M  V30 5 C 2.9871 2.6674 0.0 0
M  V30 6 C 4.5271 2.6674 0.0 0 CFG=1
M  V30 7 O 1.4471 2.6674 0.0 0
M  V30 8 O 3.7571 4.0011 0.0 0
M  V30 9 C 2.2171 1.3338 0.0 0
M  V30 10 C 5.2971 1.3338 0.0 0
M  V30 11 C 0.6771 4.0011 0.0 0
M  V30 12 C 2.9871 5.3347 0.0 0
M  V30 13 C 2.9871 0.0000 0.0 0
M  V30 14 C 4.5271 0.0000 0.0 0
M  V30 15 C 1.4471 5.3347 0.0 0
M  V30 16 C 5.9743 3.1941 0.0 0
M  V30 17 C 7.1539 2.2042 0.0 0
M  V30 18 C 6.2416 4.7107 0.0 0
M  V30 19 C 8.6011 2.7309 0.0 0
M  V30 20 C 7.6888 5.2374 0.0 0
M  V30 21 C 8.8684 4.2476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 16 CFG=3
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H23DFNO3
2886760-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.7248 2.5065 0.0 0
M  V30 2 C 4.9046 1.5166 0.0 0
M  V30 3 O 6.3517 2.0433 0.0 0
M  V30 4 C 0.0000 3.8622 0.0 0
M  V30 5 C 1.7145 2.8723 0.0 0
M  V30 6 F 10.3155 4.9494 0.0 0
M  V30 7 C 4.5271 7.0563 0.0 0 CFG=1
M  V30 8 C 2.9871 7.0563 0.0 0
M  V30 9 C 5.2971 8.3899 0.0 0
M  V30 10 O 3.7571 5.7226 0.0 0
M  V30 11 O 1.4471 7.0563 0.0 0
M  V30 12 C 2.2171 8.3899 0.0 0
M  V30 13 C 4.5271 9.7236 0.0 0
M  V30 14 C 2.9871 4.3888 0.0 0
M  V30 15 C 0.6771 5.7226 0.0 0
M  V30 16 C 2.9871 9.7236 0.0 0
M  V30 17 C 1.4471 4.3888 0.0 0
M  V30 18 C 5.9743 6.5296 0.0 0
M  V30 19 C 7.1539 7.5195 0.0 0
M  V30 20 C 6.2416 5.0130 0.0 0
M  V30 21 C 8.6011 6.9927 0.0 0
M  V30 22 C 7.6888 4.4862 0.0 0
M  V30 23 C 8.8684 5.4761 0.0 0
M  V30 24 H 4.6371 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 17
M  V30 6 1 5 17
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 18 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 917-71-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2886760-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2886760-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41953009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senanayake, Chris Hugh; Sirasani, Gopal; Qu, Bo; Samankumara, Lalith
Palitha; Naini, Santosh Reddy; Gajula, Praveen Kumar; Gangu, Satya
Aravind; Leong, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024145422 A1 2024-07-04

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Formic-d acid-d
CD2O2
920-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 H 0.0000 2.3101 0.0 0 MASS=2
M  V30 5 H 4.0010 1.5400 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R)-7-(4-Fluorophenyl)-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-7-amine
C17H24FNO2
2886760-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.2596 4.1840 0.0 0
M  V30 2 C 1.7145 6.8515 0.0 0
M  V30 3 C 0.0000 5.8615 0.0 0
M  V30 4 F 10.3155 4.7743 0.0 0
M  V30 5 C 2.9871 2.6674 0.0 0
M  V30 6 C 4.5271 2.6674 0.0 0 CFG=1
M  V30 7 O 1.4471 2.6674 0.0 0
M  V30 8 O 3.7571 4.0011 0.0 0
M  V30 9 C 2.2171 1.3338 0.0 0
M  V30 10 C 5.2971 1.3338 0.0 0
M  V30 11 C 0.6771 4.0011 0.0 0
M  V30 12 C 2.9871 5.3347 0.0 0
M  V30 13 C 2.9871 0.0000 0.0 0
M  V30 14 C 4.5271 0.0000 0.0 0
M  V30 15 C 1.4471 5.3347 0.0 0
M  V30 16 C 5.9743 3.1941 0.0 0
M  V30 17 C 7.1539 2.2042 0.0 0
M  V30 18 C 6.2416 4.7107 0.0 0
M  V30 19 C 8.6011 2.7309 0.0 0
M  V30 20 C 7.6888 5.2374 0.0 0
M  V30 21 C 8.8684 4.2476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 16 CFG=3
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H23DFNO3
2886760-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.7248 2.5065 0.0 0
M  V30 2 C 4.9046 1.5166 0.0 0
M  V30 3 O 6.3517 2.0433 0.0 0
M  V30 4 C 0.0000 3.8622 0.0 0
M  V30 5 C 1.7145 2.8723 0.0 0
M  V30 6 F 10.3155 4.9494 0.0 0
M  V30 7 C 4.5271 7.0563 0.0 0 CFG=1
M  V30 8 C 2.9871 7.0563 0.0 0
M  V30 9 C 5.2971 8.3899 0.0 0
M  V30 10 O 3.7571 5.7226 0.0 0
M  V30 11 O 1.4471 7.0563 0.0 0
M  V30 12 C 2.2171 8.3899 0.0 0
M  V30 13 C 4.5271 9.7236 0.0 0
M  V30 14 C 2.9871 4.3888 0.0 0
M  V30 15 C 0.6771 5.7226 0.0 0
M  V30 16 C 2.9871 9.7236 0.0 0
M  V30 17 C 1.4471 4.3888 0.0 0
M  V30 18 C 5.9743 6.5296 0.0 0
M  V30 19 C 7.1539 7.5195 0.0 0
M  V30 20 C 6.2416 5.0130 0.0 0
M  V30 21 C 8.6011 6.9927 0.0 0
M  V30 22 C 7.6888 4.4862 0.0 0
M  V30 23 C 8.8684 5.4761 0.0 0
M  V30 24 H 4.6371 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 17
M  V30 6 1 5 17
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 18 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 920-42-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2886760-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2886760-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35913469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylcyclohexylamine derivatives and their use in the treatment of
psychiatric disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kruegel, Andrew Carry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022272174 A1 2022-12-29

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
1,6-Naphthyridin-7-amine, N-[(4-methoxyphenyl)methyl]-N-methyl-3-(2-methyl-5-...
C24H22N4O3
2919561-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.0900 4.0011 0.0 0
M  V30 2 C 13.8600 5.3347 0.0 0
M  V30 3 C 13.8600 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3347 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 20.0200 5.3347 0.0 0
M  V30 9 C 20.7900 6.6685 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 10.7800 2.6674 0.0 0
M  V30 15 N 8.4700 1.3338 0.0 0
M  V30 16 C 6.1600 2.6674 0.0 0
M  V30 17 N 10.7800 5.3347 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 6.9300 1.3338 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 3.8500 4.0011 0.0 0
M  V30 22 C 3.8500 1.3338 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 2.3100 1.3338 0.0 0
M  V30 25 C 1.5400 2.6674 0.0 0
M  V30 26 C 15.4000 5.3347 0.0 0
M  V30 27 C 16.1700 6.6685 0.0 0
M  V30 28 C 16.1700 4.0011 0.0 0
M  V30 29 C 17.7100 6.6685 0.0 0
M  V30 30 C 17.7100 4.0011 0.0 0
M  V30 31 C 18.4800 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 26
M  V30 5 1 4 22
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-methyl-3-(2-methyl-5-nitrophenyl)-1,6-naphthyridin...
C16H14N4O2.CH2O2
2919561-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.3100 0.0 0
M  V30 2 N 1.5400 7.6448 0.0 0 VAL=5
M  V30 3 O 2.3101 8.9787 0.0 0
M  V30 4 O 0.0000 7.6448 0.0 0
M  V30 5 N 13.0903 6.3112 0.0 0
M  V30 6 C 13.8603 7.6448 0.0 0
M  V30 7 C 6.1601 4.9775 0.0 0
M  V30 8 C 6.9302 6.3112 0.0 0
M  V30 9 C 6.9302 3.6438 0.0 0
M  V30 10 C 8.4702 6.3112 0.0 0
M  V30 11 N 8.4702 3.6438 0.0 0
M  V30 12 C 9.2402 4.9775 0.0 0
M  V30 13 C 9.2402 7.6448 0.0 0
M  V30 14 C 10.7802 4.9775 0.0 0
M  V30 15 N 10.7802 7.6448 0.0 0
M  V30 16 C 11.5503 6.3112 0.0 0
M  V30 17 C 4.6201 4.9775 0.0 0
M  V30 18 C 3.8501 6.3112 0.0 0
M  V30 19 C 3.8501 3.6438 0.0 0
M  V30 20 C 2.3101 6.3112 0.0 0
M  V30 21 C 2.3101 3.6438 0.0 0
M  V30 22 C 1.5400 4.9775 0.0 0
M  V30 23 C 6.9302 0.0000 0.0 0
M  V30 24 O 5.5965 0.7700 0.0 0
M  V30 25 O 8.2638 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2919561-60-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919561-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36302060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out by HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-aza-quinoline derivatives for preventing or treating
cancer in patients with oncogenic mutations in the BRAF gene and B-Raf
protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yee Ng, Pui; Jewett, Ivan; Padilla, Fernando
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023039505 A1 2023-03-16

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-[(4-bromo-2-iodophenyl)amino]-1-cyclopropyl-
C11H11BrINO
2959485-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 I 2.6675 0.0000 0.0 0
M  V30 6 Br 0.0000 4.6201 0.0 0
M  V30 7 C 9.3359 2.3100 0.0 0
M  V30 8 C 10.8759 2.3100 0.0 0
M  V30 9 C 10.1059 3.6437 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 10
M  V30 6 1 5 11
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-(4-bromo-2-iodophenyl)-N-(2-cyclopropyl-2-oxoethyl)-
C12H11BrINO2
2959485-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 O 8.0022 0.7700 0.0 0
M  V30 7 I 2.6675 0.7700 0.0 0
M  V30 8 Br 0.0000 5.3901 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 1.3337 3.0800 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 9.3359 3.0800 0.0 0
M  V30 16 C 10.1059 4.4137 0.0 0
M  V30 17 C 10.8759 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 4 15
M  V30 8 1 7 10
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2959485-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2959485-96-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37674546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1,unspecified reagent used to adjust
pH in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole derivatives as modulators of Rho-associated
protein kinase (ROCK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guisot, Nicolas E.S.; Jones, Clifford D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023139379 A1 2023-07-27

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL

C70H118N14O17S
3000569-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  102 104 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8479 13.5830 0.0 0
M  V30 2 C 4.8479 7.4230 0.0 0
M  V30 3 S 7.5152 12.0430 0.0 0 VAL=6
M  V30 4 N 8.8490 12.8130 0.0 0
M  V30 5 O 8.2852 10.7093 0.0 0
M  V30 6 O 6.7452 13.3766 0.0 0
M  V30 7 C 10.1826 12.0430 0.0 0
M  V30 8 N 11.5163 12.8130 0.0 0
M  V30 9 N 10.1826 10.5030 0.0 0
M  V30 10 C 12.8499 12.0430 0.0 0
M  V30 11 C 14.1837 12.8130 0.0 0
M  V30 12 C 15.5173 12.0430 0.0 0
M  V30 13 C 0.0000 9.4725 0.0 0
M  V30 14 C 0.0000 11.5334 0.0 0
M  V30 15 C 7.5152 8.9630 0.0 0
M  V30 16 O 15.3475 14.9072 0.0 0
M  V30 17 O 16.5926 9.8688 0.0 0
M  V30 18 C 16.1671 17.2928 0.0 0
M  V30 19 C 15.8347 18.7965 0.0 0
M  V30 20 N 14.3664 19.2606 0.0 0
M  V30 21 C 14.0340 20.7644 0.0 0
M  V30 22 O 12.5656 21.2284 0.0 0
M  V30 23 O 15.1702 21.8039 0.0 0
M  V30 24 C 11.4296 20.1889 0.0 0
M  V30 25 C 12.4691 19.0527 0.0 0
M  V30 26 C 10.2934 19.1493 0.0 0
M  V30 27 C 10.3899 21.3250 0.0 0
M  V30 28 C 18.6194 7.9449 0.0 0
M  V30 29 C 17.1123 7.6275 0.0 0
M  V30 30 C 16.6337 6.1638 0.0 0
M  V30 31 C 16.0841 8.7738 0.0 0
M  V30 32 O 18.3377 19.3703 0.0 0
M  V30 33 O 20.8464 6.9841 0.0 0
M  V30 34 C 20.8633 20.1363 0.0 0
M  V30 35 C 21.9179 21.2585 0.0 0
M  V30 36 N 21.4733 22.7329 0.0 0
M  V30 37 C 22.5279 23.8552 0.0 0
M  V30 38 O 22.0831 25.3296 0.0 0
M  V30 39 O 24.0271 23.5030 0.0 0
M  V30 40 C 20.5839 25.6818 0.0 0
M  V30 41 C 20.9361 27.1810 0.0 0
M  V30 42 C 19.0848 26.0339 0.0 0
M  V30 43 C 20.2319 24.1826 0.0 0
M  V30 44 C 23.7157 6.9633 0.0 0
M  V30 45 C 22.8571 5.6848 0.0 0
M  V30 46 N 23.5351 4.3020 0.0 0
M  V30 47 C 22.6765 3.0235 0.0 0
M  V30 48 O 23.3546 1.6407 0.0 0
M  V30 49 O 21.1400 3.1277 0.0 0
M  V30 50 C 24.8910 1.5365 0.0 0
M  V30 51 C 24.9953 3.0729 0.0 0
M  V30 52 C 26.4275 1.4322 0.0 0
M  V30 53 C 24.7868 0.0000 0.0 0
M  V30 54 O 23.8762 19.4222 0.0 0
M  V30 55 O 26.0554 7.9057 0.0 0
M  V30 56 C 28.0172 10.1814 0.0 0
M  V30 57 C 29.0504 11.3235 0.0 0
M  V30 58 N 27.7811 15.7152 0.0 0
M  V30 59 C 29.2779 15.3527 0.0 0
M  V30 60 C 30.3402 16.4677 0.0 0
M  V30 61 O 29.7123 13.8752 0.0 0
M  V30 62 C 31.8369 16.1052 0.0 0
M  V30 63 C 32.8992 17.2201 0.0 0
M  V30 64 C 34.3959 16.8576 0.0 0
M  V30 65 C 35.4582 17.9726 0.0 0
M  V30 66 C 36.9549 17.6101 0.0 0
M  V30 67 C 38.0172 18.7250 0.0 0
M  V30 68 C 39.5139 18.3627 0.0 0
M  V30 69 C 40.5762 19.4776 0.0 0
M  V30 70 O 28.6509 12.7435 0.0 0
M  V30 71 C 3.5143 11.2730 0.0 0
M  V30 72 C 3.5143 9.7330 0.0 0
M  V30 73 C 4.8479 12.0430 0.0 0
M  V30 74 C 2.0496 11.7488 0.0 0
M  V30 75 C 4.8479 8.9630 0.0 0
M  V30 76 O 2.0496 9.2571 0.0 0
M  V30 77 C 6.1816 11.2730 0.0 0
M  V30 78 C 1.1444 10.5030 0.0 0
M  V30 79 C 6.1816 9.7330 0.0 0
M  V30 80 C 16.8510 12.8130 0.0 0 CFG=2
M  V30 81 C 16.7635 14.3021 0.0 0
M  V30 82 N 18.1455 11.9607 0.0 0
M  V30 83 N 17.9385 15.3007 0.0 0
M  V30 84 C 18.0295 10.4229 0.0 0
M  V30 85 C 17.6355 16.8287 0.0 0 CFG=1
M  V30 86 C 19.0980 9.4086 0.0 0 CFG=2
M  V30 87 C 18.7393 17.8836 0.0 0
M  V30 88 N 20.6277 9.6044 0.0 0
M  V30 89 N 20.2433 17.5235 0.0 0
M  V30 90 C 21.5461 8.3559 0.0 0
M  V30 91 C 21.3079 18.6619 0.0 0 CFG=1
M  V30 92 C 23.0376 8.3460 0.0 0 CFG=2
M  V30 93 C 22.8180 18.3034 0.0 0
M  V30 94 N 23.9739 9.5713 0.0 0
M  V30 95 N 23.2602 16.8146 0.0 0
M  V30 96 C 25.5156 9.3480 0.0 0
M  V30 97 C 24.7706 16.4541 0.0 0
M  V30 98 C 26.5117 10.5053 0.0 0
M  V30 99 C 25.2092 14.9643 0.0 0
M  V30 100 N 26.0739 11.9884 0.0 0
M  V30 101 C 26.7188 14.6003 0.0 0 CFG=2
M  V30 102 C 27.1553 13.1108 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 73
M  V30 2 1 2 75
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 77
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 80 12 CFG=1
M  V30 14 1 13 78
M  V30 15 1 14 78
M  V30 16 1 15 79
M  V30 17 2 16 81
M  V30 18 2 17 84
M  V30 19 1 18 19
M  V30 20 1 85 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 28 29
M  V30 30 1 86 28 CFG=1
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 2 32 87
M  V30 34 2 33 90
M  V30 35 1 34 35
M  V30 36 1 91 34 CFG=1
M  V30 37 1 35 36
M  V30 38 1 36 37
M  V30 39 1 37 38
M  V30 40 2 37 39
M  V30 41 1 38 40
M  V30 42 1 40 41
M  V30 43 1 40 42
M  V30 44 1 40 43
M  V30 45 1 44 45
M  V30 46 1 92 44 CFG=1
M  V30 47 1 45 46
M  V30 48 1 46 47
M  V30 49 1 47 48
M  V30 50 2 47 49
M  V30 51 1 48 50
M  V30 52 1 50 51
M  V30 53 1 50 52
M  V30 54 1 50 53
M  V30 55 2 54 93
M  V30 56 2 55 96
M  V30 57 1 56 57
M  V30 58 2 56 98
M  V30 59 1 58 59
M  V30 60 1 101 58 CFG=3
M  V30 61 1 59 60
M  V30 62 2 59 61
M  V30 63 1 60 62
M  V30 64 1 62 63
M  V30 65 1 63 64
M  V30 66 1 64 65
M  V30 67 1 65 66
M  V30 68 1 66 67
M  V30 69 1 67 68
M  V30 70 1 68 69
M  V30 71 2 70 102
M  V30 72 1 71 72
M  V30 73 2 71 73
M  V30 74 1 71 74
M  V30 75 2 72 75
M  V30 76 1 72 76
M  V30 77 1 73 77
M  V30 78 1 74 78
M  V30 79 1 75 79
M  V30 80 1 76 78
M  V30 81 2 77 79
M  V30 82 1 80 81
M  V30 83 1 80 82
M  V30 84 1 81 83
M  V30 85 1 82 84
M  V30 86 1 83 85
M  V30 87 1 84 86
M  V30 88 1 85 87
M  V30 89 1 86 88
M  V30 90 1 87 89
M  V30 91 1 88 90
M  V30 92 1 89 91
M  V30 93 1 90 92
M  V30 94 1 91 93
M  V30 95 1 92 94
M  V30 96 1 93 95
M  V30 97 1 94 96
M  V30 98 1 95 97
M  V30 99 1 96 98
M  V30 100 1 97 99
M  V30 101 1 98 100
M  V30 102 1 99 101
M  V30 103 1 100 102
M  V30 104 1 101 102
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 80 85 86 91 92 101)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[(3S,6S,9S,12S,15S,18Z,21S)-3,6,15-tris(2-aminoeth...
C42H78N14O8.4CH2O2
3000569-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 66 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5662 10.2492 0.0 0
M  V30 2 C 5.3110 11.1414 0.0 0
M  V30 3 C 3.9107 10.5004 0.0 0
M  V30 4 N 2.6555 11.3926 0.0 0
M  V30 5 C 1.2552 10.7515 0.0 0
M  V30 6 N 1.1103 9.2185 0.0 0
M  V30 7 N 0.0000 11.6438 0.0 0
M  V30 8 O 6.7819 13.2461 0.0 0
M  V30 9 O 7.5588 7.9305 0.0 0
M  V30 10 C 9.6063 5.9206 0.0 0
M  V30 11 C 8.1009 5.5967 0.0 0
M  V30 12 C 7.0677 6.7387 0.0 0
M  V30 13 C 7.6284 4.1312 0.0 0
M  V30 14 C 8.1409 15.5084 0.0 0
M  V30 15 C 8.1700 17.0480 0.0 0
M  V30 16 N 6.8511 17.8431 0.0 0
M  V30 17 O 10.8540 17.0002 0.0 0
M  V30 18 O 11.8623 5.0299 0.0 0
M  V30 19 C 14.6559 4.9629 0.0 0
M  V30 20 C 13.7514 3.7166 0.0 0
M  V30 21 N 14.3785 2.3100 0.0 0
M  V30 22 C 13.5453 16.9389 0.0 0
M  V30 23 C 14.8971 17.6767 0.0 0
M  V30 24 N 14.9341 19.2161 0.0 0
M  V30 25 O 14.7944 13.0494 0.0 0
M  V30 26 O 16.9519 5.7444 0.0 0
M  V30 27 C 19.0935 7.6539 0.0 0
M  V30 28 C 20.3026 8.6075 0.0 0
M  V30 29 O 20.1962 9.9226 0.0 0
M  V30 30 N 20.1241 12.9262 0.0 0
M  V30 31 C 21.4577 12.1563 0.0 0
M  V30 32 C 22.7915 12.9262 0.0 0
M  V30 33 O 21.4577 10.6163 0.0 0
M  V30 34 C 24.1251 12.1563 0.0 0
M  V30 35 C 25.4587 12.9262 0.0 0
M  V30 36 C 26.7922 12.1563 0.0 0
M  V30 37 C 28.1260 12.9262 0.0 0
M  V30 38 C 29.4596 12.1563 0.0 0
M  V30 39 C 30.7932 12.9262 0.0 0
M  V30 40 C 32.1268 12.1563 0.0 0
M  V30 41 C 33.4605 12.9262 0.0 0
M  V30 42 C 7.9663 10.8903 0.0 0 CFG=1
M  V30 43 N 9.2163 9.9606 0.0 0
M  V30 44 C 8.0772 12.4130 0.0 0
M  V30 45 C 9.0148 8.4318 0.0 0
M  V30 46 N 9.4340 13.1549 0.0 0
M  V30 47 C 10.0788 7.3863 0.0 0 CFG=2
M  V30 48 C 9.4597 14.7133 0.0 0 CFG=1
M  V30 49 N 11.6104 7.6227 0.0 0
M  V30 50 C 10.8199 15.4605 0.0 0
M  V30 51 C 12.5561 6.4046 0.0 0
M  V30 52 N 12.1465 14.6533 0.0 0
M  V30 53 C 14.0289 6.3693 0.0 0 CFG=2
M  V30 54 C 13.5085 15.3994 0.0 0 CFG=1
M  V30 55 N 15.0317 7.5407 0.0 0
M  V30 56 C 14.8332 14.5889 0.0 0
M  V30 57 C 16.5504 7.2311 0.0 0
M  V30 58 N 16.1970 15.3316 0.0 0
M  V30 59 C 17.6630 8.2245 0.0 0
M  V30 60 C 17.5198 14.5201 0.0 0
M  V30 61 N 17.5352 9.7610 0.0 0
M  V30 62 C 17.4708 12.9623 0.0 0
M  V30 63 C 18.8283 10.6299 0.0 0
M  V30 64 C 18.7905 12.1563 0.0 0 CFG=2
M  V30 65 C 16.7303 0.0000 0.0 0
M  V30 66 O 15.3966 0.7700 0.0 0
M  V30 67 O 18.0639 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 42 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 2 8 44
M  V30 9 2 9 45
M  V30 10 1 10 11
M  V30 11 1 47 10 CFG=1
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 48 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 17 50
M  V30 18 2 18 51
M  V30 19 1 19 20
M  V30 20 1 53 19 CFG=1
M  V30 21 1 20 21
M  V30 22 1 22 23
M  V30 23 1 54 22 CFG=1
M  V30 24 1 23 24
M  V30 25 2 25 56
M  V30 26 2 26 57
M  V30 27 1 27 28
M  V30 28 2 27 59
M  V30 29 2 29 63
M  V30 30 1 30 31
M  V30 31 1 64 30 CFG=3
M  V30 32 1 31 32
M  V30 33 2 31 33
M  V30 34 1 32 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 42 43
M  V30 43 1 42 44
M  V30 44 1 43 45
M  V30 45 1 44 46
M  V30 46 1 45 47
M  V30 47 1 46 48
M  V30 48 1 47 49
M  V30 49 1 48 50
M  V30 50 1 49 51
M  V30 51 1 50 52
M  V30 52 1 51 53
M  V30 53 1 52 54
M  V30 54 1 53 55
M  V30 55 1 54 56
M  V30 56 1 55 57
M  V30 57 1 56 58
M  V30 58 1 57 59
M  V30 59 1 58 60
M  V30 60 1 59 61
M  V30 61 1 60 62
M  V30 62 1 61 63
M  V30 63 1 62 64
M  V30 64 1 63 64
M  V30 65 1 65 66
M  V30 66 2 65 67
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 42 47 48 53 54 64)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3000569-53-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3000569-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38497556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reverse phase HPLC carried out in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical Synthetic Method for Ogipeptin Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takiguchi, Shingo; Nishi, Takahide
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2023), 34(3), 277-282

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-[[(Phenylmethoxy)amino]methyl]cyclopentanepropanoic acid
C16H23NO3
301684-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 3.9098 0.0 0
M  V30 2 C 2.5796 4.6799 0.0 0 CFG=1
M  V30 3 C 3.9134 3.9098 0.0 0
M  V30 4 C 2.5796 6.2199 0.0 0
M  V30 5 N 5.2470 4.6799 0.0 0
M  V30 6 O 1.2459 6.9899 0.0 0
M  V30 7 O 3.9134 6.9899 0.0 0
M  V30 8 O 6.5807 3.9098 0.0 0
M  V30 9 C 7.9144 4.6799 0.0 0
M  V30 10 C 1.2459 2.3698 0.0 0
M  V30 11 C 2.4918 1.4646 0.0 0
M  V30 12 C 0.0000 1.4646 0.0 0
M  V30 13 C 2.0159 0.0000 0.0 0
M  V30 14 C 0.4759 0.0000 0.0 0
M  V30 15 C 9.2482 3.9098 0.0 0
M  V30 16 C 10.5819 4.6799 0.0 0
M  V30 17 C 9.2482 2.3698 0.0 0
M  V30 18 C 11.9155 3.9098 0.0 0
M  V30 19 C 10.5819 1.5998 0.0 0
M  V30 20 C 11.9155 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[[Formyl(phenylmethoxy)amino]methyl]cyclopentanepropanoic acid
C17H23NO4
301684-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5796 4.6799 0.0 0 CFG=1
M  V30 2 C 1.2459 3.9098 0.0 0
M  V30 3 C 3.9134 3.9098 0.0 0
M  V30 4 C 2.5796 6.2199 0.0 0
M  V30 5 N 5.2470 4.6799 0.0 0
M  V30 6 O 1.2459 6.9899 0.0 0
M  V30 7 O 3.9134 6.9899 0.0 0
M  V30 8 O 6.5807 3.9098 0.0 0
M  V30 9 C 5.2470 6.2199 0.0 0
M  V30 10 C 7.9144 4.6799 0.0 0
M  V30 11 O 6.5807 6.9899 0.0 0
M  V30 12 C 1.2459 2.3698 0.0 0
M  V30 13 C 0.0000 1.4646 0.0 0
M  V30 14 C 2.4918 1.4646 0.0 0
M  V30 15 C 0.4759 0.0000 0.0 0
M  V30 16 C 2.0159 0.0000 0.0 0
M  V30 17 C 9.2482 3.9098 0.0 0
M  V30 18 C 9.2482 2.3698 0.0 0
M  V30 19 C 10.5819 4.6799 0.0 0
M  V30 20 C 10.5819 1.5998 0.0 0
M  V30 21 C 11.9155 3.9098 0.0 0
M  V30 22 C 11.9155 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 17
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 301684-95-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 301684-75-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-780181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2R)-3-Cyclopenty2-({formyl[(pheny)oxy]amino}methyl)propanoic acid Under
a nitrogen atmosphere, formic acid (192 mL, 5 mol) was dissolved in
CH2Cl2 (450 mL) and cooled to 0 °C Acetic anhydride (73 mL, 0.77 mol) was
then added, and the reaction mixture was stirred for 45 min. After this
time, a solution of
(2R)-3-cyclopenty2-({[(pheny)oxy]amino}methyl)propanoic acid (22.85 g
crude material, assumed 77.1 mmol) in CH2Cl2 (450 mL) was added, and the
resulting mixture was stirred for 1.5 h at 0 °C The volatiles were then
removed, the crude residue was dissolved in EtOAc (500 mL), and the
mixture was washed with brine (4 X 100 mL). The organics were dried
(MgSO4) and concentrated to provide
(2R)-3-cyclopenty2-({formyl[(pheny)oxy]amino}methyl)propanoic acid. Thick
syrup, yield (23.5 g, 100%). LCMS: (M+H)+: 306.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
[2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl]hydroxyformamide
compounds as peptide deformylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aubart, Kelly Marshall; Gillian, Jason Michael; Qin, Donghui; McKeown,
Robert Rahn; Williams, Glenn R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013082388 A1 2013-06-06

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-[[(Phenylmethoxy)amino]methyl]cyclopentanepropanoic acid
C16H23NO3
301684-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 3.9098 0.0 0
M  V30 2 C 2.5796 4.6799 0.0 0 CFG=1
M  V30 3 C 3.9134 3.9098 0.0 0
M  V30 4 C 2.5796 6.2199 0.0 0
M  V30 5 N 5.2470 4.6799 0.0 0
M  V30 6 O 1.2459 6.9899 0.0 0
M  V30 7 O 3.9134 6.9899 0.0 0
M  V30 8 O 6.5807 3.9098 0.0 0
M  V30 9 C 7.9144 4.6799 0.0 0
M  V30 10 C 1.2459 2.3698 0.0 0
M  V30 11 C 2.4918 1.4646 0.0 0
M  V30 12 C 0.0000 1.4646 0.0 0
M  V30 13 C 2.0159 0.0000 0.0 0
M  V30 14 C 0.4759 0.0000 0.0 0
M  V30 15 C 9.2482 3.9098 0.0 0
M  V30 16 C 10.5819 4.6799 0.0 0
M  V30 17 C 9.2482 2.3698 0.0 0
M  V30 18 C 11.9155 3.9098 0.0 0
M  V30 19 C 10.5819 1.5998 0.0 0
M  V30 20 C 11.9155 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[[Formyl(phenylmethoxy)amino]methyl]cyclopentanepropanoic acid
C17H23NO4
301684-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5796 4.6799 0.0 0 CFG=1
M  V30 2 C 1.2459 3.9098 0.0 0
M  V30 3 C 3.9134 3.9098 0.0 0
M  V30 4 C 2.5796 6.2199 0.0 0
M  V30 5 N 5.2470 4.6799 0.0 0
M  V30 6 O 1.2459 6.9899 0.0 0
M  V30 7 O 3.9134 6.9899 0.0 0
M  V30 8 O 6.5807 3.9098 0.0 0
M  V30 9 C 5.2470 6.2199 0.0 0
M  V30 10 C 7.9144 4.6799 0.0 0
M  V30 11 O 6.5807 6.9899 0.0 0
M  V30 12 C 1.2459 2.3698 0.0 0
M  V30 13 C 0.0000 1.4646 0.0 0
M  V30 14 C 2.4918 1.4646 0.0 0
M  V30 15 C 0.4759 0.0000 0.0 0
M  V30 16 C 2.0159 0.0000 0.0 0
M  V30 17 C 9.2482 3.9098 0.0 0
M  V30 18 C 9.2482 2.3698 0.0 0
M  V30 19 C 10.5819 4.6799 0.0 0
M  V30 20 C 10.5819 1.5998 0.0 0
M  V30 21 C 11.9155 3.9098 0.0 0
M  V30 22 C 11.9155 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 17
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 301684-95-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 301684-75-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1774708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part H:
(2R)-3-Cyclopentyl-2-({formyl[(phenylmethyl)oxy]amino}methyl)propanoic
acid. Under a nitrogen atmosphere, formic acid (192 mL, 5 mol) was
dissolved in CH2Cl2 (450 mL) and cooled to 0 °C. Acetic anhydride (73 mL,
0.77 mol) was then added, and the reaction mixture was stirred for 45
min. After this time, a solution of
(2R)-3-cyclopentyl-2-({[(phenylmethyl)oxy]amino}methyl)propanoic acid
(22.85 g crude material, assumed 77.1 mmol) in CH2Cl2 (450 mL) was added,
and the resulting mixture was stirred for 1.5 h at 0 °C. The volatiles
were then removed, the crude residue was dissolved in EtOAc (500 mL), and
the mixture was washed with brine (4 × 100 mL). The organics were dried
(MgSO4) and concentrated to provide
(2R)-3-cyclopentyl-2-({formyl[(phenylmethyl)oxy]amino}methyl)propanoic
acid (23.5 g, 100%) as a thick syrup. LCMS:(M+H)+: 306.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [(Pyrimidinylhydrazino)-3-oxopropyl]hydroxyformamide derivatives as
bacterial peptide deformylase inhibitors and preparation, pharmaceutical
compositions and use in the treatment of bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qin, Donghui; Norton, Beth; Liao, Xiangmin; Knox, Andrew Nicholson; Fang,
Yuhong; Lee, Jinhwa; Dreabit, Jason Christopher; Christensen, Siegfried
Benjamin, IV; Benowitz, Andrew B.; Aubart, Kelly M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009061879 A1 2009-05-14

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Alanine
C3H7NO2
302-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 N 4.0010 2.3101 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylalanine
C4H7NO3
5893-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 O 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 302-72-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5893-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37335573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease
Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kilpelainen, Tommi P.; Patsi, Henri T.; Svarcbahs, Reinis; Julku, Ulrika
H.; Etelainen, Tony S.; Cui, Hengjing; Auno, Samuli; Sipari, Nina;
Norrbacka, Susanna; Leino, Teppo O.; Jantti, Maria; Myohanen, Timo T.;
Wallen, Erik A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7475-7496

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H42O4
3027425-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 2.3100 0.0 0
M  V30 2 C 3.3501 6.0157 0.0 0
M  V30 3 C 5.3347 0.7700 0.0 0
M  V30 4 C 6.6684 0.0000 0.0 0
M  V30 5 C 6.6684 9.2400 0.0 0
M  V30 6 C 8.8404 8.8127 0.0 0 CFG=2
M  V30 7 C 9.7455 10.0586 0.0 0
M  V30 8 C 7.3087 8.9736 0.0 0
M  V30 9 C 9.1192 11.4655 0.0 0
M  V30 10 C 10.0244 12.7114 0.0 0
M  V30 11 O 9.3981 14.1182 0.0 0
M  V30 12 O 11.5559 12.5504 0.0 0
M  V30 13 O 0.0000 2.3100 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 15 C 5.3347 5.3900 0.0 0 CFG=2
M  V30 16 C 8.0020 5.3900 0.0 0 CFG=2
M  V30 17 C 6.6684 3.0800 0.0 0
M  V30 18 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 8.0020 6.9300 0.0 0 CFG=1
M  V30 21 C 9.4667 4.9140 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 23 C 4.0011 3.0800 0.0 0 CFG=1
M  V30 24 C 2.6673 5.3900 0.0 0
M  V30 25 C 6.6684 7.7000 0.0 0 CFG=1
M  V30 26 C 9.4667 7.4059 0.0 0 CFG=2
M  V30 27 C 10.3720 6.1600 0.0 0
M  V30 28 C 2.6673 2.3100 0.0 0
M  V30 29 C 1.3336 4.6200 0.0 0
M  V30 30 C 1.3336 3.0800 0.0 0 CFG=2
M  V30 31 H 7.7573 3.5309 0.0 0
M  V30 32 H 4.2458 6.4790 0.0 0
M  V30 33 H 8.5540 3.9523 0.0 0
M  V30 34 H 8.1631 8.4616 0.0 0
M  V30 35 H 4.0011 1.5400 0.0 0
M  V30 36 H 10.8004 8.1759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 22 3 CFG=3
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 26
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 30 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 31 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 32 CFG=3
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 16 33 CFG=3
M  V30 24 1 17 22
M  V30 25 1 18 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 20 25
M  V30 29 1 20 26
M  V30 30 1 20 34 CFG=1
M  V30 31 1 21 27
M  V30 32 1 22 23
M  V30 33 1 23 28
M  V30 34 1 23 35 CFG=1
M  V30 35 1 24 29
M  V30 36 1 26 27
M  V30 37 1 26 36 CFG=1
M  V30 38 1 28 30
M  V30 39 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 6 14 15 16 18 20 22 23 25 26 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H42O5
3027426-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 6.0176 6.0158 0.0 0
M  V30 3 C 8.0021 0.7700 0.0 0
M  V30 4 C 9.3357 0.0000 0.0 0
M  V30 5 C 9.3357 9.2401 0.0 0
M  V30 6 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 7 C 12.4130 10.0586 0.0 0
M  V30 8 C 9.9762 8.9737 0.0 0
M  V30 9 C 11.7865 11.4656 0.0 0
M  V30 10 C 12.6917 12.7114 0.0 0
M  V30 11 O 12.0654 14.1182 0.0 0
M  V30 12 O 14.2233 12.5505 0.0 0
M  V30 13 O 2.6673 2.3100 0.0 0
M  V30 14 C 1.3337 3.0800 0.0 0
M  V30 15 O 0.0000 2.3100 0.0 0
M  V30 16 C 9.3357 4.6200 0.0 0 CFG=1
M  V30 17 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 18 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 19 C 9.3357 3.0800 0.0 0
M  V30 20 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 21 C 8.0021 6.9301 0.0 0
M  V30 22 C 10.6695 6.9301 0.0 0 CFG=1
M  V30 23 C 12.1341 4.9140 0.0 0
M  V30 24 C 8.0021 2.3100 0.0 0 CFG=2
M  V30 25 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 26 C 5.3348 5.3901 0.0 0
M  V30 27 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 28 C 12.1341 7.4059 0.0 0 CFG=2
M  V30 29 C 13.0393 6.1601 0.0 0
M  V30 30 C 5.3348 2.3100 0.0 0
M  V30 31 C 4.0010 4.6200 0.0 0
M  V30 32 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 33 H 10.4247 3.5309 0.0 0
M  V30 34 H 6.9131 6.4790 0.0 0
M  V30 35 H 11.2213 3.9523 0.0 0
M  V30 36 H 10.8305 8.4616 0.0 0
M  V30 37 H 6.6684 1.5400 0.0 0
M  V30 38 H 13.4677 8.1759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 20 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 24 3 CFG=3
M  V30 5 1 27 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 28
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=1
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 34 CFG=3
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 1 18 35 CFG=3
M  V30 26 1 19 24
M  V30 27 1 20 25
M  V30 28 1 20 26
M  V30 29 1 21 27
M  V30 30 1 22 27
M  V30 31 1 22 28
M  V30 32 1 22 36 CFG=1
M  V30 33 1 23 29
M  V30 34 1 24 25
M  V30 35 1 25 30
M  V30 36 1 25 37 CFG=1
M  V30 37 1 26 31
M  V30 38 1 28 29
M  V30 39 1 28 38 CFG=1
M  V30 40 1 30 32
M  V30 41 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 6 16 17 18 20 22 24 25 27 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3027425-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3027426-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36251405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and
selective TGR5 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luxenburger, Andreas; Harris, Lawrence D.; Ure, Elizabeth M.; Jiao,
Wanting; Woolhouse, Anthony D.; Cameron, Scott A.; Weymouth-Wilson, Alex;
Furneaux, Richard H.; Pitman, Janet L.; Hinkley, Simon F. R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 250115143

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl]amino]-3-nitro-, methyl...
C19H22N2O4
3036767-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 4.0011 0.0 0
M  V30 2 C 7.7000 5.3349 0.0 0
M  V30 3 N 10.0100 1.3338 0.0 0 VAL=5
M  V30 4 O 8.4700 1.3338 0.0 0
M  V30 5 O 10.7800 0.0000 0.0 0
M  V30 6 C 14.6300 4.0011 0.0 0
M  V30 7 O 15.4000 5.3349 0.0 0
M  V30 8 O 15.4000 2.6674 0.0 0
M  V30 9 C 16.9400 5.3349 0.0 0
M  V30 10 C 1.5400 5.3349 0.0 0
M  V30 11 C 1.5400 6.8749 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 1.5400 3.7949 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 10.7800 2.6674 0.0 0
M  V30 16 C 10.7800 5.3349 0.0 0
M  V30 17 C 12.3200 2.6674 0.0 0
M  V30 18 C 12.3200 5.3349 0.0 0
M  V30 19 C 13.0900 4.0011 0.0 0
M  V30 20 C 6.1600 5.3349 0.0 0
M  V30 21 C 5.3900 6.6685 0.0 0
M  V30 22 C 5.3900 4.0011 0.0 0
M  V30 23 C 3.8500 6.6685 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 3.0800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 20
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-5-carboxylic acid, 1-[[4-(1,1-dimethylethyl)phenyl]methyl]-,...
C20H22N2O2
3036767-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.4287 0.0 0
M  V30 2 C 14.3953 1.5064 0.0 0
M  V30 3 O 15.5398 2.5368 0.0 0
M  V30 4 O 14.7156 0.0000 0.0 0
M  V30 5 C 17.0044 2.0610 0.0 0
M  V30 6 C 1.5400 4.4287 0.0 0
M  V30 7 C 1.5400 2.8887 0.0 0
M  V30 8 C 0.0000 4.4287 0.0 0
M  V30 9 C 1.5400 5.9687 0.0 0
M  V30 10 C 10.0015 2.9340 0.0 0
M  V30 11 C 10.3217 1.4277 0.0 0
M  V30 12 N 8.4700 3.0951 0.0 0
M  V30 13 C 11.1459 3.9646 0.0 0
M  V30 14 C 11.7862 0.9519 0.0 0
M  V30 15 N 8.9881 0.6577 0.0 0
M  V30 16 C 7.8435 1.6881 0.0 0
M  V30 17 C 12.6106 3.4886 0.0 0
M  V30 18 C 12.9308 1.9823 0.0 0
M  V30 19 C 6.1600 4.4287 0.0 0
M  V30 20 C 5.3900 5.7624 0.0 0
M  V30 21 C 5.3900 3.0951 0.0 0
M  V30 22 C 3.8500 5.7624 0.0 0
M  V30 23 C 3.8500 3.0951 0.0 0
M  V30 24 C 3.0800 4.4287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 24
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3036767-89-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036767-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36515408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of FXR/PPARγ dual partial agonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamashita, Yukiko; Gohda, Keigo; Iguchi, Yusuke; Fujimori, Ko; Oda,
Keisuke; Masuda, Arisa; Une, Mizuho; Teno, Naoki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 85117238

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
3,7-Dibromodecahydro-3,5,1,7-[1,2,3,4]butanetetraylnaphthalene
C14H18Br2
30651-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.7289 0.0 0
M  V30 2 Br 7.9206 1.1815 0.0 0
M  V30 3 C 3.7791 3.1297 0.0 0
M  V30 4 C 5.1028 3.8993 0.0 0
M  V30 5 C 3.7791 1.5906 0.0 0
M  V30 6 C 2.2914 3.6223 0.0 0
M  V30 7 C 4.1485 2.3088 0.0 0
M  V30 8 C 6.4368 3.1297 0.0 0
M  V30 9 C 2.8147 0.0000 0.0 0
M  V30 10 C 5.1028 0.8210 0.0 0
M  V30 11 C 1.4807 2.3088 0.0 0
M  V30 12 C 4.1485 0.7696 0.0 0
M  V30 13 C 2.8147 3.0783 0.0 0
M  V30 14 C 6.4368 1.5906 0.0 0
M  V30 15 C 1.4807 0.7696 0.0 0
M  V30 16 C 5.6467 0.2669 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 1 9 15
M  V30 16 1 10 14
M  V30 17 1 11 13
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Octahydro-3,5,1,7-[1,2,3,4]butanetetraylnaphthalene-3,7-dicarboxylic acid
C16H20O4
55981-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0196 3.0350 0.0 0
M  V30 2 O 10.1239 1.9621 0.0 0
M  V30 3 O 9.3967 4.5277 0.0 0
M  V30 4 C 1.0962 1.4899 0.0 0
M  V30 5 O 0.0000 2.5708 0.0 0
M  V30 6 O 0.7081 0.0000 0.0 0
M  V30 7 C 7.5384 2.6153 0.0 0
M  V30 8 C 6.7279 3.9294 0.0 0
M  V30 9 C 6.2042 3.3856 0.0 0
M  V30 10 C 7.5378 1.0757 0.0 0
M  V30 11 C 5.2396 3.4373 0.0 0
M  V30 12 C 4.8698 2.6161 0.0 0
M  V30 13 C 6.2032 0.3064 0.0 0
M  V30 14 C 5.2390 1.8977 0.0 0
M  V30 15 C 3.9157 4.2076 0.0 0
M  V30 16 C 4.8692 1.0765 0.0 0
M  V30 17 C 3.9148 1.1284 0.0 0
M  V30 18 C 2.5812 3.4381 0.0 0
M  V30 19 C 3.3704 0.5743 0.0 0
M  V30 20 C 2.5805 1.8985 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 30651-02-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55981-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29080173
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10294-26-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4,9-Diamantanedicarboxylic Acid (3) Warning! This reaction generates
extremely toxic carbon monoxide and must be performed in a
well-ventilated hood. The reaction foams and should be run in a vessel at
least three times the total volume of the reagents. A 2 L, single-neck,
round-bottomed flask equipped with a magnetic stirbar was charged with
300 mL of conc. H2SO4 and 25.9 g of Ag2SO4 (0.083 mol, 1.1 equiv) and
placed in an ice bath to stir. In one portion, 26.1 g of 1 (0.075 mol)
was added to the reaction mixture. A 250 mL pressure-equalizing addition
funnel equipped with a gas outlet adapter was attached to the flask.
Tubing was attached to the gas outlet adapter to exhaust the apparatus to
the back of the hood. The funnel was charged with 100 mL of 95-97% formic
acid, and the addition was made over 1 h. The cooling bath was removed,
and the mixture stirred at rt 18 h. The mixture was filtered through a
medium-porosity glass fritted funnel. The solid on the filter was washed
with H2O into a 1 L beaker. H2O (500 mL) was added to the beaker, and 50%
aqueous NaOH was added portionwise to basify the mixture (pH 10). The
mixture was filtered through a medium-porosity glass frit to remove the
insoluble silver salts. The colorless filtrate was stirred and made
acidic with conc HCl. The white precipitate was filtered on a medium
glass frit and washed three times with 200 mL portions of H2O. The solid
was placed in a vacuum oven to remove residual H2O (60°C, 10 torr, 18 h),
yielding 18.8 g of the title compound. The initial filtrate from the
reaction can be diluted with H2O to give, after drying, an additional 1.9
g of product. The total yield was 20.7 g (100%). The compound
precipitates as a white amorphous powder from DMSO.
4,9-Diamantanedicarboxylic Acid (3), yield 1.9 g, 100%. Mp > 400°C
(lit.[4] 456°C]. δH (DMSO): 12.00 (bs, 2H), 1.76 (s, 18H).
$DTYPE RXN:VAR(1):NOTES
$DATUM safety (- CO gas is generated)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective apical bromination of diamantane and conversion to the
dihydroxy and dicarboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davis, Matthew C.; Liu, Shenggao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2006), 36(23), 3509-3514

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate), (1R,2S,5R)-
C17H25NO2
307556-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3336 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 4.6200 1.3336 0.0 0
M  V30 4 O 4.6200 4.0011 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 N 6.9300 8.0021 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 10 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0 CFG=2
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 7.7000 6.6685 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 4 5
M  V30 5 1 10 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 5 15
M  V30 8 1 14 7 CFG=1
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl 2-(formylamino)benzoate
C18H25NO3
1418290-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.3348 0.0 0
M  V30 2 O 4.6201 5.3348 0.0 0
M  V30 3 O 6.9302 4.0012 0.0 0
M  V30 4 N 9.2402 5.3348 0.0 0
M  V30 5 C 10.7802 5.3348 0.0 0
M  V30 6 O 11.5503 4.0012 0.0 0
M  V30 7 C 1.5400 5.3348 0.0 0
M  V30 8 C 2.3101 6.6685 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 6.9302 6.6685 0.0 0
M  V30 12 C 8.4702 6.6685 0.0 0
M  V30 13 C 6.1601 8.0023 0.0 0
M  V30 14 C 9.2402 8.0023 0.0 0
M  V30 15 C 6.9302 9.3360 0.0 0
M  V30 16 C 8.4702 9.3360 0.0 0
M  V30 17 C 3.8501 4.0012 0.0 0 CFG=2
M  V30 18 C 2.3101 4.0012 0.0 0 CFG=2
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 1.5400 2.6675 0.0 0
M  V30 21 C 3.8501 1.3337 0.0 0 CFG=2
M  V30 22 C 2.3101 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 2 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 21 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 307556-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1418290-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16591474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The multicomponent approach to N-methyl peptides: total synthesis of
antibacterial (-)-viridic acid and analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neves Filho, Ricardo A. W.; Stark, Sebastian; Westermann, Bernhard;
Wessjohann, Ludger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2012), 82085-2090

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(trifluoromethyl)benzenamine
C8H5F6N
328-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 4.6201 0.0 0
M  V30 2 F 5.8986 5.9538 0.0 0
M  V30 3 F 8.0023 5.3901 0.0 0
M  V30 4 F 7.4387 3.2864 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 F 2.1037 5.9538 0.0 0
M  V30 7 F 0.0000 5.3901 0.0 0
M  V30 8 F 0.5637 3.2864 0.0 0
M  V30 9 N 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3,5-Bis(trifluoromethyl)phenyl]formamide
C9H5F6NO
2356-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4938 0.0 0
M  V30 3 F 0.0000 6.9302 0.0 0
M  V30 4 F 0.5637 4.8265 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 F 5.5412 1.5400 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 F 2.4611 1.5400 0.0 0
M  V30 9 N 6.6685 6.1601 0.0 0
M  V30 10 C 8.0023 5.3901 0.0 0
M  V30 11 O 9.3360 6.1601 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 6.1601 0.0 0
M  V30 15 C 4.0012 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 328-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2356-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22766000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Access to Known and Unknown Thiourea Catalyst via a
Multicomponent-Reaction Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nickisch, Roman; Gabrielsen, Solveig M.; Meier, Michael A. R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2020), 5(38), 11915-11920

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2E)-5-amino-2-penten-1-yl]-L-methionyl-L-leucyl-, (3→1)-...
C25H38N4O3S
333438-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.0255 0.0 0
M  V30 2 O 4.0011 9.1055 0.0 0
M  V30 3 O 5.8442 3.4886 0.0 0
M  V30 4 C 8.7735 2.5369 0.0 0
M  V30 5 C 7.6291 1.5064 0.0 0
M  V30 6 C 6.1644 1.9823 0.0 0
M  V30 7 C 7.9492 0.0000 0.0 0
M  V30 8 O 11.7557 3.5058 0.0 0
M  V30 9 C 13.5661 5.9976 0.0 0
M  V30 10 C 14.4714 7.2436 0.0 0
M  V30 11 S 16.0029 7.0825 0.0 0
M  V30 12 C 16.9081 8.3284 0.0 0
M  V30 13 C 5.3348 6.7955 0.0 0 CFG=1
M  V30 14 N 6.6684 6.0255 0.0 0
M  V30 15 C 5.3348 8.3355 0.0 0
M  V30 16 C 6.9887 4.5192 0.0 0
M  V30 17 N 6.6684 9.1055 0.0 0
M  V30 18 C 8.4533 4.0432 0.0 0 CFG=2
M  V30 19 C 6.9887 10.6119 0.0 0
M  V30 20 N 9.5978 5.0737 0.0 0
M  V30 21 C 8.4533 11.0878 0.0 0
M  V30 22 C 11.1294 4.9128 0.0 0
M  V30 23 C 9.5978 10.0572 0.0 0
M  V30 24 C 12.0346 6.1587 0.0 0 CFG=2
M  V30 25 C 11.1294 10.2183 0.0 0
M  V30 26 N 11.4081 7.5655 0.0 0
M  V30 27 C 12.0346 8.9724 0.0 0
M  V30 28 C 2.6675 6.7955 0.0 0
M  V30 29 C 1.3337 6.0255 0.0 0
M  V30 30 C 2.6675 8.3355 0.0 0
M  V30 31 C 0.0000 6.7955 0.0 0
M  V30 32 C 1.3337 9.1055 0.0 0
M  V30 33 C 0.0000 8.3355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 28
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2E)-5-amino-2-penten-1-yl]-N-formyl-L-methionyl-L-leucyl...
C26H38N4O4S
333438-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.2440 0.0 0
M  V30 2 O 3.0800 5.9114 0.0 0
M  V30 3 O 7.4846 1.9687 0.0 0
M  V30 4 C 10.4973 2.6091 0.0 0
M  V30 5 C 10.0212 1.1444 0.0 0
M  V30 6 C 11.0518 0.0000 0.0 0
M  V30 7 C 8.5150 0.8242 0.0 0
M  V30 8 O 12.5954 4.9392 0.0 0
M  V30 9 C 12.9174 8.0025 0.0 0
M  V30 10 C 14.1632 7.0972 0.0 0
M  V30 11 S 15.5700 7.7236 0.0 0
M  V30 12 C 16.8159 6.8183 0.0 0
M  V30 13 C 11.5982 9.0512 0.0 0
M  V30 14 O 11.5982 10.5912 0.0 0
M  V30 15 C 5.3900 4.5778 0.0 0 CFG=1
M  V30 16 N 6.9300 4.5778 0.0 0
M  V30 17 C 4.6200 5.9114 0.0 0
M  V30 18 C 7.9604 3.4333 0.0 0
M  V30 19 N 5.3900 7.2451 0.0 0
M  V30 20 C 9.4667 3.7534 0.0 0 CFG=2
M  V30 21 C 4.9140 8.7098 0.0 0
M  V30 22 N 9.9425 5.2181 0.0 0
M  V30 23 C 5.9446 9.8542 0.0 0
M  V30 24 C 11.3495 5.8445 0.0 0
M  V30 25 C 7.4508 9.5340 0.0 0
M  V30 26 C 11.5104 7.3760 0.0 0 CFG=2
M  V30 27 C 8.6967 10.4392 0.0 0
M  V30 28 N 10.2646 8.2812 0.0 0
M  V30 29 C 10.1036 9.8127 0.0 0
M  V30 30 C 3.0800 3.2440 0.0 0
M  V30 31 C 2.3100 1.9104 0.0 0
M  V30 32 C 2.3100 4.5778 0.0 0
M  V30 33 C 0.7700 1.9104 0.0 0
M  V30 34 C 0.7700 4.5778 0.0 0
M  V30 35 C 0.0000 3.2440 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 30
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-42-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12169732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of N-Formyl-cyclotripeptides The free amine macrocycle (see
example 2) was added to a mixture of formic acid (0.2 mL) and acetic
anhydride (0.1 mL) and the reaction mixture was stirred for 15 min at
room temperature, then for 5 min at 55° C. and finally for 2 h at room
temperature. The reaction mixture was evaporated to dryness and purified
by column chromatography, The desired compounds in yields ranging from 81
to 100%. Data for Formylated c-Met-Leu-Phe-Linker Compounds: Trans-Linker
(c-f-MLF-1) 1H NMR (CDCl3, 300 MHz): 8.72 (1H, s), 7.92 (1H, s),
7.38-7.22 (5H, m), 6.78 (1H, br), 5.83 (1H, d, J=10.0 Hz), 5.68-5.58 (1H,
m), 4.96-4.89 (1H, m), 4.02-3.68 (5H, m), 3.34 (1H, dd, J=14.0 and 10.0
Hz), 2.78 (1H, dd, J=13.5 and 5.2 Hz), 2.67-2.51 (3H, m), 2.42-2.31 (1H,
m), 2.18-2.04 (1H, m), 2.06 (3H, s), 1.99-1.53 (6H, m), 1.03 (3H, d,
J=6.0 Hz), 0.94 (3H, d, J=6.0 Hz). LC-MS: m/e: 502 (M+) (84.2%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2284459 C 2012-12-11

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2E)-5-amino-2-penten-1-yl]-L-methionyl-L-leucyl-, (3→1)-...
C25H38N4O3S
333438-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.0255 0.0 0
M  V30 2 O 4.0011 9.1055 0.0 0
M  V30 3 O 5.8442 3.4886 0.0 0
M  V30 4 C 8.7735 2.5369 0.0 0
M  V30 5 C 7.6291 1.5064 0.0 0
M  V30 6 C 6.1644 1.9823 0.0 0
M  V30 7 C 7.9492 0.0000 0.0 0
M  V30 8 O 11.7557 3.5058 0.0 0
M  V30 9 C 13.5661 5.9976 0.0 0
M  V30 10 C 14.4714 7.2436 0.0 0
M  V30 11 S 16.0029 7.0825 0.0 0
M  V30 12 C 16.9081 8.3284 0.0 0
M  V30 13 C 5.3348 6.7955 0.0 0 CFG=1
M  V30 14 N 6.6684 6.0255 0.0 0
M  V30 15 C 5.3348 8.3355 0.0 0
M  V30 16 C 6.9887 4.5192 0.0 0
M  V30 17 N 6.6684 9.1055 0.0 0
M  V30 18 C 8.4533 4.0432 0.0 0 CFG=2
M  V30 19 C 6.9887 10.6119 0.0 0
M  V30 20 N 9.5978 5.0737 0.0 0
M  V30 21 C 8.4533 11.0878 0.0 0
M  V30 22 C 11.1294 4.9128 0.0 0
M  V30 23 C 9.5978 10.0572 0.0 0
M  V30 24 C 12.0346 6.1587 0.0 0 CFG=2
M  V30 25 C 11.1294 10.2183 0.0 0
M  V30 26 N 11.4081 7.5655 0.0 0
M  V30 27 C 12.0346 8.9724 0.0 0
M  V30 28 C 2.6675 6.7955 0.0 0
M  V30 29 C 1.3337 6.0255 0.0 0
M  V30 30 C 2.6675 8.3355 0.0 0
M  V30 31 C 0.0000 6.7955 0.0 0
M  V30 32 C 1.3337 9.1055 0.0 0
M  V30 33 C 0.0000 8.3355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 28
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2E)-5-amino-2-penten-1-yl]-N-formyl-L-methionyl-L-leucyl...
C26H38N4O4S
333438-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.2440 0.0 0
M  V30 2 O 3.0800 5.9114 0.0 0
M  V30 3 O 7.4846 1.9687 0.0 0
M  V30 4 C 10.4973 2.6091 0.0 0
M  V30 5 C 10.0212 1.1444 0.0 0
M  V30 6 C 11.0518 0.0000 0.0 0
M  V30 7 C 8.5150 0.8242 0.0 0
M  V30 8 O 12.5954 4.9392 0.0 0
M  V30 9 C 12.9174 8.0025 0.0 0
M  V30 10 C 14.1632 7.0972 0.0 0
M  V30 11 S 15.5700 7.7236 0.0 0
M  V30 12 C 16.8159 6.8183 0.0 0
M  V30 13 C 11.5982 9.0512 0.0 0
M  V30 14 O 11.5982 10.5912 0.0 0
M  V30 15 C 5.3900 4.5778 0.0 0 CFG=1
M  V30 16 N 6.9300 4.5778 0.0 0
M  V30 17 C 4.6200 5.9114 0.0 0
M  V30 18 C 7.9604 3.4333 0.0 0
M  V30 19 N 5.3900 7.2451 0.0 0
M  V30 20 C 9.4667 3.7534 0.0 0 CFG=2
M  V30 21 C 4.9140 8.7098 0.0 0
M  V30 22 N 9.9425 5.2181 0.0 0
M  V30 23 C 5.9446 9.8542 0.0 0
M  V30 24 C 11.3495 5.8445 0.0 0
M  V30 25 C 7.4508 9.5340 0.0 0
M  V30 26 C 11.5104 7.3760 0.0 0 CFG=2
M  V30 27 C 8.6967 10.4392 0.0 0
M  V30 28 N 10.2646 8.2812 0.0 0
M  V30 29 C 10.1036 9.8127 0.0 0
M  V30 30 C 3.0800 3.2440 0.0 0
M  V30 31 C 2.3100 1.9104 0.0 0
M  V30 32 C 2.3100 4.5778 0.0 0
M  V30 33 C 0.7700 1.9104 0.0 0
M  V30 34 C 0.7700 4.5778 0.0 0
M  V30 35 C 0.0000 3.2440 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 30
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-42-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13336847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001025257 A2 2001-04-12

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2Z)-4-amino-2-buten-1-yl]-L-methionyl-L-leucyl-, (3→1)-l...
C24H36N4O3S
333438-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 14 N 6.6685 6.1600 0.0 0
M  V30 15 C 5.3347 8.4700 0.0 0
M  V30 16 C 6.6685 4.6200 0.0 0
M  V30 17 N 6.6685 9.2400 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 19 C 8.0021 8.4700 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 10.6694 3.8500 0.0 0
M  V30 23 C 10.6694 8.4700 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 25 C 10.6694 6.9300 0.0 0
M  V30 26 N 12.0032 6.1600 0.0 0
M  V30 27 C 2.6674 6.9300 0.0 0
M  V30 28 C 1.3338 6.1600 0.0 0
M  V30 29 C 2.6674 8.4700 0.0 0
M  V30 30 C 0.0000 6.9300 0.0 0
M  V30 31 C 1.3338 9.2400 0.0 0
M  V30 32 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 27
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2Z)-4-amino-2-buten-1-yl]-N-formyl-L-methionyl-L-leucyl-...
C25H36N4O4S
333438-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 13.3369 6.9300 0.0 0
M  V30 14 O 13.3369 8.4700 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 16 N 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 8.4700 0.0 0
M  V30 18 C 6.6685 4.6200 0.0 0
M  V30 19 N 6.6685 9.2400 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 21 C 8.0021 8.4700 0.0 0
M  V30 22 N 9.3358 4.6200 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 10.6694 3.8500 0.0 0
M  V30 25 C 10.6694 8.4700 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 27 C 10.6694 6.9300 0.0 0
M  V30 28 N 12.0032 6.1600 0.0 0
M  V30 29 C 2.6674 6.9300 0.0 0
M  V30 30 C 1.3338 6.1600 0.0 0
M  V30 31 C 2.6674 8.4700 0.0 0
M  V30 32 C 0.0000 6.9300 0.0 0
M  V30 33 C 1.3338 9.2400 0.0 0
M  V30 34 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 29
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14299493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of N-Formyl-cyclotripeptides The
free amine macrocycle (see example 2) was added to a mixture of formic
acid (0.2 mL) and acetic anhydride (0.1 mL) and the reaction mixture was
stirred for 15 min at room temperature, then for 5 min at 55° C. and
finally for 2 h at room temperature. The reaction mixture was evaporated
to dryness and purified by column chromatography, The desired compounds
in yields ranging from 81 to 100%. Data for Formylated
c-Met-Leu-Phe-Linker Compounds: Cis-Linker (c-f-MLF-2): 1H NMR (CDCl3,
300 MHz): 8.04 (1H, s), 7.29-7.18 (5H, m), 6.82-6.74 (1H, m), 6.39 (1H,
d, J=9.5 Hz), 6.16 (1H, dd, J=18.0 and 7.5 Hz), 6.94-6.85 (1H, m),
4.80-4.72 (1H, m), 4.24-3.68 (5H, m), 3.50-3.43 (1H, m), 2.87-2.79 (1H,
m), 2.61-2.45 (3H, m), 2.14-2.01 (1H, m), 2.11 (3H, s), 1.74-1.62 (1H,
m), 1.43-1.25 (3H, m), 0.93-0.78 (6H, m). LC-MS: m/e: 488 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2284459 C 2012-12-11

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2Z)-4-amino-2-buten-1-yl]-L-methionyl-L-leucyl-, (3→1)-l...
C24H36N4O3S
333438-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 14 N 6.6685 6.1600 0.0 0
M  V30 15 C 5.3347 8.4700 0.0 0
M  V30 16 C 6.6685 4.6200 0.0 0
M  V30 17 N 6.6685 9.2400 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 19 C 8.0021 8.4700 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 10.6694 3.8500 0.0 0
M  V30 23 C 10.6694 8.4700 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 25 C 10.6694 6.9300 0.0 0
M  V30 26 N 12.0032 6.1600 0.0 0
M  V30 27 C 2.6674 6.9300 0.0 0
M  V30 28 C 1.3338 6.1600 0.0 0
M  V30 29 C 2.6674 8.4700 0.0 0
M  V30 30 C 0.0000 6.9300 0.0 0
M  V30 31 C 1.3338 9.2400 0.0 0
M  V30 32 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 27
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[(2Z)-4-amino-2-buten-1-yl]-N-formyl-L-methionyl-L-leucyl-...
C25H36N4O4S
333438-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 13.3369 6.9300 0.0 0
M  V30 14 O 13.3369 8.4700 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 16 N 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 8.4700 0.0 0
M  V30 18 C 6.6685 4.6200 0.0 0
M  V30 19 N 6.6685 9.2400 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 21 C 8.0021 8.4700 0.0 0
M  V30 22 N 9.3358 4.6200 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 10.6694 3.8500 0.0 0
M  V30 25 C 10.6694 8.4700 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 27 C 10.6694 6.9300 0.0 0
M  V30 28 N 12.0032 6.1600 0.0 0
M  V30 29 C 2.6674 6.9300 0.0 0
M  V30 30 C 1.3338 6.1600 0.0 0
M  V30 31 C 2.6674 8.4700 0.0 0
M  V30 32 C 0.0000 6.9300 0.0 0
M  V30 33 C 1.3338 9.2400 0.0 0
M  V30 34 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 29
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15466462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001025257 A2 2001-04-12

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-(4-amino-2-butyn-1-yl)-L-methionyl-L-leucyl-, (3→1)-lactam
C24H34N4O3S
333438-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 14 N 6.6685 6.1600 0.0 0
M  V30 15 C 5.3347 8.4700 0.0 0
M  V30 16 C 6.6685 4.6200 0.0 0
M  V30 17 N 6.6685 9.2400 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 19 C 8.0021 8.4700 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 10.6694 3.8500 0.0 0
M  V30 23 C 10.6694 8.4700 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 25 C 10.6694 6.9300 0.0 0
M  V30 26 N 12.0032 6.1600 0.0 0
M  V30 27 C 2.6674 6.9300 0.0 0
M  V30 28 C 1.3338 6.1600 0.0 0
M  V30 29 C 2.6674 8.4700 0.0 0
M  V30 30 C 0.0000 6.9300 0.0 0
M  V30 31 C 1.3338 9.2400 0.0 0
M  V30 32 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 27
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 3 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-(4-amino-2-butyn-1-yl)-N-formyl-L-methionyl-L-leucyl-, (3→...
C25H34N4O4S
333438-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 13.3369 6.9300 0.0 0
M  V30 14 O 13.3369 8.4700 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 16 N 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 8.4700 0.0 0
M  V30 18 C 6.6685 4.6200 0.0 0
M  V30 19 N 6.6685 9.2400 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 21 C 8.0021 8.4700 0.0 0
M  V30 22 N 9.3358 4.6200 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 10.6694 3.8500 0.0 0
M  V30 25 C 10.6694 8.4700 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 27 C 10.6694 6.9300 0.0 0
M  V30 28 N 12.0032 6.1600 0.0 0
M  V30 29 C 2.6674 6.9300 0.0 0
M  V30 30 C 2.6674 8.4700 0.0 0
M  V30 31 C 1.3338 6.1600 0.0 0
M  V30 32 C 1.3338 9.2400 0.0 0
M  V30 33 C 0.0000 6.9300 0.0 0
M  V30 34 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 29
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 3 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-905390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of N-Formyl-cyclotripeptides The
free amine macrocycle (see example 2) was added to a mixture of formic
acid (0.2 mL) and acetic anhydride (0.1 mL) and the reaction mixture was
stirred for 15 min at room temperature, then for 5 min at 55° C. and
finally for 2 h at room temperature. The reaction mixture was evaporated
to dryness and purified by column chromatography, The desired compounds
in yields ranging from 81 to 100%. Data for Formylated
c-Met-Leu-Phe-Linker Compounds: Acetylene-Linker (c-f-MLF-3): 1H NMR
(CDCl3, 300 MHz): 8.10 (1H, s), 7.83 (1H, br), 7.31-7.16 (5H, m), 6.97
(1H, br), 6.45 (1H, br), 4.35-4.01 (5H, m), 3.87-3.71 (2H, m), 3.38 (1H,
dd, J=14.5 and 5.0 Hz), 3.24-3.16 (1H, m), 2.59-2.23 (3H, m), 2.08 (3H,
s), 1.66-1.25 (4H, m), 0.84 (6H, t, J=6.0 Hz). LC-MS: m/e: 486 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2284459 C 2012-12-11

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-(4-amino-2-butyn-1-yl)-L-methionyl-L-leucyl-, (3→1)-lactam
C24H34N4O3S
333438-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 14 N 6.6685 6.1600 0.0 0
M  V30 15 C 5.3347 8.4700 0.0 0
M  V30 16 C 6.6685 4.6200 0.0 0
M  V30 17 N 6.6685 9.2400 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 19 C 8.0021 8.4700 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 10.6694 3.8500 0.0 0
M  V30 23 C 10.6694 8.4700 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 25 C 10.6694 6.9300 0.0 0
M  V30 26 N 12.0032 6.1600 0.0 0
M  V30 27 C 2.6674 6.9300 0.0 0
M  V30 28 C 1.3338 6.1600 0.0 0
M  V30 29 C 2.6674 8.4700 0.0 0
M  V30 30 C 0.0000 6.9300 0.0 0
M  V30 31 C 1.3338 9.2400 0.0 0
M  V30 32 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 1 27
M  V30 3 2 2 15
M  V30 4 2 3 16
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 22
M  V30 10 1 9 10
M  V30 11 1 24 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 3 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-(4-amino-2-butyn-1-yl)-N-formyl-L-methionyl-L-leucyl-, (3→...
C25H34N4O4S
333438-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 O 10.6694 2.3100 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 S 16.0041 3.8500 0.0 0
M  V30 12 C 17.3379 4.6200 0.0 0
M  V30 13 C 13.3369 6.9300 0.0 0
M  V30 14 O 13.3369 8.4700 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 16 N 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 8.4700 0.0 0
M  V30 18 C 6.6685 4.6200 0.0 0
M  V30 19 N 6.6685 9.2400 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 21 C 8.0021 8.4700 0.0 0
M  V30 22 N 9.3358 4.6200 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 10.6694 3.8500 0.0 0
M  V30 25 C 10.6694 8.4700 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0 CFG=2
M  V30 27 C 10.6694 6.9300 0.0 0
M  V30 28 N 12.0032 6.1600 0.0 0
M  V30 29 C 2.6674 6.9300 0.0 0
M  V30 30 C 2.6674 8.4700 0.0 0
M  V30 31 C 1.3338 6.1600 0.0 0
M  V30 32 C 1.3338 9.2400 0.0 0
M  V30 33 C 0.0000 6.9300 0.0 0
M  V30 34 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 1 29
M  V30 3 2 2 17
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 24
M  V30 10 1 9 10
M  V30 11 1 26 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 3 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 20 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333438-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333438-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2072296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of libraries of macrocyclic compounds useful in
drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deslongchamps, Pierre; Dory, Yves; Berthiaume, Gilles; Ouellet, Luc; Lan,
Ruoxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001025257 A2 2001-04-12

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-[3-(phenylthio)propyl]benzenemethanamine
C18H23NO2S
341547-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3347 0.0 0
M  V30 7 C 9.2400 5.3347 0.0 0
M  V30 8 C 10.0100 6.6684 0.0 0
M  V30 9 C 11.5500 6.6684 0.0 0
M  V30 10 S 12.3200 8.0021 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 13.8600 8.0021 0.0 0
M  V30 18 C 14.6300 9.3358 0.0 0
M  V30 19 C 14.6300 6.6684 0.0 0
M  V30 20 C 16.1700 9.3358 0.0 0
M  V30 21 C 16.1700 6.6684 0.0 0
M  V30 22 C 16.9400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3,4-Dimethoxyphenyl)methyl]-N-[3-(phenylthio)propyl]formamide
C19H23NO3S
341547-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 C 6.9300 1.3336 0.0 0
M  V30 5 C 10.0100 4.0011 0.0 0
M  V30 6 O 7.7000 0.0000 0.0 0
M  V30 7 C 11.5500 4.0011 0.0 0
M  V30 8 S 12.3200 5.3347 0.0 0
M  V30 9 O 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 8.0021 0.0 0
M  V30 11 O 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 3.0800 2.6674 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 13.8600 5.3347 0.0 0
M  V30 20 C 14.6300 4.0011 0.0 0
M  V30 21 C 14.6300 6.6685 0.0 0
M  V30 22 C 16.1700 4.0011 0.0 0
M  V30 23 C 16.1700 6.6685 0.0 0
M  V30 24 C 16.9400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 1 11 12
M  V30 13 1 11 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 341547-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 341547-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-618171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2,3,4,5-tetrahydro-1H-2-benzazepines via Pummerer-type
cyclization of N-arylmethyl-N-(3-phenylsulfinylpropyl)formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horiguchi, Yoshie; Saitoh, Toshiaki; Terakado, Sachiko; Honda, Konomi;
Kimura, Tomoko; Toda, Jun; Sano, Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2001), 54(2), 967-984

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxy-N-[3-(phenylthio)propyl]benzenemethanamine
C18H23NO2S
341547-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0035 5.3901 0.0 0
M  V30 6 S 13.3372 4.6201 0.0 0
M  V30 7 O 1.3338 5.3901 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 O 4.0012 0.7700 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 3.0801 0.0 0
M  V30 17 C 14.6708 5.3901 0.0 0
M  V30 18 C 16.0045 4.6201 0.0 0
M  V30 19 C 14.6708 6.9302 0.0 0
M  V30 20 C 17.3383 5.3901 0.0 0
M  V30 21 C 16.0045 7.7002 0.0 0
M  V30 22 C 17.3383 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 14
M  V30 10 1 9 10
M  V30 11 1 9 15
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3,5-Dimethoxyphenyl)methyl]-N-[3-(phenylthio)propyl]formamide
C19H23NO3S
341547-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 6.1600 1.3338 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 O 6.9300 0.0000 0.0 0
M  V30 7 C 10.7800 4.0011 0.0 0
M  V30 8 S 11.5500 5.3347 0.0 0
M  V30 9 O 1.5400 6.6685 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 O 1.5400 1.3338 0.0 0
M  V30 12 C 0.0000 1.3338 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 13.0900 5.3347 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 21 C 13.8600 6.6685 0.0 0
M  V30 22 C 15.4000 4.0011 0.0 0
M  V30 23 C 15.4000 6.6685 0.0 0
M  V30 24 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 1 11 12
M  V30 13 1 11 17
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 341547-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 341547-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2568330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2,3,4,5-tetrahydro-1H-2-benzazepines via Pummerer-type
cyclization of N-arylmethyl-N-(3-phenylsulfinylpropyl)formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horiguchi, Yoshie; Saitoh, Toshiaki; Terakado, Sachiko; Honda, Konomi;
Kimura, Tomoko; Toda, Jun; Sano, Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2001), 54(2), 967-984

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
DL-Kynurenine
C10H12N2O3
343-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 O 5.3348 5.3901 0.0 0
M  V30 4 C 2.6675 6.9302 0.0 0
M  V30 5 C 1.3338 7.7002 0.0 0
M  V30 6 N 4.0012 7.7002 0.0 0
M  V30 7 O 0.0000 6.9302 0.0 0
M  V30 8 O 1.3338 9.2402 0.0 0
M  V30 9 N 6.6687 3.0801 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylkynurenine
C11H12N2O4
1022-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 O 5.3348 5.3901 0.0 0
M  V30 4 C 2.6675 6.9302 0.0 0
M  V30 5 C 1.3337 7.7002 0.0 0
M  V30 6 N 4.0012 7.7002 0.0 0
M  V30 7 O 0.0000 6.9302 0.0 0
M  V30 8 O 1.3337 9.2402 0.0 0
M  V30 9 N 6.6685 3.0801 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 O 9.3360 3.0801 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 1 9 13
M  V30 11 2 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 343-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2152480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation of fluorophores from the kynurenine pathway metabolite
N-formylkynurenine and cyclic amines involves transamidation and
carbon-carbon bond formation at the 2-position of the amine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tomek, Petr; Palmer, Brian D.; Kendall, Jackie D.; Flanagan, Jack U.;
Ching, Lai-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochimica et Biophysica Acta, General Subjects (2015), 1850(9),
1772-1780

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitroaniline
C6H5FN2O2
364-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 N 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluoro-3-nitrophenyl)formamide
C7H5FN2O3
361549-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 O 9.3360 1.5400 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361549-63-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8197435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isosteric exchange of the acylsulfonamide moiety in Abbott's Bcl-XL
protein interaction antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Doemling, Alexander; Antuch, Walfrido; Beck, Barbara;
Schauer-Vukasinovic, Vesna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(14), 4115-4117

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C12H21NO5
37813-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6439 5.3026 0.0 0
M  V30 2 O 2.1038 5.3026 0.0 0
M  V30 3 O 4.4139 6.6363 0.0 0
M  V30 4 C 1.3338 6.6363 0.0 0
M  V30 5 C 0.0000 5.8663 0.0 0
M  V30 6 C 0.5638 7.9700 0.0 0
M  V30 7 C 2.6675 7.4063 0.0 0
M  V30 8 C 6.9759 4.9524 0.0 0
M  V30 9 O 8.4824 4.6323 0.0 0
M  V30 10 O 6.5000 6.4170 0.0 0
M  V30 11 C 9.5128 5.7767 0.0 0
M  V30 12 C 11.0192 5.4565 0.0 0
M  V30 13 O 4.7710 0.0000 0.0 0
M  V30 14 N 4.4139 3.9690 0.0 0
M  V30 15 C 5.9455 3.8079 0.0 0 CFG=2
M  V30 16 C 3.7874 2.5620 0.0 0
M  V30 17 C 6.2656 2.3016 0.0 0
M  V30 18 C 4.9320 1.5316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 18 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2S,4S)-4-(formyloxy)-1,2-pyrrolidinedicarboxylate
C13H21NO6
1023754-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.4640 0.0 0
M  V30 2 O 3.0800 7.7977 0.0 0
M  V30 3 O 3.0800 5.1304 0.0 0
M  V30 4 C 1.5400 7.7977 0.0 0
M  V30 5 C 1.5400 6.2577 0.0 0
M  V30 6 C 0.0000 7.7977 0.0 0
M  V30 7 C 1.5400 9.3377 0.0 0
M  V30 8 C 5.8194 3.7535 0.0 0
M  V30 9 O 6.8498 2.6091 0.0 0
M  V30 10 O 4.3129 3.4333 0.0 0
M  V30 11 C 6.3739 1.1444 0.0 0
M  V30 12 C 7.4043 0.0000 0.0 0
M  V30 13 O 9.0056 8.1392 0.0 0
M  V30 14 C 10.4126 7.5128 0.0 0
M  V30 15 O 11.6584 8.4180 0.0 0
M  V30 16 N 5.3900 6.4640 0.0 0
M  V30 17 C 6.2952 5.2181 0.0 0 CFG=2
M  V30 18 C 6.2952 7.7099 0.0 0
M  V30 19 C 7.7598 5.6940 0.0 0
M  V30 20 C 7.7598 7.2340 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 20 13 CFG=1
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37813-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1023754-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1683740
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1972-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a newly peptide nucleic acid that contains tertiary amino
groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kitamatsu, Mizuki; Kashiwagi, Tomoko; Sisido, Masahiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Symposium Series (2005), (49), 363-364

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C12H21NO5
37813-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6439 5.3026 0.0 0
M  V30 2 O 2.1038 5.3026 0.0 0
M  V30 3 O 4.4139 6.6363 0.0 0
M  V30 4 C 1.3338 6.6363 0.0 0
M  V30 5 C 0.0000 5.8663 0.0 0
M  V30 6 C 0.5638 7.9700 0.0 0
M  V30 7 C 2.6675 7.4063 0.0 0
M  V30 8 C 6.9759 4.9524 0.0 0
M  V30 9 O 8.4824 4.6323 0.0 0
M  V30 10 O 6.5000 6.4170 0.0 0
M  V30 11 C 9.5128 5.7767 0.0 0
M  V30 12 C 11.0192 5.4565 0.0 0
M  V30 13 O 4.7710 0.0000 0.0 0
M  V30 14 N 4.4139 3.9690 0.0 0
M  V30 15 C 5.9455 3.8079 0.0 0 CFG=2
M  V30 16 C 3.7874 2.5620 0.0 0
M  V30 17 C 6.2656 2.3016 0.0 0
M  V30 18 C 4.9320 1.5316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 18 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2S,4R)-4-(formyloxy)-1,2-pyrrolidinedicarboxylate
C13H21NO6
938075-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.4640 0.0 0
M  V30 2 O 3.0800 7.7977 0.0 0
M  V30 3 O 3.0800 5.1304 0.0 0
M  V30 4 C 1.5400 7.7977 0.0 0
M  V30 5 C 1.5400 6.2577 0.0 0
M  V30 6 C 0.0000 7.7977 0.0 0
M  V30 7 C 1.5400 9.3377 0.0 0
M  V30 8 C 5.8194 3.7535 0.0 0
M  V30 9 O 6.8498 2.6091 0.0 0
M  V30 10 O 4.3129 3.4333 0.0 0
M  V30 11 C 6.3739 1.1444 0.0 0
M  V30 12 C 7.4043 0.0000 0.0 0
M  V30 13 O 9.0056 8.1392 0.0 0
M  V30 14 C 10.4126 7.5128 0.0 0
M  V30 15 O 11.6584 8.4180 0.0 0
M  V30 16 N 5.3900 6.4640 0.0 0
M  V30 17 C 6.2952 5.2181 0.0 0 CFG=2
M  V30 18 C 6.2952 7.7099 0.0 0
M  V30 19 C 7.7598 5.6940 0.0 0
M  V30 20 C 7.7598 7.2340 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 20 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37813-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 938075-41-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1892493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1972-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hybrid formation between DNAs and pyrrolidine-based oxy-peptide nucleic
acids with tertiary amino groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kashiwagi, Tomoko; Kitamatsu, Mizuki; Sisido, Masahiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Peptide Science (2006), 42nd439-442

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-2-decanone
C10H20O2
38836-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formyloxy)-2-decanone
C11H20O3
1629366-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 C 3.8500 1.3336 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 13 C 9.2400 8.0021 0.0 0
M  V30 14 C 10.7800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38836-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629366-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-18126781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formic acid 1-(2-oxo-propyl)-heptyl ester [34]: General protocol for
synthesis of formates: A mixture of beta-hydroxyketone and formic acid
was stirred at 65 degC for 2 hr. After cooling the reaction mixture to
room temperature, diethylether was added and the mixture was washed with
ice-cold aqueous NaHCO3 sat., extracted with diethylether, dried over
Na2SO4 and concentrated in vacuo. Product 34 was prepared according to
the General protocol for synthesis of formates. Reaction conditions:
4-Hydroxydecane-2-one 22 (500 mg, 2.9 mmol), formic acid (15 mL). The
crude product 34 was obtained as brown oil in 100 % yield in 87 % purity
(GC/MS) and was not purified. Yield: 590 mg (100 %) 87 % purity (GC/MS),
brown oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biooxidation of Polycyclic and Linear Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lengar, Alenka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2008), (20140701), No pp.

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminotetrahydro-2H-thiopyran-4-carboxylic acid
C6H11NO2S
39124-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2598 1.5166 0.0 0
M  V30 2 O 3.9923 0.0000 0.0 0
M  V30 3 O 5.7069 2.0433 0.0 0
M  V30 4 N 4.2598 3.4964 0.0 0
M  V30 5 C 3.0800 2.5065 0.0 0
M  V30 6 C 2.3100 1.1729 0.0 0
M  V30 7 C 2.3100 3.8401 0.0 0
M  V30 8 C 0.7700 1.1729 0.0 0
M  V30 9 C 0.7700 3.8401 0.0 0
M  V30 10 S 0.0000 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)tetrahydro-2H-thiopyran-4-carboxylic acid
C7H11NO3S
1343946-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7571 1.9798 0.0 0
M  V30 2 C 4.9368 2.9696 0.0 0
M  V30 3 O 6.3839 2.4429 0.0 0
M  V30 4 C 2.0425 0.9899 0.0 0
M  V30 5 O 0.5954 0.4631 0.0 0
M  V30 6 O 3.2223 0.0000 0.0 0
M  V30 7 C 2.3100 2.5065 0.0 0
M  V30 8 C 3.0800 3.8401 0.0 0
M  V30 9 C 0.7700 2.5065 0.0 0
M  V30 10 C 2.3100 5.1738 0.0 0
M  V30 11 C 0.0000 3.8401 0.0 0
M  V30 12 S 0.7700 5.1738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39124-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1343946-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18485699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The α-tertiary amine motif drives remarkable selectivity for Pd-catalyzed
carbonylation of β-methylene C-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogg, Kirsten F.; Trowbridge, Aaron; Alvarez-Perez, Andrea; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 8198-8203

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminotetrahydro-2H-pyran-4-carboxylic acid
C6H11NO3
39124-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2598 1.5166 0.0 0
M  V30 2 O 3.9923 0.0000 0.0 0
M  V30 3 O 5.7069 2.0433 0.0 0
M  V30 4 N 4.2598 3.4964 0.0 0
M  V30 5 C 3.0800 2.5065 0.0 0
M  V30 6 C 2.3100 1.1729 0.0 0
M  V30 7 C 2.3100 3.8401 0.0 0
M  V30 8 C 0.7700 1.1729 0.0 0
M  V30 9 C 0.7700 3.8401 0.0 0
M  V30 10 O 0.0000 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)tetrahydro-2H-pyran-4-carboxylic acid
C7H11NO4
1342965-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7571 1.9798 0.0 0
M  V30 2 C 4.9368 2.9696 0.0 0
M  V30 3 O 6.3839 2.4429 0.0 0
M  V30 4 C 2.0425 0.9899 0.0 0
M  V30 5 O 0.5954 0.4631 0.0 0
M  V30 6 O 3.2223 0.0000 0.0 0
M  V30 7 C 2.3100 2.5065 0.0 0
M  V30 8 C 3.0800 3.8401 0.0 0
M  V30 9 C 0.7700 2.5065 0.0 0
M  V30 10 C 2.3100 5.1738 0.0 0
M  V30 11 C 0.0000 3.8401 0.0 0
M  V30 12 O 0.7700 5.1738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39124-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1342965-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18485695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The α-tertiary amine motif drives remarkable selectivity for Pd-catalyzed
carbonylation of β-methylene C-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogg, Kirsten F.; Trowbridge, Aaron; Alvarez-Perez, Andrea; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 8198-8203

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Phenylethenyl)phenol
C14H12O
39477-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-(1-phenylethenyl)-, 1-formate
C15H12O2
1396690-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3349 0.0 0
M  V30 3 O 7.7000 4.0011 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 O 10.0100 5.3349 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 7.7000 1.3338 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 2 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39477-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396690-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-6667913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 1: To a solution of
methyltriphenylphosphonium bromide (18.9 mmol, 2.3 equiv) in dry THF (30
mL) was added 1 M tBuOK solution in THF (18.9 mL, 2.3 equiv). The mixture
was stirred at RT for 2 h and cooled to -78 °C. Corresponding aldehyde or
ketone (8.20 mmol) was added, warmed to RT slowly and stirred at 30 °C
for 8-20 h. The reaction mixture was quenched with 1 M HCl aq., diluted
with EtOAc, washed with brine. The obtained solution was dried over
MgSO4, filtered, and concentrated. The obtained residue was purified by
column chromatography on silica gel. 2-(1-Phenylvinyl)phenyl formate
(5h). 5h was obtained from S8 by formylation analogous to synthesis of 5b
as a colorless oil. Yield: 100% yield. 1H NMR (400 MHz, CDCl3) δ 7.89 (s,
1H), 7.41-7.24 (m, 8H), 7.11 (d, 1H, J = 8.4 Hz), 5.72 (d, 1H, J = 1.2
Hz), 5.33 (d, 1H, J = 1.2 Hz); 13C NMR (100 MHz, CDCl3) δ 158.7, 147.3,
145.3, 140.2, 134.7, 131.4, 129.0, 128.3, 127.9, 126.7, 126.6, 122.4 and
116.9; IR (ATR) 1736, 1485, 1447, 1188, 1115, 1090, 907, 760 and 700
cm-1; HRMS (DART) [M+H]+ calcd for C15H13O2 : 225.0910; found 225.0903.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Remarkable Improvement Achieved by Imidazole Derivatives in
Ruthenium-Catalyzed Hydroesterification of Alkenes Using Formates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konishi, Hideyuki; Ueda, Tsuyoshi; Muto, Takashi; Manabe, Kei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(18), 4722-4725

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-pyridinamine
C5H5ClN2
39620-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 N 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-2-pyridinyl)formamide
C6H5ClN2O
1700458-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39620-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1700458-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24200185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed microwave vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Substituted 2-isocyanopyridines as versatile convertible isocyanides
for peptidomimetic design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollanders, Charlie; Elsocht, Mathias; Van der Poorten, Olivier; Jida,
Mouhamad; Renders, Evelien; Maes, Bert U. W.; Ballet, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(56),
6863-6866

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Phenyl-2-pyridinemethanamine
C12H12N2
39930-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 N 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 N 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenyl-2-pyridinylmethyl)formamide
C13H12N2O
52095-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 8.0023 5.3901 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 2.6675 6.9302 0.0 0
M  V30 13 N 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 7.7002 0.0 0
M  V30 15 C 0.0000 5.3901 0.0 0
M  V30 16 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39930-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52095-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40891054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyridine and Imidazo[1,5-a]pyridine: Electron Donor Groups
in the Design of D-π-A Dyes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Valla, Lea; Pitrat, Delphine; Mulatier, Jean-Christophe; Le Bahers,
Tangui; Jeanneau, Erwann; Ali, Lamiaa M. A.; Nguyen, Christophe;
Gary-Bobo, Magali; Andraud, Chantal; Bretonniere, Yann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(12), 8407-8419

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-2-methyl-1,2,3,4-tetrahydroquinoline
C10H12FN
42835-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6673 0.0 0
M  V30 2 C 8.4702 1.3337 0.0 0
M  V30 3 C 3.8501 1.3337 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 N 6.1601 2.6673 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 1.5400 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-3,4-dihydro-2-methyl-1(2H)-quinolinecarboxaldehyde
C11H12FNO
143703-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 0.0000 1.3337 0.0 0
M  V30 4 F 8.4702 2.6673 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 N 2.3101 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 6.1601 1.3337 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 1.5400 1.3337 0.0 0
M  V30 12 C 6.1601 4.0010 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42835-89-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 143703-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1573636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 3.1 6-fluoro-2-methyl-3,4-dihydroquinoline-1(2H)-carbaldehyde
[0151] The mixture of formic acid (28 ml, 726.3 mmol) and acetic
anhydride (23 ml, 242 mmol) was added to
6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline (4 g, 24.2 mmol) dropwise.
The resulting mixture was stirred at 60° C. for 1 h. After removal of
solvents, the residue was basified with 3N aqueous sodium hydroxide
solution. The product with extracted with dichloromethane and the organic
layer was washed with brine and dried over anhydrous Na2SO4 . The solvent
was removed under reduced pressure to afford a red oil (4.8 g, yield
103%). 1H NMR (300 MHz, CDCl3): δ 8.53 (s, 1H), 6.99-7.04 (m, 1H),
6.82-6.87 (m, 2H), 4.73 (t, 1H), 2.50-2.70 (m, 2H), 2.02-2.10 (m, 1H),
1.58-1.64 (m, 1H), 1.12 (d, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic benzimidazoles as metabotropic glutamate
receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Slassi, Abdelmalik; Egle, Ian; Ma, Fupeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070032469 A1 2007-02-08

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lithocholic acid
C24H40O3
434-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1630 6.9216 0.0 0
M  V30 2 C 10.8005 6.6360 0.0 0 CFG=2
M  V30 3 C 10.8005 8.1760 0.0 0
M  V30 4 C 12.1341 5.8659 0.0 0
M  V30 5 C 12.1341 8.9460 0.0 0
M  V30 6 C 12.1341 10.4860 0.0 0
M  V30 7 O 13.4678 11.2560 0.0 0
M  V30 8 O 10.8005 11.2560 0.0 0
M  V30 9 C 3.3502 4.4758 0.0 0
M  V30 10 O 0.0000 0.7700 0.0 0
M  V30 11 C 8.0021 3.8501 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0021 5.3901 0.0 0 CFG=1
M  V30 14 C 9.4668 3.3742 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 9.4668 5.8659 0.0 0 CFG=1
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 10.3721 4.6201 0.0 0
M  V30 20 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 1.3337 3.0800 0.0 0
M  V30 27 C 1.3337 1.5400 0.0 0 CFG=2
M  V30 28 H 8.7952 2.5299 0.0 0
M  V30 29 H 7.5518 1.8185 0.0 0
M  V30 30 H 4.4514 5.1115 0.0 0
M  V30 31 H 8.8403 7.2729 0.0 0
M  V30 32 H 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 28 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 29 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 15 30 CFG=3
M  V30 24 1 16 22
M  V30 25 1 17 19
M  V30 26 1 17 31 CFG=3
M  V30 27 1 18 21
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 22 23
M  V30 31 1 23 25
M  V30 32 1 23 32 CFG=1
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 11 12 13 15 17 20 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β)-3-(Formyloxy)cholan-24-oic acid
C25H40O4
5015-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8306 6.9216 0.0 0
M  V30 2 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 3 C 13.4678 8.1759 0.0 0
M  V30 4 C 14.8015 5.8659 0.0 0
M  V30 5 C 14.8015 8.9459 0.0 0
M  V30 6 C 14.8015 10.4859 0.0 0
M  V30 7 O 16.1353 11.2559 0.0 0
M  V30 8 O 13.4678 11.2559 0.0 0
M  V30 9 C 6.2698 4.5675 0.0 0
M  V30 10 O 2.6674 0.7700 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 10.6695 3.8500 0.0 0 CFG=2
M  V30 14 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=1
M  V30 16 C 12.1342 3.3742 0.0 0
M  V30 17 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 C 13.0394 4.6200 0.0 0
M  V30 22 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 23 C 8.0022 5.3900 0.0 0
M  V30 24 C 8.0022 0.7700 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0 CFG=1
M  V30 26 C 5.3347 3.8500 0.0 0
M  V30 27 C 5.3347 0.7700 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 30 H 11.2214 2.4123 0.0 0
M  V30 31 H 10.4248 1.9911 0.0 0
M  V30 32 H 7.1188 5.1114 0.0 0
M  V30 33 H 11.5079 7.2728 0.0 0
M  V30 34 H 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 22 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 29 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=1
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 32 CFG=3
M  V30 26 1 18 24
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 23
M  V30 30 1 22 25
M  V30 31 1 22 26
M  V30 32 1 24 25
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 13 14 15 17 19 22 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5015-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21386975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azobenzene-bridged bile acid dimers: an interesting class of conjugates
with conformation-controlled bioactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Weina; Li, Yan; Yin, Xianpeng; Liang, Yun; Li, Jian; Wang, Chen; Lan,
Yue; Wang, Hui; Ju, Yong; Li, Guangtao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(23), 2539-2543

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lithocholic acid
C24H40O3
434-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1630 6.9216 0.0 0
M  V30 2 C 10.8005 6.6360 0.0 0 CFG=2
M  V30 3 C 10.8005 8.1760 0.0 0
M  V30 4 C 12.1341 5.8659 0.0 0
M  V30 5 C 12.1341 8.9460 0.0 0
M  V30 6 C 12.1341 10.4860 0.0 0
M  V30 7 O 13.4678 11.2560 0.0 0
M  V30 8 O 10.8005 11.2560 0.0 0
M  V30 9 C 3.3502 4.4758 0.0 0
M  V30 10 O 0.0000 0.7700 0.0 0
M  V30 11 C 8.0021 3.8501 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0021 5.3901 0.0 0 CFG=1
M  V30 14 C 9.4668 3.3742 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 9.4668 5.8659 0.0 0 CFG=1
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 10.3721 4.6201 0.0 0
M  V30 20 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 1.3337 3.0800 0.0 0
M  V30 27 C 1.3337 1.5400 0.0 0 CFG=2
M  V30 28 H 8.7952 2.5299 0.0 0
M  V30 29 H 7.5518 1.8185 0.0 0
M  V30 30 H 4.4514 5.1115 0.0 0
M  V30 31 H 8.8403 7.2729 0.0 0
M  V30 32 H 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 28 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 29 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 15 30 CFG=3
M  V30 24 1 16 22
M  V30 25 1 17 19
M  V30 26 1 17 31 CFG=3
M  V30 27 1 18 21
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 22 23
M  V30 31 1 23 25
M  V30 32 1 23 32 CFG=1
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 11 12 13 15 17 20 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β)-3-(Formyloxy)cholan-24-oic acid
C25H40O4
5015-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8306 6.9216 0.0 0
M  V30 2 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 3 C 13.4678 8.1759 0.0 0
M  V30 4 C 14.8015 5.8659 0.0 0
M  V30 5 C 14.8015 8.9459 0.0 0
M  V30 6 C 14.8015 10.4859 0.0 0
M  V30 7 O 16.1353 11.2559 0.0 0
M  V30 8 O 13.4678 11.2559 0.0 0
M  V30 9 C 6.2698 4.5675 0.0 0
M  V30 10 O 2.6674 0.7700 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 10.6695 3.8500 0.0 0 CFG=2
M  V30 14 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=1
M  V30 16 C 12.1342 3.3742 0.0 0
M  V30 17 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 C 13.0394 4.6200 0.0 0
M  V30 22 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 23 C 8.0022 5.3900 0.0 0
M  V30 24 C 8.0022 0.7700 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0 CFG=1
M  V30 26 C 5.3347 3.8500 0.0 0
M  V30 27 C 5.3347 0.7700 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 30 H 11.2214 2.4123 0.0 0
M  V30 31 H 10.4248 1.9911 0.0 0
M  V30 32 H 7.1188 5.1114 0.0 0
M  V30 33 H 11.5079 7.2728 0.0 0
M  V30 34 H 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 22 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 29 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=1
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 32 CFG=3
M  V30 26 1 18 24
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 23
M  V30 30 1 22 25
M  V30 31 1 22 26
M  V30 32 1 24 25
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 13 14 15 17 19 22 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5015-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-18225720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation on bile acid receptor regulators. Discovery of cholanoic
acid derivatives with dual G-protein coupled bile acid receptor 1
(GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sepe, Valentina; Renga, Barbara; Festa, Carmen; Finamore, Claudia;
Masullo, Dario; Carino, Adriana; Cipriani, Sabrina; Distrutti, Eleonora;
Fiorucci, Stefano; Zampella, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Steroids (2016), 10559-67

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1R,2R)-2-Aminocyclohexyl]-1H-isoindole-1,3(2H)-dione
C14H16N2O2
438588-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 5.4212 0.0 0
M  V30 2 O 4.6079 0.0000 0.0 0
M  V30 3 N 6.5771 5.3780 0.0 0
M  V30 4 N 5.0371 2.7106 0.0 0
M  V30 5 C 4.1320 3.9565 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 2.6673 3.4806 0.0 0
M  V30 8 C 2.6673 1.9406 0.0 0
M  V30 9 C 1.3337 4.2506 0.0 0
M  V30 10 C 1.3337 1.1706 0.0 0
M  V30 11 C 0.0000 3.4806 0.0 0
M  V30 12 C 0.0000 1.9406 0.0 0
M  V30 13 C 6.5771 2.7106 0.0 0 CFG=2
M  V30 14 C 7.3471 4.0442 0.0 0 CFG=2
M  V30 15 C 7.3471 1.3769 0.0 0
M  V30 16 C 8.8871 4.0442 0.0 0
M  V30 17 C 8.8871 1.3769 0.0 0
M  V30 18 C 9.6571 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 1 14 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 13 4 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R)-2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)cyclohexyl]formamide
C15H16N2O3
2412906-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.0493 2.6242 0.0 0
M  V30 2 O 5.0493 8.0454 0.0 0
M  V30 3 N 3.0801 2.6675 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 N 4.6201 5.3348 0.0 0
M  V30 7 C 5.5252 4.0889 0.0 0
M  V30 8 C 5.5252 6.5807 0.0 0
M  V30 9 C 6.9899 4.5648 0.0 0
M  V30 10 C 6.9899 6.1048 0.0 0
M  V30 11 C 8.3236 3.7948 0.0 0
M  V30 12 C 8.3236 6.8749 0.0 0
M  V30 13 C 9.6572 4.5648 0.0 0
M  V30 14 C 9.6572 6.1048 0.0 0
M  V30 15 C 3.0801 5.3348 0.0 0 CFG=2
M  V30 16 C 2.3101 4.0012 0.0 0 CFG=2
M  V30 17 C 2.3101 6.6685 0.0 0
M  V30 18 C 0.7700 4.0012 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 16 3 CFG=3
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=1
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 438588-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412906-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21775935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Selenourea-Thiourea Bronsted Acid Catalyst Facilitates Asymmetric
Conjugate Additions of Amines to α,β-Unsaturated Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Yingfu; Hirschi, William J.; Kunadia, Anuj; Paul, Anirudra;
Ghiviriga, Ion; Abboud, Khalil A.; Karugu, Rachael W.; Vetticatt, Mathew
J.; Hirschi, Jennifer S.; Seidel, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2020), 142(12), 5627-5635

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-Methoxy-4-(methylthio)phenoxy]-4-pyridinemethanamine
C14H16N2O2S
473254-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9301 4.0011 0.0 0
M  V30 2 C 10.0101 4.0011 0.0 0
M  V30 3 N 11.5501 4.0011 0.0 0
M  V30 4 O 2.3100 1.3337 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 S 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 C 7.7001 5.3348 0.0 0
M  V30 9 C 9.2401 5.3348 0.0 0
M  V30 10 C 6.9301 6.6686 0.0 0
M  V30 11 C 10.0101 6.6686 0.0 0
M  V30 12 N 7.7001 8.0022 0.0 0
M  V30 13 C 9.2401 8.0022 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 4.6201 2.6675 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 3.0800 2.6675 0.0 0
M  V30 18 C 3.0800 5.3348 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3-[3-Methoxy-4-(methylthio)phenoxy]-4-pyridinyl]methyl]formamide
C15H16N2O3S
473255-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9301 4.0011 0.0 0
M  V30 2 C 10.0101 4.0011 0.0 0
M  V30 3 N 11.5501 4.0011 0.0 0
M  V30 4 C 12.3201 2.6675 0.0 0
M  V30 5 O 13.8602 2.6675 0.0 0
M  V30 6 O 2.3100 1.3337 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 S 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 C 7.7001 5.3348 0.0 0
M  V30 11 C 9.2401 5.3348 0.0 0
M  V30 12 C 6.9301 6.6686 0.0 0
M  V30 13 C 10.0101 6.6686 0.0 0
M  V30 14 N 7.7001 8.0022 0.0 0
M  V30 15 C 9.2401 8.0022 0.0 0
M  V30 16 C 5.3901 4.0011 0.0 0
M  V30 17 C 4.6201 2.6675 0.0 0
M  V30 18 C 4.6201 5.3348 0.0 0
M  V30 19 C 3.0800 2.6675 0.0 0
M  V30 20 C 3.0800 5.3348 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473254-26-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 473255-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2290295
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl heterocyclyl ether derivatives as potent and
selective inhibitors of serotonin re-uptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adam, Mavis Diane; Andrews, Mark David; Gymer, Geoffrey Edward; Hepworth,
David; Howard, Harry Ralph, Jr.; Middleton, Donald Stuart; Stobie, Alan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002083643 A1 2002-10-24

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Indol-1-yl)benzenamine
C14H12N2
473918-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 0.3117 0.0 0
M  V30 2 N 4.0011 1.8517 0.0 0
M  V30 3 C 5.4080 2.4782 0.0 0
M  V30 4 C 4.1620 0.3202 0.0 0
M  V30 5 C 6.4384 1.3336 0.0 0
M  V30 6 C 5.8839 3.9427 0.0 0
M  V30 7 C 5.6684 0.0000 0.0 0
M  V30 8 C 7.9447 1.6538 0.0 0
M  V30 9 C 7.3902 4.2629 0.0 0
M  V30 10 C 8.4207 3.1185 0.0 0
M  V30 11 C 2.6674 2.6217 0.0 0
M  V30 12 C 1.3338 1.8517 0.0 0
M  V30 13 C 2.6674 4.1617 0.0 0
M  V30 14 C 0.0000 2.6217 0.0 0
M  V30 15 C 1.3338 4.9317 0.0 0
M  V30 16 C 0.0000 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1H-Indol-1-yl)phenyl]formamide
C15H12N2O
1656986-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5408 4.0011 0.0 0
M  V30 2 C 9.0808 4.0011 0.0 0
M  V30 3 O 9.8508 5.3348 0.0 0
M  V30 4 N 4.4608 4.0011 0.0 0
M  V30 5 C 2.9293 4.1620 0.0 0
M  V30 6 C 5.0873 5.4079 0.0 0
M  V30 7 C 2.6091 5.6685 0.0 0
M  V30 8 C 1.7849 3.1316 0.0 0
M  V30 9 C 3.9427 6.4385 0.0 0
M  V30 10 C 1.1444 6.1443 0.0 0
M  V30 11 C 0.3202 3.6075 0.0 0
M  V30 12 C 0.0000 5.1139 0.0 0
M  V30 13 C 5.2308 2.6675 0.0 0
M  V30 14 C 6.7708 2.6675 0.0 0
M  V30 15 C 4.4608 1.3337 0.0 0
M  V30 16 C 7.5408 1.3337 0.0 0
M  V30 17 C 5.2308 0.0000 0.0 0
M  V30 18 C 6.7708 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473918-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1656986-17-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16908140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Halogen-Bond-Promoted Photoactivation of Perfluoroalkyl Iodides: A
Photochemical Protocol for Perfluoroalkylation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yaxin; Wang, Junhua; Li, Guo-Xing; He, Gang; Chen, Gong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(6), 1442-1445

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-Dimethoxybenzidine
C14H16N2O2
4746-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6687 0.0 0
M  V30 2 C 3.8501 8.0023 0.0 0
M  V30 3 O 6.1601 1.3337 0.0 0
M  V30 4 C 6.9302 0.0000 0.0 0
M  V30 5 N 0.0000 4.0012 0.0 0
M  V30 6 N 10.7802 4.0012 0.0 0
M  V30 7 C 4.6201 4.0012 0.0 0
M  V30 8 C 3.8501 5.3348 0.0 0
M  V30 9 C 3.8501 2.6675 0.0 0
M  V30 10 C 2.3101 5.3348 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 C 1.5400 4.0012 0.0 0
M  V30 13 C 6.1601 4.0012 0.0 0
M  V30 14 C 6.9302 2.6675 0.0 0
M  V30 15 C 6.9302 5.3348 0.0 0
M  V30 16 C 8.4702 2.6675 0.0 0
M  V30 17 C 8.4702 5.3348 0.0 0
M  V30 18 C 9.2402 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 12
M  V30 6 1 6 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H16N2O4
2414269-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 1.3337 0.0 0
M  V30 2 C 6.1601 0.0000 0.0 0
M  V30 3 O 8.4702 6.6687 0.0 0
M  V30 4 C 9.2402 8.0023 0.0 0
M  V30 5 N 2.3101 4.0012 0.0 0
M  V30 6 C 1.5400 5.3348 0.0 0
M  V30 7 O 0.0000 5.3348 0.0 0
M  V30 8 N 13.0903 4.0012 0.0 0
M  V30 9 C 13.8603 2.6675 0.0 0
M  V30 10 O 15.4003 2.6675 0.0 0
M  V30 11 C 6.9302 4.0012 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 C 6.1601 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.8501 4.0012 0.0 0
M  V30 17 C 8.4702 4.0012 0.0 0
M  V30 18 C 9.2402 5.3348 0.0 0
M  V30 19 C 9.2402 2.6675 0.0 0
M  V30 20 C 10.7802 5.3348 0.0 0
M  V30 21 C 10.7802 2.6675 0.0 0
M  V30 22 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414269-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21873467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Outstandingly robust anodic dehydrogenative aniline coupling reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, Lara; Husmann, Jan-Ake; Waldvogel, Siegfried R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Electrochimica Acta (2020), 337135786

$RFMT $RIREG SCHEME206 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-4,6-dimethyl-2-pyridinamine
C7H9BrN2
89856-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6674 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 C 1.5400 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,N,4,6-tetramethyl-2-pyridinamine
C9H13BrN2
627098-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 C 0.0000 1.3338 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 5.3901 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 89856-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 627098-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13534448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 6-Amino-3-pyridinols: Towards diffusion-controlled chain-breaking
antioxidants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wijtmans, Maikel; Pratt, Derek A.; Valgimigli, Luca; DiLabio, Gino A.;
Pedulli, Gian Franco; Porter, Ned A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2003), 42(36), 4370-4373

$RFMT $RIREG SCHEME207 STEP1
$RXN



  3  1
$MOL
1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol
C15H23NO2
93413-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3671 2.3101 0.0 0
M  V30 2 C 4.3671 0.7700 0.0 0
M  V30 3 N 5.7007 0.0000 0.0 0
M  V30 4 O 4.0232 4.2597 0.0 0
M  V30 5 O 9.7019 5.3901 0.0 0
M  V30 6 C 11.0356 4.6201 0.0 0
M  V30 7 C 3.0333 3.0801 0.0 0
M  V30 8 C 2.5066 1.6329 0.0 0
M  V30 9 C 2.0433 4.2597 0.0 0
M  V30 10 C 0.9899 1.3655 0.0 0
M  V30 11 C 0.5267 3.9924 0.0 0
M  V30 12 C 0.0000 2.5452 0.0 0
M  V30 13 C 5.7007 3.0801 0.0 0
M  V30 14 C 7.0344 2.3101 0.0 0
M  V30 15 C 5.7007 4.6201 0.0 0
M  V30 16 C 8.3681 3.0801 0.0 0
M  V30 17 C 7.0344 5.3901 0.0 0
M  V30 18 C 8.3681 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 4 7
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Venlafaxine
C17H27NO2
93413-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6643 4.0011 0.0 0
M  V30 2 C 2.8943 2.6674 0.0 0
M  V30 3 N 3.6643 1.3338 0.0 0
M  V30 4 C 5.2043 1.3338 0.0 0
M  V30 5 C 2.8943 0.0000 0.0 0
M  V30 6 O 4.3414 5.8615 0.0 0
M  V30 7 O 9.8243 4.0011 0.0 0
M  V30 8 C 10.5943 5.3347 0.0 0
M  V30 9 C 2.8943 5.3347 0.0 0
M  V30 10 C 1.7145 4.3448 0.0 0
M  V30 11 C 2.6268 6.8513 0.0 0
M  V30 12 C 0.2675 4.8716 0.0 0
M  V30 13 C 1.1798 7.3781 0.0 0
M  V30 14 C 0.0000 6.3882 0.0 0
M  V30 15 C 5.2043 4.0011 0.0 0
M  V30 16 C 5.9743 5.3347 0.0 0
M  V30 17 C 5.9743 2.6674 0.0 0
M  V30 18 C 7.5143 5.3347 0.0 0
M  V30 19 C 7.5143 2.6674 0.0 0
M  V30 20 C 8.2843 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 6 9
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93413-77-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 93413-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1891182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of venlafaxine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nagarajan, Kuppuswamy; Gupta, Rajender Pershad; Singh, Ram Shanker;
Vaddadi, Ganapati
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2008CH00015 A 2009-08-14

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-3-[3-methoxy-4-[[2-(1-pyrrolidinyl)ethyl]amino]phenyl]thie...
C25H25ClN4O2S
515142-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.0917 6.6684 0.0 0
M  V30 2 O 6.4717 1.3336 0.0 0
M  V30 3 C 7.2417 0.0000 0.0 0
M  V30 4 Cl 21.1738 8.9328 0.0 0
M  V30 5 N 4.9317 4.0011 0.0 0
M  V30 6 C 4.1617 5.3347 0.0 0
M  V30 7 C 2.6217 5.3347 0.0 0
M  V30 8 C 13.4017 5.3347 0.0 0
M  V30 9 C 14.1717 4.0011 0.0 0
M  V30 10 S 14.4323 6.4791 0.0 0
M  V30 11 C 11.8617 5.3347 0.0 0
M  V30 12 C 15.6781 4.3212 0.0 0
M  V30 13 N 13.4017 2.6673 0.0 0
M  V30 14 C 15.8391 5.8528 0.0 0
M  V30 15 N 11.0917 4.0011 0.0 0
M  V30 16 C 11.8617 2.6673 0.0 0
M  V30 17 C 17.1727 6.6228 0.0 0
M  V30 18 C 17.1727 8.1628 0.0 0
M  V30 19 C 18.5065 5.8528 0.0 0
M  V30 20 C 18.5065 8.9328 0.0 0
M  V30 21 C 19.8401 6.6228 0.0 0
M  V30 22 C 19.8401 8.1628 0.0 0
M  V30 23 C 9.5517 4.0011 0.0 0
M  V30 24 C 8.7817 2.6673 0.0 0
M  V30 25 C 8.7817 5.3347 0.0 0
M  V30 26 C 7.2417 2.6673 0.0 0
M  V30 27 C 7.2417 5.3347 0.0 0
M  V30 28 C 6.4717 4.0011 0.0 0
M  V30 29 N 1.8517 6.6684 0.0 0
M  V30 30 C 2.4782 8.0753 0.0 0
M  V30 31 C 0.3202 6.8294 0.0 0
M  V30 32 C 1.3336 9.1057 0.0 0
M  V30 33 C 0.0000 8.3357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 7 29
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 15 23
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[6-(4-Chlorophenyl)-4-oxothieno[3,2-d]pyrimidin-3(4H)-yl]-2-methoxypheny...
C26H25ClN4O3S
515142-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.0917 6.6684 0.0 0
M  V30 2 O 6.4717 1.3336 0.0 0
M  V30 3 C 7.2417 0.0000 0.0 0
M  V30 4 N 4.9317 4.0011 0.0 0
M  V30 5 C 4.1617 5.3347 0.0 0
M  V30 6 C 4.1617 2.6673 0.0 0
M  V30 7 C 2.6217 5.3347 0.0 0
M  V30 8 O 2.6217 2.6673 0.0 0
M  V30 9 Cl 21.1738 8.9328 0.0 0
M  V30 10 C 13.4017 5.3347 0.0 0
M  V30 11 C 14.1717 4.0011 0.0 0
M  V30 12 C 11.8617 5.3347 0.0 0
M  V30 13 S 14.4323 6.4791 0.0 0
M  V30 14 C 15.6781 4.3212 0.0 0
M  V30 15 N 13.4017 2.6673 0.0 0
M  V30 16 N 11.0917 4.0011 0.0 0
M  V30 17 C 15.8391 5.8528 0.0 0
M  V30 18 C 11.8617 2.6673 0.0 0
M  V30 19 C 9.5517 4.0011 0.0 0
M  V30 20 C 8.7817 2.6673 0.0 0
M  V30 21 C 8.7817 5.3347 0.0 0
M  V30 22 C 7.2417 2.6673 0.0 0
M  V30 23 C 7.2417 5.3347 0.0 0
M  V30 24 C 6.4717 4.0011 0.0 0
M  V30 25 C 17.1727 6.6228 0.0 0
M  V30 26 C 18.5065 5.8528 0.0 0
M  V30 27 C 17.1727 8.1628 0.0 0
M  V30 28 C 19.8401 6.6228 0.0 0
M  V30 29 C 18.5065 8.9328 0.0 0
M  V30 30 C 19.8401 8.1628 0.0 0
M  V30 31 N 1.8517 6.6684 0.0 0
M  V30 32 C 2.4782 8.0753 0.0 0
M  V30 33 C 0.3202 6.8294 0.0 0
M  V30 34 C 1.3336 9.1057 0.0 0
M  V30 35 C 0.0000 8.3357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 31
M  V30 10 1 9 30
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 17 25
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 515142-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 515142-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5466097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinones as melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carpenter, Andrew J.; Cooper, Joel P.; Handlon, Anthony L.; Hertzog,
Donald L.; Hyman, Clifton E.; Guo, Yu C.; Speake, Jason D.; Witty, David
Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003033476 A1 2003-04-24

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-6-nitrobenzenamine
C6H4BrFN2O2
517920-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0 VAL=5
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 N 2.6674 6.1600 0.0 0
M  V30 5 F 0.0000 4.6200 0.0 0
M  V30 6 Br 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromo-2-fluoro-6-nitrophenyl)formamide
C7H4BrFN2O3
877134-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 8.4700 5.3347 0.0 0
M  V30 4 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 5 O 6.1600 1.3338 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 F 4.6200 6.6685 0.0 0
M  V30 8 Br 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 1 7 11
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 517920-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877134-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13376003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1: A stirred mixture of acetic anhydride
(20 mL, 213 mmol) and formic acid (8 mL, 213 mmol) was heated at 60 °C
for 3 h. The mixture was cooled to rt,-bromo-2-fluoro-6-nitroaniline (2.5
g, 10.64 mmol) was added. The mixture was heated at 60 °C for 15 h,
cooled to rt and concentrated under reduced pressure. The residue was
partitioned between saturated aq NaHCO3 and DCM. The organic layer was
separated, dried over MgSO4, filtered, and concentrated under reduced
pressure. N-(4-bromo-2-fluoro-6-nitrophenyl)formamide (2.79 g, 100%) as a
brown solid that was not purified further. LCMS (ESI) m/z 285 and 287 (M
+ H + Na)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compounds as kinase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang;
Rowbottom, Martin W.; Xu, Shimin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013056070 A2 2013-04-18

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dihydro-5H-benzocyclohepten-5-one
C11H10O
52092-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5287 0.0000 0.0 0
M  V30 2 C 2.6673 2.4617 0.0 0
M  V30 3 C 2.6673 4.0018 0.0 0
M  V30 4 C 3.8713 1.5015 0.0 0
M  V30 5 C 1.3337 1.6917 0.0 0
M  V30 6 C 1.3337 4.7718 0.0 0
M  V30 7 C 3.8713 4.9620 0.0 0
M  V30 8 C 5.3729 1.8442 0.0 0
M  V30 9 C 0.0000 2.4617 0.0 0
M  V30 10 C 0.0000 4.0018 0.0 0
M  V30 11 C 5.3729 4.6192 0.0 0
M  V30 12 C 6.0409 3.2317 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H10O3Se
2424009-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9410 4.3033 0.0 0
M  V30 2 C 8.1179 3.3101 0.0 0
M  V30 3 O 9.5666 3.8326 0.0 0
M  V30 4 O 1.8471 0.7717 0.0 0
M  V30 5 C 4.5190 4.7328 0.0 0 CFG=2
M  V30 6 C 3.0800 4.6681 0.0 0
M  V30 7 C 5.4923 3.7807 0.0 0 CFG=1
M  V30 8 Se 3.8211 3.1316 0.0 0
M  V30 9 C 2.3100 3.3343 0.0 0
M  V30 10 C 2.3100 6.0017 0.0 0
M  V30 11 C 5.3331 2.2550 0.0 0
M  V30 12 C 4.1915 1.5248 0.0 0 CFG=2
M  V30 13 C 2.8829 1.9115 0.0 0
M  V30 14 C 0.7700 3.3343 0.0 0
M  V30 15 C 0.7700 6.0017 0.0 0
M  V30 16 C 0.0000 4.6681 0.0 0
M  V30 17 H 5.0683 6.1715 0.0 0
M  V30 18 H 4.4078 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8 CFG=3
M  V30 8 1 5 17
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 12 8 CFG=3
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 1 12 18
M  V30 19 1 14 16
M  V30 20 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52092-30-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2424009-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-129-CAS-22052125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7446-08-4
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 6,7-Benzotropolone Syntheses Based on Ring-Closing Metatheses and
Four-Electron Oxidations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kreibich, Michael; Gemander, Manuel; Peter, David; Yadav, Dharmendra B.;
de Koning, Charles B.; Fernandes, Manuel A.; Green, Ivan R.; van Otterlo,
Willem A. L.; Brueckner, Reinhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(19), 2929-2955

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
1-Aminocyclopentanecarboxylic acid
C6H11NO2
52-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8119 1.5400 0.0 0
M  V30 2 O 5.1456 2.3101 0.0 0
M  V30 3 O 3.8119 0.0000 0.0 0
M  V30 4 N 3.3833 3.5559 0.0 0
M  V30 5 C 2.4782 2.3101 0.0 0
M  V30 6 C 1.8517 0.9031 0.0 0
M  V30 7 C 1.3337 3.3405 0.0 0
M  V30 8 C 0.3202 1.0642 0.0 0
M  V30 9 C 0.0000 2.5705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formylamino)cyclopentanecarboxylic acid
C7H11NO3
15026-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.4916 3.2617 0.0 0
M  V30 2 C 4.8253 2.4917 0.0 0
M  V30 3 O 6.1591 3.2617 0.0 0
M  V30 4 C 1.5317 3.8987 0.0 0
M  V30 5 O 2.4367 5.1445 0.0 0
M  V30 6 O 0.0000 4.0596 0.0 0
M  V30 7 C 2.1580 2.4917 0.0 0
M  V30 8 C 0.6933 2.0159 0.0 0
M  V30 9 C 3.0632 1.2459 0.0 0
M  V30 10 C 0.6933 0.4759 0.0 0
M  V30 11 C 2.1580 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 52-52-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15026-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18485715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The α-tertiary amine motif drives remarkable selectivity for Pd-catalyzed
carbonylation of β-methylene C-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogg, Kirsten F.; Trowbridge, Aaron; Alvarez-Perez, Andrea; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 8198-8203

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxyquinoline
C10H9NO
5263-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6-methoxy-1(2H)-quinolinecarboxaldehyde
C11H13NO2
1013-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 8.4702 2.6673 0.0 0
M  V30 4 C 9.2402 4.0010 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 N 2.3101 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 6.1601 1.3337 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 1.5400 1.3337 0.0 0
M  V30 12 C 6.1601 4.0010 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5263-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25432877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon/nitrogen doped, dendritic fibrous silica nanosphere supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, reusable catalyst, carbon and nitrogen doped
dendritic fibrous silica nanosphere supported cobalt catalyst prepared
and used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytically Active Co-Nx Species Stabilized on Nitrogen-doped Porous
Carbon for Efficient Hydrogenation and Dehydrogenation of N-heteroarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Dan; Zhao, Hong; Dong, Zhengping; Ma, Jiantai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2020), 12(17), 4406-4415

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethynylaniline
C8H7N
52670-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 N 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Ethynylphenyl)formamide
C9H7NO
36626-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3349 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 C 3.0800 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52670-38-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36626-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-926146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(2-((4-Chlorophenyl)ethynyl)phenyl)formamide (S3): To formic acid (1.21
mL, 32.0 mmol) was added acetic anhydride (1.08 mL, 11.4 mmol) and the
mixture was stirred at room temperature. After stirring for 10 min, to
the mixture was added the solution of o-ethynylaniline (1.07 g, 9.13
mmol) in CH2Cl2 (30 mL) and the mixture was stirred at room temperature.
After stirring for 1 h, the mixture was concentrated under reduced
pressure to give product. o-ethynylformanilide as a white solid, yield
1.32 g, 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Acyl-2-arylindole via Palladium-catalyzed Isocyanide
Insertion and Oxypalladation of Alkyne
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nanjo, Takeshi; Yamamoto, Sho; Tsukano, Chihiro; Takemoto, Yoshiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2013), 15(14), 3754-3757

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-methylaniline
C7H8BrN
53078-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-5-methylphenyl)formamide
C8H8BrNO
1536478-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 6.9300 4.0011 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53078-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1536478-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16979128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh2(II)-Catalyzed Ring Expansion of Cyclobutanol-Substituted Aryl Azides
To Access Medium-Sized N-Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mazumdar, Wrickban; Jana, Navendu; Thurman, Bryant T.; Wink, Donald J.;
Driver, Tom G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(14), 5031-5034

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Dehydroepiandrosterone
C19H28O2
53-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6026 3.7975 0.0 0
M  V30 2 C 8.1632 6.1516 0.0 0
M  V30 3 O 9.9426 6.5605 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 6 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 8 C 6.6684 0.7700 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 8.0022 4.6200 0.0 0 CFG=2
M  V30 12 C 9.4668 2.6040 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6684 5.3901 0.0 0
M  V30 17 C 9.4668 5.0959 0.0 0
M  V30 18 C 10.3720 3.8500 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 22 H 7.5518 1.0484 0.0 0
M  V30 23 H 4.2458 4.1690 0.0 0
M  V30 24 H 8.5540 1.6423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=1
M  V30 3 2 3 17
M  V30 4 1 21 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 23 CFG=3
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 24 CFG=3
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 2 13 14
M  V30 23 1 14 19
M  V30 24 1 15 20
M  V30 25 1 17 18
M  V30 26 1 19 21
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 6 7 9 11 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3β-Formyloxy-5-androstene-17-one
C20H28O3
29163-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0177 3.7058 0.0 0
M  V30 2 C 10.8306 6.1517 0.0 0
M  V30 3 O 12.6103 6.5605 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 0.7700 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0 CFG=2
M  V30 8 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 9 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 10.6697 3.0801 0.0 0 CFG=2
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 17 C 12.1342 2.6040 0.0 0
M  V30 18 C 8.0022 0.0000 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0012 2.3101 0.0 0
M  V30 21 C 12.1342 5.0960 0.0 0
M  V30 22 C 13.0395 3.8501 0.0 0
M  V30 23 C 4.0012 0.7700 0.0 0 CFG=1
M  V30 24 H 7.1190 4.3415 0.0 0
M  V30 25 H 10.2192 1.0485 0.0 0
M  V30 26 H 11.4628 1.7600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 16 2 CFG=1
M  V30 3 2 3 21
M  V30 4 1 4 5
M  V30 5 1 23 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 24 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 25 CFG=1
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 1 11 26 CFG=3
M  V30 20 1 12 18
M  V30 21 2 13 18
M  V30 22 1 13 19
M  V30 23 1 14 20
M  V30 24 1 15 16
M  V30 25 1 16 21
M  V30 26 1 17 22
M  V30 27 1 19 23
M  V30 28 1 20 23
M  V30 29 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 7 8 9 11 16 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53-43-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29163-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-8126167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of dehydroisoandrosterone-3-formate (DHEA formate) A solution
of 100 g (0.346 mole) of dehydroepisoandrosterone (DHEA) in 500 ml of
formic acid 80-99% was maintained 4 hours at 20-25°C and the end of the
reaction was monitored by HPLC (area% of DHEA). The solution was then
concentrated at 50°C under vacuum (40 mbar). 500 ml of CH2Cl2 were added
to the concentrate and 400 ml of saturated NaHCO3 were added to the
solution. The mixture was stirred for 30 minutes at 20-25°C. The two
layers were then separated. The organic layer was washed with 100 ml of
water. The organic layer was dehydrated and used as it was on the
triflating stage. Yield 100% from the DHEA.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by HPLC; third stage added after concentration under
vacuum; fourth stage quench
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing 17-substituted steroids from
dehydroepisoandrosterone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derrien, Yvon; Poirier, Patricia; Forcato, Massimiliano; Pintus, Tony;
Cotarca, Livius; Meunier, Sebastien; Graindorge, Laurence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013053691 A1 2013-04-18

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-1,2-phenylenediamine
C6H6Cl2N2
5348-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dichlorobenzimidazole
C7H4Cl2N2
6478-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 0.0000 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5348-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6478-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-14141927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for benzimidazoles:
Diaminobenzenes were either commercially available or were prepared from
o-dinitrobenzenes or o-nitro-anilines by catalytic hydrogenation with 5%
palladium on carbon in methanol or ethyl acetate under atmospheric
pressure of hydrogen gas at room temperature. The reaction was monitored
for completion which usually requires several hours to overnight
reaction. Upon completion, the reaction mixture is filtered and washed
through Celite. The filtrate is concentrated in vacuo to give the
o-diaminobenzene. The ortho-diaminobenzene was then stirred at reflux in
formic acid for 1-2 hrs. After removal of formic acid in vacuo, the
residue was diluted with water and neutralized with 15% NaOH to
approximately pH = 8. The solid was filtered and washed with water and
dried in air. 5,6-Dimethoxy-1H-benzoimidazole
5,6-Dichloro-1H-benzoimidazole 5,6-Dichloro-1H-benzoimidazole (6.06 g,
0.324 mol, yield 100%) from 1,2-diamino-4,5-dichlorobenzene (5.73g, 0.324
mol) according to the general procedure for benzimidazoles above. 1H-NMR
(DMSO-D6) 8.30 (s, 1H); 7.83 (s, 2H). MS M/z 188. (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(benzimidazol-1-yl)thiazole-5-carboxylic acids, their
amides and esters as polo-like kinase 1 (PLK1) inhibitors for the
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boylan, John Frederick; Cai, Jianping; Fotouhi, Nader; Gillespie, Paul;
Goodnow, Robert Alan, Jr.; Le, Kang; Michoud, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007096315 A1 2007-08-30

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazolium, 2-carboxy-1,3-dimethyl-, inner salt
C6H8N2O2
536755-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.7700 0.0 0
M  V30 2 O 4.0442 0.0000 0.0 0 CHG=-1
M  V30 3 O 1.3769 0.0000 0.0 0
M  V30 4 C 0.0000 2.7392 0.0 0
M  V30 5 C 5.4211 2.7392 0.0 0
M  V30 6 C 2.7106 2.3100 0.0 0
M  V30 7 N 1.4647 3.2152 0.0 0 CHG=1
M  V30 8 N 3.9564 3.2152 0.0 0
M  V30 9 C 1.9406 4.6798 0.0 0
M  V30 10 C 3.4806 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazolium, 1,3-dimethyl-, formate (1:1)
C5H9N2.CHO2
878492-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.9318 0.0 0
M  V30 2 C 5.3026 3.8046 0.0 0
M  V30 3 C 2.7406 4.7882 0.0 0
M  V30 4 N 1.3337 4.1618 0.0 0 CHG=1
M  V30 5 N 3.7711 3.6437 0.0 0
M  V30 6 C 1.4946 2.6302 0.0 0
M  V30 7 C 3.0011 2.3100 0.0 0
M  V30 8 C 2.6513 0.0000 0.0 0
M  V30 9 O 1.3177 0.7700 0.0 0 CHG=-1
M  V30 10 O 3.9850 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536755-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878492-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-109-CAS-22211608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of acid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses and applications of ionic liquids as solvents and reactants:
natural substances dissolution, esterification & ionic tagging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2013), (D0730-5), No pp.

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Benzenedicarboxylic acid, 2-amino-, 1,4-dimethyl ester
C10H11NO4
5372-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 O 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 N 3.8501 0.0000 0.0 0
M  V30 6 C 8.4702 2.6673 0.0 0
M  V30 7 O 9.2402 4.0010 0.0 0
M  V30 8 O 9.2402 1.3337 0.0 0
M  V30 9 C 10.7802 4.0010 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 4.6201 1.3337 0.0 0
M  V30 12 C 4.6201 4.0010 0.0 0
M  V30 13 C 6.1601 1.3337 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl 2-(formylamino)-1,4-benzenedicarboxylate
C11H11NO5
136494-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.6674 0.0 0
M  V30 2 C 4.6200 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 1.5400 6.6685 0.0 0
M  V30 6 O 1.5400 4.0011 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 8.4700 5.3347 0.0 0
M  V30 9 O 9.2400 6.6685 0.0 0
M  V30 10 O 9.2400 4.0011 0.0 0
M  V30 11 C 10.7800 6.6685 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.1600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5372-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 136494-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3701990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzobistriazinones and related heterocyclic ring systems as potent,
orally bioavailable positive allosteric AMPA receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mueller, Rudolf; Rachwal, Stanislaw; Varney, Mark A.; Johnson, Steven A.;
Alisala, Kashinatham; Zhong, Sheng; Li, Yong-Xin; Haroldsen, Peter;
Herbst, Todd; Street, Leslie J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(24), 7455-7459

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3,4-diamino-5-nitro-, methyl ester
C8H9N3O4
54226-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6684 6.1600 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 N 4.0011 0.0000 0.0 0
M  V30 9 N 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 14
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 7-nitro-1H-benzimidazole-5-carboxylate
C9H7N3O4
706793-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.7473 0.0 0 VAL=5
M  V30 2 O 1.3337 6.2873 0.0 0
M  V30 3 O 0.0000 3.9773 0.0 0
M  V30 4 C 6.6685 4.7473 0.0 0
M  V30 5 O 8.0023 3.9773 0.0 0
M  V30 6 O 6.6685 6.2873 0.0 0
M  V30 7 C 9.3360 4.7473 0.0 0
M  V30 8 C 2.6675 2.4373 0.0 0
M  V30 9 C 4.0012 1.6672 0.0 0
M  V30 10 C 2.6675 3.9773 0.0 0
M  V30 11 N 1.5229 1.4068 0.0 0
M  V30 12 C 5.3348 2.4373 0.0 0
M  V30 13 N 3.6810 0.1609 0.0 0
M  V30 14 C 4.0012 4.7473 0.0 0
M  V30 15 C 2.1494 0.0000 0.0 0
M  V30 16 C 5.3348 3.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54226-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 706793-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-3922787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 4-nitro-1H-benzimidazole-6-carboxylate (D250) A solution of methyl
3,4-diamino-5-nitrobenzoate (D245) (1.3 g, 6.16 mmol, 1 equiv) in HCOOH
(20 ml) was stirred at 100°C for 1 h then cooled to room temperature and
concentrated in vacuo. The residue was partitioned between AcOEt and a 2N
aqueous NaOH solution and the layers were separated. The organic phase
was dried over MgSO4 and concentrated in vacuo to give methyl
4-nitro-1H-benzimidazole-6-carboxylate (D250), which was used in the next
step without further purification. Yield 1.5 g, 110%, light brown solid.
[M+H]+ = 222.3, RT = 2.29 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydroxyethylamine derivatives for the treatment of
Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Demont, Emmanuel H.; Faller, Andrew; MacPherson, David Timothy; Milner,
Peter Henry; Naylor, Alan; Redshaw, Sally; Stanway, Steven James; Vesey,
David R.; Walter, Daryl S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004050619 A1 2004-06-17

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Ethyl (2E)-3-(3,4-dimethoxy-2-nitrophenyl)-2-propenoate
C13H15NO6
545362-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6673 6.9302 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 O 10.6697 3.8501 0.0 0
M  V30 10 O 9.3360 6.1601 0.0 0
M  V30 11 C 12.0033 4.6201 0.0 0
M  V30 12 C 13.3370 3.8501 0.0 0
M  V30 13 O 1.3337 1.5400 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2E)-3-[2-(formylamino)-3,4-dimethoxyphenyl]-2-propenoate
C14H17NO5
545363-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 C 6.6685 3.8501 0.0 0
M  V30 7 C 8.0022 4.6201 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 O 10.6697 4.6201 0.0 0
M  V30 10 O 9.3360 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 C 13.3370 4.6201 0.0 0
M  V30 13 O 1.3337 6.9302 0.0 0
M  V30 14 C 1.3337 8.4702 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 545362-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 545363-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-16600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereocontrolled total synthesis of (-)-aspidophytine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sumi, Shinjiro; Matsumoto, Koji; Tokuyama, Hidetoshi; Fukuyama, Tohru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(43), 8571-8587

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Ethyl (2E)-3-(3,4-dimethoxy-2-nitrophenyl)-2-propenoate
C13H15NO6
545362-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6673 6.9302 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 O 10.6697 3.8501 0.0 0
M  V30 10 O 9.3360 6.1601 0.0 0
M  V30 11 C 12.0033 4.6201 0.0 0
M  V30 12 C 13.3370 3.8501 0.0 0
M  V30 13 O 1.3337 1.5400 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2E)-3-[2-(formylamino)-3,4-dimethoxyphenyl]-2-propenoate
C14H17NO5
545363-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 C 6.6685 3.8501 0.0 0
M  V30 7 C 8.0022 4.6201 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 O 10.6697 4.6201 0.0 0
M  V30 10 O 9.3360 2.3101 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 C 13.3370 4.6201 0.0 0
M  V30 13 O 1.3337 6.9302 0.0 0
M  V30 14 C 1.3337 8.4702 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 545362-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 545363-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-14588963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(2-Formylamino-3,4-dimethoxy-phenyl)-acrylic acid ethyl ester To a
suspension of 10 (40.5 g, 144 mmol) and Zn powder in CH2Cl2 (200 mL) was
added AcOH (70 mL) dropwise at 10 °C over an hour, and the resulting
mixture was stirred for an additional 30 minutes at room temperature. The
reaction mixture was filtered through a pad of Celite and washed with
CH2Cl2 (400 mL). To the combined filtrates was added water (200 mL) and
solid NaHCO3 until pH reached to 8.0 (67 g). The resulting mixture was
separated, and aqueous phase was extracted with CH2Cl2 (30 mL). The
combined organic extracts were washed with brine (100 mL), dried over
MgSO4, filtered, and evaporated under reduced pressure to give yellow
oil. A mixture of HCO2H (16.3 mL, 432 mmol) and Ac2O (40.8 mL, 432 mmol)
was stirred at 55 °C for 30 minutes and cooled to 5 °C, to which was
added a CH2Cl2 (80 mL) solution of the above crude product at 5 °C. After
stirring for 10 minutes, the reaction mixture was poured into a mixture
of CH2Cl2 (300 mL) and water (200 mL), and solid NaHCO3 was added until
pH reached to 7 (100 g). The resulting two-phase mixture was separated,
and the aqueous phase was extracted with CH2Cl2 (40 mL). The combined
extracts were washed with brine (100 mL), dried over MgSO4, filtered, and
evaporated under reduced pressure to dryness to afford the titled
formanilide as white needles (40.6 g, quantitative in 2 steps), which was
pure enough for next step. This material was obtained as a mixture of
rotational isomers. Mp: (EtOAc-hexane, 1:4) 147.6-149.5 °C; IR (film,
cm-1) 3259, 2982, 1703, 1634, 1596, 1490, 1300, 1267, 1182; 1H-NMR (400
MHz, CDCl3) δ 8.49 (s, 0.4H), 8.33 (s, 0.3H), 8.30 (s, 0.3H), 7.76 (d,
0.4H, J = 15.9 Hz), 7.68 (d, 0.3H, J = 15.9 Hz), 7.66 (d, 0.3H, J = 15.9
Hz), 7.42 (d, 0.4H, J = 8.7 Hz), 7.36 (d, 0.6H, J = 8.7 Hz), 6.89 (d,
0.4H, J = 8.7 Hz), 6.34 (d, 1H, J = 15.9 Hz), 4.24 (q, 2H, J = 7.1 Hz),
3.93 (s, 1.8H), 3.90 (s, 1.2H), 3.83 (s, 1.2H), 3.82 (s, 1.8H), 1.32 (t,
3H, J = 7.1 Hz); 13C-NMR (100 MHz, CDCl3) δ 166.9, 166.4, 164.8, 160.3,
154.3, 154.1, 143.5, 142.5, 140.1, 138.9, 129.4, 128.7, 124.5, 123.1,
122.2, 119.1, 117.4, 111.1, 110.4, 60.8, 60.6, 60.5, 60.4, 56.0, 55.9,
14.3; HR-MS (FAB) calcd for C14H18NO5 [(M+H)+] 280.1185, found 280.1188.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Synthesis of Aspidophytine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sumi, Shinjiro; Matsumoto, Koji; Tokuyama, Hidetoshi; Fukuyama, Tohru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2003), 5(11), 1891-1893

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-6-methoxybenzenamine
C7H8BrNO
5473-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 N 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-6-methoxyphenyl)formamide
C8H8BrNO2
2090133-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 6.9300 1.3338 0.0 0
M  V30 6 Br 0.7700 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5473-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2090133-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16979132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh2(II)-Catalyzed Ring Expansion of Cyclobutanol-Substituted Aryl Azides
To Access Medium-Sized N-Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mazumdar, Wrickban; Jana, Navendu; Thurman, Bryant T.; Wink, Donald J.;
Driver, Tom G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(14), 5031-5034

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
3,4-Diaminopyridine
C5H7N3
54-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 N 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazo[4,5-c]pyridine
C6H5N3
272-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 4.1321 2.7859 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 4.1321 0.2941 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 5.0371 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 7
M  V30 9 1 6 9
M  V30 10 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 54-96-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 272-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19200026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 122-51-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as
inhibitors of aminoacyl-tRNA synthetases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Baole; De Graef, Steff; Nautiyal, Manesh; Pang, Luping; Gadakh,
Bharat; Froeyen, Matheus; Van Mellaert, Lieve; Strelkov, Sergei V.;
Weeks, Stephen D.; Van Aerschot, Arthur
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 148384-396

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrophenol
C6H5NO3
554-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Hydroxyphenyl)formamide
C7H7NO2
24891-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 554-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24891-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-15755297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1604839-72-6
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated iron oxide-bound
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, regioselective, solid-supported
catalyst, ionic liquid functionalized magnetic nanoparticle supported
palladium catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Water-Dispersible/Magnetically Separable Palladium Catalyst:
Selective Transfer Hydrogenation or Direct Reductive N-Formylation of
Nitroarenes in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Babak; Mansouri, Fariborz; Vali, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemPlusChem (2015), 80(12), 1750-1759

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycylglycylglycine
C6H11N3O4
556-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 4.0012 2.3101 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 N 8.0022 1.5400 0.0 0
M  V30 6 C 2.6673 1.5400 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 O 9.3360 3.8501 0.0 0
M  V30 11 O 0.0000 1.5400 0.0 0
M  V30 12 O 1.3337 3.8501 0.0 0
M  V30 13 N 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-[N-(N-formylglycyl)glycyl]-
C7H11N3O5
23380-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 N 8.0022 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 9.3358 2.3101 0.0 0
M  V30 5 N 4.0010 2.3101 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 O 9.3358 3.8501 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 N 12.0033 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 13.3370 1.5400 0.0 0
M  V30 13 O 0.0000 1.5400 0.0 0
M  V30 14 O 1.3337 3.8501 0.0 0
M  V30 15 O 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 556-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23380-20-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41240520
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Initial Amino Acid:Codon Assignments and Strength of Codon:Anticodon
Binding
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Meng; Roberts, Samuel J.; Sutherland, John D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2024), 146(18), 12857-12863

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Glycine
C2H5NO2
56-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formylglycine
C3H5NO3
2491-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2491-15-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12451393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of (-)-chloramphenicol via silver-catalysed
asymmetric isocyanoacetate aldol reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Franchino, Allegra; Jakubec, Pavol; Dixon, Darren J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(1), 93-96

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-phenoxybenzenamine
C12H10BrNO
56966-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 N 6.6684 0.0000 0.0 0
M  V30 3 Br 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 5
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-2-phenoxyphenyl)formamide
C13H10BrNO2
613663-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 N 2.3100 5.3347 0.0 0
M  V30 3 C 0.7700 5.3347 0.0 0
M  V30 4 O 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 2 3 4
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56966-45-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 613663-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8144428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SAR study of
2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepines as
progesterone receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dols, Paul P. M. A.; Folmer, Brigitte J. B.; Hamersma, Hans; Kuil, Cor
W.; Lucas, Hans; Ollero, Lourdes; Rewinkel, Jos B. M.; Hermkens, Pedro H.
H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(4), 1461-1467

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Nitroacetophenone
C8H7NO3
577-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0 VAL=5
M  V30 5 O 3.8500 5.3349 0.0 0
M  V30 6 O 6.1600 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Acetylphenyl)formamide
C9H9NO2
5257-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 C 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 577-59-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5257-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-15755298
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1604839-72-6
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated iron oxide-bound
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, regioselective, solid-supported
catalyst, ionic liquid functionalized magnetic nanoparticle supported
palladium catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Water-Dispersible/Magnetically Separable Palladium Catalyst:
Selective Transfer Hydrogenation or Direct Reductive N-Formylation of
Nitroarenes in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Babak; Mansouri, Fariborz; Vali, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemPlusChem (2015), 80(12), 1750-1759

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminoquinoline
C9H8N2
580-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-3-Quinolinylformamide
C10H8N2O
132873-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 N 4.0012 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 580-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132873-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21967136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM K2CO3 reagent may also be used (stage 2), alternative reaction conditions
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Silicon-assisted synthesis of new aminomethylenebisphosphonic acids with
quinolines moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prishchenko, Andrey A.; Alekseyev, Roman S.; Livantsov, Mikhail V.;
Novikova, Olga P.; Livantsova, Ludmila I.; Petrosyan, Valery S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2020), 917121286

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,7-Triazabicyclo[4.4.0]dec-5-ene
C7H13N3
5807-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 3.0801 2.6673 0.0 0
M  V30 3 N 0.7700 1.3337 0.0 0
M  V30 4 N 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine (...
C7H13N3.CH2O2
1356453-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 3.6437 0.0 0
M  V30 2 N 3.0801 4.9774 0.0 0
M  V30 3 N 0.7700 3.6437 0.0 0
M  V30 4 N 3.0801 2.3100 0.0 0
M  V30 5 C 4.6201 4.9774 0.0 0
M  V30 6 C 2.3101 6.3110 0.0 0
M  V30 7 C 0.0000 4.9774 0.0 0
M  V30 8 C 4.6201 2.3100 0.0 0
M  V30 9 C 5.3901 3.6437 0.0 0
M  V30 10 C 0.7700 6.3110 0.0 0
M  V30 11 C 2.6951 0.0000 0.0 0
M  V30 12 O 1.3614 0.7700 0.0 0
M  V30 13 O 4.0287 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5807-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356453-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25618272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-38-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Diagonal Approach to Chemical Recycling of Carbon Dioxide:
Organocatalytic Transformation for the Reductive Functionalization of CO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das Neves Gomes, Christophe; Jacquet, Olivier; Villiers, Claude; Thuery,
Pierre; Ephritikhine, Michel; Cantat, Thibault
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(1), 187-190

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-methylaniline
C7H8BrN
583-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-4-methylphenyl)formamide
C8H8BrNO
353284-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 Br 4.6201 0.0000 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 583-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 353284-16-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16979125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh2(II)-Catalyzed Ring Expansion of Cyclobutanol-Substituted Aryl Azides
To Access Medium-Sized N-Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mazumdar, Wrickban; Jana, Navendu; Thurman, Bryant T.; Wink, Donald J.;
Driver, Tom G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(14), 5031-5034

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanol
C6H7NO
586-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanol, 2-formate
C7H7NO2
401515-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-98-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 401515-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12850065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Pyridylmethyl formate (2.5): To stirring acetic anhydride (6.5 mL, 69
mmol) at 0 degC was added formic acid (2.6 mL, 99 %, 69 mmol) dropwise.
The reaction mixture was stirred at room temperature for 2 hr. The
resulting formic acetic anhydride was cannulated to a stirring mixture of
2-pyridylmethanol (5 g, 46 mmol), NaHCO3 (5.7 g, 69 mmol), and THF (23
mL). After stirring at rt for 1 hr, saturated aq. NaHCO3 was added to the
reaction mixture until gas evolution stopped. The resulting mixture was
extracted with EtOAc (3x). The organic layers were combined and washed
with H2O, saturated aq. NaHCO3, and brine, then were dried over Na2SO4,
filtered, and concentrated under reduced pressure. The resulting residue
was purified by flash chromatography (40 % EtOAc in hexanes) to give the
desired product (6.1 g, Ca. 100 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbon-carbon bond construction using electron transfer initiated
cyclization reactions. Ruthenium-catalyzed hydroesterification and its
application towards the synthesis of integramycin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2005), 66(9), 225 pages

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanol
C6H7NO
586-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanol, 2-formate
C7H7NO2
401515-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-98-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 401515-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-3652159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-pyridylmethyl formate: To stirring acetic anhydride (6.5 mL, 69 mmol)
at 0 °C was added formic acid (2.6 mL, 99%, 69 mmol) dropwise. The
reaction mixture was stirred at room temperature for 2 h. The resulting
formic acetic anhydride was cannulated to a stirring mixture of
2-pyridylmethanol (5 g, 46 mmol), NaHCO3 (5.7 g, 69 mmol), and THF (23
mL). After stirring at rt for 1h, saturated aq NaHCO3 was added to the
reaction mixture until gas evolution stopped. The resulting mixture was
extracted with EtOAc (3×). The organic layers were combined and washed
with H2O, saturated aq NaHCO3, and brine, then were dried over Na2SO4,
filtered, and concentrated under reduced pressure. The resulting residue
was purified by flash chromatography (40% EtOAc in hexanes) to give the
desired product (6.1 g, 100%). 1H NMR (300 MHz, CDCl3) δ 8.60 (d, J= 5.6
Hz, 1H), 8.20 (s, 1H), 7.76 (dt, J= 1.8, 7.7 Hz, 1H), 7.41 (d, J= 7.7 Hz,
1H), 7.30 (dd, J= 5.2, 7.7 Hz, 1H), 5.20 (s, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigations of the Scope and Mechanism of the Tandem
Hydroesterification/Lactonization Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lijun; Floreancig, Paul E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(23), 4207-4210

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromo-3-methoxypyrazine
C5H6BrN3O
5900-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 Br 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-3-methoxy-2-pyrazinyl)formamide
C6H6BrN3O2
1240469-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Br 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 N 3.8500 5.3349 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5900-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240469-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22770373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel methoxypyridine-derived gamma-secretase
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rynearson, Kevin D.; Buckle, Ronald N.; Herr, R. Jason; Mayhew, Nicholas
J.; Chen, Xinchao; Paquette, William D.; Sakwa, Samuel A.; Yang, Jinhai;
Barnes, Keith D.; Nguyen, Phuong; Mobley, William C.; Johnson, Graham;
Lin, Juinn H.; Tanzi, Rudolph E.; Wagner, Steven L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(22), 115734

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-[[(Phenylmethoxy)amino]methyl]-6-heptenoic acid
C15H21NO3
596111-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0 CFG=2
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 10.0100 1.3338 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 O 11.5500 1.3338 0.0 0
M  V30 10 O 9.2400 0.0000 0.0 0
M  V30 11 C 12.3200 5.3347 0.0 0
M  V30 12 C 13.8600 5.3347 0.0 0
M  V30 13 C 14.6300 6.6685 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-2-[[Formyl(phenylmethoxy)amino]methyl]-6-heptenoic acid
C16H21NO4
596111-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 N 6.6685 4.6201 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 O 5.3348 5.3901 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 C 12.0033 3.0801 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 O 8.0022 6.9302 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 15 C 14.6707 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 7.7002 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 16
M  V30 15 2 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 596111-58-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 596111-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3334849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2R-[(N-Benzyloxy-N-formylamino)methyl]-6-heptenoic acid (4). To a
solution of acid 11 (1.32 g, 5.0 mmol) in dichloromethane (20 mL) was
added formic acid (20.0 mmol) and acetic anhydride (10.0 mmol) in an
ice-water bath. The mixture was allowed to warm to room temperature and
stirred overnight. The volatile material was removed under vacuum to give
formylated amino acid 4 in quantitative yield. 1H NMR (400 MHz, CD3OD) β
8.08 (brs, 0.5H), 7.94 (brs, 0.5H), 7.35 (m, 5H), 5.74 (m, 1H), 4.98-4.87
(m, 2H), 3.78 (m, 1.5), 3.42 (m, 0.5H), 2.71 (m, 1H), 2.02 (m, 2H),
1.55-1.34 (m, 4H); 13C NMR (63 MHz, CD3OD) β165.2, 161.1, 139.7, 131.4,
131.2, 130.5, 130.1, 115.8, 78.7, 46.6, 44.9, 34.9, 30.6, 27.7. HRESI-MS:
C16H21NO4Na+ ([M+Na]+), calc'd 314.1363, found 314.1375.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic peptide deformylase inhibitors as novel
antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Dehua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050026821 A1 2005-02-03

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-[[(Phenylmethoxy)amino]methyl]-6-heptenoic acid
C15H21NO3
596111-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0 CFG=2
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 10.0100 1.3338 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 O 11.5500 1.3338 0.0 0
M  V30 10 O 9.2400 0.0000 0.0 0
M  V30 11 C 12.3200 5.3347 0.0 0
M  V30 12 C 13.8600 5.3347 0.0 0
M  V30 13 C 14.6300 6.6685 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-2-[[Formyl(phenylmethoxy)amino]methyl]-6-heptenoic acid
C16H21NO4
596111-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 N 6.6685 4.6201 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 O 5.3348 5.3901 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 C 12.0033 3.0801 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 O 8.0022 6.9302 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 15 C 14.6707 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 7.7002 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 16
M  V30 15 2 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 596111-58-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 596111-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8483777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2R-[(N-Benzyloxy-N-formylamino)methyl]-6-heptenoic acid (4). To a
solution of acid 11 (1.32 g, 5.0 mmol) in dichloromethane (20 mL) was
added formic acid (20.0 mmol) and acetic anhydride (10.0 mmol) in an
ice-water bath. The mixture was allowed to warm to room temperature and
stirred overnight. The volatile material was removed under vacuum to give
formylated amino acid 4 in quantitative yield. 1H NMR (400 MHz, CD3OD) δ
8.08 (brs, 0.5H), 7.94 (brs, 0.5H), 7.35 (m, 5H), 5.74 (m, 1H), 4.98-4.87
(m, 2H), 3.78 (m, 1.5H), 3.42 (m, 0.5H), 2.71 (m, 1H), 2.02 (m, 2H),
1.55-1.34 (m, 4H); 13C NMR (63 MHz, CD3OD) δ165.2, 161.1, 139.7, 131.4,
131.2, 130.5, 130.1, 115.8, 78.7, 46.6, 44.9, 34.9, 30.6, 27.7. HRESI-MS:
C16H21NO4Na+ ([M + Na]+), calcd 314.1363, found 314.1375.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of a Macrocyclic Inhibitor for Peptide Deformylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xubo; Nguyen, Kiet T.; Verlinde, Christophe L. M. J.; Hol, Wim G. J.;
Pei, Dehua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(18), 3771-3774

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Aminophenyl)pyrrole
C10H10N2
6025-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 0.0000 0.0 0
M  V30 2 N 2.3698 2.6673 0.0 0
M  V30 3 C 1.4646 1.4215 0.0 0
M  V30 4 C 1.4646 3.9132 0.0 0
M  V30 5 C 0.0000 1.8973 0.0 0
M  V30 6 C 0.0000 3.4374 0.0 0
M  V30 7 C 3.9098 2.6673 0.0 0
M  V30 8 C 4.6799 1.3337 0.0 0
M  V30 9 C 4.6799 4.0010 0.0 0
M  V30 10 C 6.2199 1.3337 0.0 0
M  V30 11 C 6.2199 4.0010 0.0 0
M  V30 12 C 6.9899 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 7
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1H-Pyrrol-1-yl)phenyl]formamide
C11H10N2O
209974-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.9318 4.0011 0.0 0
M  V30 2 C 6.4718 4.0011 0.0 0
M  V30 3 O 7.2418 5.3348 0.0 0
M  V30 4 C 2.6217 2.6675 0.0 0
M  V30 5 C 4.1618 2.6675 0.0 0
M  V30 6 C 1.8517 1.3337 0.0 0
M  V30 7 C 4.9318 1.3337 0.0 0
M  V30 8 C 2.6217 0.0000 0.0 0
M  V30 9 C 4.1618 0.0000 0.0 0
M  V30 10 N 1.8517 4.0011 0.0 0
M  V30 11 C 2.4782 5.4079 0.0 0
M  V30 12 C 0.3202 4.1621 0.0 0
M  V30 13 C 1.3337 6.4385 0.0 0
M  V30 14 C 0.0000 5.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6025-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 209974-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16908137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Halogen-Bond-Promoted Photoactivation of Perfluoroalkyl Iodides: A
Photochemical Protocol for Perfluoroalkylation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yaxin; Wang, Junhua; Li, Guo-Xing; He, Gang; Chen, Gong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(6), 1442-1445

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Hydroxysuccinimide
C4H5NO3
6066-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formyloxy)-2,5-pyrrolidinedione
C5H5NO4
17592-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7710 1.3628 0.0 0
M  V30 2 C 5.1048 2.1328 0.0 0
M  V30 3 O 6.4385 1.3628 0.0 0
M  V30 4 O 3.4208 4.6949 0.0 0
M  V30 5 O 0.7103 0.0000 0.0 0
M  V30 6 N 2.4374 2.1328 0.0 0
M  V30 7 C 2.2764 3.6643 0.0 0
M  V30 8 C 1.0306 1.5064 0.0 0
M  V30 9 C 0.7700 3.9845 0.0 0
M  V30 10 C 0.0000 2.6508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 7
M  V30 5 2 5 8
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17592-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24752801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Active Ester Functionalized Azobenzenes as Versatile Building Blocks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schultzke, Sven; Walther, Melanie; Staubitz, Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(13), 3916

$RFMT $RIREG SCHEME236 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthracene
C14H11N
613-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 8.0023 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Anthracenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C19H13N3O3
2178914-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 10.0100 2.6674 0.0 0
M  V30 3 O 11.5500 0.0000 0.0 0
M  V30 4 O 11.5500 5.3347 0.0 0
M  V30 5 O 16.1700 2.6674 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 6.6685 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 12.3200 1.3336 0.0 0
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 23 N 13.8600 1.3336 0.0 0
M  V30 24 N 13.8600 4.0011 0.0 0
M  V30 25 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 20
M  V30 4 2 3 21
M  V30 5 2 4 22
M  V30 6 2 5 25
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 613-13-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22140343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME237 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminoanthracene
C14H11N
613-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 8.0023 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Anthracenylamino)methylene]-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
C21H17N3O3
2178914-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 10.7800 5.3347 0.0 0
M  V30 9 C 11.5500 4.0011 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 13.0900 4.0011 0.0 0
M  V30 13 C 10.7800 2.6674 0.0 0
M  V30 14 C 13.0900 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 13.8600 5.3347 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 13.8600 8.0021 0.0 0
M  V30 19 C 15.4000 5.3347 0.0 0
M  V30 20 C 15.4000 8.0021 0.0 0
M  V30 21 C 16.1700 6.6685 0.0 0
M  V30 22 C 4.6200 2.6674 0.0 0
M  V30 23 C 3.8500 4.0011 0.0 0
M  V30 24 C 3.8500 1.3336 0.0 0
M  V30 25 N 2.3100 4.0011 0.0 0
M  V30 26 N 2.3100 1.3336 0.0 0
M  V30 27 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 22
M  V30 4 2 3 23
M  V30 5 2 4 24
M  V30 6 1 5 25
M  V30 7 1 6 26
M  V30 8 2 7 27
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 613-13-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22139719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromoaniline
C6H6BrN
615-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromophenyl)formamide
C7H6BrNO
10113-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10113-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19206499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chalcogen-Bonding Catalysis: From Neutral to Cationic Benzodiselenazole
Scaffolds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benz, Sebastian; Besnard, Celine; Matile, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2018), 101(7), n/a

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoaniline
C6H6IN
615-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)formamide
C7H6INO
10113-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 I 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10113-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17553152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ruthenium-Catalyzed 1,6-Aromatic Enamide-Silylalkyne Cycloisomerization:
Approach to 2,3-Disubstituted Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takamoto, Kohei; Ohno, Shohei; Hyogo, Norimichi; Fujioka, Hiromichi;
Arisawa, Mitsuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(16), 8733-8742

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoaniline
C6H6IN
615-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)formamide
C7H6INO
10113-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 I 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10113-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12025034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3,3-disubstituted 2-aminoindolenines by palladium-catalyzed
allylic amidination with isocyanide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nanjo, Takeshi; Tsukano, Chihiro; Takemoto, Yoshiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2014), 25(10), 1473-1477, 5 pp.

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Diaminobenzoic acid
C7H8N2O2
619-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-5-carboxylic acid
C8H6N2O2
15788-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 N 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-9989001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives as modulators of calcium
release-activated calcium channel for treatment of non-small cell lung
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muthuppalaniappan, Meyyappan; Viswanadha, Srikant; Vakkalanka, Swaroop
Kumar Venkata Satya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2009CH02439 A 2012-03-30

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Diaminobenzoic acid
C7H8N2O2
619-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-5-carboxylic acid
C8H6N2O2
15788-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 N 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13647306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 24: 1H-benzo[d]imidazole-6-carboxylic acid:
3,4-diaminobenzoic acid (5 g, 32 mmol) and formic acid (20 ml) were mixed
and refluxed overnight. Formic acid was removed on rotavapour and water
added to the residue to obtain the solid. Solid was filtered and dried to
obtain the title compound quantitatively.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazoles derivatives modulators of calcium
release-activated calcium channel for treatment of non-small cell lung
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muthuppalaniappan, Meyyappan; Viswanadha, Srikant; Varanasi, Kanthikiran
V. S.; Merikapudi, Gayatri Swaroop; Vakkalanka, Swaroop Kumar V. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011042798 A1 2011-04-14

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzonitrile
C7H4N2O2
619-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)formamide
C8H6N2O
6321-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 N 10.0100 1.3336 0.0 0
M  V30 6 C 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 6.1600 0.0000 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-72-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6321-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-15755292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1604839-72-6
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated iron oxide-bound
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, regioselective, solid-supported
catalyst, ionic liquid functionalized magnetic nanoparticle supported
palladium catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Water-Dispersible/Magnetically Separable Palladium Catalyst:
Selective Transfer Hydrogenation or Direct Reductive N-Formylation of
Nitroarenes in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Babak; Mansouri, Fariborz; Vali, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemPlusChem (2015), 80(12), 1750-1759

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-3-Chloro-α-[(3-hydroxycyclopentyl)methyl]-4-(methylthio)benzeneacetic acid
C15H19ClO3S
625113-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 O 8.0023 6.9302 0.0 0
M  V30 5 O 5.3348 6.9302 0.0 0
M  V30 6 Cl 4.0012 0.0000 0.0 0
M  V30 7 S 1.3337 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 O 13.3050 4.9772 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0 CFG=3
M  V30 17 C 10.7428 3.9938 0.0 0
M  V30 18 C 9.4969 6.1517 0.0 0
M  V30 19 C 11.7734 5.1382 0.0 0 CFG=3
M  V30 20 C 11.0034 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-3-Chloro-α-[[3-(formyloxy)cyclopentyl]methyl]-4-(methylsulfonyl)benzenea...
C16H19ClO6S
625114-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0 CFG=2
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 C 8.4700 1.3338 0.0 0
M  V30 4 O 7.7000 0.0000 0.0 0
M  V30 5 O 10.0101 1.3338 0.0 0
M  V30 6 Cl 3.0800 5.3347 0.0 0
M  V30 7 S 1.5400 2.6674 0.0 0 VAL=6
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 O 1.5400 4.2075 0.0 0
M  V30 10 O 1.5400 1.1274 0.0 0
M  V30 11 O 13.6257 5.6763 0.0 0
M  V30 12 C 15.0326 5.0500 0.0 0
M  V30 13 O 16.2785 5.9552 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 5.3900 1.3338 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 1.3338 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0 CFG=3
M  V30 21 C 10.9153 5.2470 0.0 0
M  V30 22 C 10.9153 2.7552 0.0 0
M  V30 23 C 12.3798 4.7711 0.0 0 CFG=3
M  V30 24 C 12.3798 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 7 19
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 625113-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 625114-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-508-CAS-1815512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2(R)-(3-Chloro-4-methanesulfonyl-phenyl)-3-(3-formyloxy-cyclo-pentyl)-propionic
Acid (81). A solution of
2(R)-(3-chloro-4-methylsulfanyl-phenyl)-3-(3-hydroxy-cyclopentyl)-propionic
acid 80 (350 mg, 1.11 mmol) in formic acid (35 mL) was treated with a 30%
aqueous hydrogen peroxide solution (1 mL, 7.89 mmol) at 25 °C. The
mixture was then allowed to stir at 25 °C overnight. The solvent was
evaporated in vacuo. The resulting residue was azeotroped with toluene to
remove water and then coevaporated with N,N-dimethylformamide to remove
formic acid to afford crude
2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-(3-formyloxy-cyclopentyl)-propionic
acid 81. Yield (430 mg, 103%), off-white solid. 1H NMR (300 MHz,
chloroform-d): δ 0.70-2.53 (m, 9 H), 3.28 (s, 3 H), 3.58-3.90 (m, 1 H),
5.08-5.46 (m, 1 H), 7.51 (d, J = 8.06 Hz, 1 H), 7.63 (s, 1 H), 8.13 (d, J
= 8.06 Hz, 1 H), 8.22 (br. s., 1 H), 9.53 (br. s., 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Piragliatin-First Glucokinase Activator Studied in Type 2
Diabetic Patients
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sarabu, Ramakanth; Bizzarro, Fred T.; Corbett, Wendy L.; Dvorozniak, Mark
T.; Geng, Wanping; Grippo, Joseph F.; Haynes, Nancy-Ellen; Hutchings,
Stanley; Garofalo, Lisa; Guertin, Kevin R.; Hilliard, Darryl W.; Kabat,
Marek; Kester, Robert F.; Ka, Wang; Liang, Zhenmin; Mahaney, Paige E.;
Marcus, Linda; Matschinsky, Franz M.; Moore, David; Racha, Jagdish;
Radinov, Roumen; Ren, Yi; Qi, Lida; Pignatello, Michael; Spence, Cheryl
L.; Steele, Thomas; Tengi, John; Grimsby, Joseph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(16), 7021-7036

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-3-Chloro-α-[(3-hydroxycyclopentyl)methyl]-4-(methylthio)benzeneacetic acid
C15H19ClO3S
625113-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 O 8.0023 6.9302 0.0 0
M  V30 5 O 5.3348 6.9302 0.0 0
M  V30 6 Cl 4.0012 0.0000 0.0 0
M  V30 7 S 1.3337 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 O 13.3050 4.9772 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0 CFG=3
M  V30 17 C 10.7428 3.9938 0.0 0
M  V30 18 C 9.4969 6.1517 0.0 0
M  V30 19 C 11.7734 5.1382 0.0 0 CFG=3
M  V30 20 C 11.0034 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-3-Chloro-α-[[3-(formyloxy)cyclopentyl]methyl]-4-(methylsulfonyl)benzenea...
C16H19ClO6S
625114-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0 CFG=2
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 C 8.4700 1.3338 0.0 0
M  V30 4 O 7.7000 0.0000 0.0 0
M  V30 5 O 10.0101 1.3338 0.0 0
M  V30 6 Cl 3.0800 5.3347 0.0 0
M  V30 7 S 1.5400 2.6674 0.0 0 VAL=6
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 O 1.5400 4.2075 0.0 0
M  V30 10 O 1.5400 1.1274 0.0 0
M  V30 11 O 13.6257 5.6763 0.0 0
M  V30 12 C 15.0326 5.0500 0.0 0
M  V30 13 O 16.2785 5.9552 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 5.3900 1.3338 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 1.3338 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0 CFG=3
M  V30 21 C 10.9153 5.2470 0.0 0
M  V30 22 C 10.9153 2.7552 0.0 0
M  V30 23 C 12.3798 4.7711 0.0 0 CFG=3
M  V30 24 C 12.3798 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 7 19
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 625113-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 625114-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-508-CAS-12116868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroaryl phenylacetamides and related compounds as
glucokinase activators for treatment of type II diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corbett, Wendy Lea; Grimsby, Joseph Samuel; Haynes, Nancy-Ellen; Kester,
Robert Francis; Mahaney, Paige Erin; Racha, Jagdish Kumar; Sarabu,
Ramakanth; Wang, Ka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003095438 A1 2003-11-20

$RFMT $RIREG SCHEME243 STEP1
$RXN



  3  1
$MOL
Aniline
C6H7N
62-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Phenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C11H9N3O3
23069-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 O 6.9300 5.3349 0.0 0
M  V30 5 O 11.5500 2.6674 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 N 9.2400 1.3338 0.0 0
M  V30 10 N 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 2 12
M  V30 4 2 3 7
M  V30 5 2 4 8
M  V30 6 2 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-53-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23069-91-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21064038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME244 STEP1
$RXN



  3  1
$MOL
Aniline
C6H7N
62-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-5-[(phenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C13H13N3O3
23069-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 4.6200 5.3349 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 8
M  V30 3 1 2 14
M  V30 4 2 3 9
M  V30 5 2 4 10
M  V30 6 1 5 11
M  V30 7 1 6 12
M  V30 8 2 7 13
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-53-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23069-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21330284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-methylbenzene-1,2-diamine
C7H9ClN2
63155-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-5-methyl-1H-benzimidazole
C8H7ClN2
109943-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63155-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109943-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-3939279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Chloro-5-methyl-benzene-1,2-diamine (560 mg, 3.6 mmol, Maybridge
Chemical Co. Ltd., Cornwall, UK) was dissolved in formic acid (10 mL) and
the solution was refluxed at 100°C for 18 hr. The reaction was allowed to
cool and then evaporated to dryness in vacuo to give
5-chloro-6-methyl-1H-benzoimidazole that was used without further
purification. Tan solid, yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel thiophene amidines for treating complement-mediated
diseases and conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Subasinghe, Nalin; Khalil, Ehab; Leonard, Kristi; Ali, Farah; Hufnagel,
Heather Rae; Travins, Jeremy M.; Ballentine, Shelley K.; Wilson, Kenneth
T.; Cummings, Maxwell D.; Pan, Wenxi; Gushue, Joan; Meegalla, Sanath;
Wall, Mark; Chen, Jinsheng; Rudolph, M. Jonathan; Huang, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003099805 A1 2003-12-04

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxyaniline
C8H11NO2
6315-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 N 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethoxyphenyl)formamide
C9H11NO3
33904-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 N 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 O 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6315-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33904-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19189583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Anodic Dehydrogenative Cross- and Homo-Coupling of Formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, Lara; Franke, Robert; Waldvogel, Siegfried R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemElectroChem (2018), 5(15), 2069-2072

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-nitrobenzonitrile
C7H5N3O2
6393-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 N 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyano-2-nitrophenyl)formamide
C8H5N3O3
1430938-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3100 1.3338 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 C 1.5400 5.3349 0.0 0
M  V30 6 O 0.0000 5.3349 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 N 10.0100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 3 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6393-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430938-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13221977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1: A mixture of acetic anhydride (49 mL,
0.5 mol) and formic acid (19 mL, 0.5 mol) was heated at 60 °C for 3 h.
5-Fluoro-3-nitropyridin-2-amine was added and the mixture was stirred at
60 °C for 1 h. The mixture was concentrated under reduced pressure and
the residue was stirred vigorously in diethyl ether (200 mL) for 30
minutes. The solid was collected by filtration.
N-(4-Cyano-2-nitrophenyl)formamide was synthesized as a white solid (4.8
g, 100%) using a procedure analogous to that described in Step 1 of
Example 162, substituting 4-cyano-2-nitroaniline for
5-fluoro-3-nitropyridin-2-amine used in Example 162. LCMS (ESI) m/z 192
(M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compounds as kinase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang;
Rowbottom, Martin W.; Xu, Shimin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013056070 A2 2013-04-18

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-(2-methyl-1-propen-1-yl)-
C10H12O
6395-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-(2-methyl-1-propen-1-yl)-, 1-formate
C11H12O2
1396690-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 0.0000 2.3100 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 6.1600 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6395-29-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396690-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-13070092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 2: Formic acid (23.6 mmol, 10 equiv)
was added to acetic anhydride (18.9 mmol, 8 equiv) at RT. The resulting
mixture was stirred at 60 °C for 1 h and cooled to RT. Phenol derivative
synthesized above (2.40 mmol) and sodium hydrogen carbonate (4.80 mmol,
2.0 equiv) were added to the solution and the mixture was stirred for
9-16 h. The reaction mixture was diluted with Et2O, washed with H2O three
times, dried over MgSO4, filtered, and concentrated. The obtained residue
was purified by column chromatography on neutral silica gel to afford the
desired product. 2-(2-Methylprop-1-en-1-yl)phenyl formate (5j) 5j was
obtained from S10 by formylation analogous to synthesis of 5b as a
colorless oil. Yield: 100%. 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 1H),
7.30-7.21 (m, 3H), 7.07 (dd, 1H, J = 7.2, 1.6 Hz), 6.10 (s, 1H), 1.89 (d,
1H, J = 1.2 Hz), 1.74 (d, 3H, J = 1.2 Hz); 13C NMR (100 MHz, CDCl3) δ
159.4, 147.6, 138.4, 131.3, 131.0, 127.5, 126.1, 121.5, 119.0, 26.2 and
19.4; IR (ATR) 2913, 1738, 1483, 1445, 1188, 1171, 1111 and 760 cm-1;
HRMS (ESI) [M+H]+ calcd for C11H13O2: 177.0910; found 177.0914.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Remarkable Improvement Achieved by Imidazole Derivatives in
Ruthenium-Catalyzed Hydroesterification of Alkenes Using Formates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konishi, Hideyuki; Ueda, Tsuyoshi; Muto, Takashi; Manabe, Kei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(18), 4722-4725

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-amino-α-ethylbenzeneacetate
C12H17NO2
6480-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 C 3.2311 4.4137 0.0 0
M  V30 4 N 4.7712 1.7462 0.0 0
M  V30 5 O 6.6685 3.0801 0.0 0
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 C 4.0012 5.7474 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 9.3360 3.0801 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-ethyl-α-(formylamino)benzeneacetate
C13H17NO3
294882-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0010 0.0 0
M  V30 2 C 5.3348 3.2310 0.0 0
M  V30 3 N 3.2311 2.6673 0.0 0
M  V30 4 C 4.7712 5.3348 0.0 0
M  V30 5 O 6.6685 4.0010 0.0 0
M  V30 6 O 5.3348 1.6910 0.0 0
M  V30 7 C 4.0012 1.3337 0.0 0
M  V30 8 C 4.0012 6.6685 0.0 0
M  V30 9 C 8.0023 3.2310 0.0 0
M  V30 10 O 3.2311 0.0000 0.0 0
M  V30 11 C 9.3360 4.0010 0.0 0
M  V30 12 C 2.6675 4.7710 0.0 0
M  V30 13 C 1.3337 4.0010 0.0 0
M  V30 14 C 2.6675 6.3111 0.0 0
M  V30 15 C 0.0000 4.7710 0.0 0
M  V30 16 C 1.3337 7.0811 0.0 0
M  V30 17 C 0.0000 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6480-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 294882-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14367722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ethyl 2-Formylamino-2-phenylbutanoate (7). 12.72 mL of formic acid then
25.38 mL of acetic anhydride were added dropwise, under stirring, to 2.49
g (12.03 mmol) of amine 6. After 15 h at room temperature, solvents were
removed under reduced pressure to give 3.09 g of 7 as a green viscous oil
(100% yield). Rf=0.85 (CHCl3 /MeOH 9.5:0.5); MS(ESI), m/e 236 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of salts of trimebutine and N-desmethyl trimebutine for
treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallace, John L.; Cirino, Giuseppe; Santagada, Vincenzo; Caliendo,
Giuseppe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070275905 A1 2007-11-29

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Phenylglycine amide
C8H10N2O
6485-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 N 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Formylamino)benzeneacetamide
C9H10N2O2
14231-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 C 6.6687 3.0801 0.0 0
M  V30 5 N 2.6675 5.3901 0.0 0
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6485-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14231-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10443977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (b) From glycinamde 29: To a solution of 29 (5.08 g, 33.7 mmol) in formic
acid (6.4 mL, 170 mmol) was added dropwise acetic anhydride (16 mL, 170
mmol) at 0°C and then the whole was stirred for 30 min at room
temperature. After evaporation purification of the residue by
recrystallization from Et2O-MeOH yielded 28.
(R)-N-Formylphenylglycinamide (28) Colorless plates, yield (6.00 g,
quant.). mp 161-163 °C (lit. [7] mp 164 °C); [α]23 D -194.8 (c 1.08,
MeOH); 1H NMR (CDCl3 + TFA) δ: 5.60 (1H, dd, J = 16, 6.8 Hz), 7.23-7.51
(5H, m), 8.31 (1H, s); IR (KBr) λmax cm-1: 3277 and 3198 (NH), 1693 and
1639 (C=O).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported and polymeric chiral guanidines: Preparation and
application to the asymmetric Michael reaction of iminoacetate with
methyl vinyl ketone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wannaporn, Disadee; Ishikawa, Tsutomu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2005), 9(4), 321-331

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-4-carbonitrile, 5-amino-1-(3-nitrophenyl)-
C10H7N5O2
65973-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3956 0.9473 0.0 0
M  V30 2 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 C 10.6374 3.4372 0.0 0
M  V30 6 N 12.1690 3.2761 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 N 6.6685 3.0801 0.0 0
M  V30 14 C 8.0753 2.4536 0.0 0
M  V30 15 N 6.8294 4.6116 0.0 0
M  V30 16 C 9.1059 3.5981 0.0 0
M  V30 17 C 8.3359 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 10
M  V30 5 3 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-1-(3-nitrophenyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
C11H7N5O3
65973-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.4224 0.0 0
M  V30 2 N 10.3090 3.0801 0.0 0 VAL=5
M  V30 3 O 11.6427 2.3101 0.0 0
M  V30 4 O 10.3090 4.6201 0.0 0
M  V30 5 N 4.9742 3.0801 0.0 0
M  V30 6 C 3.5673 2.4536 0.0 0
M  V30 7 N 4.8132 4.6116 0.0 0
M  V30 8 C 2.5367 3.5981 0.0 0
M  V30 9 N 3.0915 0.9890 0.0 0
M  V30 10 C 3.3068 4.9318 0.0 0
M  V30 11 C 1.0304 3.2780 0.0 0
M  V30 12 C 1.5850 0.6688 0.0 0
M  V30 13 N 0.5546 1.8132 0.0 0
M  V30 14 C 6.3078 2.3101 0.0 0
M  V30 15 C 7.6416 3.0801 0.0 0
M  V30 16 C 6.3078 0.7700 0.0 0
M  V30 17 C 8.9753 2.3101 0.0 0
M  V30 18 C 7.6416 0.0000 0.0 0
M  V30 19 C 8.9753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65973-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65973-98-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11655390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as kinase inhibitors for the treatment
of type 2 diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Matthew Lee; Cheung, Mui; Dickerson, Scott Howard; Garrido, Dulce
Maria; Mills, Wendy Yoon; Miyazaki, Yasushi; Peat, Andrew James; Peckham,
Jennifer Poole; Smalley, Terrence L.; Thomson, Stephen Andrew; Veal,
James Marvin; Wilson, Jayme Lyn Roark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004009602 A1 2004-01-29

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[[4-(1-methylethyl)phenyl]amino]-2-oxo-1-phenylethyl]-, 1,1...
C22H28N2O3
672962-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 8.4700 5.3347 0.0 0
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 O 3.0800 6.6685 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 1.5400 5.1285 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 14.6300 5.3347 0.0 0
M  V30 14 C 15.4000 4.0011 0.0 0
M  V30 15 C 15.4000 6.6685 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 3.8500 2.6674 0.0 0
M  V30 18 C 6.1600 1.3338 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 5.3900 0.0000 0.0 0
M  V30 21 C 3.8500 0.0000 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 23 C 10.7800 6.6685 0.0 0
M  V30 24 C 10.7800 4.0011 0.0 0
M  V30 25 C 12.3200 6.6685 0.0 0
M  V30 26 C 12.3200 4.0011 0.0 0
M  V30 27 C 13.0900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 22
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with α-amino-N-[4-(1-methylethyl)phenyl]benzeneacetamide ...
C17H20N2O.CH2O2
672962-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9301 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 4.0010 8.4702 0.0 0
M  V30 4 N 6.6685 6.9301 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 13.3370 4.6201 0.0 0
M  V30 8 C 12.0033 2.3100 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 6.9301 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 0.0000 6.1601 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 8.0022 6.1601 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3360 6.9301 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 6.6685 0.0000 0.0 0
M  V30 22 O 5.3348 0.7700 0.0 0
M  V30 23 O 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672962-12-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 672962-14-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-2580198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylglycine derivatives and their use as glycine transport inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Xin, Tao; Edwards, Louise; Begleiter, Leah; Stefanac,
Tomaslav; O'Brien, Anne; Da Silva, Kathleen; Arora, Jalaj; Maddaford,
Shawn; Slassi, Abdelmalik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004022528 A2 2004-03-18

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[[4-(1-methylethyl)phenyl]amino]-2-oxo-1-phenylethyl]-, 1,1...
C22H28N2O3
672962-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 8.4700 5.3347 0.0 0
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 O 3.0800 6.6685 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 1.5400 5.1285 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 14.6300 5.3347 0.0 0
M  V30 14 C 15.4000 4.0011 0.0 0
M  V30 15 C 15.4000 6.6685 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 3.8500 2.6674 0.0 0
M  V30 18 C 6.1600 1.3338 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 5.3900 0.0000 0.0 0
M  V30 21 C 3.8500 0.0000 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 23 C 10.7800 6.6685 0.0 0
M  V30 24 C 10.7800 4.0011 0.0 0
M  V30 25 C 12.3200 6.6685 0.0 0
M  V30 26 C 12.3200 4.0011 0.0 0
M  V30 27 C 13.0900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 22
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with α-amino-N-[4-(1-methylethyl)phenyl]benzeneacetamide ...
C17H20N2O.CH2O2
672962-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9301 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 4.0010 8.4702 0.0 0
M  V30 4 N 6.6685 6.9301 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 13.3370 4.6201 0.0 0
M  V30 8 C 12.0033 2.3100 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 6.9301 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 0.0000 6.1601 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 8.0022 6.1601 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3360 6.9301 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 6.6685 0.0000 0.0 0
M  V30 22 O 5.3348 0.7700 0.0 0
M  V30 23 O 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672962-12-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 672962-14-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-4596605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N'-arylaminocarbothioyl glycinamides as glycine transport
inhibitors for treating pain and spasticity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Xin, Tao; Stefanac, Tomaslav; O'Brien, Anne; Da Silva,
Kathleen; Arora, Jalaj; Maddaford, Shawn; Slassi, Abdelmalik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004022534 A1 2004-03-18

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-oxo-1-phenyl-2-(8-quinolinylamino)ethyl]-, 1,1-dimethylethy...
C22H23N3O3
672962-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 4.6200 2.6674 0.0 0
M  V30 5 N 7.7000 5.3347 0.0 0
M  V30 6 C 9.2400 5.3347 0.0 0
M  V30 7 O 10.0100 6.6684 0.0 0
M  V30 8 O 10.0100 4.0011 0.0 0
M  V30 9 C 11.5500 6.6684 0.0 0
M  V30 10 C 11.5500 8.2084 0.0 0
M  V30 11 C 13.0900 6.6684 0.0 0
M  V30 12 C 11.5500 5.1284 0.0 0
M  V30 13 C 2.3100 6.6684 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 0.7700 6.6684 0.0 0
M  V30 16 N 3.0800 8.0021 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 C 2.3100 9.3358 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 9.3358 0.0 0
M  V30 23 C 7.7000 2.6674 0.0 0
M  V30 24 C 9.2400 2.6674 0.0 0
M  V30 25 C 6.9300 1.3336 0.0 0
M  V30 26 C 10.0100 1.3336 0.0 0
M  V30 27 C 7.7000 0.0000 0.0 0
M  V30 28 C 9.2400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 23
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 2 19 22
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with α-amino-N-8-quinolinylbenzeneacetamide (1:1)
C17H15N3O.CH2O2
672962-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.3111 0.0 0
M  V30 2 C 6.9300 6.3111 0.0 0
M  V30 3 C 7.7000 7.6447 0.0 0
M  V30 4 O 7.7000 4.9775 0.0 0
M  V30 5 N 6.9300 8.9785 0.0 0
M  V30 6 C 3.0800 4.9775 0.0 0
M  V30 7 C 4.6200 4.9775 0.0 0
M  V30 8 C 2.3100 3.6438 0.0 0
M  V30 9 N 2.3100 6.3111 0.0 0
M  V30 10 C 5.3900 3.6438 0.0 0
M  V30 11 C 3.0800 2.3100 0.0 0
M  V30 12 C 0.7700 3.6438 0.0 0
M  V30 13 C 0.7700 6.3111 0.0 0
M  V30 14 C 4.6200 2.3100 0.0 0
M  V30 15 C 0.0000 4.9775 0.0 0
M  V30 16 C 9.2400 7.6447 0.0 0
M  V30 17 C 10.0100 6.3111 0.0 0
M  V30 18 C 10.0100 8.9785 0.0 0
M  V30 19 C 11.5500 6.3111 0.0 0
M  V30 20 C 11.5500 8.9785 0.0 0
M  V30 21 C 12.3200 7.6447 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 23 O 4.8263 0.7700 0.0 0
M  V30 24 O 7.4937 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672962-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 672962-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-82141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylglycine derivatives and their use as glycine transport inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Xin, Tao; Edwards, Louise; Begleiter, Leah; Stefanac,
Tomaslav; O'Brien, Anne; Da Silva, Kathleen; Arora, Jalaj; Maddaford,
Shawn; Slassi, Abdelmalik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004022528 A2 2004-03-18

$RFMT $RIREG SCHEME254 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthylamine
C10H9N
91-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C15H11N3O3
325850-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 5.3347 0.0 0
M  V30 5 O 13.8600 2.6674 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 10.0100 1.3338 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 N 11.5500 1.3338 0.0 0
M  V30 20 N 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 16
M  V30 4 2 3 17
M  V30 5 2 4 18
M  V30 6 2 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 91-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 325850-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21291567
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME255 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Barbituric acid
C4H4N2O3
67-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobiphenyl
C12H11N
92-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 2.6673 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[([1,1′-Biphenyl]-4-ylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C17H13N3O3
2178914-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 10.0100 2.6674 0.0 0
M  V30 3 O 11.5500 5.3349 0.0 0
M  V30 4 O 11.5500 0.0000 0.0 0
M  V30 5 O 16.1700 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 6.9300 5.3349 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 20 C 12.3200 1.3338 0.0 0
M  V30 21 N 13.8600 4.0011 0.0 0
M  V30 22 N 13.8600 1.3338 0.0 0
M  V30 23 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 18
M  V30 4 2 3 19
M  V30 5 2 4 20
M  V30 6 2 5 23
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 92-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22085041
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dibromo-1,2-benzenediamine
C6H6Br2N2
69272-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6673 0.0 0
M  V30 4 Br 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Dibromo-1H-benzimidazole
C7H4Br2N2
148185-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.7034 0.0 0
M  V30 2 Br 6.1601 3.7034 0.0 0
M  V30 3 C 2.3100 2.3698 0.0 0
M  V30 4 C 3.8500 2.3698 0.0 0
M  V30 5 C 1.5400 3.7034 0.0 0
M  V30 6 N 1.8342 0.9051 0.0 0
M  V30 7 C 4.6201 3.7034 0.0 0
M  V30 8 N 4.3259 0.9051 0.0 0
M  V30 9 C 2.3100 5.0371 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 3.8500 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69272-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 148185-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22750215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM UiO-68-PT MOF-Based Sensor and Its Mixed Matrix Membrane for Detection of
HClO in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Qian-Ying; Li, Yan-An; Guan, Qun; Li, Wen-Yan; Dong, Xiao-Jie; Dong,
Yu-Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2019), 58(15), 9890-9896

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Amonafide
C16H17N3O2
69408-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 O 8.0022 2.3101 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 10.6697 5.3901 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 10.6697 6.9302 0.0 0
M  V30 8 N 0.0000 5.3901 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 N 6.6685 4.6201 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 15
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 19
M  V30 21 1 16 21
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[2-(Dimethylamino)ethyl]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinolin-5-...
C17H17N3O3
947252-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.9302 0.0 0
M  V30 2 O 4.0010 2.3101 0.0 0
M  V30 3 C 4.0010 5.3901 0.0 0
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 N 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 N 12.0033 5.3901 0.0 0
M  V30 9 C 13.3370 4.6201 0.0 0
M  V30 10 O 14.6707 5.3901 0.0 0
M  V30 11 C 8.0022 3.0801 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 9.3358 2.3101 0.0 0
M  V30 15 C 6.6685 5.3901 0.0 0
M  V30 16 C 9.3358 5.3901 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3358 0.7700 0.0 0
M  V30 21 N 5.3348 4.6201 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 8.0022 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 17
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 21
M  V30 23 1 18 23
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69408-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947252-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9713931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl
formamide. 10.1 mg of amonafide (3.56x10-5 mol; 1 eq) were dissolved in
excess formic acid (0.5 mL, 46.0 g/mol). The reaction was maintained at
room temperature for 24 hours. The solvent was then evaporated under
reduced pressure at room temperature and the residue was submitted to
flash chromatography with CH2Cl2/MeOH (80:20 v/v);
2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl
formamide yield 12.5 mg (311.34 g/mol, 3.56x10-5 mol), 100.0%.
C17H17N3O3. 1H NMR (CDCl3): δ = 2.56 (6H, s, H3C-15 and H3C-16), 3.00
(2H, t, J = 6.0 Hz, H2C-14), 4.40 (2H, t, J = 6.0 Hz, H2C-13), 7.66 (1H,
t, J = 7.8 Hz, H-7), 7.81 (1H, s, NH-17), 7.82 (1H, d, J = 7.8 Hz, H-6),
8.35-8.45 (3H, m, H-2, H-4 and H-8), 9.78 (1H, bs, OCH-19). EI-MS: 58
(100); 71 (18); 212 (5) and 311 (less than 1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-
5-yl}carbamoyl)acetamide (UNBS3157), a Novel Nonhematotoxic Naphthalimide
Derivative with Potent Antitumor Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Quaquebeke, Eric; Mahieu, Tine; Dumont, Patrick; Dewelle, Janique;
Ribaucour, Fabrice; Simon, Gentiane; Sauvage, Sebastien; Gaussin,
Jean-Francois; Tuti, Jerome; El Yazidi, Mohamed; Van Vynckt, Frank;
Mijatovic, Tatjana; Lefranc, Florence; Darro, Francis; Kiss, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(17), 4122-4134

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Vinylphenol
C8H8O
695-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-ethenyl-, 1-formate
C9H8O2
1396690-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 C 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 695-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396690-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-11246210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method 2: Formic acid (23.6 mmol, 10 equiv) was added to acetic anhydride
(18.9 mmol, 8 equiv) at RT. The resulting mixture was stirred at 60 °C
for 1 h and cooled to RT. Phenol derivative synthesized above (2.40 mmol)
and sodium hydrogen carbonate (4.80 mmol, 2.0 equiv) were added to the
solution and the mixture was stirred for 9-16 h. The reaction mixture was
diluted with Et2O, washed with H2O three times, dried over MgSO4,
filtered, and concentrated. The obtained residue was purified by column
chromatography on neutral silica gel to afford the desired product.
2-Vinylphenyl formate (5b). 5b was obtained from S2 using method 2 as a
colorless oil. Yield: 100% 1H NMR (400 MHz, CDCl3) δ 8.32 (s, 1H), 7.60
(dd, 1H, J = 7.2, 1.6 Hz), 7.33-7.23 (m, 2H), 7.08 (dd, 1H, J = 7.6, 1.2
Hz), 6.80 (dd, 1H, J = 17.6, 11.2 Hz), 5.78 (dd, 1H, J = 17.6, 0.8 Hz),
5.37 (dd, 1H, J = 11.2, 0.8 Hz); 13C NMR (100 MHz, CDCl3) δ 159.4, 147.3,
130.2, 130.1, 129.0, 126.8, 126.8, 122.2, 117.1; IR (ATR) 1759, 1736,
1483, 1450, 1211, 1173, 1107, 1086, 918 and 762 cm-1; HRMS (DART) [M+H]+
calcd for C9H9O2 : 149.0598; found 149.0600.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Remarkable Improvement Achieved by Imidazole Derivatives in
Ruthenium-Catalyzed Hydroesterification of Alkenes Using Formates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konishi, Hideyuki; Ueda, Tsuyoshi; Muto, Takashi; Manabe, Kei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(18), 4722-4725

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S,3R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2,3-dihydr...
C25H20N2O4
745831-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.5872 3.5174 0.0 0
M  V30 2 O 5.7736 7.9031 0.0 0
M  V30 3 N 9.6835 3.7827 0.0 0
M  V30 4 C 10.4535 5.1163 0.0 0
M  V30 5 O 11.9935 5.1163 0.0 0
M  V30 6 O 9.6835 6.4501 0.0 0
M  V30 7 C 12.7635 6.4501 0.0 0
M  V30 8 C 5.7736 4.5527 0.0 0 CFG=2
M  V30 9 C 5.7736 3.0127 0.0 0
M  V30 10 C 7.2383 5.0286 0.0 0
M  V30 11 C 7.2383 2.5368 0.0 0
M  V30 12 C 4.6292 1.9823 0.0 0
M  V30 13 C 8.1435 3.7827 0.0 0 CFG=2
M  V30 14 C 7.5585 1.0304 0.0 0
M  V30 15 C 4.9494 0.4759 0.0 0
M  V30 16 C 6.4141 0.0000 0.0 0
M  V30 17 N 4.5278 5.4579 0.0 0
M  V30 18 C 3.0632 4.9821 0.0 0
M  V30 19 C 4.5278 6.9979 0.0 0
M  V30 20 C 2.1580 6.2279 0.0 0
M  V30 21 C 3.0632 7.4738 0.0 0
M  V30 22 C 0.6265 6.3888 0.0 0
M  V30 23 C 2.4367 8.8807 0.0 0
M  V30 24 C 0.0000 7.7958 0.0 0
M  V30 25 C 0.9052 9.0416 0.0 0
M  V30 26 C 14.3035 6.4501 0.0 0
M  V30 27 C 15.0735 5.1163 0.0 0
M  V30 28 C 15.0735 7.7838 0.0 0
M  V30 29 C 16.6135 5.1163 0.0 0
M  V30 30 C 16.6135 7.7838 0.0 0
M  V30 31 C 17.3835 6.4501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 1 13 3 CFG=3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-[(1R,3S)-3-amino-2,3-dihydro-1H-inden-1-yl]-1H-iso...
C17H14N2O2.CH2O2
745831-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3018 2.4585 0.0 0
M  V30 2 O 5.1746 7.7611 0.0 0
M  V30 3 N 0.6234 2.3100 0.0 0
M  V30 4 C 3.8119 4.7003 0.0 0 CFG=2
M  V30 5 C 2.6675 5.7307 0.0 0
M  V30 6 C 3.1855 3.2935 0.0 0
M  V30 7 C 1.3338 4.9607 0.0 0
M  V30 8 C 2.6675 7.2708 0.0 0
M  V30 9 C 1.6540 3.4544 0.0 0 CFG=2
M  V30 10 C 0.0000 5.7307 0.0 0
M  V30 11 C 1.3338 8.0408 0.0 0
M  V30 12 C 0.0000 7.2708 0.0 0
M  V30 13 N 5.3183 5.0205 0.0 0
M  V30 14 C 6.4627 3.9900 0.0 0
M  V30 15 C 5.9447 6.4274 0.0 0
M  V30 16 C 7.7965 4.7600 0.0 0
M  V30 17 C 7.4762 6.2663 0.0 0
M  V30 18 C 9.2611 4.2842 0.0 0
M  V30 19 C 8.6208 7.2969 0.0 0
M  V30 20 C 10.4057 5.3146 0.0 0
M  V30 21 C 10.0853 6.8211 0.0 0
M  V30 22 C 5.2028 0.0000 0.0 0
M  V30 23 O 3.8692 0.7700 0.0 0
M  V30 24 O 6.5365 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 15
M  V30 3 1 9 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 745831-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745831-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-5556454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient biocatalytic resolution of cis- and
trans-3-aminoindan-1-ol: Syntheses of enantiopure orthogonally protected
cis- and trans-indane-1,3-diamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lopez-Garcia, Monica; Alfonso, Ignacio; Gotor, Vicente
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2004), 10(12), 3006-3014

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R,3R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2,3-dihydr...
C25H20N2O4
745831-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.5872 3.5174 0.0 0
M  V30 2 O 5.7736 7.9031 0.0 0
M  V30 3 N 9.6835 3.7827 0.0 0
M  V30 4 C 10.4535 5.1163 0.0 0
M  V30 5 O 11.9935 5.1163 0.0 0
M  V30 6 O 9.6835 6.4501 0.0 0
M  V30 7 C 12.7635 6.4501 0.0 0
M  V30 8 C 5.7736 4.5527 0.0 0 CFG=2
M  V30 9 C 5.7736 3.0127 0.0 0
M  V30 10 C 7.2383 5.0286 0.0 0
M  V30 11 C 7.2383 2.5368 0.0 0
M  V30 12 C 4.6292 1.9823 0.0 0
M  V30 13 C 8.1435 3.7827 0.0 0 CFG=1
M  V30 14 C 7.5585 1.0304 0.0 0
M  V30 15 C 4.9494 0.4759 0.0 0
M  V30 16 C 6.4141 0.0000 0.0 0
M  V30 17 N 4.5278 5.4579 0.0 0
M  V30 18 C 3.0632 4.9821 0.0 0
M  V30 19 C 4.5278 6.9979 0.0 0
M  V30 20 C 2.1580 6.2279 0.0 0
M  V30 21 C 3.0632 7.4738 0.0 0
M  V30 22 C 0.6265 6.3888 0.0 0
M  V30 23 C 2.4367 8.8807 0.0 0
M  V30 24 C 0.0000 7.7958 0.0 0
M  V30 25 C 0.9052 9.0416 0.0 0
M  V30 26 C 14.3035 6.4501 0.0 0
M  V30 27 C 15.0735 5.1163 0.0 0
M  V30 28 C 15.0735 7.7838 0.0 0
M  V30 29 C 16.6135 5.1163 0.0 0
M  V30 30 C 16.6135 7.7838 0.0 0
M  V30 31 C 17.3835 6.4501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 1 13 3 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-[(1R,3R)-3-amino-2,3-dihydro-1H-inden-1-yl]-1H-iso...
C17H14N2O2.CH2O2
745831-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3018 2.4585 0.0 0
M  V30 2 O 5.1746 7.7611 0.0 0
M  V30 3 N 0.6234 2.3100 0.0 0
M  V30 4 C 3.8119 4.7003 0.0 0 CFG=2
M  V30 5 C 2.6675 5.7307 0.0 0
M  V30 6 C 3.1855 3.2935 0.0 0
M  V30 7 C 1.3338 4.9607 0.0 0
M  V30 8 C 2.6675 7.2708 0.0 0
M  V30 9 C 1.6540 3.4544 0.0 0 CFG=1
M  V30 10 C 0.0000 5.7307 0.0 0
M  V30 11 C 1.3338 8.0408 0.0 0
M  V30 12 C 0.0000 7.2708 0.0 0
M  V30 13 N 5.3183 5.0205 0.0 0
M  V30 14 C 6.4627 3.9900 0.0 0
M  V30 15 C 5.9447 6.4274 0.0 0
M  V30 16 C 7.7965 4.7600 0.0 0
M  V30 17 C 7.4762 6.2663 0.0 0
M  V30 18 C 9.2611 4.2842 0.0 0
M  V30 19 C 8.6208 7.2969 0.0 0
M  V30 20 C 10.4057 5.3146 0.0 0
M  V30 21 C 10.0853 6.8211 0.0 0
M  V30 22 C 5.2028 0.0000 0.0 0
M  V30 23 O 3.8692 0.7700 0.0 0
M  V30 24 O 6.5365 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 15
M  V30 3 1 9 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 745831-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745831-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-9826435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient biocatalytic resolution of cis- and
trans-3-aminoindan-1-ol: Syntheses of enantiopure orthogonally protected
cis- and trans-indane-1,3-diamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lopez-Garcia, Monica; Alfonso, Ignacio; Gotor, Vicente
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2004), 10(12), 3006-3014

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N1-methyl-N1-phenyl-1,2-benzenediamine
C13H13ClN2
7485-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 N 6.6684 0.0000 0.0 0
M  V30 4 Cl 9.3358 4.6200 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 6.6684 1.5400 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 8.0021 2.3100 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-Chloro-2-(methylphenylamino)phenyl]formamide
C14H13ClN2O
613663-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 N 2.3100 5.3347 0.0 0
M  V30 4 C 0.7700 5.3347 0.0 0
M  V30 5 O 0.0000 6.6685 0.0 0
M  V30 6 Cl 2.3100 0.0000 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 4 5
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7485-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 613663-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6010282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SAR study of
2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepines as
progesterone receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dols, Paul P. M. A.; Folmer, Brigitte J. B.; Hamersma, Hans; Kuil, Cor
W.; Lucas, Hans; Ollero, Lourdes; Rewinkel, Jos B. M.; Hermkens, Pedro H.
H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(4), 1461-1467

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N1-methyl-N1-phenyl-1,2-benzenediamine
C13H13ClN2
7485-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 N 6.6684 0.0000 0.0 0
M  V30 4 Cl 9.3358 4.6200 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 6.6684 1.5400 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 8.0021 2.3100 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-Chloro-2-(methylphenylamino)phenyl]formamide
C14H13ClN2O
613663-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 N 2.3100 5.3347 0.0 0
M  V30 4 C 0.7700 5.3347 0.0 0
M  V30 5 O 0.0000 6.6685 0.0 0
M  V30 6 Cl 2.3100 0.0000 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 4 5
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7485-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 613663-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11058777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of non-steroidal dibenzopyridooxazepines,
dibenzopyridothiazepines, and dibenzopyridoazepines as progesterone
receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hermkens, Pedro Harold Han; Lucas, Hans; Dols, Paul Peter Marie Antonius;
Rewinkel, Johannes Bernardus Maria; Folmer, Brigitte Johanna Bernita
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003084963 A1 2003-10-16

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl (3-aminopropyl)carbamate
C8H18N2O2
75178-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-(formylamino)propyl]carbamate
C9H18N2O3
1345856-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 O 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75178-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345856-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-988002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1428443-59-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave similar results
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and convenient N-formylation protocol in water-containing solvents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aleiwi, Bilal A.; Mitachi, Katsuhiko; Kurosu, Michio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(16), 2077-2081

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Leucinol
C6H15NO
7533-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 N 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 O 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-1-(Hydroxymethyl)-3-methylbutyl]formamide
C7H15NO2
1161015-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0 CFG=1
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 2.6674 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 3.0800 0.0000 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 O 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7533-40-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1161015-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10405698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1428443-59-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave similar results
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and convenient N-formylation protocol in water-containing solvents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aleiwi, Bilal A.; Mitachi, Katsuhiko; Kurosu, Michio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(16), 2077-2081

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Difluoro-1,2-phenylenediamine
C6H6F2N2
76179-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Difluoro-1H-benzimidazole
C7H4F2N2
78581-99-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 0.0000 0.0 0
M  V30 2 F 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76179-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 78581-99-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24037073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave 79% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Di- and Trifluorinated 2-Azidobenzimidazole Derivatives: Synthesis,
Photooxygenation, and 19F NMR Prediction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kanitz, Nils E.; Fresia, Marvin; Jones, Peter G.; Lindel, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(25), 3573-3578

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1-(4-chlorophenyl)ethanone
C8H8ClNO
7644-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Chlorophenyl)-2-oxoethyl]formamide
C9H8ClNO2
3755-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 N 8.4702 1.3337 0.0 0
M  V30 5 C 9.2402 0.0000 0.0 0
M  V30 6 O 10.7802 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7644-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3755-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38328412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Hydroxy-beta-lactam derivatives as DHFS inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wencewicz, Timothy; Virgin-Downey, Brett
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20230322667 A1 2023-10-12

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Aminoanthraquinone
C14H9NO2
82-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 6.1600 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(9,10-Dihydro-9,10-dioxo-1-anthracenyl)amino]methylene]-1,3-dimethyl-2,4,...
C21H15N3O5
2178915-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7001 5.3348 0.0 0
M  V30 2 C 9.2401 5.3348 0.0 0
M  V30 3 O 5.3901 4.0011 0.0 0
M  V30 4 O 2.3100 9.3359 0.0 0
M  V30 5 O 12.3201 5.3348 0.0 0
M  V30 6 O 7.7001 2.6675 0.0 0
M  V30 7 C 13.8602 2.6675 0.0 0
M  V30 8 C 9.2401 0.0000 0.0 0
M  V30 9 O 12.3201 0.0000 0.0 0
M  V30 10 C 5.3901 6.6684 0.0 0
M  V30 11 C 4.6201 8.0022 0.0 0
M  V30 12 C 6.9301 6.6684 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 3.0800 8.0022 0.0 0
M  V30 15 C 5.3901 9.3359 0.0 0
M  V30 16 C 7.7001 8.0022 0.0 0
M  V30 17 C 3.0800 5.3348 0.0 0
M  V30 18 C 2.3100 6.6684 0.0 0
M  V30 19 C 6.9301 9.3359 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 0.7700 6.6684 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.0000 5.3348 0.0 0
M  V30 24 C 10.0101 4.0011 0.0 0
M  V30 25 C 11.5501 4.0011 0.0 0
M  V30 26 C 9.2401 2.6675 0.0 0
M  V30 27 N 12.3201 2.6675 0.0 0
M  V30 28 N 10.0101 1.3337 0.0 0
M  V30 29 C 11.5501 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 24
M  V30 4 2 3 13
M  V30 5 2 4 14
M  V30 6 2 5 25
M  V30 7 2 6 26
M  V30 8 1 7 27
M  V30 9 1 8 28
M  V30 10 2 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-45-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178915-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22131572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME267 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthylamine
C10H9N
91-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-5-[(2-naphthalenylamino)methylene]-2,4,6(1H,3H,5H)-pyrimidinetrione
C17H15N3O3
2178914-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 10.7800 5.3347 0.0 0
M  V30 9 C 11.5500 4.0011 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 11.5500 6.6685 0.0 0
M  V30 12 C 10.7800 2.6674 0.0 0
M  V30 13 C 13.0900 4.0011 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 13.0900 6.6685 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 13.8600 5.3347 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 3.8500 1.3338 0.0 0
M  V30 21 N 2.3100 4.0011 0.0 0
M  V30 22 N 2.3100 1.3338 0.0 0
M  V30 23 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 18
M  V30 4 2 3 19
M  V30 5 2 4 20
M  V30 6 1 5 21
M  V30 7 1 6 22
M  V30 8 2 7 23
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-59-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22140241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME268 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobiphenyl
C12H11N
92-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 2.6673 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[([1,1′-Biphenyl]-4-ylamino)methylene]-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimid...
C19H17N3O3
2178914-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 4.6200 5.3349 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 13.0900 4.0011 0.0 0
M  V30 21 C 13.8600 2.6674 0.0 0
M  V30 22 C 13.8600 5.3349 0.0 0
M  V30 23 C 15.4000 2.6674 0.0 0
M  V30 24 C 15.4000 5.3349 0.0 0
M  V30 25 C 16.1700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 8
M  V30 3 1 2 14
M  V30 4 2 3 9
M  V30 5 2 4 10
M  V30 6 1 5 11
M  V30 7 1 6 12
M  V30 8 2 7 13
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92-67-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178914-81-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22149940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer potential of aminomethylidene-diazinanes I. Synthesis of
arylaminomethylidene of diazinetriones and its cytotoxic effects tested
in glioblastoma cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pianovich, Nichole A.; Dean, Mathew; Lassak, Adam; Reiss, Krzysztof;
Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(19), 5068-5076

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [6-[(2-cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)amino]hex...
C42H63N3O5
774182-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 5.0297 0.0 0
M  V30 2 N 14.6708 4.2597 0.0 0
M  V30 3 O 13.3372 6.5698 0.0 0
M  V30 4 C 16.0045 5.0297 0.0 0
M  V30 5 C 17.3383 4.2597 0.0 0
M  V30 6 C 18.6720 5.0297 0.0 0
M  V30 7 C 20.0057 4.2597 0.0 0
M  V30 8 C 21.3393 5.0297 0.0 0
M  V30 9 C 22.6731 4.2597 0.0 0
M  V30 10 N 24.0068 5.0297 0.0 0
M  V30 11 C 25.3405 4.2597 0.0 0
M  V30 12 O 26.6742 5.0297 0.0 0
M  V30 13 O 25.3405 2.7197 0.0 0
M  V30 14 C 28.0080 4.2597 0.0 0
M  V30 15 C 27.2380 2.9261 0.0 0
M  V30 16 C 29.3416 3.4897 0.0 0
M  V30 17 C 28.7780 5.5934 0.0 0
M  V30 18 C 9.9868 7.1955 0.0 0
M  V30 19 O 8.0023 1.9497 0.0 0
M  V30 20 C 12.9933 0.0000 0.0 0
M  V30 21 C 11.0136 0.0000 0.0 0
M  V30 22 C 9.0913 7.6587 0.0 0
M  V30 23 C 5.3348 5.0297 0.0 0
M  V30 24 C 3.0112 10.0595 0.0 0
M  V30 25 C 4.9911 10.0595 0.0 0
M  V30 26 C 1.3337 5.7998 0.0 0
M  V30 27 N 0.0000 5.0297 0.0 0
M  V30 28 O 1.3337 8.8798 0.0 0
M  V30 29 C 12.0033 4.2597 0.0 0 CFG=1
M  V30 30 C 10.6697 3.4897 0.0 0 CFG=1
M  V30 31 C 12.0033 5.7998 0.0 0
M  V30 32 C 13.3372 3.4897 0.0 0
M  V30 33 C 9.3360 4.2597 0.0 0 CFG=1
M  V30 34 C 10.6697 1.9497 0.0 0
M  V30 35 C 10.6697 6.5698 0.0 0
M  V30 36 C 13.3372 1.9497 0.0 0
M  V30 37 C 9.3360 5.7998 0.0 0 CFG=1
M  V30 38 C 8.0023 3.4897 0.0 0
M  V30 39 C 12.0033 1.1797 0.0 0
M  V30 40 C 8.0023 6.5698 0.0 0 CFG=1
M  V30 41 C 6.6685 4.2597 0.0 0
M  V30 42 C 6.6685 5.7998 0.0 0
M  V30 43 C 8.0023 8.1098 0.0 0
M  V30 44 C 5.3348 6.5698 0.0 0 CFG=2
M  V30 45 C 6.6685 8.8798 0.0 0
M  V30 46 C 5.3348 8.1098 0.0 0 CFG=2
M  V30 47 C 4.0012 5.7998 0.0 0
M  V30 48 C 4.0012 8.8798 0.0 0
M  V30 49 C 2.6675 6.5698 0.0 0
M  V30 50 C 2.6675 8.1098 0.0 0
M  V30 51 H 9.5807 2.4008 0.0 0
M  V30 52 H 8.9374 2.7722 0.0 0
M  V30 53 H 5.3348 9.6499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 29 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 37 18 CFG=1
M  V30 19 2 19 38
M  V30 20 1 20 39
M  V30 21 1 21 39
M  V30 22 1 40 22 CFG=3
M  V30 23 1 44 23 CFG=3
M  V30 24 1 24 48
M  V30 25 1 25 48
M  V30 26 3 26 27
M  V30 27 1 26 49
M  V30 28 2 28 50
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 1 29 32
M  V30 32 1 30 33
M  V30 33 1 30 34
M  V30 34 1 30 51 CFG=3
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 1 33 38
M  V30 39 1 33 52 CFG=3
M  V30 40 1 34 39
M  V30 41 1 35 37
M  V30 42 1 36 39
M  V30 43 1 37 40
M  V30 44 1 38 41
M  V30 45 1 40 42
M  V30 46 1 40 43
M  V30 47 2 41 42
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 1 44 47
M  V30 52 1 45 46
M  V30 53 1 46 48
M  V30 54 1 46 53 CFG=1
M  V30 55 2 47 49
M  V30 56 1 48 50
M  V30 57 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 29 30 33 37 40 44 46)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-(6-aminohexyl)-2-cyano-3,12-dioxooleana-1,9(11)-di...
C37H55N3O3.CH2O2
774182-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 7.3398 0.0 0
M  V30 2 N 14.6708 6.5698 0.0 0
M  V30 3 O 13.3370 8.8798 0.0 0
M  V30 4 C 16.0045 7.3398 0.0 0
M  V30 5 C 17.3382 6.5698 0.0 0
M  V30 6 C 18.6718 7.3398 0.0 0
M  V30 7 C 20.0057 6.5698 0.0 0
M  V30 8 C 21.3393 7.3398 0.0 0
M  V30 9 C 22.6730 6.5698 0.0 0
M  V30 10 N 24.0067 7.3398 0.0 0
M  V30 11 C 9.9868 9.5055 0.0 0
M  V30 12 O 8.0022 4.2597 0.0 0
M  V30 13 C 12.9933 2.3100 0.0 0
M  V30 14 C 11.0134 2.3100 0.0 0
M  V30 15 C 8.8855 10.1414 0.0 0
M  V30 16 C 5.3348 7.3398 0.0 0
M  V30 17 C 3.0112 12.3695 0.0 0
M  V30 18 C 4.9909 12.3695 0.0 0
M  V30 19 C 1.3337 8.1098 0.0 0
M  V30 20 N 0.0000 7.3398 0.0 0
M  V30 21 O 1.3337 11.1899 0.0 0
M  V30 22 C 12.0033 6.5698 0.0 0 CFG=1
M  V30 23 C 10.6697 5.7997 0.0 0 CFG=1
M  V30 24 C 12.0033 8.1098 0.0 0
M  V30 25 C 13.3370 5.7997 0.0 0
M  V30 26 C 9.3358 6.5698 0.0 0 CFG=1
M  V30 27 C 10.6697 4.2597 0.0 0
M  V30 28 C 10.6697 8.8798 0.0 0
M  V30 29 C 13.3370 4.2597 0.0 0
M  V30 30 C 9.3358 8.1098 0.0 0 CFG=1
M  V30 31 C 8.0022 5.7997 0.0 0
M  V30 32 C 12.0033 3.4897 0.0 0
M  V30 33 C 8.0022 8.8798 0.0 0 CFG=1
M  V30 34 C 6.6685 6.5698 0.0 0
M  V30 35 C 6.6685 8.1098 0.0 0
M  V30 36 C 8.0022 10.4198 0.0 0
M  V30 37 C 5.3348 8.8798 0.0 0 CFG=2
M  V30 38 C 6.6685 11.1899 0.0 0
M  V30 39 C 5.3348 10.4198 0.0 0 CFG=2
M  V30 40 C 4.0010 8.1098 0.0 0
M  V30 41 C 4.0010 11.1899 0.0 0
M  V30 42 C 2.6673 8.8798 0.0 0
M  V30 43 C 2.6673 10.4198 0.0 0
M  V30 44 H 9.7863 4.5381 0.0 0
M  V30 45 H 8.6850 5.1740 0.0 0
M  V30 46 H 5.3348 11.9599 0.0 0
M  V30 47 C 12.0033 0.0000 0.0 0
M  V30 48 O 10.6697 0.7700 0.0 0
M  V30 49 O 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 22 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 30 11 CFG=1
M  V30 12 2 12 31
M  V30 13 1 13 32
M  V30 14 1 14 32
M  V30 15 1 33 15 CFG=3
M  V30 16 1 37 16 CFG=3
M  V30 17 1 17 41
M  V30 18 1 18 41
M  V30 19 3 19 20
M  V30 20 1 19 42
M  V30 21 2 21 43
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 1 23 44 CFG=3
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 26 31
M  V30 32 1 26 45 CFG=3
M  V30 33 1 27 32
M  V30 34 1 28 30
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 1 33 36
M  V30 40 2 34 35
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 37 40
M  V30 45 1 38 39
M  V30 46 1 39 41
M  V30 47 1 39 46 CFG=1
M  V30 48 2 40 42
M  V30 49 1 41 43
M  V30 50 1 42 43
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 22 23 26 30 33 37 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 774182-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 774182-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10730960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(6-Aminohexyl)-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-amide Formate
(9a). A solution of 8 (58 mg, 0.084 mmol) in 95% formic acid (1.7 mL) was
stirred at room temperature for 1 h. The formic acid was removed in
vacuo, and the residue was coevaporated with benzene (three times) to
yield 9a (53 mg, 100%) as a colorless glass.
N-(6-Aminohexyl)-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-amide Formate
(9a). yield (53 mg, 100%) 1H NMR (CD3OD):19 δ 8.41 (1H, s), 8.29 (2H,
brs), 7.81 (1H, t, J = 5.7 Hz), 6.13 (1H, s), 3.22 (2H, m), 3.14 (1H, d,
J = 4.4 Hz), 3.04 (1H, m), 2.92 (2H, t, J = 7.5 Hz), 1.52, 1.36, 1.25,
1.17, 1.06, 0.98, 0.90 (each 3H, s). 13C NMR (CD3OD): δ 201.8, 198.7,
180.1, 171.8, 168.6, 125.0, 115.9, 115.2, 48.6, 47.8, 47.3, 46.2, 44.2,
43.4, 40.7, 40.6, 37.2, 35.8, 35.2, 34.0, 32.9, 32.7, 31.7, 30.6, 29.0,
28.6, 27.6, 27.3, 27.2, 27.0, 25.5, 23.7, 23.5, 22.2, 19.3.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Biotin Conjugates of
2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic Acid for the Isolation of
the Protein Targets
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Honda, Tadashi; Janosik, Tomasz; Honda, Yukiko; Han, Jie; Liby, Karen T.;
Williams, Charlotte R.; Couch, Robin D.; Anderson, Amy C.; Sporn, Michael
B.; Gribble, Gordon W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(20), 4923-4932

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [6-[[4-[(2-cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)amino...
C46H70N4O6
774183-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 5.0297 0.0 0
M  V30 2 N 14.6707 4.2597 0.0 0
M  V30 3 O 13.3370 6.5698 0.0 0
M  V30 4 C 16.0045 5.0297 0.0 0
M  V30 5 C 17.3382 4.2597 0.0 0
M  V30 6 C 18.6718 5.0297 0.0 0
M  V30 7 C 20.0055 4.2597 0.0 0
M  V30 8 N 21.3393 5.0297 0.0 0
M  V30 9 O 20.0055 2.7197 0.0 0
M  V30 10 C 22.6730 4.2597 0.0 0
M  V30 11 C 24.0067 5.0297 0.0 0
M  V30 12 C 25.3403 4.2597 0.0 0
M  V30 13 C 26.6742 5.0297 0.0 0
M  V30 14 C 28.0078 4.2597 0.0 0
M  V30 15 C 29.3415 5.0297 0.0 0
M  V30 16 N 30.6752 4.2597 0.0 0
M  V30 17 C 32.0090 5.0297 0.0 0
M  V30 18 O 33.3427 4.2597 0.0 0
M  V30 19 O 32.0090 6.5698 0.0 0
M  V30 20 C 34.6763 5.0297 0.0 0
M  V30 21 C 33.9063 6.3634 0.0 0
M  V30 22 C 36.0100 5.7998 0.0 0
M  V30 23 C 35.4463 3.6961 0.0 0
M  V30 24 C 9.9868 7.1955 0.0 0
M  V30 25 O 8.0022 1.9497 0.0 0
M  V30 26 C 12.9933 0.0000 0.0 0
M  V30 27 C 11.0134 0.0000 0.0 0
M  V30 28 C 9.0911 7.6587 0.0 0
M  V30 29 C 5.3348 5.0297 0.0 0
M  V30 30 C 3.0111 10.0595 0.0 0
M  V30 31 C 4.9909 10.0595 0.0 0
M  V30 32 C 1.3337 5.7998 0.0 0
M  V30 33 N 0.0000 5.0297 0.0 0
M  V30 34 O 1.3337 8.8798 0.0 0
M  V30 35 C 12.0033 4.2597 0.0 0 CFG=1
M  V30 36 C 10.6697 3.4897 0.0 0 CFG=1
M  V30 37 C 12.0033 5.7998 0.0 0
M  V30 38 C 13.3370 3.4897 0.0 0
M  V30 39 C 9.3358 4.2597 0.0 0 CFG=1
M  V30 40 C 10.6697 1.9497 0.0 0
M  V30 41 C 10.6697 6.5698 0.0 0
M  V30 42 C 13.3370 1.9497 0.0 0
M  V30 43 C 9.3358 5.7998 0.0 0 CFG=1
M  V30 44 C 8.0022 3.4897 0.0 0
M  V30 45 C 12.0033 1.1797 0.0 0
M  V30 46 C 8.0022 6.5698 0.0 0 CFG=1
M  V30 47 C 6.6685 4.2597 0.0 0
M  V30 48 C 6.6685 5.7998 0.0 0
M  V30 49 C 8.0022 8.1098 0.0 0
M  V30 50 C 5.3348 6.5698 0.0 0 CFG=2
M  V30 51 C 6.6685 8.8798 0.0 0
M  V30 52 C 5.3348 8.1098 0.0 0 CFG=2
M  V30 53 C 4.0010 5.7998 0.0 0
M  V30 54 C 4.0010 8.8798 0.0 0
M  V30 55 C 2.6673 6.5698 0.0 0
M  V30 56 C 2.6673 8.1098 0.0 0
M  V30 57 H 9.5807 2.4008 0.0 0
M  V30 58 H 8.9373 2.7722 0.0 0
M  V30 59 H 5.3348 9.6499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 35 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 43 24 CFG=1
M  V30 25 2 25 44
M  V30 26 1 26 45
M  V30 27 1 27 45
M  V30 28 1 46 28 CFG=3
M  V30 29 1 50 29 CFG=3
M  V30 30 1 30 54
M  V30 31 1 31 54
M  V30 32 3 32 33
M  V30 33 1 32 55
M  V30 34 2 34 56
M  V30 35 1 35 36
M  V30 36 1 35 37
M  V30 37 1 35 38
M  V30 38 1 36 39
M  V30 39 1 36 40
M  V30 40 1 36 57 CFG=3
M  V30 41 1 37 41
M  V30 42 1 38 42
M  V30 43 1 39 43
M  V30 44 1 39 44
M  V30 45 1 39 58 CFG=3
M  V30 46 1 40 45
M  V30 47 1 41 43
M  V30 48 1 42 45
M  V30 49 1 43 46
M  V30 50 1 44 47
M  V30 51 1 46 48
M  V30 52 1 46 49
M  V30 53 2 47 48
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 1 50 53
M  V30 58 1 51 52
M  V30 59 1 52 54
M  V30 60 1 52 59 CFG=1
M  V30 61 2 53 55
M  V30 62 1 54 56
M  V30 63 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 35 36 39 43 46 50 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[4-[(6-aminohexyl)amino]-4-oxobutyl]-2-cyano-3,12-...
C41H62N4O4.CH2O2
774183-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 58 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3371 7.3397 0.0 0
M  V30 2 N 14.6708 6.5697 0.0 0
M  V30 3 O 13.3371 8.8798 0.0 0
M  V30 4 C 16.0044 7.3397 0.0 0
M  V30 5 C 17.3381 6.5697 0.0 0
M  V30 6 C 18.6719 7.3397 0.0 0
M  V30 7 C 20.0056 6.5697 0.0 0
M  V30 8 N 21.3392 7.3397 0.0 0
M  V30 9 O 20.0056 5.0297 0.0 0
M  V30 10 C 22.6729 6.5697 0.0 0
M  V30 11 C 24.0067 7.3397 0.0 0
M  V30 12 C 25.3404 6.5697 0.0 0
M  V30 13 C 26.6741 7.3397 0.0 0
M  V30 14 C 28.0077 6.5697 0.0 0
M  V30 15 C 29.3415 7.3397 0.0 0
M  V30 16 N 30.6752 6.5697 0.0 0
M  V30 17 C 9.9868 9.5055 0.0 0
M  V30 18 O 8.0023 4.2597 0.0 0
M  V30 19 C 12.9932 2.3100 0.0 0
M  V30 20 C 11.0134 2.3100 0.0 0
M  V30 21 C 8.8855 10.1414 0.0 0
M  V30 22 C 5.3348 7.3397 0.0 0
M  V30 23 C 3.0112 12.3695 0.0 0
M  V30 24 C 4.9911 12.3695 0.0 0
M  V30 25 C 1.3337 8.1098 0.0 0
M  V30 26 N 0.0000 7.3397 0.0 0
M  V30 27 O 1.3337 11.1898 0.0 0
M  V30 28 C 12.0033 6.5697 0.0 0 CFG=1
M  V30 29 C 10.6696 5.7997 0.0 0 CFG=1
M  V30 30 C 12.0033 8.1098 0.0 0
M  V30 31 C 13.3371 5.7997 0.0 0
M  V30 32 C 9.3360 6.5697 0.0 0 CFG=1
M  V30 33 C 10.6696 4.2597 0.0 0
M  V30 34 C 10.6696 8.8798 0.0 0
M  V30 35 C 13.3371 4.2597 0.0 0
M  V30 36 C 9.3360 8.1098 0.0 0 CFG=1
M  V30 37 C 8.0023 5.7997 0.0 0
M  V30 38 C 12.0033 3.4897 0.0 0
M  V30 39 C 8.0023 8.8798 0.0 0 CFG=1
M  V30 40 C 6.6685 6.5697 0.0 0
M  V30 41 C 6.6685 8.1098 0.0 0
M  V30 42 C 8.0023 10.4198 0.0 0
M  V30 43 C 5.3348 8.8798 0.0 0 CFG=2
M  V30 44 C 6.6685 11.1898 0.0 0
M  V30 45 C 5.3348 10.4198 0.0 0 CFG=2
M  V30 46 C 4.0011 8.1098 0.0 0
M  V30 47 C 4.0011 11.1898 0.0 0
M  V30 48 C 2.6675 8.8798 0.0 0
M  V30 49 C 2.6675 10.4198 0.0 0
M  V30 50 H 9.7863 4.5381 0.0 0
M  V30 51 H 8.6851 5.1740 0.0 0
M  V30 52 H 5.3348 11.9598 0.0 0
M  V30 53 C 15.3376 0.0000 0.0 0
M  V30 54 O 14.0039 0.7700 0.0 0
M  V30 55 O 16.6713 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 28 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 36 17 CFG=1
M  V30 18 2 18 37
M  V30 19 1 19 38
M  V30 20 1 20 38
M  V30 21 1 39 21 CFG=3
M  V30 22 1 43 22 CFG=3
M  V30 23 1 23 47
M  V30 24 1 24 47
M  V30 25 3 25 26
M  V30 26 1 25 48
M  V30 27 2 27 49
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 29 33
M  V30 33 1 29 50 CFG=3
M  V30 34 1 30 34
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 1 32 37
M  V30 38 1 32 51 CFG=3
M  V30 39 1 33 38
M  V30 40 1 34 36
M  V30 41 1 35 38
M  V30 42 1 36 39
M  V30 43 1 37 40
M  V30 44 1 39 41
M  V30 45 1 39 42
M  V30 46 2 40 41
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 1 44 45
M  V30 52 1 45 47
M  V30 53 1 45 52 CFG=1
M  V30 54 2 46 48
M  V30 55 1 47 49
M  V30 56 1 48 49
M  V30 57 1 53 54
M  V30 58 2 53 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 28 29 32 36 39 43 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 774183-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 774183-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10119643
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[3-(6-Aminohexyl)aminocarbonyl]propyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-amide
Formate (18a). A solution of 17 (490 mg, 0.63 mmol) in 95% formic acid (7
mL) was stirred at room temperature for 1 h. The formic acid was removed
in vacuo, and the residue was coevaporated with CH2Cl2 (three times) to
yield 18a (454 mg, 100%) as a colorless glass.
N-[3-(6-Aminohexyl)aminocarbonyl]propyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-amide
Formate (18a). yield (454 mg, 100%) 1H NMR (CD3OD):19 δ 8.35 (1H, s),
7.82 (1H, m), 6.06 (1H, s), 3.20-3.00 (5H, m), 2.97 (1H, m), 2.86 (2H, t,
J = 7.7 Hz), 2.15 (2H, t, J = 7.5 Hz) 1.49, 1.29, 1.18, 1.10, 0.99, 0.92,
0.84 (each 3H, s). 13C NMR (CD3OD): δ 201.9, 198.9, 180.3, 175.5, 171.8,
168.6, 125.0, 115.9, 115.2, 48.7, 47.8, 47.3, 46.2, 44.2, 43.4, 40.7,
40.5, 40.3, 37.2, 35.8, 35.2, 34.7, 34.0, 32.9, 32.7, 31.7, 30.3, 29.0,
28.6, 27.5, 27.3, 27.1, 27.0, 25.5, 23.7, 23.5, 22.2, 22.1, 19.3.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Biotin Conjugates of
2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic Acid for the Isolation of
the Protein Targets
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Honda, Tadashi; Janosik, Tomasz; Honda, Yukiko; Han, Jie; Liby, Karen T.;
Williams, Charlotte R.; Couch, Robin D.; Anderson, Amy C.; Sporn, Michael
B.; Gribble, Gordon W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(20), 4923-4932

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2R,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C12H21NO5
77450-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6439 5.3026 0.0 0
M  V30 2 O 2.1038 5.3026 0.0 0
M  V30 3 O 4.4139 6.6363 0.0 0
M  V30 4 C 1.3338 6.6363 0.0 0
M  V30 5 C 0.0000 5.8663 0.0 0
M  V30 6 C 0.5638 7.9700 0.0 0
M  V30 7 C 2.6675 7.4063 0.0 0
M  V30 8 C 6.9759 4.9524 0.0 0
M  V30 9 O 8.4824 4.6323 0.0 0
M  V30 10 O 6.5000 6.4170 0.0 0
M  V30 11 C 9.5128 5.7767 0.0 0
M  V30 12 C 11.0192 5.4565 0.0 0
M  V30 13 O 4.7710 0.0000 0.0 0
M  V30 14 N 4.4139 3.9690 0.0 0
M  V30 15 C 5.9455 3.8079 0.0 0 CFG=1
M  V30 16 C 3.7874 2.5620 0.0 0
M  V30 17 C 6.2656 2.3016 0.0 0
M  V30 18 C 4.9320 1.5316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 18 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2R,4S)-4-(formyloxy)-1,2-pyrrolidinedicarboxylate
C13H21NO6
664967-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.4640 0.0 0
M  V30 2 O 3.0800 7.7977 0.0 0
M  V30 3 O 3.0800 5.1304 0.0 0
M  V30 4 C 1.5400 7.7977 0.0 0
M  V30 5 C 1.5400 6.2577 0.0 0
M  V30 6 C 0.0000 7.7977 0.0 0
M  V30 7 C 1.5400 9.3377 0.0 0
M  V30 8 C 5.8194 3.7535 0.0 0
M  V30 9 O 6.8498 2.6091 0.0 0
M  V30 10 O 4.3129 3.4333 0.0 0
M  V30 11 C 6.3739 1.1444 0.0 0
M  V30 12 C 7.4043 0.0000 0.0 0
M  V30 13 O 9.0056 8.1392 0.0 0
M  V30 14 C 10.4126 7.5128 0.0 0
M  V30 15 O 11.6584 8.4180 0.0 0
M  V30 16 N 5.3900 6.4640 0.0 0
M  V30 17 C 6.2952 5.2181 0.0 0 CFG=1
M  V30 18 C 6.2952 7.7099 0.0 0
M  V30 19 C 7.7598 5.6940 0.0 0
M  V30 20 C 7.7598 7.2340 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 20 13 CFG=1
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77450-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 664967-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-9561993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1972-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, stereo-inversion, Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and stereoselective synthesis of four peptide nucleic acid
monomers with cyclic structures in backbone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Watanabe, Akiko; Kiyota, Naotoshi; Yamasaki, Tetsuo; Tanda, Kazuhiro;
Miyagoe, Tatsunori; Sakamoto, Masanori; Otsuka, Masami
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2011), 48(5), 1132-1139

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-Ursolic acid
C30H48O3
77-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 3.0800 6.6686 0.0 0
M  V30 5 C 5.5243 1.1333 0.0 0
M  V30 6 C 0.0000 6.6686 0.0 0
M  V30 7 C 6.7958 1.1333 0.0 0
M  V30 8 C 9.1058 5.5353 0.0 0
M  V30 9 C 12.9972 2.1408 0.0 0
M  V30 10 C 11.2827 1.1509 0.0 0
M  V30 11 O 13.8601 4.0011 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0 CFG=1
M  V30 13 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 14 C 3.0800 1.3338 0.0 0
M  V30 15 C 0.7700 2.6675 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 2.3100 5.3348 0.0 0 CFG=1
M  V30 18 C 4.6200 1.3338 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 C 5.3900 2.6675 0.0 0 CFG=1
M  V30 21 C 5.3900 5.3348 0.0 0
M  V30 22 C 0.7700 5.3348 0.0 0 CFG=2
M  V30 23 C 6.9301 2.6675 0.0 0 CFG=1
M  V30 24 C 6.9301 5.3348 0.0 0
M  V30 25 C 7.7001 4.0011 0.0 0 CFG=1
M  V30 26 C 7.7001 1.3338 0.0 0
M  V30 27 C 9.2401 4.0011 0.0 0 CFG=2
M  V30 28 C 9.2401 1.3338 0.0 0
M  V30 29 C 10.0101 2.6675 0.0 0 CFG=2
M  V30 30 C 10.0101 5.3348 0.0 0
M  V30 31 C 11.5501 2.6675 0.0 0
M  V30 32 C 11.5501 5.3348 0.0 0
M  V30 33 C 12.3201 4.0011 0.0 0 CFG=1
M  V30 34 H 3.8500 5.3348 0.0 0
M  V30 35 H 7.8344 5.5353 0.0 0
M  V30 36 H 10.7801 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 17 4 CFG=3
M  V30 5 1 20 5 CFG=1
M  V30 6 1 22 6 CFG=1
M  V30 7 1 23 7 CFG=3
M  V30 8 1 27 8 CFG=3
M  V30 9 1 9 31
M  V30 10 1 10 31
M  V30 11 1 33 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 34 CFG=3
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 30 1 25 27
M  V30 31 1 25 35 CFG=1
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 27 30
M  V30 35 1 28 29
M  V30 36 1 29 31
M  V30 37 1 29 36 CFG=1
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 12 13 17 20 22 23 25 27 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3β)-3-(Formyloxy)urs-12-en-28-oic acid
C31H48O4
6227-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 2.3101 0.0000 0.0 0
M  V30 4 C 3.0801 6.6687 0.0 0
M  V30 5 C 5.7887 1.1800 0.0 0
M  V30 6 C 0.0000 6.6687 0.0 0
M  V30 7 C 6.5316 1.1800 0.0 0
M  V30 8 C 8.8416 5.4887 0.0 0
M  V30 9 C 12.9974 2.1408 0.0 0
M  V30 10 C 11.2829 1.1509 0.0 0
M  V30 11 O 13.8603 4.0012 0.0 0
M  V30 12 C 14.6303 5.3348 0.0 0
M  V30 13 O 16.1704 5.3348 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0 CFG=1
M  V30 15 C 3.0801 4.0012 0.0 0 CFG=1
M  V30 16 C 3.0801 1.3338 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 4.6201 4.0012 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0 CFG=1
M  V30 20 C 4.6201 1.3338 0.0 0
M  V30 21 C 0.0000 4.0012 0.0 0
M  V30 22 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 23 C 5.3901 5.3348 0.0 0
M  V30 24 C 0.7700 5.3348 0.0 0 CFG=2
M  V30 25 C 6.9302 2.6675 0.0 0 CFG=1
M  V30 26 C 6.9302 5.3348 0.0 0
M  V30 27 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 28 C 7.7002 1.3338 0.0 0
M  V30 29 C 9.2402 4.0012 0.0 0 CFG=2
M  V30 30 C 9.2402 1.3338 0.0 0
M  V30 31 C 10.0102 2.6675 0.0 0 CFG=2
M  V30 32 C 10.0102 5.3348 0.0 0
M  V30 33 C 11.5503 2.6675 0.0 0
M  V30 34 C 11.5503 5.3348 0.0 0
M  V30 35 C 12.3203 4.0012 0.0 0 CFG=1
M  V30 36 H 3.8501 5.3348 0.0 0
M  V30 37 H 7.8345 5.5353 0.0 0
M  V30 38 H 10.7802 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 19 4 CFG=3
M  V30 5 1 22 5 CFG=1
M  V30 6 1 24 6 CFG=1
M  V30 7 1 25 7 CFG=3
M  V30 8 1 29 8 CFG=3
M  V30 9 1 9 33
M  V30 10 1 10 33
M  V30 11 1 11 12
M  V30 12 1 35 11 CFG=3
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 36 CFG=3
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 22
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 1 27 29
M  V30 33 1 27 37 CFG=1
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 29 32
M  V30 37 1 30 31
M  V30 38 1 31 33
M  V30 39 1 31 38 CFG=1
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 14 15 19 22 24 25 27 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77-52-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6227-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40738789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6192-52-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sustainable methods for the carboxymethylation and methylation of ursolic
acid with dimethyl carbonate under mild and acidic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kadsanit, Nuttapong; Worsawat, Pattamabhorn; Sakonsinsiri, Chadamas;
McElroy, Con R.; Macquarrie, Duncan; Noppawan, Pakin; Hunt, Andrew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2024), 14(24), 16921-16934

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Choline bicarbonate
C5H14NO.CHO3
78-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6950 6.1600 0.0 0
M  V30 2 O 1.3613 6.9301 0.0 0
M  V30 3 O 4.0287 6.9301 0.0 0 CHG=-1
M  V30 4 O 2.6950 4.6200 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 N 1.5400 1.5400 0.0 0 CHG=1 VAL=4
M  V30 7 C 3.8500 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 1.5400 3.0800 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 1 5 7
M  V30 6 1 6 8
M  V30 7 1 6 9
M  V30 8 1 6 10
M  V30 9 1 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, formate (1:1)
C5H14NO.CHO2
83687-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6950 4.6200 0.0 0
M  V30 2 O 1.3613 5.3900 0.0 0 CHG=-1
M  V30 3 O 4.0287 5.3900 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 N 1.5400 1.5400 0.0 0 CHG=1 VAL=4
M  V30 6 C 3.8500 2.8736 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.5400 3.0800 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 7 1 5 9
M  V30 8 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83687-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-18166000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product is an ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fast and efficient extraction of DNA from meat and meat derived products
using aqueous ionic liquid buffer systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ressmann, Anna K.; Garcia, Eric Gonzalez; Khlan, Diana; Gaertner, Peter;
Mach, Robert L.; Krska, Rudolf; Brunner, Kurt; Bica, Katharina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2015), 39(6), 4994-5002

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Choline bicarbonate
C5H14NO.CHO3
78-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6950 6.1600 0.0 0
M  V30 2 O 1.3613 6.9301 0.0 0
M  V30 3 O 4.0287 6.9301 0.0 0 CHG=-1
M  V30 4 O 2.6950 4.6200 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 N 1.5400 1.5400 0.0 0 CHG=1 VAL=4
M  V30 7 C 3.8500 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 1.5400 3.0800 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 1 5 7
M  V30 6 1 6 8
M  V30 7 1 6 9
M  V30 8 1 6 10
M  V30 9 1 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, formate (1:1)
C5H14NO.CHO2
83687-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6950 4.6200 0.0 0
M  V30 2 O 1.3613 5.3900 0.0 0 CHG=-1
M  V30 3 O 4.0287 5.3900 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 N 1.5400 1.5400 0.0 0 CHG=1 VAL=4
M  V30 6 C 3.8500 2.8736 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.5400 3.0800 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 7 1 5 9
M  V30 8 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83687-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-18210414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct extraction of genomic DNA from maize with aqueous ionic liquid
buffer systems for applications in genetically modified organisms
analysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gonzalez Garcia, Eric; Ressmann, Anna K.; Gaertner, Peter; Zirbs, Ronald;
Mach, Robert L.; Krska, Rudolf; Bica, Katharina; Brunner, Kurt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical and Bioanalytical Chemistry (2014), 406(30), 7773-7784

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(Phenylmethoxy)amino]methyl]heptanoic acid
C15H23NO3
791590-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 10.0100 1.3338 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 O 11.5500 1.3338 0.0 0
M  V30 10 O 9.2400 0.0000 0.0 0
M  V30 11 C 12.3200 5.3347 0.0 0
M  V30 12 C 13.8600 5.3347 0.0 0
M  V30 13 C 14.6300 6.6685 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[Formyl(phenylmethoxy)amino]methyl]heptanoic acid
C16H23NO4
791590-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 N 6.6685 4.6201 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 O 5.3348 5.3901 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 C 12.0033 3.0801 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 O 8.0022 6.9302 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 15 C 14.6707 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 7.7002 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 16
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 791590-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 791590-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14316452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 6. 2-[(Benzyloxyformylamino)methyl]heptanoic acid. To a cold
solution of 2-(benzyloxyaminomethyl)heptanoic acid (1.57 g, 5.92 mmol) in
HCO2H (29 mL) and dichloromethane (29 mL) was added acetic anhydride (5.9
mL, 62.75 mmol) at 0 °C. The mixture was stirred at 0 °C for 3 hours.
Thevolatileswere removed by evaporation under vacuum. Dichloromethane
(50mL) was added to the residue, and the solution was washed with brine,
and dried over MgSO4. Filtration and evaporation under vacuum provided
the title compound. Yield 1.73 g, 100%. 1H NMR (400 MHz, CHCl3) δ 8.07
(br s, 1H), 7.29 (m, 5H), 4.91-4.71 (m, 2H), 3.76 (m, 2H), 2.67 (m, 1H),
1.54 (m, 1H), 1.41(m, 1H), 1.20 (m, 6H), 0.80 (t, J = 7.0 Hz, 3H). MH+
294.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peptide deformylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christensen, Siegfried B., IV; Cummings, Maxwell D.; Lee, Jinhwa; Xiang,
Jia-Ning
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004098584 A1 2004-11-18

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiosemicarbazide
CH5N3S
79-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 2.6673 2.3101 0.0 0
M  V30 3 N 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 N 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Formylhydrazinecarbothioamide
C2H5N3OS
2302-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0
M  V30 4 N 0.0000 2.3100 0.0 0
M  V30 5 S 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2302-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5721017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of novel thiazolidinone derivatives
as potential anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Jie; Wang, Yi; Wei, Xiaoyan; Wu, Xixi; Chen, Gaozhi; Cao, Gaozhong;
Shen, Xueqian; Zhang, Xiuhua; Tang, Qinqin; Liang, Guang; Li, Xiaokun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 64292-301

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,3,3-Tetramethylguanidine
C5H13N3
80-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,3,3-Tetramethylguanidine formate
C5H13N3.CH2O2
56580-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 N 1.3338 4.6200 0.0 0
M  V30 4 N 2.6674 2.3100 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 C 5.3349 3.8500 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 1.3338 6.1600 0.0 0
M  V30 9 C 2.6674 0.0000 0.0 0
M  V30 10 O 1.3338 0.7700 0.0 0
M  V30 11 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 9 10
M  V30 9 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56580-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25261819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, product is an ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fast and efficient extraction of DNA from meat and meat derived products
using aqueous ionic liquid buffer systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ressmann, Anna K.; Garcia, Eric Gonzalez; Khlan, Diana; Gaertner, Peter;
Mach, Robert L.; Krska, Rudolf; Brunner, Kurt; Bica, Katharina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2015), 39(6), 4994-5002

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cholic acid
C24H40O5
81-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 C 3.3501 4.4757 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 6.6684 7.7000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 16 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 17 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 18 C 9.4667 3.3740 0.0 0
M  V30 19 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 10.3720 4.6200 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 26 C 2.6673 3.8500 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3336 3.0800 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 30 H 7.7573 1.9909 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 4.2458 4.9390 0.0 0
M  V30 33 H 10.8004 6.6359 0.0 0
M  V30 34 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 17 2 CFG=1
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 11 CFG=3
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=3
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 32 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 19 26
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 22 24
M  V30 32 1 22 33 CFG=3
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 13 14 15 16 17 19 22 23 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,7α,12α)-3,7,12-Tris(formyloxy)cholan-24-oic acid
C27H40O8
2097-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 10.8305 8.4616 0.0 0
M  V30 5 C 6.0176 6.0158 0.0 0
M  V30 6 O 9.3357 9.2401 0.0 0
M  V30 7 C 8.0021 10.0101 0.0 0
M  V30 8 O 8.0021 11.5501 0.0 0
M  V30 9 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 10 C 12.4130 10.0586 0.0 0
M  V30 11 C 9.9762 8.9737 0.0 0
M  V30 12 C 11.7865 11.4656 0.0 0
M  V30 13 C 12.6917 12.7114 0.0 0
M  V30 14 O 12.0654 14.1182 0.0 0
M  V30 15 O 14.2233 12.5505 0.0 0
M  V30 16 O 2.6673 2.3100 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 O 0.0000 2.3100 0.0 0
M  V30 19 C 9.3357 4.6200 0.0 0 CFG=2
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 21 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 22 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 23 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 24 C 12.1341 4.9140 0.0 0
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9301 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 29 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 30 C 13.0393 6.1601 0.0 0
M  V30 31 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 32 C 5.3348 5.3901 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 4.0010 4.6200 0.0 0
M  V30 35 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 36 H 10.4247 3.5309 0.0 0
M  V30 37 H 11.2213 3.9523 0.0 0
M  V30 38 H 6.9131 6.4790 0.0 0
M  V30 39 H 13.4677 8.1759 0.0 0
M  V30 40 H 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 28 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 28
M  V30 36 1 27 31
M  V30 37 1 29 30
M  V30 38 1 29 39 CFG=3
M  V30 39 1 31 33
M  V30 40 1 31 40 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 28 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21371093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azobenzene-bridged bile acid dimers: an interesting class of conjugates
with conformation-controlled bioactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Weina; Li, Yan; Yin, Xianpeng; Liang, Yun; Li, Jian; Wang, Chen; Lan,
Yue; Wang, Hui; Ju, Yong; Li, Guangtao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(23), 2539-2543

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cholic acid
C24H40O5
81-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 C 3.3501 4.4757 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 6.6684 7.7000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 16 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 17 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 18 C 9.4667 3.3740 0.0 0
M  V30 19 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 10.3720 4.6200 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 26 C 2.6673 3.8500 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3336 3.0800 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 30 H 7.7573 1.9909 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 4.2458 4.9390 0.0 0
M  V30 33 H 10.8004 6.6359 0.0 0
M  V30 34 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 17 2 CFG=1
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 11 CFG=3
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=3
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 32 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 19 26
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 22 24
M  V30 32 1 22 33 CFG=3
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 13 14 15 16 17 19 22 23 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,7α,12α)-3,7,12-Tris(formyloxy)cholan-24-oic acid
C27H40O8
2097-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 10.8305 8.4616 0.0 0
M  V30 5 C 6.0176 6.0158 0.0 0
M  V30 6 O 9.3357 9.2401 0.0 0
M  V30 7 C 8.0021 10.0101 0.0 0
M  V30 8 O 8.0021 11.5501 0.0 0
M  V30 9 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 10 C 12.4130 10.0586 0.0 0
M  V30 11 C 9.9762 8.9737 0.0 0
M  V30 12 C 11.7865 11.4656 0.0 0
M  V30 13 C 12.6917 12.7114 0.0 0
M  V30 14 O 12.0654 14.1182 0.0 0
M  V30 15 O 14.2233 12.5505 0.0 0
M  V30 16 O 2.6673 2.3100 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 O 0.0000 2.3100 0.0 0
M  V30 19 C 9.3357 4.6200 0.0 0 CFG=2
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 21 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 22 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 23 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 24 C 12.1341 4.9140 0.0 0
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9301 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 29 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 30 C 13.0393 6.1601 0.0 0
M  V30 31 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 32 C 5.3348 5.3901 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 4.0010 4.6200 0.0 0
M  V30 35 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 36 H 10.4247 3.5309 0.0 0
M  V30 37 H 11.2213 3.9523 0.0 0
M  V30 38 H 6.9131 6.4790 0.0 0
M  V30 39 H 13.4677 8.1759 0.0 0
M  V30 40 H 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 28 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 28
M  V30 36 1 27 31
M  V30 37 1 29 30
M  V30 38 1 29 39 CFG=3
M  V30 39 1 31 33
M  V30 40 1 31 40 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 28 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-13509189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Step 1) Preparation of 3 α ,7 α ,12 α -triformyloxy-5 β -cholic acid A
mixture of 2.05 g (5 mmol) of cholic acid and 2 drops of 70% HClO4 in 8
mL of 98% formic acid was stirred at 40-50°C. for 1.5 h. After the
mixture was allowed to cool to 35°C , Ac2O was added slowly to let the
temperature of the solution maintained between 40-45°C. until a large
quantity of bubbles appeared. After the solution was poured into 80 mL of
water, the precipitate was filtered, washed with water, and dried to give
2.46 g (100%) of the desired compound as white powder. 3 α ,7 α ,12 α
-triformyloxy-5 β -cholic acid, yield 2.46 g, 100%. C27H40O8; TLC
(acetoorne:n-hexarie=1:1) Rf, 0.55; mp 206-208°C ; 1H NMR (300 MHz,
CDCl3) δ 12.0 (br m, 1H), 8.15 (s, 1H), 8.09 (s, 1H), 8.01 (s, 1H), 5.25
(s, 1H, 12-CH), 5.06 (s, 1H, 7-CH), 4.70 (br, 1H, 3-CH), 2.41-0.75 (m,
33H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of cholanic acid ring based 4-(trifluoroacetyl)phenyl
derivatives for use as host material in host-guest chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chu, Junho; Pyun, Hyung Jung; Yoon, In Jun; Shin, Jae Ho; Nam, Hakhyun;
Cha, Geun Sig
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6177417 B1 2001-01-23

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-2-octanone
C8H16O2
82150-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formyloxy)-2-octanone
C9H16O3
1182266-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 C 3.8500 1.3338 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 O 2.3100 1.3338 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82150-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1182266-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-18242622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formic acid 1-(2-oxo-propyl)-pentyl ester [33]: General protocol for
synthesis of formates: A mixture of beta-hydroxyketone and formic acid
was stirred at 65 degC for 2 hr. After cooling the reaction mixture to
room temperature, diethylether was added and the mixture was washed with
ice-cold aqueous NaHCO3 sat., extracted with diethylether, dried over
Na2SO4 and concentrated in vacuo. Product 33 was prepared according to
the general protocol for synthesis of formates. Reaction conditions:
4-Hydroxyoctane-2-one 21 (300 mg, 2.1 mmol), formic acid (15 mL). The
crude product 33 was obtained as yellow oil in 100 % yield in 50 % purity
(GC/MS) and was not purified. Yield: 353 mg (100 %) 50 % purity (GC/MS),
yellow oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biooxidation of Polycyclic and Linear Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lengar, Alenka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2008), (20140701), No pp.

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[(Phenylmethoxy)amino]methyl]cyclohexanecarboxylic acid
C15H21NO3
828271-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1670 2.5065 0.0 0
M  V30 2 N 4.9370 3.8402 0.0 0
M  V30 3 O 6.4770 3.8402 0.0 0
M  V30 4 C 7.2470 5.1738 0.0 0
M  V30 5 C 2.8943 0.9899 0.0 0
M  V30 6 O 4.3414 0.4631 0.0 0
M  V30 7 O 1.7146 0.0000 0.0 0
M  V30 8 C 2.6270 2.5065 0.0 0
M  V30 9 C 2.8943 4.0231 0.0 0
M  V30 10 C 1.1798 1.9797 0.0 0
M  V30 11 C 1.7146 5.0130 0.0 0
M  V30 12 C 0.0000 2.9696 0.0 0
M  V30 13 C 0.2675 4.4862 0.0 0
M  V30 14 C 8.7870 5.1738 0.0 0
M  V30 15 C 9.5570 6.5075 0.0 0
M  V30 16 C 9.5570 3.8402 0.0 0
M  V30 17 C 11.0970 6.5075 0.0 0
M  V30 18 C 11.0970 3.8402 0.0 0
M  V30 19 C 11.8670 5.1738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[Formyl(phenylmethoxy)amino]methyl]cyclohexanecarboxylic acid
C16H21NO4
828271-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1670 2.5065 0.0 0
M  V30 2 N 4.9370 3.8402 0.0 0
M  V30 3 O 6.4770 3.8402 0.0 0
M  V30 4 C 4.1670 5.1739 0.0 0
M  V30 5 C 7.2470 5.1739 0.0 0
M  V30 6 O 4.9370 6.5075 0.0 0
M  V30 7 C 2.8943 0.9899 0.0 0
M  V30 8 O 4.3415 0.4631 0.0 0
M  V30 9 O 1.7147 0.0000 0.0 0
M  V30 10 C 2.6270 2.5065 0.0 0
M  V30 11 C 2.8943 4.0232 0.0 0
M  V30 12 C 1.1798 1.9797 0.0 0
M  V30 13 C 1.7147 5.0131 0.0 0
M  V30 14 C 0.0000 2.9696 0.0 0
M  V30 15 C 0.2675 4.4862 0.0 0
M  V30 16 C 8.7871 5.1739 0.0 0
M  V30 17 C 9.5571 3.8402 0.0 0
M  V30 18 C 9.5571 6.5075 0.0 0
M  V30 19 C 11.0971 3.8402 0.0 0
M  V30 20 C 11.0971 6.5075 0.0 0
M  V30 21 C 11.8671 5.1739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 828271-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 828271-14-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6600208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-[(Benzyloxy-formyl-amino)-methyl]-cyclohexanecarboxylic acid: To a cold
solution of formic acid (15.3 mL, 0.4 mol) in dichloromethane (100 mL) at
0°C under a nitrogen atmosphere was added acetic anhydride (5.75 mL, 60
mmol). After 1 h, a solution of
1-(benzyloxyamino-methyl)-cyclohexanecarboxylic acid from Preparation 19
(4.41 mmol theoretical) in dichloromethane (50 mL) was added. The mixture
was stirred at room temperature for 18 h and was concentrated in vacuo.
Brine (100 mL) was added and the mixture was extracted with
dichloromethane (100mL x 2). The combined organic extracts were dried
(MgSO4) and were evaporated in vacuo to yield the title compound as a
pale, orange oil (1.77 g, 100%). MH+ 292.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroarylhydrazinocarbonylcarbocycles as peptide
deformylase (PDF) inhibitors useful as antibacterials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aubart, Kelly M.; Christensen, Siegfried Benjamin, IV; Duraiswami, Chaya;
Karpinski, Joseph M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005005456 A2 2005-01-20

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21387300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azobenzene-bridged bile acid dimers: an interesting class of conjugates
with conformation-controlled bioactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Weina; Li, Yan; Yin, Xianpeng; Liang, Yun; Li, Jian; Wang, Chen; Lan,
Yue; Wang, Hui; Ju, Yong; Li, Guangtao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(23), 2539-2543

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(3,4-Dichlorophenyl)propyl]glycine methyl ester
C12H15Cl2NO2
847448-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 N 6.6685 3.0801 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 O 10.6697 2.3101 0.0 0
M  V30 8 O 9.3360 4.6201 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 Cl 0.0000 2.3101 0.0 0
M  V30 11 Cl 0.0000 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(3,4-Dichlorophenyl)propyl]-N-formylglycine methyl ester
C13H15Cl2NO3
847448-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 6.1600 5.3347 0.0 0
M  V30 3 C 3.8500 6.6685 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 6.9300 6.6685 0.0 0
M  V30 6 C 2.3100 6.6685 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 O 6.1600 8.0021 0.0 0
M  V30 9 O 9.2400 2.6674 0.0 0
M  V30 10 O 9.2400 5.3347 0.0 0
M  V30 11 C 10.7800 2.6674 0.0 0
M  V30 12 Cl 0.0000 2.6674 0.0 0
M  V30 13 Cl 1.5400 0.0000 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 1.5400 2.6674 0.0 0
M  V30 18 C 3.8500 1.3336 0.0 0
M  V30 19 C 2.3100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 12 17
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847448-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847448-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8844695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1330-20-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Mercaptoimidazoles, a new class of potent CCR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Lommen, Guy; Doyon, Julien; Coesemans, Erwin; Boeckx, Staf; Cools,
Marina; Buntinx, Mieke; Hermans, Bart; Van Wauwe, Jean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(3), 497-500

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-[1-methyl-2-(phenylthio)ethyl]benzeneethanamine
C17H20BrNS
848772-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3358 3.0801 0.0 0
M  V30 6 C 8.0022 0.7700 0.0 0
M  V30 7 S 10.6697 2.3101 0.0 0
M  V30 8 Br 1.3337 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 12.0033 3.0801 0.0 0
M  V30 16 C 13.3370 2.3101 0.0 0
M  V30 17 C 12.0033 4.6201 0.0 0
M  V30 18 C 14.6707 3.0801 0.0 0
M  V30 19 C 13.3370 5.3901 0.0 0
M  V30 20 C 14.6707 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 15
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(2-Bromophenyl)ethyl]-N-[1-methyl-2-(phenylthio)ethyl]formamide
C18H20BrNOS
848772-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 9.3358 3.0801 0.0 0
M  V30 7 C 8.0022 0.7700 0.0 0
M  V30 8 O 5.3348 5.3901 0.0 0
M  V30 9 S 10.6697 2.3101 0.0 0
M  V30 10 Br 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 13.3370 2.3101 0.0 0
M  V30 20 C 13.3370 5.3901 0.0 0
M  V30 21 C 14.6707 3.0801 0.0 0
M  V30 22 C 14.6707 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 9 17
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848772-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 848772-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10625357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7529-22-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N-[2-(2-Bromophenyl)ethyl]-N-(2-phenylthioethyl)formamide (11a). To a
stirred solution of formic acid (581 mg, 12.6 mmol) in CH2Cl2 (20 mL) was
added EDC (1.82 g, 9.47 mmol) at 0 °C, and the mixture was stirred at the
same temperature for 15 min. To the mixture was added a solution of 9
(1.06 g, 3.16 mmol) and N-methylmorpholine (639 mg, 6.31 mmol) in CH2Cl2
(20 mL), and the mixture was stirred at the same temperature for 1 h.
Compound 9 was not consumed, and therefore EDC (605 mg, 3.16 mmol) was
added to the mixture, and the mixture was stirred for 1 h. The reaction
mixture was washed with brine, dried (MgSO4), and concentrated. The
residue was chromatographed on silica gel (hexane/AcOEt, 6:1→5:1→4:1) to
give 11a (1.05 g, 91%) as a colorless oil:
N-[2-(2-Bromophenyl)ethyl]-N-(1-methyl-2-phenylthioethyl)formamide (12a).
Using a procedure similar to that for the preparation of 11a, compound 10
(1.10 g, 3.14 mmol) was treated with formic acid (577 mg, 12.6 mmol), EDC
(3.64 g, 22.0 mmol), and N-methylmorpholine (636 mg, 6.31 mmol) in CH2Cl2
(40 mL). After work-up, the crude material was purified by chromatography
on silica gel (hexane/AcOEt, 6:1→ 4:1) to give 12a (1.12 g, 100%) as a
colorless oil: colorless oil: IR (CHCl3) ν 1665 cm-1; 1H NMR (270 MHz,
CDCl3) δ 1.27 (3/4 x 3 H, d, J = 6.8 Hz), 1.43 (1/4 H x 3 H, d, J = 6.8
Hz), 2.92-3.16 (3/4 x 6 H, m), 3.22-3.43 (1/4 x 6 H, m), 3.63 (3/4 H,
sextet like, J = 6.9 Hz), 4.14 (1/4 H, sextet like, J = 6.9 Hz),
7.05-7.40 (9 H, m), 8.048 (3/4 H, s), 8.055 (1/4 H, s); 13C NMR (67.8
MHz, CDCl3) δ 17.7, 19.2, 34.7, 37.6, 38.2, 39.3, 40.8, 46.5, 50.4, 53.5,
124.3, 126.3, 126.8, 127.7, 127.8, 128.3, 128.7, 129.0, 129.2, 129.6,
130.1, 131.0, 131.5, 132.7, 133.1, 134.8, 138.3, 163.1, 163.3. 1H and 13C
NMR spectra of 12a showed it to be a mixture of rotamers. Anal. Calcd for
C18H20BrNOS: C, 57.14; H, 5.33; N, 3.70. Found: C, 56.80; H, 5.30; N,
3.74.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-endo Selective Aryl Radical Cyclization onto Enamides Leading to
3-Benzazepines: Concise Construction of a Cephalotaxine Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taniguchi, Tsuyoshi; Ishita, Atsuko; Uchiyama, Masahiko; Tamura, Osamu;
Muraoka, Osamu; Tanabe, Genzoh; Ishibashi, Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(5), 1922-1925

$RFMT $RIREG SCHEME283 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1R)-2-[(1,1-Dimethylethyl)amino]-2-oxo-1-phenylethyl]-D-leucine
C18H28N2O3
855588-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=2
M  V30 2 N 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 3.0801 6.6685 0.0 0 CFG=1
M  V30 5 N 5.3901 2.6675 0.0 0
M  V30 6 O 3.0801 4.0012 0.0 0
M  V30 7 C 2.3101 5.3348 0.0 0
M  V30 8 C 2.3101 8.0023 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 0.7700 5.3348 0.0 0
M  V30 11 O 0.7700 8.0023 0.0 0
M  V30 12 O 3.0801 9.3360 0.0 0
M  V30 13 C 5.9538 0.5637 0.0 0
M  V30 14 C 3.8501 0.0000 0.0 0
M  V30 15 C 3.2864 2.1037 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 18 C 6.9302 5.3348 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 7.7002 4.0012 0.0 0
M  V30 21 C 9.2402 6.6685 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-[(1,1-Dimethylethyl)amino]-2-oxo-1-phenylethyl]-D-leucine
C18H28N2O3
855588-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 N 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 3.0801 6.6685 0.0 0 CFG=1
M  V30 5 N 5.3901 2.6675 0.0 0
M  V30 6 O 3.0801 4.0012 0.0 0
M  V30 7 C 2.3101 5.3348 0.0 0
M  V30 8 C 2.3101 8.0023 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 0.7700 5.3348 0.0 0
M  V30 11 O 0.7700 8.0023 0.0 0
M  V30 12 O 3.0801 9.3360 0.0 0
M  V30 13 C 3.2864 2.1037 0.0 0
M  V30 14 C 3.8501 0.0000 0.0 0
M  V30 15 C 5.9538 0.5637 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 18 C 6.9302 5.3348 0.0 0
M  V30 19 C 7.7002 4.0012 0.0 0
M  V30 20 C 7.7002 6.6685 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0
M  V30 22 C 9.2402 6.6685 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[2-[(1,1-Dimethylethyl)amino]-2-oxo-1-phenylethyl]-N-formyl-D-leucine
C19H28N2O4
855588-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=3
M  V30 2 N 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 3.0801 6.6685 0.0 0 CFG=1
M  V30 5 C 5.3901 8.0023 0.0 0
M  V30 6 N 5.3901 2.6675 0.0 0
M  V30 7 O 3.0801 4.0012 0.0 0
M  V30 8 C 2.3101 5.3348 0.0 0
M  V30 9 C 2.3101 8.0023 0.0 0
M  V30 10 O 4.6201 9.3360 0.0 0
M  V30 11 C 4.6201 1.3337 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 O 0.7700 8.0023 0.0 0
M  V30 14 O 3.0801 9.3360 0.0 0
M  V30 15 C 5.9538 0.5637 0.0 0
M  V30 16 C 3.8501 0.0000 0.0 0
M  V30 17 C 3.2864 2.1037 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 20 C 6.9302 5.3348 0.0 0
M  V30 21 C 7.7002 4.0012 0.0 0
M  V30 22 C 7.7002 6.6685 0.0 0
M  V30 23 C 9.2402 4.0012 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8 CFG=3
M  V30 9 1 4 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 1 12 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 855588-11-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 855588-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 855588-13-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14434888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2R)-2-[[(1S)-2-(t-Butylamino)-2-oxo-1-phenylethyl]-
(formyl)amino]-4-methylpentanoic Acid (19). To a solution of acetic
anhydride (0.102 g) in dichloromethane (3 mL) was added formic acid
(0.046 g) and pyridine (0.079 g), and the reaction mixture was stirred
under nitrogen at ambient temperature for 20 min. To this was added
(2R)-2-{[2-(tbutylamino)- 2-oxo-1-phenylethyl]amino}-4-methylpentanoic
acid (17) (0.10 g) and triethylamine (0.031 g). After 3 h, the reaction
mixture was separated between dichloromethane and 1 N hydrochloric acid
solution. The organic phase was dried using a hydrophobic frit and
evaporated in vacuo to give (2R)-2-
[[(1S)-2-(t-butylamino)-2-oxo-1-phenylethyl](formyl)amino]-4-
methylpentanoic acid (19) as an off-white solid (0.108 g, 100%).
(2R)-2-[[(1S)-2-(t-Butylamino)-2-oxo-1-phenylethyl]-
(formyl)amino]-4-methylpentanoic Acid (19), yield (0.108 g, 100%). 1H NMR
(d6-DMS0) 13.10 (s, 1H), 8.29 (s, 1H), 7.44 (m, 1H), 7.38 (m, 1H), 7.32
(m, 1H), 5.34 (s, 1H), 5.15 (dd, 1H, J = 5,9 Hz), 1.70-1.51 (m, 3H), 1.31
(s, 9H), 0.87 (d, 3H, J = 6 Hz), 0.86 (d, 3H, J = 6 Hz); 13C NMR 20.2,
21.6, 22.5, 26.8, 36.9, 49.3, 50.6, 58.7, 126.4, 126.5, 127.2, 136.7,
162.6, 167.6, 171.6; LCMS m/z 349 (MH+) (tr 3.13 min); HRMS calcd for
C19H29N2O4 (MH+) 349.2127, found 349.2127; HPLC 99% (tr = 12.0 min).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Short and Novel Stereospecific Synthesis of Trisubstituted
2,5-Diketopiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sollis, Steven L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(12), 4735-4740

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[4-[4-(Morpholin-4-yl)piperidin-1-yl]phenyl]amine
C15H23N3O
867291-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 1.3337 0.0 0
M  V30 2 N 7.7002 1.3337 0.0 0
M  V30 3 C 6.9302 2.6673 0.0 0
M  V30 4 C 6.9302 0.0000 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 10.0102 0.0000 0.0 0
M  V30 10 C 10.0102 2.6673 0.0 0
M  V30 11 C 11.5503 0.0000 0.0 0
M  V30 12 C 11.5503 2.6673 0.0 0
M  V30 13 C 12.3203 1.3337 0.0 0
M  V30 14 N 3.0801 1.3337 0.0 0
M  V30 15 C 2.3101 2.6673 0.0 0
M  V30 16 C 2.3101 0.0000 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 19 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 7 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[4-(4-Morpholinyl)-1-piperidinyl]phenyl]formamide
C16H23N3O2
2766158-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 1.3337 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 16.1704 2.6673 0.0 0
M  V30 4 N 7.7002 1.3337 0.0 0
M  V30 5 C 6.9302 0.0000 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 5.3901 0.0000 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 9.2402 1.3337 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 11.5503 2.6673 0.0 0
M  V30 14 C 11.5503 0.0000 0.0 0
M  V30 15 C 12.3203 1.3337 0.0 0
M  V30 16 N 3.0801 1.3337 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 2.3101 2.6673 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 20 C 0.7700 2.6673 0.0 0
M  V30 21 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 1 9 16
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867291-42-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766158-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Phenylglycine
C8H9NO2
875-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0 CFG=1
M  V30 2 C 1.3337 5.3901 0.0 0
M  V30 3 N 4.0010 5.3901 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Formylamino)benzeneacetic acid
C9H9NO3
10419-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 C 6.6687 3.0801 0.0 0
M  V30 5 O 2.6675 5.3901 0.0 0
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10419-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9143955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2R)-2-(N-Formyl)amino-2-phenylacetic Acid (4) Ac2O (185 mL) was added
dropwise to a mixture of (R)-phenylglycine (3; 40.00 g, 264 mmol) in
formic acid (550 mL, 99%) at such a rate that the temperature of the
reaction mixture was maintained between 5-15 °C. After the addition was
complete the mixture was stirred at r.t. for 1 h; iced-water (400 mL) was
introduced and the mixture was concentrated at reduced pressure to give 4
White crystals, yield 47.41 g, 100%. mp 178.1-178.8 °C (dec.) (Lit.12 178
°C); [α]D25 -247.0 (c 1.00, MeOH); {Lit.12 [α]D20 -252.0 (c 1.00, MeOH)}.
1H NMR (300 MHz, DMSO-d6): δ = 8.92 (d, 1 H, 3J = 7.7 Hz), 8.08 (s, 1 H),
7.39-7.28 (m, 5 H), 5.39 (d, 1 H, 3J = 7.7 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (5R)-4-methyl-5-phenyl-1,3,4-oxadiazinan-2-one and some
N-acyl derivatives from (R)-phenylglycine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodrigues, Alessandro; Olivato, Paulo Roberto; Rittner, Roberto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (15), 2578-2582

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[2-[(1R,3R,4S,5S)-3-chloro-4-ethenyl-5-(methoxyamino)...
C25H35ClN2O3
878006-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.1079 2.5135 0.0 0
M  V30 2 O 1.6204 2.1149 0.0 0
M  V30 3 C 1.2218 0.6274 0.0 0
M  V30 4 C 7.2787 6.9761 0.0 0
M  V30 5 C 8.3677 5.0901 0.0 0
M  V30 6 C 1.5342 3.8285 0.0 0
M  V30 7 C 0.0000 3.9628 0.0 0
M  V30 8 C 1.0218 5.7409 0.0 0
M  V30 9 N 9.5616 4.0011 0.0 0
M  V30 10 C 11.1017 4.0011 0.0 0
M  V30 11 O 11.8717 5.3348 0.0 0
M  V30 12 O 11.8717 2.6673 0.0 0
M  V30 13 C 13.4117 5.3348 0.0 0
M  V30 14 C 13.4117 6.8748 0.0 0
M  V30 15 C 14.9517 5.3348 0.0 0
M  V30 16 C 13.4117 3.7948 0.0 0
M  V30 17 Cl 1.7271 7.6665 0.0 0
M  V30 18 C 4.9940 4.3997 0.0 0
M  V30 19 C 6.4816 4.0011 0.0 0
M  V30 20 C 5.3927 5.8872 0.0 0 CFG=2
M  V30 21 C 3.5065 4.0011 0.0 0 CFG=2
M  V30 22 C 6.8802 5.4886 0.0 0
M  V30 23 C 4.3037 6.9761 0.0 0
M  V30 24 C 2.4175 5.0901 0.0 0 CFG=2
M  V30 25 C 2.8161 6.5776 0.0 0 CFG=1
M  V30 26 C 7.2516 2.6673 0.0 0
M  V30 27 C 8.7916 2.6673 0.0 0
M  V30 28 C 6.4816 1.3337 0.0 0
M  V30 29 C 9.5616 1.3337 0.0 0
M  V30 30 C 7.2516 0.0000 0.0 0
M  V30 31 C 8.7916 0.0000 0.0 0
M  V30 32 H 6.1627 7.2208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 22
M  V30 5 1 5 22
M  V30 6 2 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 24 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 25 17 CFG=3
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 26
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 20 32 CFG=1
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[2-[(1R,3R,4S,5S)-3-chloro-4-ethenyl-5-(formylmethoxy...
C26H35ClN2O4
878006-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6268 5.3348 0.0 0
M  V30 2 C 3.3969 6.6685 0.0 0
M  V30 3 O 1.0868 5.3348 0.0 0
M  V30 4 O 2.6268 8.0022 0.0 0
M  V30 5 C 0.3168 6.6685 0.0 0
M  V30 6 C 7.8106 2.1037 0.0 0
M  V30 7 C 8.3742 4.2074 0.0 0
M  V30 8 C 1.4470 3.6573 0.0 0
M  V30 9 C 0.0000 3.1306 0.0 0
M  V30 10 C 1.4470 1.6774 0.0 0
M  V30 11 N 9.2457 5.5683 0.0 0
M  V30 12 C 10.7333 5.9669 0.0 0
M  V30 13 O 11.8222 4.8779 0.0 0
M  V30 14 O 11.1318 7.4544 0.0 0
M  V30 15 C 13.3097 5.2765 0.0 0
M  V30 16 C 12.9112 6.7640 0.0 0
M  V30 17 C 14.7973 5.6750 0.0 0
M  V30 18 C 13.7083 3.7889 0.0 0
M  V30 19 Cl 2.6268 0.0000 0.0 0
M  V30 20 C 4.9369 4.0010 0.0 0
M  V30 21 C 6.2706 4.7710 0.0 0
M  V30 22 C 3.3969 4.0010 0.0 0 CFG=2
M  V30 23 C 5.7069 2.6673 0.0 0 CFG=2
M  V30 24 C 7.0406 3.4374 0.0 0
M  V30 25 C 2.6268 2.6673 0.0 0 CFG=2
M  V30 26 C 4.9369 1.3337 0.0 0
M  V30 27 C 3.3969 1.3337 0.0 0 CFG=2
M  V30 28 C 6.6691 6.2587 0.0 0
M  V30 29 C 8.1568 6.6573 0.0 0
M  V30 30 C 5.5802 7.3477 0.0 0
M  V30 31 C 8.5554 8.1448 0.0 0
M  V30 32 C 5.9787 8.8352 0.0 0
M  V30 33 C 7.4664 9.2337 0.0 0
M  V30 34 H 6.7959 1.5784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 22 1 CFG=1
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 24
M  V30 7 1 7 24
M  V30 8 2 8 9
M  V30 9 1 25 8 CFG=1
M  V30 10 1 25 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 27 19 CFG=1
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 28
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 1 23 26
M  V30 28 1 23 34 CFG=3
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 22 23 25 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 878006-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878006-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5288705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of methoxyamide 16. To a solution of S5 (54 mg, 0.121 mmol)
in 6 mL of CH2Cl2 at under N2 was added 100 μL of acetic formic anhydride
(prepared from heating 0.4 mL HCOOH and 0.8 mL of (CH3CO)2O to 65 °C for
45 min under N2). The resulting solution was stirred for 1 hour at room
temperature, then concentrated under reduced pressure. The residue was
purified by silica gel chromatography (gradient elution, 0→30%
EtOAc/Hexanes) to give 58 mg (100% yield) of 16 as a colorless oil. Due
to the rotational barrier around the C11-N bond, 1H NMR spectra shows two
sets of broad peaks for 16 (see attached spectra). The material was
generally used immediately in the subsequent reaction. LRMS (ES+) calc’d
for C26H36ClN2O4 [M+H] 475.24, found 475.47.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (±)-Welwitindolinone A Isonitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reisman, Sarah E.; Ready, Joseph M.; Hasuoka, Atsushi; Smith, Catherine
J.; Wood, John L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(5), 1448-1449

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-1,6-dihydro-6-oxo-5-pyrimidinecarboxaldehyde
C5H6N4O2
88075-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 N 2.3100 5.3349 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 N 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanine
C5H5N5O
73-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 N 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88075-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24812462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen-Doped Carbon Supported Co/Ni Bimetallic Catalyst for Selectively
Reductive N-Formylation of Nitroso in Guanine Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ke; Liu, Peng; Shi, Dongxu; Zhang, Hong-yu; Zhang, Yuecheng; Zhao,
Jiquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Letters (2022), 152(9), 2812-2822

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrophenol
C6H5NO3
88-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyphenyl)formamide
C7H7NO2
2843-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-75-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2843-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-15755299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1604839-72-6
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated iron oxide-bound
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, regioselective, solid-supported
catalyst, ionic liquid functionalized magnetic nanoparticle supported
palladium catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Water-Dispersible/Magnetically Separable Palladium Catalyst:
Selective Transfer Hydrogenation or Direct Reductive N-Formylation of
Nitroarenes in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Babak; Mansouri, Fariborz; Vali, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemPlusChem (2015), 80(12), 1750-1759

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(1,1-Dimethylethyl)-5,6,7,8-tetrahydrothiazolo[5,4-b]quinolin-2-amine
C14H19N3S
910306-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 N 11.9121 3.0800 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 6.6684 4.6201 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 8.0023 2.3100 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 N 9.4668 1.8342 0.0 0
M  V30 17 S 9.4668 4.3259 0.0 0
M  V30 18 C 10.3720 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 18
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[7-(1,1-Dimethylethyl)-5,6,7,8-tetrahydrothiazolo[5,4-b]quinolin-2-yl]forma...
C15H19N3OS
910306-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 N 11.9121 3.0800 0.0 0
M  V30 6 C 12.6821 4.4137 0.0 0
M  V30 7 O 14.2221 4.4137 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6684 1.5400 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 N 6.6684 4.6201 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 8.0023 2.3100 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 17 C 2.6675 3.8501 0.0 0
M  V30 18 N 9.4668 1.8342 0.0 0
M  V30 19 S 9.4668 4.3259 0.0 0
M  V30 20 C 10.3720 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 910306-88-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910306-89-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13754027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 134: Step A:
N-(7-tert-Butyl-5,6,7,8-tetrahydrothiazolo[5,4-b]quinolin-2-yl)-formamide:
A solution of
7-tert-butyl-5,6,7,8-tetrahydrothiazolo[5,4-b]quinolin-2-ylamine (20 mg,
0.077 mmol) in 2 mL of CH2Cl2 was added into a solution of acetic
anhydride (46 mg, 0.46 mmol) and formic acid (21.2 mg, 0.46 mmol) in 1 mL
of CH2Cl2. The reaction was stirred at room temperature for 24 h. It was
diluted by 20 mL of CH2Cl2, washed with 20 mL of saturated aqueous
NaHCO3, and dried over anhydrous Na2SO4. The solvent was removed under
vacuum and the residue was purified by flash chromatography eluting with
50% EtOAc/CH2Cl2 to give 73 mg (100%) of
N-(7-tert-butyl-5,6,7,8-tetrahydrothiazolo[5,4-b]quinolin-2-yl)-formamide.
LCMS: MH+=290; mp (°C)=241-244 (dec.).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydrothieno[2,3-b]quinolines and related compounds and their
preparation, pharmaceutical composition, and use for inhibiting KSP
kinesin activity and treatment of proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tagat, Jayaraman R.; Guzi, Timothy J.; Labroli, Marc; Poker, Cory; Xiao,
Yushi; Kerekes, Angela D.; Yu, Tao; Paliwal, Sunil; Tsui, Hong-Chung;
Shih, Neng-Yang; McCombie, Stuart W.; Madison, Vincent S.; Lesburg,
Charles A.; Duca, Jose S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006098961 A2 2006-09-21

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-amino-2,3-dihydro-4H-1,4-benzoxazine-4-carboxylate
C13H18N2O3
928118-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 O 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 8.7721 5.1836 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 C 7.2321 2.5164 0.0 0
M  V30 8 N 1.3336 0.0000 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 N 4.0011 4.6200 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 4.0011 6.1600 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 O 1.3336 6.1600 0.0 0
M  V30 16 C 1.3336 1.5400 0.0 0
M  V30 17 C 2.6674 6.9300 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-(formylamino)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxylate
C14H18N2O4
928118-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 4.0012 0.0 0
M  V30 2 O 2.1037 4.0012 0.0 0
M  V30 3 O 4.4137 5.3348 0.0 0
M  V30 4 C 1.3337 5.3348 0.0 0
M  V30 5 C 2.6673 6.1048 0.0 0
M  V30 6 C 0.5637 6.6687 0.0 0
M  V30 7 C 0.0000 4.5648 0.0 0
M  V30 8 N 9.0338 5.3348 0.0 0
M  V30 9 C 10.5739 5.3348 0.0 0
M  V30 10 O 11.3439 6.6687 0.0 0
M  V30 11 C 5.9538 2.6675 0.0 0
M  V30 12 N 4.4137 2.6675 0.0 0
M  V30 13 C 6.7238 1.3338 0.0 0
M  V30 14 C 6.7238 4.0012 0.0 0
M  V30 15 C 3.6437 1.3338 0.0 0
M  V30 16 C 8.2638 1.3338 0.0 0
M  V30 17 O 5.9538 0.0000 0.0 0
M  V30 18 C 8.2638 4.0012 0.0 0
M  V30 19 C 4.4137 0.0000 0.0 0
M  V30 20 C 9.0338 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928118-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928118-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14322928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. To a flask with AC2O (2.02 mL, 21.4 mmol) at 0 °C was added HCO2H
(0.82 mL, 21.4 mmol) by syringe. After stirring at 0 °C for 5 min, the
mixture was heated up to 55 °C for 2h, and then was cooled to 0 °C again.
Amine 5A (2g, 8.0 mmol) in anhydrous THF (100 mL) was added and the
mixture was stirred at 0 °C for 30 min. The reaction mixture was
concentrated under vacuum and diluted with 2 N NaOH solution to pH 9,
extracted with EtOAc (3 × 50 mL). The organic layer was dried(MgSO4),
filtered, and concentrated under vacuum to give a foam 6A (quantitative
yield).
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3,4-Dihydro-1,4-benzoxazine, 3,4-dihydro-1,4-benzothiazine and
1,2,3,4-tetrahydroquinoxaline derivatives as alpha2C adrenoreceptor
agonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McCormick, Kevin D.; Boyce, Christopher W.; Shih, Neng-Yang; Aslanian,
Robert G.; Fevrier, Salem; Mangiaracina, Pietro; De Lera Ruiz, Manuel;
Yu, Younong; Zheng, Junying; Huang, Chia-Yu; Liang, Bo; Liu, Rong-Qiang;
Liu, Ruiyan; Guise Zawacki, Lisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008100463 A1 2008-08-21

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′,4′-Dihydro-4′,5′,7′-trimethyl-1-(phenylmethyl)spiro[piperidine-4,2′(1′H)-q...
C23H30N2
936112-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.0000 0.0 0
M  V30 2 C 10.6697 6.1601 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 C 6.6685 5.3901 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 9.3358 3.8501 0.0 0
M  V30 13 C 8.0022 6.1601 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 N 9.3358 5.3901 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 13.3370 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 14.6707 5.3901 0.0 0
M  V30 24 C 13.3370 3.0801 0.0 0
M  V30 25 C 14.6707 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 16
M  V30 3 1 2 20
M  V30 4 1 3 17
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 14
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′,4′-Dihydro-4′,5′,7′-trimethyl-1-(phenylmethyl)spiro[piperidine-4,2′(1′H)-q...
C24H30N2O
1339850-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 O 4.0010 6.9302 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 10.6697 6.1601 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 N 5.3348 4.6201 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0022 3.0801 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 4.0010 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 9.3358 3.8501 0.0 0
M  V30 15 C 8.0022 6.1601 0.0 0
M  V30 16 C 4.0010 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 N 9.3358 5.3901 0.0 0
M  V30 19 C 2.6673 1.5400 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 1.3337 2.3101 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 23 C 12.0033 3.8501 0.0 0
M  V30 24 C 13.3370 6.1601 0.0 0
M  V30 25 C 13.3370 3.0801 0.0 0
M  V30 26 C 14.6707 5.3901 0.0 0
M  V30 27 C 14.6707 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 13
M  V30 4 1 4 18
M  V30 5 1 4 22
M  V30 6 1 5 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936112-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1339850-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1428991
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 2.1.1 Formylation: (Compounds 3a, 3d, 3i, 3k).
A solution of Ac2O (2.00 mmol), HCOOH (3.00 mmol) and two drops of
pyridine was added to the respective 1-benzyl-4'-methyl-
3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinolines] 2 (1.00 mmol) at 0°C.
The reaction mixture was stirred for 0.5-1 h at the same temperature.
Then, the reaction mixture was treated with NH4OH to get a pH 7-8, and
then it was extracted with CH2Cl2 (3 x 10 mL). Organic extracts were
washed with water and dried over Na2SO4, concentrated, then purified by
column chromatography on neural alumina, using heptane-ethyl acetate
mixture (15:1, 10:1, 5:1) as an eluent. Compound 3k as oil, yield 100%.
Condensed Formula: C24H30N2O. Weight (g mol-1): 362.61. GC: tR (min):
33.49. M +: 362 (1). IR νN-C=O (cm-1): 1660.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular N to N acyl migration in conformationally mobile
1'-acyl-1-benzyl-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinoline]
systems promoted by debenzylation conditions (HCOONH4/Pd/C)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mendez, Leonor Y. Vargas; Kouznetsov, Vladimir V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Central European Journal of Chemistry (2011), 9(5), 877-885

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-methyl-N-[2-(2-pyridinyl)ethyl]benzenesulfonamide
C14H17N3O2S
936126-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.6201 0.0 0 VAL=6
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 O 4.7712 3.2864 0.0 0
M  V30 4 O 3.2311 5.9538 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 1.3337 6.1601 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 N 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 15
M  V30 8 1 7 10
M  V30 9 1 8 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Formylamino)-2-methyl-N-[2-(2-pyridinyl)ethyl]benzenesulfonamide
C15H17N3O3S
2760914-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6674 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 O 6.9300 4.2074 0.0 0
M  V30 4 O 6.9300 1.1274 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 8.4700 0.0000 0.0 0
M  V30 8 N 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 O 13.8600 6.6685 0.0 0
M  V30 11 C 8.4700 2.6674 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 1.3336 0.0 0
M  V30 14 C 10.7800 4.0011 0.0 0
M  V30 15 C 10.7800 1.3336 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 N 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 17
M  V30 8 1 7 13
M  V30 9 1 8 9
M  V30 10 1 8 14
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936126-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760914-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31571253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazinecarboxamides as PRMT5-substrate
adaptor interaction inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porter, Dale; Sellers, William; Wagner, Florence Fevrier; McKinney,
David; Ianari, Alessandra; Campbell, Arthur J.; Drysdale, Martin;
Hilgraf, Robert; McCarren, Patrick; McMillan, Brian; Singh, Ritu;
Mulvaney, Kathleen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022032144 A1 2022-02-10

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-methyl-N-[2-(2-pyridinyl)ethyl]benzenesulfonamide
C14H17N3O2S
936126-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.6201 0.0 0 VAL=6
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 O 4.7712 3.2864 0.0 0
M  V30 4 O 3.2311 5.9538 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 1.3337 6.1601 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 N 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 15
M  V30 8 1 7 10
M  V30 9 1 8 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Formylamino)-2-methyl-N-[2-(2-pyridinyl)ethyl]benzenesulfonamide
C15H17N3O3S
2760914-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6674 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 O 6.9300 4.2074 0.0 0
M  V30 4 O 6.9300 1.1274 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 8.4700 0.0000 0.0 0
M  V30 8 N 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 O 13.8600 6.6685 0.0 0
M  V30 11 C 8.4700 2.6674 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 1.3336 0.0 0
M  V30 14 C 10.7800 4.0011 0.0 0
M  V30 15 C 10.7800 1.3336 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 N 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 17
M  V30 8 1 7 13
M  V30 9 1 8 9
M  V30 10 1 8 14
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936126-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760914-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33617338
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor
Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McKinney, David C.; McMillan, Brian J.; Ranaghan, Matthew J.; Moroco,
Jamie A.; Brousseau, Merissa; Mullin-Bernstein, Zachary; O'Keefe, Meghan;
McCarren, Patrick; Mesleh, Michael F.; Mulvaney, Kathleen M.; Robinson,
Foxy; Singh, Ritu; Bajrami, Besnik; Wagner, Florence F.; Hilgraf, Robert;
Drysdale, Martin J.; Campbell, Arthur J.; Skepner, Adam; Timm, David E.;
Porter, Dale; Kaushik, Virendar K.; Sellers, William R.; Ianari,
Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 11148-11168

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Phenylmethyl 4-(4-nitrophenyl)-1-piperazinecarboxylate
C18H19N3O4
947673-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 6.9302 0.0 0
M  V30 2 O 5.3348 6.1601 0.0 0
M  V30 3 O 6.6687 8.4702 0.0 0
M  V30 4 C 4.0012 6.9302 0.0 0
M  V30 5 N 16.0045 1.5400 0.0 0 VAL=5
M  V30 6 O 17.3383 2.3101 0.0 0
M  V30 7 O 16.0045 0.0000 0.0 0
M  V30 8 N 10.6697 4.6201 0.0 0
M  V30 9 C 10.6697 6.1601 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 C 9.3360 6.9302 0.0 0
M  V30 12 C 8.0023 4.6201 0.0 0
M  V30 13 N 8.0023 6.1601 0.0 0
M  V30 14 C 12.0035 3.8501 0.0 0
M  V30 15 C 13.3372 4.6201 0.0 0
M  V30 16 C 12.0035 2.3101 0.0 0
M  V30 17 C 14.6708 3.8501 0.0 0
M  V30 18 C 13.3372 1.5400 0.0 0
M  V30 19 C 14.6708 2.3101 0.0 0
M  V30 20 C 2.6675 6.1601 0.0 0
M  V30 21 C 1.3338 6.9302 0.0 0
M  V30 22 C 2.6675 4.6201 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 24 C 1.3338 3.8501 0.0 0
M  V30 25 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[4-(formylamino)phenyl]-1-piperazinecarboxylate
C19H21N3O3
2648346-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 N 16.0045 6.9302 0.0 0
M  V30 6 C 17.3383 6.1601 0.0 0
M  V30 7 O 18.6720 6.9302 0.0 0
M  V30 8 N 10.6697 3.8501 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 8.0023 3.8501 0.0 0
M  V30 13 N 8.0023 2.3101 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 C 13.3372 3.8501 0.0 0
M  V30 16 C 12.0035 6.1601 0.0 0
M  V30 17 C 14.6708 4.6201 0.0 0
M  V30 18 C 13.3372 6.9302 0.0 0
M  V30 19 C 14.6708 6.1601 0.0 0
M  V30 20 C 2.6675 2.3101 0.0 0
M  V30 21 C 1.3337 1.5400 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 0.0000 2.3101 0.0 0
M  V30 24 C 1.3337 4.6201 0.0 0
M  V30 25 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 947673-13-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648346-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-23809240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, stage 1 intermediate added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused pyrimidine pyridinone compounds as JAK inhibitors
for treatment of gastrointestinal inflammatory disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McKinnell, Robert Murray; Fenster, Erik; Lam, Tom M.; Wang, Diana Jin;
Palermo, Anthony Francesco; Boralsky, Luke; Fraga, Breena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021108803 A1 2021-06-03

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Benzeneacetic acid, α-hydroxy-, (αS)-, compd. with (1R)-1,2,3,4,5,6,7,8-octah...
C17H23NO.C8H8O3
94992-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 9.5421 0.0 0
M  V30 2 O 11.5500 9.5421 0.0 0
M  V30 3 C 12.3200 10.8759 0.0 0
M  V30 4 C 3.0800 8.2084 0.0 0
M  V30 5 C 4.6200 8.2084 0.0 0 CFG=1
M  V30 6 C 2.3100 6.8748 0.0 0
M  V30 7 C 2.3100 9.5421 0.0 0
M  V30 8 N 5.3900 6.8748 0.0 0
M  V30 9 C 3.0800 5.5410 0.0 0
M  V30 10 C 0.7700 6.8748 0.0 0
M  V30 11 C 0.7700 9.5421 0.0 0
M  V30 12 C 4.6200 5.5410 0.0 0
M  V30 13 C 0.0000 8.2084 0.0 0
M  V30 14 C 6.9300 9.5421 0.0 0
M  V30 15 C 7.7000 10.8759 0.0 0
M  V30 16 C 7.7000 8.2084 0.0 0
M  V30 17 C 9.2400 10.8759 0.0 0
M  V30 18 C 9.2400 8.2084 0.0 0
M  V30 19 C 10.0100 9.5421 0.0 0
M  V30 20 C 7.3150 2.6673 0.0 0 CFG=2
M  V30 21 C 8.0850 1.3337 0.0 0
M  V30 22 O 8.0850 4.0010 0.0 0
M  V30 23 O 7.3150 0.0000 0.0 0
M  V30 24 O 9.6251 1.3337 0.0 0
M  V30 25 C 5.7750 2.6673 0.0 0
M  V30 26 C 5.0050 4.0010 0.0 0
M  V30 27 C 5.0050 1.3337 0.0 0
M  V30 28 C 3.4649 4.0010 0.0 0
M  V30 29 C 3.4649 1.3337 0.0 0
M  V30 30 C 2.6949 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=1
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22 CFG=3
M  V30 24 1 20 25
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Isoquinolinecarboxaldehyde, 3,4,5,6,7,8-hexahydro-1-[(4-methoxyphenyl)m...
C18H23NO2
51773-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 1.3338 0.0 0
M  V30 3 O 7.7000 0.0000 0.0 0
M  V30 4 O 11.5500 4.0011 0.0 0
M  V30 5 C 12.3200 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 0.0000 2.6674 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 7.7000 5.3349 0.0 0
M  V30 18 C 7.7000 2.6674 0.0 0
M  V30 19 C 9.2400 5.3349 0.0 0
M  V30 20 C 9.2400 2.6674 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=1
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94992-57-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51773-23-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22680599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of L-3-hydroxy-N-methylmorphinan tartrate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anonymous
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM IP.com Journal (2019), 19(10B), 1-6

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-[[4-(Methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d...
C22H29N7O3S2
956034-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9312 9.2903 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 S 15.2660 6.2102 0.0 0 VAL=6
M  V30 5 C 16.5997 5.4402 0.0 0
M  V30 6 O 14.4960 4.8765 0.0 0
M  V30 7 O 16.0361 7.5440 0.0 0
M  V30 8 C 6.1601 8.0022 0.0 0
M  V30 9 C 4.6201 8.0022 0.0 0
M  V30 10 C 6.9302 6.6685 0.0 0
M  V30 11 S 7.1906 9.1467 0.0 0
M  V30 12 N 3.8501 6.6685 0.0 0
M  V30 13 N 6.1601 5.3348 0.0 0
M  V30 14 C 8.4365 6.9887 0.0 0
M  V30 15 C 8.5975 8.5202 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 N 3.8501 9.3360 0.0 0
M  V30 18 C 2.3101 9.3360 0.0 0
M  V30 19 C 4.6201 10.6697 0.0 0
M  V30 20 C 1.5400 10.6697 0.0 0
M  V30 21 C 3.8501 12.0033 0.0 0
M  V30 22 O 2.3101 12.0033 0.0 0
M  V30 23 C 3.8501 4.0012 0.0 0
M  V30 24 C 2.3101 4.0012 0.0 0
M  V30 25 C 4.6201 2.6673 0.0 0
M  V30 26 C 1.5400 2.6673 0.0 0
M  V30 27 C 3.8501 1.3337 0.0 0
M  V30 28 C 2.3101 1.3337 0.0 0
M  V30 29 N 11.2649 8.5202 0.0 0
M  V30 30 C 12.5986 9.2903 0.0 0
M  V30 31 C 11.2649 6.9802 0.0 0
M  V30 32 C 13.9324 8.5202 0.0 0
M  V30 33 C 12.5986 6.2102 0.0 0
M  V30 34 N 13.9324 6.9802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 29
M  V30 3 1 2 26
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 34
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 17
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 16
M  V30 19 2 14 15
M  V30 20 1 16 23
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Benzimidazol-6-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-mo...
C23H27N7O3S2
956033-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 6.1600 0.0 0
M  V30 2 S 1.3336 11.4947 0.0 0 VAL=6
M  V30 3 C 0.5636 12.8285 0.0 0
M  V30 4 O 2.6673 12.2647 0.0 0
M  V30 5 O 0.0000 10.7247 0.0 0
M  V30 6 C 8.3234 5.3900 0.0 0
M  V30 7 C 9.6572 4.6200 0.0 0
M  V30 8 C 8.3234 6.9300 0.0 0
M  V30 9 S 6.8589 4.9142 0.0 0
M  V30 10 N 10.9909 5.3900 0.0 0
M  V30 11 N 9.6572 7.7000 0.0 0
M  V30 12 C 6.8589 7.4060 0.0 0
M  V30 13 C 5.9537 6.1600 0.0 0
M  V30 14 C 10.9909 6.9300 0.0 0
M  V30 15 N 9.6572 3.0800 0.0 0
M  V30 16 C 8.3234 2.3100 0.0 0
M  V30 17 C 10.9909 2.3100 0.0 0
M  V30 18 C 8.3234 0.7700 0.0 0
M  V30 19 C 10.9909 0.7700 0.0 0
M  V30 20 O 9.6572 0.0000 0.0 0
M  V30 21 C 12.3245 7.7000 0.0 0
M  V30 22 C 13.6583 6.9300 0.0 0
M  V30 23 C 12.3245 9.2400 0.0 0
M  V30 24 C 14.9919 7.7000 0.0 0
M  V30 25 C 13.6583 10.0100 0.0 0
M  V30 26 C 14.9919 9.2400 0.0 0
M  V30 27 N 16.4565 7.2242 0.0 0
M  V30 28 N 16.4565 9.7160 0.0 0
M  V30 29 C 17.3617 8.4700 0.0 0
M  V30 30 N 3.6436 7.4938 0.0 0
M  V30 31 C 2.1036 7.4938 0.0 0
M  V30 32 C 4.4137 8.8275 0.0 0
M  V30 33 C 1.3336 8.8275 0.0 0
M  V30 34 C 3.6436 10.1611 0.0 0
M  V30 35 N 2.1036 10.1611 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 35
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 15
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 2 12 13
M  V30 18 1 14 21
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 24 27
M  V30 31 2 25 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 956034-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956033-66-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-513312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-benzene-1,2-diamine
(95mg) was refluxed in formic acid (1 mL) for 1 hour. The reaction
mixture was basified with aqueous sodium hydrogen carbonate and extracted
into DCM. Flash chromatography and recrystallisation from hot DCM/hexane
gave the title compound (32mg). 135, yield (32mg). NMR (CDCl3): 2.67-2.71
(4H, m), 2.81 (3H, s), 3.29-3.33 (4H, m), 3.89 (2H, s), 3.89-3.93 (4H,
m), 4.08-4.12 (4H, m), 7.35 (1H, s), 7.70-7.80 (1H, br), 8.10 (1H, s),
8.48 (1H, d, J=8.6), 8.80 (1H, br) MS (ESI+): MH+ 514.20 (100%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrimidines and furopyrimidines as lipid kinase
inhibitors for treating cancer and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Folkes, Adrian; Shuttleworth, Stephen; Chuckowree, Irina; Oxenford,
Sally; Wan, Nan Chi; Castanedo, Georgette; Gunzner, Janet; Heffron, Tim;
Mathieu, Simon; Olivero, Alan; Sutherlin, Daniel P.; Zhu, Bing-Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007127175 A2 2007-11-08

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1,2-phenylenediamine
C6H7ClN2
95-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chlorobenzimidazole
C7H5ClN2
4887-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-6591854
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of selected benzimidazole derivatives as
potential antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alasmary, Fatmah A. S.; Snelling, Anna M.; Zain, Mohammed E.; Alafeefy,
Ahmed M.; Awaad, Amani S.; Karodia, Nazira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2015), 20(8), 15206-15223

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methoxy-N-(4-methoxy-2-methylphenyl)benzamide
C16H18N2O3
958633-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 O 6.9302 1.3338 0.0 0
M  V30 4 N 4.6201 0.0000 0.0 0
M  V30 5 O 1.5400 5.3348 0.0 0
M  V30 6 C 0.0000 5.3348 0.0 0
M  V30 7 C 8.4702 6.6687 0.0 0
M  V30 8 O 13.0903 4.0012 0.0 0
M  V30 9 C 13.8603 5.3348 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 3.8501 1.3338 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 2.3101 1.3338 0.0 0
M  V30 15 C 1.5400 2.6675 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 C 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-3-(4-methoxy-2-methylphenyl)-4(3H)-quinazolinone
C17H16N2O3
958633-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 5.3348 0.0 0
M  V30 2 C 8.4702 0.0000 0.0 0
M  V30 3 O 13.0903 2.6675 0.0 0
M  V30 4 C 13.8603 4.0012 0.0 0
M  V30 5 O 1.5400 6.6687 0.0 0
M  V30 6 C 0.0000 6.6687 0.0 0
M  V30 7 N 6.9302 2.6675 0.0 0
M  V30 8 C 6.1601 4.0012 0.0 0
M  V30 9 C 6.1601 1.3338 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 N 4.6201 1.3338 0.0 0
M  V30 12 C 3.8501 2.6675 0.0 0
M  V30 13 C 3.8501 5.3348 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 1.5400 4.0012 0.0 0
M  V30 17 C 8.4702 2.6675 0.0 0
M  V30 18 C 9.2402 1.3338 0.0 0
M  V30 19 C 9.2402 4.0012 0.0 0
M  V30 20 C 10.7802 1.3338 0.0 0
M  V30 21 C 10.7802 4.0012 0.0 0
M  V30 22 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 12
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 958633-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958633-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1679305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of qunazoline-4-one 5 A mixture of 4 (2.70 g, 9.43 mmol) and
formic acid (5 mL) was refluxed for 1 h and treated with 5 N NaOH
solution (30 mL). The precipitate was collected by filtration. The crude
product was dissolved in CHCl3. The organic layer was dried over MgSO4.
The solvent was evaporated in vacuo to give the product 5 as an ivory
solid (2.79 g, quantitatively) 5, yield (2.79 g, quantitatively) 1H NMR
(400 MHz, CDCl3) δ 7.89 (s, 1H), 7.72 (d, J = 3.2 Hz, 1H), 7.70 (d, J =
9.2 Hz, 1H), 7.39 (dd, J = 8.8, 2.8 Hz, 1H), 7.16 (d, J = 8.8 Hz, 1H),
6.90 (d, J = 2.4 Hz, 1H), 6.87 (dd, J = 8.8, 2.4 Hz, 1H), 3.93 (s, 3H),
3.85 (s, 3H), 2.16 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 160.43, 159.93,
158.68, 144.49, 142.47, 136.94, 129.42, 128.97, 128.64, 124.48, 123.12,
116.29, 112.30, 106.43, 55.89, 55.51, 18.12.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Neuroprotective Dictyoquinazol A, B, and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Oh, Chang Ho; Song, Chung Hyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2007), 37(19), 3311-3317

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]benzenamine
C16H26N4
959795-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 N 15.4003 1.3337 0.0 0
M  V30 3 C 6.1601 1.3337 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 6.9302 0.0000 0.0 0
M  V30 6 C 8.4702 2.6673 0.0 0
M  V30 7 C 8.4702 0.0000 0.0 0
M  V30 8 N 9.2402 1.3337 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 3.8501 2.6673 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 N 1.5400 1.3337 0.0 0
M  V30 15 C 10.7802 1.3337 0.0 0
M  V30 16 C 11.5503 2.6673 0.0 0
M  V30 17 C 11.5503 0.0000 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 C 13.0903 0.0000 0.0 0
M  V30 20 C 13.8603 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 8 15
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]phenyl]formamide
C17H26N4O
2766157-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 15.4003 1.3337 0.0 0
M  V30 2 C 16.1704 2.6673 0.0 0
M  V30 3 O 17.7104 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 N 9.2402 1.3337 0.0 0
M  V30 6 C 8.4702 0.0000 0.0 0
M  V30 7 C 8.4702 2.6673 0.0 0
M  V30 8 C 6.9302 0.0000 0.0 0
M  V30 9 C 6.9302 2.6673 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 10.7802 1.3337 0.0 0
M  V30 12 C 11.5503 2.6673 0.0 0
M  V30 13 C 11.5503 0.0000 0.0 0
M  V30 14 C 13.0903 2.6673 0.0 0
M  V30 15 C 13.0903 0.0000 0.0 0
M  V30 16 C 13.8603 1.3337 0.0 0
M  V30 17 N 4.6201 1.3337 0.0 0
M  V30 18 C 3.8501 0.0000 0.0 0
M  V30 19 C 3.8501 2.6673 0.0 0
M  V30 20 C 2.3101 0.0000 0.0 0
M  V30 21 C 2.3101 2.6673 0.0 0
M  V30 22 N 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 10 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 959795-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766157-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31979858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as HPK1 modulator and
methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Weiguo; Ma, Weiping; Sun, Yongkui; Ho, Koc Kan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022063140 A1 2022-03-31

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aR,3bR,10aS,10bR,12aS)-Hexadecahydro-10a,12a-dimethylbenz[d]indeno[4,5-b]az...
C19H29NO2
960529-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5033 4.7343 0.0 0
M  V30 2 C 1.8258 5.8158 0.0 0
M  V30 3 O 0.0000 5.8184 0.0 0
M  V30 4 O 11.4096 3.2211 0.0 0
M  V30 5 C 4.1378 2.4032 0.0 0 CFG=1
M  V30 6 C 5.2668 3.4505 0.0 0 CFG=2
M  V30 7 C 2.6664 2.8570 0.0 0 CFG=2
M  V30 8 N 4.2530 0.8675 0.0 0
M  V30 9 C 6.7896 3.2211 0.0 0 CFG=2
M  V30 10 C 4.9241 4.9520 0.0 0
M  V30 11 C 2.3236 4.3585 0.0 0 CFG=2
M  V30 12 C 1.3443 2.0671 0.0 0
M  V30 13 C 5.5254 0.0000 0.0 0
M  V30 14 C 7.5596 1.8874 0.0 0 CFG=3
M  V30 15 C 7.5596 4.5547 0.0 0
M  V30 16 C 3.4525 5.4059 0.0 0
M  V30 17 C 0.7899 4.4965 0.0 0
M  V30 18 C 0.1845 3.0805 0.0 0
M  V30 19 C 6.9970 0.4538 0.0 0
M  V30 20 C 9.0996 1.8874 0.0 0
M  V30 21 C 9.0996 4.5547 0.0 0
M  V30 22 C 9.8696 3.2211 0.0 0
M  V30 23 H 2.9339 1.4430 0.0 0
M  V30 24 H 5.7390 4.9164 0.0 0
M  V30 25 H 2.1868 1.3935 0.0 0
M  V30 26 H 8.4270 0.6149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 11 2 CFG=3
M  V30 3 2 3 17
M  V30 4 2 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 23 CFG=3
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 24 CFG=1
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 25 CFG=1
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 1 13 19
M  V30 23 1 14 19
M  V30 24 1 14 20
M  V30 25 1 14 26
M  V30 26 1 15 21
M  V30 27 1 17 18
M  V30 28 1 20 22
M  V30 29 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 5 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,3bR,10aS,10bR,12aS)-Hexadecahydro-10a,12a-dimethyl-1,8-dioxobenz[d]inden...
C20H29NO3
960529-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9192 1.5400 0.0 0
M  V30 2 O 2.9192 0.0000 0.0 0
M  V30 3 C 6.7705 6.2036 0.0 0
M  V30 4 C 1.8258 7.2583 0.0 0
M  V30 5 O 0.0000 7.2611 0.0 0
M  V30 6 O 11.4096 4.6636 0.0 0
M  V30 7 C 4.1378 3.8457 0.0 0 CFG=1
M  V30 8 C 5.2668 4.8932 0.0 0 CFG=2
M  V30 9 C 2.6664 4.2997 0.0 0 CFG=2
M  V30 10 N 4.2530 2.3100 0.0 0
M  V30 11 C 6.7896 4.6636 0.0 0 CFG=2
M  V30 12 C 4.9241 6.3945 0.0 0
M  V30 13 C 2.3236 5.8010 0.0 0 CFG=2
M  V30 14 C 1.3443 3.5098 0.0 0
M  V30 15 C 5.5254 1.4425 0.0 0
M  V30 16 C 7.5596 3.3299 0.0 0 CFG=3
M  V30 17 C 7.5596 5.9974 0.0 0
M  V30 18 C 3.4525 6.8485 0.0 0
M  V30 19 C 0.7899 5.9390 0.0 0
M  V30 20 C 0.1845 4.5230 0.0 0
M  V30 21 C 6.9970 1.8964 0.0 0
M  V30 22 C 9.0996 3.3299 0.0 0
M  V30 23 C 9.0996 5.9974 0.0 0
M  V30 24 C 9.8696 4.6636 0.0 0
M  V30 25 H 2.9339 2.8855 0.0 0
M  V30 26 H 5.7390 6.3590 0.0 0
M  V30 27 H 2.1868 2.8362 0.0 0
M  V30 28 H 8.4270 2.0576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 11 3 CFG=3
M  V30 4 1 13 4 CFG=3
M  V30 5 2 5 19
M  V30 6 2 6 24
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 25 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 26 CFG=1
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 9 27 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 1 11 17
M  V30 20 1 12 18
M  V30 21 1 13 18
M  V30 22 1 13 19
M  V30 23 1 14 20
M  V30 24 1 15 21
M  V30 25 1 16 21
M  V30 26 1 16 22
M  V30 27 1 16 28
M  V30 28 1 17 23
M  V30 29 1 19 20
M  V30 30 1 22 24
M  V30 31 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 9 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960529-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960529-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3072906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 6-Aza-6-formyl-7a-homoandrostane-3,17-dione
(II-g) A 1 M solution of formic acid in CHCl3 (3.9 mL) was added dropwise
to a solution of DCC (403 mg) in CHCl3 at 0 °C. The mixture was stirred
for further 5 min and then added to an ice-cooled solution of
6-aza-7a-homoandrostane-3,17-dione (II-f, Prepn. 5, 300 mg) in pyridine
(2.9 mL). The mixture was then stirred in an ice bath for 1 h.
Evaporation of the solvent, followed by addition of EtOAc, gave a
precipitate which was removed by filtration and washed with EtOAc. The
combined organic extracts were evaporated to dryness and the residue was
purified by flash chromatography (SiO2, hexane/acetone 1/1).
7a-Aza-7a-formyl-7a-homoandrostane-3,17-dione (II-1)
7a-Aza-7a-formyl-7a-homoandrostane-3,17-dione was prepared in
quantitative yield from 7a-aza-7a-homoandrostane-3,17-dione (II-k, Prepn.
10 55 mg) by the procedure described above for the preparation of
6-aza-6- formyl-7a-homoandrostane 3,17-dione (Prepn. 6). The crude
product was purified by flash chromatography (SiO2, hexane/acetone 60/40)
to give the title compound II-1 (60 mg). 1H-NMR (300 MHz, DMSO-d6, ppm
from TMS): δ 8.13 (s, 1H), 4.15 (m, 1H), 3.52-3.39 (m, 1H), 3.18 (m, 1H),
2.47-1.08 (m, 19H), 0.91 (s, 3H), 0.89 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino derivatives of B-homoandrostanes and
B-heteroandrostanes for the treatment of cardiovascular disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cerri, Alberto; Moro, Barbara; Torri, Maco; Carzana, Giulio; Bianchi,
Giuseppe; Ferrandi, Mara; Ferrari, Patrizia; Zappavigna, Maria Pia;
Banfi, Leonardo; Giacalone, Giuseppe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007147713 A1 2007-12-27

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Trifluoromethyl)aniline
C7H6F3N
98-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 F 2.1038 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5638 1.7464 0.0 0
M  V30 5 N 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Trifluoromethyl)phenyl]formamide
C8H6F3NO
657-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 2.1037 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5637 1.7464 0.0 0
M  V30 5 N 6.6685 3.0801 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 O 9.3360 3.0801 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 657-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37946278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isocyanides as Catalytic Electron Acceptors in the Visible Light Promoted
Oxidative Formation of Benzyl and Acyl Radicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Russo, Camilla; Donati, Greta; Giustiniano, Francesco; Amato, Jussara;
Marinelli, Luciana; Whitby, Richard John; Giustiniano, Mariateresa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(60), e202301852

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitroaniline
C6H6N2O2
99-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)formamide
C7H6N2O3
102-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 1.5400 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 102-38-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37946255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isocyanides as Catalytic Electron Acceptors in the Visible Light Promoted
Oxidative Formation of Benzyl and Acyl Radicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Russo, Camilla; Donati, Greta; Giustiniano, Francesco; Amato, Jussara;
Marinelli, Luciana; Whitby, Richard John; Giustiniano, Mariateresa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(60), e202301852

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitrotoluene
C7H8N2O2
99-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methyl-4-nitrophenyl)formamide
C8H8N2O3
26198-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 4.0012 6.1601 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 26198-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2361764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Acetic anhydride (400 mL, 4.26 mol, 2.6 equiv.) was added to formic acid
(200 mL, 5.25 mol, 3.2 equiv.) and the resulting solution was heated at
60°C. for 2.25 h. After cooling to room temp., a solution of 2-methyl
-4-nitroaniline (152 g, 1.64 mol, 1.0 equiv.) in anh. THE (1.2 L) was
added at such a rate that the reaction temp. did not exceed 45°C.
(approximately 30 min.). When the resulting solution had cooled to room
temp. it was concentrated to half the volume under reduced pressure and
the reaction product was removed by filtration yielding 2-methyl
-4-nitroformanilide. Light tan solid, 295 g, 100%. 1H NMR (CDCl3) 82.31
(s, 3H) 8.03 (m, 2H), 8.24 (d, J=8.8 Hz, 1H), 8.39 (br s, 1H), 9.94 (br
s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and use of, e.g., 2-arylimino-1,3-thiazolidines as
progesterone receptor binding ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Brian R.; Bagi, Cedo M.; Brennan, Catherine R.; Brittelli, David
R.; Bullock, William H.; Chen, Jinshan; Collibee, William L.; Dally,
Robert; Johnson, Jeffrey S.; Kluender, Harold C. E.; Lathrop, William F.;
Liu, Peiying; Mase, Carol Ann; Redman, Aniko M.; Scott, William J.;
Urbahns, Klaus; Wolanin, Donald J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6353006 B1 2002-03-05

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitrotoluene
C7H8N2O2
99-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methyl-4-nitrophenyl)formamide
C8H8N2O3
26198-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 4.0012 6.1601 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 26198-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20753414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aryliminothiazolidines and related compounds
progesterone receptor binding agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Brian R.; Bagi, Cedo M.; Brennan, Catherine R.; Brittelli, David
R.; Bullock, William H.; Chen, Jinshan; Collibee, William L.; Dally,
Robert; Johnson, Jeffrey S.; Kluender, Harold C. E.; Lathrop, William F.;
Liu, Peiying; Mase, Carol Ann; Redman, Aniko M.; Scott, William J.;
Urbahns, Klaus; Wolanin, John J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000042031 A2 2000-07-20

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitro-1,2-phenylenediamine
C6H7N3O2
99-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitrobenzimidazole
C7H5N3O2
94-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 1.5400 0.0 0 VAL=5
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 N 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-56-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94-52-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11683548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of selected benzimidazole derivatives as
potential antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alasmary, Fatmah A. S.; Snelling, Anna M.; Zain, Mohammed E.; Alafeefy,
Ahmed M.; Awaad, Amani S.; Karodia, Nazira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2015), 20(8), 15206-15223

$RFMT $RIREG SCHEME304 STEP1
$RXN



  3  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenzoylmethane
C15H12O2
120-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 12
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-3-Amino-1,3-diphenyl-2-propen-1-one
C15H13NO
98815-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 12
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, (2,6-diphenyl-3,5-pyridinediyl)bis[phenyl-
C31H21NO2
301656-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 5.3348 0.0 0
M  V30 2 O 2.3101 4.0012 0.0 0
M  V30 3 C 7.7002 8.0022 0.0 0
M  V30 4 O 9.2402 8.0022 0.0 0
M  V30 5 C 5.3901 4.0012 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 N 6.9302 4.0012 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 C 7.7002 5.3348 0.0 0
M  V30 10 C 6.9302 6.6685 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 3.0801 2.6673 0.0 0
M  V30 13 C 5.3901 1.3337 0.0 0
M  V30 14 C 2.3101 1.3337 0.0 0
M  V30 15 C 4.6201 0.0000 0.0 0
M  V30 16 C 3.0801 0.0000 0.0 0
M  V30 17 C 2.3101 6.6685 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 3.0801 8.0022 0.0 0
M  V30 20 C 0.0000 8.0022 0.0 0
M  V30 21 C 2.3101 9.3360 0.0 0
M  V30 22 C 0.7700 9.3360 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 10.0102 4.0012 0.0 0
M  V30 26 C 11.5503 6.6685 0.0 0
M  V30 27 C 11.5503 4.0012 0.0 0
M  V30 28 C 12.3203 5.3348 0.0 0
M  V30 29 C 6.9302 9.3360 0.0 0
M  V30 30 C 7.7002 10.6697 0.0 0
M  V30 31 C 5.3901 9.3360 0.0 0
M  V30 32 C 6.9302 12.0033 0.0 0
M  V30 33 C 4.6201 10.6697 0.0 0
M  V30 34 C 5.3901 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 17
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 3 29
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 5 11
M  V30 10 1 6 8
M  V30 11 2 7 9
M  V30 12 2 8 10
M  V30 13 1 9 10
M  V30 14 1 9 23
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-46-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 98815-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 301656-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29076266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 19
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3251-23-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Efficient Synthesis of Polysubstituted Pyridines via Csp3-H Oxidation
and C-S Cleavage of Dimethyl Sulfoxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Xia; Zhang, Jingjing; Liu, Shan; Gao, Qinghe; Wu, Anxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(2), 218-225

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Phenylacrylic acid
C9H8O2
492-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 C 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1E)-1-Buten-3-yne-1,4-diylbis[benzene]
C16H12
13343-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 6.9302 2.6673 0.0 0
M  V30 4 C 8.4702 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 10.7802 1.3337 0.0 0
M  V30 13 C 10.7802 4.0010 0.0 0
M  V30 14 C 12.3203 1.3337 0.0 0
M  V30 15 C 12.3203 4.0010 0.0 0
M  V30 16 C 13.0903 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 492-38-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 13343-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30037656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 2759828-29-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, sealed Teflon-lined stainless-steel
autoclave used, conversion, 73%, selectivity, 7%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrocarboxylation of alkynes with formic acid over multifunctional
ligand modified Pd-catalyst with co-catalytic effect
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Lei; Yao, Yin-Qing; Chen, Xiao-Chao; Guo, Lin; Lu, Yong; Zhao,
Xiao-Li; Liu, Ye
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2022), 405322-332

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333227-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=2
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-, 2-methyl ester, aceta...
C18H22N4O5.2C2H4O2
1333227-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 10.5184 0.0 0 CFG=2
M  V30 2 C 10.0101 9.1848 0.0 0
M  V30 3 N 7.7000 10.5184 0.0 0
M  V30 4 C 10.0101 11.8522 0.0 0
M  V30 5 C 6.9300 9.1848 0.0 0
M  V30 6 O 9.2400 13.1859 0.0 0
M  V30 7 O 11.5501 11.8522 0.0 0
M  V30 8 C 5.3900 9.1848 0.0 0
M  V30 9 O 7.7000 7.8511 0.0 0
M  V30 10 C 10.0101 14.5195 0.0 0
M  V30 11 N 4.6200 7.8511 0.0 0
M  V30 12 C 3.0800 7.8511 0.0 0
M  V30 13 C 5.3900 6.5173 0.0 0
M  V30 14 C 4.6200 5.1837 0.0 0
M  V30 15 O 3.0800 5.1837 0.0 0
M  V30 16 O 5.3900 3.8501 0.0 0
M  V30 17 C 11.5501 9.1848 0.0 0
M  V30 18 C 12.4553 7.9389 0.0 0
M  V30 19 N 12.4553 10.4307 0.0 0
M  V30 20 N 13.9198 8.4148 0.0 0
M  V30 21 C 13.9198 9.9548 0.0 0
M  V30 22 C 2.3100 9.1848 0.0 0
M  V30 23 C 3.0800 10.5184 0.0 0
M  V30 24 C 0.7700 9.1848 0.0 0
M  V30 25 C 2.3100 11.8522 0.0 0
M  V30 26 C 0.0000 10.5184 0.0 0
M  V30 27 C 0.7700 11.8522 0.0 0
M  V30 28 C 6.9599 1.5400 0.0 0
M  V30 29 C 5.6262 2.3101 0.0 0
M  V30 30 O 8.2936 2.3101 0.0 0
M  V30 31 O 6.9599 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 22
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-00-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-10920005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for deprotection (67-82):
The tritylated compound or t-Bu-squaric derivative was deprotected in DCM
with TFA (5-50% volume). Triisopropylsilane was added until the yellow
solution became colorless. The mixture was stirred at room temperature
for 1h. The solvent was evaporated and the crude product was triturated
in diethyl ether and purified by preparative HPLC if necessary.
(R)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester•2CH3COOH (68) was obtained from (39) as a white powder
(100%). Purity 99% ;1H NMR (DMSO-d6) δ ppm: 3.16 (m, 2H), 3.32 (s, 2H),
3.39 (s, 2H), 3.65 (s, 3H), 3.81 (s, 1H), 4.70 (m, 1H), 7.32 (m, 5H),
7.36 (s, 1H), 8.46 (d, J = 8.1Hz, 1H), 8.97 (s, 1H). 13C NMR (DMSO-d6) δ
ppm: 26.1, 50.8, 52.3, 53.5, 55.9, 57.5, 117.0, 127.6, 128.3, 129.0,
129.2, 133.8, 136.9, 169.8, 170.8, 171.7. LC tr = 0.783 min; MS (ESI+) :
m/z = 375 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
L-Histidine, N-(carboxymethyl)-N-[(4-methylphenyl)methyl]glycyl-1-(triphenylm...
C38H38N4O5.CH2O2
1333227-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3110 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3110 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3110 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 C 16.7544 15.6468 0.0 0
M  V30 19 N 5.1446 8.4148 0.0 0
M  V30 20 C 6.6091 8.8906 0.0 0
M  V30 21 C 5.1446 6.8748 0.0 0
M  V30 22 C 7.5143 7.6448 0.0 0
M  V30 23 N 6.6091 6.3989 0.0 0
M  V30 24 C 4.8037 10.5658 0.0 0
M  V30 25 C 6.3354 10.4048 0.0 0
M  V30 26 C 4.1774 11.9726 0.0 0
M  V30 27 C 7.2407 11.6508 0.0 0
M  V30 28 C 5.0826 13.2185 0.0 0
M  V30 29 C 6.6142 13.0576 0.0 0
M  V30 30 C 2.6527 10.2250 0.0 0
M  V30 31 C 1.2459 9.5987 0.0 0
M  V30 32 C 2.8137 11.7567 0.0 0
M  V30 33 C 0.0000 10.5039 0.0 0
M  V30 34 C 1.5679 12.6620 0.0 0
M  V30 35 C 0.1609 12.0355 0.0 0
M  V30 36 C 2.9935 8.0740 0.0 0
M  V30 37 C 1.4619 8.2350 0.0 0
M  V30 38 C 3.6198 6.6672 0.0 0
M  V30 39 C 0.5567 6.9892 0.0 0
M  V30 40 C 2.7146 5.4213 0.0 0
M  V30 41 C 1.1830 5.5822 0.0 0
M  V30 42 C 14.4444 11.6459 0.0 0
M  V30 43 C 13.6743 12.9795 0.0 0
M  V30 44 C 15.9844 11.6459 0.0 0
M  V30 45 C 14.4444 14.3131 0.0 0
M  V30 46 C 16.7544 12.9795 0.0 0
M  V30 47 C 15.9844 14.3131 0.0 0
M  V30 48 C 9.1472 0.0000 0.0 0
M  V30 49 O 7.8135 0.7700 0.0 0
M  V30 50 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 1 36
M  V30 5 1 2 3
M  V30 6 1 2 22
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 42
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 47
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 2 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 2 44 46
M  V30 50 2 45 47
M  V30 51 1 46 47
M  V30 52 1 48 49
M  V30 53 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-[(4-methylphenyl)methyl]glycyl-, 2-methyl es...
C19H24N4O5.2C2H4O2
1333227-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1618 7.8512 0.0 0 CFG=1
M  V30 2 C 2.6218 7.8512 0.0 0
M  V30 3 N 4.9318 9.1849 0.0 0
M  V30 4 C 4.9318 6.5174 0.0 0
M  V30 5 C 6.4718 9.1849 0.0 0
M  V30 6 O 4.1618 5.1837 0.0 0
M  V30 7 O 6.4718 6.5174 0.0 0
M  V30 8 C 7.2419 10.5186 0.0 0
M  V30 9 O 7.2419 7.8512 0.0 0
M  V30 10 C 4.9318 3.8501 0.0 0
M  V30 11 N 8.7819 10.5186 0.0 0
M  V30 12 C 9.5519 9.1849 0.0 0
M  V30 13 C 9.5519 11.8524 0.0 0
M  V30 14 C 8.7819 13.1860 0.0 0
M  V30 15 O 7.2419 13.1860 0.0 0
M  V30 16 O 9.5519 14.5197 0.0 0
M  V30 17 C 15.7120 9.1849 0.0 0
M  V30 18 C 1.8517 9.1849 0.0 0
M  V30 19 C 2.4782 10.5917 0.0 0
M  V30 20 N 0.3202 9.3458 0.0 0
M  V30 21 N 1.3337 11.6223 0.0 0
M  V30 22 C 0.0000 10.8523 0.0 0
M  V30 23 C 11.0919 9.1849 0.0 0
M  V30 24 C 11.8620 7.8512 0.0 0
M  V30 25 C 11.8620 10.5186 0.0 0
M  V30 26 C 13.4020 7.8512 0.0 0
M  V30 27 C 13.4020 10.5186 0.0 0
M  V30 28 C 14.1720 9.1849 0.0 0
M  V30 29 C 7.8560 1.5400 0.0 0
M  V30 30 C 6.5224 2.3101 0.0 0
M  V30 31 O 9.1897 2.3101 0.0 0
M  V30 32 O 7.8560 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 23
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 17 28
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 2 29 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-04-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-6978233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for deprotection (67-82):
The tritylated compound or t-Bu-squaric derivative was deprotected in DCM
with TFA (5-50% volume). Triisopropylsilane was added until the yellow
solution became colorless. The mixture was stirred at room temperature
for 1h. The solvent was evaporated and the crude product was triturated
in diethyl ether and purified by preparative HPLC if necessary.
(S)-2-{2-[Carboxymethyl-(4-methyl-benzyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester•2CH3COOH (70) was obtained from (41) as a white powder
(100 %). Purity 99%; 1H NMR (DMSO-d6) δ ppm: 2.29 (s, 3H), 3.08 (dd, J =
9.0 and 15.3 Hz, 1H), 3.19 (dd, J = 5.4 and 15.3 Hz, 1H), 3.41 (s, 2H),
3.45 (s, 2H), 3.65 (s, 3H), 3.83 (s, 2H), 4.70 (m, 1H), 7.15 (d, J = 8.1
Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 7.38 (d, J = 1.2 Hz, 1H), 8.54 (d, J =
8.1 Hz, 1H), 8.98 (d, J = 1.2 Hz, 1H). 13C NMR (DMSO-d6) δ ppm: 171.0,
170.7, 169.7, 158.0, 137.1, 133.7, 132.7, 129.5, 129.1, 129.0, 117.1,
57.3, 55.5, 53.6, 52.4, 50.9, 26.2, 20.7. LC tr = 2.86 min; MS (ESI+) :
m/z = 389 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(3-phenylpropyl)glycyl-1-(triphenylmethyl)-,...
C39H40N4O5.CH2O2
1333227-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5948 10.3673 0.0 0
M  V30 2 C 9.8975 9.2402 0.0 0
M  V30 3 C 11.2312 10.0102 0.0 0 CFG=2
M  V30 4 N 12.5648 9.2402 0.0 0
M  V30 5 C 11.2312 11.5502 0.0 0
M  V30 6 C 12.5648 7.7001 0.0 0
M  V30 7 O 12.5648 12.3202 0.0 0
M  V30 8 O 9.8975 12.3202 0.0 0
M  V30 9 C 13.8986 6.9301 0.0 0
M  V30 10 O 11.2312 6.9301 0.0 0
M  V30 11 C 12.5648 13.8603 0.0 0
M  V30 12 N 13.8986 5.3901 0.0 0
M  V30 13 C 15.2323 4.6201 0.0 0
M  V30 14 C 12.5648 4.6201 0.0 0
M  V30 15 C 16.5660 5.3901 0.0 0
M  V30 16 C 12.5648 3.0800 0.0 0
M  V30 17 C 17.8997 4.6201 0.0 0
M  V30 18 O 11.2312 2.3100 0.0 0
M  V30 19 O 13.8986 2.3100 0.0 0
M  V30 20 N 6.1264 10.5283 0.0 0
M  V30 21 C 7.1568 9.3837 0.0 0
M  V30 22 C 6.8964 11.8619 0.0 0
M  V30 23 C 8.5638 10.0102 0.0 0
M  V30 24 N 8.4027 11.5417 0.0 0
M  V30 25 C 4.4338 11.8989 0.0 0
M  V30 26 C 5.6796 12.8041 0.0 0
M  V30 27 C 3.0269 12.5252 0.0 0
M  V30 28 C 5.5187 14.3357 0.0 0
M  V30 29 C 2.8660 14.0568 0.0 0
M  V30 30 C 4.1119 14.9620 0.0 0
M  V30 31 C 3.0631 10.2062 0.0 0
M  V30 32 C 2.1580 11.4521 0.0 0
M  V30 33 C 2.4368 8.7994 0.0 0
M  V30 34 C 0.6263 11.2912 0.0 0
M  V30 35 C 0.9052 8.6385 0.0 0
M  V30 36 C 0.0000 9.8844 0.0 0
M  V30 37 C 4.7558 8.8356 0.0 0
M  V30 38 C 6.1626 8.2093 0.0 0
M  V30 39 C 3.5099 7.9304 0.0 0
M  V30 40 C 6.3237 6.6777 0.0 0
M  V30 41 C 3.6708 6.3988 0.0 0
M  V30 42 C 5.0776 5.7725 0.0 0
M  V30 43 C 19.2335 5.3901 0.0 0
M  V30 44 C 20.5671 4.6201 0.0 0
M  V30 45 C 19.2335 6.9301 0.0 0
M  V30 46 C 21.9008 5.3901 0.0 0
M  V30 47 C 20.5671 7.7001 0.0 0
M  V30 48 C 21.9008 6.9301 0.0 0
M  V30 49 C 10.9504 0.0000 0.0 0
M  V30 50 O 9.6167 0.7700 0.0 0
M  V30 51 O 12.2841 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 25
M  V30 3 1 1 31
M  V30 4 1 1 37
M  V30 5 1 2 3
M  V30 6 1 2 23
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 1 17 43
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 48
M  V30 53 1 49 50
M  V30 54 2 49 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Histidine, N-(carboxymethyl)-N-(3-phenylpropyl)glycyl-, 2-methyl ester, ace...
C20H26N4O5.2C2H4O2
1333227-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 10.5184 0.0 0 CFG=2
M  V30 2 C 3.9098 9.1848 0.0 0
M  V30 3 N 6.2198 10.5184 0.0 0
M  V30 4 C 3.9098 11.8522 0.0 0
M  V30 5 C 6.9898 9.1848 0.0 0
M  V30 6 O 4.6798 13.1859 0.0 0
M  V30 7 O 2.3698 11.8522 0.0 0
M  V30 8 C 8.5298 9.1848 0.0 0
M  V30 9 O 6.2198 7.8511 0.0 0
M  V30 10 C 3.9098 14.5195 0.0 0
M  V30 11 N 9.2998 7.8511 0.0 0
M  V30 12 C 10.8398 7.8511 0.0 0
M  V30 13 C 8.5298 6.5173 0.0 0
M  V30 14 C 11.6098 9.1848 0.0 0
M  V30 15 C 9.2998 5.1837 0.0 0
M  V30 16 C 13.1498 9.1848 0.0 0
M  V30 17 O 10.8398 5.1837 0.0 0
M  V30 18 O 8.5298 3.8501 0.0 0
M  V30 19 C 2.3698 9.1848 0.0 0
M  V30 20 C 1.4645 10.4307 0.0 0
M  V30 21 N 1.4645 7.9389 0.0 0
M  V30 22 N 0.0000 9.9548 0.0 0
M  V30 23 C 0.0000 8.4148 0.0 0
M  V30 24 C 13.9198 10.5184 0.0 0
M  V30 25 C 13.1498 11.8522 0.0 0
M  V30 26 C 15.4598 10.5184 0.0 0
M  V30 27 C 13.9198 13.1859 0.0 0
M  V30 28 C 16.2298 11.8522 0.0 0
M  V30 29 C 15.4598 13.1859 0.0 0
M  V30 30 C 8.1149 1.5400 0.0 0
M  V30 31 C 6.7812 2.3101 0.0 0
M  V30 32 O 9.4486 2.3101 0.0 0
M  V30 33 O 8.1149 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-10-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-11219011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for deprotection (67-82):
The tritylated compound or t-Bu-squaric derivative was deprotected in DCM
with TFA (5-50% volume). Triisopropylsilane was added until the yellow
solution became colorless. The mixture was stirred at room temperature
for 1h. The solvent was evaporated and the crude product was triturated
in diethyl ether and purified by preparative HPLC if necessary.
(R)-2-{2-[Carboxymethyl-(3-phenyl-propyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester•2CH3COOH (72) was obtained from (44) as a white powder
(100%). Purity 94% ;1H NMR (DMSO-d6) δ ppm: 1.79 (m, 2H), 2.57 (m, 2H),
2.90 (m, 2H), 3.11 (m, 2H), 3.62 (s, 3H), 3.70 (s, 2H), 3.78 (s, 2H),
4.70 (m, 1H), 7.17-7.30 (m, 5H), 7.41 (s, 1H), 8.86 (d, J = 7.2Hz, H),
8.98 (s, 1H). 13C NMR (DMSO-d6) δ ppm: 26.1, 26.8, 32.2, 51.2, 52.4,
54.7, 54.8, 55.7, 117.2, 126.0, 128.3, 128.4, 128.9, 133.7, 141.1, 167.5,
169.7, 170.6. LC tr = 3.06 min; MS (ESI+): m/z = 403 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H33N5O5S.CH2O2
2275632-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.9240 0.0 0 CFG=1
M  V30 2 N 6.6685 8.6940 0.0 0
M  V30 3 C 4.0010 8.6940 0.0 0 CFG=2
M  V30 4 C 6.6685 10.2341 0.0 0
M  V30 5 N 2.6673 7.9240 0.0 0
M  V30 6 C 4.0010 10.2341 0.0 0
M  V30 7 O 5.3348 11.0041 0.0 0
M  V30 8 N 1.3337 8.6940 0.0 0 CHG=1 VAL=4
M  V30 9 N 0.0000 9.4640 0.0 0 CHG=-1
M  V30 10 O 3.2913 4.6693 0.0 0
M  V30 11 S 9.3580 5.7390 0.0 0
M  V30 12 C 10.3479 4.5594 0.0 0
M  V30 13 O 5.2712 2.3100 0.0 0
M  V30 14 O 8.3044 2.8449 0.0 0
M  V30 15 C 7.0187 13.5661 0.0 0
M  V30 16 C 11.9711 11.3612 0.0 0
M  V30 17 C 12.8763 12.6071 0.0 0
M  V30 18 C 14.4079 12.4462 0.0 0
M  V30 19 C 5.3348 6.3840 0.0 0 CFG=2
M  V30 20 O 6.8514 6.6513 0.0 0
M  V30 21 C 4.8081 4.9368 0.0 0 CFG=2
M  V30 22 C 7.8413 5.4717 0.0 0 CFG=2
M  V30 23 C 5.7979 3.7572 0.0 0 CFG=2
M  V30 24 C 7.3145 4.0245 0.0 0 CFG=2
M  V30 25 C 8.0021 11.0041 0.0 0 CFG=1
M  V30 26 C 9.4091 10.3777 0.0 0
M  V30 27 N 8.1632 12.5356 0.0 0
M  V30 28 C 10.4395 11.5221 0.0 0 CFG=1
M  V30 29 C 9.6695 12.8558 0.0 0
M  V30 30 H 3.8182 6.6513 0.0 0
M  V30 31 C 7.2039 0.0000 0.0 0
M  V30 32 O 5.8703 0.7700 0.0 0
M  V30 33 O 8.5376 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=1
M  V30 7 2 4 7
M  V30 8 1 25 4 CFG=1
M  V30 9 2 5 8
M  V30 10 2 8 9
M  V30 11 1 21 10 CFG=1
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 23 13 CFG=1
M  V30 15 1 24 14 CFG=3
M  V30 16 1 15 27
M  V30 17 1 16 17
M  V30 18 1 28 16 CFG=3
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 30 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 31 32
M  V30 33 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 1 3 19 21 22 23 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H35N3O5S.2C2H4O2
2275632-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8614 9.1472 0.0 0 CFG=1
M  V30 2 N 7.3780 9.4145 0.0 0
M  V30 3 C 4.8715 10.3268 0.0 0 CFG=1
M  V30 4 C 7.9047 10.8617 0.0 0
M  V30 5 C 3.3549 10.0595 0.0 0
M  V30 6 N 5.3982 11.7740 0.0 0
M  V30 7 O 6.9148 12.0415 0.0 0
M  V30 8 O 6.6684 5.3901 0.0 0
M  V30 9 S 1.3336 8.4701 0.0 0
M  V30 10 C 0.0000 7.7001 0.0 0
M  V30 11 O 4.0009 3.8501 0.0 0
M  V30 12 O 1.3336 5.3901 0.0 0
M  V30 13 C 9.3734 13.8730 0.0 0
M  V30 14 C 13.2730 10.1072 0.0 0
M  V30 15 C 14.5496 10.9684 0.0 0
M  V30 16 C 15.9338 10.2933 0.0 0
M  V30 17 C 5.3347 7.7001 0.0 0 CFG=2
M  V30 18 O 4.0009 8.4701 0.0 0
M  V30 19 C 5.3347 6.1601 0.0 0 CFG=2
M  V30 20 C 2.6673 7.7001 0.0 0 CFG=2
M  V30 21 C 4.0009 5.3901 0.0 0 CFG=2
M  V30 22 C 2.6673 6.1601 0.0 0 CFG=2
M  V30 23 C 9.4213 11.1292 0.0 0 CFG=1
M  V30 24 C 10.5291 10.0593 0.0 0
M  V30 25 N 10.0964 12.5133 0.0 0
M  V30 26 C 11.8888 10.7824 0.0 0 CFG=1
M  V30 27 C 11.6215 12.2990 0.0 0
M  V30 28 H 6.8513 7.4326 0.0 0
M  V30 29 C 7.9669 1.5400 0.0 0
M  V30 30 C 6.6332 2.3101 0.0 0
M  V30 31 O 9.3006 2.3101 0.0 0
M  V30 32 O 7.9669 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 23 4 CFG=1
M  V30 9 1 19 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 20 9 CFG=1
M  V30 12 1 21 11 CFG=3
M  V30 13 1 22 12 CFG=1
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 26 14 CFG=3
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 28 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 2 29 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 1 3 17 19 20 21 22 23 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2275632-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2275632-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-527-CAS-19932903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of lincosamide antibiotics and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Myers, Andrew G.; Mitcheltree, Matthew James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019032956 A1 2019-02-14

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-hexylglycyl-1-(triphenylmethyl)-, 2-methyl e...
C36H42N4O5.CH2O2
1333227-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 12.8874 0.0 0
M  V30 2 C 9.7758 14.5626 0.0 0
M  V30 3 C 11.1826 13.9362 0.0 0 CFG=1
M  V30 4 N 11.3437 12.4046 0.0 0
M  V30 5 C 12.4286 14.8414 0.0 0
M  V30 6 C 12.7505 11.7783 0.0 0
M  V30 7 O 12.2675 16.3729 0.0 0
M  V30 8 O 13.8354 14.2150 0.0 0
M  V30 9 C 12.9114 10.2468 0.0 0
M  V30 10 O 13.9964 12.6835 0.0 0
M  V30 11 C 13.5134 17.2781 0.0 0
M  V30 12 N 14.3184 9.6203 0.0 0
M  V30 13 C 14.4793 8.0887 0.0 0
M  V30 14 C 15.5642 10.5255 0.0 0
M  V30 15 C 13.2334 7.1835 0.0 0
M  V30 16 C 16.9710 9.8992 0.0 0
M  V30 17 C 13.3944 5.6520 0.0 0
M  V30 18 O 18.2171 10.8044 0.0 0
M  V30 19 O 17.1321 8.3676 0.0 0
M  V30 20 C 12.1485 4.7468 0.0 0
M  V30 21 C 12.3094 3.2152 0.0 0
M  V30 22 C 11.0636 2.3100 0.0 0
M  V30 23 N 6.1600 12.8874 0.0 0
M  V30 24 C 7.0652 14.1333 0.0 0
M  V30 25 C 7.0652 11.6415 0.0 0
M  V30 26 C 8.5299 13.6574 0.0 0
M  V30 27 N 8.5299 12.1174 0.0 0
M  V30 28 C 4.6200 11.3474 0.0 0
M  V30 29 C 5.9538 10.5774 0.0 0
M  V30 30 C 3.2864 10.5774 0.0 0
M  V30 31 C 5.9538 9.0374 0.0 0
M  V30 32 C 3.2864 9.0374 0.0 0
M  V30 33 C 4.6200 8.2674 0.0 0
M  V30 34 C 3.0800 12.8874 0.0 0
M  V30 35 C 2.3100 11.5538 0.0 0
M  V30 36 C 2.3100 14.2211 0.0 0
M  V30 37 C 0.7700 11.5538 0.0 0
M  V30 38 C 0.7700 14.2211 0.0 0
M  V30 39 C 0.0000 12.8874 0.0 0
M  V30 40 C 4.6200 14.4274 0.0 0
M  V30 41 C 3.2864 15.1974 0.0 0
M  V30 42 C 5.9538 15.1974 0.0 0
M  V30 43 C 3.2864 16.7374 0.0 0
M  V30 44 C 5.9538 16.7374 0.0 0
M  V30 45 C 4.6200 17.5074 0.0 0
M  V30 46 C 9.1085 0.0000 0.0 0
M  V30 47 O 7.7749 0.7700 0.0 0
M  V30 48 O 10.4422 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 28
M  V30 3 1 1 34
M  V30 4 1 1 40
M  V30 5 1 2 3
M  V30 6 1 2 26
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 49 1 46 47
M  V30 50 2 46 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-hexylglycyl-, 2-methyl ester, 2,2,2-trifluor...
C17H28N4O5.C2HF3O2
1333227-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 11.8521 0.0 0 CFG=1
M  V30 2 C 3.9098 10.5185 0.0 0
M  V30 3 N 6.2198 11.8521 0.0 0
M  V30 4 C 3.9098 13.1859 0.0 0
M  V30 5 C 6.9898 10.5185 0.0 0
M  V30 6 O 4.6798 14.5196 0.0 0
M  V30 7 O 2.3698 13.1859 0.0 0
M  V30 8 C 8.5298 10.5185 0.0 0
M  V30 9 O 6.2198 9.1848 0.0 0
M  V30 10 C 3.9098 15.8532 0.0 0
M  V30 11 N 9.2998 9.1848 0.0 0
M  V30 12 C 10.8398 9.1848 0.0 0
M  V30 13 C 8.5298 7.8510 0.0 0
M  V30 14 C 11.6098 10.5185 0.0 0
M  V30 15 C 9.2998 6.5174 0.0 0
M  V30 16 C 13.1498 10.5185 0.0 0
M  V30 17 O 8.5298 5.1837 0.0 0
M  V30 18 O 10.8398 6.5174 0.0 0
M  V30 19 C 13.9198 11.8521 0.0 0
M  V30 20 C 15.4598 11.8521 0.0 0
M  V30 21 C 16.2298 13.1859 0.0 0
M  V30 22 C 2.3698 10.5185 0.0 0
M  V30 23 C 1.4645 11.7643 0.0 0
M  V30 24 N 1.4645 9.2726 0.0 0
M  V30 25 N 0.0000 11.2885 0.0 0
M  V30 26 C 0.0000 9.7485 0.0 0
M  V30 27 C 7.4481 2.3101 0.0 0
M  V30 28 C 8.7818 1.5400 0.0 0
M  V30 29 F 8.2181 3.6437 0.0 0
M  V30 30 F 6.1144 3.0801 0.0 0
M  V30 31 F 6.6781 0.9764 0.0 0
M  V30 32 O 10.1154 2.3101 0.0 0
M  V30 33 O 8.7818 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 31
M  V30 31 1 28 32
M  V30 32 2 28 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333227-22-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-487688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Exemple 7: synthesis of final products
according to the invention (67-82). General procedure for deprotection
(67-82): The tritylated compound or t-Bu-squaric derivative was
deprotected in DCM with TFA (5-50% volume). Triisopropylsilane was added
until the yellow solution became colorless. The mixture was stirred at
room temperature for 1H. The solvent was evaporated and the crude product
was triturated in diethyl ether and purified by preparative HPLC if
necessary. Reactant:
(S)-2-[2-(Carboxymethyl-pyridin-4-ylmethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (59). Reactant:
(S)-2-[2-(Carboxymethyl-hexyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester as the formiate salt (52).
(S)-2-[2-(Carboxymethyl-hexyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (73) as the trifluoroacetate salt was obtained as an
oil (100%). Purity: 98%. 1H NMR (DMSO-d6) δ ppm: 8.99 (s, 1H), 8.80 (m,
1H), 7.41 (s, 1H), 4.70 (m, 1H), 3.76 (s, 2H), 3.65 (s, 5H), 3.19 (dd, J=
5.7 Hz and J - 15.3 Hz, 1H), 3 .07(dd, J= 9.3 Hz and J= 15.3 Hz, 1H),
2.85 (m, 2H), 1.45 (m, 2H), 1.22 (m, 6H), 0.85 (t, J= 6.3 Hz, 3H); 13C
NMR (DMSO-d6) δ ppm: 171.1, 170.6, 168.5, 134.5, 129.0, 117.1, 56.1,
54.9, 54.7, 52.4, 51.1, 30.9, 26.5, 26.1, 25.9, 21.9,13.9; LC: tr =
3.03min; MS (ESI+): m/z - 369 (M+H)+. IC50: 0.4 μM. pIC50: 6.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-hexylglycyl-1-(triphenylmethyl)-, 2-methyl e...
C36H42N4O5.CH2O2
1333227-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 12.8874 0.0 0
M  V30 2 C 9.7758 14.5626 0.0 0
M  V30 3 C 11.1826 13.9362 0.0 0 CFG=1
M  V30 4 N 11.3437 12.4046 0.0 0
M  V30 5 C 12.4286 14.8414 0.0 0
M  V30 6 C 12.7505 11.7783 0.0 0
M  V30 7 O 12.2675 16.3729 0.0 0
M  V30 8 O 13.8354 14.2150 0.0 0
M  V30 9 C 12.9114 10.2468 0.0 0
M  V30 10 O 13.9964 12.6835 0.0 0
M  V30 11 C 13.5134 17.2781 0.0 0
M  V30 12 N 14.3184 9.6203 0.0 0
M  V30 13 C 14.4793 8.0887 0.0 0
M  V30 14 C 15.5642 10.5255 0.0 0
M  V30 15 C 13.2334 7.1835 0.0 0
M  V30 16 C 16.9710 9.8992 0.0 0
M  V30 17 C 13.3944 5.6520 0.0 0
M  V30 18 O 18.2171 10.8044 0.0 0
M  V30 19 O 17.1321 8.3676 0.0 0
M  V30 20 C 12.1485 4.7468 0.0 0
M  V30 21 C 12.3094 3.2152 0.0 0
M  V30 22 C 11.0636 2.3100 0.0 0
M  V30 23 N 6.1600 12.8874 0.0 0
M  V30 24 C 7.0652 14.1333 0.0 0
M  V30 25 C 7.0652 11.6415 0.0 0
M  V30 26 C 8.5299 13.6574 0.0 0
M  V30 27 N 8.5299 12.1174 0.0 0
M  V30 28 C 4.6200 11.3474 0.0 0
M  V30 29 C 5.9538 10.5774 0.0 0
M  V30 30 C 3.2864 10.5774 0.0 0
M  V30 31 C 5.9538 9.0374 0.0 0
M  V30 32 C 3.2864 9.0374 0.0 0
M  V30 33 C 4.6200 8.2674 0.0 0
M  V30 34 C 3.0800 12.8874 0.0 0
M  V30 35 C 2.3100 11.5538 0.0 0
M  V30 36 C 2.3100 14.2211 0.0 0
M  V30 37 C 0.7700 11.5538 0.0 0
M  V30 38 C 0.7700 14.2211 0.0 0
M  V30 39 C 0.0000 12.8874 0.0 0
M  V30 40 C 4.6200 14.4274 0.0 0
M  V30 41 C 3.2864 15.1974 0.0 0
M  V30 42 C 5.9538 15.1974 0.0 0
M  V30 43 C 3.2864 16.7374 0.0 0
M  V30 44 C 5.9538 16.7374 0.0 0
M  V30 45 C 4.6200 17.5074 0.0 0
M  V30 46 C 9.1085 0.0000 0.0 0
M  V30 47 O 7.7749 0.7700 0.0 0
M  V30 48 O 10.4422 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 28
M  V30 3 1 1 34
M  V30 4 1 1 40
M  V30 5 1 2 3
M  V30 6 1 2 26
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 49 1 46 47
M  V30 50 2 46 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-hexylglycyl-, 2-methyl ester, 2,2,2-trifluor...
C17H28N4O5.C2HF3O2
1333227-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 11.8521 0.0 0 CFG=1
M  V30 2 C 3.9098 10.5185 0.0 0
M  V30 3 N 6.2198 11.8521 0.0 0
M  V30 4 C 3.9098 13.1859 0.0 0
M  V30 5 C 6.9898 10.5185 0.0 0
M  V30 6 O 4.6798 14.5196 0.0 0
M  V30 7 O 2.3698 13.1859 0.0 0
M  V30 8 C 8.5298 10.5185 0.0 0
M  V30 9 O 6.2198 9.1848 0.0 0
M  V30 10 C 3.9098 15.8532 0.0 0
M  V30 11 N 9.2998 9.1848 0.0 0
M  V30 12 C 10.8398 9.1848 0.0 0
M  V30 13 C 8.5298 7.8510 0.0 0
M  V30 14 C 11.6098 10.5185 0.0 0
M  V30 15 C 9.2998 6.5174 0.0 0
M  V30 16 C 13.1498 10.5185 0.0 0
M  V30 17 O 8.5298 5.1837 0.0 0
M  V30 18 O 10.8398 6.5174 0.0 0
M  V30 19 C 13.9198 11.8521 0.0 0
M  V30 20 C 15.4598 11.8521 0.0 0
M  V30 21 C 16.2298 13.1859 0.0 0
M  V30 22 C 2.3698 10.5185 0.0 0
M  V30 23 C 1.4645 11.7643 0.0 0
M  V30 24 N 1.4645 9.2726 0.0 0
M  V30 25 N 0.0000 11.2885 0.0 0
M  V30 26 C 0.0000 9.7485 0.0 0
M  V30 27 C 7.4481 2.3101 0.0 0
M  V30 28 C 8.7818 1.5400 0.0 0
M  V30 29 F 8.2181 3.6437 0.0 0
M  V30 30 F 6.1144 3.0801 0.0 0
M  V30 31 F 6.6781 0.9764 0.0 0
M  V30 32 O 10.1154 2.3101 0.0 0
M  V30 33 O 8.7818 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 31
M  V30 31 1 28 32
M  V30 32 2 28 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333227-22-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-13333996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for deprotection (67-82):
The tritylated compound or t-Bu-squaric derivative was deprotected in DCM
with TFA (5-50% volume). Triisopropylsilane was added until the yellow
solution became colorless. The mixture was stirred at room temperature
for 1h. The solvent was evaporated and the crude product was triturated
in diethyl ether and purified by preparative HPLC if necessary.
(S)-2-[2-(Carboxymethyl-hexyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (73) as the trifluoroacetate salt was obtained from
(52) as an oil (100%). Purity : 98% ; 1H NMR (DMSO-d6) δ ppm: 8.99 (s,
1H), 8.80 (m, 1H), 7.41 (s, 1H), 4.70 (m, 1H), 3.76 (s, 2H), 3.65 (s,
5H), 3.19 (dd, J = 5.7 Hz and J = 15.3 Hz, 1H), 3.07(dd, J = 9.3 Hz and J
= 15.3 Hz, 1H), 2.85 (m, 2H), 1.45 (m, 2H), 1.22 (m, 6H), 0.85 (t, J =
6.3 Hz, 3H); 13C NMR (DMSO-d6) δ ppm : 171.1, 170.6, 168.5, 134.5, 129.0,
117.1, 56.1, 54.9, 54.7, 52.4, 51.1, 30.9, 26.5, 26.1, 25.9, 21.9, 13.9;
LC : tr = 3.03min; MS (ESI+) : m/z = 369 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C46H58N7O9.CHO2
2735752-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  65 70 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 13.4478 0.0 0
M  V30 2 O 10.6783 7.1326 0.0 0
M  V30 3 C 4.7350 6.0706 0.0 0
M  V30 4 C 3.2407 5.6979 0.0 0
M  V30 5 O 4.5280 4.1015 0.0 0
M  V30 6 C 2.6675 15.7579 0.0 0
M  V30 7 N 1.3337 14.9878 0.0 0
M  V30 8 O 2.6675 17.2979 0.0 0
M  V30 9 C 0.0000 15.7579 0.0 0
M  V30 10 O 5.3348 17.2979 0.0 0
M  V30 11 C 6.6685 18.0679 0.0 0
M  V30 12 O 5.5259 2.3100 0.0 0
M  V30 13 N 14.6708 10.3678 0.0 0 CHG=1 VAL=4
M  V30 14 C 16.0044 9.5977 0.0 0
M  V30 15 C 15.4408 11.7016 0.0 0
M  V30 16 C 13.9008 9.0341 0.0 0
M  V30 17 N 21.3393 12.6778 0.0 0
M  V30 18 C 22.6729 11.9078 0.0 0
M  V30 19 C 24.0067 12.6778 0.0 0 CFG=2
M  V30 20 O 22.6729 10.3678 0.0 0
M  V30 21 N 25.3404 11.9078 0.0 0
M  V30 22 C 24.0067 14.2178 0.0 0
M  V30 23 C 26.6741 12.6778 0.0 0
M  V30 24 O 28.0077 11.9078 0.0 0
M  V30 25 O 26.6741 14.2178 0.0 0
M  V30 26 C 29.3416 12.6778 0.0 0
M  V30 27 C 30.1116 11.3441 0.0 0
M  V30 28 C 30.6752 13.4478 0.0 0
M  V30 29 C 28.5715 14.0116 0.0 0
M  V30 30 C 6.6685 10.3678 0.0 0
M  V30 31 C 8.0023 11.1378 0.0 0
M  V30 32 C 6.9887 8.8615 0.0 0
M  V30 33 N 5.3348 11.1378 0.0 0
M  V30 34 C 8.0023 12.6778 0.0 0
M  V30 35 C 9.1467 10.1073 0.0 0
M  V30 36 N 8.5204 8.7005 0.0 0
M  V30 37 C 6.0836 7.6156 0.0 0
M  V30 38 C 5.3348 12.6778 0.0 0
M  V30 39 C 6.6685 13.4478 0.0 0
M  V30 40 C 9.1467 7.2936 0.0 0
M  V30 41 C 6.7099 6.2086 0.0 0
M  V30 42 C 4.0011 13.4478 0.0 0
M  V30 43 C 6.6685 14.9878 0.0 0
M  V30 44 C 8.2415 6.0477 0.0 0
M  V30 45 C 5.8047 4.9627 0.0 0 CFG=1
M  V30 46 C 4.0011 14.9878 0.0 0
M  V30 47 C 5.3348 15.7579 0.0 0
M  V30 48 C 8.8679 4.6409 0.0 0
M  V30 49 C 6.4310 3.5559 0.0 0
M  V30 50 O 7.9627 3.3948 0.0 0
M  V30 51 N 10.6696 12.6778 0.0 0
M  V30 52 C 10.6696 11.1378 0.0 0
M  V30 53 C 12.0033 13.4478 0.0 0
M  V30 54 C 12.0033 10.3678 0.0 0
M  V30 55 C 13.3371 12.6778 0.0 0
M  V30 56 C 13.3371 11.1378 0.0 0
M  V30 57 C 17.3381 10.3678 0.0 0
M  V30 58 C 17.3381 11.9078 0.0 0
M  V30 59 C 18.6719 9.5977 0.0 0
M  V30 60 C 18.6719 12.6778 0.0 0
M  V30 61 C 20.0056 10.3678 0.0 0
M  V30 62 C 20.0056 11.9078 0.0 0
M  V30 63 C 15.3376 0.0000 0.0 0
M  V30 64 O 14.0039 0.7700 0.0 0 CHG=-1
M  V30 65 O 16.6713 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 34
M  V30 2 1 1 51
M  V30 3 2 2 40
M  V30 4 1 3 4
M  V30 5 1 45 3 CFG=3
M  V30 6 1 45 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 46
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 47
M  V30 13 2 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 56
M  V30 18 1 14 57
M  V30 19 1 17 18
M  V30 20 1 17 62
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22 CFG=3
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 2 30 33
M  V30 35 2 31 34
M  V30 36 1 31 35
M  V30 37 1 32 36
M  V30 38 2 32 37
M  V30 39 1 33 38
M  V30 40 1 34 39
M  V30 41 1 35 36
M  V30 42 1 36 40
M  V30 43 1 37 41
M  V30 44 1 38 39
M  V30 45 2 38 42
M  V30 46 2 39 43
M  V30 47 1 40 44
M  V30 48 2 41 44
M  V30 49 1 41 45
M  V30 50 1 42 46
M  V30 51 1 43 47
M  V30 52 1 44 48
M  V30 53 1 45 49
M  V30 54 2 46 47
M  V30 55 1 48 50
M  V30 56 1 49 50
M  V30 57 1 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 56
M  V30 63 2 57 58
M  V30 64 1 57 59
M  V30 65 1 58 60
M  V30 66 2 59 61
M  V30 67 2 60 62
M  V30 68 1 61 62
M  V30 69 1 63 64
M  V30 70 2 63 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C41H50N7O7.C2F3O2
2735752-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  62 67 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 16.3215 0.0 0
M  V30 2 O 10.6782 10.0063 0.0 0
M  V30 3 C 4.7348 8.9443 0.0 0
M  V30 4 C 3.2405 8.5716 0.0 0
M  V30 5 O 4.5278 6.9752 0.0 0
M  V30 6 C 2.6673 18.6315 0.0 0
M  V30 7 N 1.3337 17.8615 0.0 0
M  V30 8 O 2.6673 20.1715 0.0 0
M  V30 9 C 0.0000 18.6315 0.0 0
M  V30 10 O 5.3348 20.1715 0.0 0
M  V30 11 C 6.6685 20.9416 0.0 0
M  V30 12 O 5.5258 5.1837 0.0 0
M  V30 13 N 14.6706 13.2414 0.0 0 CHG=1 VAL=4
M  V30 14 C 16.0044 12.4714 0.0 0
M  V30 15 C 15.4406 14.5752 0.0 0
M  V30 16 C 13.9006 11.9078 0.0 0
M  V30 17 N 21.3392 15.5515 0.0 0
M  V30 18 C 22.6729 14.7815 0.0 0
M  V30 19 C 24.0065 15.5515 0.0 0 CFG=1
M  V30 20 O 22.6729 13.2414 0.0 0
M  V30 21 C 25.3402 14.7815 0.0 0
M  V30 22 N 24.0065 17.0915 0.0 0
M  V30 23 C 6.6685 13.2414 0.0 0
M  V30 24 C 8.0021 14.0114 0.0 0
M  V30 25 C 6.9886 11.7351 0.0 0
M  V30 26 N 5.3348 14.0114 0.0 0
M  V30 27 C 8.0021 15.5515 0.0 0
M  V30 28 C 9.1467 12.9810 0.0 0
M  V30 29 N 8.5202 11.5742 0.0 0
M  V30 30 C 6.0834 10.4893 0.0 0
M  V30 31 C 5.3348 15.5515 0.0 0
M  V30 32 C 6.6685 16.3215 0.0 0
M  V30 33 C 9.1467 10.1672 0.0 0
M  V30 34 C 6.7097 9.0823 0.0 0
M  V30 35 C 4.0010 16.3215 0.0 0
M  V30 36 C 6.6685 17.8615 0.0 0
M  V30 37 C 8.2414 8.9214 0.0 0
M  V30 38 C 5.8047 7.8364 0.0 0 CFG=1
M  V30 39 C 4.0010 17.8615 0.0 0
M  V30 40 C 5.3348 18.6315 0.0 0
M  V30 41 C 8.8678 7.5145 0.0 0
M  V30 42 C 6.4310 6.4296 0.0 0
M  V30 43 O 7.9625 6.2685 0.0 0
M  V30 44 N 10.6696 15.5515 0.0 0
M  V30 45 C 10.6696 14.0114 0.0 0
M  V30 46 C 12.0033 16.3215 0.0 0
M  V30 47 C 12.0033 13.2414 0.0 0
M  V30 48 C 13.3369 15.5515 0.0 0
M  V30 49 C 13.3369 14.0114 0.0 0
M  V30 50 C 17.3381 13.2414 0.0 0
M  V30 51 C 17.3381 14.7815 0.0 0
M  V30 52 C 18.6717 12.4714 0.0 0
M  V30 53 C 18.6717 15.5515 0.0 0
M  V30 54 C 20.0054 13.2414 0.0 0
M  V30 55 C 20.0054 14.7815 0.0 0
M  V30 56 C 12.0033 2.3101 0.0 0
M  V30 57 C 13.3369 1.5400 0.0 0
M  V30 58 F 12.7733 3.6437 0.0 0
M  V30 59 F 10.6696 3.0801 0.0 0
M  V30 60 F 11.2332 0.9764 0.0 0
M  V30 61 O 14.6706 2.3101 0.0 0 CHG=-1
M  V30 62 O 13.3369 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 1 44
M  V30 3 2 2 33
M  V30 4 1 3 4
M  V30 5 1 38 3 CFG=3
M  V30 6 1 38 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 39
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 40
M  V30 13 2 12 42
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 49
M  V30 18 1 14 50
M  V30 19 1 17 18
M  V30 20 1 17 55
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22 CFG=1
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 2 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 25 30
M  V30 32 1 26 31
M  V30 33 1 27 32
M  V30 34 1 28 29
M  V30 35 1 29 33
M  V30 36 1 30 34
M  V30 37 1 31 32
M  V30 38 2 31 35
M  V30 39 2 32 36
M  V30 40 1 33 37
M  V30 41 2 34 37
M  V30 42 1 34 38
M  V30 43 1 35 39
M  V30 44 1 36 40
M  V30 45 1 37 41
M  V30 46 1 38 42
M  V30 47 2 39 40
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 50 1 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 49
M  V30 56 2 50 51
M  V30 57 1 50 52
M  V30 58 1 51 53
M  V30 59 2 52 54
M  V30 60 2 53 55
M  V30 61 1 54 55
M  V30 62 1 56 57
M  V30 63 1 56 58
M  V30 64 1 56 59
M  V30 65 1 56 60
M  V30 66 1 57 61
M  V30 67 2 57 62
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2735752-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735752-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32219700
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specific conjugation of an antibody
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Liu, Xiaolei; Zhang, Lingli; Huang,
Yuanyuan; Li, Wenjun; Ye, Hangbo; Wang, Juan; Guo, Huihui; Zhou, You
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022078524 A2 2022-04-21

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C46H58N7O9.CHO2
2735752-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  65 70 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 13.4478 0.0 0
M  V30 2 O 10.6783 7.1326 0.0 0
M  V30 3 C 4.7350 6.0706 0.0 0
M  V30 4 C 3.2407 5.6979 0.0 0
M  V30 5 O 4.5280 4.1015 0.0 0
M  V30 6 C 2.6675 15.7579 0.0 0
M  V30 7 N 1.3337 14.9878 0.0 0
M  V30 8 O 2.6675 17.2979 0.0 0
M  V30 9 C 0.0000 15.7579 0.0 0
M  V30 10 O 5.3348 17.2979 0.0 0
M  V30 11 C 6.6685 18.0679 0.0 0
M  V30 12 O 5.5259 2.3100 0.0 0
M  V30 13 N 14.6708 10.3678 0.0 0 CHG=1 VAL=4
M  V30 14 C 16.0044 9.5977 0.0 0
M  V30 15 C 15.4408 11.7016 0.0 0
M  V30 16 C 13.9008 9.0341 0.0 0
M  V30 17 N 21.3393 12.6778 0.0 0
M  V30 18 C 22.6729 11.9078 0.0 0
M  V30 19 C 24.0067 12.6778 0.0 0 CFG=2
M  V30 20 O 22.6729 10.3678 0.0 0
M  V30 21 N 25.3404 11.9078 0.0 0
M  V30 22 C 24.0067 14.2178 0.0 0
M  V30 23 C 26.6741 12.6778 0.0 0
M  V30 24 O 28.0077 11.9078 0.0 0
M  V30 25 O 26.6741 14.2178 0.0 0
M  V30 26 C 29.3416 12.6778 0.0 0
M  V30 27 C 30.1116 11.3441 0.0 0
M  V30 28 C 30.6752 13.4478 0.0 0
M  V30 29 C 28.5715 14.0116 0.0 0
M  V30 30 C 6.6685 10.3678 0.0 0
M  V30 31 C 8.0023 11.1378 0.0 0
M  V30 32 C 6.9887 8.8615 0.0 0
M  V30 33 N 5.3348 11.1378 0.0 0
M  V30 34 C 8.0023 12.6778 0.0 0
M  V30 35 C 9.1467 10.1073 0.0 0
M  V30 36 N 8.5204 8.7005 0.0 0
M  V30 37 C 6.0836 7.6156 0.0 0
M  V30 38 C 5.3348 12.6778 0.0 0
M  V30 39 C 6.6685 13.4478 0.0 0
M  V30 40 C 9.1467 7.2936 0.0 0
M  V30 41 C 6.7099 6.2086 0.0 0
M  V30 42 C 4.0011 13.4478 0.0 0
M  V30 43 C 6.6685 14.9878 0.0 0
M  V30 44 C 8.2415 6.0477 0.0 0
M  V30 45 C 5.8047 4.9627 0.0 0 CFG=1
M  V30 46 C 4.0011 14.9878 0.0 0
M  V30 47 C 5.3348 15.7579 0.0 0
M  V30 48 C 8.8679 4.6409 0.0 0
M  V30 49 C 6.4310 3.5559 0.0 0
M  V30 50 O 7.9627 3.3948 0.0 0
M  V30 51 N 10.6696 12.6778 0.0 0
M  V30 52 C 10.6696 11.1378 0.0 0
M  V30 53 C 12.0033 13.4478 0.0 0
M  V30 54 C 12.0033 10.3678 0.0 0
M  V30 55 C 13.3371 12.6778 0.0 0
M  V30 56 C 13.3371 11.1378 0.0 0
M  V30 57 C 17.3381 10.3678 0.0 0
M  V30 58 C 17.3381 11.9078 0.0 0
M  V30 59 C 18.6719 9.5977 0.0 0
M  V30 60 C 18.6719 12.6778 0.0 0
M  V30 61 C 20.0056 10.3678 0.0 0
M  V30 62 C 20.0056 11.9078 0.0 0
M  V30 63 C 15.3376 0.0000 0.0 0
M  V30 64 O 14.0039 0.7700 0.0 0 CHG=-1
M  V30 65 O 16.6713 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 34
M  V30 2 1 1 51
M  V30 3 2 2 40
M  V30 4 1 3 4
M  V30 5 1 45 3 CFG=3
M  V30 6 1 45 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 46
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 47
M  V30 13 2 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 56
M  V30 18 1 14 57
M  V30 19 1 17 18
M  V30 20 1 17 62
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22 CFG=3
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 2 30 33
M  V30 35 2 31 34
M  V30 36 1 31 35
M  V30 37 1 32 36
M  V30 38 2 32 37
M  V30 39 1 33 38
M  V30 40 1 34 39
M  V30 41 1 35 36
M  V30 42 1 36 40
M  V30 43 1 37 41
M  V30 44 1 38 39
M  V30 45 2 38 42
M  V30 46 2 39 43
M  V30 47 1 40 44
M  V30 48 2 41 44
M  V30 49 1 41 45
M  V30 50 1 42 46
M  V30 51 1 43 47
M  V30 52 1 44 48
M  V30 53 1 45 49
M  V30 54 2 46 47
M  V30 55 1 48 50
M  V30 56 1 49 50
M  V30 57 1 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 56
M  V30 63 2 57 58
M  V30 64 1 57 59
M  V30 65 1 58 60
M  V30 66 2 59 61
M  V30 67 2 60 62
M  V30 68 1 61 62
M  V30 69 1 63 64
M  V30 70 2 63 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C41H50N7O7.C2HF3O2.C2F3O2
2735752-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  69 73 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 24.7916 0.0 0
M  V30 2 C 13.3369 24.0216 0.0 0
M  V30 3 F 12.7733 26.1253 0.0 0
M  V30 4 F 10.6696 25.5616 0.0 0
M  V30 5 F 11.2332 23.4579 0.0 0
M  V30 6 O 14.6706 24.7916 0.0 0
M  V30 7 O 13.3369 22.4816 0.0 0
M  V30 8 C 9.3358 16.3215 0.0 0
M  V30 9 O 10.6782 10.0063 0.0 0
M  V30 10 C 4.7348 8.9443 0.0 0
M  V30 11 C 3.2405 8.5716 0.0 0
M  V30 12 O 4.5278 6.9752 0.0 0
M  V30 13 C 2.6673 18.6315 0.0 0
M  V30 14 N 1.3337 17.8615 0.0 0
M  V30 15 O 2.6673 20.1715 0.0 0
M  V30 16 C 0.0000 18.6315 0.0 0
M  V30 17 O 5.3348 20.1715 0.0 0
M  V30 18 C 6.6685 20.9416 0.0 0
M  V30 19 O 5.5258 5.1837 0.0 0
M  V30 20 N 14.6706 13.2414 0.0 0 CHG=1 VAL=4
M  V30 21 C 16.0044 12.4714 0.0 0
M  V30 22 C 15.4406 14.5752 0.0 0
M  V30 23 C 13.9006 11.9078 0.0 0
M  V30 24 N 21.3392 15.5515 0.0 0
M  V30 25 C 22.6729 14.7815 0.0 0
M  V30 26 C 24.0065 15.5515 0.0 0 CFG=1
M  V30 27 O 22.6729 13.2414 0.0 0
M  V30 28 C 25.3402 14.7815 0.0 0
M  V30 29 N 24.0065 17.0915 0.0 0
M  V30 30 C 6.6685 13.2414 0.0 0
M  V30 31 C 8.0021 14.0114 0.0 0
M  V30 32 C 6.9886 11.7351 0.0 0
M  V30 33 N 5.3348 14.0114 0.0 0
M  V30 34 C 8.0021 15.5515 0.0 0
M  V30 35 C 9.1467 12.9810 0.0 0
M  V30 36 N 8.5202 11.5742 0.0 0
M  V30 37 C 6.0834 10.4893 0.0 0
M  V30 38 C 5.3348 15.5515 0.0 0
M  V30 39 C 6.6685 16.3215 0.0 0
M  V30 40 C 9.1467 10.1672 0.0 0
M  V30 41 C 6.7097 9.0823 0.0 0
M  V30 42 C 4.0010 16.3215 0.0 0
M  V30 43 C 6.6685 17.8615 0.0 0
M  V30 44 C 8.2414 8.9214 0.0 0
M  V30 45 C 5.8047 7.8364 0.0 0 CFG=1
M  V30 46 C 4.0010 17.8615 0.0 0
M  V30 47 C 5.3348 18.6315 0.0 0
M  V30 48 C 8.8678 7.5145 0.0 0
M  V30 49 C 6.4310 6.4296 0.0 0
M  V30 50 O 7.9625 6.2685 0.0 0
M  V30 51 N 10.6696 15.5515 0.0 0
M  V30 52 C 10.6696 14.0114 0.0 0
M  V30 53 C 12.0033 16.3215 0.0 0
M  V30 54 C 12.0033 13.2414 0.0 0
M  V30 55 C 13.3369 15.5515 0.0 0
M  V30 56 C 13.3369 14.0114 0.0 0
M  V30 57 C 17.3381 13.2414 0.0 0
M  V30 58 C 17.3381 14.7815 0.0 0
M  V30 59 C 18.6717 12.4714 0.0 0
M  V30 60 C 18.6717 15.5515 0.0 0
M  V30 61 C 20.0054 13.2414 0.0 0
M  V30 62 C 20.0054 14.7815 0.0 0
M  V30 63 C 12.0033 2.3101 0.0 0
M  V30 64 C 13.3369 1.5400 0.0 0
M  V30 65 F 12.7733 3.6437 0.0 0
M  V30 66 F 10.6696 3.0801 0.0 0
M  V30 67 F 11.2332 0.9764 0.0 0
M  V30 68 O 14.6706 2.3101 0.0 0 CHG=-1
M  V30 69 O 13.3369 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 8 34
M  V30 8 1 8 51
M  V30 9 2 9 40
M  V30 10 1 10 11
M  V30 11 1 45 10 CFG=3
M  V30 12 1 45 12 CFG=1
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 46
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 47
M  V30 19 2 19 49
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 56
M  V30 24 1 21 57
M  V30 25 1 24 25
M  V30 26 1 24 62
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 26 29 CFG=1
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 2 31 34
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 2 32 37
M  V30 38 1 33 38
M  V30 39 1 34 39
M  V30 40 1 35 36
M  V30 41 1 36 40
M  V30 42 1 37 41
M  V30 43 1 38 39
M  V30 44 2 38 42
M  V30 45 2 39 43
M  V30 46 1 40 44
M  V30 47 2 41 44
M  V30 48 1 41 45
M  V30 49 1 42 46
M  V30 50 1 43 47
M  V30 51 1 44 48
M  V30 52 1 45 49
M  V30 53 2 46 47
M  V30 54 1 48 50
M  V30 55 1 49 50
M  V30 56 1 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 55
M  V30 60 1 54 56
M  V30 61 1 55 56
M  V30 62 2 57 58
M  V30 63 1 57 59
M  V30 64 1 58 60
M  V30 65 2 59 61
M  V30 66 2 60 62
M  V30 67 1 61 62
M  V30 68 1 63 64
M  V30 69 1 63 65
M  V30 70 1 63 66
M  V30 71 1 63 67
M  V30 72 1 64 68
M  V30 73 2 64 69
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2735752-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735752-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24850012
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugates of a cell-binding molecule with camptothecin analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Ye, Hangbo; Huang, Yuanyuan; Xu, Yifang;
Zhao, Gengxiang; Chen, Diancheng; Guo, Huihui; Kong, Xiangfei; Li,
Wenjun; Bai, Lu; Cai, Xiang; Zhang, Xiuzhen; Jia, Junxiang; Guo,
Zhixiang; Huang, Shangma; Wang, Xiaoxu; Zheng, Jun; Du, Yong; Li, Yanhua;
Zheng, Yunxia; Lin, Chen; Chen, Xiaoxiao; Zheng, Wei; Jiang, Xinyan;
Zhang, Lingli; Ye, Riping; Chen, Miaomiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021212638 A1 2021-10-28

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[4-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2H-py...
C22H30N4O5.CH2O2
3023411-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 2.3100 0.0 0
M  V30 2 C 15.4000 7.6447 0.0 0
M  V30 3 O 16.1700 8.9785 0.0 0
M  V30 4 O 16.1700 6.3111 0.0 0
M  V30 5 C 17.7100 8.9785 0.0 0
M  V30 6 C 17.7100 7.4385 0.0 0
M  V30 7 C 19.2500 8.9785 0.0 0
M  V30 8 C 17.7100 10.5185 0.0 0
M  V30 9 O 0.0000 4.9775 0.0 0
M  V30 10 C 8.4700 6.3111 0.0 0
M  V30 11 C 6.9300 6.3111 0.0 0
M  V30 12 C 9.2400 7.6447 0.0 0
M  V30 13 O 9.2400 4.9775 0.0 0
M  V30 14 N 6.1600 4.9775 0.0 0
M  V30 15 C 6.1600 7.6447 0.0 0
M  V30 16 C 8.4700 8.9785 0.0 0
M  V30 17 C 8.4700 3.6438 0.0 0
M  V30 18 C 6.9300 3.6438 0.0 0
M  V30 19 N 6.9300 8.9785 0.0 0
M  V30 20 C 10.7800 7.6447 0.0 0
M  V30 21 C 11.5500 6.3111 0.0 0
M  V30 22 C 11.5500 8.9785 0.0 0
M  V30 23 C 13.0900 6.3111 0.0 0
M  V30 24 C 13.0900 8.9785 0.0 0
M  V30 25 N 13.8600 7.6447 0.0 0
M  V30 26 C 4.6200 4.9775 0.0 0
M  V30 27 C 3.8500 3.6438 0.0 0
M  V30 28 C 3.8500 6.3111 0.0 0
M  V30 29 N 2.3100 3.6438 0.0 0
M  V30 30 C 2.3100 6.3111 0.0 0
M  V30 31 C 1.5400 4.9775 0.0 0
M  V30 32 C 9.6250 0.0000 0.0 0
M  V30 33 O 8.2913 0.7700 0.0 0
M  V30 34 O 10.9587 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 27
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 31
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 20
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 26
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Piperidinedione, 3-[2,3-dihydro-8-(4-piperidinyl)-4H-pyrido[4,3-b]-1,4-ox...
C17H22N4O3.C2HF3O2
3023410-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 5.1837 0.0 0
M  V30 2 O 13.8600 7.8512 0.0 0
M  V30 3 C 5.3900 9.1848 0.0 0
M  V30 4 C 6.9300 9.1848 0.0 0
M  V30 5 C 4.6200 10.5184 0.0 0
M  V30 6 O 4.6200 7.8512 0.0 0
M  V30 7 N 7.7000 7.8512 0.0 0
M  V30 8 C 7.7000 10.5184 0.0 0
M  V30 9 C 5.3900 11.8522 0.0 0
M  V30 10 C 5.3900 6.5175 0.0 0
M  V30 11 C 6.9300 6.5175 0.0 0
M  V30 12 N 6.9300 11.8522 0.0 0
M  V30 13 C 3.0800 10.5184 0.0 0
M  V30 14 C 2.3100 9.1848 0.0 0
M  V30 15 C 2.3100 11.8522 0.0 0
M  V30 16 C 0.7700 9.1848 0.0 0
M  V30 17 C 0.7700 11.8522 0.0 0
M  V30 18 N 0.0000 10.5184 0.0 0
M  V30 19 C 9.2400 7.8512 0.0 0
M  V30 20 C 10.0100 6.5175 0.0 0
M  V30 21 C 10.0100 9.1848 0.0 0
M  V30 22 N 11.5500 6.5175 0.0 0
M  V30 23 C 11.5500 9.1848 0.0 0
M  V30 24 C 12.3200 7.8512 0.0 0
M  V30 25 C 6.2632 2.3101 0.0 0
M  V30 26 C 7.5968 1.5400 0.0 0
M  V30 27 F 7.0332 3.6437 0.0 0
M  V30 28 F 4.9295 3.0801 0.0 0
M  V30 29 F 5.4931 0.9764 0.0 0
M  V30 30 O 8.9305 2.3101 0.0 0
M  V30 31 O 7.5968 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 2 2 24
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 13
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 19
M  V30 13 1 8 12
M  V30 14 2 9 12
M  V30 15 1 10 11
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 25 29
M  V30 32 1 26 30
M  V30 33 2 26 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3023411-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3023410-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38956045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic-substituted glutarimides as cereblon binders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasveschuk, Christopher G.; Lazarski, Kiel; Hird, Alexander W.; Yin,
Ning; Good, Andrew Charles; Huang, Hongwei; Eron, Scott Joseph; Veits,
Gesine Kerstin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023239750 A1 2023-12-14

$RFMT $RIREG SCHEME314 STEP1
$RXN



  3  1
$MOL
Isobutyraldehyde
C4H8O
78-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanoic acid, β-amino-α-hydroxy-, methyl ester, (αR,βS)-, formate (1:1)
C10H13NO3.CH2O2
1033517-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 5.3900 0.0 0 CFG=2
M  V30 2 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 3 N 4.0011 6.9300 0.0 0
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 O 5.3347 3.0800 0.0 0
M  V30 6 O 8.0021 4.6200 0.0 0
M  V30 7 O 6.6684 6.9300 0.0 0
M  V30 8 C 9.3358 5.3900 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 5.3900 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 0.0000 4.6200 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 4.6679 0.0000 0.0 0
M  V30 16 O 3.3342 0.7700 0.0 0
M  V30 17 O 6.0016 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl) 5-methyl (2R,4S,5R)-2-(1-methylethyl)-4-phenyl-3,5-oxaz...
C19H27NO5
1033517-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.8384 0.0 0
M  V30 2 O 2.6673 4.0684 0.0 0
M  V30 3 O 4.0011 6.3785 0.0 0
M  V30 4 C 1.3337 4.8384 0.0 0
M  V30 5 C 0.5636 3.5048 0.0 0
M  V30 6 C 0.0000 5.6084 0.0 0
M  V30 7 C 2.1037 6.1721 0.0 0
M  V30 8 C 9.3037 3.7113 0.0 0
M  V30 9 O 10.2090 2.4654 0.0 0
M  V30 10 O 9.9301 5.1183 0.0 0
M  V30 11 C 11.7405 2.6264 0.0 0
M  V30 12 C 4.3513 1.5064 0.0 0
M  V30 13 C 2.8866 1.9823 0.0 0
M  V30 14 C 4.6715 0.0000 0.0 0
M  V30 15 C 6.7416 4.6948 0.0 0 CFG=1
M  V30 16 N 5.3348 4.0684 0.0 0
M  V30 17 C 7.7722 3.5504 0.0 0 CFG=2
M  V30 18 C 5.4957 2.5369 0.0 0 CFG=1
M  V30 19 O 7.0022 2.2167 0.0 0
M  V30 20 C 7.0619 6.2012 0.0 0
M  V30 21 C 5.9174 7.2316 0.0 0
M  V30 22 C 8.5265 6.6771 0.0 0
M  V30 23 C 6.2375 8.7381 0.0 0
M  V30 24 C 8.8466 8.1835 0.0 0
M  V30 25 C 7.7023 9.2139 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 18 12 CFG=3
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20 CFG=1
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-84-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033517-29-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033517-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-1631129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2 Preparation of (2R,4S,5R)-3-t-butoxycarbonyl-2-isopropyl-4-
Preparation of
(2R,4S,5R)-3-t-butoxycarbonyl-2-isopropyl-4-phenyl-1,3-oxazolidine-5-carbonyl
methyl ester 5 g of (2R,3S)-3-phenyl isoserine methyl ester formate was
dissolved in a mixture of 1.6 ml of pyridine and 100 ml of CHCl3. 1.8 ml
isobutylaldehyde was added dropwise thereto and stirred for 2 hours while
keeping the solution temperature at 50°C. The resulting solution was
cooled to room temperature. 3 g of NaHCO3was added in small portions
thereto and stirred for 1 hour. The solid in the reaction mixture was
filtered off, and 4.4 g of di-t-butyl-dicarbonate was slowly added
dropwise to the filtrate. The resulting solution was stirred at room
temperature for 12 hours, and the solvent was removed under a reduced
pressure to obtain an unpurified form of the title compound (7.24 g;
yield: 100%). aD23=−24.0° (c=1, CHCl3); IR (KBr, cm−1)3499, 3395, 3090,
3064, 3032,4 2974, 2933, 2876, 1757, 1705, 1456, 1367, 1253, 1164, 1115,
1092, 1018, 942, 849, 764, 698, 600, 465; 1H-NMR (CDCl3, 300 MHz) δ
7.27-7.40 (m, 5H), 5.32 (d, J=7.1 Hz, 1H), 5.20 (b, 1H), 4.73 (d, J=4.7
Hz, 1H), 3.81 (s, 3H), 2.00 (m, 1H), 1.40 (s, 9H), 1.06 (d, J=6.8 Hz 3H),
0.97 (d, J=6.8 Hz, 3H); Elemental analysis: C19H27N1O5; Theoretical
value: C, 65.31; H, 7.79; N, 4.01; and Experimental value: C, 65.43H,
7.71 N, 4.12.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of preparing docetaxel and intermediates used therein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Nam Du; Shin, Wooseob; Jung, Jaehyuk; Kim, Dong Jun; Kim, Gi Jeong;
Moon, Young Ho; Chang, Young-Kil; Lee, Gwan Sun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008072849 A1 2008-06-19

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (αS)-α-amino-N-methyl-1-(triphenylmethyl)-1H-imidazo...
C26H26N4O.CH2O2
1333228-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.9300 0.0 0
M  V30 2 C 9.7758 8.6053 0.0 0
M  V30 3 C 11.1826 7.9788 0.0 0 CFG=2
M  V30 4 C 12.4285 8.8840 0.0 0
M  V30 5 N 11.3435 6.4472 0.0 0
M  V30 6 N 13.8354 8.2577 0.0 0
M  V30 7 O 12.2675 10.4157 0.0 0
M  V30 8 C 15.0813 9.1629 0.0 0
M  V30 9 N 6.1600 6.9300 0.0 0
M  V30 10 C 7.0652 8.1759 0.0 0
M  V30 11 C 7.0652 5.6842 0.0 0
M  V30 12 C 8.5298 7.7000 0.0 0
M  V30 13 N 8.5298 6.1600 0.0 0
M  V30 14 C 4.6200 8.4700 0.0 0
M  V30 15 C 3.2864 9.2401 0.0 0
M  V30 16 C 5.9537 9.2401 0.0 0
M  V30 17 C 3.2864 10.7801 0.0 0
M  V30 18 C 5.9537 10.7801 0.0 0
M  V30 19 C 4.6200 11.5501 0.0 0
M  V30 20 C 3.0800 6.9300 0.0 0
M  V30 21 C 2.3100 8.2637 0.0 0
M  V30 22 C 2.3100 5.5964 0.0 0
M  V30 23 C 0.7700 8.2637 0.0 0
M  V30 24 C 0.7700 5.5964 0.0 0
M  V30 25 C 0.0000 6.9300 0.0 0
M  V30 26 C 4.6200 5.3900 0.0 0
M  V30 27 C 3.2864 4.6200 0.0 0
M  V30 28 C 5.9537 4.6200 0.0 0
M  V30 29 C 3.2864 3.0800 0.0 0
M  V30 30 C 5.9537 3.0800 0.0 0
M  V30 31 C 4.6200 2.3100 0.0 0
M  V30 32 C 7.5406 0.0000 0.0 0
M  V30 33 O 6.2070 0.7700 0.0 0
M  V30 34 O 8.8743 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 1 2 12
M  V30 7 1 3 4
M  V30 8 1 3 5 CFG=1
M  V30 9 1 4 6
M  V30 10 2 4 7
M  V30 11 1 6 8
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[(2-Chloroacetyl)amino]-N-methyl-1-(triphenylmethyl)-1H-imidazole-4-pr...
C28H27ClN4O2
1333228-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.4327 0.0 0
M  V30 2 C 9.3038 5.3056 0.0 0
M  V30 3 C 10.2090 4.0597 0.0 0 CFG=1
M  V30 4 N 11.7406 4.2206 0.0 0
M  V30 5 C 9.5826 2.6527 0.0 0
M  V30 6 C 12.3669 5.6274 0.0 0
M  V30 7 N 10.4878 1.4068 0.0 0
M  V30 8 O 8.0510 2.4918 0.0 0
M  V30 9 C 13.8986 5.7885 0.0 0
M  V30 10 O 11.4619 6.8735 0.0 0
M  V30 11 C 9.8615 0.0000 0.0 0
M  V30 12 Cl 14.5250 7.1953 0.0 0
M  V30 13 N 5.3348 5.6627 0.0 0
M  V30 14 C 6.7417 6.2890 0.0 0
M  V30 15 C 5.4958 4.1310 0.0 0
M  V30 16 C 7.7722 5.1446 0.0 0
M  V30 17 N 7.0022 3.8108 0.0 0
M  V30 18 C 4.7712 7.7664 0.0 0
M  V30 19 C 4.0012 9.1001 0.0 0
M  V30 20 C 6.3112 7.7664 0.0 0
M  V30 21 C 4.7712 10.4337 0.0 0
M  V30 22 C 7.0812 9.1001 0.0 0
M  V30 23 C 6.3112 10.4337 0.0 0
M  V30 24 C 2.6673 7.2027 0.0 0
M  V30 25 C 2.6673 8.7428 0.0 0
M  V30 26 C 1.3337 6.4327 0.0 0
M  V30 27 C 1.3337 9.5128 0.0 0
M  V30 28 C 0.0000 7.2027 0.0 0
M  V30 29 C 0.0000 8.7428 0.0 0
M  V30 30 C 3.2311 5.0989 0.0 0
M  V30 31 C 1.6911 5.0989 0.0 0
M  V30 32 C 4.0012 3.7652 0.0 0
M  V30 33 C 0.9211 3.7652 0.0 0
M  V30 34 C 3.2311 2.4316 0.0 0
M  V30 35 C 1.6911 2.4316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 2 16
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333228-00-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14216672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-(2-Chloro-acetylamino)-N-methyl-3-(1-trityl-1H-imidazol-4-yl)-propionamide
(86) To a stirred suspension of (23) (1 g, 2,43 mmol) in dichloromethane
(25 mL), were added NaHCO3 (409 mg, 4,87 mmol) and acetylchloride (213μL,
1,68 mmol) at room temperature. After an hour, the mixture was washed
with water, saturated NaHCO3 and brine. The organic layer was dried over
MgSO4 and the solvent was evaporated.
(S)-2-(2-Chloro-acetylamino)-N-methyl-3-(1-trityl-1H-imidazol-4-yl)-propionamide
(86) yellow solid (1,2 g, quant.). Purity: 95%. 1H NMR (DMSO-d6) δ (ppm):
8.35 (d, J= 8.3Hz, CONH), 7.91 (q, J= 4.7Hz, CONHMe), 7.40-7.37 (m, 10H),
7.23 (d, J=1.4Hz, 1H), 7.06-7.03 (m, 5H), 6.62 (d, J=1.2Hz, 1H), 4.41
(ddd, J= 8.4,8.3 and 5.6 Hz, 1H), 4.04 (d, J= 13.5Hz, 1H), 3.98 (d, J=
13.5Hz, 1H), 2.86 (dd, J= 14.4Hz and 5.6Hz, 1H), 2.70 (dd, J= 14.4Hz and
8.4Hz, 1H), 2.52 (d, J= 4.7Hz, 3H); LC : tr = 3.10 min MS (ESI+): m/z =
487 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME316 STEP1
$RXN



  3  1
$MOL
Pivalaldehyde
C5H10O
630-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 C 0.5637 2.6673 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 C 2.1037 0.0000 0.0 0
M  V30 6 O 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanoic acid, β-amino-α-hydroxy-, methyl ester, (αR,βS)-, formate (1:1)
C10H13NO3.CH2O2
1033517-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 5.3900 0.0 0 CFG=2
M  V30 2 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 3 N 4.0011 6.9300 0.0 0
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 O 5.3347 3.0800 0.0 0
M  V30 6 O 8.0021 4.6200 0.0 0
M  V30 7 O 6.6684 6.9300 0.0 0
M  V30 8 C 9.3358 5.3900 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 5.3900 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 0.0000 4.6200 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 4.6679 0.0000 0.0 0
M  V30 16 O 3.3342 0.7700 0.0 0
M  V30 17 O 6.0016 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl) 5-methyl (2R,4S,5R)-2-(1,1-dimethylethyl)-4-phenyl-3,5-...
C20H29NO5
1033517-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.3755 0.0 0
M  V30 2 O 2.6673 5.1455 0.0 0
M  V30 3 O 4.0011 2.8355 0.0 0
M  V30 4 C 1.3336 4.3755 0.0 0
M  V30 5 C 0.5636 5.7091 0.0 0
M  V30 6 C 0.0000 3.6055 0.0 0
M  V30 7 C 2.1037 3.0418 0.0 0
M  V30 8 C 9.3036 5.5026 0.0 0
M  V30 9 O 10.2089 6.7485 0.0 0
M  V30 10 O 9.9300 4.0957 0.0 0
M  V30 11 C 11.7404 6.5875 0.0 0
M  V30 12 C 4.3513 7.7074 0.0 0
M  V30 13 C 4.6715 9.2139 0.0 0
M  V30 14 C 3.2068 8.7380 0.0 0
M  V30 15 C 2.8866 7.2316 0.0 0
M  V30 16 C 6.7415 4.5192 0.0 0 CFG=1
M  V30 17 N 5.3347 5.1455 0.0 0
M  V30 18 C 7.7721 5.6635 0.0 0 CFG=2
M  V30 19 C 5.4957 6.6770 0.0 0 CFG=1
M  V30 20 O 7.0021 6.9972 0.0 0
M  V30 21 C 7.0619 3.0127 0.0 0
M  V30 22 C 5.9173 1.9823 0.0 0
M  V30 23 C 8.5264 2.5369 0.0 0
M  V30 24 C 6.2375 0.4759 0.0 0
M  V30 25 C 8.8466 1.0304 0.0 0
M  V30 26 C 7.7022 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 18 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 19 12 CFG=1
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 630-19-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033517-29-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033517-33-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-5850363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3-1) Preparation of
(2R,4S,5R)-3-t-butoxylcarbonyl-2-(4-t-butyl)-4-phenyl-1,3-oxazolidine-5-carbonyl
methyl ester 5 g of (2R,3S)-3-phenyl isoserine methyl ester formate was
dissolved in a mixture of 1.6 ml of pyridine and 100 ml of CHCl3. 1.8 ml
of isobutylaldehyde was added dropwise thereto and stirred for 2 hours
while keeping the solution temperature at 50° C. The resulting solution
was cooled to room temperature. 3 g of NaHCO3was added in small portions
thereto and stirred for 1 hour. The solid in the reaction mixture was
filtered off, and 4.4 g of di-t-butyl-dicarbonate was slowly added
dropwise to the filtrate. The resulting solution was stirred at room
temperature for 12 hours, and the solvent was removed under a reduced
pressure to obtain an unpurified form of the title compound The procedure
of (2-1) of Example 2 was repeated except for using trimethylacetaldehyde
instead of isobutylaldehyde, to obtain the title compound (7.53 g; yield:
100%). aD23=+0.5° (c=1, CHCl3); IR (KBr, cm−1) 3063, 2974, 2934, 1756,
1710, 1480, 1451, 1367, 1351, 1254, 1163, 948, 879, 778, 697; 1H-NMR
(CDCl3, 300 MHz) δ 7.27-7.44 (m, 5H), 5.46 (s, 1H), 5.41 (d, J=4.2 Hz,
1H), 4.73 (d, J=4.2 Hz, 1H), 3.83 (s, 3H), 1.47 (s, 9H), 0.83 (s, 3H);
Elemental analysis: C20H29N1O5; Theoretical value: C, 66.09; H, 8.04; N,
3.85; and Experimental value: C, 66.13H, 7.98 N, 3.88.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of preparing docetaxel and intermediates used therein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Nam Du; Shin, Wooseob; Jung, Jaehyuk; Kim, Dong Jun; Kim, Gi Jeong;
Moon, Young Ho; Chang, Young-Kil; Lee, Gwan Sun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008072849 A1 2008-06-19

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-, 2-methyl este...
C22H24N4O5.CH2O2
1333226-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 7.6448 0.0 0
M  V30 2 N 8.4702 6.3110 0.0 0
M  V30 3 C 6.9302 6.3110 0.0 0
M  V30 4 C 9.2402 4.9774 0.0 0
M  V30 5 C 6.1601 7.6448 0.0 0
M  V30 6 C 8.4702 3.6437 0.0 0
M  V30 7 N 4.6201 7.6448 0.0 0
M  V30 8 O 6.9302 8.9785 0.0 0
M  V30 9 O 9.2402 2.3100 0.0 0
M  V30 10 O 6.9302 3.6437 0.0 0
M  V30 11 C 3.8501 8.9785 0.0 0 CFG=2
M  V30 12 C 4.6201 10.3122 0.0 0
M  V30 13 C 2.3101 8.9785 0.0 0
M  V30 14 O 1.5400 7.6448 0.0 0
M  V30 15 O 1.5400 10.3122 0.0 0
M  V30 16 C 0.0000 7.6448 0.0 0
M  V30 17 C 13.0903 8.9785 0.0 0
M  V30 18 C 13.8603 7.6448 0.0 0
M  V30 19 C 11.5503 8.9785 0.0 0
M  V30 20 C 13.8603 10.3122 0.0 0
M  V30 21 C 13.0903 6.3110 0.0 0
M  V30 22 C 15.4003 7.6448 0.0 0
M  V30 23 C 10.7802 7.6448 0.0 0
M  V30 24 C 15.4003 10.3122 0.0 0
M  V30 25 C 11.5503 6.3110 0.0 0
M  V30 26 C 16.1704 8.9785 0.0 0
M  V30 27 C 3.8501 11.6460 0.0 0
M  V30 28 C 4.4764 13.0528 0.0 0
M  V30 29 N 2.3185 11.8069 0.0 0
M  V30 30 N 3.3320 14.0833 0.0 0
M  V30 31 C 1.9983 13.3133 0.0 0
M  V30 32 C 8.0852 0.0000 0.0 0
M  V30 33 O 6.7515 0.7700 0.0 0
M  V30 34 O 9.4188 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-N-methyl-L-histidinamide
C22H25N5O4
1333227-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 5.3348 0.0 0
M  V30 2 N 8.4702 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 C 9.2402 2.6673 0.0 0
M  V30 5 C 6.1601 5.3348 0.0 0
M  V30 6 C 8.4702 1.3337 0.0 0
M  V30 7 N 4.6201 5.3348 0.0 0
M  V30 8 O 6.9302 6.6685 0.0 0
M  V30 9 O 9.2402 0.0000 0.0 0
M  V30 10 O 6.9302 1.3337 0.0 0
M  V30 11 C 3.8501 6.6685 0.0 0 CFG=2
M  V30 12 C 4.6201 8.0022 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 N 1.5400 5.3348 0.0 0
M  V30 15 O 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 C 13.0903 6.6685 0.0 0
M  V30 18 C 13.8603 5.3348 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.8603 8.0022 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 15.4003 5.3348 0.0 0
M  V30 23 C 10.7802 5.3348 0.0 0
M  V30 24 C 15.4003 8.0022 0.0 0
M  V30 25 C 11.5503 4.0010 0.0 0
M  V30 26 C 16.1704 6.6685 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 4.4764 10.7428 0.0 0
M  V30 29 N 2.3185 9.4969 0.0 0
M  V30 30 N 3.3320 11.7733 0.0 0
M  V30 31 C 1.9983 11.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1123514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound. Reactant: (S)-
2-[2-(Carboxymethyl-naphthalen-2-ylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (33).
({[(S)-2-(1H-Imidazol-4-yl)-1-methylcarbamoyl-ethylcarbamoyl]-methyl}-naphthalen-2-ylmethyl-amino)-acetic
acid (66) was obtained (100%). Purity: 97%. 1H NMR (DMSO-d6) δ ppm: 8.90
(d, J= 8.3Hz, 1H), 8.05 (q, J= 4.9Hz, 1H), 7.89-7.8 (m, 4H), 7.53-7.44
(m, 3H+1H), 6.76 (s, 1H), 4.41 (m, 1H), 3.84 (s, 2H), 3.16 (s, 2H), 3.05
(s, 2H), 2.91 (m, 2H), 2.59 (d, J= 4.9Hz, 3H); LC : tr = 3.12min; MS
(ESI+) : m/z = 424 (M+H)+. pIC50: 5.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-, 2-methyl este...
C22H24N4O5.CH2O2
1333226-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 7.6448 0.0 0
M  V30 2 N 8.4702 6.3110 0.0 0
M  V30 3 C 6.9302 6.3110 0.0 0
M  V30 4 C 9.2402 4.9774 0.0 0
M  V30 5 C 6.1601 7.6448 0.0 0
M  V30 6 C 8.4702 3.6437 0.0 0
M  V30 7 N 4.6201 7.6448 0.0 0
M  V30 8 O 6.9302 8.9785 0.0 0
M  V30 9 O 9.2402 2.3100 0.0 0
M  V30 10 O 6.9302 3.6437 0.0 0
M  V30 11 C 3.8501 8.9785 0.0 0 CFG=2
M  V30 12 C 4.6201 10.3122 0.0 0
M  V30 13 C 2.3101 8.9785 0.0 0
M  V30 14 O 1.5400 7.6448 0.0 0
M  V30 15 O 1.5400 10.3122 0.0 0
M  V30 16 C 0.0000 7.6448 0.0 0
M  V30 17 C 13.0903 8.9785 0.0 0
M  V30 18 C 13.8603 7.6448 0.0 0
M  V30 19 C 11.5503 8.9785 0.0 0
M  V30 20 C 13.8603 10.3122 0.0 0
M  V30 21 C 13.0903 6.3110 0.0 0
M  V30 22 C 15.4003 7.6448 0.0 0
M  V30 23 C 10.7802 7.6448 0.0 0
M  V30 24 C 15.4003 10.3122 0.0 0
M  V30 25 C 11.5503 6.3110 0.0 0
M  V30 26 C 16.1704 8.9785 0.0 0
M  V30 27 C 3.8501 11.6460 0.0 0
M  V30 28 C 4.4764 13.0528 0.0 0
M  V30 29 N 2.3185 11.8069 0.0 0
M  V30 30 N 3.3320 14.0833 0.0 0
M  V30 31 C 1.9983 13.3133 0.0 0
M  V30 32 C 8.0852 0.0000 0.0 0
M  V30 33 O 6.7515 0.7700 0.0 0
M  V30 34 O 9.4188 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-N-methyl-L-histidinamide
C22H25N5O4
1333227-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 5.3348 0.0 0
M  V30 2 N 8.4702 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 C 9.2402 2.6673 0.0 0
M  V30 5 C 6.1601 5.3348 0.0 0
M  V30 6 C 8.4702 1.3337 0.0 0
M  V30 7 N 4.6201 5.3348 0.0 0
M  V30 8 O 6.9302 6.6685 0.0 0
M  V30 9 O 9.2402 0.0000 0.0 0
M  V30 10 O 6.9302 1.3337 0.0 0
M  V30 11 C 3.8501 6.6685 0.0 0 CFG=2
M  V30 12 C 4.6201 8.0022 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 N 1.5400 5.3348 0.0 0
M  V30 15 O 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 C 13.0903 6.6685 0.0 0
M  V30 18 C 13.8603 5.3348 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.8603 8.0022 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 15.4003 5.3348 0.0 0
M  V30 23 C 10.7802 5.3348 0.0 0
M  V30 24 C 15.4003 8.0022 0.0 0
M  V30 25 C 11.5503 4.0010 0.0 0
M  V30 26 C 16.1704 6.6685 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 4.4764 10.7428 0.0 0
M  V30 29 N 2.3185 9.4969 0.0 0
M  V30 30 N 3.3320 11.7733 0.0 0
M  V30 31 C 1.9983 11.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6661039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of ester (0.5mmol) in methanol (1 mL) were added
622 μL of a solution of methylamine in ethanol (33%). The mixture was
refluxed overnight. The solvent was evaporated and the crude product was
precipitated in water and filtrated to give the compound.
({[(S)-2-(1H-Imidazol-4-yl)-1-methylcarbamoyl-ethylcarbamoyl]-methyl}-naphthalen-2-ylmethyl-amino)-acetic
acid (66) was obtained from (33) (100%). Purity : 97% ; 1H NMR (DMSO-d6)
δ ppm: 8.90 (d, J = 8.3Hz, 1H), 8.05 (q, J = 4.9Hz, 1H), 7.89-7.8 (m,
4H), 7.53-7.44 (m, 3H+1H), 6.76 (s, 1H), 4.41 (m, 1H), 3.84 (s, 2H), 3.16
(s, 2H), 3.05 (s, 2H), 2.91 (m, 2H), 2.59 (d, J = 4.9Hz, 3H); LC : tr =
3.12min; MS (ESI+) : m/z = 424 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333226-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-N-methyl-1-(triphenylmethyl)-L-histi...
C37H37N5O4
1333228-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 7.0100 0.0 0
M  V30 2 C 9.0543 5.3347 0.0 0
M  V30 3 C 9.8243 4.0011 0.0 0 CFG=1
M  V30 4 N 11.3643 4.0011 0.0 0
M  V30 5 C 9.0543 2.6673 0.0 0
M  V30 6 C 12.1343 5.3347 0.0 0
M  V30 7 N 9.8243 1.3336 0.0 0
M  V30 8 O 7.5143 2.6673 0.0 0
M  V30 9 C 13.6743 5.3347 0.0 0
M  V30 10 O 11.3643 6.6684 0.0 0
M  V30 11 C 9.0543 0.0000 0.0 0
M  V30 12 N 14.4444 6.6684 0.0 0
M  V30 13 C 13.6743 8.0020 0.0 0
M  V30 14 C 15.9844 6.6684 0.0 0
M  V30 15 C 16.7544 5.3347 0.0 0
M  V30 16 O 15.9844 4.0011 0.0 0
M  V30 17 O 18.2944 5.3347 0.0 0
M  V30 18 N 5.1446 6.1047 0.0 0
M  V30 19 C 6.6091 6.5806 0.0 0
M  V30 20 C 5.1446 4.5647 0.0 0
M  V30 21 C 7.5143 5.3347 0.0 0
M  V30 22 N 6.6091 4.0889 0.0 0
M  V30 23 C 4.8037 8.2558 0.0 0
M  V30 24 C 6.3354 8.0949 0.0 0
M  V30 25 C 4.1774 9.6626 0.0 0
M  V30 26 C 7.2407 9.3408 0.0 0
M  V30 27 C 5.0826 10.9086 0.0 0
M  V30 28 C 6.6142 10.7476 0.0 0
M  V30 29 C 2.6527 7.9152 0.0 0
M  V30 30 C 1.2459 7.2887 0.0 0
M  V30 31 C 2.8137 9.4467 0.0 0
M  V30 32 C 0.0000 8.1939 0.0 0
M  V30 33 C 1.5679 10.3519 0.0 0
M  V30 34 C 0.1609 9.7255 0.0 0
M  V30 35 C 2.9935 5.7641 0.0 0
M  V30 36 C 1.4619 5.9250 0.0 0
M  V30 37 C 3.6198 4.3571 0.0 0
M  V30 38 C 0.5567 4.6792 0.0 0
M  V30 39 C 2.7146 3.1113 0.0 0
M  V30 40 C 1.1830 3.2722 0.0 0
M  V30 41 C 14.4444 9.3358 0.0 0
M  V30 42 C 13.6743 10.6695 0.0 0
M  V30 43 C 15.9844 9.3358 0.0 0
M  V30 44 C 14.4444 12.0031 0.0 0
M  V30 45 C 16.7544 10.6695 0.0 0
M  V30 46 C 15.9844 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7537821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound. Reactant: (S)-
2-[2-(Carboxymethyl-naphthalen-2-ylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (33). Reactant:
(S)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester as the formiate salt (38).
(Benzyl-{[(S)-1-methylcarbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-amino)-acetic
acid (64) as the formiate salt was obtained (100%). Purity: 97%. LC : tr
= 4.5min; MS (ESI+) : m/z = 616 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333226-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-N-methyl-1-(triphenylmethyl)-L-histi...
C37H37N5O4
1333228-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 7.0100 0.0 0
M  V30 2 C 9.0543 5.3347 0.0 0
M  V30 3 C 9.8243 4.0011 0.0 0 CFG=1
M  V30 4 N 11.3643 4.0011 0.0 0
M  V30 5 C 9.0543 2.6673 0.0 0
M  V30 6 C 12.1343 5.3347 0.0 0
M  V30 7 N 9.8243 1.3336 0.0 0
M  V30 8 O 7.5143 2.6673 0.0 0
M  V30 9 C 13.6743 5.3347 0.0 0
M  V30 10 O 11.3643 6.6684 0.0 0
M  V30 11 C 9.0543 0.0000 0.0 0
M  V30 12 N 14.4444 6.6684 0.0 0
M  V30 13 C 13.6743 8.0020 0.0 0
M  V30 14 C 15.9844 6.6684 0.0 0
M  V30 15 C 16.7544 5.3347 0.0 0
M  V30 16 O 15.9844 4.0011 0.0 0
M  V30 17 O 18.2944 5.3347 0.0 0
M  V30 18 N 5.1446 6.1047 0.0 0
M  V30 19 C 6.6091 6.5806 0.0 0
M  V30 20 C 5.1446 4.5647 0.0 0
M  V30 21 C 7.5143 5.3347 0.0 0
M  V30 22 N 6.6091 4.0889 0.0 0
M  V30 23 C 4.8037 8.2558 0.0 0
M  V30 24 C 6.3354 8.0949 0.0 0
M  V30 25 C 4.1774 9.6626 0.0 0
M  V30 26 C 7.2407 9.3408 0.0 0
M  V30 27 C 5.0826 10.9086 0.0 0
M  V30 28 C 6.6142 10.7476 0.0 0
M  V30 29 C 2.6527 7.9152 0.0 0
M  V30 30 C 1.2459 7.2887 0.0 0
M  V30 31 C 2.8137 9.4467 0.0 0
M  V30 32 C 0.0000 8.1939 0.0 0
M  V30 33 C 1.5679 10.3519 0.0 0
M  V30 34 C 0.1609 9.7255 0.0 0
M  V30 35 C 2.9935 5.7641 0.0 0
M  V30 36 C 1.4619 5.9250 0.0 0
M  V30 37 C 3.6198 4.3571 0.0 0
M  V30 38 C 0.5567 4.6792 0.0 0
M  V30 39 C 2.7146 3.1113 0.0 0
M  V30 40 C 1.1830 3.2722 0.0 0
M  V30 41 C 14.4444 9.3358 0.0 0
M  V30 42 C 13.6743 10.6695 0.0 0
M  V30 43 C 15.9844 9.3358 0.0 0
M  V30 44 C 14.4444 12.0031 0.0 0
M  V30 45 C 16.7544 10.6695 0.0 0
M  V30 46 C 15.9844 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3134765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound.
(Benzyl-{[(S)-1-methylcarbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-amino)-acetic
acid (64) as the formiate salt was obtained from (38) (100%). Purity :
97% ; LC : tr = 4.5min; MS (ESI+) : m/z = 616 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methyl-d3 iodide
CD3I
865-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 I 0.0000 1.5400 0.0 0
M  V30 3 H 3.0800 1.5400 0.0 0 MASS=2
M  V30 4 H 1.5400 0.0000 0.0 0 MASS=2
M  V30 5 H 1.5400 3.0800 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1...
C14H24BN3O2.CH2O2
2945858-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 3.2022 0.0 0
M  V30 2 C 0.1272 4.7337 0.0 0
M  V30 3 C 0.0000 5.9451 0.0 0
M  V30 4 C 1.0304 7.7300 0.0 0
M  V30 5 B 3.9437 5.7472 0.0 0
M  V30 6 O 3.1737 4.4135 0.0 0
M  V30 7 O 2.9131 6.8918 0.0 0
M  V30 8 C 1.6672 4.7337 0.0 0
M  V30 9 C 1.5063 6.2653 0.0 0
M  V30 10 C 5.4753 5.9082 0.0 0
M  V30 11 C 6.5057 4.7638 0.0 0
M  V30 12 C 6.2453 7.2420 0.0 0
M  V30 13 N 7.9127 5.3901 0.0 0
M  V30 14 N 7.7516 6.9216 0.0 0
M  V30 15 C 9.2464 4.6201 0.0 0
M  V30 16 C 10.5800 5.3901 0.0 0
M  V30 17 C 9.2464 3.0800 0.0 0
M  V30 18 C 11.9137 4.6201 0.0 0
M  V30 19 C 10.5800 2.3100 0.0 0
M  V30 20 N 11.9137 3.0800 0.0 0
M  V30 21 C 5.9569 0.0000 0.0 0
M  V30 22 O 4.6232 0.7700 0.0 0
M  V30 23 O 7.2905 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H23BD3N3O2
2945858-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.6832 0.0 0
M  V30 2 C 0.0000 1.6222 0.0 0
M  V30 3 C 0.7159 0.6369 0.0 0
M  V30 4 C 2.6759 0.0000 0.0 0
M  V30 5 C 13.2899 5.0980 0.0 0
M  V30 6 B 3.5143 3.4228 0.0 0
M  V30 7 O 2.0496 3.8987 0.0 0
M  V30 8 O 3.5143 1.8828 0.0 0
M  V30 9 C 1.1444 2.6528 0.0 0
M  V30 10 C 2.0496 1.4069 0.0 0
M  V30 11 C 4.7601 4.3280 0.0 0
M  V30 12 C 6.2247 3.8520 0.0 0
M  V30 13 C 4.7601 5.8680 0.0 0
M  V30 14 N 7.1299 5.0980 0.0 0
M  V30 15 N 6.2247 6.3439 0.0 0
M  V30 16 C 8.6699 5.0980 0.0 0
M  V30 17 C 9.4399 3.7642 0.0 0
M  V30 18 C 9.4399 6.4317 0.0 0
M  V30 19 C 10.9799 3.7642 0.0 0
M  V30 20 C 10.9799 6.4317 0.0 0
M  V30 21 N 11.7499 5.0980 0.0 0
M  V30 22 H 14.0599 3.7642 0.0 0 MASS=2
M  V30 23 H 14.8299 5.0980 0.0 0 MASS=2
M  V30 24 H 14.0599 6.4317 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 21
M  V30 6 1 5 22
M  V30 7 1 5 23
M  V30 8 1 5 24
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 9
M  V30 13 1 8 10
M  V30 14 1 9 10
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 1 14 15
M  V30 20 1 14 16
M  V30 21 1 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 865-50-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2945858-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2945858-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37404986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional arylsulfonamide compounds for treating
necroptosis and/or inhibiting and/or degrading MLKL
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garnier, Jean-Marc Daniel; Gardner, Christopher; Lessene, Guillaume
Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023115150 A1 2023-06-29

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methyl-d3 iodide
CD3I
865-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 I 0.0000 1.5400 0.0 0
M  V30 3 H 3.0800 1.5400 0.0 0 MASS=2
M  V30 4 H 1.5400 0.0000 0.0 0 MASS=2
M  V30 5 H 1.5400 3.0800 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1...
C14H24BN3O2.CH2O2
2945858-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 3.2022 0.0 0
M  V30 2 C 0.1272 4.7337 0.0 0
M  V30 3 C 0.0000 5.9451 0.0 0
M  V30 4 C 1.0304 7.7300 0.0 0
M  V30 5 B 3.9437 5.7472 0.0 0
M  V30 6 O 3.1737 4.4135 0.0 0
M  V30 7 O 2.9131 6.8918 0.0 0
M  V30 8 C 1.6672 4.7337 0.0 0
M  V30 9 C 1.5063 6.2653 0.0 0
M  V30 10 C 5.4753 5.9082 0.0 0
M  V30 11 C 6.5057 4.7638 0.0 0
M  V30 12 C 6.2453 7.2420 0.0 0
M  V30 13 N 7.9127 5.3901 0.0 0
M  V30 14 N 7.7516 6.9216 0.0 0
M  V30 15 C 9.2464 4.6201 0.0 0
M  V30 16 C 10.5800 5.3901 0.0 0
M  V30 17 C 9.2464 3.0800 0.0 0
M  V30 18 C 11.9137 4.6201 0.0 0
M  V30 19 C 10.5800 2.3100 0.0 0
M  V30 20 N 11.9137 3.0800 0.0 0
M  V30 21 C 5.9569 0.0000 0.0 0
M  V30 22 O 4.6232 0.7700 0.0 0
M  V30 23 O 7.2905 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H23BD3N3O2
2945858-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.6832 0.0 0
M  V30 2 C 0.0000 1.6222 0.0 0
M  V30 3 C 0.7159 0.6369 0.0 0
M  V30 4 C 2.6759 0.0000 0.0 0
M  V30 5 C 13.2899 5.0980 0.0 0
M  V30 6 B 3.5143 3.4228 0.0 0
M  V30 7 O 2.0496 3.8987 0.0 0
M  V30 8 O 3.5143 1.8828 0.0 0
M  V30 9 C 1.1444 2.6528 0.0 0
M  V30 10 C 2.0496 1.4069 0.0 0
M  V30 11 C 4.7601 4.3280 0.0 0
M  V30 12 C 6.2247 3.8520 0.0 0
M  V30 13 C 4.7601 5.8680 0.0 0
M  V30 14 N 7.1299 5.0980 0.0 0
M  V30 15 N 6.2247 6.3439 0.0 0
M  V30 16 C 8.6699 5.0980 0.0 0
M  V30 17 C 9.4399 3.7642 0.0 0
M  V30 18 C 9.4399 6.4317 0.0 0
M  V30 19 C 10.9799 3.7642 0.0 0
M  V30 20 C 10.9799 6.4317 0.0 0
M  V30 21 N 11.7499 5.0980 0.0 0
M  V30 22 H 14.0599 3.7642 0.0 0 MASS=2
M  V30 23 H 14.8299 5.0980 0.0 0 MASS=2
M  V30 24 H 14.0599 6.4317 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 21
M  V30 6 1 5 22
M  V30 7 1 5 23
M  V30 8 1 5 24
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 9
M  V30 13 1 8 10
M  V30 14 1 9 10
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 1 14 15
M  V30 20 1 14 16
M  V30 21 1 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 865-50-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2945858-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2945858-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37237237
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylsulfonamide compounds for treating necroptosis and/or
inhibiting MLKL
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brzozowski, Martin; Poitevin, Christophe; Garnier, Jean-Marc Daniel;
Gardner, Christopher; Lessene, Guillaume Laurent; Czabotar, Peter Edward;
Schuster-Klein, Carole Annie; Davies, Katherine; Cowan, Angus; Kersten,
Wilco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023115142 A1 2023-06-29

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Chloroacetyl chloride
C2H2Cl2O
79-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (αS)-α-amino-N-methyl-1-(triphenylmethyl)-1H-imidazo...
C26H26N4O.CH2O2
1333228-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.9300 0.0 0
M  V30 2 C 9.7758 8.6053 0.0 0
M  V30 3 C 11.1826 7.9788 0.0 0 CFG=2
M  V30 4 C 12.4285 8.8840 0.0 0
M  V30 5 N 11.3435 6.4472 0.0 0
M  V30 6 N 13.8354 8.2577 0.0 0
M  V30 7 O 12.2675 10.4157 0.0 0
M  V30 8 C 15.0813 9.1629 0.0 0
M  V30 9 N 6.1600 6.9300 0.0 0
M  V30 10 C 7.0652 8.1759 0.0 0
M  V30 11 C 7.0652 5.6842 0.0 0
M  V30 12 C 8.5298 7.7000 0.0 0
M  V30 13 N 8.5298 6.1600 0.0 0
M  V30 14 C 4.6200 8.4700 0.0 0
M  V30 15 C 3.2864 9.2401 0.0 0
M  V30 16 C 5.9537 9.2401 0.0 0
M  V30 17 C 3.2864 10.7801 0.0 0
M  V30 18 C 5.9537 10.7801 0.0 0
M  V30 19 C 4.6200 11.5501 0.0 0
M  V30 20 C 3.0800 6.9300 0.0 0
M  V30 21 C 2.3100 8.2637 0.0 0
M  V30 22 C 2.3100 5.5964 0.0 0
M  V30 23 C 0.7700 8.2637 0.0 0
M  V30 24 C 0.7700 5.5964 0.0 0
M  V30 25 C 0.0000 6.9300 0.0 0
M  V30 26 C 4.6200 5.3900 0.0 0
M  V30 27 C 3.2864 4.6200 0.0 0
M  V30 28 C 5.9537 4.6200 0.0 0
M  V30 29 C 3.2864 3.0800 0.0 0
M  V30 30 C 5.9537 3.0800 0.0 0
M  V30 31 C 4.6200 2.3100 0.0 0
M  V30 32 C 7.5406 0.0000 0.0 0
M  V30 33 O 6.2070 0.7700 0.0 0
M  V30 34 O 8.8743 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 1 2 12
M  V30 7 1 3 4
M  V30 8 1 3 5 CFG=1
M  V30 9 1 4 6
M  V30 10 2 4 7
M  V30 11 1 6 8
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[(2-Chloroacetyl)amino]-N-methyl-1-(triphenylmethyl)-1H-imidazole-4-pr...
C28H27ClN4O2
1333228-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.4327 0.0 0
M  V30 2 C 9.3038 5.3056 0.0 0
M  V30 3 C 10.2090 4.0597 0.0 0 CFG=1
M  V30 4 N 11.7406 4.2206 0.0 0
M  V30 5 C 9.5826 2.6527 0.0 0
M  V30 6 C 12.3669 5.6274 0.0 0
M  V30 7 N 10.4878 1.4068 0.0 0
M  V30 8 O 8.0510 2.4918 0.0 0
M  V30 9 C 13.8986 5.7885 0.0 0
M  V30 10 O 11.4619 6.8735 0.0 0
M  V30 11 C 9.8615 0.0000 0.0 0
M  V30 12 Cl 14.5250 7.1953 0.0 0
M  V30 13 N 5.3348 5.6627 0.0 0
M  V30 14 C 6.7417 6.2890 0.0 0
M  V30 15 C 5.4958 4.1310 0.0 0
M  V30 16 C 7.7722 5.1446 0.0 0
M  V30 17 N 7.0022 3.8108 0.0 0
M  V30 18 C 4.7712 7.7664 0.0 0
M  V30 19 C 4.0012 9.1001 0.0 0
M  V30 20 C 6.3112 7.7664 0.0 0
M  V30 21 C 4.7712 10.4337 0.0 0
M  V30 22 C 7.0812 9.1001 0.0 0
M  V30 23 C 6.3112 10.4337 0.0 0
M  V30 24 C 2.6673 7.2027 0.0 0
M  V30 25 C 2.6673 8.7428 0.0 0
M  V30 26 C 1.3337 6.4327 0.0 0
M  V30 27 C 1.3337 9.5128 0.0 0
M  V30 28 C 0.0000 7.2027 0.0 0
M  V30 29 C 0.0000 8.7428 0.0 0
M  V30 30 C 3.2311 5.0989 0.0 0
M  V30 31 C 1.6911 5.0989 0.0 0
M  V30 32 C 4.0012 3.7652 0.0 0
M  V30 33 C 0.9211 3.7652 0.0 0
M  V30 34 C 3.2311 2.4316 0.0 0
M  V30 35 C 1.6911 2.4316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 2 16
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-04-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333228-00-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-8259703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-(2-Chloro-acetylamino)-N-methyl-3-(1-trityl-1H-imidazol-4-yl)-propionamide
(86) To a stirred suspension of (23) (1 g, 2,43 mmol) in dichloromethane
(25 mL), were added NaHCO3 (409 mg, 4,87 mmol) and acetylchloride (213μL,
1,68 mmol) at room temperature. After an hour, the mixture was washed
with water, saturated NaHCO3 and brine. The organic layer was dried over
MgSO4 and the solvent was evaporated. Yellow solid, yield 1,2 g, quant.
Purity : 95% ; 1H NMR (DMSO-d6) δ (ppm): 8.35 (d, J = 8.3Hz, CONH), 7.91
(q, J = 4.7Hz, CONHMe), 7.40-7.37 (m, 10H), 7.23 (d, J = 1.4Hz, 1H),
7.06-7.03 (m, 5H), 6.62 (d, J = 1.2Hz, 1H), 4.41 (ddd, J = 8.4, 8.3 and
5.6 Hz, 1H), 4.04 (d, J = 13.5Hz, 1H), 3.98 (d, J = 13.5Hz, 1H), 2.86
(dd, J = 14.4Hz and 5.6Hz, 1H), 2.70 (dd, J = 14.4Hz and 8.4Hz, 1H), 2.52
(d, J = 4.7Hz, 3H) ; LC : tr = 3.10 min MS (ESI+) : m/z = 487 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (αR)-4-piperidinylmethyl α,4-dihydroxy-α-phenylbenze...
C20H23NO4.CH2O2
2173079-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.3110 0.0 0 CFG=1
M  V30 2 C 6.6685 5.5410 0.0 0
M  V30 3 O 6.1048 7.6448 0.0 0
M  V30 4 O 8.0022 6.3110 0.0 0
M  V30 5 O 6.6685 4.0010 0.0 0
M  V30 6 C 9.3360 5.5410 0.0 0
M  V30 7 O 0.0000 9.3911 0.0 0
M  V30 8 C 4.0010 7.0810 0.0 0
M  V30 9 C 2.6673 6.3110 0.0 0
M  V30 10 C 4.0010 8.6211 0.0 0
M  V30 11 C 1.3337 7.0810 0.0 0
M  V30 12 C 2.6673 9.3911 0.0 0
M  V30 13 C 1.3337 8.6211 0.0 0
M  V30 14 C 4.5648 4.9774 0.0 0
M  V30 15 C 3.0248 4.9774 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 17 C 2.2548 3.6437 0.0 0
M  V30 18 C 4.5648 2.3100 0.0 0
M  V30 19 C 3.0248 2.3100 0.0 0
M  V30 20 C 10.6697 6.3110 0.0 0
M  V30 21 C 10.6697 7.8511 0.0 0
M  V30 22 C 12.0033 5.5410 0.0 0
M  V30 23 C 12.0033 8.6211 0.0 0
M  V30 24 C 13.3370 6.3110 0.0 0
M  V30 25 N 13.3370 7.8511 0.0 0
M  V30 26 C 6.6685 0.0000 0.0 0
M  V30 27 O 5.3348 0.7700 0.0 0
M  V30 28 O 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 2 4
M  V30 6 2 2 5
M  V30 7 1 4 6
M  V30 8 1 6 20
M  V30 9 1 7 13
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[1-(Phenylmethyl)-4-piperidinyl]methyl (αS)-α,4-dihydroxy-α-phenylbenzeneacetate
C27H29NO4
2173079-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.0010 0.0 0 CFG=2
M  V30 2 C 6.6685 3.2310 0.0 0
M  V30 3 O 6.1048 5.3348 0.0 0
M  V30 4 O 8.0023 4.0010 0.0 0
M  V30 5 O 6.6685 1.6910 0.0 0
M  V30 6 C 9.3360 3.2310 0.0 0
M  V30 7 O 0.0000 7.0811 0.0 0
M  V30 8 C 14.6708 6.3111 0.0 0
M  V30 9 C 4.0012 4.7710 0.0 0
M  V30 10 C 2.6675 4.0010 0.0 0
M  V30 11 C 4.0012 6.3111 0.0 0
M  V30 12 C 1.3337 4.7710 0.0 0
M  V30 13 C 2.6675 7.0811 0.0 0
M  V30 14 C 1.3337 6.3111 0.0 0
M  V30 15 C 4.5648 2.6673 0.0 0
M  V30 16 C 5.3348 1.3337 0.0 0
M  V30 17 C 3.0248 2.6673 0.0 0
M  V30 18 C 4.5648 0.0000 0.0 0
M  V30 19 C 2.2548 1.3337 0.0 0
M  V30 20 C 3.0248 0.0000 0.0 0
M  V30 21 C 10.6697 4.0010 0.0 0
M  V30 22 C 10.6697 5.5410 0.0 0
M  V30 23 C 12.0035 3.2310 0.0 0
M  V30 24 C 12.0035 6.3111 0.0 0
M  V30 25 C 13.3372 4.0010 0.0 0
M  V30 26 N 13.3372 5.5410 0.0 0
M  V30 27 C 16.0045 5.5410 0.0 0
M  V30 28 C 17.3383 6.3111 0.0 0
M  V30 29 C 16.0045 4.0010 0.0 0
M  V30 30 C 18.6720 5.5410 0.0 0
M  V30 31 C 17.3383 3.2310 0.0 0
M  V30 32 C 18.6720 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 2 4
M  V30 6 2 2 5
M  V30 7 1 4 6
M  V30 8 1 6 21
M  V30 9 1 7 14
M  V30 10 1 8 26
M  V30 11 1 8 27
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173079-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173079-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19910717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyquinolinone compounds as muscarinic receptor antagonists and beta2
adrenergic receptor agonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rancati, Fabio; Rizzi, Andrea; Carzaniga, Laura; Linney, Ian; Knight,
Chris; Schmidt, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018011090 A1 2018-01-18

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-amino-N-(4-methoxyphenyl)-N-methylacetamide (1:1)
C10H14N2O2.CH2O2
1651176-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.8500 0.0 0
M  V30 2 C 2.6673 4.6200 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 1.3337 3.8500 0.0 0
M  V30 5 O 2.6673 6.1601 0.0 0
M  V30 6 N 0.0000 4.6200 0.0 0
M  V30 7 O 9.3359 6.9301 0.0 0
M  V30 8 C 10.6695 6.1601 0.0 0
M  V30 9 C 5.3348 4.6200 0.0 0
M  V30 10 C 5.3348 6.1601 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 6.6684 6.9301 0.0 0
M  V30 13 C 8.0022 4.6200 0.0 0
M  V30 14 C 8.0022 6.1601 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 O 4.0011 0.7700 0.0 0
M  V30 17 O 6.6684 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-N-methyl-2-[[(phenylamino)thioxomethyl]amino]acetamide
C17H19N3O2S
1651176-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6695 2.3100 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 C 10.6695 0.7700 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 9.3359 4.6201 0.0 0
M  V30 6 N 6.6686 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 4.0011 3.0800 0.0 0
M  V30 9 S 5.3348 0.7700 0.0 0
M  V30 10 O 16.0043 5.3901 0.0 0
M  V30 11 C 17.3381 4.6201 0.0 0
M  V30 12 C 12.0034 3.0800 0.0 0
M  V30 13 C 13.3370 2.3100 0.0 0
M  V30 14 C 12.0034 4.6201 0.0 0
M  V30 15 C 14.6707 3.0800 0.0 0
M  V30 16 C 13.3370 5.3901 0.0 0
M  V30 17 C 14.6707 4.6201 0.0 0
M  V30 18 C 2.6675 2.3100 0.0 0
M  V30 19 C 1.3338 3.0800 0.0 0
M  V30 20 C 2.6675 0.7700 0.0 0
M  V30 21 C 0.0000 2.3100 0.0 0
M  V30 22 C 1.3338 0.0000 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 18
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1651176-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1651176-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-9791945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of TEA
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Access to newly functionalized imidazole derivatives: efficient synthesis
of novel 5-amino-2-thioimidazoles using propylphosphonic anhydride (®T3P)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lasalle, Manuel; Picon, Sylvain; Boulahjar, Rajaa; Hoguet, Vanessa; Van
Obbergen, Jolien; Roussel, Pascal; Deprez, Benoit; Charton, Julie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(8), 1011-1014

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
2,2,2-Trifluoroethyl trifluoromethanesulfonate
C3H2F6O3S
6226-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 1.3337 0.0 0 VAL=6
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 3.6439 2.1037 0.0 0
M  V30 4 O 0.9764 0.5637 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 F 2.3101 4.0010 0.0 0
M  V30 7 F 0.7700 4.0010 0.0 0
M  V30 8 F 0.0000 2.6673 0.0 0
M  V30 9 C 4.9775 1.3337 0.0 0
M  V30 10 C 6.3112 2.1037 0.0 0
M  V30 11 F 5.5412 3.4374 0.0 0
M  V30 12 F 7.6450 2.8737 0.0 0
M  V30 13 F 7.0812 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 7-(5-pyrimidinyl)-1H-benzimidazole (1:1)
C11H8N4.CH2O2
1393359-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4781 5.3901 0.0 0
M  V30 2 C 3.8119 4.6201 0.0 0
M  V30 3 C 1.1444 4.6201 0.0 0
M  V30 4 N 2.1579 6.8964 0.0 0
M  V30 5 C 3.8119 3.0800 0.0 0
M  V30 6 N 0.0000 5.6505 0.0 0
M  V30 7 C 1.1444 3.0800 0.0 0
M  V30 8 C 0.6263 7.0575 0.0 0
M  V30 9 C 2.4781 2.3100 0.0 0
M  V30 10 C 5.1456 5.3901 0.0 0
M  V30 11 C 6.4792 4.6201 0.0 0
M  V30 12 C 5.1456 6.9301 0.0 0
M  V30 13 N 7.8129 5.3901 0.0 0
M  V30 14 N 6.4792 7.7001 0.0 0
M  V30 15 C 7.8129 6.9301 0.0 0
M  V30 16 C 3.9064 0.0000 0.0 0
M  V30 17 O 2.5728 0.7700 0.0 0
M  V30 18 O 5.2401 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 10
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 2 5 9
M  V30 10 2 6 8
M  V30 11 1 7 9
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole, 4-(5-pyrimidinyl)-1-(2,2,2-trifluoroethyl)-
C13H9F3N4
1370001-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3193 3.0203 0.0 0
M  V30 2 C 10.3498 4.1649 0.0 0
M  V30 3 F 11.4942 3.1343 0.0 0
M  V30 4 F 11.3802 5.3092 0.0 0
M  V30 5 F 9.2054 5.1953 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 6.6685 2.3100 0.0 0
M  V30 8 C 4.0010 2.3100 0.0 0
M  V30 9 N 5.6550 4.5864 0.0 0
M  V30 10 N 7.8129 3.3405 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0010 0.7700 0.0 0
M  V30 13 C 7.1865 4.7474 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3100 0.0 0
M  V30 18 N 1.3337 5.3901 0.0 0
M  V30 19 N 0.0000 3.0801 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 15
M  V30 13 2 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6226-25-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1393359-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1370001-99-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6357755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 44B:
4-(Pyrimidin-5-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole To a
solution of 4-(pyrimidin-5-yl)-1H-benzo[d]imidazole, formic acid salt
(0.060 g, 0.248 mmol) in DMSO (Volume: 1.732 ml) was added cesium
carbonate (0.161 g, 0.495 mmol) and 2,2,2-trifluoroethyl
trifluoromethanesulfonate (0.060 g, 0.260 mmol). The reaction mixture was
stirred at room temperature for 24 h, then quenched with H2O and
extracted with EtOAc (5X). The organic layers were combined, dried over
Na2SO4, filtered, and concentrated to afford a yellow liquid, which was
further dried under high vacuum to afford a yellow solid. The crude
material was dissolved in a minimal amount of CH2Cl2 and chromatographed.
Purification of the crude material by silica gel chromatography using an
ISCO machine (24 g column, 35 mL/min, 0-20% MeOH in CH2Cl2 over 23 min,
tr = 12 min) gave Preparation 44B. HPLC conditions: Column:Luna C18
4.6x30mm 3u A: 10:90 H2O:ACN NH4OAc/B: 10:90 H2O:ACN NH4OAc; 0%-95%B in 2
min; 4mL/min flow. Colorless solid, yield(70.7 mg, 0.252 mmol, 102%). MS
(ESI): m/z = 279.1 [M+H]+. HPLC Peak tr = 1.35 minutes.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazole and imidazopyridine compounds
useful as CYP17 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Audris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012044537 A1 2012-04-05

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Trifluoromethanesulfonic anhydride
C2F6O5S2
358-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 1.3337 0.0 0 VAL=6
M  V30 2 O 3.6437 2.1037 0.0 0
M  V30 3 C 1.5400 2.6673 0.0 0
M  V30 4 O 0.9762 0.5637 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 S 4.9774 1.3337 0.0 0 VAL=6
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 F 0.7700 4.0010 0.0 0
M  V30 9 F 2.3101 4.0010 0.0 0
M  V30 10 C 5.7474 2.6673 0.0 0
M  V30 11 O 6.3112 0.5637 0.0 0
M  V30 12 O 4.2074 0.0000 0.0 0
M  V30 13 F 4.9774 4.0010 0.0 0
M  V30 14 F 6.5174 4.0010 0.0 0
M  V30 15 F 7.2874 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 2 6 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 7,8-difluoro-3,4-dihydro-6-hydroxy-1(2H)-isoquinolin...
C9H7F2NO2.CH2O2
2857092-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3901 7.6448 0.0 0
M  V30 2 O 3.0801 8.9787 0.0 0
M  V30 3 F 6.9302 4.9775 0.0 0
M  V30 4 O 5.3901 2.3100 0.0 0
M  V30 5 C 3.0801 6.3112 0.0 0
M  V30 6 C 2.3101 4.9775 0.0 0
M  V30 7 C 4.6201 6.3112 0.0 0
M  V30 8 C 2.3101 7.6448 0.0 0
M  V30 9 C 3.0801 3.6438 0.0 0
M  V30 10 C 0.7700 4.9775 0.0 0
M  V30 11 C 5.3901 4.9775 0.0 0
M  V30 12 N 0.7700 7.6448 0.0 0
M  V30 13 C 4.6201 3.6438 0.0 0
M  V30 14 C 0.0000 6.3112 0.0 0
M  V30 15 C 3.4651 0.0000 0.0 0
M  V30 16 O 2.1314 0.7700 0.0 0
M  V30 17 O 4.7987 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,8-Difluoro-1,2,3,4-tetrahydro-1-oxo-6-isoquinolinyl 1,1,1-trifluoromethanes...
C10H6F5NO4S
2857092-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.3100 0.0000 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 S 7.7000 4.0011 0.0 0 VAL=6
M  V30 5 C 9.0336 3.2311 0.0 0
M  V30 6 O 8.4700 5.3349 0.0 0
M  V30 7 O 6.3662 4.7711 0.0 0
M  V30 8 F 10.3673 4.0011 0.0 0
M  V30 9 F 10.3673 2.4611 0.0 0
M  V30 10 F 9.0336 1.6911 0.0 0
M  V30 11 F 5.3900 0.0000 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 3.0800 1.3338 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 0.7700 5.3349 0.0 0
M  V30 20 C 4.6200 1.3338 0.0 0
M  V30 21 N 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 17
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 20
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 358-23-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2857092-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2857092-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35021445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted amino pyridine compounds as inhibitors of the
hematopoietic progenitor kinase 1 (HPK1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Awar, Rima; Isaac, Methvin; Joseph, Babu; Laufer, Radek; Poda,
Gennady; Posternak, Ganna; Prakesch, Michael; Subramanian, Pandiaraju;
Uehling, David; Watson, Iain; Wilson, Brian; Zepeda-Velazquez, Carlos
Armando; Chau, Anh; Xin, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022226667 A1 2022-11-03

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-nitrophenyl isocyanate
C8H6N2O4
59741-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 0.7700 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6686 3.0800 0.0 0
M  V30 5 C 8.0022 3.8500 0.0 0
M  V30 6 N 1.3337 6.1601 0.0 0 VAL=5
M  V30 7 O 0.0000 5.3901 0.0 0
M  V30 8 O 1.3337 7.7001 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0011 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with α-amino-N-8-quinolinylbenzeneacetamide (1:1)
C17H15N3O.CH2O2
672962-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.3111 0.0 0
M  V30 2 C 6.9300 6.3111 0.0 0
M  V30 3 C 7.7000 7.6447 0.0 0
M  V30 4 O 7.7000 4.9775 0.0 0
M  V30 5 N 6.9300 8.9785 0.0 0
M  V30 6 C 3.0800 4.9775 0.0 0
M  V30 7 C 4.6200 4.9775 0.0 0
M  V30 8 C 2.3100 3.6438 0.0 0
M  V30 9 N 2.3100 6.3111 0.0 0
M  V30 10 C 5.3900 3.6438 0.0 0
M  V30 11 C 3.0800 2.3100 0.0 0
M  V30 12 C 0.7700 3.6438 0.0 0
M  V30 13 C 0.7700 6.3111 0.0 0
M  V30 14 C 4.6200 2.3100 0.0 0
M  V30 15 C 0.0000 4.9775 0.0 0
M  V30 16 C 9.2400 7.6447 0.0 0
M  V30 17 C 10.0100 6.3111 0.0 0
M  V30 18 C 10.0100 8.9785 0.0 0
M  V30 19 C 11.5500 6.3111 0.0 0
M  V30 20 C 11.5500 8.9785 0.0 0
M  V30 21 C 12.3200 7.6447 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 23 O 4.8263 0.7700 0.0 0
M  V30 24 O 7.4937 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[[(2-Methoxy-5-nitrophenyl)amino]carbonyl]amino]-N-8-quinolinylbenzeneacet...
C25H21N5O5
672962-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 6.6684 0.0 0
M  V30 3 C 6.9301 6.6684 0.0 0
M  V30 4 O 4.6201 8.0022 0.0 0
M  V30 5 N 7.7001 5.3348 0.0 0
M  V30 6 C 9.2401 5.3348 0.0 0
M  V30 7 N 10.0101 4.0011 0.0 0
M  V30 8 O 10.0101 6.6684 0.0 0
M  V30 9 O 11.5501 1.3337 0.0 0
M  V30 10 C 12.3201 0.0000 0.0 0
M  V30 11 N 14.6302 6.6684 0.0 0 VAL=5
M  V30 12 O 13.8602 8.0022 0.0 0
M  V30 13 O 16.1702 6.6684 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 N 3.0800 2.6673 0.0 0
M  V30 18 C 2.3100 6.6684 0.0 0
M  V30 19 C 0.0000 5.3348 0.0 0
M  V30 20 C 0.0000 2.6673 0.0 0
M  V30 21 C 2.3100 1.3337 0.0 0
M  V30 22 C 0.7700 6.6684 0.0 0
M  V30 23 C 0.7700 1.3337 0.0 0
M  V30 24 C 7.7001 8.0022 0.0 0
M  V30 25 C 6.9301 9.3359 0.0 0
M  V30 26 C 9.2401 8.0022 0.0 0
M  V30 27 C 7.7001 10.6695 0.0 0
M  V30 28 C 10.0101 9.3359 0.0 0
M  V30 29 C 9.2401 10.6695 0.0 0
M  V30 30 C 11.5501 4.0011 0.0 0
M  V30 31 C 12.3201 2.6673 0.0 0
M  V30 32 C 12.3201 5.3348 0.0 0
M  V30 33 C 13.8602 2.6673 0.0 0
M  V30 34 C 13.8602 5.3348 0.0 0
M  V30 35 C 14.6302 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 24
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 30
M  V30 11 1 9 10
M  V30 12 1 9 31
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 34
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 59741-17-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672962-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 672962-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-2252505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylglycine derivatives and their use as glycine transport inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Xin, Tao; Edwards, Louise; Begleiter, Leah; Stefanac,
Tomaslav; O'Brien, Anne; Da Silva, Kathleen; Arora, Jalaj; Maddaford,
Shawn; Slassi, Abdelmalik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004022528 A2 2004-03-18

$RFMT $RIREG SCHEME326 STEP1
$RXN



  1  1
$MOL
4-Pyridinecarboxylic acid, 3-[[4-[3-[(3-amino-1-oxopropyl)amino]phenyl]-1-oxo...
C21H26N4O4.CH2O2
1461603-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.9301 0.0 0
M  V30 2 C 6.6684 7.7001 0.0 0
M  V30 3 C 8.0021 6.9301 0.0 0
M  V30 4 O 6.6684 9.2401 0.0 0
M  V30 5 C 9.3359 7.7001 0.0 0
M  V30 6 C 10.6695 6.9301 0.0 0
M  V30 7 C 2.6673 5.3901 0.0 0
M  V30 8 O 1.3337 4.6200 0.0 0
M  V30 9 O 4.0011 4.6200 0.0 0
M  V30 10 C 1.3337 3.0800 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 N 16.0043 6.9301 0.0 0
M  V30 13 C 17.3380 7.7001 0.0 0
M  V30 14 C 18.6718 6.9301 0.0 0
M  V30 15 O 17.3380 9.2401 0.0 0
M  V30 16 C 20.0054 7.7001 0.0 0
M  V30 17 N 21.3391 6.9301 0.0 0
M  V30 18 C 4.0011 7.7001 0.0 0
M  V30 19 C 2.6673 6.9301 0.0 0
M  V30 20 C 4.0011 9.2401 0.0 0
M  V30 21 C 1.3337 7.7001 0.0 0
M  V30 22 N 2.6673 10.0101 0.0 0
M  V30 23 C 1.3337 9.2401 0.0 0
M  V30 24 C 12.0032 7.7001 0.0 0
M  V30 25 C 13.3370 6.9301 0.0 0
M  V30 26 C 12.0032 9.2401 0.0 0
M  V30 27 C 14.6707 7.7001 0.0 0
M  V30 28 C 13.3370 10.0101 0.0 0
M  V30 29 C 14.6707 9.2401 0.0 0
M  V30 30 C 10.6695 0.0000 0.0 0
M  V30 31 O 9.3359 0.7700 0.0 0
M  V30 32 O 12.0032 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[4-[3-[(3-Amino-1-oxopropyl)amino]phenyl]-1-oxobutyl]amino]-4-pyridinecarb...
C19H22N4O4
1461601-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 8.0022 3.0800 0.0 0
M  V30 6 C 9.3359 2.3100 0.0 0
M  V30 7 C 1.3337 0.7700 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 N 14.6707 2.3100 0.0 0
M  V30 11 C 16.0043 3.0800 0.0 0
M  V30 12 C 17.3380 2.3100 0.0 0
M  V30 13 O 16.0043 4.6201 0.0 0
M  V30 14 C 18.6718 3.0800 0.0 0
M  V30 15 N 20.0054 2.3100 0.0 0
M  V30 16 C 2.6675 3.0800 0.0 0
M  V30 17 C 1.3337 2.3100 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 20 N 1.3337 5.3901 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 10.6695 3.0800 0.0 0
M  V30 23 C 12.0032 2.3100 0.0 0
M  V30 24 C 10.6695 4.6201 0.0 0
M  V30 25 C 13.3370 3.0800 0.0 0
M  V30 26 C 12.0032 5.3901 0.0 0
M  V30 27 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1461603-59-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1461601-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-15811973
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-66-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Lithium hydroxide hydrate (5.0 mg, 0.12 mmol) was added in a single
portion to a stirred solution of ethyl
3-(4-(3-(3-aminopropanamido)phenyl)butanamido)isonicotinate, formic acid
salt (24 mg, 0.054 mmol) in THF (5 mL) and water (1.6 mL) at room
temperature. Following stirring at room temperature for 30 minutes,
aqueoua 2 M HCl (2 mL) was added. The resultant solution was then
evaporated under reduced pressure to give a white solid. The solid was
dissolved in MeOH (10 mL) and loaded onto an SCX column (2 g) that had
been prewashed with MeOH (2 CV). The column was then eluted with MeOH (2
CV), followed by 2 M NH3 in MeOH (2 CV). The methanolic ammonia fractions
were combined and evaporated under reduced pressure.
3-(4-(3-(3-aminopropanamido)phenyl)-butanamido)isonicotinic acid as a
pale yellow solid (20 mg, 100%). 1H NMR (400 MHz, MeOD): δ = 9.70 (s,
1H), 8.24 (d, J= 5.0 Hz, 1H), 8.05 (bs, 1H), 7.91 (d, J= 5.0 Hz, 1H),
7.43 (d, J= 8.1 Hz, 1H), 7.38 (s, 1H), 7.19 (t, J= 7.8 Hz, 1H), 6.96 (d,
J= 7.6 Hz, 1H), 3.27 (t, J= 6.2 Hz, 2H), 2.81 (t, J= 6.2 Hz, 2H), 2.67
(t, J= 7.1 Hz, 2H), 2.41 (t, J= 7.1 Hz, 2H), 2.06 (p, J= 7.1 Hz, 2H).
HRMS (C19H23N4O4 +, [M+H]+ ): calcd. 371.1714; found 371.1714. LC MS
(Method B) m/z371 [M+H]+ (Rt = 0.40 min).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Interrogating the Druggability of the 2-Oxoglutarate-Dependent
Dioxygenase Target Class by Chemical Proteomics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joberty, Gerard; Boesche, Markus; Brown, Jack A.; Eberhard, Dirk; Garton,
Neil S.; Mathieson, Toby; Muelbaier, Marcel; Ramsden, Nigel G.; Reader,
Valerie; Rueger, Anne; Sheppard, Robert J.; Westaway, Susan M.;
Bantscheff, Marcus; Lee, Kevin; Wilson, David M.; Prinjha, Rab K.;
Drewes, Gerard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Biology (2016), 11(7), 2002-2010

$RFMT $RIREG SCHEME326 STEP1
$RXN



  1  1
$MOL
4-Pyridinecarboxylic acid, 3-[[4-[3-[(3-amino-1-oxopropyl)amino]phenyl]-1-oxo...
C21H26N4O4.CH2O2
1461603-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.9301 0.0 0
M  V30 2 C 6.6684 7.7001 0.0 0
M  V30 3 C 8.0021 6.9301 0.0 0
M  V30 4 O 6.6684 9.2401 0.0 0
M  V30 5 C 9.3359 7.7001 0.0 0
M  V30 6 C 10.6695 6.9301 0.0 0
M  V30 7 C 2.6673 5.3901 0.0 0
M  V30 8 O 1.3337 4.6200 0.0 0
M  V30 9 O 4.0011 4.6200 0.0 0
M  V30 10 C 1.3337 3.0800 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 N 16.0043 6.9301 0.0 0
M  V30 13 C 17.3380 7.7001 0.0 0
M  V30 14 C 18.6718 6.9301 0.0 0
M  V30 15 O 17.3380 9.2401 0.0 0
M  V30 16 C 20.0054 7.7001 0.0 0
M  V30 17 N 21.3391 6.9301 0.0 0
M  V30 18 C 4.0011 7.7001 0.0 0
M  V30 19 C 2.6673 6.9301 0.0 0
M  V30 20 C 4.0011 9.2401 0.0 0
M  V30 21 C 1.3337 7.7001 0.0 0
M  V30 22 N 2.6673 10.0101 0.0 0
M  V30 23 C 1.3337 9.2401 0.0 0
M  V30 24 C 12.0032 7.7001 0.0 0
M  V30 25 C 13.3370 6.9301 0.0 0
M  V30 26 C 12.0032 9.2401 0.0 0
M  V30 27 C 14.6707 7.7001 0.0 0
M  V30 28 C 13.3370 10.0101 0.0 0
M  V30 29 C 14.6707 9.2401 0.0 0
M  V30 30 C 10.6695 0.0000 0.0 0
M  V30 31 O 9.3359 0.7700 0.0 0
M  V30 32 O 12.0032 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[4-[3-[(3-Amino-1-oxopropyl)amino]phenyl]-1-oxobutyl]amino]-4-pyridinecarb...
C19H22N4O4
1461601-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 8.0022 3.0800 0.0 0
M  V30 6 C 9.3359 2.3100 0.0 0
M  V30 7 C 1.3337 0.7700 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 N 14.6707 2.3100 0.0 0
M  V30 11 C 16.0043 3.0800 0.0 0
M  V30 12 C 17.3380 2.3100 0.0 0
M  V30 13 O 16.0043 4.6201 0.0 0
M  V30 14 C 18.6718 3.0800 0.0 0
M  V30 15 N 20.0054 2.3100 0.0 0
M  V30 16 C 2.6675 3.0800 0.0 0
M  V30 17 C 1.3337 2.3100 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 20 N 1.3337 5.3901 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 10.6695 3.0800 0.0 0
M  V30 23 C 12.0032 2.3100 0.0 0
M  V30 24 C 10.6695 4.6201 0.0 0
M  V30 25 C 13.3370 3.0800 0.0 0
M  V30 26 C 12.0032 5.3901 0.0 0
M  V30 27 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1461603-59-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1461601-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-7748079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1:
3-{[(4-chlorophenyl)acetyl]amino)-4-pyridinecarboxylic acid hydrochloride
To a solution of ethyl
3-{[(4-chlorophenyl)acetyl]amino}-4-pyridinecarboxylate (184 mg, 0.58
mmol) in THF (10 ml) and water (3.33ml) was added lithium hydroxide
monohydrate (48mg, 1.15 mmol). The reaction mixture was stirred
overnight, then acidified with 2.ON aq. HCl and stirred for five minutes.
The resulting orange suspension was filtered then washed with water (50
ml), then ethanol (30 ml) then ether (50 ml) and dried in vacuo.
3-({4-[3-(β-alanylamino)phenyl]butanoyl}amino)-4-pyridinecarboxylic acid
Yield 100% Rt 0.43 min, MH+ 371.0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridine-4-carboxylic acids as demethylase enzymes inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barker, Michael David; Campbell, Matthew; Diallo, Hawa; Douault, Clement;
Humphreys, Philip; Liddle, John; Sheppard, Robert John; Thomas, Pamela
Joan; Wilson, David Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013143597 A1 2013-10-03

$RFMT $RIREG SCHEME327 STEP1
$RXN



  1  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333227-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=2
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-, 2-methyl ester, aceta...
C18H22N4O5.2C2H4O2
1333227-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 10.5184 0.0 0 CFG=2
M  V30 2 C 10.0101 9.1848 0.0 0
M  V30 3 N 7.7000 10.5184 0.0 0
M  V30 4 C 10.0101 11.8522 0.0 0
M  V30 5 C 6.9300 9.1848 0.0 0
M  V30 6 O 9.2400 13.1859 0.0 0
M  V30 7 O 11.5501 11.8522 0.0 0
M  V30 8 C 5.3900 9.1848 0.0 0
M  V30 9 O 7.7000 7.8511 0.0 0
M  V30 10 C 10.0101 14.5195 0.0 0
M  V30 11 N 4.6200 7.8511 0.0 0
M  V30 12 C 3.0800 7.8511 0.0 0
M  V30 13 C 5.3900 6.5173 0.0 0
M  V30 14 C 4.6200 5.1837 0.0 0
M  V30 15 O 3.0800 5.1837 0.0 0
M  V30 16 O 5.3900 3.8501 0.0 0
M  V30 17 C 11.5501 9.1848 0.0 0
M  V30 18 C 12.4553 7.9389 0.0 0
M  V30 19 N 12.4553 10.4307 0.0 0
M  V30 20 N 13.9198 8.4148 0.0 0
M  V30 21 C 13.9198 9.9548 0.0 0
M  V30 22 C 2.3100 9.1848 0.0 0
M  V30 23 C 3.0800 10.5184 0.0 0
M  V30 24 C 0.7700 9.1848 0.0 0
M  V30 25 C 2.3100 11.8522 0.0 0
M  V30 26 C 0.0000 10.5184 0.0 0
M  V30 27 C 0.7700 11.8522 0.0 0
M  V30 28 C 6.9599 1.5400 0.0 0
M  V30 29 C 5.6262 2.3101 0.0 0
M  V30 30 O 8.2936 2.3101 0.0 0
M  V30 31 O 6.9599 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 22
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-5366896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Exemple 7: synthesis of final products
according to the invention (67-82). General procedure for deprotection
(67-82): The tritylated compound or t-Bu-squaric derivative was
deprotected in DCM with TFA (5-50% volume). Triisopropylsilane was added
until the yellow solution became colorless. The mixture was stirred at
room temperature for 1H. The solvent was evaporated and the crude product
was triturated in diethyl ether and purified by preparative HPLC if
necessary. Reactant:
(S)-2-[2-(Carboxymethyl-pyridin-4-ylmethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (59).
(R)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (39).
(R)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester .2CH3COOH (68), white powder (100%). Purity 99%. 1H NMR
(DMSO-d6) δ ppm: 3.16 (m, 2H), 3.32 (s, 2H), 3.39 (s, 2H), 3.65 (s, 3H),
3.81 (s, 1H), 4.70 (m, 1H), 7.32 (m, 5H), 7.36 (s, 1H), 8.46 (d, J=
8.1Hz, 1H), 8.97 (s, 1H). 13C NMR (DMSO-d6) δ ppm: 26.1, 50.8, 52.3,
53.5, 55.9, 57.5, 117.0, 127.6, 128.3, 129.0, 129.2, 133.8, 136.9, 169.8,
170.8, 171.7. LC tr = 0.783 min; MS (ESI+) : m/z = 375 (M+H)+. IC50: 1.4
μM, 0.5 μM. pIC50: 5.9, 6.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as acetate salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL

C15H19F2NO3
2919072-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 8.0021 6.1601 0.0 0
M  V30 2 F 8.0021 0.0000 0.0 0
M  V30 3 N 5.3348 4.6201 0.0 0
M  V30 4 C 4.0011 3.8501 0.0 0
M  V30 5 O 2.6673 4.6201 0.0 0
M  V30 6 O 4.0011 2.3100 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 0.5636 5.1837 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 2.1037 2.5164 0.0 0
M  V30 11 C 13.2457 3.0800 0.0 0
M  V30 12 O 14.0157 1.7464 0.0 0
M  V30 13 C 9.3359 3.8501 0.0 0
M  V30 14 C 9.3359 2.3100 0.0 0
M  V30 15 C 8.0021 4.6201 0.0 0
M  V30 16 C 10.8005 4.3259 0.0 0
M  V30 17 C 10.8005 1.8342 0.0 0
M  V30 18 C 8.0021 1.5400 0.0 0
M  V30 19 C 6.6684 3.8501 0.0 0
M  V30 20 C 11.7057 3.0800 0.0 0
M  V30 21 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 20
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H15N5O4.CH2O2
2713997-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3594 2.3100 0.0 0
M  V30 2 O 0.0000 9.0217 0.0 0
M  V30 3 C 9.2998 5.7906 0.0 0
M  V30 4 C 7.8353 6.2665 0.0 0
M  V30 5 O 9.2998 4.2506 0.0 0
M  V30 6 C 10.7068 5.1643 0.0 0
M  V30 7 C 9.1389 7.3221 0.0 0
M  V30 8 N 6.9300 5.0206 0.0 0
M  V30 9 C 7.8353 3.7747 0.0 0
M  V30 10 C 11.9526 6.0693 0.0 0
M  V30 11 C 10.3847 8.2273 0.0 0
M  V30 12 N 11.7917 7.6010 0.0 0
M  V30 13 C 5.3900 5.0206 0.0 0
M  V30 14 N 4.6200 6.3542 0.0 0
M  V30 15 C 4.6200 3.6869 0.0 0
M  V30 16 C 3.0800 6.3542 0.0 0
M  V30 17 N 3.0800 3.6869 0.0 0
M  V30 18 C 2.3100 5.0206 0.0 0
M  V30 19 N 2.3100 7.6879 0.0 0
M  V30 20 O 0.7700 5.0206 0.0 0
M  V30 21 C 0.7700 7.6879 0.0 0
M  V30 22 C 0.0000 6.3542 0.0 0
M  V30 23 C 5.9763 0.0000 0.0 0
M  V30 24 O 4.6426 0.7700 0.0 0
M  V30 25 O 7.3100 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 21
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 8 13
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Oxa-3,8-diazaspiro[4.5]decan-2-one, 8-[(5-amino-4,7-difluoro-2,3-dihydro-1H...
C23H24F2N6O4
2919071-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4540 0.5141 0.0 0
M  V30 2 C 13.7488 6.0828 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 F 19.8298 6.1283 0.0 0
M  V30 5 F 16.7498 0.7936 0.0 0
M  V30 6 N 21.3699 3.4610 0.0 0
M  V30 7 C 9.7477 3.7727 0.0 0
M  V30 8 C 8.3409 4.3992 0.0 0
M  V30 9 O 9.5867 2.2412 0.0 0
M  V30 10 C 11.0813 3.0027 0.0 0
M  V30 11 C 9.7477 5.3127 0.0 0
M  V30 12 N 7.3103 3.2547 0.0 0
M  V30 13 C 8.0803 1.9210 0.0 0
M  V30 14 C 12.4151 3.7727 0.0 0
M  V30 15 C 11.0813 6.0828 0.0 0
M  V30 16 N 12.4151 5.3127 0.0 0
M  V30 17 C 5.7788 3.4156 0.0 0
M  V30 18 N 4.8735 2.1697 0.0 0
M  V30 19 C 5.1524 4.8226 0.0 0
M  V30 20 C 3.3420 2.3308 0.0 0
M  V30 21 N 3.6209 4.9835 0.0 0
M  V30 22 C 2.7157 3.7376 0.0 0
M  V30 23 N 2.4368 1.0848 0.0 0
M  V30 24 O 1.1840 3.8985 0.0 0
M  V30 25 C 0.9052 1.2459 0.0 0
M  V30 26 C 0.2789 2.6527 0.0 0
M  V30 27 C 15.0824 5.3127 0.0 0
M  V30 28 C 16.4894 5.9392 0.0 0
M  V30 29 C 15.2434 3.7812 0.0 0
M  V30 30 C 17.5198 4.7947 0.0 0
M  V30 31 C 16.7498 3.4610 0.0 0
M  V30 32 C 19.0598 4.7947 0.0 0
M  V30 33 C 17.5198 2.1274 0.0 0
M  V30 34 C 19.8298 3.4610 0.0 0
M  V30 35 C 19.0598 2.1274 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 16
M  V30 3 1 2 27
M  V30 4 2 3 25
M  V30 5 1 4 32
M  V30 6 1 5 33
M  V30 7 1 6 34
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 12 17
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 22
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2919072-75-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713997-65-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919071-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36370667
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 87413-09-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dess-Martin oxidation stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new pyrazino-oxazines useful in the treatment of bacterial
infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andreotti, Daniele; Cumming, John G.; Fossati, Giacomo; Sampaolesi,
Susanna; Serra, Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023041756 A1 2023-03-23

$RFMT $RIREG SCHEME329 STEP1
$RXN



  1  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(3-phenylpropyl)glycyl-1-(triphenylmethyl)-,...
C39H40N4O5.CH2O2
1333227-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5948 10.3673 0.0 0
M  V30 2 C 9.8975 9.2402 0.0 0
M  V30 3 C 11.2312 10.0102 0.0 0 CFG=2
M  V30 4 N 12.5648 9.2402 0.0 0
M  V30 5 C 11.2312 11.5502 0.0 0
M  V30 6 C 12.5648 7.7001 0.0 0
M  V30 7 O 12.5648 12.3202 0.0 0
M  V30 8 O 9.8975 12.3202 0.0 0
M  V30 9 C 13.8986 6.9301 0.0 0
M  V30 10 O 11.2312 6.9301 0.0 0
M  V30 11 C 12.5648 13.8603 0.0 0
M  V30 12 N 13.8986 5.3901 0.0 0
M  V30 13 C 15.2323 4.6201 0.0 0
M  V30 14 C 12.5648 4.6201 0.0 0
M  V30 15 C 16.5660 5.3901 0.0 0
M  V30 16 C 12.5648 3.0800 0.0 0
M  V30 17 C 17.8997 4.6201 0.0 0
M  V30 18 O 11.2312 2.3100 0.0 0
M  V30 19 O 13.8986 2.3100 0.0 0
M  V30 20 N 6.1264 10.5283 0.0 0
M  V30 21 C 7.1568 9.3837 0.0 0
M  V30 22 C 6.8964 11.8619 0.0 0
M  V30 23 C 8.5638 10.0102 0.0 0
M  V30 24 N 8.4027 11.5417 0.0 0
M  V30 25 C 4.4338 11.8989 0.0 0
M  V30 26 C 5.6796 12.8041 0.0 0
M  V30 27 C 3.0269 12.5252 0.0 0
M  V30 28 C 5.5187 14.3357 0.0 0
M  V30 29 C 2.8660 14.0568 0.0 0
M  V30 30 C 4.1119 14.9620 0.0 0
M  V30 31 C 3.0631 10.2062 0.0 0
M  V30 32 C 2.1580 11.4521 0.0 0
M  V30 33 C 2.4368 8.7994 0.0 0
M  V30 34 C 0.6263 11.2912 0.0 0
M  V30 35 C 0.9052 8.6385 0.0 0
M  V30 36 C 0.0000 9.8844 0.0 0
M  V30 37 C 4.7558 8.8356 0.0 0
M  V30 38 C 6.1626 8.2093 0.0 0
M  V30 39 C 3.5099 7.9304 0.0 0
M  V30 40 C 6.3237 6.6777 0.0 0
M  V30 41 C 3.6708 6.3988 0.0 0
M  V30 42 C 5.0776 5.7725 0.0 0
M  V30 43 C 19.2335 5.3901 0.0 0
M  V30 44 C 20.5671 4.6201 0.0 0
M  V30 45 C 19.2335 6.9301 0.0 0
M  V30 46 C 21.9008 5.3901 0.0 0
M  V30 47 C 20.5671 7.7001 0.0 0
M  V30 48 C 21.9008 6.9301 0.0 0
M  V30 49 C 10.9504 0.0000 0.0 0
M  V30 50 O 9.6167 0.7700 0.0 0
M  V30 51 O 12.2841 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 25
M  V30 3 1 1 31
M  V30 4 1 1 37
M  V30 5 1 2 3
M  V30 6 1 2 23
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 1 17 43
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 48
M  V30 53 1 49 50
M  V30 54 2 49 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Histidine, N-(carboxymethyl)-N-(3-phenylpropyl)glycyl-, 2-methyl ester, ace...
C20H26N4O5.2C2H4O2
1333227-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 10.5184 0.0 0 CFG=2
M  V30 2 C 3.9098 9.1848 0.0 0
M  V30 3 N 6.2198 10.5184 0.0 0
M  V30 4 C 3.9098 11.8522 0.0 0
M  V30 5 C 6.9898 9.1848 0.0 0
M  V30 6 O 4.6798 13.1859 0.0 0
M  V30 7 O 2.3698 11.8522 0.0 0
M  V30 8 C 8.5298 9.1848 0.0 0
M  V30 9 O 6.2198 7.8511 0.0 0
M  V30 10 C 3.9098 14.5195 0.0 0
M  V30 11 N 9.2998 7.8511 0.0 0
M  V30 12 C 10.8398 7.8511 0.0 0
M  V30 13 C 8.5298 6.5173 0.0 0
M  V30 14 C 11.6098 9.1848 0.0 0
M  V30 15 C 9.2998 5.1837 0.0 0
M  V30 16 C 13.1498 9.1848 0.0 0
M  V30 17 O 10.8398 5.1837 0.0 0
M  V30 18 O 8.5298 3.8501 0.0 0
M  V30 19 C 2.3698 9.1848 0.0 0
M  V30 20 C 1.4645 10.4307 0.0 0
M  V30 21 N 1.4645 7.9389 0.0 0
M  V30 22 N 0.0000 9.9548 0.0 0
M  V30 23 C 0.0000 8.4148 0.0 0
M  V30 24 C 13.9198 10.5184 0.0 0
M  V30 25 C 13.1498 11.8522 0.0 0
M  V30 26 C 15.4598 10.5184 0.0 0
M  V30 27 C 13.9198 13.1859 0.0 0
M  V30 28 C 16.2298 11.8522 0.0 0
M  V30 29 C 15.4598 13.1859 0.0 0
M  V30 30 C 8.1149 1.5400 0.0 0
M  V30 31 C 6.7812 2.3101 0.0 0
M  V30 32 O 9.4486 2.3101 0.0 0
M  V30 33 O 8.1149 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-13892448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Exemple 7: synthesis of final products
according to the invention (67-82). General procedure for deprotection
(67-82): The tritylated compound or t-Bu-squaric derivative was
deprotected in DCM with TFA (5-50% volume). Triisopropylsilane was added
until the yellow solution became colorless. The mixture was stirred at
room temperature for 1H. The solvent was evaporated and the crude product
was triturated in diethyl ether and purified by preparative HPLC if
necessary. Reactant:
(S)-2-[2-(Carboxymethyl-pyridin-4-ylmethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (59). Reactant:
(R)-2-{2-[Carboxymethyl-(3-phenyl-propyl)-amino]-acetylandino}-3-(1-trityl-1H-imidazot-a-y))-propionic
acid methyl ester as the formiate salt (44).
(R)-2-{2-[Carboxymethyl-(3-phenyl-propyl)-amino]-acetylamino)-3-(1H-imidazol-4-yl)-propionic
acid methyl ester .2CH3COOH (72) was obtained as a white powder (100%).
Purity 94%. 1H NMR (DMSO-d6) δ ppm: 1.79 (m, 2H), 2.57 (m, 2H), 2.90 (m,
2H), 3.11 (m, 2H), 3.62 (s, 3H), 3.70 (s, 2H), 3.78 (s, 2H), 4.70 (m,
1H), 7.17-7.30 (m, 5H), 7.41 (s, 1H), 8.86 (d, J= 7.2Hz, H), 8.98 (s,
1H). 13C NMR (DMSO-d6) δ ppm: 26.1, 26.8, 32.2, 51.2, 52.4, 54.7, 54.8,
55.7, 117.2, 126.0, 128.3, 128.4, 128.9, 133.7, 141.1, 167.5, 169.7,
170.6. LC tr = 3.06 min; MS (ESI+): m/z = 403 (M+H)+. IC50: 0.4 μM.
pIC50: 6.4.
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as acetate salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME330 STEP1
$RXN



  1  1
$MOL
L-Histidine, N-(carboxymethyl)-N-[(4-methylphenyl)methyl]glycyl-1-(triphenylm...
C38H38N4O5.CH2O2
1333227-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3110 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3110 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3110 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 C 16.7544 15.6468 0.0 0
M  V30 19 N 5.1446 8.4148 0.0 0
M  V30 20 C 6.6091 8.8906 0.0 0
M  V30 21 C 5.1446 6.8748 0.0 0
M  V30 22 C 7.5143 7.6448 0.0 0
M  V30 23 N 6.6091 6.3989 0.0 0
M  V30 24 C 4.8037 10.5658 0.0 0
M  V30 25 C 6.3354 10.4048 0.0 0
M  V30 26 C 4.1774 11.9726 0.0 0
M  V30 27 C 7.2407 11.6508 0.0 0
M  V30 28 C 5.0826 13.2185 0.0 0
M  V30 29 C 6.6142 13.0576 0.0 0
M  V30 30 C 2.6527 10.2250 0.0 0
M  V30 31 C 1.2459 9.5987 0.0 0
M  V30 32 C 2.8137 11.7567 0.0 0
M  V30 33 C 0.0000 10.5039 0.0 0
M  V30 34 C 1.5679 12.6620 0.0 0
M  V30 35 C 0.1609 12.0355 0.0 0
M  V30 36 C 2.9935 8.0740 0.0 0
M  V30 37 C 1.4619 8.2350 0.0 0
M  V30 38 C 3.6198 6.6672 0.0 0
M  V30 39 C 0.5567 6.9892 0.0 0
M  V30 40 C 2.7146 5.4213 0.0 0
M  V30 41 C 1.1830 5.5822 0.0 0
M  V30 42 C 14.4444 11.6459 0.0 0
M  V30 43 C 13.6743 12.9795 0.0 0
M  V30 44 C 15.9844 11.6459 0.0 0
M  V30 45 C 14.4444 14.3131 0.0 0
M  V30 46 C 16.7544 12.9795 0.0 0
M  V30 47 C 15.9844 14.3131 0.0 0
M  V30 48 C 9.1472 0.0000 0.0 0
M  V30 49 O 7.8135 0.7700 0.0 0
M  V30 50 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 1 36
M  V30 5 1 2 3
M  V30 6 1 2 22
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 42
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 47
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 2 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 2 44 46
M  V30 50 2 45 47
M  V30 51 1 46 47
M  V30 52 1 48 49
M  V30 53 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-[(4-methylphenyl)methyl]glycyl-, 2-methyl es...
C19H24N4O5.2C2H4O2
1333227-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1618 7.8512 0.0 0 CFG=1
M  V30 2 C 2.6218 7.8512 0.0 0
M  V30 3 N 4.9318 9.1849 0.0 0
M  V30 4 C 4.9318 6.5174 0.0 0
M  V30 5 C 6.4718 9.1849 0.0 0
M  V30 6 O 4.1618 5.1837 0.0 0
M  V30 7 O 6.4718 6.5174 0.0 0
M  V30 8 C 7.2419 10.5186 0.0 0
M  V30 9 O 7.2419 7.8512 0.0 0
M  V30 10 C 4.9318 3.8501 0.0 0
M  V30 11 N 8.7819 10.5186 0.0 0
M  V30 12 C 9.5519 9.1849 0.0 0
M  V30 13 C 9.5519 11.8524 0.0 0
M  V30 14 C 8.7819 13.1860 0.0 0
M  V30 15 O 7.2419 13.1860 0.0 0
M  V30 16 O 9.5519 14.5197 0.0 0
M  V30 17 C 15.7120 9.1849 0.0 0
M  V30 18 C 1.8517 9.1849 0.0 0
M  V30 19 C 2.4782 10.5917 0.0 0
M  V30 20 N 0.3202 9.3458 0.0 0
M  V30 21 N 1.3337 11.6223 0.0 0
M  V30 22 C 0.0000 10.8523 0.0 0
M  V30 23 C 11.0919 9.1849 0.0 0
M  V30 24 C 11.8620 7.8512 0.0 0
M  V30 25 C 11.8620 10.5186 0.0 0
M  V30 26 C 13.4020 7.8512 0.0 0
M  V30 27 C 13.4020 10.5186 0.0 0
M  V30 28 C 14.1720 9.1849 0.0 0
M  V30 29 C 7.8560 1.5400 0.0 0
M  V30 30 C 6.5224 2.3101 0.0 0
M  V30 31 O 9.1897 2.3101 0.0 0
M  V30 32 O 7.8560 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 23
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 17 28
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 2 29 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-04-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-9636986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Exemple 7: synthesis of final products
according to the invention (67-82). General procedure for deprotection
(67-82): The tritylated compound or t-Bu-squaric derivative was
deprotected in DCM with TFA (5-50% volume). Triisopropylsilane was added
until the yellow solution became colorless. The mixture was stirred at
room temperature for 1H. The solvent was evaporated and the crude product
was triturated in diethyl ether and purified by preparative HPLC if
necessary. Reactant:
(S)-2-[2-(Carboxymethyl-pyridin-4-ylmethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (59). Reactant:
(S)-2-{2-[Carboxymethyl-(4-methyl-benzyl)-amino]-acetylamino}-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester as the formiate salt (41).
(S)-2-{2-[Carboxymethyl-(4-methyl-benzyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester.2CH3COOH (70) was obtained as a white powder (100 %).
Purity 99%. 1H NMR (DMSO-d6) δ ppm: 2.29 (s, 3H), 3.08 (dd, J= 9.0 and
15.3 Hz, 1H), 3.19 (dd, J=5.4 and 15.3 Hz, 1H), 3.41 (s, 2H), 3.45 (s,
2H), 3.65 (s, 3H), 3.83 (s, 2H), 4.70 (m, 1H), 7.15 (d, J= 8.1 Hz, 2H),
7.20 (d, J= 8.1 Hz, 2H), 7.38 (d, J= 1.2 Hz, 1H), 8.54 (d, J= 8.1 Hz,
1H), 8.98 (d, J= 1.2 Hz, 1H). 13C NMR (DMSO-d6) δ ppm: 171.0, 170.7,
169.7, 158.0, 137.1, 133.7, 132.7, 129.5, 129.1, 129.0, 117.1, 57.3,
55.5, 53.6, 52.4, 50.9, 26.2, 20.7. LC tr = 2.86 min; MS (ESI+): m/z =
389 (M+H)+. IC50: 1.7 μM. pIC50: 5.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as acetate salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME331 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with 4-cyclohexyl-6-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)...
C25H35N5O.2CH2O2
1013110-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1467 10.0102 0.0 0
M  V30 2 C 10.4804 9.2402 0.0 0
M  V30 3 O 15.8152 12.3202 0.0 0
M  V30 4 C 17.1489 11.5502 0.0 0
M  V30 5 C 5.1456 9.2402 0.0 0
M  V30 6 C 5.1456 7.7001 0.0 0
M  V30 7 N 6.4792 10.0102 0.0 0
M  V30 8 C 6.4792 6.9301 0.0 0
M  V30 9 C 7.8129 9.2402 0.0 0
M  V30 10 N 7.8129 7.7001 0.0 0
M  V30 11 N 3.8119 10.0102 0.0 0
M  V30 12 C 3.8119 11.5502 0.0 0
M  V30 13 C 2.4781 9.2402 0.0 0
M  V30 14 C 2.4781 12.3202 0.0 0
M  V30 15 C 1.1444 10.0102 0.0 0
M  V30 16 N 1.1444 11.5502 0.0 0
M  V30 17 C 2.1579 13.8265 0.0 0
M  V30 18 C 0.0000 12.5807 0.0 0
M  V30 19 C 0.6263 13.9875 0.0 0
M  V30 20 C 6.4792 5.3901 0.0 0
M  V30 21 C 7.8129 4.6201 0.0 0
M  V30 22 C 5.1456 4.6201 0.0 0
M  V30 23 C 7.8129 3.0800 0.0 0
M  V30 24 C 5.1456 3.0800 0.0 0
M  V30 25 C 6.4792 2.3100 0.0 0
M  V30 26 C 11.8141 10.0102 0.0 0
M  V30 27 C 11.8141 11.5502 0.0 0
M  V30 28 C 13.1477 9.2402 0.0 0
M  V30 29 C 13.1477 12.3202 0.0 0
M  V30 30 C 14.4816 10.0102 0.0 0
M  V30 31 C 14.4816 11.5502 0.0 0
M  V30 32 C 8.5744 0.0000 0.0 0
M  V30 33 O 7.2408 0.7700 0.0 0
M  V30 34 O 9.9081 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 31
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 8 20
M  V30 13 2 9 10
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyclohexyl-6-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-2-pyrimidinamine
C17H27N5
1013104-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 N 8.0022 4.6201 0.0 0
M  V30 3 C 9.3360 3.8501 0.0 0
M  V30 4 C 8.0022 6.1601 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 C 9.3360 6.9302 0.0 0
M  V30 7 N 10.6697 6.1601 0.0 0
M  V30 8 C 12.1342 4.1442 0.0 0
M  V30 9 C 12.1342 6.6360 0.0 0
M  V30 10 C 13.0395 5.3901 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 N 4.0012 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 7
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1013110-25-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013104-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-8944631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 8. Synthesis of
4-cyclohexyl-6-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)pyrimidin-2-amine
(Compound 10). Intermediate 11 (52 mg) is dissolved in TFA (1.5ml) and
the solution is stirred and heated at 75°C for 90 mins. The solution is
cooled, and concentrated in vacuo. The residue is dissolved in DCM
(20ml), and washed with saturated NaHCO3 (10ml). The organic phase is
dried (MgSO4) and concentrated in vacuo. Purification of the residue by
preparative HPLC (Method 8) affords pure product which after isolation in
vacuo is partitioned between DCM (20ml) and saturated NaHCO3 solution
(10ml); the organic phase is dried (MgSO4) and concentrated in vacuo to
afford the title compound as a pale yellow solid (30.1mg, 100%). LCMS 302
[M+H]+ RT 2.06 mins (pH 5.8). 1H NMR 300 MHz (CDCl3) (δ ppm): 5.82 (1 H,
5), 4.81 (2H, br s), 4.45 (1 H, br d), 4.29 (1 H, br d), 2.91 - 3.19 (3H,
m), 2.61 (1H, dd), 2.10 - 2.40 (3H, rn), 1.65 - 2.01 (9H, m), 1.15 - 1.55
(7H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 2-aminopyrimidine derivatives as histamine receptor
H4 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raphy, Gilles; Watson, Robert John; Hannah, Duncan; Pegurier, Cecile;
Ortmans, Isabelle; Lock, Christopher James; Knight, Roland Laurence;
Owen, David Alan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008031556 A2 2008-03-20

$RFMT $RIREG SCHEME332 STEP1
$RXN



  1  1
$MOL
D-Glucitol, 1,1′-[[trans-4-[[(1,1-dimethylethoxy)carbonyl]amino]cyclohexyl]im...
C37H54N2O12.CH2O2
2227486-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.4993 12.9537 0.0 0
M  V30 2 C 8.9727 11.5066 0.0 0
M  V30 3 C 11.0159 13.2211 0.0 0
M  V30 4 C 9.9626 10.3268 0.0 0 CFG=2
M  V30 5 C 11.5426 14.6682 0.0 0 CFG=2
M  V30 6 C 9.4357 8.8797 0.0 0 CFG=2
M  V30 7 O 11.4792 10.5943 0.0 0
M  V30 8 C 13.0592 14.9357 0.0 0 CFG=2
M  V30 9 O 10.5527 15.8480 0.0 0
M  V30 10 O 7.9191 8.6123 0.0 0
M  V30 11 O 14.0491 13.7559 0.0 0
M  V30 12 N 5.5397 17.6724 0.0 0
M  V30 13 C 4.0231 17.4051 0.0 0
M  V30 14 O 3.0332 18.5847 0.0 0
M  V30 15 O 3.4964 15.9580 0.0 0
M  V30 16 C 1.5166 18.3174 0.0 0
M  V30 17 C 1.7841 16.8008 0.0 0
M  V30 18 C 0.0000 18.0499 0.0 0
M  V30 19 C 1.2492 19.8340 0.0 0
M  V30 20 O 13.0931 7.7000 0.0 0
M  V30 21 O 12.2522 18.6927 0.0 0
M  V30 22 C 8.5094 14.1334 0.0 0 CFG=1
M  V30 23 C 9.0361 15.5805 0.0 0
M  V30 24 C 6.9928 13.8660 0.0 0
M  V30 25 C 8.0462 16.7603 0.0 0
M  V30 26 C 6.0029 15.0457 0.0 0
M  V30 27 C 6.5296 16.4928 0.0 0 CFG=1
M  V30 28 C 10.4256 7.7000 0.0 0 CFG=1
M  V30 29 O 9.0920 6.9300 0.0 0
M  V30 30 C 11.7593 6.9300 0.0 0 CFG=2
M  V30 31 C 9.0920 5.3900 0.0 0 CFG=3
M  V30 32 C 11.7593 5.3900 0.0 0
M  V30 33 O 10.4256 4.6200 0.0 0
M  V30 34 C 13.5859 16.3827 0.0 0 CFG=1
M  V30 35 O 14.9197 15.6127 0.0 0
M  V30 36 C 13.5859 17.9227 0.0 0 CFG=2
M  V30 37 C 16.2533 16.3827 0.0 0 CFG=3
M  V30 38 C 14.9197 18.6927 0.0 0
M  V30 39 O 16.2533 17.9227 0.0 0
M  V30 40 C 7.7584 4.6200 0.0 0
M  V30 41 C 6.4246 5.3900 0.0 0
M  V30 42 C 7.7584 3.0800 0.0 0
M  V30 43 C 5.0909 4.6200 0.0 0
M  V30 44 C 6.4246 2.3100 0.0 0
M  V30 45 C 5.0909 3.0800 0.0 0
M  V30 46 C 17.5870 15.6127 0.0 0
M  V30 47 C 17.5870 14.0727 0.0 0
M  V30 48 C 18.9206 16.3827 0.0 0
M  V30 49 C 18.9206 13.3027 0.0 0
M  V30 50 C 20.2544 15.6127 0.0 0
M  V30 51 C 20.2544 14.0727 0.0 0
M  V30 52 H 11.4156 8.8797 0.0 0
M  V30 53 H 12.0693 16.6502 0.0 0
M  V30 54 C 10.1272 0.0000 0.0 0
M  V30 55 O 8.7935 0.7700 0.0 0
M  V30 56 O 11.4609 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 22 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9 CFG=3
M  V30 10 1 6 10 CFG=3
M  V30 11 1 6 28
M  V30 12 1 8 11 CFG=3
M  V30 13 1 8 34
M  V30 14 1 12 13
M  V30 15 1 27 12 CFG=3
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 30 20 CFG=3
M  V30 23 1 36 21 CFG=3
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 28 52 CFG=3
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 31 40
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 34 53 CFG=3
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 37 46
M  V30 45 1 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 52 2 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 2 48 50
M  V30 56 2 49 51
M  V30 57 1 50 51
M  V30 58 1 54 55
M  V30 59 2 54 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 4 5 6 8 22 27 28 30 34 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Glucitol, 1,1′-[(trans-4-aminocyclohexyl)imino]bis[1-deoxy-4,6-O-(phenylmet...
C32H46N2O10.CH2O2
2227486-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6436 8.3764 0.0 0
M  V30 2 C 11.8234 9.3663 0.0 0
M  V30 3 C 9.1964 8.9031 0.0 0
M  V30 4 C 11.5559 10.8829 0.0 0 CFG=2
M  V30 5 C 8.0168 7.9132 0.0 0 CFG=2
M  V30 6 C 12.7356 11.8728 0.0 0 CFG=2
M  V30 7 O 10.1087 11.4096 0.0 0
M  V30 8 C 6.5696 8.4400 0.0 0 CFG=2
M  V30 9 O 8.2841 6.3966 0.0 0
M  V30 10 O 14.1828 11.3461 0.0 0
M  V30 11 O 6.3023 9.9566 0.0 0
M  V30 12 N 11.7132 2.3100 0.0 0
M  V30 13 O 10.1581 14.7230 0.0 0
M  V30 14 O 5.3900 4.7826 0.0 0
M  V30 15 C 10.9111 6.8598 0.0 0 CFG=1
M  V30 16 C 12.3582 6.3331 0.0 0
M  V30 17 C 9.7313 5.8699 0.0 0
M  V30 18 C 12.6255 4.8165 0.0 0
M  V30 19 C 9.9988 4.3533 0.0 0
M  V30 20 C 11.4459 3.8266 0.0 0 CFG=1
M  V30 21 C 12.4681 13.3894 0.0 0 CFG=1
M  V30 22 O 14.0081 13.3894 0.0 0
M  V30 23 C 11.6981 14.7230 0.0 0 CFG=2
M  V30 24 C 14.7781 14.7230 0.0 0 CFG=3
M  V30 25 C 12.4681 16.0567 0.0 0
M  V30 26 O 14.0081 16.0567 0.0 0
M  V30 27 C 5.3900 7.4501 0.0 0 CFG=1
M  V30 28 O 4.6200 8.7837 0.0 0
M  V30 29 C 4.6200 6.1163 0.0 0 CFG=2
M  V30 30 C 3.0800 8.7837 0.0 0 CFG=3
M  V30 31 C 3.0800 6.1163 0.0 0
M  V30 32 O 2.3100 7.4501 0.0 0
M  V30 33 C 16.3181 14.7230 0.0 0
M  V30 34 C 17.0881 13.3894 0.0 0
M  V30 35 C 17.0881 16.0567 0.0 0
M  V30 36 C 18.6281 13.3894 0.0 0
M  V30 37 C 18.6281 16.0567 0.0 0
M  V30 38 C 19.3981 14.7230 0.0 0
M  V30 39 C 2.3100 10.1174 0.0 0
M  V30 40 C 3.0800 11.4510 0.0 0
M  V30 41 C 0.7700 10.1174 0.0 0
M  V30 42 C 2.3100 12.7848 0.0 0
M  V30 43 C 0.0000 11.4510 0.0 0
M  V30 44 C 0.7700 12.7848 0.0 0
M  V30 45 H 11.0210 12.8627 0.0 0
M  V30 46 H 6.5696 6.4602 0.0 0
M  V30 47 C 9.6991 0.0000 0.0 0
M  V30 48 O 8.3654 0.7700 0.0 0
M  V30 49 O 11.0327 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9 CFG=3
M  V30 10 1 6 10 CFG=3
M  V30 11 1 6 21
M  V30 12 1 8 11 CFG=3
M  V30 13 1 8 27
M  V30 14 1 20 12 CFG=1
M  V30 15 1 23 13 CFG=3
M  V30 16 1 29 14 CFG=3
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 45 CFG=3
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 33
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 27 46 CFG=3
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 30 39
M  V30 38 1 31 32
M  V30 39 2 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 4 5 6 8 15 20 21 23 27 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227486-47-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227486-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-20190201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolopyrazinyl formylamido benzodiazolium derivatives as
ENAC inhibitors for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McCarthy, Clive; Hargrave, Jonathan David; Hay, Duncan Alexander;
Schofield, Thomas Beauregard; Went, Naomi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018096325 A1 2018-05-31

$RFMT $RIREG SCHEME333 STEP1
$RXN



  1  1
$MOL
Cyclohexanecarboxylic acid, 4-[4-[[trans-4-(dimethylamino)cyclohexyl]oxy]pyrr...
C22H32N4O3.CH2O2
2222808-24-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6841 6.9300 0.0 0
M  V30 2 C 1.9821 10.9544 0.0 0
M  V30 3 O 0.4759 11.2745 0.0 0
M  V30 4 O 3.0127 12.0989 0.0 0
M  V30 5 C 0.0000 12.7392 0.0 0
M  V30 6 N 12.0188 10.0100 0.0 0
M  V30 7 C 13.3524 9.2400 0.0 0
M  V30 8 C 12.0188 11.5500 0.0 0
M  V30 9 C 5.3504 4.6200 0.0 0
M  V30 10 C 3.8857 5.0959 0.0 0
M  V30 11 C 6.6841 5.3900 0.0 0
M  V30 12 N 5.3504 3.0800 0.0 0
M  V30 13 C 2.9805 3.8500 0.0 0
M  V30 14 N 8.0177 4.6200 0.0 0
M  V30 15 C 3.8857 2.6042 0.0 0
M  V30 16 N 6.6841 2.3100 0.0 0
M  V30 17 C 8.0177 3.0800 0.0 0
M  V30 18 C 3.4099 6.5606 0.0 0 CFG=3
M  V30 19 C 1.9034 6.8807 0.0 0
M  V30 20 C 4.4403 7.7050 0.0 0
M  V30 21 C 1.4276 8.3453 0.0 0
M  V30 22 C 3.9644 9.1697 0.0 0
M  V30 23 C 2.4582 9.4898 0.0 0 CFG=3
M  V30 24 C 8.0177 7.7000 0.0 0 CFG=2
M  V30 25 C 9.3514 6.9300 0.0 0
M  V30 26 C 8.0177 9.2400 0.0 0
M  V30 27 C 10.6852 7.7000 0.0 0
M  V30 28 C 9.3514 10.0100 0.0 0
M  V30 29 C 10.6852 9.2400 0.0 0 CFG=2
M  V30 30 C 6.6762 0.0000 0.0 0
M  V30 31 O 5.3426 0.7700 0.0 0
M  V30 32 O 8.0099 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 24 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 23
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 29 6 CFG=1
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 18
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 2 13 15
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[4-[[trans-4-(Dimethylamino)cyclohexyl]oxy]pyrrolo[2,1-f][1,2,4]triazin-5-y...
C21H30N4O3
2222808-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2082 4.6200 0.0 0
M  V30 2 C 1.5063 8.6444 0.0 0
M  V30 3 O 0.0000 8.9647 0.0 0
M  V30 4 O 2.5369 9.7889 0.0 0
M  V30 5 N 11.5430 7.7000 0.0 0
M  V30 6 C 12.8766 6.9300 0.0 0
M  V30 7 C 11.5430 9.2400 0.0 0
M  V30 8 C 4.8746 2.3100 0.0 0
M  V30 9 C 3.4099 2.7859 0.0 0
M  V30 10 C 6.2082 3.0800 0.0 0
M  V30 11 N 4.8746 0.7700 0.0 0
M  V30 12 C 2.5047 1.5400 0.0 0
M  V30 13 N 7.5419 2.3100 0.0 0
M  V30 14 C 3.4099 0.2941 0.0 0
M  V30 15 N 6.2082 0.0000 0.0 0
M  V30 16 C 7.5419 0.7700 0.0 0
M  V30 17 C 2.9340 4.2506 0.0 0 CFG=3
M  V30 18 C 3.9644 5.3950 0.0 0
M  V30 19 C 1.4276 4.5707 0.0 0
M  V30 20 C 3.4886 6.8597 0.0 0
M  V30 21 C 0.9517 6.0353 0.0 0
M  V30 22 C 1.9823 7.1798 0.0 0 CFG=3
M  V30 23 C 7.5419 5.3900 0.0 0 CFG=1
M  V30 24 C 8.8755 4.6200 0.0 0
M  V30 25 C 7.5419 6.9300 0.0 0
M  V30 26 C 10.2093 5.3900 0.0 0
M  V30 27 C 8.8755 7.7000 0.0 0
M  V30 28 C 10.2093 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 28 5 CFG=3
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 17
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 2 12 14
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2222808-24-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222808-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-19014568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of permeability in a series of pyrrolotriazine inhibitors of
IRAK4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Degorce, Sebastien L.; Anjum, Rana; Dillman, Keith S.; Drew, Lisa;
Groombridge, Sam D.; Halsall, Christopher T.; Lenz, Eva M.; Lindsay,
Nicola A.; Mayo, Michele F.; Pink, Jennifer H.; Robb, Graeme R.; Scott,
James S.; Stokes, Stephen; Xue, Yafeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(4), 913-924

$RFMT $RIREG SCHEME334 STEP1
$RXN



  1  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333227-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=2
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-D-histidinamide
C36H35N5O4
1333228-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 7.2353 0.0 0
M  V30 2 C 9.7758 8.9105 0.0 0
M  V30 3 C 11.1826 8.2842 0.0 0 CFG=2
M  V30 4 N 11.3435 6.7526 0.0 0
M  V30 5 C 12.4285 9.1894 0.0 0
M  V30 6 C 12.7505 6.1262 0.0 0
M  V30 7 N 13.8354 8.5629 0.0 0
M  V30 8 O 12.2675 10.7209 0.0 0
M  V30 9 C 12.9114 4.5946 0.0 0
M  V30 10 O 13.9964 7.0314 0.0 0
M  V30 11 N 14.3182 3.9683 0.0 0
M  V30 12 C 15.5642 4.8735 0.0 0
M  V30 13 C 14.4793 2.4368 0.0 0
M  V30 14 C 13.2334 1.5315 0.0 0
M  V30 15 O 13.3944 0.0000 0.0 0
M  V30 16 O 11.8265 2.1579 0.0 0
M  V30 17 N 6.1600 7.2353 0.0 0
M  V30 18 C 7.0652 8.4813 0.0 0
M  V30 19 C 7.0652 5.9894 0.0 0
M  V30 20 C 8.5298 8.0053 0.0 0
M  V30 21 N 8.5298 6.4653 0.0 0
M  V30 22 C 4.6200 8.7754 0.0 0
M  V30 23 C 5.9537 9.5454 0.0 0
M  V30 24 C 3.2864 9.5454 0.0 0
M  V30 25 C 5.9537 11.0853 0.0 0
M  V30 26 C 3.2864 11.0854 0.0 0
M  V30 27 C 4.6200 11.8553 0.0 0
M  V30 28 C 3.0800 7.2353 0.0 0
M  V30 29 C 2.3100 5.9016 0.0 0
M  V30 30 C 2.3100 8.5691 0.0 0
M  V30 31 C 0.7700 5.9016 0.0 0
M  V30 32 C 0.7700 8.5691 0.0 0
M  V30 33 C 0.0000 7.2354 0.0 0
M  V30 34 C 4.6200 5.6953 0.0 0
M  V30 35 C 3.2864 4.9254 0.0 0
M  V30 36 C 5.9537 4.9253 0.0 0
M  V30 37 C 3.2864 3.3854 0.0 0
M  V30 38 C 5.9537 3.3852 0.0 0
M  V30 39 C 4.6200 2.6152 0.0 0
M  V30 40 C 16.9710 4.2470 0.0 0
M  V30 41 C 17.1320 2.7155 0.0 0
M  V30 42 C 18.2169 5.1523 0.0 0
M  V30 43 C 18.5389 2.0892 0.0 0
M  V30 44 C 19.6239 4.5259 0.0 0
M  V30 45 C 19.7848 2.9944 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 22
M  V30 3 1 1 28
M  V30 4 1 1 34
M  V30 5 1 2 3
M  V30 6 1 2 20
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 9 11
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 12 40
M  V30 18 1 13 14
M  V30 19 1 14 15
M  V30 20 2 14 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5405066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A stirred solution of ester (0.14mmol) in
methanol (2 mL) was saturated with gaseous ammonia. The mixture was
stirred for 24 hours with frequent saturation of the solution. The
solvent was evaporated and the crude product was purified by preparative
HPLC. Reactant:
(S)-2-[2-(Carboxymethyl-phenethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (29). Reactant:
(R)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester as the formiate salt (39). and used without further
purification.
(Benzyl-{[(R)-1-carbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-amino)-acetic
acid (62) was obtained as a yellow oil (yield 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME334 STEP1
$RXN



  1  1
$MOL
D-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333227-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=2
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=1
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-D-histidinamide
C36H35N5O4
1333228-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 7.2353 0.0 0
M  V30 2 C 9.7758 8.9105 0.0 0
M  V30 3 C 11.1826 8.2842 0.0 0 CFG=2
M  V30 4 N 11.3435 6.7526 0.0 0
M  V30 5 C 12.4285 9.1894 0.0 0
M  V30 6 C 12.7505 6.1262 0.0 0
M  V30 7 N 13.8354 8.5629 0.0 0
M  V30 8 O 12.2675 10.7209 0.0 0
M  V30 9 C 12.9114 4.5946 0.0 0
M  V30 10 O 13.9964 7.0314 0.0 0
M  V30 11 N 14.3182 3.9683 0.0 0
M  V30 12 C 15.5642 4.8735 0.0 0
M  V30 13 C 14.4793 2.4368 0.0 0
M  V30 14 C 13.2334 1.5315 0.0 0
M  V30 15 O 13.3944 0.0000 0.0 0
M  V30 16 O 11.8265 2.1579 0.0 0
M  V30 17 N 6.1600 7.2353 0.0 0
M  V30 18 C 7.0652 8.4813 0.0 0
M  V30 19 C 7.0652 5.9894 0.0 0
M  V30 20 C 8.5298 8.0053 0.0 0
M  V30 21 N 8.5298 6.4653 0.0 0
M  V30 22 C 4.6200 8.7754 0.0 0
M  V30 23 C 5.9537 9.5454 0.0 0
M  V30 24 C 3.2864 9.5454 0.0 0
M  V30 25 C 5.9537 11.0853 0.0 0
M  V30 26 C 3.2864 11.0854 0.0 0
M  V30 27 C 4.6200 11.8553 0.0 0
M  V30 28 C 3.0800 7.2353 0.0 0
M  V30 29 C 2.3100 5.9016 0.0 0
M  V30 30 C 2.3100 8.5691 0.0 0
M  V30 31 C 0.7700 5.9016 0.0 0
M  V30 32 C 0.7700 8.5691 0.0 0
M  V30 33 C 0.0000 7.2354 0.0 0
M  V30 34 C 4.6200 5.6953 0.0 0
M  V30 35 C 3.2864 4.9254 0.0 0
M  V30 36 C 5.9537 4.9253 0.0 0
M  V30 37 C 3.2864 3.3854 0.0 0
M  V30 38 C 5.9537 3.3852 0.0 0
M  V30 39 C 4.6200 2.6152 0.0 0
M  V30 40 C 16.9710 4.2470 0.0 0
M  V30 41 C 17.1320 2.7155 0.0 0
M  V30 42 C 18.2169 5.1523 0.0 0
M  V30 43 C 18.5389 2.0892 0.0 0
M  V30 44 C 19.6239 4.5259 0.0 0
M  V30 45 C 19.7848 2.9944 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 22
M  V30 3 1 1 28
M  V30 4 1 1 34
M  V30 5 1 2 3
M  V30 6 1 2 20
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 9 11
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 12 40
M  V30 18 1 13 14
M  V30 19 1 14 15
M  V30 20 2 14 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333227-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1029344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A stirred solution of ester (0.14mmol) in
methanol (2 mL) was saturated with gaseous ammonia. The mixture was
stirred for 24 hours with frequent saturation of the solution. The
solvent was evaporated and the crude product was purified by preparative
HPLC.
(Benzyl-{[(R)-1-carbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl-methyl}-amino)-acetic
acid (62) was obtained from (39) as a yellow oil and used without further
purification (yield 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME335 STEP1
$RXN



  1  1
$MOL

C54H74N8O10.CH2O2
1835700-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  76 79 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 30.3676 9.2727 0.0 0
M  V30 2 O 29.0339 8.5027 0.0 0
M  V30 3 C 27.7003 9.2727 0.0 0
M  V30 4 N 26.3665 8.5027 0.0 0
M  V30 5 O 27.7003 10.8127 0.0 0
M  V30 6 C 25.0328 9.2727 0.0 0 CFG=1
M  V30 7 C 26.3665 6.9627 0.0 0
M  V30 8 C 23.6992 8.5027 0.0 0
M  V30 9 C 25.0328 10.8127 0.0 0
M  V30 10 N 22.3655 9.2727 0.0 0
M  V30 11 O 23.6992 6.9627 0.0 0
M  V30 12 C 26.3665 11.5827 0.0 0
M  V30 13 C 23.6992 11.5827 0.0 0
M  V30 14 C 21.0317 8.5027 0.0 0 CFG=1
M  V30 15 C 19.6981 9.2727 0.0 0
M  V30 16 C 21.0317 6.9627 0.0 0 CFG=2
M  V30 17 N 18.3644 8.5027 0.0 0
M  V30 18 O 19.6981 10.8127 0.0 0
M  V30 19 N 22.3655 6.1927 0.0 0
M  V30 20 C 19.6981 6.1927 0.0 0
M  V30 21 C 17.0308 9.2727 0.0 0 CFG=1
M  V30 22 C 18.3644 6.9627 0.0 0
M  V30 23 N 22.3655 4.6527 0.0 0 CHG=1 VAL=4
M  V30 24 C 15.6970 8.5027 0.0 0 CFG=2
M  V30 25 C 17.0308 10.8127 0.0 0 CFG=1
M  V30 26 N 22.3655 3.1127 0.0 0 CHG=-1
M  V30 27 C 14.3633 9.2727 0.0 0
M  V30 28 O 15.6970 6.9627 0.0 0
M  V30 29 C 15.6970 11.5827 0.0 0
M  V30 30 C 18.3644 11.5827 0.0 0
M  V30 31 C 13.0297 8.5027 0.0 0
M  V30 32 C 14.3633 6.1927 0.0 0
M  V30 33 C 15.6970 13.1227 0.0 0
M  V30 34 O 13.0297 6.9627 0.0 0
M  V30 35 C 9.0432 7.7412 0.0 0 CFG=2
M  V30 36 C 7.6364 8.3675 0.0 0 CFG=1
M  V30 37 O 9.2042 6.2096 0.0 0
M  V30 38 C 6.3904 7.4623 0.0 0
M  V30 39 C 7.4754 9.8992 0.0 0
M  V30 40 C 10.6111 5.5831 0.0 0
M  V30 41 N 4.9836 8.0887 0.0 0
M  V30 42 O 6.5515 5.9307 0.0 0
M  V30 43 C 3.7378 7.1835 0.0 0 CFG=2
M  V30 44 C 3.8987 5.6520 0.0 0
M  V30 45 C 2.3308 7.8098 0.0 0
M  V30 46 O 2.1699 9.3415 0.0 0
M  V30 47 O 1.0849 6.9048 0.0 0
M  V30 48 C 0.7631 9.9679 0.0 0
M  V30 49 C 31.7012 8.5027 0.0 0
M  V30 50 C 31.8623 6.9712 0.0 0
M  V30 51 C 33.1082 9.1290 0.0 0
M  V30 52 C 33.3686 6.6510 0.0 0
M  V30 53 C 30.8317 5.8266 0.0 0
M  V30 54 C 34.1386 7.9846 0.0 0
M  V30 55 C 33.5840 10.5937 0.0 0
M  V30 56 C 33.8444 5.1863 0.0 0
M  V30 57 C 31.3077 4.3621 0.0 0
M  V30 58 C 35.6450 8.3048 0.0 0
M  V30 59 C 35.0903 10.9139 0.0 0
M  V30 60 C 32.8140 4.0419 0.0 0
M  V30 61 C 36.1209 9.7695 0.0 0
M  V30 62 N 11.6961 9.2727 0.0 0
M  V30 63 C 10.2891 8.6464 0.0 0 CFG=2
M  V30 64 C 11.5350 10.8042 0.0 0
M  V30 65 C 9.2587 9.7908 0.0 0
M  V30 66 C 10.0287 11.1246 0.0 0
M  V30 67 C 2.6528 4.7468 0.0 0
M  V30 68 C 2.8137 3.2152 0.0 0
M  V30 69 C 1.2459 5.3731 0.0 0
M  V30 70 C 1.5679 2.3100 0.0 0
M  V30 71 C 0.0000 4.4679 0.0 0
M  V30 72 C 0.1609 2.9363 0.0 0
M  V30 73 H 11.0591 7.3127 0.0 0
M  V30 74 C 18.0604 0.0000 0.0 0
M  V30 75 O 16.7268 0.7700 0.0 0
M  V30 76 O 19.3941 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 49
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 10 CFG=1
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20 CFG=1
M  V30 21 1 21 17 CFG=3
M  V30 22 1 17 22
M  V30 23 2 19 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 1 24 28 CFG=3
M  V30 29 1 25 29
M  V30 30 1 25 30 CFG=3
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 31 34
M  V30 35 1 31 62
M  V30 36 1 35 36
M  V30 37 1 35 37 CFG=3
M  V30 38 1 35 63
M  V30 39 1 36 38
M  V30 40 1 36 39 CFG=3
M  V30 41 1 37 40
M  V30 42 1 38 41
M  V30 43 2 38 42
M  V30 44 1 41 43
M  V30 45 1 43 44 CFG=1
M  V30 46 1 43 45
M  V30 47 1 44 67
M  V30 48 1 45 46
M  V30 49 2 45 47
M  V30 50 1 46 48
M  V30 51 1 49 50
M  V30 52 1 49 51
M  V30 53 1 50 52
M  V30 54 2 50 53
M  V30 55 1 51 54
M  V30 56 2 51 55
M  V30 57 1 52 54
M  V30 58 2 52 56
M  V30 59 1 53 57
M  V30 60 2 54 58
M  V30 61 1 55 59
M  V30 62 1 56 60
M  V30 63 2 57 60
M  V30 64 1 58 61
M  V30 65 2 59 61
M  V30 66 1 62 63
M  V30 67 1 62 64
M  V30 68 1 63 65
M  V30 69 1 63 73 CFG=1
M  V30 70 1 64 66
M  V30 71 1 65 66
M  V30 72 2 67 68
M  V30 73 1 67 69
M  V30 74 1 68 70
M  V30 75 2 69 71
M  V30 76 2 70 72
M  V30 77 1 71 72
M  V30 78 1 74 75
M  V30 79 2 74 76
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 6 14 16 21 24 25 35 36 43 63)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C39H64N8O8
1835700-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.9737 6.6684 0.0 0 CFG=2
M  V30 2 C 14.7437 5.3347 0.0 0 CFG=1
M  V30 3 O 12.4337 6.6684 0.0 0
M  V30 4 C 16.2837 5.3347 0.0 0
M  V30 5 C 13.9737 4.0009 0.0 0
M  V30 6 C 11.6637 5.3347 0.0 0
M  V30 7 N 17.0537 4.0009 0.0 0
M  V30 8 O 17.0537 6.6684 0.0 0
M  V30 9 C 18.5937 4.0009 0.0 0 CFG=2
M  V30 10 C 19.3637 5.3347 0.0 0
M  V30 11 C 19.3637 2.6673 0.0 0
M  V30 12 O 18.5937 1.3336 0.0 0
M  V30 13 O 20.9037 2.6673 0.0 0
M  V30 14 C 19.3637 0.0000 0.0 0
M  V30 15 C 12.0031 7.8583 0.0 0
M  V30 16 C 10.6694 8.6283 0.0 0
M  V30 17 O 12.0031 6.3183 0.0 0
M  V30 18 C 9.3358 7.8583 0.0 0 CFG=1
M  V30 19 C 8.0021 8.6283 0.0 0 CFG=2
M  V30 20 O 9.3358 6.3183 0.0 0
M  V30 21 N 6.6684 7.8583 0.0 0
M  V30 22 C 8.0021 10.1683 0.0 0 CFG=1
M  V30 23 C 8.0021 5.5483 0.0 0
M  V30 24 C 5.3347 8.6283 0.0 0
M  V30 25 C 6.6684 6.3183 0.0 0
M  V30 26 C 9.3358 10.9383 0.0 0
M  V30 27 C 6.6684 10.9383 0.0 0
M  V30 28 C 4.0011 7.8583 0.0 0 CFG=2
M  V30 29 O 5.3347 10.1683 0.0 0
M  V30 30 C 9.3358 12.4783 0.0 0
M  V30 31 N 4.0011 6.3183 0.0 0
M  V30 32 C 2.6674 8.6283 0.0 0 CFG=2
M  V30 33 C 2.6674 5.5483 0.0 0
M  V30 34 N 2.6674 10.1683 0.0 0
M  V30 35 C 1.3336 7.8583 0.0 0
M  V30 36 C 2.6674 4.0083 0.0 0 CFG=1
M  V30 37 O 1.3336 6.3183 0.0 0
M  V30 38 N 1.3336 10.9383 0.0 0 CHG=1 VAL=4
M  V30 39 C 1.3336 3.2383 0.0 0
M  V30 40 N 4.0011 3.2383 0.0 0
M  V30 41 N 0.0000 11.7083 0.0 0 CHG=-1
M  V30 42 C 0.0000 4.0083 0.0 0
M  V30 43 C 1.3336 1.6983 0.0 0
M  V30 44 C 4.0011 1.6983 0.0 0
M  V30 45 C 14.7437 8.0020 0.0 0 CFG=2
M  V30 46 N 13.3369 8.6283 0.0 0
M  V30 47 C 15.7741 9.1465 0.0 0
M  V30 48 C 13.4978 10.1600 0.0 0
M  V30 49 C 15.0041 10.4802 0.0 0
M  V30 50 C 20.9037 5.3347 0.0 0
M  V30 51 C 21.6737 6.6684 0.0 0
M  V30 52 C 21.6737 4.0009 0.0 0
M  V30 53 C 23.2137 6.6684 0.0 0
M  V30 54 C 23.2137 4.0009 0.0 0
M  V30 55 C 23.9837 5.3347 0.0 0
M  V30 56 H 15.9895 7.0968 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 45
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 50
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 46
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20 CFG=1
M  V30 22 1 19 21 CFG=1
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 22 27 CFG=1
M  V30 29 1 24 28
M  V30 30 2 24 29
M  V30 31 1 26 30
M  V30 32 1 28 31 CFG=1
M  V30 33 1 28 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 32 35 CFG=3
M  V30 37 1 33 36
M  V30 38 2 33 37
M  V30 39 2 34 38
M  V30 40 1 36 39
M  V30 41 1 36 40 CFG=1
M  V30 42 2 38 41
M  V30 43 1 39 42
M  V30 44 1 39 43
M  V30 45 1 40 44
M  V30 46 1 45 46
M  V30 47 1 45 47
M  V30 48 1 45 56 CFG=3
M  V30 49 1 46 48
M  V30 50 1 47 49
M  V30 51 1 48 49
M  V30 52 2 50 51
M  V30 53 1 50 52
M  V30 54 1 51 53
M  V30 55 2 52 54
M  V30 56 2 53 55
M  V30 57 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 2 9 18 19 22 28 32 36 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1835700-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1835700-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-8485961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of derivatives of dolaproine-dolaisoleuine peptides as
tubulin polymerization inhibitors for treating cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mendelsohn, Brian Alan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015183978 A1 2015-12-03

$RFMT $RIREG SCHEME336 STEP1
$RXN



  1  1
$MOL

C83H95F2N13O16.2CHO2
2735753-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  117 129 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 13.2910 0.0 0
M  V30 2 O 11.6807 9.3161 0.0 0
M  V30 3 C 7.8106 4.6822 0.0 0
M  V30 4 C 6.9054 3.4364 0.0 0
M  V30 5 O 8.9177 3.0411 0.0 0
M  V30 6 F 0.0000 10.7742 0.0 0
M  V30 7 O 1.0534 13.6684 0.0 0
M  V30 8 C 1.5802 15.1156 0.0 0
M  V30 9 O 10.8337 2.3100 0.0 0
M  V30 10 C 12.4766 13.3233 0.0 0
M  V30 11 C 12.1329 15.2730 0.0 0
M  V30 12 N 17.8113 16.4033 0.0 0
M  V30 13 C 17.8113 17.9433 0.0 0
M  V30 14 C 19.1450 18.7133 0.0 0 CFG=2
M  V30 15 O 16.4777 18.7133 0.0 0
M  V30 16 N 19.1450 20.2533 0.0 0
M  V30 17 C 20.4788 17.9433 0.0 0
M  V30 18 C 20.4786 21.0233 0.0 0
M  V30 19 C 20.4786 22.5633 0.0 0
M  V30 20 O 21.8124 20.2533 0.0 0
M  V30 21 N 21.8124 23.3333 0.0 0
M  V30 22 C 23.1460 22.5633 0.0 0
M  V30 23 C 21.8124 24.8733 0.0 0
M  V30 24 C 24.4797 23.3333 0.0 0
M  V30 25 O 20.4788 25.6433 0.0 0
M  V30 26 O 23.1460 25.6433 0.0 0
M  V30 27 N 25.8135 22.5633 0.0 0
M  V30 28 O 24.4797 24.8733 0.0 0
M  V30 29 C 20.4786 27.1833 0.0 0
M  V30 30 C 27.1471 23.3333 0.0 0 CFG=1
M  V30 31 C 22.0186 27.1833 0.0 0
M  V30 32 C 20.4786 28.7233 0.0 0
M  V30 33 C 18.9386 27.1833 0.0 0
M  V30 34 C 28.4808 22.5633 0.0 0
M  V30 35 C 27.1471 24.8733 0.0 0
M  V30 36 N 29.8144 23.3333 0.0 0
M  V30 37 O 28.4808 21.0233 0.0 0
M  V30 38 C 35.1491 20.2533 0.0 0
M  V30 39 C 35.4930 22.2030 0.0 0
M  V30 40 C 41.0327 20.2210 0.0 0
M  V30 41 O 46.1091 17.9717 0.0 0
M  V30 42 C 47.6257 17.7042 0.0 0
M  V30 43 O 37.6114 25.6961 0.0 0
M  V30 44 F 48.0890 20.3311 0.0 0
M  V30 45 C 42.8329 28.7269 0.0 0
M  V30 46 C 44.1098 29.5880 0.0 0
M  V30 47 O 42.3540 30.6479 0.0 0
M  V30 48 O 40.8035 31.9901 0.0 0
M  V30 49 C 6.5296 9.2171 0.0 0
M  V30 50 C 7.0563 10.6642 0.0 0
M  V30 51 C 7.7431 8.2689 0.0 0
M  V30 52 N 5.0130 8.9496 0.0 0
M  V30 53 C 6.0664 11.8438 0.0 0
M  V30 54 C 8.5954 10.6105 0.0 0
M  V30 55 N 9.0198 9.1301 0.0 0
M  V30 56 C 7.8506 6.7327 0.0 0
M  V30 57 C 4.0231 10.1294 0.0 0
M  V30 58 C 4.5498 11.5765 0.0 0
M  V30 59 C 10.4039 8.4549 0.0 0
M  V30 60 C 9.2348 6.0576 0.0 0
M  V30 61 C 2.5065 9.8619 0.0 0
M  V30 62 C 3.5599 12.7561 0.0 0
M  V30 63 C 10.5114 6.9188 0.0 0
M  V30 64 C 9.3421 4.5213 0.0 0 CFG=1
M  V30 65 C 1.5166 11.0417 0.0 0
M  V30 66 C 2.0433 12.4888 0.0 0
M  V30 67 C 11.8956 6.2436 0.0 0
M  V30 68 C 10.7263 3.8462 0.0 0
M  V30 69 O 12.0029 4.7073 0.0 0
M  V30 70 N 8.1098 13.5585 0.0 0
M  V30 71 C 8.6365 15.0055 0.0 0
M  V30 72 C 9.0996 12.3787 0.0 0
M  V30 73 C 10.1531 15.2730 0.0 0
M  V30 74 C 10.6163 12.6462 0.0 0
M  V30 75 N 11.1430 14.0933 0.0 0 CHG=1 VAL=4
M  V30 76 C 13.8103 14.0933 0.0 0
M  V30 77 C 13.8103 15.6333 0.0 0
M  V30 78 C 15.1441 13.3233 0.0 0
M  V30 79 C 15.1439 16.4033 0.0 0
M  V30 80 C 16.4777 14.0933 0.0 0
M  V30 81 C 16.4777 15.6333 0.0 0
M  V30 82 C 31.1482 22.5633 0.0 0
M  V30 83 C 32.4818 23.3333 0.0 0
M  V30 84 C 31.1482 21.0233 0.0 0
M  V30 85 C 33.8155 22.5633 0.0 0
M  V30 86 C 32.4818 20.2533 0.0 0
M  V30 87 C 33.8155 21.0233 0.0 0
M  V30 88 N 36.4829 21.0233 0.0 0 CHG=1 VAL=4
M  V30 89 C 37.0096 19.5762 0.0 0
M  V30 90 C 37.4727 22.2030 0.0 0
M  V30 91 C 38.5262 19.3087 0.0 0
M  V30 92 C 38.9893 21.9356 0.0 0
M  V30 93 N 39.5161 20.4885 0.0 0
M  V30 94 C 42.0226 21.4008 0.0 0
M  V30 95 C 41.4958 22.8479 0.0 0
M  V30 96 C 43.5392 21.1333 0.0 0
M  V30 97 C 42.4857 24.0276 0.0 0
M  V30 98 C 40.0680 23.4248 0.0 0
M  V30 99 C 44.5291 22.3131 0.0 0
M  V30 100 C 44.0659 19.6861 0.0 0
M  V30 101 C 41.6696 25.3336 0.0 0
M  V30 102 N 44.0023 23.7602 0.0 0
M  V30 103 N 40.1754 24.9610 0.0 0
M  V30 104 C 46.0457 22.0456 0.0 0
M  V30 105 C 45.5825 19.4188 0.0 0
M  V30 106 C 42.0942 26.8139 0.0 0
M  V30 107 C 39.1057 26.0688 0.0 0
M  V30 108 C 46.5724 20.5984 0.0 0
M  V30 109 C 41.0244 27.9218 0.0 0
M  V30 110 C 39.5301 27.5491 0.0 0
M  V30 111 C 41.4488 29.4020 0.0 0 CFG=1
M  V30 112 C 38.4603 28.6570 0.0 0
M  V30 113 C 40.3791 30.5099 0.0 0
M  V30 114 O 38.8848 30.1372 0.0 0
M  V30 115 C 24.0445 0.0000 0.0 0
M  V30 116 O 22.7108 0.7700 0.0 0 CHG=-1
M  V30 117 O 25.3782 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 53
M  V30 2 1 1 70
M  V30 3 2 2 59
M  V30 4 1 3 4
M  V30 5 1 64 3 CFG=3
M  V30 6 1 64 5 CFG=1
M  V30 7 1 6 65
M  V30 8 1 7 8
M  V30 9 1 7 66
M  V30 10 2 9 68
M  V30 11 1 10 75
M  V30 12 1 10 76
M  V30 13 1 11 75
M  V30 14 1 12 13
M  V30 15 1 12 81
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 2 24 28
M  V30 31 1 25 29
M  V30 32 1 27 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 36 1 30 34
M  V30 37 1 30 35 CFG=1
M  V30 38 1 34 36
M  V30 39 2 34 37
M  V30 40 1 36 82
M  V30 41 1 38 87
M  V30 42 1 38 88
M  V30 43 1 39 88
M  V30 44 1 40 93
M  V30 45 1 40 94
M  V30 46 1 41 42
M  V30 47 1 41 105
M  V30 48 2 43 107
M  V30 49 1 44 108
M  V30 50 1 45 46
M  V30 51 1 111 45 CFG=3
M  V30 52 1 111 47 CFG=1
M  V30 53 2 48 113
M  V30 54 1 49 50
M  V30 55 1 49 51
M  V30 56 2 49 52
M  V30 57 2 50 53
M  V30 58 1 50 54
M  V30 59 1 51 55
M  V30 60 2 51 56
M  V30 61 1 52 57
M  V30 62 1 53 58
M  V30 63 1 54 55
M  V30 64 1 55 59
M  V30 65 1 56 60
M  V30 66 1 57 58
M  V30 67 2 57 61
M  V30 68 2 58 62
M  V30 69 1 59 63
M  V30 70 2 60 63
M  V30 71 1 60 64
M  V30 72 1 61 65
M  V30 73 1 62 66
M  V30 74 1 63 67
M  V30 75 1 64 68
M  V30 76 2 65 66
M  V30 77 1 67 69
M  V30 78 1 68 69
M  V30 79 1 70 71
M  V30 80 1 70 72
M  V30 81 1 71 73
M  V30 82 1 72 74
M  V30 83 1 73 75
M  V30 84 1 74 75
M  V30 85 2 76 77
M  V30 86 1 76 78
M  V30 87 1 77 79
M  V30 88 2 78 80
M  V30 89 2 79 81
M  V30 90 1 80 81
M  V30 91 2 82 83
M  V30 92 1 82 84
M  V30 93 1 83 85
M  V30 94 2 84 86
M  V30 95 2 85 87
M  V30 96 1 86 87
M  V30 97 1 88 89
M  V30 98 1 88 90
M  V30 99 1 89 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 1 92 93
M  V30 103 2 94 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 1 95 98
M  V30 107 1 96 99
M  V30 108 2 96 100
M  V30 109 1 97 101
M  V30 110 2 97 102
M  V30 111 1 98 103
M  V30 112 1 99 102
M  V30 113 2 99 104
M  V30 114 1 100 105
M  V30 115 1 101 103
M  V30 116 2 101 106
M  V30 117 1 103 107
M  V30 118 1 104 108
M  V30 119 2 105 108
M  V30 120 1 106 109
M  V30 121 1 107 110
M  V30 122 2 109 110
M  V30 123 1 109 111
M  V30 124 1 110 112
M  V30 125 1 111 113
M  V30 126 1 112 114
M  V30 127 1 113 114
M  V30 128 1 115 116
M  V30 129 2 115 117
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 30 64 111)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C78H87F2N13O14.2CHO2
2735753-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  110 122 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 44.1632 13.2910 0.0 0
M  V30 2 O 39.0757 9.3161 0.0 0
M  V30 3 C 42.9457 4.6824 0.0 0
M  V30 4 C 43.8509 3.4364 0.0 0
M  V30 5 O 41.8387 3.0411 0.0 0
M  V30 6 F 50.7562 10.7742 0.0 0
M  V30 7 O 49.7029 13.6684 0.0 0
M  V30 8 C 51.2195 13.4011 0.0 0
M  V30 9 O 39.9227 2.3100 0.0 0
M  V30 10 C 38.2796 13.3233 0.0 0
M  V30 11 C 38.6235 15.2730 0.0 0
M  V30 12 N 32.9449 16.4033 0.0 0
M  V30 13 C 31.6113 15.6333 0.0 0
M  V30 14 C 30.2776 16.4033 0.0 0 CFG=2
M  V30 15 O 31.6113 14.0933 0.0 0
M  V30 16 N 28.9440 15.6333 0.0 0
M  V30 17 C 30.2776 17.9433 0.0 0
M  V30 18 C 27.6102 16.4033 0.0 0
M  V30 19 C 26.2766 15.6333 0.0 0
M  V30 20 O 27.6102 17.9433 0.0 0
M  V30 21 N 24.9429 16.4033 0.0 0
M  V30 22 C 23.6093 15.6333 0.0 0
M  V30 23 C 22.2755 16.4033 0.0 0
M  V30 24 N 20.9418 15.6333 0.0 0
M  V30 25 O 22.2755 17.9433 0.0 0
M  V30 26 C 19.6082 16.4033 0.0 0 CFG=1
M  V30 27 C 18.2746 15.6333 0.0 0
M  V30 28 C 19.6082 17.9433 0.0 0
M  V30 29 N 18.2746 14.0933 0.0 0
M  V30 30 O 16.9408 16.4033 0.0 0
M  V30 31 C 12.9399 11.0133 0.0 0
M  V30 32 C 12.5960 12.9630 0.0 0
M  V30 33 C 7.0563 10.9810 0.0 0
M  V30 34 O 1.9798 8.7317 0.0 0
M  V30 35 C 0.4632 8.4642 0.0 0
M  V30 36 O 10.4775 16.4561 0.0 0
M  V30 37 F 0.0000 11.0911 0.0 0
M  V30 38 C 5.2560 19.4869 0.0 0
M  V30 39 C 3.9792 20.3480 0.0 0
M  V30 40 O 5.7350 21.4079 0.0 0
M  V30 41 O 7.2854 22.7501 0.0 0
M  V30 42 C 44.2266 9.2171 0.0 0
M  V30 43 C 43.7000 10.6642 0.0 0
M  V30 44 C 43.0131 8.2689 0.0 0
M  V30 45 N 45.7432 8.9496 0.0 0
M  V30 46 C 44.6899 11.8438 0.0 0
M  V30 47 C 42.1609 10.6105 0.0 0
M  V30 48 N 41.7365 9.1301 0.0 0
M  V30 49 C 42.9058 6.7327 0.0 0
M  V30 50 C 46.7331 10.1294 0.0 0
M  V30 51 C 46.2065 11.5765 0.0 0
M  V30 52 C 40.3523 8.4549 0.0 0
M  V30 53 C 41.5216 6.0576 0.0 0
M  V30 54 C 48.2497 9.8619 0.0 0
M  V30 55 C 47.1964 12.7561 0.0 0
M  V30 56 C 40.2448 6.9188 0.0 0
M  V30 57 C 41.4141 4.5213 0.0 0 CFG=1
M  V30 58 C 49.2397 11.0417 0.0 0
M  V30 59 C 48.7130 12.4888 0.0 0
M  V30 60 C 38.8607 6.2436 0.0 0
M  V30 61 C 40.0300 3.8463 0.0 0
M  V30 62 O 38.7533 4.7073 0.0 0
M  V30 63 N 42.6466 13.5585 0.0 0
M  V30 64 C 42.1199 15.0056 0.0 0
M  V30 65 C 41.6567 12.3787 0.0 0
M  V30 66 C 40.6033 15.2730 0.0 0
M  V30 67 C 40.1401 12.6462 0.0 0
M  V30 68 N 39.6134 14.0933 0.0 0 CHG=1 VAL=4
M  V30 69 C 36.9460 14.0933 0.0 0
M  V30 70 C 35.6123 13.3233 0.0 0
M  V30 71 C 36.9460 15.6333 0.0 0
M  V30 72 C 34.2787 14.0933 0.0 0
M  V30 73 C 35.6123 16.4033 0.0 0
M  V30 74 C 34.2787 15.6333 0.0 0
M  V30 75 C 16.9408 13.3233 0.0 0
M  V30 76 C 16.9408 11.7833 0.0 0
M  V30 77 C 15.6071 14.0933 0.0 0
M  V30 78 C 15.6071 11.0133 0.0 0
M  V30 79 C 14.2735 13.3233 0.0 0
M  V30 80 C 14.2735 11.7833 0.0 0
M  V30 81 N 11.6061 11.7833 0.0 0 CHG=1 VAL=4
M  V30 82 C 11.0794 10.3362 0.0 0
M  V30 83 C 10.6161 12.9630 0.0 0
M  V30 84 C 9.5628 10.0687 0.0 0
M  V30 85 C 9.0996 12.6956 0.0 0
M  V30 86 N 8.5729 11.2485 0.0 0
M  V30 87 C 6.0664 12.1608 0.0 0
M  V30 88 C 6.5930 13.6078 0.0 0
M  V30 89 C 4.5498 11.8933 0.0 0
M  V30 90 C 5.6031 14.7876 0.0 0
M  V30 91 C 8.0209 14.1848 0.0 0
M  V30 92 C 3.5599 13.0731 0.0 0
M  V30 93 C 4.0231 10.4461 0.0 0
M  V30 94 C 6.4193 16.0935 0.0 0
M  V30 95 N 4.0865 14.5201 0.0 0
M  V30 96 N 7.9136 15.7210 0.0 0
M  V30 97 C 2.0433 12.8056 0.0 0
M  V30 98 C 2.5065 10.1788 0.0 0
M  V30 99 C 5.9948 17.5739 0.0 0
M  V30 100 C 8.9833 16.8288 0.0 0
M  V30 101 C 1.5166 11.3584 0.0 0
M  V30 102 C 7.0646 18.6816 0.0 0
M  V30 103 C 8.5589 18.3091 0.0 0
M  V30 104 C 6.6402 20.1620 0.0 0 CFG=1
M  V30 105 C 9.6285 19.4170 0.0 0
M  V30 106 C 7.7099 21.2697 0.0 0
M  V30 107 O 9.2041 20.8972 0.0 0
M  V30 108 C 25.6097 0.0000 0.0 0
M  V30 109 O 24.2761 0.7700 0.0 0 CHG=-1
M  V30 110 O 26.9434 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 46
M  V30 2 1 1 63
M  V30 3 2 2 52
M  V30 4 1 3 4
M  V30 5 1 57 3 CFG=1
M  V30 6 1 57 5 CFG=3
M  V30 7 1 6 58
M  V30 8 1 7 8
M  V30 9 1 7 59
M  V30 10 2 9 61
M  V30 11 1 10 68
M  V30 12 1 10 69
M  V30 13 1 11 68
M  V30 14 1 12 13
M  V30 15 1 12 74
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 26 28 CFG=3
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 29 75
M  V30 34 1 31 80
M  V30 35 1 31 81
M  V30 36 1 32 81
M  V30 37 1 33 86
M  V30 38 1 33 87
M  V30 39 1 34 35
M  V30 40 1 34 98
M  V30 41 2 36 100
M  V30 42 1 37 101
M  V30 43 1 38 39
M  V30 44 1 104 38 CFG=1
M  V30 45 1 104 40 CFG=3
M  V30 46 2 41 106
M  V30 47 1 42 43
M  V30 48 1 42 44
M  V30 49 2 42 45
M  V30 50 2 43 46
M  V30 51 1 43 47
M  V30 52 1 44 48
M  V30 53 2 44 49
M  V30 54 1 45 50
M  V30 55 1 46 51
M  V30 56 1 47 48
M  V30 57 1 48 52
M  V30 58 1 49 53
M  V30 59 1 50 51
M  V30 60 2 50 54
M  V30 61 2 51 55
M  V30 62 1 52 56
M  V30 63 2 53 56
M  V30 64 1 53 57
M  V30 65 1 54 58
M  V30 66 1 55 59
M  V30 67 1 56 60
M  V30 68 1 57 61
M  V30 69 2 58 59
M  V30 70 1 60 62
M  V30 71 1 61 62
M  V30 72 1 63 64
M  V30 73 1 63 65
M  V30 74 1 64 66
M  V30 75 1 65 67
M  V30 76 1 66 68
M  V30 77 1 67 68
M  V30 78 2 69 70
M  V30 79 1 69 71
M  V30 80 1 70 72
M  V30 81 2 71 73
M  V30 82 2 72 74
M  V30 83 1 73 74
M  V30 84 2 75 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 2 77 79
M  V30 88 2 78 80
M  V30 89 1 79 80
M  V30 90 1 81 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 1 83 85
M  V30 94 1 84 86
M  V30 95 1 85 86
M  V30 96 2 87 88
M  V30 97 1 87 89
M  V30 98 1 88 90
M  V30 99 1 88 91
M  V30 100 1 89 92
M  V30 101 2 89 93
M  V30 102 1 90 94
M  V30 103 2 90 95
M  V30 104 1 91 96
M  V30 105 1 92 95
M  V30 106 2 92 97
M  V30 107 1 93 98
M  V30 108 1 94 96
M  V30 109 2 94 99
M  V30 110 1 96 100
M  V30 111 1 97 101
M  V30 112 2 98 101
M  V30 113 1 99 102
M  V30 114 1 100 103
M  V30 115 2 102 103
M  V30 116 1 102 104
M  V30 117 1 103 105
M  V30 118 1 104 106
M  V30 119 1 105 107
M  V30 120 1 106 107
M  V30 121 1 108 109
M  V30 122 2 108 110
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 26 57 104)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2735753-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735753-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32219629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specific conjugation of an antibody
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Liu, Xiaolei; Zhang, Lingli; Huang,
Yuanyuan; Li, Wenjun; Ye, Hangbo; Wang, Juan; Guo, Huihui; Zhou, You
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022078524 A2 2022-04-21

$RFMT $RIREG SCHEME336 STEP1
$RXN



  1  1
$MOL

C83H95F2N13O16.2CHO2
2735753-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  117 129 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 13.2910 0.0 0
M  V30 2 O 11.6807 9.3161 0.0 0
M  V30 3 C 7.8106 4.6822 0.0 0
M  V30 4 C 6.9054 3.4364 0.0 0
M  V30 5 O 8.9177 3.0411 0.0 0
M  V30 6 F 0.0000 10.7742 0.0 0
M  V30 7 O 1.0534 13.6684 0.0 0
M  V30 8 C 1.5802 15.1156 0.0 0
M  V30 9 O 10.8337 2.3100 0.0 0
M  V30 10 C 12.4766 13.3233 0.0 0
M  V30 11 C 12.1329 15.2730 0.0 0
M  V30 12 N 17.8113 16.4033 0.0 0
M  V30 13 C 17.8113 17.9433 0.0 0
M  V30 14 C 19.1450 18.7133 0.0 0 CFG=2
M  V30 15 O 16.4777 18.7133 0.0 0
M  V30 16 N 19.1450 20.2533 0.0 0
M  V30 17 C 20.4788 17.9433 0.0 0
M  V30 18 C 20.4786 21.0233 0.0 0
M  V30 19 C 20.4786 22.5633 0.0 0
M  V30 20 O 21.8124 20.2533 0.0 0
M  V30 21 N 21.8124 23.3333 0.0 0
M  V30 22 C 23.1460 22.5633 0.0 0
M  V30 23 C 21.8124 24.8733 0.0 0
M  V30 24 C 24.4797 23.3333 0.0 0
M  V30 25 O 20.4788 25.6433 0.0 0
M  V30 26 O 23.1460 25.6433 0.0 0
M  V30 27 N 25.8135 22.5633 0.0 0
M  V30 28 O 24.4797 24.8733 0.0 0
M  V30 29 C 20.4786 27.1833 0.0 0
M  V30 30 C 27.1471 23.3333 0.0 0 CFG=1
M  V30 31 C 22.0186 27.1833 0.0 0
M  V30 32 C 20.4786 28.7233 0.0 0
M  V30 33 C 18.9386 27.1833 0.0 0
M  V30 34 C 28.4808 22.5633 0.0 0
M  V30 35 C 27.1471 24.8733 0.0 0
M  V30 36 N 29.8144 23.3333 0.0 0
M  V30 37 O 28.4808 21.0233 0.0 0
M  V30 38 C 35.1491 20.2533 0.0 0
M  V30 39 C 35.4930 22.2030 0.0 0
M  V30 40 C 41.0327 20.2210 0.0 0
M  V30 41 O 46.1091 17.9717 0.0 0
M  V30 42 C 47.6257 17.7042 0.0 0
M  V30 43 O 37.6114 25.6961 0.0 0
M  V30 44 F 48.0890 20.3311 0.0 0
M  V30 45 C 42.8329 28.7269 0.0 0
M  V30 46 C 44.1098 29.5880 0.0 0
M  V30 47 O 42.3540 30.6479 0.0 0
M  V30 48 O 40.8035 31.9901 0.0 0
M  V30 49 C 6.5296 9.2171 0.0 0
M  V30 50 C 7.0563 10.6642 0.0 0
M  V30 51 C 7.7431 8.2689 0.0 0
M  V30 52 N 5.0130 8.9496 0.0 0
M  V30 53 C 6.0664 11.8438 0.0 0
M  V30 54 C 8.5954 10.6105 0.0 0
M  V30 55 N 9.0198 9.1301 0.0 0
M  V30 56 C 7.8506 6.7327 0.0 0
M  V30 57 C 4.0231 10.1294 0.0 0
M  V30 58 C 4.5498 11.5765 0.0 0
M  V30 59 C 10.4039 8.4549 0.0 0
M  V30 60 C 9.2348 6.0576 0.0 0
M  V30 61 C 2.5065 9.8619 0.0 0
M  V30 62 C 3.5599 12.7561 0.0 0
M  V30 63 C 10.5114 6.9188 0.0 0
M  V30 64 C 9.3421 4.5213 0.0 0 CFG=1
M  V30 65 C 1.5166 11.0417 0.0 0
M  V30 66 C 2.0433 12.4888 0.0 0
M  V30 67 C 11.8956 6.2436 0.0 0
M  V30 68 C 10.7263 3.8462 0.0 0
M  V30 69 O 12.0029 4.7073 0.0 0
M  V30 70 N 8.1098 13.5585 0.0 0
M  V30 71 C 8.6365 15.0055 0.0 0
M  V30 72 C 9.0996 12.3787 0.0 0
M  V30 73 C 10.1531 15.2730 0.0 0
M  V30 74 C 10.6163 12.6462 0.0 0
M  V30 75 N 11.1430 14.0933 0.0 0 CHG=1 VAL=4
M  V30 76 C 13.8103 14.0933 0.0 0
M  V30 77 C 13.8103 15.6333 0.0 0
M  V30 78 C 15.1441 13.3233 0.0 0
M  V30 79 C 15.1439 16.4033 0.0 0
M  V30 80 C 16.4777 14.0933 0.0 0
M  V30 81 C 16.4777 15.6333 0.0 0
M  V30 82 C 31.1482 22.5633 0.0 0
M  V30 83 C 32.4818 23.3333 0.0 0
M  V30 84 C 31.1482 21.0233 0.0 0
M  V30 85 C 33.8155 22.5633 0.0 0
M  V30 86 C 32.4818 20.2533 0.0 0
M  V30 87 C 33.8155 21.0233 0.0 0
M  V30 88 N 36.4829 21.0233 0.0 0 CHG=1 VAL=4
M  V30 89 C 37.0096 19.5762 0.0 0
M  V30 90 C 37.4727 22.2030 0.0 0
M  V30 91 C 38.5262 19.3087 0.0 0
M  V30 92 C 38.9893 21.9356 0.0 0
M  V30 93 N 39.5161 20.4885 0.0 0
M  V30 94 C 42.0226 21.4008 0.0 0
M  V30 95 C 41.4958 22.8479 0.0 0
M  V30 96 C 43.5392 21.1333 0.0 0
M  V30 97 C 42.4857 24.0276 0.0 0
M  V30 98 C 40.0680 23.4248 0.0 0
M  V30 99 C 44.5291 22.3131 0.0 0
M  V30 100 C 44.0659 19.6861 0.0 0
M  V30 101 C 41.6696 25.3336 0.0 0
M  V30 102 N 44.0023 23.7602 0.0 0
M  V30 103 N 40.1754 24.9610 0.0 0
M  V30 104 C 46.0457 22.0456 0.0 0
M  V30 105 C 45.5825 19.4188 0.0 0
M  V30 106 C 42.0942 26.8139 0.0 0
M  V30 107 C 39.1057 26.0688 0.0 0
M  V30 108 C 46.5724 20.5984 0.0 0
M  V30 109 C 41.0244 27.9218 0.0 0
M  V30 110 C 39.5301 27.5491 0.0 0
M  V30 111 C 41.4488 29.4020 0.0 0 CFG=1
M  V30 112 C 38.4603 28.6570 0.0 0
M  V30 113 C 40.3791 30.5099 0.0 0
M  V30 114 O 38.8848 30.1372 0.0 0
M  V30 115 C 24.0445 0.0000 0.0 0
M  V30 116 O 22.7108 0.7700 0.0 0 CHG=-1
M  V30 117 O 25.3782 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 53
M  V30 2 1 1 70
M  V30 3 2 2 59
M  V30 4 1 3 4
M  V30 5 1 64 3 CFG=3
M  V30 6 1 64 5 CFG=1
M  V30 7 1 6 65
M  V30 8 1 7 8
M  V30 9 1 7 66
M  V30 10 2 9 68
M  V30 11 1 10 75
M  V30 12 1 10 76
M  V30 13 1 11 75
M  V30 14 1 12 13
M  V30 15 1 12 81
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 2 24 28
M  V30 31 1 25 29
M  V30 32 1 27 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 36 1 30 34
M  V30 37 1 30 35 CFG=1
M  V30 38 1 34 36
M  V30 39 2 34 37
M  V30 40 1 36 82
M  V30 41 1 38 87
M  V30 42 1 38 88
M  V30 43 1 39 88
M  V30 44 1 40 93
M  V30 45 1 40 94
M  V30 46 1 41 42
M  V30 47 1 41 105
M  V30 48 2 43 107
M  V30 49 1 44 108
M  V30 50 1 45 46
M  V30 51 1 111 45 CFG=3
M  V30 52 1 111 47 CFG=1
M  V30 53 2 48 113
M  V30 54 1 49 50
M  V30 55 1 49 51
M  V30 56 2 49 52
M  V30 57 2 50 53
M  V30 58 1 50 54
M  V30 59 1 51 55
M  V30 60 2 51 56
M  V30 61 1 52 57
M  V30 62 1 53 58
M  V30 63 1 54 55
M  V30 64 1 55 59
M  V30 65 1 56 60
M  V30 66 1 57 58
M  V30 67 2 57 61
M  V30 68 2 58 62
M  V30 69 1 59 63
M  V30 70 2 60 63
M  V30 71 1 60 64
M  V30 72 1 61 65
M  V30 73 1 62 66
M  V30 74 1 63 67
M  V30 75 1 64 68
M  V30 76 2 65 66
M  V30 77 1 67 69
M  V30 78 1 68 69
M  V30 79 1 70 71
M  V30 80 1 70 72
M  V30 81 1 71 73
M  V30 82 1 72 74
M  V30 83 1 73 75
M  V30 84 1 74 75
M  V30 85 2 76 77
M  V30 86 1 76 78
M  V30 87 1 77 79
M  V30 88 2 78 80
M  V30 89 2 79 81
M  V30 90 1 80 81
M  V30 91 2 82 83
M  V30 92 1 82 84
M  V30 93 1 83 85
M  V30 94 2 84 86
M  V30 95 2 85 87
M  V30 96 1 86 87
M  V30 97 1 88 89
M  V30 98 1 88 90
M  V30 99 1 89 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 1 92 93
M  V30 103 2 94 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 1 95 98
M  V30 107 1 96 99
M  V30 108 2 96 100
M  V30 109 1 97 101
M  V30 110 2 97 102
M  V30 111 1 98 103
M  V30 112 1 99 102
M  V30 113 2 99 104
M  V30 114 1 100 105
M  V30 115 1 101 103
M  V30 116 2 101 106
M  V30 117 1 103 107
M  V30 118 1 104 108
M  V30 119 2 105 108
M  V30 120 1 106 109
M  V30 121 1 107 110
M  V30 122 2 109 110
M  V30 123 1 109 111
M  V30 124 1 110 112
M  V30 125 1 111 113
M  V30 126 1 112 114
M  V30 127 1 113 114
M  V30 128 1 115 116
M  V30 129 2 115 117
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 30 64 111)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C78H87F2N13O14.2CHO2
2735753-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  110 122 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 44.1632 13.2910 0.0 0
M  V30 2 O 39.0757 9.3161 0.0 0
M  V30 3 C 42.9457 4.6824 0.0 0
M  V30 4 C 43.8509 3.4364 0.0 0
M  V30 5 O 41.8387 3.0411 0.0 0
M  V30 6 F 50.7562 10.7742 0.0 0
M  V30 7 O 49.7029 13.6684 0.0 0
M  V30 8 C 51.2195 13.4011 0.0 0
M  V30 9 O 39.9227 2.3100 0.0 0
M  V30 10 C 38.2796 13.3233 0.0 0
M  V30 11 C 38.6235 15.2730 0.0 0
M  V30 12 N 32.9449 16.4033 0.0 0
M  V30 13 C 31.6113 15.6333 0.0 0
M  V30 14 C 30.2776 16.4033 0.0 0 CFG=2
M  V30 15 O 31.6113 14.0933 0.0 0
M  V30 16 N 28.9440 15.6333 0.0 0
M  V30 17 C 30.2776 17.9433 0.0 0
M  V30 18 C 27.6102 16.4033 0.0 0
M  V30 19 C 26.2766 15.6333 0.0 0
M  V30 20 O 27.6102 17.9433 0.0 0
M  V30 21 N 24.9429 16.4033 0.0 0
M  V30 22 C 23.6093 15.6333 0.0 0
M  V30 23 C 22.2755 16.4033 0.0 0
M  V30 24 N 20.9418 15.6333 0.0 0
M  V30 25 O 22.2755 17.9433 0.0 0
M  V30 26 C 19.6082 16.4033 0.0 0 CFG=1
M  V30 27 C 18.2746 15.6333 0.0 0
M  V30 28 C 19.6082 17.9433 0.0 0
M  V30 29 N 18.2746 14.0933 0.0 0
M  V30 30 O 16.9408 16.4033 0.0 0
M  V30 31 C 12.9399 11.0133 0.0 0
M  V30 32 C 12.5960 12.9630 0.0 0
M  V30 33 C 7.0563 10.9810 0.0 0
M  V30 34 O 1.9798 8.7317 0.0 0
M  V30 35 C 0.4632 8.4642 0.0 0
M  V30 36 O 10.4775 16.4561 0.0 0
M  V30 37 F 0.0000 11.0911 0.0 0
M  V30 38 C 5.2560 19.4869 0.0 0
M  V30 39 C 3.9792 20.3480 0.0 0
M  V30 40 O 5.7350 21.4079 0.0 0
M  V30 41 O 7.2854 22.7501 0.0 0
M  V30 42 C 44.2266 9.2171 0.0 0
M  V30 43 C 43.7000 10.6642 0.0 0
M  V30 44 C 43.0131 8.2689 0.0 0
M  V30 45 N 45.7432 8.9496 0.0 0
M  V30 46 C 44.6899 11.8438 0.0 0
M  V30 47 C 42.1609 10.6105 0.0 0
M  V30 48 N 41.7365 9.1301 0.0 0
M  V30 49 C 42.9058 6.7327 0.0 0
M  V30 50 C 46.7331 10.1294 0.0 0
M  V30 51 C 46.2065 11.5765 0.0 0
M  V30 52 C 40.3523 8.4549 0.0 0
M  V30 53 C 41.5216 6.0576 0.0 0
M  V30 54 C 48.2497 9.8619 0.0 0
M  V30 55 C 47.1964 12.7561 0.0 0
M  V30 56 C 40.2448 6.9188 0.0 0
M  V30 57 C 41.4141 4.5213 0.0 0 CFG=1
M  V30 58 C 49.2397 11.0417 0.0 0
M  V30 59 C 48.7130 12.4888 0.0 0
M  V30 60 C 38.8607 6.2436 0.0 0
M  V30 61 C 40.0300 3.8463 0.0 0
M  V30 62 O 38.7533 4.7073 0.0 0
M  V30 63 N 42.6466 13.5585 0.0 0
M  V30 64 C 42.1199 15.0056 0.0 0
M  V30 65 C 41.6567 12.3787 0.0 0
M  V30 66 C 40.6033 15.2730 0.0 0
M  V30 67 C 40.1401 12.6462 0.0 0
M  V30 68 N 39.6134 14.0933 0.0 0 CHG=1 VAL=4
M  V30 69 C 36.9460 14.0933 0.0 0
M  V30 70 C 35.6123 13.3233 0.0 0
M  V30 71 C 36.9460 15.6333 0.0 0
M  V30 72 C 34.2787 14.0933 0.0 0
M  V30 73 C 35.6123 16.4033 0.0 0
M  V30 74 C 34.2787 15.6333 0.0 0
M  V30 75 C 16.9408 13.3233 0.0 0
M  V30 76 C 16.9408 11.7833 0.0 0
M  V30 77 C 15.6071 14.0933 0.0 0
M  V30 78 C 15.6071 11.0133 0.0 0
M  V30 79 C 14.2735 13.3233 0.0 0
M  V30 80 C 14.2735 11.7833 0.0 0
M  V30 81 N 11.6061 11.7833 0.0 0 CHG=1 VAL=4
M  V30 82 C 11.0794 10.3362 0.0 0
M  V30 83 C 10.6161 12.9630 0.0 0
M  V30 84 C 9.5628 10.0687 0.0 0
M  V30 85 C 9.0996 12.6956 0.0 0
M  V30 86 N 8.5729 11.2485 0.0 0
M  V30 87 C 6.0664 12.1608 0.0 0
M  V30 88 C 6.5930 13.6078 0.0 0
M  V30 89 C 4.5498 11.8933 0.0 0
M  V30 90 C 5.6031 14.7876 0.0 0
M  V30 91 C 8.0209 14.1848 0.0 0
M  V30 92 C 3.5599 13.0731 0.0 0
M  V30 93 C 4.0231 10.4461 0.0 0
M  V30 94 C 6.4193 16.0935 0.0 0
M  V30 95 N 4.0865 14.5201 0.0 0
M  V30 96 N 7.9136 15.7210 0.0 0
M  V30 97 C 2.0433 12.8056 0.0 0
M  V30 98 C 2.5065 10.1788 0.0 0
M  V30 99 C 5.9948 17.5739 0.0 0
M  V30 100 C 8.9833 16.8288 0.0 0
M  V30 101 C 1.5166 11.3584 0.0 0
M  V30 102 C 7.0646 18.6816 0.0 0
M  V30 103 C 8.5589 18.3091 0.0 0
M  V30 104 C 6.6402 20.1620 0.0 0 CFG=1
M  V30 105 C 9.6285 19.4170 0.0 0
M  V30 106 C 7.7099 21.2697 0.0 0
M  V30 107 O 9.2041 20.8972 0.0 0
M  V30 108 C 25.6097 0.0000 0.0 0
M  V30 109 O 24.2761 0.7700 0.0 0 CHG=-1
M  V30 110 O 26.9434 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 46
M  V30 2 1 1 63
M  V30 3 2 2 52
M  V30 4 1 3 4
M  V30 5 1 57 3 CFG=1
M  V30 6 1 57 5 CFG=3
M  V30 7 1 6 58
M  V30 8 1 7 8
M  V30 9 1 7 59
M  V30 10 2 9 61
M  V30 11 1 10 68
M  V30 12 1 10 69
M  V30 13 1 11 68
M  V30 14 1 12 13
M  V30 15 1 12 74
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 26 28 CFG=3
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 29 75
M  V30 34 1 31 80
M  V30 35 1 31 81
M  V30 36 1 32 81
M  V30 37 1 33 86
M  V30 38 1 33 87
M  V30 39 1 34 35
M  V30 40 1 34 98
M  V30 41 2 36 100
M  V30 42 1 37 101
M  V30 43 1 38 39
M  V30 44 1 104 38 CFG=1
M  V30 45 1 104 40 CFG=3
M  V30 46 2 41 106
M  V30 47 1 42 43
M  V30 48 1 42 44
M  V30 49 2 42 45
M  V30 50 2 43 46
M  V30 51 1 43 47
M  V30 52 1 44 48
M  V30 53 2 44 49
M  V30 54 1 45 50
M  V30 55 1 46 51
M  V30 56 1 47 48
M  V30 57 1 48 52
M  V30 58 1 49 53
M  V30 59 1 50 51
M  V30 60 2 50 54
M  V30 61 2 51 55
M  V30 62 1 52 56
M  V30 63 2 53 56
M  V30 64 1 53 57
M  V30 65 1 54 58
M  V30 66 1 55 59
M  V30 67 1 56 60
M  V30 68 1 57 61
M  V30 69 2 58 59
M  V30 70 1 60 62
M  V30 71 1 61 62
M  V30 72 1 63 64
M  V30 73 1 63 65
M  V30 74 1 64 66
M  V30 75 1 65 67
M  V30 76 1 66 68
M  V30 77 1 67 68
M  V30 78 2 69 70
M  V30 79 1 69 71
M  V30 80 1 70 72
M  V30 81 2 71 73
M  V30 82 2 72 74
M  V30 83 1 73 74
M  V30 84 2 75 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 2 77 79
M  V30 88 2 78 80
M  V30 89 1 79 80
M  V30 90 1 81 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 1 83 85
M  V30 94 1 84 86
M  V30 95 1 85 86
M  V30 96 2 87 88
M  V30 97 1 87 89
M  V30 98 1 88 90
M  V30 99 1 88 91
M  V30 100 1 89 92
M  V30 101 2 89 93
M  V30 102 1 90 94
M  V30 103 2 90 95
M  V30 104 1 91 96
M  V30 105 1 92 95
M  V30 106 2 92 97
M  V30 107 1 93 98
M  V30 108 1 94 96
M  V30 109 2 94 99
M  V30 110 1 96 100
M  V30 111 1 97 101
M  V30 112 2 98 101
M  V30 113 1 99 102
M  V30 114 1 100 103
M  V30 115 2 102 103
M  V30 116 1 102 104
M  V30 117 1 103 105
M  V30 118 1 104 106
M  V30 119 1 105 107
M  V30 120 1 106 107
M  V30 121 1 108 109
M  V30 122 2 108 110
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 26 57 104)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2735753-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735753-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24850115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugates of a cell-binding molecule with camptothecin analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Ye, Hangbo; Huang, Yuanyuan; Xu, Yifang;
Zhao, Gengxiang; Chen, Diancheng; Guo, Huihui; Kong, Xiangfei; Li,
Wenjun; Bai, Lu; Cai, Xiang; Zhang, Xiuzhen; Jia, Junxiang; Guo,
Zhixiang; Huang, Shangma; Wang, Xiaoxu; Zheng, Jun; Du, Yong; Li, Yanhua;
Zheng, Yunxia; Lin, Chen; Chen, Xiaoxiao; Zheng, Wei; Jiang, Xinyan;
Zhang, Lingli; Ye, Riping; Chen, Miaomiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021212638 A1 2021-10-28

$RFMT $RIREG SCHEME337 STEP1
$RXN



  1  1
$MOL

C91H109F2N15O18.2CHO2
2735753-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  129 141 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 52.1888 16.7147 0.0 0
M  V30 2 O 46.4883 13.6837 0.0 0
M  V30 3 C 49.4950 8.4481 0.0 0
M  V30 4 C 50.1701 7.0640 0.0 0
M  V30 5 O 48.1196 7.0240 0.0 0
M  V30 6 F 58.2447 13.0912 0.0 0
M  V30 7 O 57.7098 16.1244 0.0 0
M  V30 8 C 57.4425 17.6410 0.0 0
M  V30 9 O 46.1058 6.6368 0.0 0
M  V30 10 C 47.0773 19.6284 0.0 0
M  V30 11 C 46.4002 17.7681 0.0 0
M  V30 12 N 40.9173 19.6284 0.0 0
M  V30 13 C 40.1473 20.9622 0.0 0
M  V30 14 C 38.6073 20.9622 0.0 0 CFG=2
M  V30 15 O 40.9173 22.2958 0.0 0
M  V30 16 N 37.8373 19.6284 0.0 0
M  V30 17 C 37.8373 22.2958 0.0 0
M  V30 18 C 36.2973 19.6284 0.0 0
M  V30 19 C 35.5273 18.2948 0.0 0
M  V30 20 O 35.5273 20.9622 0.0 0
M  V30 21 C 33.9873 18.2948 0.0 0
M  V30 22 C 33.2173 16.9611 0.0 0
M  V30 23 N 31.6773 16.9611 0.0 0
M  V30 24 O 33.9873 15.6275 0.0 0
M  V30 25 C 30.9073 15.6275 0.0 0
M  V30 26 C 29.3673 15.6275 0.0 0
M  V30 27 N 28.5973 14.2937 0.0 0
M  V30 28 C 27.0573 14.2937 0.0 0
M  V30 29 C 29.3673 12.9600 0.0 0
M  V30 30 C 26.2873 15.6275 0.0 0
M  V30 31 O 30.9073 12.9600 0.0 0
M  V30 32 O 28.5973 11.6264 0.0 0
M  V30 33 N 24.7473 15.6275 0.0 0
M  V30 34 C 31.6773 11.6264 0.0 0
M  V30 35 C 23.9773 16.9611 0.0 0
M  V30 36 C 33.0111 12.3964 0.0 0
M  V30 37 C 32.4473 10.2928 0.0 0
M  V30 38 C 30.3437 10.8564 0.0 0
M  V30 39 C 22.4373 16.9611 0.0 0
M  V30 40 O 24.7473 18.2948 0.0 0
M  V30 41 C 21.6673 18.2948 0.0 0
M  V30 42 C 20.1273 18.2948 0.0 0
M  V30 43 N 19.3573 16.9611 0.0 0
M  V30 44 O 19.3573 19.6284 0.0 0
M  V30 45 C 17.8173 16.9611 0.0 0 CFG=1
M  V30 46 C 17.0473 15.6275 0.0 0
M  V30 47 C 17.0473 18.2948 0.0 0
M  V30 48 N 15.5073 15.6275 0.0 0
M  V30 49 O 17.8173 14.2937 0.0 0
M  V30 50 C 12.4273 10.2928 0.0 0
M  V30 51 C 11.1548 11.8094 0.0 0
M  V30 52 C 7.3483 7.3230 0.0 0
M  V30 53 O 4.0765 2.8367 0.0 0
M  V30 54 C 5.5237 2.3100 0.0 0
M  V30 55 O 7.5736 13.7753 0.0 0
M  V30 56 F 1.1823 3.8902 0.0 0
M  V30 57 C 1.5362 13.7892 0.0 0
M  V30 58 C 0.0000 13.8967 0.0 0
M  V30 59 O 0.9905 15.6923 0.0 0
M  V30 60 O 1.6621 17.6299 0.0 0
M  V30 61 C 51.5440 12.6916 0.0 0
M  V30 62 C 51.2765 14.2082 0.0 0
M  V30 63 C 50.1841 11.9686 0.0 0
M  V30 64 N 52.9911 12.1648 0.0 0
M  V30 65 C 52.4563 15.1980 0.0 0
M  V30 66 C 49.7515 14.4224 0.0 0
M  V30 67 N 49.0764 13.0383 0.0 0
M  V30 68 C 49.8116 10.4743 0.0 0
M  V30 69 C 54.1707 13.1547 0.0 0
M  V30 70 C 53.9034 14.6713 0.0 0
M  V30 71 C 47.5960 12.6138 0.0 0
M  V30 72 C 48.3312 10.0497 0.0 0
M  V30 73 C 55.6179 12.6280 0.0 0
M  V30 74 C 55.0830 15.6612 0.0 0
M  V30 75 C 47.2235 11.1196 0.0 0
M  V30 76 C 47.9587 8.5556 0.0 0 CFG=1
M  V30 77 C 56.7975 13.6179 0.0 0
M  V30 78 C 56.5302 15.1345 0.0 0
M  V30 79 C 45.7431 10.6952 0.0 0
M  V30 80 C 46.4784 8.1311 0.0 0
M  V30 81 O 45.3706 9.2009 0.0 0
M  V30 82 N 50.7416 17.2414 0.0 0
M  V30 83 C 49.5620 16.2515 0.0 0
M  V30 84 C 50.4743 18.7580 0.0 0
M  V30 85 C 48.1148 16.7782 0.0 0
M  V30 86 C 49.0271 19.2847 0.0 0
M  V30 87 N 47.8473 18.2948 0.0 0 CHG=1 VAL=4
M  V30 88 C 45.5373 19.6284 0.0 0
M  V30 89 C 44.7673 18.2948 0.0 0
M  V30 90 C 44.7673 20.9622 0.0 0
M  V30 91 C 43.2273 18.2948 0.0 0
M  V30 92 C 43.2273 20.9622 0.0 0
M  V30 93 C 42.4573 19.6284 0.0 0
M  V30 94 C 14.7373 14.2937 0.0 0
M  V30 95 C 13.1973 14.2937 0.0 0
M  V30 96 C 15.5073 12.9600 0.0 0
M  V30 97 C 12.4273 12.9600 0.0 0
M  V30 98 C 14.7373 11.6264 0.0 0
M  V30 99 C 13.1973 11.6264 0.0 0
M  V30 100 N 10.8873 10.2928 0.0 0 CHG=1 VAL=4
M  V30 101 C 11.1548 8.7762 0.0 0
M  V30 102 C 9.4404 10.8194 0.0 0
M  V30 103 C 9.9750 7.7863 0.0 0
M  V30 104 C 8.2606 9.8295 0.0 0
M  V30 105 N 8.5281 8.3129 0.0 0
M  V30 106 C 5.9011 7.8497 0.0 0
M  V30 107 C 5.6338 9.3663 0.0 0
M  V30 108 C 4.7215 6.8598 0.0 0
M  V30 109 C 4.1866 9.8930 0.0 0
M  V30 110 C 6.5818 10.5798 0.0 0
M  V30 111 C 3.2743 7.3866 0.0 0
M  V30 112 C 4.9888 5.3432 0.0 0
M  V30 113 C 4.2404 11.4321 0.0 0
M  V30 114 N 3.0069 8.9032 0.0 0
M  V30 115 N 5.7206 11.8566 0.0 0
M  V30 116 C 2.0946 6.3967 0.0 0
M  V30 117 C 3.8092 4.3533 0.0 0
M  V30 118 C 3.1325 12.5019 0.0 0
M  V30 119 C 6.0933 13.3509 0.0 0
M  V30 120 C 2.3621 4.8801 0.0 0
M  V30 121 C 3.5052 13.9962 0.0 0
M  V30 122 C 4.9854 14.4206 0.0 0
M  V30 123 C 2.3973 15.0660 0.0 0 CFG=1
M  V30 124 C 5.3580 15.9148 0.0 0
M  V30 125 C 2.7698 16.5601 0.0 0
M  V30 126 O 4.2502 16.9847 0.0 0
M  V30 127 C 29.1223 0.0000 0.0 0
M  V30 128 O 27.7887 0.7700 0.0 0 CHG=-1
M  V30 129 O 30.4560 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 65
M  V30 2 1 1 82
M  V30 3 2 2 71
M  V30 4 1 3 4
M  V30 5 1 76 3 CFG=1
M  V30 6 1 76 5 CFG=3
M  V30 7 1 6 77
M  V30 8 1 7 8
M  V30 9 1 7 78
M  V30 10 2 9 80
M  V30 11 1 10 87
M  V30 12 1 10 88
M  V30 13 1 11 87
M  V30 14 1 12 13
M  V30 15 1 12 93
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 29 32
M  V30 35 1 30 33
M  V30 36 1 31 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 34 37
M  V30 40 1 34 38
M  V30 41 1 35 39
M  V30 42 2 35 40
M  V30 43 1 39 41
M  V30 44 1 41 42
M  V30 45 1 42 43
M  V30 46 2 42 44
M  V30 47 1 43 45
M  V30 48 1 45 46
M  V30 49 1 45 47 CFG=3
M  V30 50 1 46 48
M  V30 51 2 46 49
M  V30 52 1 48 94
M  V30 53 1 50 99
M  V30 54 1 50 100
M  V30 55 1 51 100
M  V30 56 1 52 105
M  V30 57 1 52 106
M  V30 58 1 53 54
M  V30 59 1 53 117
M  V30 60 2 55 119
M  V30 61 1 56 120
M  V30 62 1 57 58
M  V30 63 1 123 57 CFG=1
M  V30 64 1 123 59 CFG=3
M  V30 65 2 60 125
M  V30 66 1 61 62
M  V30 67 1 61 63
M  V30 68 2 61 64
M  V30 69 2 62 65
M  V30 70 1 62 66
M  V30 71 1 63 67
M  V30 72 2 63 68
M  V30 73 1 64 69
M  V30 74 1 65 70
M  V30 75 1 66 67
M  V30 76 1 67 71
M  V30 77 1 68 72
M  V30 78 1 69 70
M  V30 79 2 69 73
M  V30 80 2 70 74
M  V30 81 1 71 75
M  V30 82 2 72 75
M  V30 83 1 72 76
M  V30 84 1 73 77
M  V30 85 1 74 78
M  V30 86 1 75 79
M  V30 87 1 76 80
M  V30 88 2 77 78
M  V30 89 1 79 81
M  V30 90 1 80 81
M  V30 91 1 82 83
M  V30 92 1 82 84
M  V30 93 1 83 85
M  V30 94 1 84 86
M  V30 95 1 85 87
M  V30 96 1 86 87
M  V30 97 2 88 89
M  V30 98 1 88 90
M  V30 99 1 89 91
M  V30 100 2 90 92
M  V30 101 2 91 93
M  V30 102 1 92 93
M  V30 103 2 94 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 2 96 98
M  V30 107 2 97 99
M  V30 108 1 98 99
M  V30 109 1 100 101
M  V30 110 1 100 102
M  V30 111 1 101 103
M  V30 112 1 102 104
M  V30 113 1 103 105
M  V30 114 1 104 105
M  V30 115 2 106 107
M  V30 116 1 106 108
M  V30 117 1 107 109
M  V30 118 1 107 110
M  V30 119 1 108 111
M  V30 120 2 108 112
M  V30 121 1 109 113
M  V30 122 2 109 114
M  V30 123 1 110 115
M  V30 124 1 111 114
M  V30 125 2 111 116
M  V30 126 1 112 117
M  V30 127 1 113 115
M  V30 128 2 113 118
M  V30 129 1 115 119
M  V30 130 1 116 120
M  V30 131 2 117 120
M  V30 132 1 118 121
M  V30 133 1 119 122
M  V30 134 2 121 122
M  V30 135 1 121 123
M  V30 136 1 122 124
M  V30 137 1 123 125
M  V30 138 1 124 126
M  V30 139 1 125 126
M  V30 140 1 127 128
M  V30 141 2 127 129
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 45 76 123)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C86H101F2N15O16.2CHO2
2735753-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  122 134 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3483 7.7861 0.0 0
M  V30 2 O 7.5736 14.2384 0.0 0
M  V30 3 O 4.0765 3.2998 0.0 0
M  V30 4 C 2.8969 2.3100 0.0 0
M  V30 5 C 1.5362 14.2523 0.0 0
M  V30 6 C 0.0000 14.3597 0.0 0
M  V30 7 O 0.9905 16.1554 0.0 0
M  V30 8 F 1.1823 4.3533 0.0 0
M  V30 9 O 1.6621 18.0930 0.0 0
M  V30 10 C 12.4273 10.7558 0.0 0
M  V30 11 C 11.1548 12.2724 0.0 0
M  V30 12 N 15.5073 16.0906 0.0 0
M  V30 13 C 14.7373 17.4242 0.0 0
M  V30 14 C 15.5073 18.7578 0.0 0 CFG=2
M  V30 15 O 13.1973 17.4242 0.0 0
M  V30 16 N 14.7373 20.0916 0.0 0
M  V30 17 C 17.0473 18.7578 0.0 0
M  V30 18 C 15.5073 21.4253 0.0 0
M  V30 19 C 17.0473 21.4253 0.0 0
M  V30 20 O 14.7373 22.7589 0.0 0
M  V30 21 C 17.8173 22.7589 0.0 0
M  V30 22 C 19.3575 22.7589 0.0 0
M  V30 23 N 20.1275 21.4253 0.0 0
M  V30 24 O 20.1275 24.0925 0.0 0
M  V30 25 C 21.6673 21.4253 0.0 0
M  V30 26 C 22.4373 20.0916 0.0 0
M  V30 27 N 23.9773 20.0916 0.0 0
M  V30 28 C 24.7473 18.7578 0.0 0
M  V30 29 C 26.2873 18.7578 0.0 0
M  V30 30 N 27.0573 17.4242 0.0 0
M  V30 31 C 28.5973 17.4242 0.0 0
M  V30 32 C 29.3673 16.0906 0.0 0
M  V30 33 O 29.3673 18.7578 0.0 0
M  V30 34 C 30.9073 16.0906 0.0 0
M  V30 35 C 31.6773 14.7569 0.0 0
M  V30 36 N 33.2173 14.7569 0.0 0
M  V30 37 O 30.9073 13.4231 0.0 0
M  V30 38 C 33.9873 13.4231 0.0 0 CFG=1
M  V30 39 C 35.5273 13.4231 0.0 0
M  V30 40 C 33.2173 12.0895 0.0 0
M  V30 41 N 36.2973 12.0895 0.0 0
M  V30 42 O 36.2973 14.7569 0.0 0
M  V30 43 C 42.4573 12.0895 0.0 0
M  V30 44 C 41.7804 13.9500 0.0 0
M  V30 45 C 47.5688 15.0033 0.0 0
M  V30 46 O 53.0898 15.5936 0.0 0
M  V30 47 C 54.5369 16.1203 0.0 0
M  V30 48 O 41.8683 18.0343 0.0 0
M  V30 49 F 53.6247 18.6268 0.0 0
M  V30 50 C 44.8750 23.2699 0.0 0
M  V30 51 C 45.5500 24.6540 0.0 0
M  V30 52 O 43.4996 24.6939 0.0 0
M  V30 53 O 41.4858 25.0811 0.0 0
M  V30 54 C 5.6338 9.8294 0.0 0
M  V30 55 C 4.1866 10.3562 0.0 0
M  V30 56 C 5.9011 8.3128 0.0 0
M  V30 57 C 6.5818 11.0430 0.0 0
M  V30 58 C 4.2404 11.8953 0.0 0
M  V30 59 N 3.0069 9.3663 0.0 0
M  V30 60 C 4.7215 7.3230 0.0 0
M  V30 61 N 5.7206 12.3197 0.0 0
M  V30 62 C 3.1325 12.9650 0.0 0
M  V30 63 C 3.2743 7.8497 0.0 0
M  V30 64 C 4.9888 5.8063 0.0 0
M  V30 65 C 6.0933 13.8140 0.0 0
M  V30 66 C 3.5052 14.4592 0.0 0
M  V30 67 C 2.0946 6.8598 0.0 0
M  V30 68 C 3.8092 4.8165 0.0 0
M  V30 69 C 4.9854 14.8837 0.0 0
M  V30 70 C 2.3973 15.5291 0.0 0 CFG=1
M  V30 71 C 2.3621 5.3432 0.0 0
M  V30 72 C 5.3580 16.3779 0.0 0
M  V30 73 C 2.7698 17.0233 0.0 0
M  V30 74 O 4.2502 17.4478 0.0 0
M  V30 75 N 8.5281 8.7760 0.0 0
M  V30 76 C 8.2606 10.2926 0.0 0
M  V30 77 C 9.9752 8.2493 0.0 0
M  V30 78 C 9.4404 11.2825 0.0 0
M  V30 79 C 11.1548 9.2392 0.0 0
M  V30 80 N 10.8873 10.7558 0.0 0 CHG=1 VAL=4
M  V30 81 C 13.1973 12.0895 0.0 0
M  V30 82 C 14.7373 12.0895 0.0 0
M  V30 83 C 12.4273 13.4231 0.0 0
M  V30 84 C 15.5073 13.4231 0.0 0
M  V30 85 C 13.1973 14.7569 0.0 0
M  V30 86 C 14.7373 14.7569 0.0 0
M  V30 87 C 37.8373 12.0895 0.0 0
M  V30 88 C 38.6073 13.4231 0.0 0
M  V30 89 C 38.6073 10.7558 0.0 0
M  V30 90 C 40.1473 13.4231 0.0 0
M  V30 91 C 40.1473 10.7558 0.0 0
M  V30 92 C 40.9173 12.0895 0.0 0
M  V30 93 N 43.2273 13.4231 0.0 0 CHG=1 VAL=4
M  V30 94 C 44.4071 12.4334 0.0 0
M  V30 95 C 43.4948 14.9399 0.0 0
M  V30 96 C 45.8543 12.9600 0.0 0
M  V30 97 C 44.9420 15.4665 0.0 0
M  V30 98 N 46.1216 14.4766 0.0 0
M  V30 99 C 47.8363 16.5199 0.0 0
M  V30 100 C 46.6565 17.5098 0.0 0
M  V30 101 C 49.2834 17.0466 0.0 0
M  V30 102 C 46.9240 19.0264 0.0 0
M  V30 103 C 45.1315 17.2954 0.0 0
M  V30 104 C 49.5507 18.5632 0.0 0
M  V30 105 C 50.4630 16.0568 0.0 0
M  V30 106 C 45.5641 19.7494 0.0 0
M  V30 107 N 48.3711 19.5531 0.0 0
M  V30 108 N 44.4564 18.6796 0.0 0
M  V30 109 C 50.9979 19.0900 0.0 0
M  V30 110 C 51.9102 16.5835 0.0 0
M  V30 111 C 45.1916 21.2437 0.0 0
M  V30 112 C 42.9760 19.1042 0.0 0
M  V30 113 C 52.1775 18.1001 0.0 0
M  V30 114 C 43.7112 21.6681 0.0 0
M  V30 115 C 42.6035 20.5983 0.0 0
M  V30 116 C 43.3387 23.1624 0.0 0 CFG=1
M  V30 117 C 41.1231 21.0229 0.0 0
M  V30 118 C 41.8583 23.5868 0.0 0
M  V30 119 O 40.7506 22.5171 0.0 0
M  V30 120 C 27.2685 0.0000 0.0 0
M  V30 121 O 25.9348 0.7700 0.0 0 CHG=-1
M  V30 122 O 28.6021 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 56
M  V30 2 1 1 75
M  V30 3 2 2 65
M  V30 4 1 3 4
M  V30 5 1 3 68
M  V30 6 1 5 6
M  V30 7 1 70 5 CFG=1
M  V30 8 1 70 7 CFG=3
M  V30 9 1 8 71
M  V30 10 2 9 73
M  V30 11 1 10 80
M  V30 12 1 10 81
M  V30 13 1 11 80
M  V30 14 1 12 13
M  V30 15 1 12 86
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17 CFG=1
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 1 28 29
M  V30 32 1 29 30
M  V30 33 1 30 31
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 34 35
M  V30 38 1 35 36
M  V30 39 2 35 37
M  V30 40 1 36 38
M  V30 41 1 38 39
M  V30 42 1 38 40 CFG=3
M  V30 43 1 39 41
M  V30 44 2 39 42
M  V30 45 1 41 87
M  V30 46 1 43 92
M  V30 47 1 43 93
M  V30 48 1 44 93
M  V30 49 1 45 98
M  V30 50 1 45 99
M  V30 51 1 46 47
M  V30 52 1 46 110
M  V30 53 2 48 112
M  V30 54 1 49 113
M  V30 55 1 50 51
M  V30 56 1 116 50 CFG=3
M  V30 57 1 116 52 CFG=1
M  V30 58 2 53 118
M  V30 59 1 54 55
M  V30 60 2 54 56
M  V30 61 1 54 57
M  V30 62 1 55 58
M  V30 63 2 55 59
M  V30 64 1 56 60
M  V30 65 1 57 61
M  V30 66 1 58 61
M  V30 67 2 58 62
M  V30 68 1 59 63
M  V30 69 1 60 63
M  V30 70 2 60 64
M  V30 71 1 61 65
M  V30 72 1 62 66
M  V30 73 2 63 67
M  V30 74 1 64 68
M  V30 75 1 65 69
M  V30 76 2 66 69
M  V30 77 1 66 70
M  V30 78 1 67 71
M  V30 79 2 68 71
M  V30 80 1 69 72
M  V30 81 1 70 73
M  V30 82 1 72 74
M  V30 83 1 73 74
M  V30 84 1 75 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 1 77 79
M  V30 88 1 78 80
M  V30 89 1 79 80
M  V30 90 2 81 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 2 83 85
M  V30 94 2 84 86
M  V30 95 1 85 86
M  V30 96 2 87 88
M  V30 97 1 87 89
M  V30 98 1 88 90
M  V30 99 2 89 91
M  V30 100 2 90 92
M  V30 101 1 91 92
M  V30 102 1 93 94
M  V30 103 1 93 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 1 96 98
M  V30 107 1 97 98
M  V30 108 2 99 100
M  V30 109 1 99 101
M  V30 110 1 100 102
M  V30 111 1 100 103
M  V30 112 1 101 104
M  V30 113 2 101 105
M  V30 114 1 102 106
M  V30 115 2 102 107
M  V30 116 1 103 108
M  V30 117 1 104 107
M  V30 118 2 104 109
M  V30 119 1 105 110
M  V30 120 1 106 108
M  V30 121 2 106 111
M  V30 122 1 108 112
M  V30 123 1 109 113
M  V30 124 2 110 113
M  V30 125 1 111 114
M  V30 126 1 112 115
M  V30 127 2 114 115
M  V30 128 1 114 116
M  V30 129 1 115 117
M  V30 130 1 116 118
M  V30 131 1 117 119
M  V30 132 1 118 119
M  V30 133 1 120 121
M  V30 134 2 120 122
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 38 70 116)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2735753-10-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735753-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24850105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugates of a cell-binding molecule with camptothecin analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Ye, Hangbo; Huang, Yuanyuan; Xu, Yifang;
Zhao, Gengxiang; Chen, Diancheng; Guo, Huihui; Kong, Xiangfei; Li,
Wenjun; Bai, Lu; Cai, Xiang; Zhang, Xiuzhen; Jia, Junxiang; Guo,
Zhixiang; Huang, Shangma; Wang, Xiaoxu; Zheng, Jun; Du, Yong; Li, Yanhua;
Zheng, Yunxia; Lin, Chen; Chen, Xiaoxiao; Zheng, Wei; Jiang, Xinyan;
Zhang, Lingli; Ye, Riping; Chen, Miaomiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021212638 A1 2021-10-28

$RFMT $RIREG SCHEME338 STEP1
$RXN



  1  1
$MOL

C87H103F2N13O16.2CHO2
2735753-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  121 133 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1535 18.3142 0.0 0
M  V30 2 O 7.1584 12.1739 0.0 0
M  V30 3 O 7.6135 23.6490 0.0 0
M  V30 4 C 6.8435 24.9826 0.0 0
M  V30 5 C 1.4803 14.2258 0.0 0
M  V30 6 C 0.0000 14.6503 0.0 0
M  V30 7 O 0.3166 12.6242 0.0 0
M  V30 8 F 4.5335 23.6490 0.0 0
M  V30 9 O 0.2851 10.5737 0.0 0
M  V30 10 N 12.2335 12.9795 0.0 0 CHG=1 VAL=4
M  V30 11 C 13.0035 11.6459 0.0 0
M  V30 12 C 13.5672 13.7495 0.0 0
M  V30 13 C 10.8999 12.2095 0.0 0
M  V30 14 N 19.1636 11.6459 0.0 0
M  V30 15 C 19.9336 10.3121 0.0 0
M  V30 16 C 21.4736 10.3121 0.0 0 CFG=2
M  V30 17 O 19.1636 8.9784 0.0 0
M  V30 18 N 22.2436 8.9784 0.0 0
M  V30 19 C 22.2436 11.6459 0.0 0
M  V30 20 C 23.7836 8.9784 0.0 0
M  V30 21 C 24.5536 7.6448 0.0 0
M  V30 22 O 24.5536 10.3121 0.0 0
M  V30 23 N 26.0936 7.6448 0.0 0
M  V30 24 C 26.8636 8.9784 0.0 0
M  V30 25 C 26.8636 6.3111 0.0 0
M  V30 26 C 28.4036 8.9784 0.0 0
M  V30 27 O 26.0936 4.9773 0.0 0
M  V30 28 O 28.4036 6.3111 0.0 0
M  V30 29 N 29.1736 10.3121 0.0 0
M  V30 30 O 29.1736 7.6448 0.0 0
M  V30 31 C 26.8636 3.6437 0.0 0
M  V30 32 C 30.7136 10.3121 0.0 0 CFG=1
M  V30 33 C 25.5299 2.8737 0.0 0
M  V30 34 C 27.6336 2.3100 0.0 0
M  V30 35 C 28.1972 4.4137 0.0 0
M  V30 36 C 31.4836 11.6459 0.0 0
M  V30 37 C 31.4836 8.9784 0.0 0
M  V30 38 N 33.0236 11.6459 0.0 0
M  V30 39 O 30.7136 12.9795 0.0 0
M  V30 40 C 36.1036 16.9806 0.0 0
M  V30 41 N 37.6436 16.9806 0.0 0 CHG=1 VAL=4
M  V30 42 C 37.6436 18.5206 0.0 0
M  V30 43 C 37.6436 15.4406 0.0 0
M  V30 44 C 43.8037 16.9806 0.0 0
M  V30 45 O 49.1937 15.6468 0.0 0
M  V30 46 C 50.7337 15.6468 0.0 0
M  V30 47 O 39.4836 21.7785 0.0 0
M  V30 48 F 50.7337 18.3142 0.0 0
M  V30 49 C 44.0997 25.6699 0.0 0
M  V30 50 C 45.2074 26.7396 0.0 0
M  V30 51 O 43.2944 27.4785 0.0 0
M  V30 52 O 41.5343 28.5311 0.0 0
M  V30 53 C 6.8435 16.9806 0.0 0
M  V30 54 C 5.3035 16.9806 0.0 0
M  V30 55 C 7.6135 18.3142 0.0 0
M  V30 56 C 7.3194 15.5159 0.0 0
M  V30 57 C 4.8276 15.5159 0.0 0
M  V30 58 N 4.5335 18.3142 0.0 0
M  V30 59 C 6.8435 19.6479 0.0 0
M  V30 60 N 6.0735 14.6107 0.0 0
M  V30 61 C 3.4207 14.8896 0.0 0
M  V30 62 C 5.3035 19.6479 0.0 0
M  V30 63 C 7.6135 20.9815 0.0 0
M  V30 64 C 5.9126 13.0791 0.0 0
M  V30 65 C 3.2597 13.3579 0.0 0
M  V30 66 C 4.5335 20.9815 0.0 0
M  V30 67 C 6.8435 22.3153 0.0 0
M  V30 68 C 4.5056 12.4528 0.0 0
M  V30 69 C 1.8529 12.7316 0.0 0 CFG=1
M  V30 70 C 5.3035 22.3153 0.0 0
M  V30 71 C 4.3447 10.9211 0.0 0
M  V30 72 C 1.6919 11.2000 0.0 0
M  V30 73 O 2.9379 10.2948 0.0 0
M  V30 74 N 9.9235 16.9806 0.0 0
M  V30 75 C 11.4635 16.9806 0.0 0
M  V30 76 C 9.1535 15.6468 0.0 0
M  V30 77 C 12.2335 15.6468 0.0 0
M  V30 78 C 9.9235 14.3131 0.0 0
M  V30 79 C 11.4635 14.3131 0.0 0
M  V30 80 C 14.5435 11.6459 0.0 0
M  V30 81 C 15.3135 10.3121 0.0 0
M  V30 82 C 15.3135 12.9795 0.0 0
M  V30 83 C 16.8535 10.3121 0.0 0
M  V30 84 C 16.8535 12.9795 0.0 0
M  V30 85 C 17.6235 11.6459 0.0 0
M  V30 86 C 33.7936 12.9795 0.0 0
M  V30 87 C 33.0236 14.3131 0.0 0
M  V30 88 C 35.3336 12.9795 0.0 0
M  V30 89 C 33.7936 15.6468 0.0 0
M  V30 90 C 36.1036 14.3131 0.0 0
M  V30 91 C 35.3336 15.6468 0.0 0
M  V30 92 C 39.1837 16.9806 0.0 0
M  V30 93 C 39.9537 18.3142 0.0 0
M  V30 94 C 39.9537 15.6468 0.0 0
M  V30 95 C 41.4937 18.3142 0.0 0
M  V30 96 C 41.4937 15.6468 0.0 0
M  V30 97 N 42.2637 16.9806 0.0 0
M  V30 98 C 44.5737 18.3142 0.0 0
M  V30 99 C 43.8037 19.6479 0.0 0
M  V30 100 C 46.1137 18.3142 0.0 0
M  V30 101 C 44.5737 20.9815 0.0 0
M  V30 102 C 42.2974 19.9681 0.0 0
M  V30 103 C 46.8837 19.6479 0.0 0
M  V30 104 C 46.8837 16.9806 0.0 0
M  V30 105 C 43.5433 22.1261 0.0 0
M  V30 106 N 46.1137 20.9815 0.0 0
M  V30 107 N 42.1363 21.4996 0.0 0
M  V30 108 C 48.4237 19.6479 0.0 0
M  V30 109 C 48.4237 16.9806 0.0 0
M  V30 110 C 43.7042 23.6576 0.0 0
M  V30 111 C 40.8904 22.4048 0.0 0
M  V30 112 C 49.1937 18.3142 0.0 0
M  V30 113 C 42.4583 24.5628 0.0 0
M  V30 114 C 41.0514 23.9365 0.0 0
M  V30 115 C 42.6193 26.0944 0.0 0 CFG=1
M  V30 116 C 39.8055 24.8416 0.0 0
M  V30 117 C 41.3734 26.9996 0.0 0
M  V30 118 O 39.9666 26.3733 0.0 0
M  V30 119 C 25.3669 0.0000 0.0 0
M  V30 120 O 24.0332 0.7700 0.0 0 CHG=-1
M  V30 121 O 26.7005 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 55
M  V30 2 1 1 74
M  V30 3 2 2 64
M  V30 4 1 3 4
M  V30 5 1 3 67
M  V30 6 1 5 6
M  V30 7 1 69 5 CFG=3
M  V30 8 1 69 7 CFG=1
M  V30 9 1 8 70
M  V30 10 2 9 72
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 79
M  V30 15 1 11 80
M  V30 16 1 14 15
M  V30 17 1 14 85
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 16 19 CFG=3
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 2 26 30
M  V30 33 1 27 31
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 1 31 34
M  V30 37 1 31 35
M  V30 38 1 32 36
M  V30 39 1 32 37 CFG=3
M  V30 40 1 36 38
M  V30 41 2 36 39
M  V30 42 1 38 86
M  V30 43 1 40 41
M  V30 44 1 40 91
M  V30 45 1 41 42
M  V30 46 1 41 43
M  V30 47 1 41 92
M  V30 48 1 44 97
M  V30 49 1 44 98
M  V30 50 1 45 46
M  V30 51 1 45 109
M  V30 52 2 47 111
M  V30 53 1 48 112
M  V30 54 1 49 50
M  V30 55 1 115 49 CFG=3
M  V30 56 1 115 51 CFG=1
M  V30 57 2 52 117
M  V30 58 1 53 54
M  V30 59 2 53 55
M  V30 60 1 53 56
M  V30 61 1 54 57
M  V30 62 2 54 58
M  V30 63 1 55 59
M  V30 64 1 56 60
M  V30 65 1 57 60
M  V30 66 2 57 61
M  V30 67 1 58 62
M  V30 68 1 59 62
M  V30 69 2 59 63
M  V30 70 1 60 64
M  V30 71 1 61 65
M  V30 72 2 62 66
M  V30 73 1 63 67
M  V30 74 1 64 68
M  V30 75 2 65 68
M  V30 76 1 65 69
M  V30 77 1 66 70
M  V30 78 2 67 70
M  V30 79 1 68 71
M  V30 80 1 69 72
M  V30 81 1 71 73
M  V30 82 1 72 73
M  V30 83 1 74 75
M  V30 84 1 74 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 1 77 79
M  V30 88 1 78 79
M  V30 89 2 80 81
M  V30 90 1 80 82
M  V30 91 1 81 83
M  V30 92 2 82 84
M  V30 93 2 83 85
M  V30 94 1 84 85
M  V30 95 2 86 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 2 88 90
M  V30 99 2 89 91
M  V30 100 1 90 91
M  V30 101 1 92 93
M  V30 102 1 92 94
M  V30 103 1 93 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 1 96 97
M  V30 107 2 98 99
M  V30 108 1 98 100
M  V30 109 1 99 101
M  V30 110 1 99 102
M  V30 111 1 100 103
M  V30 112 2 100 104
M  V30 113 1 101 105
M  V30 114 2 101 106
M  V30 115 1 102 107
M  V30 116 1 103 106
M  V30 117 2 103 108
M  V30 118 1 104 109
M  V30 119 1 105 107
M  V30 120 2 105 110
M  V30 121 1 107 111
M  V30 122 1 108 112
M  V30 123 2 109 112
M  V30 124 1 110 113
M  V30 125 1 111 114
M  V30 126 2 113 114
M  V30 127 1 113 115
M  V30 128 1 114 116
M  V30 129 1 115 117
M  V30 130 1 116 118
M  V30 131 1 117 118
M  V30 132 1 119 120
M  V30 133 2 119 121
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 32 69 115)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C82H95F2N13O14.2CHO2
2735753-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  114 126 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 24.2126 19.2501 0.0 0
M  V30 2 O 29.0106 14.9300 0.0 0
M  V30 3 O 22.8789 24.6401 0.0 0
M  V30 4 C 21.5453 23.8701 0.0 0
M  V30 5 C 32.9020 19.5460 0.0 0
M  V30 6 C 33.9717 20.6538 0.0 0
M  V30 7 O 34.7106 18.7408 0.0 0
M  V30 8 F 25.5464 26.1801 0.0 0
M  V30 9 O 35.7632 16.9807 0.0 0
M  V30 10 N 24.2126 13.0900 0.0 0 CHG=1 VAL=4
M  V30 11 C 24.2126 11.5500 0.0 0
M  V30 12 C 25.7526 13.0900 0.0 0
M  V30 13 C 22.6726 13.0900 0.0 0
M  V30 14 N 18.8778 8.4700 0.0 0
M  V30 15 C 18.8778 6.9300 0.0 0
M  V30 16 C 17.5442 6.1600 0.0 0 CFG=2
M  V30 17 O 20.2116 6.1600 0.0 0
M  V30 18 N 17.5442 4.6200 0.0 0
M  V30 19 C 16.2105 6.9300 0.0 0
M  V30 20 C 16.2105 3.8500 0.0 0
M  V30 21 C 14.8769 4.6200 0.0 0
M  V30 22 O 16.2105 2.3100 0.0 0
M  V30 23 N 13.5431 3.8500 0.0 0
M  V30 24 C 12.2095 4.6200 0.0 0
M  V30 25 C 10.8758 3.8500 0.0 0
M  V30 26 N 9.5422 4.6200 0.0 0
M  V30 27 O 10.8758 2.3100 0.0 0
M  V30 28 C 8.2084 3.8500 0.0 0 CFG=1
M  V30 29 C 6.8747 4.6200 0.0 0
M  V30 30 C 8.2084 2.3100 0.0 0
M  V30 31 N 6.8747 6.1600 0.0 0
M  V30 32 O 5.5411 3.8500 0.0 0
M  V30 33 C 1.5400 9.2400 0.0 0
M  V30 34 N 1.5400 10.7800 0.0 0 CHG=1 VAL=4
M  V30 35 C 3.0800 10.7800 0.0 0
M  V30 36 C 0.0000 10.7800 0.0 0
M  V30 37 C 1.5400 16.9401 0.0 0
M  V30 38 O 0.2062 22.3301 0.0 0
M  V30 39 C 0.2062 23.8701 0.0 0
M  V30 40 O 6.3379 12.6200 0.0 0
M  V30 41 F 2.8736 23.8701 0.0 0
M  V30 42 C 10.2293 17.2360 0.0 0
M  V30 43 C 11.2990 18.3438 0.0 0
M  V30 44 O 12.0379 16.4308 0.0 0
M  V30 45 O 13.0905 14.6707 0.0 0
M  V30 46 C 26.8800 19.2501 0.0 0
M  V30 47 C 28.2136 20.0201 0.0 0
M  V30 48 C 25.5464 20.0201 0.0 0
M  V30 49 C 27.2002 17.7438 0.0 0
M  V30 50 C 29.3582 18.9896 0.0 0
M  V30 51 N 28.2136 21.5601 0.0 0
M  V30 52 C 25.5464 21.5601 0.0 0
M  V30 53 N 28.7317 17.5827 0.0 0
M  V30 54 C 30.8897 19.1506 0.0 0
M  V30 55 C 26.8800 22.3301 0.0 0
M  V30 56 C 24.2126 22.3301 0.0 0
M  V30 57 C 29.6369 16.3368 0.0 0
M  V30 58 C 31.7949 17.9047 0.0 0
M  V30 59 C 26.8800 23.8701 0.0 0
M  V30 60 C 24.2126 23.8701 0.0 0
M  V30 61 C 31.1684 16.4978 0.0 0
M  V30 62 C 33.3265 18.0656 0.0 0 CFG=1
M  V30 63 C 25.5464 24.6401 0.0 0
M  V30 64 C 32.0737 15.2519 0.0 0
M  V30 65 C 34.2317 16.8198 0.0 0
M  V30 66 O 33.6052 15.4128 0.0 0
M  V30 67 N 24.2126 17.7101 0.0 0
M  V30 68 C 25.5464 16.9401 0.0 0
M  V30 69 C 22.8789 16.9401 0.0 0
M  V30 70 C 25.5464 15.4001 0.0 0
M  V30 71 C 22.8789 15.4001 0.0 0
M  V30 72 C 24.2126 14.6300 0.0 0
M  V30 73 C 22.8789 10.7800 0.0 0
M  V30 74 C 21.5453 11.5500 0.0 0
M  V30 75 C 22.8789 9.2400 0.0 0
M  V30 76 C 20.2116 10.7800 0.0 0
M  V30 77 C 21.5453 8.4700 0.0 0
M  V30 78 C 20.2116 9.2400 0.0 0
M  V30 79 C 5.5411 6.9300 0.0 0
M  V30 80 C 5.5411 8.4700 0.0 0
M  V30 81 C 4.2074 6.1600 0.0 0
M  V30 82 C 4.2074 9.2400 0.0 0
M  V30 83 C 2.8736 6.9300 0.0 0
M  V30 84 C 2.8736 8.4700 0.0 0
M  V30 85 C 1.5400 12.3200 0.0 0
M  V30 86 C 0.2064 13.0900 0.0 0
M  V30 87 C 2.8736 13.0900 0.0 0
M  V30 88 C 0.2064 14.6300 0.0 0
M  V30 89 C 2.8736 14.6300 0.0 0
M  V30 90 N 1.5400 15.4001 0.0 0
M  V30 91 C 2.8736 17.7101 0.0 0
M  V30 92 C 4.2073 16.9401 0.0 0
M  V30 93 C 2.8736 19.2501 0.0 0
M  V30 94 C 5.5409 17.7101 0.0 0
M  V30 95 C 4.5275 15.4336 0.0 0
M  V30 96 C 4.2073 20.0201 0.0 0
M  V30 97 C 1.5400 20.0201 0.0 0
M  V30 98 C 6.6855 16.6796 0.0 0
M  V30 99 N 5.5409 19.2501 0.0 0
M  V30 100 N 6.0591 15.2727 0.0 0
M  V30 101 C 4.2073 21.5601 0.0 0
M  V30 102 C 1.5398 21.5601 0.0 0
M  V30 103 C 8.2170 16.8406 0.0 0
M  V30 104 C 6.9642 14.0268 0.0 0
M  V30 105 C 2.8736 22.3301 0.0 0
M  V30 106 C 9.1222 15.5947 0.0 0
M  V30 107 C 8.4959 14.1878 0.0 0
M  V30 108 C 10.6537 15.7556 0.0 0 CFG=1
M  V30 109 C 9.4010 12.9419 0.0 0
M  V30 110 C 11.5590 14.5098 0.0 0
M  V30 111 O 10.9326 13.1030 0.0 0
M  V30 112 C 17.8816 0.0000 0.0 0
M  V30 113 O 16.5479 0.7700 0.0 0 CHG=-1
M  V30 114 O 19.2153 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 48
M  V30 2 1 1 67
M  V30 3 2 2 57
M  V30 4 1 3 4
M  V30 5 1 3 60
M  V30 6 1 5 6
M  V30 7 1 62 5 CFG=1
M  V30 8 1 62 7 CFG=3
M  V30 9 1 8 63
M  V30 10 2 9 65
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 72
M  V30 15 1 11 73
M  V30 16 1 14 15
M  V30 17 1 14 78
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 16 19 CFG=1
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 28 29
M  V30 32 1 28 30 CFG=1
M  V30 33 1 29 31
M  V30 34 2 29 32
M  V30 35 1 31 79
M  V30 36 1 33 34
M  V30 37 1 33 84
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 34 85
M  V30 41 1 37 90
M  V30 42 1 37 91
M  V30 43 1 38 39
M  V30 44 1 38 102
M  V30 45 2 40 104
M  V30 46 1 41 105
M  V30 47 1 42 43
M  V30 48 1 108 42 CFG=1
M  V30 49 1 108 44 CFG=3
M  V30 50 2 45 110
M  V30 51 1 46 47
M  V30 52 2 46 48
M  V30 53 1 46 49
M  V30 54 1 47 50
M  V30 55 2 47 51
M  V30 56 1 48 52
M  V30 57 1 49 53
M  V30 58 1 50 53
M  V30 59 2 50 54
M  V30 60 1 51 55
M  V30 61 1 52 55
M  V30 62 2 52 56
M  V30 63 1 53 57
M  V30 64 1 54 58
M  V30 65 2 55 59
M  V30 66 1 56 60
M  V30 67 1 57 61
M  V30 68 2 58 61
M  V30 69 1 58 62
M  V30 70 1 59 63
M  V30 71 2 60 63
M  V30 72 1 61 64
M  V30 73 1 62 65
M  V30 74 1 64 66
M  V30 75 1 65 66
M  V30 76 1 67 68
M  V30 77 1 67 69
M  V30 78 1 68 70
M  V30 79 1 69 71
M  V30 80 1 70 72
M  V30 81 1 71 72
M  V30 82 2 73 74
M  V30 83 1 73 75
M  V30 84 1 74 76
M  V30 85 2 75 77
M  V30 86 2 76 78
M  V30 87 1 77 78
M  V30 88 2 79 80
M  V30 89 1 79 81
M  V30 90 1 80 82
M  V30 91 2 81 83
M  V30 92 2 82 84
M  V30 93 1 83 84
M  V30 94 1 85 86
M  V30 95 1 85 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 1 88 90
M  V30 99 1 89 90
M  V30 100 2 91 92
M  V30 101 1 91 93
M  V30 102 1 92 94
M  V30 103 1 92 95
M  V30 104 1 93 96
M  V30 105 2 93 97
M  V30 106 1 94 98
M  V30 107 2 94 99
M  V30 108 1 95 100
M  V30 109 1 96 99
M  V30 110 2 96 101
M  V30 111 1 97 102
M  V30 112 1 98 100
M  V30 113 2 98 103
M  V30 114 1 100 104
M  V30 115 1 101 105
M  V30 116 2 102 105
M  V30 117 1 103 106
M  V30 118 1 104 107
M  V30 119 2 106 107
M  V30 120 1 106 108
M  V30 121 1 107 109
M  V30 122 1 108 110
M  V30 123 1 109 111
M  V30 124 1 110 111
M  V30 125 1 112 113
M  V30 126 2 112 114
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 28 62 108)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2735753-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735753-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32219628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specific conjugation of an antibody
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Liu, Xiaolei; Zhang, Lingli; Huang,
Yuanyuan; Li, Wenjun; Ye, Hangbo; Wang, Juan; Guo, Huihui; Zhou, You
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022078524 A2 2022-04-21

$RFMT $RIREG SCHEME338 STEP1
$RXN



  1  1
$MOL

C87H103F2N13O16.2CHO2
2735753-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  121 133 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1535 18.3142 0.0 0
M  V30 2 O 7.1584 12.1739 0.0 0
M  V30 3 O 7.6135 23.6490 0.0 0
M  V30 4 C 6.8435 24.9826 0.0 0
M  V30 5 C 1.4803 14.2258 0.0 0
M  V30 6 C 0.0000 14.6503 0.0 0
M  V30 7 O 0.3166 12.6242 0.0 0
M  V30 8 F 4.5335 23.6490 0.0 0
M  V30 9 O 0.2851 10.5737 0.0 0
M  V30 10 N 12.2335 12.9795 0.0 0 CHG=1 VAL=4
M  V30 11 C 13.0035 11.6459 0.0 0
M  V30 12 C 13.5672 13.7495 0.0 0
M  V30 13 C 10.8999 12.2095 0.0 0
M  V30 14 N 19.1636 11.6459 0.0 0
M  V30 15 C 19.9336 10.3121 0.0 0
M  V30 16 C 21.4736 10.3121 0.0 0 CFG=2
M  V30 17 O 19.1636 8.9784 0.0 0
M  V30 18 N 22.2436 8.9784 0.0 0
M  V30 19 C 22.2436 11.6459 0.0 0
M  V30 20 C 23.7836 8.9784 0.0 0
M  V30 21 C 24.5536 7.6448 0.0 0
M  V30 22 O 24.5536 10.3121 0.0 0
M  V30 23 N 26.0936 7.6448 0.0 0
M  V30 24 C 26.8636 8.9784 0.0 0
M  V30 25 C 26.8636 6.3111 0.0 0
M  V30 26 C 28.4036 8.9784 0.0 0
M  V30 27 O 26.0936 4.9773 0.0 0
M  V30 28 O 28.4036 6.3111 0.0 0
M  V30 29 N 29.1736 10.3121 0.0 0
M  V30 30 O 29.1736 7.6448 0.0 0
M  V30 31 C 26.8636 3.6437 0.0 0
M  V30 32 C 30.7136 10.3121 0.0 0 CFG=1
M  V30 33 C 25.5299 2.8737 0.0 0
M  V30 34 C 27.6336 2.3100 0.0 0
M  V30 35 C 28.1972 4.4137 0.0 0
M  V30 36 C 31.4836 11.6459 0.0 0
M  V30 37 C 31.4836 8.9784 0.0 0
M  V30 38 N 33.0236 11.6459 0.0 0
M  V30 39 O 30.7136 12.9795 0.0 0
M  V30 40 C 36.1036 16.9806 0.0 0
M  V30 41 N 37.6436 16.9806 0.0 0 CHG=1 VAL=4
M  V30 42 C 37.6436 18.5206 0.0 0
M  V30 43 C 37.6436 15.4406 0.0 0
M  V30 44 C 43.8037 16.9806 0.0 0
M  V30 45 O 49.1937 15.6468 0.0 0
M  V30 46 C 50.7337 15.6468 0.0 0
M  V30 47 O 39.4836 21.7785 0.0 0
M  V30 48 F 50.7337 18.3142 0.0 0
M  V30 49 C 44.0997 25.6699 0.0 0
M  V30 50 C 45.2074 26.7396 0.0 0
M  V30 51 O 43.2944 27.4785 0.0 0
M  V30 52 O 41.5343 28.5311 0.0 0
M  V30 53 C 6.8435 16.9806 0.0 0
M  V30 54 C 5.3035 16.9806 0.0 0
M  V30 55 C 7.6135 18.3142 0.0 0
M  V30 56 C 7.3194 15.5159 0.0 0
M  V30 57 C 4.8276 15.5159 0.0 0
M  V30 58 N 4.5335 18.3142 0.0 0
M  V30 59 C 6.8435 19.6479 0.0 0
M  V30 60 N 6.0735 14.6107 0.0 0
M  V30 61 C 3.4207 14.8896 0.0 0
M  V30 62 C 5.3035 19.6479 0.0 0
M  V30 63 C 7.6135 20.9815 0.0 0
M  V30 64 C 5.9126 13.0791 0.0 0
M  V30 65 C 3.2597 13.3579 0.0 0
M  V30 66 C 4.5335 20.9815 0.0 0
M  V30 67 C 6.8435 22.3153 0.0 0
M  V30 68 C 4.5056 12.4528 0.0 0
M  V30 69 C 1.8529 12.7316 0.0 0 CFG=1
M  V30 70 C 5.3035 22.3153 0.0 0
M  V30 71 C 4.3447 10.9211 0.0 0
M  V30 72 C 1.6919 11.2000 0.0 0
M  V30 73 O 2.9379 10.2948 0.0 0
M  V30 74 N 9.9235 16.9806 0.0 0
M  V30 75 C 11.4635 16.9806 0.0 0
M  V30 76 C 9.1535 15.6468 0.0 0
M  V30 77 C 12.2335 15.6468 0.0 0
M  V30 78 C 9.9235 14.3131 0.0 0
M  V30 79 C 11.4635 14.3131 0.0 0
M  V30 80 C 14.5435 11.6459 0.0 0
M  V30 81 C 15.3135 10.3121 0.0 0
M  V30 82 C 15.3135 12.9795 0.0 0
M  V30 83 C 16.8535 10.3121 0.0 0
M  V30 84 C 16.8535 12.9795 0.0 0
M  V30 85 C 17.6235 11.6459 0.0 0
M  V30 86 C 33.7936 12.9795 0.0 0
M  V30 87 C 33.0236 14.3131 0.0 0
M  V30 88 C 35.3336 12.9795 0.0 0
M  V30 89 C 33.7936 15.6468 0.0 0
M  V30 90 C 36.1036 14.3131 0.0 0
M  V30 91 C 35.3336 15.6468 0.0 0
M  V30 92 C 39.1837 16.9806 0.0 0
M  V30 93 C 39.9537 18.3142 0.0 0
M  V30 94 C 39.9537 15.6468 0.0 0
M  V30 95 C 41.4937 18.3142 0.0 0
M  V30 96 C 41.4937 15.6468 0.0 0
M  V30 97 N 42.2637 16.9806 0.0 0
M  V30 98 C 44.5737 18.3142 0.0 0
M  V30 99 C 43.8037 19.6479 0.0 0
M  V30 100 C 46.1137 18.3142 0.0 0
M  V30 101 C 44.5737 20.9815 0.0 0
M  V30 102 C 42.2974 19.9681 0.0 0
M  V30 103 C 46.8837 19.6479 0.0 0
M  V30 104 C 46.8837 16.9806 0.0 0
M  V30 105 C 43.5433 22.1261 0.0 0
M  V30 106 N 46.1137 20.9815 0.0 0
M  V30 107 N 42.1363 21.4996 0.0 0
M  V30 108 C 48.4237 19.6479 0.0 0
M  V30 109 C 48.4237 16.9806 0.0 0
M  V30 110 C 43.7042 23.6576 0.0 0
M  V30 111 C 40.8904 22.4048 0.0 0
M  V30 112 C 49.1937 18.3142 0.0 0
M  V30 113 C 42.4583 24.5628 0.0 0
M  V30 114 C 41.0514 23.9365 0.0 0
M  V30 115 C 42.6193 26.0944 0.0 0 CFG=1
M  V30 116 C 39.8055 24.8416 0.0 0
M  V30 117 C 41.3734 26.9996 0.0 0
M  V30 118 O 39.9666 26.3733 0.0 0
M  V30 119 C 25.3669 0.0000 0.0 0
M  V30 120 O 24.0332 0.7700 0.0 0 CHG=-1
M  V30 121 O 26.7005 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 55
M  V30 2 1 1 74
M  V30 3 2 2 64
M  V30 4 1 3 4
M  V30 5 1 3 67
M  V30 6 1 5 6
M  V30 7 1 69 5 CFG=3
M  V30 8 1 69 7 CFG=1
M  V30 9 1 8 70
M  V30 10 2 9 72
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 79
M  V30 15 1 11 80
M  V30 16 1 14 15
M  V30 17 1 14 85
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 16 19 CFG=3
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 2 26 30
M  V30 33 1 27 31
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 1 31 34
M  V30 37 1 31 35
M  V30 38 1 32 36
M  V30 39 1 32 37 CFG=3
M  V30 40 1 36 38
M  V30 41 2 36 39
M  V30 42 1 38 86
M  V30 43 1 40 41
M  V30 44 1 40 91
M  V30 45 1 41 42
M  V30 46 1 41 43
M  V30 47 1 41 92
M  V30 48 1 44 97
M  V30 49 1 44 98
M  V30 50 1 45 46
M  V30 51 1 45 109
M  V30 52 2 47 111
M  V30 53 1 48 112
M  V30 54 1 49 50
M  V30 55 1 115 49 CFG=3
M  V30 56 1 115 51 CFG=1
M  V30 57 2 52 117
M  V30 58 1 53 54
M  V30 59 2 53 55
M  V30 60 1 53 56
M  V30 61 1 54 57
M  V30 62 2 54 58
M  V30 63 1 55 59
M  V30 64 1 56 60
M  V30 65 1 57 60
M  V30 66 2 57 61
M  V30 67 1 58 62
M  V30 68 1 59 62
M  V30 69 2 59 63
M  V30 70 1 60 64
M  V30 71 1 61 65
M  V30 72 2 62 66
M  V30 73 1 63 67
M  V30 74 1 64 68
M  V30 75 2 65 68
M  V30 76 1 65 69
M  V30 77 1 66 70
M  V30 78 2 67 70
M  V30 79 1 68 71
M  V30 80 1 69 72
M  V30 81 1 71 73
M  V30 82 1 72 73
M  V30 83 1 74 75
M  V30 84 1 74 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 1 77 79
M  V30 88 1 78 79
M  V30 89 2 80 81
M  V30 90 1 80 82
M  V30 91 1 81 83
M  V30 92 2 82 84
M  V30 93 2 83 85
M  V30 94 1 84 85
M  V30 95 2 86 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 2 88 90
M  V30 99 2 89 91
M  V30 100 1 90 91
M  V30 101 1 92 93
M  V30 102 1 92 94
M  V30 103 1 93 95
M  V30 104 1 94 96
M  V30 105 1 95 97
M  V30 106 1 96 97
M  V30 107 2 98 99
M  V30 108 1 98 100
M  V30 109 1 99 101
M  V30 110 1 99 102
M  V30 111 1 100 103
M  V30 112 2 100 104
M  V30 113 1 101 105
M  V30 114 2 101 106
M  V30 115 1 102 107
M  V30 116 1 103 106
M  V30 117 2 103 108
M  V30 118 1 104 109
M  V30 119 1 105 107
M  V30 120 2 105 110
M  V30 121 1 107 111
M  V30 122 1 108 112
M  V30 123 2 109 112
M  V30 124 1 110 113
M  V30 125 1 111 114
M  V30 126 2 113 114
M  V30 127 1 113 115
M  V30 128 1 114 116
M  V30 129 1 115 117
M  V30 130 1 116 118
M  V30 131 1 117 118
M  V30 132 1 119 120
M  V30 133 2 119 121
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 32 69 115)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C82H95F2N13O14.2CHO2
2735753-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  114 126 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 24.2126 19.2501 0.0 0
M  V30 2 O 29.0106 14.9300 0.0 0
M  V30 3 O 22.8789 24.6401 0.0 0
M  V30 4 C 21.5453 23.8701 0.0 0
M  V30 5 C 32.9020 19.5460 0.0 0
M  V30 6 C 33.9717 20.6538 0.0 0
M  V30 7 O 34.7106 18.7408 0.0 0
M  V30 8 F 25.5464 26.1801 0.0 0
M  V30 9 O 35.7632 16.9807 0.0 0
M  V30 10 N 24.2126 13.0900 0.0 0 CHG=1 VAL=4
M  V30 11 C 24.2126 11.5500 0.0 0
M  V30 12 C 25.7526 13.0900 0.0 0
M  V30 13 C 22.6726 13.0900 0.0 0
M  V30 14 N 18.8778 8.4700 0.0 0
M  V30 15 C 18.8778 6.9300 0.0 0
M  V30 16 C 17.5442 6.1600 0.0 0 CFG=2
M  V30 17 O 20.2116 6.1600 0.0 0
M  V30 18 N 17.5442 4.6200 0.0 0
M  V30 19 C 16.2105 6.9300 0.0 0
M  V30 20 C 16.2105 3.8500 0.0 0
M  V30 21 C 14.8769 4.6200 0.0 0
M  V30 22 O 16.2105 2.3100 0.0 0
M  V30 23 N 13.5431 3.8500 0.0 0
M  V30 24 C 12.2095 4.6200 0.0 0
M  V30 25 C 10.8758 3.8500 0.0 0
M  V30 26 N 9.5422 4.6200 0.0 0
M  V30 27 O 10.8758 2.3100 0.0 0
M  V30 28 C 8.2084 3.8500 0.0 0 CFG=1
M  V30 29 C 6.8747 4.6200 0.0 0
M  V30 30 C 8.2084 2.3100 0.0 0
M  V30 31 N 6.8747 6.1600 0.0 0
M  V30 32 O 5.5411 3.8500 0.0 0
M  V30 33 C 1.5400 9.2400 0.0 0
M  V30 34 N 1.5400 10.7800 0.0 0 CHG=1 VAL=4
M  V30 35 C 3.0800 10.7800 0.0 0
M  V30 36 C 0.0000 10.7800 0.0 0
M  V30 37 C 1.5400 16.9401 0.0 0
M  V30 38 O 0.2062 22.3301 0.0 0
M  V30 39 C 0.2062 23.8701 0.0 0
M  V30 40 O 6.3379 12.6200 0.0 0
M  V30 41 F 2.8736 23.8701 0.0 0
M  V30 42 C 10.2293 17.2360 0.0 0
M  V30 43 C 11.2990 18.3438 0.0 0
M  V30 44 O 12.0379 16.4308 0.0 0
M  V30 45 O 13.0905 14.6707 0.0 0
M  V30 46 C 26.8800 19.2501 0.0 0
M  V30 47 C 28.2136 20.0201 0.0 0
M  V30 48 C 25.5464 20.0201 0.0 0
M  V30 49 C 27.2002 17.7438 0.0 0
M  V30 50 C 29.3582 18.9896 0.0 0
M  V30 51 N 28.2136 21.5601 0.0 0
M  V30 52 C 25.5464 21.5601 0.0 0
M  V30 53 N 28.7317 17.5827 0.0 0
M  V30 54 C 30.8897 19.1506 0.0 0
M  V30 55 C 26.8800 22.3301 0.0 0
M  V30 56 C 24.2126 22.3301 0.0 0
M  V30 57 C 29.6369 16.3368 0.0 0
M  V30 58 C 31.7949 17.9047 0.0 0
M  V30 59 C 26.8800 23.8701 0.0 0
M  V30 60 C 24.2126 23.8701 0.0 0
M  V30 61 C 31.1684 16.4978 0.0 0
M  V30 62 C 33.3265 18.0656 0.0 0 CFG=1
M  V30 63 C 25.5464 24.6401 0.0 0
M  V30 64 C 32.0737 15.2519 0.0 0
M  V30 65 C 34.2317 16.8198 0.0 0
M  V30 66 O 33.6052 15.4128 0.0 0
M  V30 67 N 24.2126 17.7101 0.0 0
M  V30 68 C 25.5464 16.9401 0.0 0
M  V30 69 C 22.8789 16.9401 0.0 0
M  V30 70 C 25.5464 15.4001 0.0 0
M  V30 71 C 22.8789 15.4001 0.0 0
M  V30 72 C 24.2126 14.6300 0.0 0
M  V30 73 C 22.8789 10.7800 0.0 0
M  V30 74 C 21.5453 11.5500 0.0 0
M  V30 75 C 22.8789 9.2400 0.0 0
M  V30 76 C 20.2116 10.7800 0.0 0
M  V30 77 C 21.5453 8.4700 0.0 0
M  V30 78 C 20.2116 9.2400 0.0 0
M  V30 79 C 5.5411 6.9300 0.0 0
M  V30 80 C 5.5411 8.4700 0.0 0
M  V30 81 C 4.2074 6.1600 0.0 0
M  V30 82 C 4.2074 9.2400 0.0 0
M  V30 83 C 2.8736 6.9300 0.0 0
M  V30 84 C 2.8736 8.4700 0.0 0
M  V30 85 C 1.5400 12.3200 0.0 0
M  V30 86 C 0.2064 13.0900 0.0 0
M  V30 87 C 2.8736 13.0900 0.0 0
M  V30 88 C 0.2064 14.6300 0.0 0
M  V30 89 C 2.8736 14.6300 0.0 0
M  V30 90 N 1.5400 15.4001 0.0 0
M  V30 91 C 2.8736 17.7101 0.0 0
M  V30 92 C 4.2073 16.9401 0.0 0
M  V30 93 C 2.8736 19.2501 0.0 0
M  V30 94 C 5.5409 17.7101 0.0 0
M  V30 95 C 4.5275 15.4336 0.0 0
M  V30 96 C 4.2073 20.0201 0.0 0
M  V30 97 C 1.5400 20.0201 0.0 0
M  V30 98 C 6.6855 16.6796 0.0 0
M  V30 99 N 5.5409 19.2501 0.0 0
M  V30 100 N 6.0591 15.2727 0.0 0
M  V30 101 C 4.2073 21.5601 0.0 0
M  V30 102 C 1.5398 21.5601 0.0 0
M  V30 103 C 8.2170 16.8406 0.0 0
M  V30 104 C 6.9642 14.0268 0.0 0
M  V30 105 C 2.8736 22.3301 0.0 0
M  V30 106 C 9.1222 15.5947 0.0 0
M  V30 107 C 8.4959 14.1878 0.0 0
M  V30 108 C 10.6537 15.7556 0.0 0 CFG=1
M  V30 109 C 9.4010 12.9419 0.0 0
M  V30 110 C 11.5590 14.5098 0.0 0
M  V30 111 O 10.9326 13.1030 0.0 0
M  V30 112 C 17.8816 0.0000 0.0 0
M  V30 113 O 16.5479 0.7700 0.0 0 CHG=-1
M  V30 114 O 19.2153 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 48
M  V30 2 1 1 67
M  V30 3 2 2 57
M  V30 4 1 3 4
M  V30 5 1 3 60
M  V30 6 1 5 6
M  V30 7 1 62 5 CFG=1
M  V30 8 1 62 7 CFG=3
M  V30 9 1 8 63
M  V30 10 2 9 65
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 72
M  V30 15 1 11 73
M  V30 16 1 14 15
M  V30 17 1 14 78
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 16 19 CFG=1
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 28 29
M  V30 32 1 28 30 CFG=1
M  V30 33 1 29 31
M  V30 34 2 29 32
M  V30 35 1 31 79
M  V30 36 1 33 34
M  V30 37 1 33 84
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 34 85
M  V30 41 1 37 90
M  V30 42 1 37 91
M  V30 43 1 38 39
M  V30 44 1 38 102
M  V30 45 2 40 104
M  V30 46 1 41 105
M  V30 47 1 42 43
M  V30 48 1 108 42 CFG=1
M  V30 49 1 108 44 CFG=3
M  V30 50 2 45 110
M  V30 51 1 46 47
M  V30 52 2 46 48
M  V30 53 1 46 49
M  V30 54 1 47 50
M  V30 55 2 47 51
M  V30 56 1 48 52
M  V30 57 1 49 53
M  V30 58 1 50 53
M  V30 59 2 50 54
M  V30 60 1 51 55
M  V30 61 1 52 55
M  V30 62 2 52 56
M  V30 63 1 53 57
M  V30 64 1 54 58
M  V30 65 2 55 59
M  V30 66 1 56 60
M  V30 67 1 57 61
M  V30 68 2 58 61
M  V30 69 1 58 62
M  V30 70 1 59 63
M  V30 71 2 60 63
M  V30 72 1 61 64
M  V30 73 1 62 65
M  V30 74 1 64 66
M  V30 75 1 65 66
M  V30 76 1 67 68
M  V30 77 1 67 69
M  V30 78 1 68 70
M  V30 79 1 69 71
M  V30 80 1 70 72
M  V30 81 1 71 72
M  V30 82 2 73 74
M  V30 83 1 73 75
M  V30 84 1 74 76
M  V30 85 2 75 77
M  V30 86 2 76 78
M  V30 87 1 77 78
M  V30 88 2 79 80
M  V30 89 1 79 81
M  V30 90 1 80 82
M  V30 91 2 81 83
M  V30 92 2 82 84
M  V30 93 1 83 84
M  V30 94 1 85 86
M  V30 95 1 85 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 1 88 90
M  V30 99 1 89 90
M  V30 100 2 91 92
M  V30 101 1 91 93
M  V30 102 1 92 94
M  V30 103 1 92 95
M  V30 104 1 93 96
M  V30 105 2 93 97
M  V30 106 1 94 98
M  V30 107 2 94 99
M  V30 108 1 95 100
M  V30 109 1 96 99
M  V30 110 2 96 101
M  V30 111 1 97 102
M  V30 112 1 98 100
M  V30 113 2 98 103
M  V30 114 1 100 104
M  V30 115 1 101 105
M  V30 116 2 102 105
M  V30 117 1 103 106
M  V30 118 1 104 107
M  V30 119 2 106 107
M  V30 120 1 106 108
M  V30 121 1 107 109
M  V30 122 1 108 110
M  V30 123 1 109 111
M  V30 124 1 110 111
M  V30 125 1 112 113
M  V30 126 2 112 114
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 28 62 108)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2735753-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2735753-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24850117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugates of a cell-binding molecule with camptothecin analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Robert; Yang, Qingliang; Ye, Hangbo; Huang, Yuanyuan; Xu, Yifang;
Zhao, Gengxiang; Chen, Diancheng; Guo, Huihui; Kong, Xiangfei; Li,
Wenjun; Bai, Lu; Cai, Xiang; Zhang, Xiuzhen; Jia, Junxiang; Guo,
Zhixiang; Huang, Shangma; Wang, Xiaoxu; Zheng, Jun; Du, Yong; Li, Yanhua;
Zheng, Yunxia; Lin, Chen; Chen, Xiaoxiao; Zheng, Wei; Jiang, Xinyan;
Zhang, Lingli; Ye, Riping; Chen, Miaomiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021212638 A1 2021-10-28

$RFMT $RIREG SCHEME339 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-3-phenyl-2-[[(phenylmethoxy)amino]methyl]-2-propenoate
C18H19NO3
1000393-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 2.6673 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 O 4.6200 1.3336 0.0 0
M  V30 6 O 6.9300 2.6673 0.0 0
M  V30 7 N 6.9300 5.3347 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 O 7.7000 6.6684 0.0 0
M  V30 10 C 9.2400 6.6684 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 3.0800 6.6684 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 9.2400 9.3358 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 10.0100 10.6694 0.0 0
M  V30 21 C 12.3200 9.3358 0.0 0
M  V30 22 C 11.5500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-phenyl-2-[[(phenylmethoxy)amino]methyl]-2-propenoate
C18H19NO3
1000393-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 5.3900 1.3336 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 N 7.7000 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 O 9.2400 5.3347 0.0 0
M  V30 10 C 10.0100 6.6685 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 11.5500 6.6685 0.0 0
M  V30 18 C 12.3200 5.3347 0.0 0
M  V30 19 C 12.3200 8.0021 0.0 0
M  V30 20 C 13.8600 5.3347 0.0 0
M  V30 21 C 13.8600 8.0021 0.0 0
M  V30 22 C 14.6300 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-2-[[formyl(phenylmethoxy)amino]methyl]-3-phenyl-2-propenoate
C19H19NO4
1000393-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 C 6.9300 2.6673 0.0 0
M  V30 5 N 5.3900 5.3347 0.0 0
M  V30 6 O 7.7000 1.3336 0.0 0
M  V30 7 O 5.3900 2.6673 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 C 3.0800 6.6684 0.0 0
M  V30 12 O 3.0800 4.0011 0.0 0
M  V30 13 C 10.0100 5.3347 0.0 0
M  V30 14 C 11.5500 5.3347 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 12.3200 6.6684 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 11.5500 8.0021 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 3.0800 9.3358 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 2.3100 10.6694 0.0 0
M  V30 23 C 0.0000 9.3358 0.0 0
M  V30 24 C 0.7700 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 11 19
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000393-22-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1000393-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000393-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25606432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM E:Z = 80:20
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective hydrogenation of α-aminomethylacrylates containing a
free N-H group for the synthesis of β-amino acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiu, Liqin; Prashad, Mahavir; Hu, Bin; Prasad, Kapa; Repic, Oljan;
Blacklock, Thomas J.; Kwong, Fuk Yee; Kok, Stanton H. L.; Lee, Hang Wai;
Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2007), 104(43), 16787-16792

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl chloride
C7H7Cl
100-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 Cl 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetic acid
C8H8O2
103-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26962696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, sealed tube used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylation of benzyl chlorides:
Additive-controlled divergent synthesis of benzyl arylacetates and
arylacetic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Jin-Bao; Wang, Wei-Feng; Wu, Fu-Peng; Ying, Jun; Qi, Xinxin; Wu,
Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2018), 368275-278

$RFMT $RIREG SCHEME341 STEP1
$RXN



  4  1
$MOL
Isobutyraldehyde
C4H8O
78-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-isocyanobenzene
C7H4BrN
183209-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0 CHG=1 VAL=4
M  V30 2 C 6.1601 2.6673 0.0 0 CHG=-1
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromophenyl)-2-[formyl(phenylmethyl)amino]-3-methylbutanamide
C19H21BrN2O2
1001609-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 5.3348 0.0 0
M  V30 2 C 5.3901 5.3348 0.0 0
M  V30 3 C 7.7002 4.0012 0.0 0
M  V30 4 C 7.7002 6.6687 0.0 0
M  V30 5 C 4.6201 4.0012 0.0 0
M  V30 6 C 4.6201 6.6687 0.0 0
M  V30 7 O 6.9302 8.0023 0.0 0
M  V30 8 N 3.0801 4.0012 0.0 0
M  V30 9 O 5.3901 2.6675 0.0 0
M  V30 10 C 5.3901 8.0023 0.0 0
M  V30 11 C 3.0801 6.6687 0.0 0
M  V30 12 Br 0.0000 4.0012 0.0 0
M  V30 13 C 9.2402 4.0012 0.0 0
M  V30 14 C 10.0102 2.6675 0.0 0
M  V30 15 C 10.0102 5.3348 0.0 0
M  V30 16 C 11.5503 2.6675 0.0 0
M  V30 17 C 11.5503 5.3348 0.0 0
M  V30 18 C 12.3203 4.0012 0.0 0
M  V30 19 C 2.3101 2.6675 0.0 0
M  V30 20 C 0.7700 2.6675 0.0 0
M  V30 21 C 3.0801 1.3337 0.0 0
M  V30 22 C 0.0000 1.3337 0.0 0
M  V30 23 C 2.3101 0.0000 0.0 0
M  V30 24 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 13
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 19
M  V30 13 1 12 20
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-84-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 183209-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001609-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11388246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity oriented synthesis of benzoxazoles and benzothiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spatz, Julia H.; Bach, Thorsten; Umkehrer, Michael; Bardin, Julien; Ross,
Guenther; Burdack, Christoph; Kolb, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(51), 9030-9034

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-hydrazinylpyridine
C5H6BrN3
1019918-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 N 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 4 CFG=2
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-1,2,4-triazolo[4,3-a]pyridine
C6H4BrN3
832735-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 N 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 C 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 N 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1019918-39-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 832735-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-6275441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine A solution of
(4-bromo-pyridin-2-yl)-hydrazine (0.50 g) in formic acid (0.50 mL) is
stirred at reflux temperature overnight. After cooling to room
temperature, the solution was concentrated under reduced pressure. Water
was added to the residue and the resulting mixture was extracted with
ethyl acetate. The combined organic extracts were washed with brine,
dried (MgSO4), and concentrated to give the title compound. Yield: 0.52 g
(99% of theory). 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine, yield (0.52 g,
99% of theory) Mass spectrum (ESI+): m/z = 198/200 (Br) [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxazinanone derivatives as 11β-HSD1 inhibitors and their preparation and
use for the treatment of 11β-HSD1-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eckhardt, Matthias; Himmelsbach, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010089303 A1 2010-08-12

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-hydrazinyl-3-methylpyridine
C6H8BrN3
1019918-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 5 CFG=2
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-8-methyl-1,2,4-triazolo[4,3-a]pyridine
C7H6BrN3
2708292-17-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7036 0.0000 0.0 0
M  V30 2 Br 6.3710 1.5400 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 N 2.3699 3.8500 0.0 0
M  V30 5 C 3.7036 1.5400 0.0 0
M  V30 6 N 0.9052 1.8341 0.0 0
M  V30 7 C 3.7036 4.6200 0.0 0
M  V30 8 C 0.9052 4.3259 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 N 0.0000 3.0800 0.0 0
M  V30 11 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1019918-82-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2708292-17-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34248161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclic SHP2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ciammaichella, Alina; Di Fabio, Romano; Ferrigno, Federica; Fezzardi,
Paola; Montalbetti, Christian; Petrocchi, Alessia; Relitti, Nicola;
Rossetti, Ilaria; Sferrazza, Alessio; Torrente, Esther; Ferrante, Luca;
Grillo, Alessandro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022167682 A1 2022-08-11

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(cyanoamino)-4-(3-fluorophenyl)-1,4-dihydro-6-methyl-5-pyrimidinecarb...
C15H15FN4O2
1020851-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 2.6674 0.0 0
M  V30 3 O 3.0800 4.0011 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 N 7.7000 9.3358 0.0 0
M  V30 8 C 9.2400 9.3358 0.0 0
M  V30 9 N 10.7800 9.3358 0.0 0
M  V30 10 F 0.0000 9.3358 0.0 0
M  V30 11 C 4.6200 6.6684 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 N 5.3900 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 N 7.7000 6.6684 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 3 8 9
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-amino-4-(3-fluorophenyl)-1,4-dihydro-6-methyl-...
C14H16FN3O2.CH2O2
2087929-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 7.6447 0.0 0
M  V30 2 O 8.4700 7.6447 0.0 0
M  V30 3 O 6.1600 8.9785 0.0 0
M  V30 4 C 9.2400 8.9785 0.0 0
M  V30 5 C 10.7800 8.9785 0.0 0
M  V30 6 C 8.4700 4.9775 0.0 0
M  V30 7 N 3.8500 2.3100 0.0 0
M  V30 8 F 0.0000 8.9785 0.0 0
M  V30 9 C 4.6200 6.3111 0.0 0
M  V30 10 C 6.1600 6.3111 0.0 0
M  V30 11 N 3.8500 4.9775 0.0 0
M  V30 12 C 6.9300 4.9775 0.0 0
M  V30 13 C 4.6200 3.6437 0.0 0
M  V30 14 N 6.1600 3.6437 0.0 0
M  V30 15 C 3.8500 7.6447 0.0 0
M  V30 16 C 2.3100 7.6447 0.0 0
M  V30 17 C 4.6200 8.9785 0.0 0
M  V30 18 C 1.5400 8.9785 0.0 0
M  V30 19 C 3.8500 10.3122 0.0 0
M  V30 20 C 2.3100 10.3122 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 O 4.0563 0.7700 0.0 0
M  V30 23 O 6.7237 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1020851-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2087929-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29588095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Biginelli reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the synthesis of deceptively simple Biginelli products through
N-CN bond cleavage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fidencio, Juan Jesus Nolasco; Rios-Guerra, Hulme; Gonzalez-Villanueva,
Gilberto; Penieres-Carrillo, Jose Guillermo; Balcazar, Gustavo Guevara;
Nicolas-Vazquez, Ma. Ines; Delgado, Francisco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2016), 92(10), 1803-1809

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1R,4R)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]benzoate
C21H24N2O2
1024010-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2298 2.4282 0.0 0
M  V30 2 C 13.3563 5.9301 0.0 0
M  V30 3 O 14.6899 5.1600 0.0 0
M  V30 4 O 13.3563 7.4701 0.0 0
M  V30 5 C 16.0236 5.9301 0.0 0
M  V30 6 C 17.3574 5.1600 0.0 0
M  V30 7 C 6.5741 2.5203 0.0 0 CFG=1
M  V30 8 N 8.0214 2.8500 0.0 0
M  V30 9 C 5.8278 0.0000 0.0 0
M  V30 10 C 5.5136 3.4344 0.0 0
M  V30 11 C 7.1441 1.9036 0.0 0
M  V30 12 C 5.8968 1.4190 0.0 0 CFG=1
M  V30 13 N 4.7672 2.5175 0.0 0
M  V30 14 C 9.3551 3.6200 0.0 0
M  V30 15 C 10.6888 2.8500 0.0 0
M  V30 16 C 9.3551 5.1600 0.0 0
M  V30 17 C 12.0224 3.6200 0.0 0
M  V30 18 C 10.6888 5.9301 0.0 0
M  V30 19 C 12.0224 5.1600 0.0 0
M  V30 20 C 2.3837 3.7150 0.0 0
M  V30 21 C 3.0750 5.0910 0.0 0
M  V30 22 C 0.8461 3.6257 0.0 0
M  V30 23 C 2.2289 6.3779 0.0 0
M  V30 24 C 0.0000 4.9124 0.0 0
M  V30 25 C 0.6915 6.2886 0.0 0
M  V30 26 H 6.9457 4.0147 0.0 0
M  V30 27 H 4.4639 0.8544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 26 CFG=1
M  V30 12 1 8 11
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 1 12 27 CFG=3
M  V30 19 2 14 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 2 16 18
M  V30 23 2 17 19
M  V30 24 1 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(1R,4R)-2,5-diazabicyclo[2.2.1]hept-2-yl-, ethyl ester, forma...
C14H18N2O2.CH2O2
1024010-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2388 4.9775 0.0 0
M  V30 2 O 11.0088 3.6437 0.0 0
M  V30 3 O 11.0088 6.3112 0.0 0
M  V30 4 C 12.5488 3.6437 0.0 0
M  V30 5 C 13.3188 2.3100 0.0 0
M  V30 6 N 4.0786 4.9775 0.0 0
M  V30 7 C 2.6604 5.4156 0.0 0 CFG=1
M  V30 8 C 2.8457 4.5965 0.0 0
M  V30 9 C 0.7540 3.6063 0.0 0
M  V30 10 C 2.1990 6.7376 0.0 0
M  V30 11 C 1.5231 4.8006 0.0 0 CFG=2
M  V30 12 N 1.0942 6.3167 0.0 0
M  V30 13 C 5.6187 4.9775 0.0 0
M  V30 14 C 6.3887 6.3112 0.0 0
M  V30 15 C 6.3887 3.6437 0.0 0
M  V30 16 C 7.9287 6.3112 0.0 0
M  V30 17 C 7.9287 3.6437 0.0 0
M  V30 18 C 8.6987 4.9775 0.0 0
M  V30 19 H 3.7295 6.5240 0.0 0
M  V30 20 H 0.0000 5.0280 0.0 0
M  V30 21 C 6.6594 0.0000 0.0 0
M  V30 22 O 5.3257 0.7700 0.0 0
M  V30 23 O 7.9931 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 19 CFG=1
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 1 11 20 CFG=3
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024010-91-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024010-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-4481392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: ethyl 4-((1R.4R)-2.5-diazabicyclo[2.2.1]heptan-2-yl)benzoate
formate (208) Title compound 207 (0.32 g, 0.878 mmol) and Pd/C (0.093 g,
0.088 mmol) were combined in methanol (16.73 mL) and formic acid (0.836
mL). The reaction mixture was stirred at reflux for 2h. The mixture was
filtered and concentrated to afford title compound 208 (0.278 g, 99%) as
a clear oil. LRMS: (calc) 246.14 (found) 247.3 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclo[2.2.1]heptan-2-yl compounds as HDAC inhibitors
and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Shapiro, Gideon; Chantigny, Yves; Mancuso, John;
Deziel, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137503 A1 2009-11-12

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1R,4R)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]benzoate
C21H24N2O2
1024010-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2298 2.4282 0.0 0
M  V30 2 C 13.3563 5.9301 0.0 0
M  V30 3 O 14.6899 5.1600 0.0 0
M  V30 4 O 13.3563 7.4701 0.0 0
M  V30 5 C 16.0236 5.9301 0.0 0
M  V30 6 C 17.3574 5.1600 0.0 0
M  V30 7 C 6.5741 2.5203 0.0 0 CFG=1
M  V30 8 N 8.0214 2.8500 0.0 0
M  V30 9 C 5.8278 0.0000 0.0 0
M  V30 10 C 5.5136 3.4344 0.0 0
M  V30 11 C 7.1441 1.9036 0.0 0
M  V30 12 C 5.8968 1.4190 0.0 0 CFG=1
M  V30 13 N 4.7672 2.5175 0.0 0
M  V30 14 C 9.3551 3.6200 0.0 0
M  V30 15 C 10.6888 2.8500 0.0 0
M  V30 16 C 9.3551 5.1600 0.0 0
M  V30 17 C 12.0224 3.6200 0.0 0
M  V30 18 C 10.6888 5.9301 0.0 0
M  V30 19 C 12.0224 5.1600 0.0 0
M  V30 20 C 2.3837 3.7150 0.0 0
M  V30 21 C 3.0750 5.0910 0.0 0
M  V30 22 C 0.8461 3.6257 0.0 0
M  V30 23 C 2.2289 6.3779 0.0 0
M  V30 24 C 0.0000 4.9124 0.0 0
M  V30 25 C 0.6915 6.2886 0.0 0
M  V30 26 H 6.9457 4.0147 0.0 0
M  V30 27 H 4.4639 0.8544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 26 CFG=1
M  V30 12 1 8 11
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 1 12 27 CFG=3
M  V30 19 2 14 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 2 16 18
M  V30 23 2 17 19
M  V30 24 1 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(1R,4R)-2,5-diazabicyclo[2.2.1]hept-2-yl-, ethyl ester, forma...
C14H18N2O2.CH2O2
1024010-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2388 4.9775 0.0 0
M  V30 2 O 11.0088 3.6437 0.0 0
M  V30 3 O 11.0088 6.3112 0.0 0
M  V30 4 C 12.5488 3.6437 0.0 0
M  V30 5 C 13.3188 2.3100 0.0 0
M  V30 6 N 4.0786 4.9775 0.0 0
M  V30 7 C 2.6604 5.4156 0.0 0 CFG=1
M  V30 8 C 2.8457 4.5965 0.0 0
M  V30 9 C 0.7540 3.6063 0.0 0
M  V30 10 C 2.1990 6.7376 0.0 0
M  V30 11 C 1.5231 4.8006 0.0 0 CFG=2
M  V30 12 N 1.0942 6.3167 0.0 0
M  V30 13 C 5.6187 4.9775 0.0 0
M  V30 14 C 6.3887 6.3112 0.0 0
M  V30 15 C 6.3887 3.6437 0.0 0
M  V30 16 C 7.9287 6.3112 0.0 0
M  V30 17 C 7.9287 3.6437 0.0 0
M  V30 18 C 8.6987 4.9775 0.0 0
M  V30 19 H 3.7295 6.5240 0.0 0
M  V30 20 H 0.0000 5.0280 0.0 0
M  V30 21 C 6.6594 0.0000 0.0 0
M  V30 22 O 5.3257 0.7700 0.0 0
M  V30 23 O 7.9931 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 19 CFG=1
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 1 11 20 CFG=3
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024010-91-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024010-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-3758780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: ethyl 4-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzoate
formate (208). Title compound 207 (0.32 g, 0.878 mmol) and Pd/C (0.093 g,
0.088 mmol) were combined in methanol (16.73 mL) and formic acid (0.836
mL). The reaction mixture was stirred at reflux for 2h. The mixture was
filtered and concentrated to afford title compound 208 (0.278 g, 99%) as
a clear oil. LRMS: (calc) 246.14 (found) 247.3 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzo-fused 7-membered heterocyclic compounds and methods
for treating cognitive disorders using inhibitors of histone deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rogers, Kathryn; Patzke, Holger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137462 A2 2009-11-12

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1R,4R)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]benzoate
C21H24N2O2
1024010-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2298 2.4282 0.0 0
M  V30 2 C 13.3563 5.9301 0.0 0
M  V30 3 O 14.6899 5.1600 0.0 0
M  V30 4 O 13.3563 7.4701 0.0 0
M  V30 5 C 16.0236 5.9301 0.0 0
M  V30 6 C 17.3574 5.1600 0.0 0
M  V30 7 C 6.5741 2.5203 0.0 0 CFG=1
M  V30 8 N 8.0214 2.8500 0.0 0
M  V30 9 C 5.8278 0.0000 0.0 0
M  V30 10 C 5.5136 3.4344 0.0 0
M  V30 11 C 7.1441 1.9036 0.0 0
M  V30 12 C 5.8968 1.4190 0.0 0 CFG=1
M  V30 13 N 4.7672 2.5175 0.0 0
M  V30 14 C 9.3551 3.6200 0.0 0
M  V30 15 C 10.6888 2.8500 0.0 0
M  V30 16 C 9.3551 5.1600 0.0 0
M  V30 17 C 12.0224 3.6200 0.0 0
M  V30 18 C 10.6888 5.9301 0.0 0
M  V30 19 C 12.0224 5.1600 0.0 0
M  V30 20 C 2.3837 3.7150 0.0 0
M  V30 21 C 3.0750 5.0910 0.0 0
M  V30 22 C 0.8461 3.6257 0.0 0
M  V30 23 C 2.2289 6.3779 0.0 0
M  V30 24 C 0.0000 4.9124 0.0 0
M  V30 25 C 0.6915 6.2886 0.0 0
M  V30 26 H 6.9457 4.0147 0.0 0
M  V30 27 H 4.4639 0.8544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 26 CFG=1
M  V30 12 1 8 11
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 1 12 27 CFG=3
M  V30 19 2 14 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 2 16 18
M  V30 23 2 17 19
M  V30 24 1 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(1R,4R)-2,5-diazabicyclo[2.2.1]hept-2-yl-, ethyl ester, forma...
C14H18N2O2.CH2O2
1024010-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2388 4.9775 0.0 0
M  V30 2 O 11.0088 3.6437 0.0 0
M  V30 3 O 11.0088 6.3112 0.0 0
M  V30 4 C 12.5488 3.6437 0.0 0
M  V30 5 C 13.3188 2.3100 0.0 0
M  V30 6 N 4.0786 4.9775 0.0 0
M  V30 7 C 2.6604 5.4156 0.0 0 CFG=1
M  V30 8 C 2.8457 4.5965 0.0 0
M  V30 9 C 0.7540 3.6063 0.0 0
M  V30 10 C 2.1990 6.7376 0.0 0
M  V30 11 C 1.5231 4.8006 0.0 0 CFG=2
M  V30 12 N 1.0942 6.3167 0.0 0
M  V30 13 C 5.6187 4.9775 0.0 0
M  V30 14 C 6.3887 6.3112 0.0 0
M  V30 15 C 6.3887 3.6437 0.0 0
M  V30 16 C 7.9287 6.3112 0.0 0
M  V30 17 C 7.9287 3.6437 0.0 0
M  V30 18 C 8.6987 4.9775 0.0 0
M  V30 19 H 3.7295 6.5240 0.0 0
M  V30 20 H 0.0000 5.0280 0.0 0
M  V30 21 C 6.6594 0.0000 0.0 0
M  V30 22 O 5.3257 0.7700 0.0 0
M  V30 23 O 7.9931 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 19 CFG=1
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 1 11 20 CFG=3
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024010-91-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1024010-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-253008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: ethyl 4-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzoate
formate (208) Title compound 207 (0.32 g, 0.878 mmol) and Pd/C (0.093 g,
0.088 mmol) were combined in methanol (16.73 mL) and formic acid (0.836
mL). The reaction mixture was stirred at reflux for 2h. The mixture was
filtered and concentrated to afford title compound 208 (0.278 g, 99%) as
a clear oil. ethyl 4-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzoate
formate, yield 0.278 g, 99%. LRMS: (calc) 246.14 (found) 247.3 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic hydroxamic acids as inhibitors of histone
deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shapiro, Gideon; Moncuso, John; Pierre, Tessier; Leit, Silvana; Deziel,
Robert; David, Smil; Richard, Chesworth; Chantigny, Yves Andre; Patrick,
Beaulieu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008055068 A2 2008-05-08

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl (3S,5S)-5-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-5-met...
C30H38N2O4SSi
1040396-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 7.5451 0.0 0
M  V30 2 O 6.1600 7.5451 0.0 0
M  V30 3 C 4.6200 6.0051 0.0 0
M  V30 4 C 6.9300 6.2114 0.0 0
M  V30 5 C 3.0800 6.0051 0.0 0
M  V30 6 C 4.6200 4.4651 0.0 0
M  V30 7 C 6.1600 6.0051 0.0 0
M  V30 8 C 8.3091 7.7430 0.0 0
M  V30 9 C 6.9754 3.9098 0.0 0
M  V30 10 O 5.6416 4.6798 0.0 0
M  V30 11 C 12.2780 5.0369 0.0 0
M  V30 12 O 13.1832 6.2827 0.0 0
M  V30 13 O 12.9043 3.6301 0.0 0
M  V30 14 C 14.7147 6.1218 0.0 0
M  V30 15 C 15.3410 4.7150 0.0 0
M  V30 16 C 15.6199 7.3677 0.0 0
M  V30 17 C 3.0800 7.5451 0.0 0
M  V30 18 C 2.3100 8.8787 0.0 0
M  V30 19 C 2.3100 6.2114 0.0 0
M  V30 20 C 0.7700 8.8787 0.0 0
M  V30 21 C 0.7700 6.2114 0.0 0
M  V30 22 C 0.0000 7.5451 0.0 0
M  V30 23 C 4.6200 9.0851 0.0 0
M  V30 24 C 3.2864 9.8551 0.0 0
M  V30 25 C 5.9536 9.8551 0.0 0
M  V30 26 C 3.2864 11.3951 0.0 0
M  V30 27 C 5.9536 11.3951 0.0 0
M  V30 28 C 4.6200 12.1651 0.0 0
M  V30 29 C 8.4700 6.2114 0.0 0 CFG=2
M  V30 30 N 8.3091 4.6798 0.0 0
M  V30 31 C 9.9764 6.5316 0.0 0
M  V30 32 N 9.7159 4.0534 0.0 0
M  V30 33 C 10.7464 5.1980 0.0 0 CFG=1
M  V30 34 C 6.9754 2.3698 0.0 0
M  V30 35 C 8.2213 1.4647 0.0 0
M  V30 36 S 5.7294 1.4647 0.0 0
M  V30 37 C 7.7454 0.0000 0.0 0
M  V30 38 C 6.2054 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 1 23
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 29 4 CFG=3
M  V30 10 1 29 8 CFG=1
M  V30 11 2 9 10
M  V30 12 1 9 30
M  V30 13 1 9 34
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 33 11 CFG=1
M  V30 17 1 12 14
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Methylethyl (3S,5S)-5-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-2-for...
C31H38N2O5SSi
1040396-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 4.6200 6.1600 0.0 0
M  V30 4 C 6.9300 5.9536 0.0 0
M  V30 5 C 6.1600 6.1600 0.0 0
M  V30 6 C 4.6200 7.7000 0.0 0
M  V30 7 C 3.0800 6.1600 0.0 0
M  V30 8 C 8.3091 4.4221 0.0 0
M  V30 9 C 6.9754 8.2553 0.0 0
M  V30 10 O 5.6416 7.4853 0.0 0
M  V30 11 C 10.0360 9.6179 0.0 0
M  V30 12 O 11.5007 10.0939 0.0 0
M  V30 13 C 12.2780 7.1282 0.0 0
M  V30 14 O 13.1832 5.8823 0.0 0
M  V30 15 O 12.9043 8.5350 0.0 0
M  V30 16 C 14.7147 6.0433 0.0 0
M  V30 17 C 15.3410 7.4501 0.0 0
M  V30 18 C 15.6199 4.7974 0.0 0
M  V30 19 C 3.0800 4.6200 0.0 0
M  V30 20 C 2.3100 3.2864 0.0 0
M  V30 21 C 2.3100 5.9536 0.0 0
M  V30 22 C 0.7700 3.2864 0.0 0
M  V30 23 C 0.7700 5.9536 0.0 0
M  V30 24 C 0.0000 4.6200 0.0 0
M  V30 25 C 4.6200 3.0800 0.0 0
M  V30 26 C 5.9536 2.3100 0.0 0
M  V30 27 C 3.2864 2.3100 0.0 0
M  V30 28 C 5.9536 0.7700 0.0 0
M  V30 29 C 3.2864 0.7700 0.0 0
M  V30 30 C 4.6200 0.0000 0.0 0
M  V30 31 C 8.4700 5.9536 0.0 0 CFG=2
M  V30 32 N 8.3091 7.4853 0.0 0
M  V30 33 C 9.9764 5.6335 0.0 0
M  V30 34 N 9.7159 8.1116 0.0 0
M  V30 35 C 10.7464 6.9671 0.0 0 CFG=1
M  V30 36 C 6.9754 9.7953 0.0 0
M  V30 37 C 5.7294 10.7004 0.0 0
M  V30 38 S 8.2213 10.7004 0.0 0
M  V30 39 C 6.2054 12.1651 0.0 0
M  V30 40 C 7.7454 12.1651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 31 4 CFG=1
M  V30 10 1 31 8 CFG=3
M  V30 11 2 9 10
M  V30 12 1 9 32
M  V30 13 1 9 36
M  V30 14 2 11 12
M  V30 15 1 11 34
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 35 13 CFG=3
M  V30 19 1 14 16
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1040396-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1040396-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3557858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a round bottom flask charged with formic acid (0.270 mL, 6.27 mmol)
was added acetic anhydride (0.590 mL, 6.27 mmol) dropwise and the
resulting mixture was stirred for 15 min at 40 °C to give mixed
formic-acetic anhydride.3 To a cooled (0 °C) solution of pyrazolidine
ent-12 (0.690 g, 1.25 mmol) in methylene chloride (6.5 mL) was added the
mixed anhydride dropwise via syringe and the reaction mixture was stirred
at room temperature for 24 h. The reaction was diluted with methylene
chloride (10 mL) and quenched by the dropwise addition of saturated
aqueous NaHCO3 (20 mL). The layers were separated and the aqueous layer
was extracted with methylene chloride (3 x 20 mL). The combined organic
fractions were dried (MgSO4), filtered and concentrated under reduced
pressure to give the target compound (0.715 g, 99%) as a foamy white
solid. Pyrazolidine 13 was sufficiently pure by NMR and was used without
further purification. [α]23D = - 124.6° (c 1.48, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 8.29 (s, 1H, NCHO), 8.08 (d, J = 2.9 Hz, 1H, Ar-H), 7.64-7.61
(m, 4H, Ar-H), 7.52 (d, J = 4.6 Hz, 1H, Ar-H), 7.45-7.37 (m, 6H, Ar-H),
7.07 (d, J = 4.1 Hz, 1H, Ar-H), 5.21 (br d, J = 8.8 Hz, 1H, NCHCH2), 5.10
(septet, J = 6.2 Hz, 1H, (CH3)2CHO), 4.36 (br d, J = 10.2, 1H,
CCH2OTBDPS), 3.58 (br d, J = 10.2, 1H, CCH2OTBDPS), 2.91 (br dd, J =
12.1, 12.1 Hz, 1H, CHCH2CH), 2.35 (br d, J = 12.7 Hz, 1H, CHCH2CH), 1.54
(s, 3H, CHCH3), 1.24 (d, J = 6.2, 3H, (CH3)2CHO), 1.20 (d, J = 6.2, 3H,
(CH3)2CHO), 1.05 (s, 9H, SiC(CH3)3)13C NMR (100 MHz, CDCl3) δ169.3,
169.1, 159.8, 136.5, 135.6, 135.4, 133.8, 132.6, 131.9, 130.0, 129.9,
127.93, 127.90, 127.3, 70.1, 67.7, 56.7, 39.7, 26.9, 21.6, 20.9, 19.2; IR
(Thin Film) 3420, 3054, 2985, 2934, 2860, 1734, 1709, 1628, 1423, 1386,
1266, 1104, 739, 705 cm-1; HRMS (FAB+) calc'd for C31H39N2O5SSi ([M +
H]+): 579.2349, Found 579.2343 ([M + H]+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Efficient Asymmetric Synthesis of Manzacidin C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Kristy; Lombardi, Pamela J.; Leighton, James L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(14), 3165-3167

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzyl chloride
C7H6Cl2
104-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)acetic acid
C8H7ClO2
1878-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29102451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylation of benzyl chlorides:
Additive-controlled divergent synthesis of benzyl arylacetates and
arylacetic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Jin-Bao; Wang, Wei-Feng; Wu, Fu-Peng; Ying, Jun; Qi, Xinxin; Wu,
Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2018), 368275-278

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21733608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 439937-65-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, alternative preparation shown,alternate
reaction conditions gave lower yield,product obtained as mixture of
rotamers with ratio 3:1,no solvent,ionic liquid used as
catalyst,recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reusable Bronsted Acidic Ionic Liquid Efficiently Catalyzed N-Formylation
and N-Acylation of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Chun; Wang, Mengna; Lu, Xunhua; Zhang, Ling; Jiang, Jian; Zhang, Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2020), 8(11), 4353-4361

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4579413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1343-93-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM phosphotungstic acid supported on silica-coated cobalt ferrite (CoFe2O4)
(magnetic nanoparticles)
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, no solvent, Phosphotungstic
acid supported on silica-coated CoFe2O4 nanoparticles used as a catalyst,
catalyst prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphotungstic acid supported on silica-coated CoFe2O4 nanoparticles: An
efficient and magnetically-recoverable catalyst for N-formylation of
amines under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kooti, M.; Nasiri, E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2015), 406168-177

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5311269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of 4-bromoaniline (17.1 g, 100
mmol) and 98 % formic acid (7.7 ml, 200 mmol) in 60 ml toluene is
refluxed under a condenser attached to a water separator. After the
reaction was complete, volatile materials were removed by evaporation.
Intremediate product of 1h, Yield: Quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multicomponent Cascade Cycloaddition Involving Tropone, Allenoate, and
Isocyanide: A Rapid Access to a 7,6,5-Fused Tricyclic Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Shuanglong; Su, Shikuan; Li, Chunju; Jia, Xueshun; Li, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(21), 5604-5607

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2740993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nanoceria-catalyzed highly efficient procedure for N-formylation of
amines at room temperature under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patil, Umakant B.; Singh, Abhilash S.; Nagarkar, Jayashree M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2013), 42(5), 524-526

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15263696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM water separator used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Silver hexafluoroantimonate-catalyzed three-component [2+2+1]
cycloadditions of allenoates, dual activated olefins, and isocyanides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Jian; Liu, Yue-Jin; Li, Chun-Ju; Jia, Xue-Shun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2011), 353(6), 913-917

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-724335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, 5 wt% sulfated
titania [TiO2 - SO4(2-)] used as catalyst, other catalyst (TiO2-P25) gave
lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient method for the N-formylation of amines at room temperature
using TiO2-P25 or sulfated titania
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krishnakumar, B.; Swaminathan, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2011), 334(1-2), 98-102

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)aniline
C7H9NS
104-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-4-(methylthio)benzenamine
C9H13NS
2388-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2388-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25651994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-53-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6737-42-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 11057-89-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, conversion >99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General catalytic methylation of amines with formic acid under mild
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorribes, Ivan; Junge, Kathrin; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(26), 7878-7883

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3659717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of 4-bromoaniline (17.1 g, 100
mmol) and 98 % formic acid (7.7 ml, 200 mmol) in 60 ml toluene is
refluxed under a condenser attached to a water separator. After the
reaction was complete, volatile materials were removed by evaporation.
4-bromo-1-formanilide, Yield: Quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multicomponent Cascade Cycloaddition Involving Tropone, Allenoate, and
Isocyanide: A Rapid Access to a 7,6,5-Fused Tricyclic Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Shuanglong; Su, Shikuan; Li, Chunju; Jia, Xueshun; Li, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(21), 5604-5607

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11836552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alkyne matrix metalloproteinase inhibitors for treatment
of cancer and arthritis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bunker, Amy Mae; Harter, William Glen; Hicks, James Lester; O'Brien,
Patrick Michael; Pham, Ly Thi; Picard, Joseph Armand; Roark, William
Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003032999 A1 2003-04-24

$RFMT $RIREG SCHEME351 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorophenol
C6H5ClO
106-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thianthrenium, 5-(4-methoxyphenyl)-, 1,1,1-trifluoromethanesulfonate (1:1)
C19H15OS2.CF3O3S
2489620-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 12.3200 0.0 0
M  V30 2 C 10.6694 11.5500 0.0 0
M  V30 3 S 4.0011 9.2400 0.0 0 CHG=1 VAL=3
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 2.6673 10.0100 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 1.3336 9.2400 0.0 0
M  V30 9 C 2.6673 11.5500 0.0 0
M  V30 10 S 1.3336 7.7000 0.0 0
M  V30 11 C 2.6673 5.3900 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 0.0000 10.0100 0.0 0
M  V30 14 C 1.3336 12.3200 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 0.0000 11.5500 0.0 0
M  V30 17 C 5.3347 10.0100 0.0 0
M  V30 18 C 6.6684 9.2400 0.0 0
M  V30 19 C 5.3347 11.5500 0.0 0
M  V30 20 C 8.0021 10.0100 0.0 0
M  V30 21 C 6.6684 12.3200 0.0 0
M  V30 22 C 8.0021 11.5500 0.0 0
M  V30 23 C 4.5647 1.5400 0.0 0
M  V30 24 S 6.1047 1.5400 0.0 0 VAL=6
M  V30 25 F 3.7947 2.8736 0.0 0
M  V30 26 F 3.0247 1.5400 0.0 0
M  V30 27 F 3.7947 0.2064 0.0 0
M  V30 28 O 6.1047 3.0800 0.0 0
M  V30 29 O 6.1047 0.0000 0.0 0
M  V30 30 O 7.6447 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 2 24 28
M  V30 31 2 24 29
M  V30 32 1 24 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-methoxy-, 4-chlorophenyl ester
C14H11ClO3
29558-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 O 6.1601 4.0010 0.0 0
M  V30 4 O 13.0903 2.6673 0.0 0
M  V30 5 C 13.8603 4.0010 0.0 0
M  V30 6 Cl 0.0000 1.3337 0.0 0
M  V30 7 C 8.4702 2.6673 0.0 0
M  V30 8 C 9.2402 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 10.7802 4.0010 0.0 0
M  V30 11 C 10.7802 1.3337 0.0 0
M  V30 12 C 11.5503 2.6673 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 3.8501 2.6673 0.0 0
M  V30 15 C 3.8501 0.0000 0.0 0
M  V30 16 C 2.3101 2.6673 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2489620-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29558-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33647059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective in stage 3, Schlenk tube used in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of Esters from Arenes through C-H
Thianthrenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Mengning; Zhang, Xiaomei; Ma, Mengtao; Zhao, Binlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(32), 6031-6036

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 13-hydroxy-13-[3-nitro-4-(phenylmethoxy)phenyl]-11-(phenylm...
C33H43N3O8
1068147-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 12.0034 0.0 0
M  V30 2 C 3.0800 13.3370 0.0 0
M  V30 3 N 0.7700 9.3359 0.0 0 VAL=5
M  V30 4 O 0.0000 8.0022 0.0 0
M  V30 5 O 0.0000 10.6695 0.0 0
M  V30 6 C 5.3901 6.6686 0.0 0
M  V30 7 C 6.9301 6.6686 0.0 0
M  V30 8 O 4.6201 5.3348 0.0 0
M  V30 9 N 7.7001 5.3348 0.0 0
M  V30 10 C 6.9301 4.0011 0.0 0
M  V30 11 C 9.2401 5.3348 0.0 0
M  V30 12 C 10.0101 6.6686 0.0 0
M  V30 13 O 11.5501 6.6686 0.0 0
M  V30 14 C 12.3201 8.0022 0.0 0
M  V30 15 C 13.8602 8.0022 0.0 0
M  V30 16 O 14.6302 9.3359 0.0 0
M  V30 17 C 16.1702 9.3359 0.0 0
M  V30 18 C 16.9402 10.6695 0.0 0
M  V30 19 N 18.4802 10.6695 0.0 0
M  V30 20 C 19.2502 12.0034 0.0 0
M  V30 21 O 20.7902 12.0034 0.0 0
M  V30 22 O 18.4802 13.3370 0.0 0
M  V30 23 C 21.5602 13.3370 0.0 0
M  V30 24 C 22.8939 12.5670 0.0 0
M  V30 25 C 22.3302 14.6707 0.0 0
M  V30 26 C 20.2266 14.1070 0.0 0
M  V30 27 C 3.0800 10.6695 0.0 0
M  V30 28 C 2.3100 9.3359 0.0 0
M  V30 29 C 4.6201 10.6695 0.0 0
M  V30 30 C 3.0800 8.0022 0.0 0
M  V30 31 C 5.3901 9.3359 0.0 0
M  V30 32 C 4.6201 8.0022 0.0 0
M  V30 33 C 2.3100 14.6707 0.0 0
M  V30 34 C 3.0800 16.0043 0.0 0
M  V30 35 C 0.7700 14.6707 0.0 0
M  V30 36 C 2.3100 17.3381 0.0 0
M  V30 37 C 0.0000 16.0043 0.0 0
M  V30 38 C 0.7700 17.3381 0.0 0
M  V30 39 C 7.7001 2.6675 0.0 0
M  V30 40 C 6.9301 1.3338 0.0 0
M  V30 41 C 9.2401 2.6675 0.0 0
M  V30 42 C 7.7001 0.0000 0.0 0
M  V30 43 C 10.0101 1.3338 0.0 0
M  V30 44 C 9.2401 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 33
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 28
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 32
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 39
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 41 2 39 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 2 41 43
M  V30 45 2 42 44
M  V30 46 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 13-[3-(formylamino)-4-(phenylmethoxy)phenyl]-13-hydroxy-11-...
C34H45N3O7
1068147-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 9.3358 0.0 0
M  V30 2 C 1.5400 8.0021 0.0 0
M  V30 3 O 0.0000 8.0021 0.0 0
M  V30 4 O 3.8500 12.0032 0.0 0
M  V30 5 C 4.6200 13.3369 0.0 0
M  V30 6 C 6.9300 6.6685 0.0 0
M  V30 7 C 8.4700 6.6685 0.0 0
M  V30 8 O 6.1600 5.3347 0.0 0
M  V30 9 N 9.2400 5.3347 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 11.5500 6.6685 0.0 0
M  V30 13 O 13.0900 6.6685 0.0 0
M  V30 14 C 13.8600 8.0021 0.0 0
M  V30 15 C 15.4000 8.0021 0.0 0
M  V30 16 O 16.1700 9.3358 0.0 0
M  V30 17 C 17.7100 9.3358 0.0 0
M  V30 18 C 18.4800 10.6694 0.0 0
M  V30 19 N 20.0200 10.6694 0.0 0
M  V30 20 C 20.7900 12.0032 0.0 0
M  V30 21 O 22.3300 12.0032 0.0 0
M  V30 22 O 20.0200 13.3369 0.0 0
M  V30 23 C 23.1000 13.3369 0.0 0
M  V30 24 C 21.7664 14.1069 0.0 0
M  V30 25 C 23.8700 14.6705 0.0 0
M  V30 26 C 24.4336 12.5669 0.0 0
M  V30 27 C 3.8500 9.3358 0.0 0
M  V30 28 C 4.6200 10.6694 0.0 0
M  V30 29 C 4.6200 8.0021 0.0 0
M  V30 30 C 6.1600 10.6694 0.0 0
M  V30 31 C 6.1600 8.0021 0.0 0
M  V30 32 C 6.9300 9.3358 0.0 0
M  V30 33 C 3.8500 14.6705 0.0 0
M  V30 34 C 4.6200 16.0041 0.0 0
M  V30 35 C 2.3100 14.6705 0.0 0
M  V30 36 C 3.8500 17.3379 0.0 0
M  V30 37 C 1.5400 16.0041 0.0 0
M  V30 38 C 2.3100 17.3379 0.0 0
M  V30 39 C 9.2400 2.6674 0.0 0
M  V30 40 C 8.4700 1.3338 0.0 0
M  V30 41 C 10.7800 2.6674 0.0 0
M  V30 42 C 9.2400 0.0000 0.0 0
M  V30 43 C 11.5500 1.3338 0.0 0
M  V30 44 C 10.7800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 33
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 31
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 39
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 41 2 39 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 2 41 43
M  V30 45 2 42 44
M  V30 46 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1068147-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1068147-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-5530325
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-Butyl
2-(Benzyl(2-(4-(benzyloxy)-3-formamidophenyl)hydroxyethyl)
amino)ethylcarbamate (9a). Acetic anhydride (1.02 mL, 10.8 mol) was added
to formic acid (406 μL, 10.8 mol) at 0 °C, and the solution was stirred
at 60 °C for 15 min. After cooling to 0 °C, a solution of 8a (240 mg,
0.49 mmol) in CH2Cl2 (15 mL) was added, and the reaction was stirred at
room temperature for 1 h under argon. The solvent was removed under
reduced pressure, and the residue was redissolved in methanol (15 mL). To
the solution was added 1 M NaOH (1.47 mL, 1.47 mmol), and the mixture was
left to stir for 30 min. The solvent was removed, and the residue was
redissolved in ethyl acetate, washed with water, and dried over MgSO4 to
yield the title compound (230 mg, 91% yield) as a yellow oil. tert-Butyl
2-(2-(2-(Benzyl(2-(4-(benzyloxy)-3-formamidophenyl)-
hydroxyethyl)amino)ethoxy)ethoxy)ethylcarbamate (15). The title compound
was prepared using the same method that was described for 9a. The product
was obtained as a light-yellow oil in 99% yield. 1H NMR (MeOD, δ): 1.39
(s, 9H, 3 × CH3), 2.65-2.90 (m, 4H, 2 × CH2), 3.20 (t, 2H, J = 5.4, CH2),
3.44-3.63 (m, 8H, 4 × CH2), 3.72, 3.81 (d, 2H, J = 13.5, CH2), 4.61 (t,
1H, J = 6.6, CH), 5.17 (s, 2H, CH2), 6.95-7.13 (m, 2H, ArH), 7.15-7.51
(m, 10H, ArH), 8.19 (s, 1H, ArH), 8.32 (s, 1H, CHO). 13C NMR (MeOD, δ):
28.8, 41.3, 54.7, 60.7, 63.6, 70.0, 71.1, 71.2, 71.3 or (2C at 71.2),
71.7, 71.9, 80.0 113.2, 120.6, 123.5, 127.9, 128.3, 128.8, 129.1, 129.4,
129.6, 130.4, 136.6, 138.1, 139.7, 148.6, 158.3, 162.0. LCMS
(hydrophilic): Rf (min) ) 8.71, (ESI + ve) found 608 [M + H]+ calcd for
C34H46N3O7.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Bivalent β2-Adrenergic and Adenosine A1 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karellas, Peter; McNaughton, Michael; Baker, Stephen P.; Scammells, Peter
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(19), 6128-6137

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-2,3,5,6,7,8-hexahydro-2-mercapto[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H13N3OS2
1083353-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3200 0.0000 0.0 0
M  V30 2 N 7.4001 0.0000 0.0 0
M  V30 3 S 8.9401 2.6673 0.0 0
M  V30 4 C 4.3200 2.6673 0.0 0
M  V30 5 C 2.8138 2.9876 0.0 0
M  V30 6 C 5.0901 4.0011 0.0 0
M  V30 7 C 5.0901 1.3337 0.0 0
M  V30 8 C 2.6527 4.5192 0.0 0
M  V30 9 C 1.5679 2.0824 0.0 0
M  V30 10 S 4.0596 5.1455 0.0 0
M  V30 11 N 6.6301 4.0011 0.0 0
M  V30 12 N 6.6301 1.3337 0.0 0
M  V30 13 C 1.2459 5.1455 0.0 0
M  V30 14 C 0.1609 2.7087 0.0 0
M  V30 15 C 7.4001 2.6673 0.0 0
M  V30 16 C 0.0000 4.2403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3a,4,6,7,8,9-Hexahydro-10H-[1]benzothieno[2,3-d][1,3,4]thiadiazolo[3,2-a]pyri...
C11H11N3OS2
1252794-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8614 0.0000 0.0 0
M  V30 2 C 4.5278 2.3100 0.0 0
M  V30 3 C 4.5278 3.8500 0.0 0
M  V30 4 C 3.0631 1.8341 0.0 0
M  V30 5 C 5.8614 1.5400 0.0 0
M  V30 6 S 3.0631 4.3259 0.0 0
M  V30 7 N 5.8614 4.6200 0.0 0
M  V30 8 C 2.1580 3.0800 0.0 0
M  V30 9 C 2.4367 0.4272 0.0 0
M  V30 10 N 7.1952 2.3100 0.0 0
M  V30 11 C 7.1952 3.8500 0.0 0
M  V30 12 C 0.6263 2.9191 0.0 0
M  V30 13 C 0.9052 0.2663 0.0 0
M  V30 14 N 8.6597 1.8341 0.0 0
M  V30 15 S 8.6597 4.3259 0.0 0
M  V30 16 C 0.0000 1.5121 0.0 0
M  V30 17 C 9.5650 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1083353-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1252794-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-310-CAS-12787589
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimicrobial activity of some 1,3,4-thiadiazoles and
1,3,4-thiadiazines of
3-amino-2-mercapto-5,6,7,8-tetrahydrobenzothieno[2,4-d]pyrimidin-4(3H)-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Visagaperumal, D.; Anbalagan, N.; Kumar, T. V. Kiran; Krishnanjaneyulu,
M.; Ambika, K.; Madhuri, D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Chemical Sciences (2009), 7(4), 2647-2654

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
4-(Tetrahydro-4-hydroxy-2H-pyran-4-yl)benzonitrile
C12H13NO2
1085453-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.8943 4.0231 0.0 0
M  V30 2 C 8.7869 2.5065 0.0 0
M  V30 3 N 10.3269 2.5065 0.0 0
M  V30 4 C 2.6269 2.5065 0.0 0
M  V30 5 C 1.1798 3.0332 0.0 0
M  V30 6 C 2.8943 0.9899 0.0 0
M  V30 7 C 0.0000 2.0433 0.0 0
M  V30 8 C 1.7146 0.0000 0.0 0
M  V30 9 O 0.2675 0.5267 0.0 0
M  V30 10 C 4.1669 2.5065 0.0 0
M  V30 11 C 4.9369 1.1729 0.0 0
M  V30 12 C 4.9369 3.8401 0.0 0
M  V30 13 C 6.4769 1.1729 0.0 0
M  V30 14 C 6.4769 3.8401 0.0 0
M  V30 15 C 7.2469 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 3 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-hydroxy-4-(tetrahydro-4-hydroxy-2H-pyran-4-yl)benz...
C12H16N2O3.CH2O2
1085453-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0231 8.1097 0.0 0
M  V30 2 C 8.3680 3.8500 0.0 0
M  V30 3 N 9.7018 4.6200 0.0 0
M  V30 4 N 8.3680 2.3100 0.0 0
M  V30 5 O 11.0354 3.8500 0.0 0
M  V30 6 C 3.0332 6.9301 0.0 0
M  V30 7 C 2.0433 8.1097 0.0 0
M  V30 8 C 2.5065 5.4829 0.0 0
M  V30 9 C 0.5267 7.8424 0.0 0
M  V30 10 C 0.9899 5.2154 0.0 0
M  V30 11 O 0.0000 6.3952 0.0 0
M  V30 12 C 4.3670 6.1600 0.0 0
M  V30 13 C 5.7007 6.9301 0.0 0
M  V30 14 C 4.3670 4.6200 0.0 0
M  V30 15 C 7.0343 6.1600 0.0 0
M  V30 16 C 5.7007 3.8500 0.0 0
M  V30 17 C 7.0343 4.6200 0.0 0
M  V30 18 C 5.5177 0.0000 0.0 0
M  V30 19 O 4.1840 0.7700 0.0 0
M  V30 20 O 6.8514 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1085453-54-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1085453-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-3347326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 5470-11-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: Preparation of
N'-Hydroxy-4-(4-hydroxytetrahydro-2H-pyran-4-yl)benzene-carboximidamide
hydroformiate A solution of
4-(4-hydroxytetrahydro-2H-pyran-4-yl)benzonitrile (Step 1, 200 mg, 0.984
mmol), hydroxylamine hydrochloride (150 mg, 2.17 mmol) and triethylamine
(219 mg, 2.17 mmol) in ethanol (5 mL) was stirred and heated at reflux
for 4 h. After being cooled to rt, the reaction mixture as such was
subjected to preparative HPLC, affording the pure title compound (278 mg,
99%)
N'-Hydroxy-4-(4-hydroxytetrahydro-2H-pyran-4-yl)benzene-carboximidamide
hydroformiate, yield (278 mg, 99%) 1H NMR (500 MHz, DMSO-d6) 5 9.71
(broad, 1H), 9.58 (s, 1H), 7.62 (d, 2H), 7.48 (d, 2H), 7.22 (broad, 1H),
5.78 (s, 2H), 5.07 (s, 1H), 3.80-3.75 (m, 2H), 3.72-3.68 (m, 2H),
2.00-1.93 (m, 2H), 1.53-1.49 (m, 2H); ES-MS m/z 237 (MH)+; HPLC RT
(Method F) 0.72 min.
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaryl-substituted pyrazole derivatives useful for treating
hyperproliferative disorders and diseases associated with angiogenesis
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boyer, Stephen; Haerter, Michael; Wickens, Philip; Patel, Manoj;
Kumarasinghe, Ellalahewage Sathyajith; Bhargava, Ajay Kumar; Thierauch,
Karl-Heinz; Beck, Hartmut; Greschat, Susanne; Ellinghaus, Peter; Paulus,
Patrick; Hess-Stumpp, Holger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008141731 A2 2008-11-27

$RFMT $RIREG SCHEME355 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol
C6H6O
108-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Iodocyclohexene
C6H9I
17497-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl 1-cyclohexene-1-carboxylate
C13H14O2
91909-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 O 4.6201 1.3337 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 7.7002 4.0010 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 10.0102 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 17497-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91909-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28590666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, optimization study (optimized on solvent, reagent,
catalyst, temperature and stoichiometry of reactant and reagent),
conversion = 92%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylations of alkenyl halides with formic acid to
get corresponding α,β-unsaturated carboxylic acids and esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartal, Brigitta; Mikle, Gabor; Kollar, Laszlo; Pongracz, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Catalysis (2019), 467143-149

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine
C4H11NO2
111-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine formate
C4H11NO2.CH2O2
68391-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 6.6687 2.3100 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 O 8.0023 3.0800 0.0 0
M  V30 7 O 0.0000 3.0800 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 2.6675 0.7700 0.0 0
M  V30 10 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 8 9
M  V30 8 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 111-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68391-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28961954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid prepd.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Hydroxyethylammonium carboxylates - highly biodegradable and slightly
toxic ionic liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zicmanis, A.; Pavlovica, S.; Gzibovska, E.; Mekss, P.; Klavins, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Latvijas Kimijas Zurnals (2010), (3/4), 269-276

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-α-Santalol
C15H24O
115-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0434 3.8308 0.0 0
M  V30 2 C 4.0434 0.7400 0.0 0
M  V30 3 C 5.3271 1.4800 0.0 0
M  V30 4 C 6.6109 0.7400 0.0 0
M  V30 5 C 8.0950 0.7400 0.0 0
M  V30 6 C 9.3787 1.4800 0.0 0
M  V30 7 C 9.3787 0.0000 0.0 0
M  V30 8 O 10.6625 0.7400 0.0 0
M  V30 9 C 2.7597 0.0000 0.0 0
M  V30 10 C 2.7597 3.0908 0.0 0 CFG=2
M  V30 11 C 0.0000 3.0908 0.0 0 CFG=2
M  V30 12 C 1.3819 3.8962 0.0 0 CFG=1
M  V30 13 C 2.7597 1.4800 0.0 0 CFG=2
M  V30 14 C 0.0000 1.4800 0.0 0
M  V30 15 C 2.1300 2.2854 0.0 0
M  V30 16 C 1.3819 0.6746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 13 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 1 11 14
M  V30 15 1 12 15 CFG=3
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Penten-1-ol, 5-[(1R,3R,6S)-2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl]-2-met...
C16H24O2
1345675-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6219 5.8300 0.0 0
M  V30 2 C 5.8017 4.1522 0.0 0
M  V30 3 C 7.2487 3.6251 0.0 0
M  V30 4 C 8.4286 4.6145 0.0 0
M  V30 5 C 9.8756 4.0876 0.0 0
M  V30 6 C 10.1426 2.5708 0.0 0
M  V30 7 C 11.0557 5.0770 0.0 0
M  V30 8 O 11.5896 2.0437 0.0 0
M  V30 9 C 11.8566 0.5271 0.0 0
M  V30 10 O 13.3036 0.0000 0.0 0
M  V30 11 C 5.8011 2.1723 0.0 0
M  V30 12 C 3.8519 4.4964 0.0 0 CFG=3
M  V30 13 C 2.3112 4.4961 0.0 0 CFG=1
M  V30 14 C 1.5400 3.1620 0.0 0 CFG=2
M  V30 15 C 4.6218 3.1627 0.0 0 CFG=2
M  V30 16 C 2.4141 2.7775 0.0 0
M  V30 17 C 2.3098 1.8283 0.0 0
M  V30 18 C 3.8507 1.8286 0.0 0
M  V30 19 H 1.5414 5.8299 0.0 0
M  V30 20 H 0.0000 3.1627 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 15 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 13 16
M  V30 17 1 13 19 CFG=3
M  V30 18 1 14 17
M  V30 19 1 14 20 CFG=1
M  V30 20 1 15 18
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115-71-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345675-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1958293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of both formic acid and magnesium sulfate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-odor relationships of α-santalol derivatives with modified side
chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasegawa, Toshio; Izumi, Hiroaki; Tajima, Yuji; Yamada, Hideo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 172259-2270

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Methoxyphenyl)ethynyl]-4-methyl-N-(phenylmethyl)benzenesulfonamide
C23H21NO3S
1160723-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0
M  V30 2 S 9.3358 5.3901 0.0 0 VAL=6
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 6.6685 5.3901 0.0 0
M  V30 5 O 8.5658 6.7238 0.0 0
M  V30 6 O 10.1059 4.0564 0.0 0
M  V30 7 C 5.3348 6.1601 0.0 0
M  V30 8 C 14.6707 8.4702 0.0 0
M  V30 9 O 0.0000 9.2402 0.0 0
M  V30 10 C 0.0000 10.7802 0.0 0
M  V30 11 C 10.6697 6.1601 0.0 0
M  V30 12 C 10.6697 7.7002 0.0 0
M  V30 13 C 12.0033 5.3901 0.0 0
M  V30 14 C 12.0033 8.4702 0.0 0
M  V30 15 C 13.3370 6.1601 0.0 0
M  V30 16 C 13.3370 7.7002 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 5.3348 0.0000 0.0 0
M  V30 21 C 4.0010 2.3101 0.0 0
M  V30 22 C 4.0010 0.7700 0.0 0
M  V30 23 C 4.0010 6.9302 0.0 0
M  V30 24 C 4.0010 8.4702 0.0 0
M  V30 25 C 2.6673 6.1601 0.0 0
M  V30 26 C 2.6673 9.2402 0.0 0
M  V30 27 C 1.3337 6.9302 0.0 0
M  V30 28 C 1.3337 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 11
M  V30 7 1 3 17
M  V30 8 3 4 7
M  V30 9 1 7 23
M  V30 10 1 8 16
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1E)-1-(Formyloxy)-2-(4-methoxyphenyl)ethenyl]-4-methyl-N-(phenylmethyl)be...
C24H23NO5S
1632351-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 5.3348 2.3101 0.0 0
M  V30 7 O 6.1048 6.7238 0.0 0
M  V30 8 O 4.5648 4.0564 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 O 4.0010 0.0000 0.0 0
M  V30 11 C 0.0000 8.4702 0.0 0
M  V30 12 O 13.3370 5.3901 0.0 0
M  V30 13 C 14.6707 4.6201 0.0 0
M  V30 14 C 4.0010 6.1601 0.0 0
M  V30 15 C 4.0010 7.7002 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 2.6673 8.4702 0.0 0
M  V30 18 C 1.3337 6.1601 0.0 0
M  V30 19 C 1.3337 7.7002 0.0 0
M  V30 20 C 8.0022 6.9302 0.0 0
M  V30 21 C 9.3358 7.7002 0.0 0
M  V30 22 C 6.6685 7.7002 0.0 0
M  V30 23 C 9.3358 9.2402 0.0 0
M  V30 24 C 6.6685 9.2402 0.0 0
M  V30 25 C 8.0022 10.0102 0.0 0
M  V30 26 C 9.3358 3.0801 0.0 0
M  V30 27 C 9.3358 4.6201 0.0 0
M  V30 28 C 10.6697 2.3101 0.0 0
M  V30 29 C 10.6697 5.3901 0.0 0
M  V30 30 C 12.0033 3.0801 0.0 0
M  V30 31 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 3 8
M  V30 8 1 3 14
M  V30 9 1 4 20
M  V30 10 1 5 26
M  V30 11 1 6 9
M  V30 12 2 9 10
M  V30 13 1 11 19
M  V30 14 1 12 13
M  V30 15 1 12 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1160723-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632351-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-237-CAS-13373142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal-free hydroacyloxylation and hydration reactions of ynamides:
synthesis of α-acyloxyenamides and N-acylsulfonamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Shijie; Liu, Jianquan; Hu, Donghua; Bi, Xihe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2015), 17(1), 184-187

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(aminomethyl)-3-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-2-pyrazin...
C16H21FN4O2Si
1168091-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 O 0.7700 6.6684 0.0 0
M  V30 4 O 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 N 4.6200 0.0000 0.0 0
M  V30 8 F 6.9300 9.3358 0.0 0
M  V30 9 Si 11.5500 6.6684 0.0 0
M  V30 10 C 13.0900 6.6684 0.0 0
M  V30 11 C 11.5500 5.1284 0.0 0
M  V30 12 C 11.5500 8.2084 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 4.0011 0.0 0
M  V30 16 N 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 7.7000 8.0021 0.0 0
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 24
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-5-[(formylamino)methyl]-2...
C17H21FN4O3Si
1168091-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 9.3358 0.0 0
M  V30 2 C 2.3100 9.3358 0.0 0
M  V30 3 O 0.7700 9.3358 0.0 0
M  V30 4 O 3.0800 10.6694 0.0 0
M  V30 5 C 0.0000 10.6694 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 N 4.6200 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 F 6.9300 12.0031 0.0 0
M  V30 11 Si 11.5500 9.3358 0.0 0
M  V30 12 C 13.0900 9.3358 0.0 0
M  V30 13 C 11.5500 10.8758 0.0 0
M  V30 14 C 11.5500 7.7958 0.0 0
M  V30 15 C 4.6200 8.0020 0.0 0
M  V30 16 C 3.0800 8.0020 0.0 0
M  V30 17 N 5.3900 6.6684 0.0 0
M  V30 18 N 2.3100 6.6684 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 7.7000 10.6694 0.0 0
M  V30 23 C 7.7000 8.0020 0.0 0
M  V30 24 C 9.2400 10.6694 0.0 0
M  V30 25 C 9.2400 8.0020 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 26
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1168091-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1168091-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10611445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6:
3-(2-Fluoro-4-trimethylsilanyl-phenylamino)-5-formylaminomethylpyrazine-2-carboxylic
acid methyl ester A solution of
5-aminomethyl-3-(2-fluoro-4-trimethylsilanyl-phenylamino)-pyrazine-2-carboxylic
acid methyl ester (800 mg, 2.30 mmol) from above in formic acid (12 mL)
and acetic anhydride (4 mL) was stirred at ambient temperature under N2
for 1.5 hour. The reaction mixture was concentrated in vacuo, and the
residue was azeotroped with toluene. The resultant residue was diluted
with ethyl acetate. The organic layer was washed with saturated aqueous
solution of sodium bicarbonate, water and brine, dried (Na2SO4), filtered
and concentrated in vacuo to afford the title compound as a yellow foam
(850 mg, 98.3%).
3-(2-Fluoro-4-trimethylsilanyl-phenylamino)-5-formylaminomethylpyrazine-2-carboxylic
acid methyl ester, yield (850 mg, 98.3%) LCMS (method D1): RT = 1.09 min,
[M+H]+ = 377.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-anilinoimidazopyridines and their use as anti-cancer
and/or anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Price, Stephen; Heald, Robert; Lee, Wendy; Zak, Mark E.; Hewitt, Joanne
Frances Mary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009085983 A1 2009-07-09

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylenecyclohexane
C7H12
1192-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexaneacetic acid
C8H14O2
5292-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5292-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-20419267
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 18437-78-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-Catalyzed Highly Chemo- and Regioselective Hydrocarboxylation of
Terminal Alkyl Olefins with Formic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Wenlong; Chu, Jianxiao; Sun, Fei; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(15), 5967-5970

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Diamino-1,4-anthracenedione
C14H10N2O2
1194654-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.1601 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 N 0.0000 4.6201 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 1.5400 0.0 0
M  V30 17 C 9.3359 3.8500 0.0 0
M  V30 18 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 2 12 14
M  V30 17 2 13 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Anthra[2,3-d]imidazole-4,11-dione
C15H8N2O2
2247881-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 6.1600 0.0 0
M  V30 2 O 6.6684 0.0000 0.0 0
M  V30 3 C 5.3347 3.8500 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6684 4.6200 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 8.0022 3.8500 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 8.0022 2.3100 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 N 9.4667 4.3259 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 N 9.4667 1.8341 0.0 0
M  V30 16 C 1.3336 1.5400 0.0 0
M  V30 17 C 10.3720 3.0800 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1194654-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2247881-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-21871333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antitumor activity of 1-monosubstituted
1H-naphth[2,3-d]imidazole-4,9-diones and
1H-anthra[2,3-d]imidazole-4,11-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zhanxiong; Yuan, Jing; Zhang, Zhenfeng; Yan, Deyue; Zhang, Wanbin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Youji Huaxue (2018), 38(12), 3302-3317

$RFMT $RIREG SCHEME362 STEP1
$RXN



  3  1
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6,7-dimethoxy-1-methyl-1-phenyl-2(1H)-isoquinolinecarboxaldehyde
C19H21NO3
371157-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6088 2.4845 0.0 0
M  V30 2 C 2.0313 5.3347 0.0 0
M  V30 3 O 1.2613 6.6685 0.0 0
M  V30 4 O 8.9613 1.3338 0.0 0
M  V30 5 C 8.1913 0.0000 0.0 0
M  V30 6 O 10.5013 4.0011 0.0 0
M  V30 7 C 11.2713 5.3347 0.0 0
M  V30 8 C 5.8813 4.0011 0.0 0
M  V30 9 C 4.3413 4.0011 0.0 0
M  V30 10 C 6.6513 5.3347 0.0 0
M  V30 11 C 6.6513 2.6674 0.0 0
M  V30 12 N 3.5713 5.3347 0.0 0
M  V30 13 C 8.1913 5.3347 0.0 0
M  V30 14 C 5.8813 6.6685 0.0 0
M  V30 15 C 8.1913 2.6674 0.0 0
M  V30 16 C 4.3413 6.6685 0.0 0
M  V30 17 C 8.9613 4.0011 0.0 0
M  V30 18 C 2.8941 3.4744 0.0 0
M  V30 19 C 2.6268 1.9578 0.0 0
M  V30 20 C 1.7145 4.4643 0.0 0
M  V30 21 C 1.1796 1.4311 0.0 0
M  V30 22 C 0.2673 3.9376 0.0 0
M  V30 23 C 0.0000 2.4210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371157-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11523792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Pictet-Spengler reaction, alternative reaction conditions shown,
alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient synthesis of 1,1-disubstituted
1,2,3,4-tetrahydroisoquinolines via Pictet-Spengler reaction using
titanium(IV) isopropoxide and acetic-formic anhydride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horiguchi, Yoshie; Kodama, Hirokazu; Nakamura, Masayoshi; Yoshimura,
Tsuyoshi; Hanezi, Kaori; Hamada, Hiroko; Saitoh, Toshiaki; Sano, Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2002), 50(2), 253-257

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(2-amino-4-chlorophenyl)-1-(4-cyano-2-methylphenyl)-1H-pyrrole-2-prop...
C23H22ClN3O2
1208318-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8149 8.1292 0.0 0
M  V30 2 C 10.9593 9.1598 0.0 0
M  V30 3 C 12.4240 8.6839 0.0 0
M  V30 4 O 13.5683 9.7143 0.0 0
M  V30 5 O 12.7441 7.1775 0.0 0
M  V30 6 C 15.0330 9.2385 0.0 0
M  V30 7 C 16.1774 10.2689 0.0 0
M  V30 8 C 9.7718 6.1600 0.0 0
M  V30 9 N 3.5696 10.6660 0.0 0
M  V30 10 C 7.1043 1.5400 0.0 0
M  V30 11 N 7.1043 0.0000 0.0 0
M  V30 12 Cl 0.0000 6.7016 0.0 0
M  V30 13 N 7.1043 7.7000 0.0 0
M  V30 14 C 5.8585 8.6052 0.0 0
M  V30 15 C 8.3502 8.6052 0.0 0
M  V30 16 C 6.3343 10.0698 0.0 0
M  V30 17 C 7.8743 10.0698 0.0 0
M  V30 18 C 7.1043 6.1600 0.0 0
M  V30 19 C 8.4380 5.3900 0.0 0
M  V30 20 C 5.7707 5.3900 0.0 0
M  V30 21 C 8.4380 3.8500 0.0 0
M  V30 22 C 5.7707 3.8500 0.0 0
M  V30 23 C 7.1043 3.0800 0.0 0
M  V30 24 C 4.3938 8.1292 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6229 0.0 0
M  V30 27 C 1.7847 8.6839 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1775 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 19
M  V30 9 1 9 25
M  V30 10 3 10 11
M  V30 11 1 10 23
M  V30 12 1 12 29
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 2 14 16
M  V30 17 1 14 24
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[4-chloro-2-(formylamino)phenyl]-1-(4-cyano-2-methylphenyl)-1H-pyrrol...
C24H22ClN3O3
1208869-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 6.8938 0.0 0
M  V30 2 C 11.1826 7.5203 0.0 0
M  V30 3 C 12.4286 6.6151 0.0 0
M  V30 4 O 13.8354 7.2414 0.0 0
M  V30 5 O 12.2675 5.0834 0.0 0
M  V30 6 C 15.0813 6.3362 0.0 0
M  V30 7 C 16.4882 6.9627 0.0 0
M  V30 8 C 9.1262 5.0343 0.0 0
M  V30 9 N 4.6200 11.2364 0.0 0
M  V30 10 C 3.8500 12.5702 0.0 0
M  V30 11 O 4.6200 13.9038 0.0 0
M  V30 12 C 5.1618 1.4647 0.0 0
M  V30 13 N 4.6858 0.0000 0.0 0
M  V30 14 Cl 0.0000 8.5691 0.0 0
M  V30 15 N 7.0652 7.3232 0.0 0
M  V30 16 C 6.1600 8.5691 0.0 0
M  V30 17 C 8.5299 7.7991 0.0 0
M  V30 18 C 7.0652 9.8149 0.0 0
M  V30 19 C 8.5299 9.3391 0.0 0
M  V30 20 C 6.5894 5.8585 0.0 0
M  V30 21 C 7.6198 4.7141 0.0 0
M  V30 22 C 5.0831 5.5383 0.0 0
M  V30 23 C 7.1439 3.2494 0.0 0
M  V30 24 C 4.6071 4.0738 0.0 0
M  V30 25 C 5.6377 2.9292 0.0 0
M  V30 26 C 4.6200 8.5691 0.0 0
M  V30 27 C 3.8500 9.9027 0.0 0
M  V30 28 C 3.8500 7.2354 0.0 0
M  V30 29 C 2.3100 9.9027 0.0 0
M  V30 30 C 2.3100 7.2354 0.0 0
M  V30 31 C 1.5400 8.5691 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 3 12 13
M  V30 13 1 12 25
M  V30 14 1 14 31
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 1 16 26
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1208318-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208869-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2853087
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
3-(1-(4-carbamoyl-2-methylphenyl)-5-(4-chloro-2-formamidophenyl)-1H-pyrrol-2-yl)propanoic
acid (21) : Synthesis of ethyl
3-(5-(4-chloro-2-formamidophenyl)-1-(4-cyano-2-methylphenyl)-1Hpyrrol-2-yl)propanoate:
A mixture of Ac2O (301 mg, 2.948 mmol) and HCO2H (226 mg, 4.914 mmol) was
stirred at 55 °C for 5 min. The mixture was added to the solution of
ethyl
3-(5-(2-amino-4-chlorophenyl)-1-(4-cyano-2-methylphenyl)-1H-pyrrol-2-yl)propanoate
(300 mg, 0.737 mmol) in THF (6 ml) and stirred at 55 °C for 10 min. TLC
showed the reaction was complete. The volatiles were removed under
reduced pressure, and the residue was dissolved in EA (50 ml), washed
with saturated NaHCO3 (10 ml x 3) and brine (10 ml). The organic layer
was dried over anhydrous sodium sulfate, filtered and concentrated to
afford the crude product as a yellow solid (320 mg, yield: 99%) which was
used for the next step directly.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of S-Nitrosoglutathione Reductase Inhibitors: Potential Agents
for the Treatment of Asthma and Other Inflammatory Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Xicheng; Wasley, Jan W. F.; Qiu, Jian; Blonder, Joan P.; Stout, Adam
M.; Green, Louis S.; Strong, Sarah A.; Colagiovanni, Dorothy B.;
Richards, Jane P.; Mutka, Sarah C.; Chun, Lawrence; Rosenthal, Gary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2011), 2(5), 402-406

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
D-glycero-α-L-talo-Heptofuranuronic acid, 1,6-dideoxy-5-O-[5-deoxy-5-[[(1,1-d...
C39H60Cl3N5O15
1211774-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 71 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6839 6.1601 0.0 0 CFG=2
M  V30 2 O 9.3503 5.3901 0.0 0
M  V30 3 C 12.0176 5.3901 0.0 0 CFG=1
M  V30 4 N 13.3514 6.1601 0.0 0
M  V30 5 C 12.0176 3.8501 0.0 0
M  V30 6 C 14.6851 5.3901 0.0 0
M  V30 7 O 13.3514 3.0800 0.0 0
M  V30 8 O 10.6839 3.0800 0.0 0
M  V30 9 C 16.0187 6.1601 0.0 0
M  V30 10 C 13.3514 1.5400 0.0 0
M  V30 11 C 17.3525 5.3901 0.0 0
M  V30 12 C 11.8114 1.5400 0.0 0
M  V30 13 C 13.3514 0.0000 0.0 0
M  V30 14 C 14.8914 1.5400 0.0 0
M  V30 15 N 18.6862 6.1601 0.0 0
M  V30 16 C 20.0198 5.3901 0.0 0
M  V30 17 O 21.3535 6.1601 0.0 0
M  V30 18 O 20.0198 3.8501 0.0 0
M  V30 19 C 22.6873 5.3901 0.0 0
M  V30 20 C 24.0210 6.1601 0.0 0
M  V30 21 Cl 25.3546 6.9301 0.0 0
M  V30 22 Cl 24.7910 4.8263 0.0 0
M  V30 23 Cl 23.2510 7.4938 0.0 0
M  V30 24 C 8.3810 12.1197 0.0 0
M  V30 25 C 10.1659 13.1501 0.0 0
M  V30 26 O 13.7937 11.8753 0.0 0
M  V30 27 C 5.7229 9.4186 0.0 0
M  V30 28 N 4.1912 9.5797 0.0 0
M  V30 29 C 3.5648 10.9865 0.0 0
M  V30 30 O 2.0333 11.1475 0.0 0
M  V30 31 O 4.4701 12.2324 0.0 0
M  V30 32 C 1.4068 12.5544 0.0 0
M  V30 33 C 2.8138 13.1808 0.0 0
M  V30 34 C 0.7805 13.9612 0.0 0
M  V30 35 C 0.0000 11.9281 0.0 0
M  V30 36 C 4.1724 2.9886 0.0 0
M  V30 37 C 5.4183 2.0833 0.0 0
M  V30 38 C 2.7933 4.5201 0.0 0
M  V30 39 C 2.0233 3.1865 0.0 0
M  V30 40 O 18.8674 10.2267 0.0 0
M  V30 41 C 10.6839 7.7001 0.0 0 CFG=1
M  V30 42 C 10.3637 9.2064 0.0 0 CFG=1
M  V30 43 O 12.2155 7.5390 0.0 0
M  V30 44 C 11.6974 9.9764 0.0 0 CFG=1
M  V30 45 O 9.2194 10.2368 0.0 0
M  V30 46 C 12.8420 8.9460 0.0 0 CFG=1
M  V30 47 O 11.3772 11.4829 0.0 0
M  V30 48 C 9.8457 11.6438 0.0 0
M  V30 49 C 8.0166 6.1601 0.0 0 CFG=2
M  V30 50 C 6.6096 5.5336 0.0 0 CFG=2
M  V30 51 O 7.8555 7.6916 0.0 0
M  V30 52 C 5.5792 6.6782 0.0 0 CFG=2
M  V30 53 O 5.8396 4.2000 0.0 0
M  V30 54 C 6.3492 8.0118 0.0 0 CFG=2
M  V30 55 O 4.1724 6.0517 0.0 0
M  V30 56 C 4.3333 4.5201 0.0 0
M  V30 57 N 14.3482 9.2662 0.0 0
M  V30 58 C 14.8241 10.7309 0.0 0
M  V30 59 C 15.3788 8.1216 0.0 0
M  V30 60 N 16.3306 11.0511 0.0 0
M  V30 61 C 16.8851 8.4419 0.0 0
M  V30 62 C 17.3610 9.9065 0.0 0
M  V30 63 H 9.1524 7.5390 0.0 0
M  V30 64 H 9.0301 8.4364 0.0 0
M  V30 65 H 13.0312 10.7464 0.0 0
M  V30 66 H 7.6402 4.3892 0.0 0
M  V30 67 H 4.5488 7.8226 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 41
M  V30 4 1 49 2 CFG=1
M  V30 5 1 3 4 CFG=3
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 24 48
M  V30 26 1 25 48
M  V30 27 2 26 58
M  V30 28 1 27 28
M  V30 29 1 54 27 CFG=1
M  V30 30 1 28 29
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 32 35
M  V30 37 1 36 37
M  V30 38 1 36 56
M  V30 39 1 38 39
M  V30 40 1 38 56
M  V30 41 2 40 62
M  V30 42 1 41 42
M  V30 43 1 41 43
M  V30 44 1 41 63 CFG=1
M  V30 45 1 42 44
M  V30 46 1 42 45
M  V30 47 1 42 64 CFG=3
M  V30 48 1 43 46
M  V30 49 1 44 46
M  V30 50 1 44 47
M  V30 51 1 44 65 CFG=3
M  V30 52 1 45 48
M  V30 53 1 46 57 CFG=3
M  V30 54 1 47 48
M  V30 55 1 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 1 50 53
M  V30 59 1 50 66 CFG=1
M  V30 60 1 51 54
M  V30 61 1 52 54
M  V30 62 1 52 55
M  V30 63 1 52 67 CFG=1
M  V30 64 1 53 56
M  V30 65 1 55 56
M  V30 66 1 57 58
M  V30 67 1 57 59
M  V30 68 1 58 60
M  V30 69 2 59 61
M  V30 70 1 60 62
M  V30 71 1 61 62
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 3 41 42 44 46 49 50 52 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-glycero-α-L-talo-Heptofuranuronic acid, 1,6-dideoxy-5-O-[5-deoxy-5-[[(1,1-d...
C37H59N5O14
1146698-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.9054 0.0 0 CFG=2
M  V30 2 O 10.0101 5.5717 0.0 0
M  V30 3 C 7.7000 6.9054 0.0 0 CFG=1
M  V30 4 N 6.9300 8.2392 0.0 0
M  V30 5 C 6.9300 5.5717 0.0 0
M  V30 6 C 5.3900 8.2392 0.0 0
M  V30 7 O 5.3900 5.5717 0.0 0
M  V30 8 O 7.7000 4.2381 0.0 0
M  V30 9 C 4.6200 9.5728 0.0 0
M  V30 10 C 4.6200 4.2381 0.0 0
M  V30 11 C 3.0800 9.5728 0.0 0
M  V30 12 C 5.9537 3.4681 0.0 0
M  V30 13 C 3.8500 2.9045 0.0 0
M  V30 14 C 3.2864 5.0081 0.0 0
M  V30 15 N 2.3100 10.9065 0.0 0
M  V30 16 C 0.7700 10.9065 0.0 0
M  V30 17 O 0.0000 12.2401 0.0 0
M  V30 18 C 14.2143 10.9151 0.0 0
M  V30 19 C 13.1837 12.7000 0.0 0
M  V30 20 O 9.4045 13.4098 0.0 0
M  V30 21 C 15.1658 7.2470 0.0 0
M  V30 22 N 16.5726 6.6205 0.0 0
M  V30 23 C 17.8185 7.5257 0.0 0
M  V30 24 O 19.2255 6.8994 0.0 0
M  V30 25 O 17.6576 9.0574 0.0 0
M  V30 26 C 20.4713 7.8046 0.0 0
M  V30 27 C 19.5661 9.0505 0.0 0
M  V30 28 C 21.7172 8.7098 0.0 0
M  V30 29 C 21.3765 6.5587 0.0 0
M  V30 30 C 13.2935 0.9031 0.0 0
M  V30 31 C 11.7620 0.7421 0.0 0
M  V30 32 C 15.2536 1.5400 0.0 0
M  V30 33 C 15.2536 0.0000 0.0 0
M  V30 34 O 4.1864 14.5189 0.0 0
M  V30 35 C 10.0101 8.2392 0.0 0 CFG=1
M  V30 36 C 11.0405 9.3836 0.0 0 CFG=1
M  V30 37 O 8.6033 8.8655 0.0 0
M  V30 38 C 10.2705 10.7172 0.0 0 CFG=1
M  V30 39 O 12.5469 9.7037 0.0 0
M  V30 40 C 8.7642 10.3971 0.0 0 CFG=1
M  V30 41 O 11.3010 11.8618 0.0 0
M  V30 42 C 12.7078 11.2353 0.0 0
M  V30 43 C 11.5501 5.5717 0.0 0 CFG=2
M  V30 44 C 12.4553 4.3259 0.0 0 CFG=2
M  V30 45 O 12.4553 6.8176 0.0 0
M  V30 46 C 13.9198 4.8017 0.0 0 CFG=2
M  V30 47 O 12.4553 2.7859 0.0 0
M  V30 48 C 13.9198 6.3418 0.0 0 CFG=2
M  V30 49 O 14.8250 3.5559 0.0 0
M  V30 50 C 13.9198 2.3100 0.0 0
M  V30 51 N 7.6197 11.4275 0.0 0
M  V30 52 C 7.9398 12.9339 0.0 0
M  V30 53 C 6.1551 10.9516 0.0 0
M  V30 54 N 6.7954 13.9643 0.0 0
M  V30 55 C 5.0106 11.9822 0.0 0
M  V30 56 C 5.3307 13.4885 0.0 0
M  V30 57 H 11.2559 7.3340 0.0 0
M  V30 58 H 11.8105 8.0499 0.0 0
M  V30 59 H 9.5005 12.0509 0.0 0
M  V30 60 H 10.9906 3.8500 0.0 0
M  V30 61 H 15.3845 5.2776 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 35
M  V30 4 1 43 2 CFG=3
M  V30 5 1 3 4 CFG=1
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 15 16
M  V30 18 2 16 17
M  V30 19 1 18 42
M  V30 20 1 19 42
M  V30 21 2 20 52
M  V30 22 1 21 22
M  V30 23 1 48 21 CFG=3
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 26 29
M  V30 31 1 30 31
M  V30 32 1 30 50
M  V30 33 1 32 33
M  V30 34 1 32 50
M  V30 35 2 34 56
M  V30 36 1 35 36
M  V30 37 1 35 37
M  V30 38 1 35 57 CFG=3
M  V30 39 1 36 38
M  V30 40 1 36 39
M  V30 41 1 36 58 CFG=1
M  V30 42 1 37 40
M  V30 43 1 38 40
M  V30 44 1 38 41
M  V30 45 1 38 59 CFG=1
M  V30 46 1 39 42
M  V30 47 1 40 51 CFG=1
M  V30 48 1 41 42
M  V30 49 1 43 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 1 44 47
M  V30 53 1 44 60 CFG=3
M  V30 54 1 45 48
M  V30 55 1 46 48
M  V30 56 1 46 49
M  V30 57 1 46 61 CFG=3
M  V30 58 1 47 50
M  V30 59 1 49 50
M  V30 60 1 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 2 53 55
M  V30 64 1 54 56
M  V30 65 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 3 35 36 38 40 43 44 46 48)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1211774-35-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1146698-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6314328
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl 5-O-[5-tert-Butoxycarbonylamino-5-deoxy-2,3
-O-(3-pentylidene)-β-D-ribo-pentofuranosyl]-6-deoxy-6-N-(3-formylaminopropyl)
amino-2,3-O-isopropylidene-1-(uracil-1-yl) -β-Dglycelo
-L-talo-heptofuranuronate (50). A mixture of 49 (28.9 mg, 0.031 mmol) and
NH4Cl (50.0 mg, 0.93 mmol) in MeOH (1 mL) was treated with activated Zn
powder (85% purity, 33.3 mg, 0.51 mmol) at room temperature for 2 h. The
insoluble portion was filtered off through a Celite pad, and the filtrate
was concentrated in vacuo. A mixture of the residue and
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI, 35mg,
0.18 mmol) in CH2Cl2 (1mL) at 0 °C was treated with formic acid (10.0 μL,
0.25 mmol) for 15 h. The mixture was partitioned between AcOEt and H2O,
and the organic phase was washed with saturated aq NaCl, dried (Na2SO4),
filtered, and concentrated in vacuo. The residue was purified by neutral
silica gel column chromatography (2 x 4 cm, 66% AcOEt/hexane containing
3%MeOH) to afford 50 (30.4 mg, 99% over two steps) as a white foam:.
[α]22D +30.7 (c 1.09, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.67 (br s,
1H,NH-3), 7.21 (d, 1H, H-6, J6,5=8.0Hz), 5.98 (br s, 1H, NH-Troc), 5.75
(br s, 1H, NH-Boc), 5.68 (d, 1H, H-5, J5,6=8.0Hz), 5.46 (s, 1H,H-10),
5.17 (d, 1H,H-20, J20,30 =5.7 Hz), 4.95 (s, 1H, H-100), 4.84 (t, 1H,
H-30, J30,20 = J30,40 = 5.7 Hz), 4.75 (d, 1H, CH2CCl3, J = 13.0 Hz), 4.69
(d, 1H, CH2CCl3, J = 13.0 Hz), 4.55 (m, 2H, H-4 0 and 300, J40,30 = 5.7
Hz), 4.49 (m, 1H, H-200), 4.22 (m, 1H, H-400), 4.08 (m, 1H, H-50), 3.33
(d, 2H, H-80, J80a,80b = 5.2 Hz), 3.26 (m, 1H, 500a), 3.23 (s, 1H, H-60),
3.05 (d, 1H, H-500b, J50 0b,50 0a=6.9Hz), 2.90 (m, 1H, H-100a), 2.33 (m,
1H, H-100b), 1.70 (m, 1H, H-90a), 1.56 (m, 1H, H-90b), 1.55 (s, 4H,
CH2CH3), 1.51 (s, 9H, tBu), 1.44 (s, 12H, tBu and acetonide), 1.37 (s,
3H, acetonide), 0.76 (m, 6H, CH2CH3); 13C NMR (CDCl3, 125 MHz) δ 172.1,
162.9, 156.1, 154.5, 149.9, 143.8, 116.0, 114.8, 112.8, 102.3, 96.7,
95.8, 89.0, 86.7, 84.8, 82.6, 82.0, 81.8, 81.5, 79.0, 74.4, 62.5, 45.2,
43.3, 38.7, 29.3, 28.8, 28.4, 28.2, 26.8, 25.1, 8.4, 7.3; ESIMS-LR m/z
798 [(M + H) + ]; ESIMS-HR calcd for C37 -H60N5O14 798.4137, found
798.4142.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (-)-Muraymycin D2 and Its Epimer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanino, Tetsuya; Ichikawa, Satoshi; Shiro, Motoo; Matsuda, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(5), 1366-1377

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(9R)-9-(Aminomethyl)-6,7,10,11-tetrahydro-19-(phenylmethyl)-9H,18H-5,21:12,17...
C33H30N4O3
1224599-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.0618 1.6763 0.0 0
M  V30 2 O 4.3423 6.3610 0.0 0
M  V30 3 C 4.0011 3.0390 0.0 0
M  V30 4 C 14.8422 8.1269 0.0 0
M  V30 5 N 16.3071 7.6513 0.0 0
M  V30 6 C 7.7721 4.3271 0.0 0
M  V30 7 C 6.9879 5.6852 0.0 0
M  V30 8 C 9.2320 4.2171 0.0 0
M  V30 9 C 6.7417 3.1826 0.0 0
M  V30 10 C 7.7035 7.0018 0.0 0
M  V30 11 C 5.4958 5.3406 0.0 0
M  V30 12 C 9.6490 2.6987 0.0 0
M  V30 13 C 10.4697 5.0866 0.0 0
M  V30 14 N 5.3347 3.8090 0.0 0
M  V30 15 C 6.8150 8.2972 0.0 0
M  V30 16 C 9.1770 7.3935 0.0 0
M  V30 17 C 11.1887 2.6668 0.0 0
M  V30 18 C 8.8516 1.3814 0.0 0
M  V30 19 N 11.7160 4.1557 0.0 0 CFG=3
M  V30 20 C 7.7956 9.5238 0.0 0
M  V30 21 C 5.2925 8.5285 0.0 0
M  V30 22 N 9.2563 8.9605 0.0 0 CFG=3
M  V30 23 C 11.9309 1.3175 0.0 0
M  V30 24 C 9.5937 0.0320 0.0 0
M  V30 25 C 13.1555 4.4178 0.0 0
M  V30 26 C 7.2158 10.9343 0.0 0
M  V30 27 C 4.7317 9.9627 0.0 0
M  V30 28 C 10.5527 9.7633 0.0 0
M  V30 29 C 11.1334 0.0000 0.0 0
M  V30 30 C 14.0596 5.6101 0.0 0
M  V30 31 C 5.6932 11.1656 0.0 0
M  V30 32 C 11.9730 9.1679 0.0 0
M  V30 33 C 13.6980 7.0962 0.0 0 CFG=2
M  V30 34 O 12.2262 7.6215 0.0 0
M  V30 35 C 2.6674 3.8090 0.0 0
M  V30 36 C 1.3338 3.0390 0.0 0
M  V30 37 C 2.6674 5.3490 0.0 0
M  V30 38 C 0.0000 3.8090 0.0 0
M  V30 39 C 1.3338 6.1190 0.0 0
M  V30 40 C 0.0000 5.3490 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 14
M  V30 4 1 3 35
M  V30 5 1 4 5
M  V30 6 1 33 4 CFG=1
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 11 14
M  V30 18 1 12 17
M  V30 19 2 12 18
M  V30 20 1 13 19
M  V30 21 1 15 20
M  V30 22 2 15 21
M  V30 23 1 16 22
M  V30 24 1 17 19
M  V30 25 2 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 20 22
M  V30 29 2 20 26
M  V30 30 1 21 27
M  V30 31 1 22 28
M  V30 32 1 23 29
M  V30 33 2 24 29
M  V30 34 1 25 30
M  V30 35 1 26 31
M  V30 36 2 27 31
M  V30 37 1 28 32
M  V30 38 1 30 33
M  V30 39 1 32 34
M  V30 40 1 33 34
M  V30 41 2 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 2 37 39
M  V30 45 2 38 40
M  V30 46 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(9R)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-19-(phenylmethyl)-9H,18H-...
C35H34N4O3
1224599-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 3.4875 0.0 0
M  V30 2 O 5.0366 8.9043 0.0 0
M  V30 3 C 3.0800 6.1981 0.0 0
M  V30 4 C 15.0128 5.1838 0.0 0
M  V30 5 N 16.0436 4.0396 0.0 0
M  V30 6 C 15.5681 2.5749 0.0 0
M  V30 7 C 17.5499 4.3601 0.0 0
M  V30 8 C 6.9899 5.4281 0.0 0
M  V30 9 C 6.9899 6.9964 0.0 0
M  V30 10 C 8.1993 4.6029 0.0 0
M  V30 11 C 5.5252 4.9522 0.0 0
M  V30 12 C 8.2678 7.7787 0.0 0
M  V30 13 C 5.5252 7.4439 0.0 0
M  V30 14 C 7.8014 3.0794 0.0 0
M  V30 15 C 9.7060 4.7371 0.0 0
M  V30 16 N 4.6200 6.1981 0.0 0
M  V30 17 C 8.1462 9.3449 0.0 0
M  V30 18 C 9.7399 7.3814 0.0 0
M  V30 19 C 9.1187 2.2818 0.0 0
M  V30 20 C 6.4519 2.3373 0.0 0
M  V30 21 N 10.3199 3.3078 0.0 0 CFG=3
M  V30 22 C 9.6087 9.9169 0.0 0
M  V30 23 C 6.9433 10.3065 0.0 0
M  V30 24 N 10.5920 8.6987 0.0 0 CFG=3
M  V30 25 C 9.0868 0.7423 0.0 0
M  V30 26 C 6.4200 0.7976 0.0 0
M  V30 27 C 11.6974 2.8150 0.0 0
M  V30 28 C 9.8117 11.4282 0.0 0
M  V30 29 C 7.1747 11.8289 0.0 0
M  V30 30 C 12.1160 8.7457 0.0 0
M  V30 31 C 7.7373 0.0000 0.0 0
M  V30 32 C 13.0765 3.3956 0.0 0
M  V30 33 C 8.6089 12.3900 0.0 0
M  V30 34 C 13.0485 7.5199 0.0 0
M  V30 35 C 13.5066 4.8632 0.0 0 CFG=2
M  V30 36 O 12.4945 6.0541 0.0 0
M  V30 37 C 2.3100 7.5317 0.0 0
M  V30 38 C 0.7700 7.5317 0.0 0
M  V30 39 C 3.0800 8.8655 0.0 0
M  V30 40 C 0.0000 8.8655 0.0 0
M  V30 41 C 2.3100 10.1992 0.0 0
M  V30 42 C 0.7700 10.1992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 1 3 16
M  V30 4 1 3 37
M  V30 5 1 4 5
M  V30 6 1 35 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 16
M  V30 20 1 14 19
M  V30 21 2 14 20
M  V30 22 1 15 21
M  V30 23 1 17 22
M  V30 24 2 17 23
M  V30 25 1 18 24
M  V30 26 1 19 21
M  V30 27 2 19 25
M  V30 28 1 20 26
M  V30 29 1 21 27
M  V30 30 1 22 24
M  V30 31 2 22 28
M  V30 32 1 23 29
M  V30 33 1 24 30
M  V30 34 1 25 31
M  V30 35 2 26 31
M  V30 36 1 27 32
M  V30 37 1 28 33
M  V30 38 2 29 33
M  V30 39 1 30 34
M  V30 40 1 32 35
M  V30 41 1 34 36
M  V30 42 1 35 36
M  V30 43 2 37 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 41
M  V30 47 2 40 42
M  V30 48 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224599-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224599-84-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27787339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 100-97-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 8. 9H,18H-5,21 :12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]
oxadiazacyclohexadecine-18,20(19H)-dione,6,7,10,11-tetrahydro-19-(phenylmethyl)-9-dimethylaminomethyl-,(9R)-(9Cl)
(12847). To a solution of 44.8 mg (82.9 μmol) 12835 and 17.4 mg (124.3
μmol) urotropine in 1 mL water were added 57.3 mg (124.3 μmol) formic
acid. The reaction mixture was stirred at RT for 15 min and then heated
to 100°C. The reaction was monitored by HPLC. After completion of the
reaction the reaction mixture was allowed to cool to RT and THF was added
until a homogenous solution was obtained. The product was purified by
chromatography (15 g silica gel, ethyl acetate/ethanol 1:1 to 1:2) to
yield 44.0 mg 12847. MS(ES): M+1 = 559.
$DTYPE RXN:VAR(1):NOTES
$DATUM Eschweiler-Clark conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of ruboxistaurin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kral, Vladimir; Jirman, Josef; Flubacher, Dietmar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2181999 A1 2010-05-05

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenoxyethanol
C8H10O2
122-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-phenoxy-, 1-formate
C9H10O3
58214-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-99-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58214-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24454085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(4-Methylphenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C17H13NO2
123017-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 C 13.5070 4.0442 0.0 0
M  V30 6 C 2.6673 1.9406 0.0 0
M  V30 7 C 2.6673 3.4806 0.0 0
M  V30 8 C 4.1320 1.4647 0.0 0
M  V30 9 C 1.3336 1.1706 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 1.3336 4.2506 0.0 0
M  V30 12 N 5.0370 2.7106 0.0 0
M  V30 13 C 0.0000 1.9406 0.0 0
M  V30 14 C 0.0000 3.4806 0.0 0
M  V30 15 C 8.8870 4.0442 0.0 0
M  V30 16 C 9.6570 5.3780 0.0 0
M  V30 17 C 9.6570 2.7106 0.0 0
M  V30 18 C 11.1970 5.3778 0.0 0
M  V30 19 C 11.1970 2.7106 0.0 0
M  V30 20 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-α-(4-methylphenyl)-1,3-dioxo-2H-isoindole-2-propanoic acid
C18H15NO4
2173410-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 8.4743 6.4615 0.0 0
M  V30 5 O 5.8172 6.2291 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 C 13.5070 4.0442 0.0 0
M  V30 9 N 5.0370 2.7104 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 4.1320 1.4645 0.0 0
M  V30 12 C 2.6673 3.4804 0.0 0
M  V30 13 C 2.6673 1.9404 0.0 0
M  V30 14 C 1.3336 4.2504 0.0 0
M  V30 15 C 1.3336 1.1704 0.0 0
M  V30 16 C 0.0000 3.4804 0.0 0
M  V30 17 C 0.0000 1.9404 0.0 0
M  V30 18 C 8.8870 4.0442 0.0 0
M  V30 19 C 9.6570 5.3778 0.0 0
M  V30 20 C 9.6570 2.7104 0.0 0
M  V30 21 C 11.1970 5.3778 0.0 0
M  V30 22 C 11.1970 2.7104 0.0 0
M  V30 23 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 10
M  V30 8 2 7 11
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123017-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Isoindole-1,3(2H)-dione, 2-[2-(4-methylphenyl)ethenyl]-, (Z)-
C17H13NO2
123017-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7671 1.4753 0.0 0
M  V30 2 O 2.2826 5.6281 0.0 0
M  V30 3 C 5.0045 5.2234 0.0 0
M  V30 4 C 6.5387 5.3577 0.0 0
M  V30 5 C 11.8734 2.2777 0.0 0
M  V30 6 C 3.0332 1.7145 0.0 0
M  V30 7 C 2.0433 2.8943 0.0 0
M  V30 8 C 4.4611 2.2914 0.0 0
M  V30 9 C 2.5065 0.2673 0.0 0
M  V30 10 C 2.8595 4.2002 0.0 0
M  V30 11 C 0.5267 2.6268 0.0 0
M  V30 12 N 4.3537 3.8277 0.0 0
M  V30 13 C 0.9899 0.0000 0.0 0
M  V30 14 C 0.0000 1.1796 0.0 0
M  V30 15 C 7.8723 4.5877 0.0 0
M  V30 16 C 9.2060 5.3577 0.0 0
M  V30 17 C 7.8723 3.0477 0.0 0
M  V30 18 C 10.5398 4.5877 0.0 0
M  V30 19 C 9.2060 2.2777 0.0 0
M  V30 20 C 10.5398 3.0477 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-α-(4-methylphenyl)-1,3-dioxo-2H-isoindole-2-propanoic acid
C18H15NO4
2173410-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 8.4743 6.4615 0.0 0
M  V30 5 O 5.8172 6.2291 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 C 13.5070 4.0442 0.0 0
M  V30 9 N 5.0370 2.7104 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 4.1320 1.4645 0.0 0
M  V30 12 C 2.6673 3.4804 0.0 0
M  V30 13 C 2.6673 1.9404 0.0 0
M  V30 14 C 1.3336 4.2504 0.0 0
M  V30 15 C 1.3336 1.1704 0.0 0
M  V30 16 C 0.0000 3.4804 0.0 0
M  V30 17 C 0.0000 1.9404 0.0 0
M  V30 18 C 8.8870 4.0442 0.0 0
M  V30 19 C 9.6570 5.3778 0.0 0
M  V30 20 C 9.6570 2.7104 0.0 0
M  V30 21 C 11.1970 5.3778 0.0 0
M  V30 22 C 11.1970 2.7104 0.0 0
M  V30 23 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 10
M  V30 8 2 7 11
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123017-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-779373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, reusable catalyst, silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Formylation of anilines with silica sulfuric acid under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Habibi, Davood; Rahmani, Payam; Akbaripanah, Ziba
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 972960, 6 pp.

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-[[2-chloro-4-(4-ethyl-1-piperazinyl)phenyl]sulfon...
C26H36ClN5O5S
1252633-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3648 4.3752 0.0 0
M  V30 2 N 6.2699 3.1293 0.0 0
M  V30 3 O 3.8331 4.2143 0.0 0
M  V30 4 C 3.6896 7.2768 0.0 0
M  V30 5 O 3.0631 8.6836 0.0 0
M  V30 6 O 2.7844 6.0309 0.0 0
M  V30 7 C 1.5316 8.8447 0.0 0
M  V30 8 C 1.6925 10.3762 0.0 0
M  V30 9 C 0.0000 9.0056 0.0 0
M  V30 10 C 1.3706 7.3130 0.0 0
M  V30 11 S 8.9922 8.4039 0.0 0 VAL=6
M  V30 12 O 8.2222 9.7376 0.0 0
M  V30 13 O 9.7622 7.0701 0.0 0
M  V30 14 C 6.9203 0.8612 0.0 0
M  V30 15 N 8.1971 0.0000 0.0 0
M  V30 16 Cl 8.9922 11.4840 0.0 0
M  V30 17 C 18.3281 13.7940 0.0 0
M  V30 18 C 19.6618 13.0240 0.0 0
M  V30 19 C 5.9912 5.7820 0.0 0 CFG=2
M  V30 20 N 5.2211 7.1158 0.0 0
M  V30 21 C 7.4975 6.1022 0.0 0
M  V30 22 C 6.2516 8.2602 0.0 0
M  V30 23 C 7.6585 7.6339 0.0 0 CFG=1
M  V30 24 C 5.6436 1.7224 0.0 0
M  V30 25 C 4.1493 2.0949 0.0 0
M  V30 26 C 4.5737 0.6146 0.0 0
M  V30 27 C 10.3259 9.1739 0.0 0
M  V30 28 C 10.3259 10.7139 0.0 0
M  V30 29 C 11.6597 8.4039 0.0 0
M  V30 30 C 11.6597 11.4840 0.0 0
M  V30 31 C 12.9933 9.1739 0.0 0
M  V30 32 C 12.9933 10.7139 0.0 0
M  V30 33 N 14.3270 11.4840 0.0 0
M  V30 34 C 15.6607 10.7139 0.0 0
M  V30 35 C 14.3270 13.0240 0.0 0
M  V30 36 C 16.9945 11.4840 0.0 0
M  V30 37 C 15.6607 13.7940 0.0 0
M  V30 38 N 16.9945 13.0240 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=1
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 23 11 CFG=3
M  V30 15 1 11 27
M  V30 16 3 14 15
M  V30 17 1 14 24
M  V30 18 1 16 28
M  V30 19 1 17 18
M  V30 20 1 17 38
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 32 33
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (2S,4R)-4-[[2-chloro-4-(4-ethyl-1-piperazinyl)phenyl...
C21H28ClN5O3S.CH2O2
1252633-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.4613 6.0262 0.0 0
M  V30 2 C 4.8682 6.6525 0.0 0
M  V30 3 O 5.0292 8.1840 0.0 0
M  V30 4 C 1.1077 5.8616 0.0 0
M  V30 5 N 0.0000 4.7917 0.0 0
M  V30 6 S 10.0240 4.9773 0.0 0 VAL=6
M  V30 7 O 10.0240 6.5173 0.0 0
M  V30 8 O 10.0240 3.4373 0.0 0
M  V30 9 Cl 11.5640 2.3100 0.0 0
M  V30 10 C 20.8039 4.9773 0.0 0
M  V30 11 C 21.5739 6.3109 0.0 0
M  V30 12 C 2.2154 6.9312 0.0 0
M  V30 13 C 2.8906 8.3154 0.0 0
M  V30 14 C 1.3543 8.2081 0.0 0
M  V30 15 C 6.1141 5.7473 0.0 0 CFG=1
M  V30 16 C 7.5788 6.2232 0.0 0
M  V30 17 N 6.1141 4.2073 0.0 0
M  V30 18 C 8.4840 4.9773 0.0 0 CFG=1
M  V30 19 C 7.5788 3.7314 0.0 0
M  V30 20 C 11.5640 4.9773 0.0 0
M  V30 21 C 12.3340 3.6437 0.0 0
M  V30 22 C 12.3339 6.3109 0.0 0
M  V30 23 C 13.8740 3.6437 0.0 0
M  V30 24 C 13.8740 6.3109 0.0 0
M  V30 25 C 14.6440 4.9773 0.0 0
M  V30 26 N 16.1840 4.9773 0.0 0
M  V30 27 C 16.9540 6.3109 0.0 0
M  V30 28 C 16.9540 3.6437 0.0 0
M  V30 29 C 18.4940 6.3109 0.0 0
M  V30 30 C 18.4940 3.6437 0.0 0
M  V30 31 N 19.2639 4.9773 0.0 0
M  V30 32 C 10.7869 0.0000 0.0 0
M  V30 33 O 9.4533 0.7700 0.0 0
M  V30 34 O 12.1206 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 15 2 CFG=3
M  V30 5 3 4 5
M  V30 6 1 4 12
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 18 6 CFG=1
M  V30 10 1 6 20
M  V30 11 1 9 21
M  V30 12 1 10 11
M  V30 13 1 10 31
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1252633-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1252633-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-481281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(2S,4R)-4-(2-Chloro-4-piperidin-1-yl-benzenesulfonyl)-pyrrolidine-2-carboxylic
Acid (1-cyano-cyclopropyl)-amide Example 121 (480 mg) was dissolved in
formic acid (10 ml)and stirred at room temperature for 3.5 h. The
reaction mixture was then evaporated to half of the volume, then diluted
with AcOEt (30 ml) and extracted with aq. 10% Na2CO3-solution (40 ml).
The water phase was washed with AcOEt (30 ml), the combined organic
layers were washed with brine, dried over Na2SO4, filtered and evaporated
to dryness to yield the title compound as colorless amorphous material
(231 mg; 59%).
(2S,4R)-4-[2-Chloro-4-(4-ethyl-piperazin-1-yl)-benzenesulfonyl]-pyrrolidine-2-carboxylic
Acid (1-cyano-cyclopropyl)-amide Formiate The title compound was prepared
in analogy to example 127 using example 138 (52 mg) as starting material
to yield 47 mg (99%) of a yellow gum. MS (ESI): m/z=466.2 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of proline dipeptidyl nitrile derivatives as cathepsin,
particularly cathepsin S and L, inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanchez, Ruben Alvarez; Banner, David; Ceccarelli, Simona M.; Grether,
Uwe; Haap, Wolfgang; Hartman, Peter; Hartmann, Guido; Hilpert, Hans;
Kuehne, Holger; Mauser, Harald; Plancher, Jean-Marc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100267722 A1 2010-10-21

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-[4-[di(methyl-13C)amino]phenyl]ethanone
C10H12BrNO
1254941-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 Br 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0 MASS=13
M  V30 7 C 1.3337 0.0000 0.0 0 MASS=13
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-[Di(methyl-13C)amino]phenyl]-2-(formyloxy)ethanone
C11H13NO3
1262973-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 O 12.0033 4.6201 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0 MASS=13
M  V30 9 C 0.0000 2.3101 0.0 0 MASS=13
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1254941-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262973-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-9439418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 595-91-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 102-71-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Labeling Reaction. Figure 1 shows the reaction
scheme for labeling carboxylic acids using the isotope reagents, 13C- or
12CDmPABr. For labeling human urine samples, urine in 50% (v: v) of
acetonitrile was centrifuged for 10 min at 12 000 rpm. About 50 μL of
human urine in acetonitrile (v:v) or 50 μL of carboxylic acid standards
in acetonitrile (1.2 mM each) were mixed with an equal volume of 750 mM
of triethanolamine (TEOA) in a reaction vial. The solutions were
vortexed, spun down, and then mixed with 50 μL of freshly prepared
13C-DmPA (20 mg/mL) (for heavy labeling) or 12C-DmPA (20 mg/mL) (for
light labeling). The derivatization reaction proceeded for 60 min at 90
°C in a water bath. After 60 min, the mixtures were vortexed, spun down,
and 100 μL of triphenylacetic acid (30 mg/mL) was added to consume the
excess labeling reagent, 12C-/13C-DmPA, at 90 °C in TEOA for 30 min. The
solutions were vortexed and spun down. The labeling reactions were
carried out in sealed glass vials with Teflon lined caps. After labeling,
the 13C-labeled mixtures were combined with their 12C-labeled mixtures
for LC-MS analysis. We note that the labeled sample was usually analyzed
within 2 weeks. No degradation products for the labeled standards were
observed after storing the labeled samples in -20 °C for up to 2 weeks.
Yield 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed vial used, alternate solvents (acetone, DMF) may be
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM High-Performance Isotope Labeling for Profiling Carboxylic
Acid-Containing Metabolites in Biofluids by Mass Spectrometry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Kevin; Li, Liang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical Chemistry (Washington, DC, United States) (2010), 82(21),
8789-8793

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[2-Methyl-6-(phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)...
C21H23N5O2S
1315497-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9474 7.0618 0.0 0
M  V30 2 S 9.6660 3.6952 0.0 0 VAL=6
M  V30 3 O 9.6660 2.1552 0.0 0
M  V30 4 O 9.6660 5.2352 0.0 0
M  V30 5 N 0.0000 0.0000 0.0 0
M  V30 6 C 4.6117 5.4956 0.0 0
M  V30 7 C 5.7561 4.4652 0.0 0
M  V30 8 N 3.0800 5.3347 0.0 0
M  V30 9 C 4.9318 7.0021 0.0 0
M  V30 10 C 7.2208 4.9411 0.0 0
M  V30 11 C 5.7561 2.9252 0.0 0
M  V30 12 C 2.4537 6.7417 0.0 0
M  V30 13 N 3.5982 7.7721 0.0 0
M  V30 14 C 6.3964 7.4779 0.0 0
M  V30 15 N 8.1260 3.6952 0.0 0
M  V30 16 N 7.5409 6.4475 0.0 0
M  V30 17 C 7.2208 2.4494 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 22 C 2.3100 1.3336 0.0 0
M  V30 23 C 0.7700 1.3336 0.0 0 CFG=1
M  V30 24 C 11.2060 3.6952 0.0 0
M  V30 25 C 11.9760 2.3616 0.0 0
M  V30 26 C 11.9760 5.0289 0.0 0
M  V30 27 C 13.5160 2.3616 0.0 0
M  V30 28 C 13.5160 5.0289 0.0 0
M  V30 29 C 14.2860 3.6952 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 2 24
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 18 8 CFG=1
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 2 11 17
M  V30 19 2 12 13
M  V30 20 2 14 16
M  V30 21 1 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[2-Methyl-6-(phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(...
C22H23N5O3S
1315497-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8684 10.3549 0.0 0
M  V30 2 S 4.0010 3.0801 0.0 0 VAL=6
M  V30 3 O 3.2310 4.4137 0.0 0
M  V30 4 O 4.7710 1.7462 0.0 0
M  V30 5 N 14.2197 4.7128 0.0 0
M  V30 6 C 15.5534 5.4828 0.0 0
M  V30 7 O 16.8871 4.7128 0.0 0
M  V30 8 C 7.4779 7.1665 0.0 0
M  V30 9 C 7.0021 5.7018 0.0 0
M  V30 10 N 8.8849 7.7929 0.0 0
M  V30 11 C 6.4475 8.3109 0.0 0
M  V30 12 C 5.4958 5.3816 0.0 0
M  V30 13 C 7.7721 4.3682 0.0 0
M  V30 14 C 8.7240 9.3244 0.0 0
M  V30 15 N 7.2175 9.6446 0.0 0
M  V30 16 C 4.9412 7.9908 0.0 0
M  V30 17 N 5.3348 3.8501 0.0 0
M  V30 18 N 4.4653 6.5260 0.0 0
M  V30 19 C 6.7417 3.2236 0.0 0
M  V30 20 C 10.2186 7.0229 0.0 0 CFG=1
M  V30 21 C 11.5523 7.7929 0.0 0
M  V30 22 C 10.2186 5.4828 0.0 0
M  V30 23 C 12.8861 7.0229 0.0 0
M  V30 24 C 11.5523 4.7128 0.0 0
M  V30 25 C 12.8861 5.4828 0.0 0 CFG=1
M  V30 26 C 2.6673 2.3101 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3337 3.0801 0.0 0
M  V30 29 C 1.3337 0.0000 0.0 0
M  V30 30 C 0.0000 2.3101 0.0 0
M  V30 31 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 2 26
M  V30 6 1 5 6
M  V30 7 1 25 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 20 10 CFG=3
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 12 18
M  V30 20 2 13 19
M  V30 21 2 14 15
M  V30 22 2 16 18
M  V30 23 1 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 20 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315497-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315497-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4649922
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Trans
N-[4-(6-benzenesulfonyl-2-methyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexyl]-formamide
Acetic anhydride (342 μL, 3.6 mmol) was dissolved in formic acid (680
μ1,18 mmol) at 0 °C. The mixture was stirred for 5 min, then stirred at
50 °C for 10 min, then cooled to 0 °C. A solution of trans
4-(6-benzenesulfonyl-2-methyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexylamine
(370 mg, 0.90 mmol) in THF (1 mL) was added and the mixture was stirred
for 1.75 h at 0 °C. Further acetic anhydride (86 μL, 0.90 mmol) and
formic acid (170 μL, 4.5 mmol), premixed as described above, were added
and the mixture was stirred a further 30 min at 0 °C. Saturated aqueous
NaHCO3 was added and the mixture extracted with DCM (x3). The combined
organic extracts were washed with brine then dried (Na2SO4) and
concentrated under vacuum to give of trans
N-[4-(6-benzenesulfonyl-2-methyl-6H-1,3,5,6-tetraaza-as-indacen-1-yl)-cyclohexyl]-formamide
which was used without further purification. Yield 390 mg (99%) LCMS
(Method B, ESI): RT = 2.66 min, m+H = 438.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of Ac2O and HCOOH in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic heterocyclic compounds as JAK1 inhibitors, and their
preparation, compositions and use in the treatment of immunological and
hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babu, Srinivasan; Bergeron, Phillippe; Dragovich, Peter; Dyke, Hazel
Joan; Gibbons, Paul; Gradl, Stefan; Hanan, Emily; Hurley, Christopher;
Johnson, Tony; Koehler, Michael; Kulagowski, Janusz Josef; Labadie,
Sharada Shenvi; Lyssikatos, Joseph P.; Mendonca, Rohan; Pulk, Rebecca;
Ward, Stuard; Waszkowycz, Bohdan; Zak, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011086053 A1 2011-07-21

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R,8aS)-Octahydro-2-(phenylmethyl)pyrrolo[1,2-a]pyrazin-7-ol
C14H20N2O
132715-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.7617 0.0 0
M  V30 2 O 11.9119 2.3017 0.0 0
M  V30 3 C 8.0021 1.5317 0.0 0 CFG=1
M  V30 4 N 8.0021 3.0717 0.0 0
M  V30 5 C 6.6684 0.7617 0.0 0
M  V30 6 C 9.4667 1.0557 0.0 0
M  V30 7 C 6.6684 3.8417 0.0 0
M  V30 8 C 9.4667 3.5475 0.0 0
M  V30 9 N 5.3347 1.5317 0.0 0
M  V30 10 C 10.3719 2.3017 0.0 0 CFG=1
M  V30 11 C 5.3347 3.0717 0.0 0
M  V30 12 C 2.6674 1.5317 0.0 0
M  V30 13 C 2.6674 3.0717 0.0 0
M  V30 14 C 1.3336 0.7617 0.0 0
M  V30 15 C 1.3336 3.8417 0.0 0
M  V30 16 C 0.0000 1.5317 0.0 0
M  V30 17 C 0.0000 3.0717 0.0 0
M  V30 18 H 8.1631 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 12
M  V30 3 1 10 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 18 CFG=3
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 5 9
M  V30 11 1 6 10
M  V30 12 1 7 11
M  V30 13 1 8 10
M  V30 14 1 9 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (7R,8aS)-octahydropyrrolo[1,2-a]pyrazin-7-ol (1:1)
C7H14N2O.CH2O2
1515936-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5770 4.6117 0.0 0
M  V30 2 C 2.6673 3.8417 0.0 0 CFG=2
M  V30 3 N 2.6673 5.3817 0.0 0
M  V30 4 C 4.1320 3.3657 0.0 0
M  V30 5 C 1.3336 3.0717 0.0 0
M  V30 6 C 4.1320 5.8576 0.0 0
M  V30 7 C 1.3336 6.1517 0.0 0
M  V30 8 C 5.0370 4.6117 0.0 0 CFG=1
M  V30 9 N 0.0000 3.8417 0.0 0
M  V30 10 C 0.0000 5.3817 0.0 0
M  V30 11 H 2.8282 2.3100 0.0 0
M  V30 12 C 3.2885 0.0000 0.0 0
M  V30 13 O 1.9548 0.7700 0.0 0
M  V30 14 O 4.6222 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 11 CFG=3
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 8
M  V30 11 1 7 10
M  V30 12 1 9 10
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132715-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1515936-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-9794590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of octahydropyrrolo[1,2-a]pyrazine derivatives of carbapenem
as antibacterial antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Zhenhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Singapore, SG185170 A1 2012-11-29

$RFMT $RIREG SCHEME374 STEP1
$RXN



  3  1
$MOL
Magnesium, bromo(1-methylethenyl)-
C3H5BrMg
13291-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Mg 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 Br 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(1,1-Dimethylethyl)phenyl]methylene]-2-methyl-2-propanesulfinamide
C15H23NOS
1431851-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 4.0009 0.0 0
M  V30 2 N 3.6436 2.6673 0.0 0
M  V30 3 S 2.1036 2.6673 0.0 0 VAL=4
M  V30 4 C 1.3336 1.3336 0.0 0
M  V30 5 O 1.3336 4.0009 0.0 0
M  V30 6 C 2.6673 0.5636 0.0 0
M  V30 7 C 0.5636 0.0000 0.0 0
M  V30 8 C 0.0000 2.1036 0.0 0
M  V30 9 C 10.5736 4.0009 0.0 0
M  V30 10 C 10.5736 5.5409 0.0 0
M  V30 11 C 12.1136 4.0009 0.0 0
M  V30 12 C 10.5736 2.4609 0.0 0
M  V30 13 C 5.9536 4.0009 0.0 0
M  V30 14 C 6.7236 5.3347 0.0 0
M  V30 15 C 6.7236 2.6673 0.0 0
M  V30 16 C 8.2636 5.3347 0.0 0
M  V30 17 C 8.2636 2.6673 0.0 0
M  V30 18 C 9.0336 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[4-(1,1-Dimethylethyl)phenyl]-2-methyl-2-propen-1-yl]formamide
C15H21NO
1431851-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 2.3100 4.0011 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 0.7700 1.3338 0.0 0
M  V30 7 O 0.0000 5.3349 0.0 0
M  V30 8 C 9.2400 2.6674 0.0 0
M  V30 9 C 9.2400 1.1274 0.0 0
M  V30 10 C 10.7800 2.6674 0.0 0
M  V30 11 C 9.2400 4.2074 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.9300 1.3338 0.0 0
M  V30 17 C 7.7000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13291-18-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1431851-31-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1431851-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26631728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(1-(4-(tert-butyl)phenyl)-2-methylallyl)formamide (1m) A solution of
N-(4-(tert-butyl)benzylidene)-2-methylpropane-2-sulfinamide (S8) (0.500
g, 1.88 mmol, 1.0 eq.) in THF (6.3 mL) was cooled to -78 °C (dry
ice/acetone bath) and treated dropwise with a solution of allylmagnesium
bromide (0.5 M in THF) (6.41 mL, 3.20 mmol, 1.7 eq.). The mixture was
allowed to warm up to room temperature over 30 min and stirred for
additional 20 minutes. The mixture was then cooled to 0 °C and quenched
by careful addition of sat. aq. NH4Cl solution (5 mL). The resulting
mixture was extracted with EtOAc (80 mL) and the organic layer washed
sequentially with sat. aq. NH4Cl, water and brine (20 mL each), dried
over Na2SO4 and concentrated to give the addition product as an
inconsequential mixture of diastereomers (ratio 4:1-unassigned). The
crude mixture was taken up in MeOH (12.6 mL), cooled to 0 °C and treated
dropwise with HCl (4M solution in dioxane) (2.36 mL, 9.42 mmol, 5.0 eq.).
The resulting mixture was stirred for 10min at room temperature and then
evaporated to dryness under reduced pressure. The crude hydrochloride
salt was suspended in dry THF (12.6 mL), treated with sodium bicarbonate
(0.396 g, 4.71 mmol, 2.5 eq.) and cooled to 0 °C. In a separate flask,
formic acid (0.72 mL, 19 mmol, 10 eq.) was added slowly to cooled (0 °C,
ice bath) acetic anhydride (0.72 mL, 7.5 mmol, 4 eq.). This mixture was
stirred at 40 °C for 15 min and then cooled back to 0 °C. This
formic-acetic anhydride (FAA) solution was then added dropwise to the
cooled (0 °C) mixture containing the amine (prepared above) and the
resulting mixture stirred at r.t. for 12h. The mixture was finally
treated with water (5 mL) sat. aq. NaHCO3 (10 mL) and extracted with
EtOAc (50 mL). The organic layer was washed sequentially with sat. aq.
NaHCO3 (5x 10 mL), water (10 mL) and brine (10 mL), dried over Na2SO4 and
concentrated. The residue was purified by flash chromatography on silica
gel, eluting with 33-50% EtOAc in hexanes to give the title compound
N-(1-(4-(tert-butyl)phenyl)-2-methylallyl)formamide. (0.433 g, 1.87 mmol,
99%), clear oil. Rf (Hexanes/EtOAc 1:1): 0.44 1H NMR (CDCl3, 400MHz,
293K) (1:0.25 mixture of rotamers): δ 8.24 (s, 1HM), 8.13 (d, J = 12.0
Hz, 1Hm), 7.41 -7.34 (m, 2HM+m), 7.24 -7.15 (m, 2HM+m), 5.93 -5.76 (s,
br, 1HM+m), 5.53 (d, J = 8.3 Hz, 1HM), 5.08 -5.00 (m, 2HM+m), 4.98 (d, J
= 8.2 Hz, 1Hm), 1.69 (s, 1HM), 1.68 (s, 1Hm), 1.32 (s, 9Hm), 1.31 (s,
9HM) 13C NMR (CDCl3, 101MHz, 293K) (1:0.25 mixture of rotamers): δ 164.2,
159.9, 151.2, 151.0, 144.6, 143.4, 136.3, 135.8, 127.0, 126.7, 125.9,
125.8, 113.4, 111.6, 61.1, 56.8, 34.6, 34.5, 31.3, 31.3, 20.4, 19.7 IR: ν
3279, 2963, 2868, 1662, 1510, 1380, 1233, 901, 828 HRMS (ESI): calcd for
C15H22NO+ (M+H)+ 232.1696 Found: 232.1695.
$DTYPE RXN:VAR(1):NOTES
$DATUM mixtures from stage 4 and stage 5 combined in stage 6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ruthenium-Catalyzed Intramolecular Hydrocarbamoylation of Allylic
Formamides: Convenient Access to Chiral Pyrrolidones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Armanino, Nicolas; Carreira, Erick M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(18), 6814-6817

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-methyl-1H-pyrazole
C4H5ClN2
134589-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 0.0000 0.0 0
M  V30 2 Cl 3.9563 1.9692 0.0 0
M  V30 3 C 1.2459 1.5400 0.0 0
M  V30 4 C 2.4917 2.4452 0.0 0
M  V30 5 C 0.0000 2.4452 0.0 0
M  V30 6 N 2.0159 3.9098 0.0 0
M  V30 7 N 0.4759 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-methyl-1H-pyrazole-1-carboxaldehyde
C5H5ClN2O
2794913-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 C 1.6752 0.0000 0.0 0
M  V30 4 Cl 0.0000 2.9016 0.0 0
M  V30 5 N 3.9690 3.2587 0.0 0
M  V30 6 C 3.8079 1.7271 0.0 0
M  V30 7 N 2.5620 3.8850 0.0 0
M  V30 8 C 2.3016 1.4070 0.0 0
M  V30 9 C 1.5316 2.7406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134589-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2794913-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33618185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of galactosides as inhibitor of galectins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zetterberg, Fredrik; Peterson, Kristoffer
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022136307 A1 2022-06-30

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Methylphenoxy)ethanol
C9H12O2
13605-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(3-methylphenoxy)-, 1-formate
C10H12O3
2417431-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 O 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13605-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24466973
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1Z)-2-Phenylethenyl]-1H-isoindole-1,3(2H)-dione
C16H11NO2
136613-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1423 5.3386 0.0 0
M  V30 2 O 4.2009 0.0000 0.0 0
M  V30 3 C 6.3558 1.7114 0.0 0
M  V30 4 C 7.7516 2.3622 0.0 0
M  V30 5 C 2.8942 3.7646 0.0 0
M  V30 6 C 2.6268 2.2480 0.0 0
M  V30 7 C 4.4193 3.9790 0.0 0
M  V30 8 C 1.7145 4.7545 0.0 0
M  V30 9 C 3.9865 1.5249 0.0 0
M  V30 10 C 1.1797 1.7213 0.0 0
M  V30 11 N 5.0944 2.5948 0.0 0
M  V30 12 C 0.2673 4.2278 0.0 0
M  V30 13 C 0.0000 2.7112 0.0 0
M  V30 14 C 8.5216 3.6961 0.0 0
M  V30 15 C 10.0616 3.6961 0.0 0
M  V30 16 C 7.7516 5.0297 0.0 0
M  V30 17 C 10.8316 5.0297 0.0 0
M  V30 18 C 8.5216 6.3634 0.0 0
M  V30 19 C 10.0616 6.3634 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-1,3-dioxo-α-phenyl-2H-isoindole-2-propanoic acid
C17H13NO4
54373-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 5.8172 6.2291 0.0 0
M  V30 5 O 8.4743 6.4615 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 N 5.0370 2.7104 0.0 0
M  V30 9 C 4.1320 3.9564 0.0 0
M  V30 10 C 4.1320 1.4645 0.0 0
M  V30 11 C 2.6673 3.4804 0.0 0
M  V30 12 C 2.6673 1.9404 0.0 0
M  V30 13 C 1.3336 4.2504 0.0 0
M  V30 14 C 1.3336 1.1704 0.0 0
M  V30 15 C 0.0000 3.4804 0.0 0
M  V30 16 C 0.0000 1.9404 0.0 0
M  V30 17 C 8.8870 4.0442 0.0 0
M  V30 18 C 9.6570 2.7104 0.0 0
M  V30 19 C 9.6570 5.3778 0.0 0
M  V30 20 C 11.1970 2.7104 0.0 0
M  V30 21 C 11.1970 5.3778 0.0 0
M  V30 22 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 136613-13-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54373-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-ethenyl-4-hydroxybenzoate
C11H12O3
1396690-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-ethenyl-4-(formyloxy)benzoate
C12H12O4
1396690-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2401 4.0011 0.0 0
M  V30 2 C 10.0101 5.3348 0.0 0
M  V30 3 O 11.5501 5.3348 0.0 0
M  V30 4 C 7.7001 1.3338 0.0 0
M  V30 5 C 6.9301 0.0000 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 O 2.3100 5.3348 0.0 0
M  V30 8 O 2.3100 2.6675 0.0 0
M  V30 9 C 0.7700 5.3348 0.0 0
M  V30 10 C 0.0000 6.6686 0.0 0
M  V30 11 C 7.7001 4.0011 0.0 0
M  V30 12 C 6.9301 2.6675 0.0 0
M  V30 13 C 6.9301 5.3348 0.0 0
M  V30 14 C 5.3901 2.6675 0.0 0
M  V30 15 C 5.3901 5.3348 0.0 0
M  V30 16 C 4.6201 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1396690-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396690-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-15517588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 2: Formic acid (23.6 mmol, 10 equiv)
was added to acetic anhydride (18.9 mmol, 8 equiv) at RT. The resulting
mixture was stirred at 60 °C for 1 h and cooled to RT. Phenol derivative
synthesized above (2.40 mmol) and sodium hydrogen carbonate (4.80 mmol,
2.0 equiv) were added to the solution and the mixture was stirred for
9-16 h. The reaction mixture was diluted with Et2O, washed with H2O three
times, dried over MgSO4, filtered, and concentrated. The obtained residue
was purified by column chromatography on neutral silica gel to afford the
desired product. Ethyl 4-(formyloxy)-3-vinylbenzoate (5d). 5d was
obtained from S4 using method 2 as a colorless oil. Yield: 99%. 1H NMR
(400 MHz, CDCl3) δ 8.33 (s, 1H), 8.29 (d, 1H, J = 2.0 Hz), 7.98 (dd, 1H,
J = 8.8, 2.0 Hz), 7.18 (d, 1H, J = 8.8 Hz), 6.80 (dd, 1H, J = 17.2, 11.2
Hz), 5.90 (dd, 1H, J = 17.2, 0.8 Hz), 5.45 (dd, 1H, J = 11.2, 0.8 Hz),
4.40 (q, 2H, J = 6.8 Hz), 1.41 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz,
CDCl3) δ 165.5, 158.3, 150.1, 130.1, 129.8, 129.2, 128.9, 128.2, 122.1,
118.1, 61.2, 14.2; IR (ATR) 1744, 1713, 1287, 1248, 1171, 1105, 1074 and
758 cm-1; HRMS (DART) [M+H]+ calcd for C12H13O4 : 221.0809; found
221.0801.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Remarkable Improvement Achieved by Imidazole Derivatives in
Ruthenium-Catalyzed Hydroesterification of Alkenes Using Formates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konishi, Hideyuki; Ueda, Tsuyoshi; Muto, Takashi; Manabe, Kei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(18), 4722-4725

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
N-(1,1-Diethyl-2-propen-1-yl)-2-methyl-2-propanesulfinamide
C11H23NOS
1431851-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.6675 0.0 0
M  V30 2 N 4.0012 3.4375 0.0 0
M  V30 3 C 6.1048 4.0012 0.0 0
M  V30 4 C 6.6687 1.8975 0.0 0
M  V30 5 C 4.5648 1.3338 0.0 0
M  V30 6 S 2.6675 2.6675 0.0 0 VAL=4
M  V30 7 C 5.3348 5.3350 0.0 0
M  V30 8 C 8.0023 2.6675 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 1.3337 3.4375 0.0 0
M  V30 11 O 2.6675 1.1275 0.0 0
M  V30 12 C 2.1037 4.7712 0.0 0
M  V30 13 C 0.0000 4.2075 0.0 0
M  V30 14 C 0.5637 2.1038 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,1-Diethyl-2-propen-1-yl)formamide
C8H15NO
1431851-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.6675 0.0 0
M  V30 2 N 4.0012 3.4375 0.0 0
M  V30 3 C 3.4375 1.3338 0.0 0
M  V30 4 C 1.8975 4.0012 0.0 0
M  V30 5 C 1.3338 1.8975 0.0 0
M  V30 6 C 5.3348 2.6675 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 2.6675 5.3350 0.0 0
M  V30 9 C 0.0000 2.6675 0.0 0
M  V30 10 O 6.6687 3.4375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1431851-24-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1431851-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27669399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure C: A solution of the substrate allyl-t-butylsulfinamide
(1.50 mmol, 1.0 eq.) in MeOH (10 mL) was cooled to 0 °C (ice bath) and
treated dropwise with a solution of hydrogen chloride in dioxane (1.88
mL, 4M solution, 7.50 mmol, 5 eq.). The resulting solution was allowed to
warm to r.t. and stirred for 10min until complete disappearance of the
starting material by TLC analysis (silica plate, elution with 100%
EtOAc). The solvent was then removed by rotary evaporation at 40 °C under
reduced pressure and the remaining residue dried at 0.5 mbar for 2h. The
residue was suspended in dry THF (10 mL), cooled to 0 °C (ice bath) and
treated with sodium bicarbonate (0.151 g, 1.80 mmol, 1.2 eq.). In a
separate dry flask, formic acid (0.58 mL, 15 mmol, 10 eq.) was added
slowly to cooled (0 °C, ice bath) acetic anhydride (0.58 mL, 6.0 mmol, 4
eq.). This mixture was stirred at 40 °C for 15 min and then cooled back
to 0 °C. This formic-acetic anhydride (FAA) solution was then added
dropwise to the cooled (0 °C) mixture containing the allylic amine
(prepared above) and the resulting mixture stirred at r.t. for 3h. The
resulting mixture was diluted with EtOAc (50 mL) and washed with sat. aq.
NaHCO3 (3x30 mL). The aqueous layers were back-extracted with EtOAc (50
mL) and the combined organic layers washed with water (20 mL) and brine
(20 mL), dried over Na2SO4, filtered and concentrated. The residue was
purified by flash column chromatography on silica gel, eluting with 20
-50% EtOAc in hexanes. N-(3-ethylpent-1-en-3-yl)formamide (1 g) Prepared
following general procedure C, using
N-(3-ethylpent-1-en-3-yl)-2-methylpropane-2-sulfinamide (S1) (0.326 g,
1.50 mmol) to give the desired product N-(3-ethylpent-1-en-3-yl)formamide
(1 g). (0.210 g, 1.49 mmol, 99%), pale yellow oil. Rf (hexane:EtOAc =
2:1): 0.37 1H NMR (CDCl3, 400MHz, 293K) (1:0.6 mixture of rotamers): δ
8.21 -8.13 (m, 1H), 5.83 -5.63 (m, 2H), 5.33 -5.03 (m, 2H), 2.10 -1.59
(m, 4H), 0.90 (t, J = 7.4 Hz, 3HM), 0.84 (t, J = 7.5 Hz, 3Hm) 13C NMR
(CDCl3, 101MHz, 293K) (1:0.6 mixture of rotamers): δ 164.2, 160.2, 141.5,
141.3, 115.3, 113.2, 61.3, 59.6, 31.2, 29.2, 7.7, 7.4 IR: ν 3294, 2971,
2938, 2881, 1686, 1525, 1461, 1389, 1308 HRMS (ESI): calcd for C8H16NO+
(M+H)+ 142.1226 Found: 142.1223.
$DTYPE RXN:VAR(1):NOTES
$DATUM mixtures from stage 2 and stage 3 combined in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ruthenium-Catalyzed Intramolecular Hydrocarbamoylation of Allylic
Formamides: Convenient Access to Chiral Pyrrolidones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Armanino, Nicolas; Carreira, Erick M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(18), 6814-6817

$RFMT $RIREG SCHEME380 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2S)-2-[[(1S)-1-Phenylethyl]amino]cyclohexanol
C14H21NO
145166-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0 CFG=1
M  V30 6 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=3
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 11
M  V30 5 1 6 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2S)-2-[Methyl[(1S)-1-phenylethyl]amino]cyclohexanol
C15H23NO
507224-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 3 C 5.3900 1.3338 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0 CFG=1
M  V30 7 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 12
M  V30 6 1 7 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 145166-02-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 507224-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15328605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some new tertiary amines and their application as
co-catalysts in combination with L-proline in enantioselective
Baylis-Hillman reaction between ortho-nitrobenzaldehyde and methyl vinyl
ketone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Hongying; Zhao, Guofeng; Zhou, Zhenghong; Zhou, Qilin; Tang, Chuchi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2006), 47(32), 5717-5721

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-3,6-dideoxy-2,4-bis-O-(phenylmethyl)-α-D-galactopyranoside
C21H27NO4
1485588-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0
M  V30 3 O 5.3347 1.5400 0.0 0
M  V30 4 C 5.3347 0.0000 0.0 0
M  V30 5 N 8.0021 6.1600 0.0 0
M  V30 6 O 10.6696 4.6200 0.0 0
M  V30 7 C 12.0032 3.8500 0.0 0
M  V30 8 C 10.6696 1.5400 0.0 0
M  V30 9 C 6.6685 3.8500 0.0 0 CFG=2
M  V30 10 C 6.6685 2.3100 0.0 0 CFG=1
M  V30 11 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 12 O 8.0021 1.5400 0.0 0
M  V30 13 C 9.3358 3.8500 0.0 0 CFG=1
M  V30 14 C 9.3358 2.3100 0.0 0 CFG=2
M  V30 15 C 2.6674 4.6200 0.0 0
M  V30 16 C 2.6674 6.1600 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 1.3338 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 21 C 13.3369 4.6200 0.0 0
M  V30 22 C 14.6705 3.8500 0.0 0
M  V30 23 C 13.3369 6.1600 0.0 0
M  V30 24 C 16.0043 4.6200 0.0 0
M  V30 25 C 14.6705 6.9300 0.0 0
M  V30 26 C 16.0043 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 10 3 CFG=3
M  V30 6 1 11 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 13 6 CFG=1
M  V30 9 1 7 21
M  V30 10 1 14 8 CFG=1
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 11 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3,6-dideoxy-3-(formylamino)-2,4-bis-O-(phenylmethyl)-α-D-galactopyrano...
C22H27NO5
1485588-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0021 6.1600 0.0 0
M  V30 2 C 9.3358 6.9300 0.0 0
M  V30 3 O 9.3358 8.4700 0.0 0
M  V30 4 O 5.3347 4.6200 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 O 10.6696 4.6200 0.0 0
M  V30 7 C 12.0032 3.8500 0.0 0
M  V30 8 O 5.3347 1.5400 0.0 0
M  V30 9 C 5.3347 0.0000 0.0 0
M  V30 10 C 10.6696 1.5400 0.0 0
M  V30 11 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 12 C 6.6685 3.8500 0.0 0 CFG=1
M  V30 13 C 9.3358 3.8500 0.0 0 CFG=1
M  V30 14 C 6.6685 2.3100 0.0 0 CFG=1
M  V30 15 C 9.3358 2.3100 0.0 0 CFG=1
M  V30 16 O 8.0021 1.5400 0.0 0
M  V30 17 C 2.6674 4.6200 0.0 0
M  V30 18 C 2.6674 6.1600 0.0 0
M  V30 19 C 1.3338 3.8500 0.0 0
M  V30 20 C 1.3338 6.9300 0.0 0
M  V30 21 C 0.0000 4.6200 0.0 0
M  V30 22 C 0.0000 6.1600 0.0 0
M  V30 23 C 13.3369 4.6200 0.0 0
M  V30 24 C 14.6705 3.8500 0.0 0
M  V30 25 C 13.3369 6.1600 0.0 0
M  V30 26 C 16.0043 4.6200 0.0 0
M  V30 27 C 14.6705 6.9300 0.0 0
M  V30 28 C 16.0043 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 12 4 CFG=3
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 13 6 CFG=1
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 1 14 8 CFG=3
M  V30 12 1 15 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1485588-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1485588-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12620333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of methyl 3-amino-3,6-dideoxy-α-D-galactopyranoside carrying
different amide substituents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mobarak, Hani; Engstroem, Olof; Widmalm, Goeran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(45), 23090-23097

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzoic acid
C7H7NO2
150-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)benzoic acid
C8H7NO3
28533-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28533-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14084019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thioester-isocyanides: versatile reagents for the synthesis of cycle-tail
peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rotstein, Benjamin H.; Winternheimer, David J.; Yin, Lois M.; Deber,
Charles M.; Yudin, Andrei K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(31),
3775-3777

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-5-fluoro-1,3-dihydro-2H-indol-2-one
C8H7FN2O
150544-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 0.0000 0.0 0
M  V30 2 O 7.9110 1.5400 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 C 4.0011 0.7700 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 C 5.4658 0.2941 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 N 5.4658 2.7859 0.0 0
M  V30 10 C 1.3338 0.7700 0.0 0
M  V30 11 C 6.3710 1.5400 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Fluoro-2,3-dihydro-2-oxo-1H-indol-6-yl)formamide
C9H7FN2O2
945379-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6213 2.6673 0.0 0
M  V30 2 C 8.3913 4.0010 0.0 0
M  V30 3 O 9.9313 4.0010 0.0 0
M  V30 4 O 0.0000 5.2891 0.0 0
M  V30 5 F 6.0812 0.0000 0.0 0
M  V30 6 C 3.7712 4.0010 0.0 0
M  V30 7 C 3.0012 2.6673 0.0 0
M  V30 8 C 5.3112 4.0010 0.0 0
M  V30 9 N 2.7406 5.1455 0.0 0
M  V30 10 C 3.7712 1.3337 0.0 0
M  V30 11 C 1.4947 2.9875 0.0 0
M  V30 12 C 6.0812 2.6673 0.0 0
M  V30 13 C 1.3338 4.5190 0.0 0
M  V30 14 C 5.3112 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 2 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150544-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945379-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7195937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of acetic anhydride (1.6 ml) and formic acid (1.2 ml) was
stirred for 1 hour at room temperature, and added with
6-amino-5-fluoro-1,3-dihydro-indol-2-one (4.0 g, 24 mmol) obtained from
Example 7 in 60 ml of tetrahydrofuran and piperidine (0.04 ml). Upon the
completion of the addition, the mixture was stirred for 3 hours at room
temperature until a precipitate was formed. The solid was filtered and
recrystallized from methanol to give
N-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-7-yl) -formamide (4.6 g, 99%) as a
white solid. MS m/z (ESI):195 [M+1]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolo[3,2-c]pyridine-4-one 2-indolinone as protein kinase inhibitors
and their preparation, pharmaceutical compositions and use in the
treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deng, Bingchu; Su, Yidong; Zhang, Lei; Xiao, Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007085188 A1 2007-08-02

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Methylphenoxy)ethanol
C9H12O2
15149-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(4-methylphenoxy)-, 1-formate
C10H12O3
2417431-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 O 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15149-10-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24446290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Morpholinoaniline
C10H14N2O
159724-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0021 3.0800 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 5.3347 3.0800 0.0 0
M  V30 4 C 4.0011 0.7700 0.0 0
M  V30 5 C 6.6685 2.3100 0.0 0
M  V30 6 C 5.3347 0.0000 0.0 0
M  V30 7 C 6.6685 0.7700 0.0 0
M  V30 8 N 2.6674 3.0800 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 1.3336 5.3900 0.0 0
M  V30 13 O 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(4-morpholinyl)benzenamine
C11H16N2O
84995-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 N 2.6675 3.0801 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 O 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159724-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84995-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30786799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryloxypyrido[3,4-d]pyrimidin-4-ol derivatives as histone
demethylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boloor, Amogh; Kanouni, Toufike; Stafford, Jeffrey Alan; Veal, James
Marvin; Wallace, Michael Brennan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160194323 A1 2016-07-07

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-nitroaniline
C6H5ClN2O2
1635-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chlorobenzimidazole
C7H5ClN2
4887-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1635-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-2505613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Experimental Procedure
1H-Benzo[d]imidazole15 (1): A 40 mL glass vial was charged with
o-nitroaniline (0.138 g, 1.00 mmol), iron powder 325 mesh (0.558 g, 10.0
mmol), NH4Cl (0.535 g, 10.0 mmol), and a magnetic stir bar. 2-PrOH (5.0
mL) and formic acid (5.0 mL) were added, and the reaction vial was sealed
with a Teflon-lined cap. The reaction mixture was stirred at 80 °C for 1
h at which time LC-MS analysis indicated that conversion into the product
was complete. The reaction mixture was diluted with 2-PrOH (10 mL) and
filtered to remove insoluble materials. The filtrate was concentrated to
dryness, and the resulting residue partitioned between CH2Cl2 (20 mL) and
(5 mL) sat. aq NaHCO3. The aqueous layer was extracted with additional
CH2Cl2 (5 x 20 mL). The combined organic extracts were dried over MgSO4,
filtered, and concentrated. 5-Chloro-1H-benzo[d]imidazole (7). ESI-MS:
m/z = 152.9 [M + H]+. 1H NMR (400 MHz, DMSO): δ = 12.60 (s, 1 H), 8.27
(s, 1 H), 7.62 (m, 2 H), 7.22 (d, J = 7.7 Hz, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and general one-pot reduction and cyclization of aromatic and
heteroaromatic 2-nitroamines to bicyclic 2H-imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanan, Emily J.; Chan, Bryan K.; Estrada, Anthony A.; Shore, Daniel G.;
Lyssikatos, Joseph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (18), 2759-2764

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-Amino-N-(8α,9S)-cinchonan-9-yl-4-methylpentanamide
C25H34N4O
1640010-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 5.3348 0.0 0 CFG=1
M  V30 2 N 6.1601 6.6685 0.0 0
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 3.8501 8.0023 0.0 0 CFG=1
M  V30 5 O 3.8501 5.3348 0.0 0
M  V30 6 C 2.3101 8.0023 0.0 0
M  V30 7 N 4.6201 9.3360 0.0 0
M  V30 8 C 1.5400 9.3360 0.0 0
M  V30 9 C 0.0000 9.3360 0.0 0
M  V30 10 C 2.3101 10.6697 0.0 0
M  V30 11 C 12.7620 8.7291 0.0 0
M  V30 12 C 14.0608 7.9018 0.0 0
M  V30 13 C 8.4702 5.3348 0.0 0 CFG=2
M  V30 14 N 9.0824 6.8601 0.0 0 CFG=1
M  V30 15 C 9.3354 6.1626 0.0 0
M  V30 16 C 10.5663 6.8585 0.0 0
M  V30 17 C 8.0049 8.0531 0.0 0
M  V30 18 C 9.8844 8.0025 0.0 0 CFG=2
M  V30 19 C 11.3959 8.0180 0.0 0 CFG=2
M  V30 20 C 8.7529 9.2342 0.0 0
M  V30 21 C 6.1601 4.0012 0.0 0
M  V30 22 C 6.9302 2.6673 0.0 0
M  V30 23 C 4.6201 4.0012 0.0 0
M  V30 24 C 6.1601 1.3337 0.0 0
M  V30 25 C 8.4702 2.6673 0.0 0
M  V30 26 C 3.8501 2.6673 0.0 0
M  V30 27 N 4.6201 1.3337 0.0 0
M  V30 28 C 6.9302 0.0000 0.0 0
M  V30 29 C 9.2402 1.3337 0.0 0
M  V30 30 C 8.4702 0.0000 0.0 0
M  V30 31 H 9.0438 3.9055 0.0 0
M  V30 32 H 10.4966 9.4156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 13
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=3
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 19 11 CFG=1
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=1
M  V30 16 1 13 31 CFG=3
M  V30 17 1 14 16 CFG=1
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 18 32 CFG=1
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 22 25
M  V30 29 1 23 26
M  V30 30 1 24 27
M  V30 31 1 24 28
M  V30 32 2 25 29
M  V30 33 2 26 27
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 4 13 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-N-(8α,9S)-Cinchonan-9-yl-2-(formylamino)-4-methylpentanamide
C26H34N4O2
1620137-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 5.3348 0.0 0 CFG=1
M  V30 2 N 6.1601 6.6685 0.0 0
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 3.8501 8.0022 0.0 0 CFG=1
M  V30 5 O 3.8501 5.3348 0.0 0
M  V30 6 C 4.6201 9.3360 0.0 0
M  V30 7 N 2.3101 8.0022 0.0 0
M  V30 8 C 3.8501 10.6697 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 2.3101 10.6697 0.0 0
M  V30 11 C 4.6201 12.0033 0.0 0
M  V30 12 O 0.0000 6.6685 0.0 0
M  V30 13 C 12.7620 8.7291 0.0 0
M  V30 14 C 14.0608 7.9016 0.0 0
M  V30 15 C 8.4702 5.3348 0.0 0 CFG=2
M  V30 16 N 9.0823 6.8601 0.0 0 CFG=1
M  V30 17 C 9.3354 6.1624 0.0 0
M  V30 18 C 10.5663 6.8585 0.0 0
M  V30 19 C 8.0049 8.0531 0.0 0
M  V30 20 C 9.8846 8.0025 0.0 0 CFG=2
M  V30 21 C 11.3959 8.0180 0.0 0 CFG=2
M  V30 22 C 8.7529 9.2342 0.0 0
M  V30 23 C 6.1601 4.0012 0.0 0
M  V30 24 C 6.9302 2.6673 0.0 0
M  V30 25 C 4.6201 4.0012 0.0 0
M  V30 26 C 6.1601 1.3337 0.0 0
M  V30 27 C 8.4702 2.6673 0.0 0
M  V30 28 C 3.8501 2.6673 0.0 0
M  V30 29 N 4.6201 1.3337 0.0 0
M  V30 30 C 6.9302 0.0000 0.0 0
M  V30 31 C 9.2402 1.3337 0.0 0
M  V30 32 C 8.4702 0.0000 0.0 0
M  V30 33 H 9.0438 3.9055 0.0 0
M  V30 34 H 10.4966 9.4156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 15
M  V30 3 1 1 23
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=1
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 21 13 CFG=1
M  V30 16 1 15 16
M  V30 17 1 15 17 CFG=1
M  V30 18 1 15 33 CFG=3
M  V30 19 1 16 18 CFG=1
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 20 34 CFG=1
M  V30 27 1 23 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 1 26 29
M  V30 33 1 26 30
M  V30 34 2 27 31
M  V30 35 2 28 29
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 4 15 16 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1640010-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620137-49-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11574577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, literature preparation, 73% global yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel cinchona-amino acid hybrid organocatalysts for
asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrulas, Pedro; Benaglia, Maurizio; Burke, Anthony J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2014), 25(12), 923-935

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Iodocyclohexene
C6H9I
17497-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclohexene-1-carboxylic acid
C7H10O2
636-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17497-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 636-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30448374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7688-25-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, optimization study (optimized on temperature and
stoichiometry of reactant and reagent), conversion = greater than 99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylations of alkenyl halides with formic acid to
get corresponding α,β-unsaturated carboxylic acids and esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartal, Brigitta; Mikle, Gabor; Kollar, Laszlo; Pongracz, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Catalysis (2019), 467143-149

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-2-methyl-, methyl ester
C9H11NO2
18583-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(formylamino)-2-methylbenzoate
C10H11NO3
1482449-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 N 8.0023 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 O 10.6697 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18583-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1482449-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5′S,7′aS)-2′,3′,5′,6′,7′,7′a-Hexahydro-4′,7′a-dimethylspiro[1,3-dioxolane-2,...
C13H20O3
1870866-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4888 4.1792 0.0 0
M  V30 2 C 6.8627 0.0000 0.0 0
M  V30 3 O 8.4027 2.6675 0.0 0
M  V30 4 C 2.2763 2.3472 0.0 0
M  V30 5 C 3.7826 2.6675 0.0 0 CFG=2
M  V30 6 C 2.1154 0.8156 0.0 0
M  V30 7 O 0.7700 2.0270 0.0 0
M  V30 8 O 2.4373 3.8789 0.0 0
M  V30 9 C 4.5526 1.3337 0.0 0
M  V30 10 C 4.5526 4.0012 0.0 0
M  V30 11 C 3.5222 0.1893 0.0 0
M  V30 12 C 0.0000 3.3608 0.0 0
M  V30 13 C 1.0304 4.5052 0.0 0
M  V30 14 C 6.0927 1.3337 0.0 0
M  V30 15 C 6.0927 4.0012 0.0 0
M  V30 16 C 6.8627 2.6675 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 2 14
M  V30 3 1 16 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Spiro[1,3-dioxolane-2,1′-[1H]inden]-5′-ol, 2′,3′,5′,6′,7′,7′a-hexahydro-4′,7′...
C14H20O4
2180145-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4888 4.1792 0.0 0
M  V30 2 C 6.8627 0.0000 0.0 0
M  V30 3 O 8.4027 2.6675 0.0 0
M  V30 4 C 9.1727 4.0012 0.0 0
M  V30 5 O 10.7128 4.0012 0.0 0
M  V30 6 C 2.2763 2.3472 0.0 0
M  V30 7 C 3.7826 2.6675 0.0 0 CFG=2
M  V30 8 C 2.1154 0.8156 0.0 0
M  V30 9 O 2.4373 3.8789 0.0 0
M  V30 10 O 0.7700 2.0270 0.0 0
M  V30 11 C 4.5526 1.3337 0.0 0
M  V30 12 C 4.5526 4.0012 0.0 0
M  V30 13 C 3.5222 0.1893 0.0 0
M  V30 14 C 1.0304 4.5052 0.0 0
M  V30 15 C 0.0000 3.3608 0.0 0
M  V30 16 C 6.0927 1.3337 0.0 0
M  V30 17 C 6.0927 4.0012 0.0 0
M  V30 18 C 6.8627 2.6675 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1870866-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2180145-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-22155826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (-)-Chromodorolide B By a Computationally-Guided
Radical Addition/Cyclization/Fragmentation Cascade
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Daniel J.; Slutskyy, Yuriy; Muuronen, Mikko; Le, Alexander; Kohler,
Philipp; Overman, Larry E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2018), 140(8), 3091-3102

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(4-Chlorophenyl)hydroxymethyl]-1-methyl-6-(1-methylethoxy)-3-[3-[(tetrahyd...
C26H32ClN3O6
1878199-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 O 6.6685 6.9302 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 O 2.6675 4.6201 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0023 0.0000 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 C 12.0035 3.8501 0.0 0
M  V30 11 C 13.3372 4.6201 0.0 0
M  V30 12 O 14.6708 3.8501 0.0 0
M  V30 13 O 10.6697 1.5400 0.0 0
M  V30 14 Cl 0.0000 9.2402 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0
M  V30 19 C 4.0012 3.8501 0.0 0
M  V30 20 N 8.0023 1.5400 0.0 0
M  V30 21 N 5.3348 1.5400 0.0 0
M  V30 22 N 9.3360 3.8501 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 9.3360 2.3101 0.0 0
M  V30 25 C 4.0012 6.9302 0.0 0
M  V30 26 C 2.6675 6.1601 0.0 0
M  V30 27 C 4.0012 8.4702 0.0 0
M  V30 28 C 1.3337 6.9302 0.0 0
M  V30 29 C 2.6675 9.2402 0.0 0
M  V30 30 C 1.3337 8.4702 0.0 0
M  V30 31 C 16.0045 4.6201 0.0 0
M  V30 32 C 16.0045 6.1601 0.0 0
M  V30 33 O 17.3383 3.8501 0.0 0
M  V30 34 C 17.3383 6.9302 0.0 0
M  V30 35 C 18.6720 4.6201 0.0 0
M  V30 36 C 18.6720 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 31
M  V30 15 2 13 24
M  V30 16 1 14 30
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(4-Chlorophenyl)methyl]-3-[3-(formyloxy)propyl]-1-methyl-6-(1-methylethoxy...
C22H24ClN3O5
1878199-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 8.4700 2.6674 0.0 0
M  V30 3 O 4.6200 6.6684 0.0 0
M  V30 4 C 3.8500 8.0021 0.0 0
M  V30 5 C 4.6200 9.3358 0.0 0
M  V30 6 C 2.3100 8.0021 0.0 0
M  V30 7 C 11.5500 8.0021 0.0 0
M  V30 8 C 11.5500 2.6674 0.0 0
M  V30 9 C 13.0900 2.6674 0.0 0
M  V30 10 C 13.8600 1.3336 0.0 0
M  V30 11 O 15.4000 1.3336 0.0 0
M  V30 12 C 16.1700 0.0000 0.0 0
M  V30 13 O 17.7100 0.0000 0.0 0
M  V30 14 O 13.0900 5.3347 0.0 0
M  V30 15 Cl 0.0000 4.0011 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 6.1600 6.6684 0.0 0
M  V30 21 N 10.7800 6.6684 0.0 0
M  V30 22 N 8.4700 8.0021 0.0 0
M  V30 23 N 10.7800 4.0011 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 11.5500 5.3347 0.0 0
M  V30 26 C 4.6200 4.0011 0.0 0
M  V30 27 C 3.8500 5.3347 0.0 0
M  V30 28 C 3.8500 2.6674 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 2.3100 2.6674 0.0 0
M  V30 31 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 2 2 19
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 2 14 25
M  V30 16 1 15 31
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1878199-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878199-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-15574829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as TRPC5 modulators
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chenard, Bertrand L.; Gallaschun, Randall J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016023830 A1 2016-02-18

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
(αR)-α-(Bromomethyl)-3-nitro-4-(phenylmethoxy)benzenemethanol
C15H14BrNO4
188690-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 1.3338 0.0 0 VAL=5
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 O 7.7000 0.0000 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0 CFG=1
M  V30 7 C 12.3200 5.3347 0.0 0
M  V30 8 O 12.3200 2.6674 0.0 0
M  V30 9 Br 13.8600 5.3347 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(1R)-2-Bromo-1-hydroxyethyl]-2-(phenylmethoxy)phenyl]formamide
C16H16BrNO3
201677-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 O 5.3900 5.3347 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 C 11.5500 5.3347 0.0 0 CFG=1
M  V30 7 C 12.3200 6.6685 0.0 0
M  V30 8 O 12.3200 4.0011 0.0 0
M  V30 9 Br 13.8600 6.6685 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 3.0800 6.6685 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 6 14
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 188690-82-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 201677-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-6500081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[2-Benzyloxy-5-(2-bromo-1-(R)-hydroxyethyl)phenyl]formamide (5). A parr
hydrogenator was charged with PtO2 and
1-(4-benzyloxy-3-nitro-phenyl)-2-bromo-1-(R)-ethanol (4). (3.60 g, 10.22
mmol) dissolved in a mixed solvent of THF (25 mL) and toluene (25 mL);
and the mixture shaken under an atmosphere of hydrogen at 55 psi at rt
for 14 h. The hydrogen pressure was then released. To the mixture was
added directly a mixture of formic acid (0.65 mL, 17.23 mmol) and acetic
anhydride (1.10 mL, 11.65 mmol). The newly resulting mixture was stirred
at rt for an additional 16 h. The catalyst was removed by filtration
through a Celite pad and the filtrate was concentrated by rotary
evaporation. The resulting residue was purified by column chromatography
(silica gel, a gradient of 30:70 to 50:50 ethyl acetate/hexanes) to give
the desired formamide 5 as a white solid (3.62 g, >99% yield). 1H NMR
(300 MHz, CDCl3) δ 2.95 (s, 1H), 3.52 (m, 1H), 3.60 (m, 1H), 4.85 (m,
1H), 5.08 (s, 2H), 6.96 (d, 1H), 7.13 (dd, 1H), 7.39 (m, 5H), 7.88 (br s,
1H), 8.37 (dd, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazinoylguanidines as sodium channel blockers with
β-agonist activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Michael Ross
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007146867 A2 2007-12-21

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-bromopyridine
C5H5BrN2
19798-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-2-pyridinyl)formamide
C6H5BrN2O
1451186-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Br 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19798-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1451186-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7960931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM slow additions of formic acid stage 1 and mixed anhydride (prepared in
stage 1) in stage 2, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Bromo-6-isocyanopyridine as a Universal Convertible Isocyanide for
Multicomponent Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM van der Heijden, Gydo; Jong, J. A. W.; Ruijter, Eelco; Orru, Romano V. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(5), 984-987

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-(oxazol-5-yl)aniline
C10H10N2O2
198821-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.3338 0.0 0
M  V30 2 C 4.6798 0.0000 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0
M  V30 4 C 3.9098 4.0011 0.0 0
M  V30 5 C 4.6798 2.6674 0.0 0
M  V30 6 C 4.6798 5.3349 0.0 0
M  V30 7 C 6.2198 2.6674 0.0 0
M  V30 8 C 6.2198 5.3349 0.0 0
M  V30 9 C 6.9898 4.0011 0.0 0
M  V30 10 C 2.3698 4.0011 0.0 0
M  V30 11 C 1.4645 2.7552 0.0 0
M  V30 12 O 1.4645 5.2469 0.0 0
M  V30 13 N 0.0000 3.2311 0.0 0
M  V30 14 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methoxy-4-(5-oxazolyl)phenyl]formamide
C11H10N2O3
478946-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.3338 0.0 0
M  V30 2 C 4.6798 0.0000 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0
M  V30 4 C 9.2998 5.3349 0.0 0
M  V30 5 O 10.8398 5.3349 0.0 0
M  V30 6 C 3.9098 4.0011 0.0 0
M  V30 7 C 4.6798 2.6674 0.0 0
M  V30 8 C 4.6798 5.3349 0.0 0
M  V30 9 C 6.2198 2.6674 0.0 0
M  V30 10 C 6.2198 5.3349 0.0 0
M  V30 11 C 6.9898 4.0011 0.0 0
M  V30 12 C 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 2.7552 0.0 0
M  V30 14 O 1.4645 5.2469 0.0 0
M  V30 15 N 0.0000 3.2311 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 198821-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478946-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11450705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid synthesis of triazine inhibitors of inosine monophosphate
dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Guo, Junqing; Dhar, T. G. Murali; Shen, Zhongqi; Gu,
Henry H.; Watterson, Scott H.; Bednarz, Mark S.; Chen, Bang-Chi; Barrish,
Joel C.; Bassolino, Donna; Cheney, Daniel; Fleener, Catherine A.;
Rouleau, Katherine A.; Hollenbaugh, Diane L.; Iwanowicz, Edwin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2137-2140

$RFMT $RIREG SCHEME395 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxy-2-adamantanone
C10H14O2
20098-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0178 0.0 0
M  V30 2 O 7.0126 2.8121 0.0 0
M  V30 3 C 1.3364 2.2463 0.0 0
M  V30 4 C 2.6270 3.0866 0.0 0
M  V30 5 C 3.0334 2.2355 0.0 0
M  V30 6 C 1.2540 0.7085 0.0 0
M  V30 7 C 3.8351 2.3890 0.0 0
M  V30 8 C 4.2414 1.5379 0.0 0
M  V30 9 C 2.4622 0.0111 0.0 0
M  V30 10 C 5.5320 2.3779 0.0 0
M  V30 11 C 3.7526 0.8513 0.0 0
M  V30 12 C 4.1590 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methoxycarbonyl)-2-adamantanone
C12H16O3
56674-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0119 1.5429 0.0 0
M  V30 2 O 8.3482 2.3143 0.0 0
M  V30 3 O 7.0119 0.0000 0.0 0
M  V30 4 C 9.6843 1.5429 0.0 0
M  V30 5 O 0.0000 1.7487 0.0 0
M  V30 6 C 5.6758 2.3143 0.0 0
M  V30 7 C 4.3853 1.4741 0.0 0
M  V30 8 C 3.9789 2.3251 0.0 0
M  V30 9 C 5.7582 3.8519 0.0 0
M  V30 10 C 3.1772 2.1716 0.0 0
M  V30 11 C 2.7709 3.0227 0.0 0
M  V30 12 C 4.5501 4.5495 0.0 0
M  V30 13 C 1.4805 2.1827 0.0 0
M  V30 14 C 3.2598 3.7092 0.0 0
M  V30 15 C 2.8534 4.5604 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20098-14-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56674-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27615941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 8014-95-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 15A 2-Adamantanone-5-carboxylic acid methyl ester A solution of
5-hydroxy-2-adamantanone (2.0 g, 12.0 mmol) in 99% formic acid (12 mL)
was added dropwise with vigorous gas evolution over 40 minutes to a
rapidly stirred 30% oleum solution (48 mL) heated to 60° C. (W. J. le
Noble, S. Srivastava, C. K. Cheung, J. Org. Chem. 48: 1099-1101, 1983).
Upon completion of addition, more 99% formic acid (12 mL) was slowly
added over the next 40 minutes. The mixture was stirred another 60
minutes at 60° C. and then slowly poured into vigorously stirred methanol
(100 mL) cooled to 0° C. The mixture was allowed to slowly warm to 23° C.
while stirring for 2 hours and then concentrated in vacuo. The residue
was poured onto ice (30 g) and methylene chloride (100 mL) added. The
layers were separated, and the aqueous phase extracted twice more with
methylene chloride (100 mL aliquots). The combined methylene chloride
solutions were concentrated in vacuo to 50 mL, washed with brine, dried
over Na2SO4, filtered, and concentrated in vacuo to provide the title
compound as a pale yellow solid (2.5 g, 99% crude). 1H NMR (300 MHz,
DMSO-d6) δ 3.61 (s, 3H), 2.47-2.40 (bs, 2H), 2.17-1.96 (m, 9H), 1.93-1.82
(m, 2H); MS (DCI) m/z 209 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of adamantyl amide derivatives as inhibitors of the
11β-hydroxysteroid dehydrogenase type 1 enzyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Link, James T.; Pliushchev, Marina A.; Rohde, Jeffrey J.; Wodka, Dariusz;
Patel, Jyoti R.; Shuai, Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050245534 A1 2005-11-03

$RFMT $RIREG SCHEME395 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxy-2-adamantanone
C10H14O2
20098-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0178 0.0 0
M  V30 2 O 7.0126 2.8121 0.0 0
M  V30 3 C 1.3364 2.2463 0.0 0
M  V30 4 C 2.6270 3.0866 0.0 0
M  V30 5 C 3.0334 2.2355 0.0 0
M  V30 6 C 1.2540 0.7085 0.0 0
M  V30 7 C 3.8351 2.3890 0.0 0
M  V30 8 C 4.2414 1.5379 0.0 0
M  V30 9 C 2.4622 0.0111 0.0 0
M  V30 10 C 5.5320 2.3779 0.0 0
M  V30 11 C 3.7526 0.8513 0.0 0
M  V30 12 C 4.1590 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methoxycarbonyl)-2-adamantanone
C12H16O3
56674-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0119 1.5429 0.0 0
M  V30 2 O 8.3482 2.3143 0.0 0
M  V30 3 O 7.0119 0.0000 0.0 0
M  V30 4 C 9.6843 1.5429 0.0 0
M  V30 5 O 0.0000 1.7487 0.0 0
M  V30 6 C 5.6758 2.3143 0.0 0
M  V30 7 C 4.3853 1.4741 0.0 0
M  V30 8 C 3.9789 2.3251 0.0 0
M  V30 9 C 5.7582 3.8519 0.0 0
M  V30 10 C 3.1772 2.1716 0.0 0
M  V30 11 C 2.7709 3.0227 0.0 0
M  V30 12 C 4.5501 4.5495 0.0 0
M  V30 13 C 1.4805 2.1827 0.0 0
M  V30 14 C 3.2598 3.7092 0.0 0
M  V30 15 C 2.8534 4.5604 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20098-14-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56674-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27698805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Oxo-adamantane-1-carboxylic acid methyl ester A solution of
5-hydroxy-2-adamantanone (2.0 g, 12.0 mmol) in 99% formic acid (12 mL)
was added dropwise with vigorous gas evolution over 40 minutes to a
rapidly stirred 30% oleum solution (48 mL) heated to 60°C. (W. J. Ie
Noble, S. Srivastava, C. K. Cheung, J. Org. Chem. 1983, 48, 1099-1101.).
Upon completion of addition, more 99% formic acid (12 mL) was slowly
added over the next 40 minutes. The mixture was stirred another 60
minutes at 60°C. and then slowly poured into vigorously stirred methanol
(100 mL) cooled to 0°C. The mixture was allowed to slowly warm to 23°C.
while stirring for 2 hours and then concentrated in vacuo. The residue
was poured onto ice (30 g), and methylene chloride (100 mL) was added.
The layers were separated, and the aqueous phase was extracted twice more
with methylene chloride (100 mL aliquots). The combined methylene
chloride solutions were concentrated in vacuo to 50 mL, washed with
brine, dried over Na2SO4, filtered, and concentrated in vacuo to provide
the title compound as a pale yellow solid (2.5 g, 99% crude).
4-Oxo-adamantane-1-carboxylic acid methyl ester, yield 2.5 g, 99% crude.
1H NMR (300 MHz, DMSO-d6) δ 3.61 (s, 3H), 2.47-2.40 (bs, 2H), 2.17-1.96
(m, 9H), 1.93-1.82 (m, 2H); MS (DCI) m/z 209 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM oleum used in stage 1, incremental addition of formic acid in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyanopyrrolidine derivatives and pharmaceutical
compositions thereof as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Madar, David J.; Djuric, Stevan W.; Michmerhuizen, Melissa J.; Kopecka,
Hana A.; LI, Xiaofeng; Longenecker, Kenton L.; Pei, Zhonghua; Pireh,
Daisy; Sham, Hing L.; Stewart, Kent D.; Szczepankiewicz, Bruce G.;
Wiedeman, Paul E.; Yong, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050215784 A1 2005-09-29

$RFMT $RIREG SCHEME396 STEP1
$RXN



  3  1
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxyphenethylamine
C9H13NO
2039-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6-methoxy-1-methyl-1-phenyl-2(1H)-isoquinolinecarboxaldehyde
C18H19NO2
473544-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6088 1.0534 0.0 0
M  V30 2 C 2.0313 3.9037 0.0 0
M  V30 3 O 1.2613 5.2373 0.0 0
M  V30 4 O 10.5014 2.5700 0.0 0
M  V30 5 C 11.2714 1.2363 0.0 0
M  V30 6 C 4.3413 2.5700 0.0 0
M  V30 7 C 5.8814 2.5700 0.0 0
M  V30 8 N 3.5713 3.9037 0.0 0
M  V30 9 C 6.6514 3.9037 0.0 0
M  V30 10 C 6.6514 1.2363 0.0 0
M  V30 11 C 4.3413 5.2373 0.0 0
M  V30 12 C 8.1914 3.9037 0.0 0
M  V30 13 C 5.8814 5.2373 0.0 0
M  V30 14 C 8.1914 1.2363 0.0 0
M  V30 15 C 8.9614 2.5700 0.0 0
M  V30 16 C 2.8942 2.0433 0.0 0
M  V30 17 C 1.7145 3.0332 0.0 0
M  V30 18 C 2.6268 0.5267 0.0 0
M  V30 19 C 0.2673 2.5064 0.0 0
M  V30 20 C 1.1797 0.0000 0.0 0
M  V30 21 C 0.0000 0.9898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 8
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2039-67-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 473544-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7559349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Pictet-Spengler reaction, alternative reaction conditions gave lower
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient synthesis of 1,1-disubstituted
1,2,3,4-tetrahydroisoquinolines via Pictet-Spengler reaction using
titanium(IV) isopropoxide and acetic-formic anhydride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horiguchi, Yoshie; Kodama, Hirokazu; Nakamura, Masayoshi; Yoshimura,
Tsuyoshi; Hanezi, Kaori; Hamada, Hiroko; Saitoh, Toshiaki; Sano, Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2002), 50(2), 253-257

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-4-Methoxy-3-(3-methoxypropoxy)-α-(1-methylethyl)benzeneethanamine
C16H27NO3
2072073-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.4701 4.0011 0.0 0
M  V30 2 C 9.2401 5.3348 0.0 0
M  V30 3 C 10.7801 5.3348 0.0 0
M  V30 4 C 11.5501 6.6684 0.0 0
M  V30 5 O 13.0901 6.6684 0.0 0
M  V30 6 C 13.8602 8.0022 0.0 0
M  V30 7 O 6.9301 1.3337 0.0 0
M  V30 8 C 6.1601 0.0000 0.0 0
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 2.3100 6.6684 0.0 0 CFG=2
M  V30 11 C 1.5400 8.0022 0.0 0
M  V30 12 N 1.5400 5.3348 0.0 0
M  V30 13 C 2.3100 9.3359 0.0 0
M  V30 14 C 0.0000 8.0022 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 6.1601 2.6675 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 4.6201 2.6675 0.0 0
M  V30 19 C 4.6201 5.3348 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-1-[[4-Methoxy-3-(3-methoxypropoxy)phenyl]methyl]-2-methylpropyl]forma...
C17H27NO4
2072073-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 7.7001 0.0 0
M  V30 2 C 9.3357 6.9301 0.0 0
M  V30 3 C 10.6695 7.7001 0.0 0
M  V30 4 C 12.0032 6.9301 0.0 0
M  V30 5 O 13.3369 7.7001 0.0 0
M  V30 6 C 14.6705 6.9301 0.0 0
M  V30 7 O 5.3348 9.2401 0.0 0
M  V30 8 C 4.0010 10.0101 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 C 4.0010 2.3100 0.0 0 CFG=1
M  V30 11 N 2.6673 3.0800 0.0 0
M  V30 12 C 4.0010 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 O 0.0000 3.0800 0.0 0
M  V30 17 C 6.6684 6.9301 0.0 0
M  V30 18 C 5.3348 7.7001 0.0 0
M  V30 19 C 6.6684 5.3901 0.0 0
M  V30 20 C 4.0010 6.9301 0.0 0
M  V30 21 C 5.3348 4.6201 0.0 0
M  V30 22 C 4.0010 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2072073-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2072073-28-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16855552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of
alkylalkoxyalkoxyoxodihydrobenzoquinolizinecarboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Du, Zhengming; Wang, Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017016960 A1 2017-02-02

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3,6-diol, 3a-1,3-benzodioxol-5-yl-2,3,3a,6,7,7a-hexahydro-1-[(4-met...
C24H25NO7S
215609-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.0082 6.9643 0.0 0
M  V30 2 C 5.1692 8.4959 0.0 0
M  V30 3 C 6.5761 9.1222 0.0 0
M  V30 4 O 3.9233 9.4011 0.0 0
M  V30 5 S 10.1640 5.2891 0.0 0 VAL=6
M  V30 6 O 10.1640 6.8291 0.0 0
M  V30 7 O 10.1640 3.7491 0.0 0
M  V30 8 O 7.2146 0.0000 0.0 0
M  V30 9 C 16.3240 5.2891 0.0 0
M  V30 10 C 6.2541 4.5191 0.0 0 CFG=1
M  V30 11 C 7.7188 4.0433 0.0 0 CFG=2
M  V30 12 C 6.2541 6.0591 0.0 0 CFG=1
M  V30 13 C 5.1097 3.4886 0.0 0
M  V30 14 N 8.6240 5.2891 0.0 0
M  V30 15 C 8.0390 2.5368 0.0 0
M  V30 16 C 7.7188 6.5350 0.0 0
M  V30 17 C 5.4299 1.9823 0.0 0
M  V30 18 C 6.8944 1.5064 0.0 0 CFG=1
M  V30 19 C 4.7144 4.4922 0.0 0
M  V30 20 C 3.9678 3.1453 0.0 0
M  V30 21 C 3.9211 5.8123 0.0 0
M  V30 22 C 2.4280 3.1185 0.0 0
M  V30 23 C 2.3815 5.7853 0.0 0
M  V30 24 C 1.6349 4.4384 0.0 0
M  V30 25 O 1.4177 1.9561 0.0 0
M  V30 26 O 0.1343 4.0921 0.0 0
M  V30 27 C 0.0000 2.5579 0.0 0
M  V30 28 C 11.7040 5.2891 0.0 0
M  V30 29 C 12.4740 6.6228 0.0 0
M  V30 30 C 12.4740 3.9555 0.0 0
M  V30 31 C 14.0140 6.6228 0.0 0
M  V30 32 C 14.0140 3.9555 0.0 0
M  V30 33 C 14.7840 5.2891 0.0 0
M  V30 34 H 9.2251 3.7229 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 5 28
M  V30 9 1 18 8 CFG=1
M  V30 10 1 9 33
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 19 CFG=3
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 34 CFG=3
M  V30 18 1 12 16
M  V30 19 2 13 17
M  V30 20 1 14 16
M  V30 21 1 15 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 2 23 24
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-Indole-3,6-diol, 3a-1,3-benzodioxol-5-yl-2,3,3a,6,7,7a-hexahydro-1-[(4-met...
C25H25NO8S
677301-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.0082 9.5010 0.0 0
M  V30 2 C 5.1692 11.0326 0.0 0
M  V30 3 C 6.5761 11.6590 0.0 0
M  V30 4 O 3.9233 11.9378 0.0 0
M  V30 5 S 10.1640 7.8258 0.0 0 VAL=6
M  V30 6 O 10.1640 6.2858 0.0 0
M  V30 7 O 10.1640 9.3658 0.0 0
M  V30 8 O 7.2146 2.5368 0.0 0
M  V30 9 C 6.0702 1.5063 0.0 0
M  V30 10 O 6.3904 0.0000 0.0 0
M  V30 11 C 16.3240 7.8258 0.0 0
M  V30 12 C 6.2541 7.0558 0.0 0 CFG=1
M  V30 13 C 7.7188 6.5800 0.0 0 CFG=2
M  V30 14 C 6.2541 8.5958 0.0 0 CFG=1
M  V30 15 C 5.1097 6.0254 0.0 0
M  V30 16 N 8.6240 7.8258 0.0 0
M  V30 17 C 8.0390 5.0735 0.0 0
M  V30 18 C 7.7188 9.0717 0.0 0
M  V30 19 C 5.4299 4.5190 0.0 0
M  V30 20 C 6.8944 4.0431 0.0 0 CFG=2
M  V30 21 C 4.7144 7.0290 0.0 0
M  V30 22 C 3.9678 5.6820 0.0 0
M  V30 23 C 3.9211 8.3490 0.0 0
M  V30 24 C 2.4280 5.6552 0.0 0
M  V30 25 C 2.3815 8.3222 0.0 0
M  V30 26 C 1.6349 6.9753 0.0 0
M  V30 27 O 1.4177 4.4930 0.0 0
M  V30 28 O 0.1343 6.6288 0.0 0
M  V30 29 C 0.0000 5.0946 0.0 0
M  V30 30 C 11.7040 7.8258 0.0 0
M  V30 31 C 12.4740 9.1595 0.0 0
M  V30 32 C 12.4740 6.4922 0.0 0
M  V30 33 C 14.0140 9.1595 0.0 0
M  V30 34 C 14.0140 6.4922 0.0 0
M  V30 35 C 14.7840 7.8258 0.0 0
M  V30 36 H 9.2251 6.2598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 5 30
M  V30 9 1 8 9
M  V30 10 1 20 8 CFG=3
M  V30 11 2 9 10
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 21 CFG=3
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 36 CFG=3
M  V30 20 1 14 18
M  V30 21 2 15 19
M  V30 22 1 16 18
M  V30 23 1 17 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 24 27
M  V30 31 2 25 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 14 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 215609-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 677301-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-13366650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1972-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3R,3aS,6R,7aS)-N-p Tolylsulfonyl-3-(acetyloxy)-3a-[3,4-
(methylenedioxy)phenyl]-6-formyloxy-2,3,3a,6,7 ,7a-hexahydroindole
(25).To a solution of 22b (48.2 mg, 0.102 mmol), PPh3 (79 mg, 0.3 mmol),
98% formic acid (38 mL, 1.0 mmol) in THF (l ml.) was added -N,N -diethyl
azodicarboxylate (63 mL, 0.4 mmol) at 0 °C and the solution was stirred
ar rt for 30min. The solvent was removed and the resultant crude product
was purified by flash column chromatography on silica gel (toluene/ethyl
acetate 4: 1 to give 25 as a white powder, yield 50.2 mg, 99%. 1H NMR
(500 MHz, CDCl3) δ2.03(3H, s), 2.31 (lH, td, J = 4.9, 13.7 Hz), 2.46 (1H,
ddd, J = 7.0, 8.5, 13.7 Hz), 3.48 (lH, dd, J = 4.9, 11.6 Hz), 3.79 (lH,
dd, J = 5.9, 11.6 Hz), 3.97 (lH, dd, J = 4.3, 8.5 Hz), 5.29 (lH, brt, J =
5.4 Hz), 5.56 (lH, m), 5.79 (lH, dd, J = 1.7, 10.4 Hz), 5.92 (2H, s),
6.02 (lH, dd, J = 3.1, 10.4 Hz), 6.33 (lH, d, J = 2.0 Hz), 6.37 (lH, dd,
Hz), 8.10 (1H, s); IR (KBr) ν 1740, 1728, 1490, 1242, 1170 cm-1 EI-MS m/z
499 (M+), 439, 198 (base peak); HRMS calcd for C25H25NO3S 499.1301, found
499.1300; [α]D25+110) (c0.51, CHCl3, 60% ee).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Asymmetric Allylic Substitution of 2-Arylcyclohexenol
Derivatives: Asymmetric Total Syntheses of (+)-Crinamine,
(-)-Haemanthidine, and (+)-Pretazettine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishimata, Toyoki; Sato, Yoshihiro; Mori, Miwako
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(6), 1837-1843

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-[4-(1,1-Dimethylethyl)phenyl]ethenyl]-1H-isoindole-1,3(2H)-dione
C20H19NO2
2173410-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4210 0.0 0
M  V30 3 C 6.5770 2.7104 0.0 0
M  V30 4 C 7.3470 4.0440 0.0 0
M  V30 5 C 13.5070 4.0442 0.0 0
M  V30 6 C 13.5070 5.5840 0.0 0
M  V30 7 C 15.0470 4.0442 0.0 0
M  V30 8 C 13.5070 2.5040 0.0 0
M  V30 9 C 2.6673 1.9404 0.0 0
M  V30 10 C 2.6673 3.4804 0.0 0
M  V30 11 C 4.1320 1.4645 0.0 0
M  V30 12 C 1.3336 1.1704 0.0 0
M  V30 13 C 4.1320 3.9563 0.0 0
M  V30 14 C 1.3336 4.2504 0.0 0
M  V30 15 N 5.0370 2.7104 0.0 0
M  V30 16 C 0.0000 1.9404 0.0 0
M  V30 17 C 0.0000 3.4804 0.0 0
M  V30 18 C 8.8870 4.0440 0.0 0
M  V30 19 C 9.6570 2.7104 0.0 0
M  V30 20 C 9.6570 5.3778 0.0 0
M  V30 21 C 11.1970 2.7104 0.0 0
M  V30 22 C 11.1970 5.3778 0.0 0
M  V30 23 C 11.9670 4.0440 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 2 3 4
M  V30 4 1 3 15
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[4-(1,1-Dimethylethyl)phenyl]-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoi...
C21H21NO4
2173410-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 5.8172 6.2291 0.0 0
M  V30 5 O 8.4743 6.4615 0.0 0
M  V30 6 O 4.6078 0.0000 0.0 0
M  V30 7 O 4.6078 5.4210 0.0 0
M  V30 8 C 13.5070 4.0442 0.0 0
M  V30 9 C 14.2770 2.7104 0.0 0
M  V30 10 C 15.0470 4.0442 0.0 0
M  V30 11 C 14.2770 5.3778 0.0 0
M  V30 12 N 5.0370 2.7104 0.0 0
M  V30 13 C 4.1320 1.4645 0.0 0
M  V30 14 C 4.1320 3.9564 0.0 0
M  V30 15 C 2.6673 1.9404 0.0 0
M  V30 16 C 2.6673 3.4804 0.0 0
M  V30 17 C 1.3336 1.1704 0.0 0
M  V30 18 C 1.3336 4.2504 0.0 0
M  V30 19 C 0.0000 1.9404 0.0 0
M  V30 20 C 0.0000 3.4804 0.0 0
M  V30 21 C 8.8870 4.0442 0.0 0
M  V30 22 C 9.6570 5.3778 0.0 0
M  V30 23 C 9.6570 2.7104 0.0 0
M  V30 24 C 11.1970 5.3778 0.0 0
M  V30 25 C 11.1970 2.7104 0.0 0
M  V30 26 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 13
M  V30 8 2 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173410-85-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(4-Fluorophenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C16H10FNO2
2173410-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 F 13.5070 4.0442 0.0 0
M  V30 6 C 2.6673 1.9406 0.0 0
M  V30 7 C 2.6673 3.4806 0.0 0
M  V30 8 C 4.1320 1.4647 0.0 0
M  V30 9 C 1.3336 1.1706 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 1.3336 4.2506 0.0 0
M  V30 12 N 5.0370 2.7106 0.0 0
M  V30 13 C 0.0000 1.9406 0.0 0
M  V30 14 C 0.0000 3.4806 0.0 0
M  V30 15 C 8.8870 4.0442 0.0 0
M  V30 16 C 9.6570 5.3780 0.0 0
M  V30 17 C 9.6570 2.7106 0.0 0
M  V30 18 C 11.1970 5.3778 0.0 0
M  V30 19 C 11.1970 2.7106 0.0 0
M  V30 20 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Fluorophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoic acid
C17H12FNO4
293731-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 8.4743 6.4615 0.0 0
M  V30 5 O 5.8172 6.2291 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 F 13.5070 4.0442 0.0 0
M  V30 9 N 5.0370 2.7104 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 4.1320 1.4645 0.0 0
M  V30 12 C 2.6673 3.4804 0.0 0
M  V30 13 C 2.6673 1.9404 0.0 0
M  V30 14 C 1.3336 4.2504 0.0 0
M  V30 15 C 1.3336 1.1704 0.0 0
M  V30 16 C 0.0000 3.4804 0.0 0
M  V30 17 C 0.0000 1.9404 0.0 0
M  V30 18 C 8.8870 4.0442 0.0 0
M  V30 19 C 9.6570 5.3778 0.0 0
M  V30 20 C 9.6570 2.7104 0.0 0
M  V30 21 C 11.1970 5.3778 0.0 0
M  V30 22 C 11.1970 2.7104 0.0 0
M  V30 23 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 10
M  V30 8 2 7 11
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173410-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 293731-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(3-Methylphenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C17H13NO2
2173410-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 0.9473 0.0 0
M  V30 2 O 5.7309 5.6421 0.0 0
M  V30 3 C 6.0811 2.3101 0.0 0
M  V30 4 C 7.4148 3.0801 0.0 0
M  V30 5 C 12.7496 3.0801 0.0 0
M  V30 6 C 2.3101 3.5981 0.0 0
M  V30 7 C 3.0801 4.9318 0.0 0
M  V30 8 C 3.3405 2.4536 0.0 0
M  V30 9 C 0.7700 3.5981 0.0 0
M  V30 10 C 4.5864 4.6116 0.0 0
M  V30 11 C 2.3101 6.2655 0.0 0
M  V30 12 N 4.7475 3.0801 0.0 0
M  V30 13 C 0.0000 4.9318 0.0 0
M  V30 14 C 0.7700 6.2655 0.0 0
M  V30 15 C 8.7485 2.3101 0.0 0
M  V30 16 C 10.0823 3.0801 0.0 0
M  V30 17 C 8.7485 0.7700 0.0 0
M  V30 18 C 11.4160 2.3101 0.0 0
M  V30 19 C 10.0823 0.0000 0.0 0
M  V30 20 C 11.4160 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-α-(3-methylphenyl)-1,3-dioxo-2H-isoindole-2-propanoic acid
C18H15NO4
2173410-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.7104 0.0 0
M  V30 2 C 4.6200 4.0442 0.0 0
M  V30 3 C 4.7541 5.5783 0.0 0
M  V30 4 O 6.1498 6.2291 0.0 0
M  V30 5 O 3.4927 6.4615 0.0 0
M  V30 6 O 7.3592 5.4210 0.0 0
M  V30 7 O 7.3592 0.0000 0.0 0
M  V30 8 C 0.0000 1.3768 0.0 0
M  V30 9 N 6.9300 2.7104 0.0 0
M  V30 10 C 7.8351 3.9564 0.0 0
M  V30 11 C 7.8351 1.4645 0.0 0
M  V30 12 C 9.2998 3.4804 0.0 0
M  V30 13 C 9.2998 1.9404 0.0 0
M  V30 14 C 10.6334 4.2504 0.0 0
M  V30 15 C 10.6334 1.1704 0.0 0
M  V30 16 C 11.9670 3.4804 0.0 0
M  V30 17 C 11.9670 1.9404 0.0 0
M  V30 18 C 3.0800 4.0442 0.0 0
M  V30 19 C 2.3100 2.7104 0.0 0
M  V30 20 C 2.3100 5.3778 0.0 0
M  V30 21 C 0.7700 2.7104 0.0 0
M  V30 22 C 0.7700 5.3778 0.0 0
M  V30 23 C 0.0000 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 10
M  V30 8 2 7 11
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173410-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(3,5-Dimethylphenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C18H15NO2
2173410-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 2.4873 0.0 0
M  V30 2 O 5.7309 7.1821 0.0 0
M  V30 3 C 6.0811 3.8501 0.0 0
M  V30 4 C 7.4148 4.6201 0.0 0
M  V30 5 C 10.0823 0.0000 0.0 0
M  V30 6 C 12.7496 4.6201 0.0 0
M  V30 7 C 2.3101 5.1382 0.0 0
M  V30 8 C 3.0801 6.4718 0.0 0
M  V30 9 C 3.3405 3.9936 0.0 0
M  V30 10 C 0.7700 5.1382 0.0 0
M  V30 11 C 4.5864 6.1517 0.0 0
M  V30 12 C 2.3101 7.8055 0.0 0
M  V30 13 N 4.7475 4.6201 0.0 0
M  V30 14 C 0.0000 6.4718 0.0 0
M  V30 15 C 0.7700 7.8055 0.0 0
M  V30 16 C 8.7485 3.8501 0.0 0
M  V30 17 C 8.7485 2.3101 0.0 0
M  V30 18 C 10.0823 4.6201 0.0 0
M  V30 19 C 10.0823 1.5400 0.0 0
M  V30 20 C 11.4160 3.8501 0.0 0
M  V30 21 C 11.4160 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 5 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,5-Dimethylphenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoic acid
C19H17NO4
2173410-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.8501 0.0 0
M  V30 2 C 7.4148 4.6201 0.0 0
M  V30 3 C 8.0656 6.0158 0.0 0
M  V30 4 O 9.5998 6.1499 0.0 0
M  V30 5 O 7.1824 7.2772 0.0 0
M  V30 6 O 5.7309 7.1821 0.0 0
M  V30 7 O 3.0203 2.4873 0.0 0
M  V30 8 C 12.7496 4.6201 0.0 0
M  V30 9 C 10.0823 0.0000 0.0 0
M  V30 10 N 4.7474 4.6201 0.0 0
M  V30 11 C 4.5864 6.1516 0.0 0
M  V30 12 C 3.3405 3.9936 0.0 0
M  V30 13 C 3.0801 6.4718 0.0 0
M  V30 14 C 2.3100 5.1381 0.0 0
M  V30 15 C 2.3100 7.8055 0.0 0
M  V30 16 C 0.7700 5.1381 0.0 0
M  V30 17 C 0.7700 7.8055 0.0 0
M  V30 18 C 0.0000 6.4718 0.0 0
M  V30 19 C 8.7484 3.8501 0.0 0
M  V30 20 C 10.0823 4.6201 0.0 0
M  V30 21 C 8.7484 2.3100 0.0 0
M  V30 22 C 11.4159 3.8501 0.0 0
M  V30 23 C 10.0823 1.5400 0.0 0
M  V30 24 C 11.4159 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 11
M  V30 8 2 7 12
M  V30 9 1 8 22
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173410-92-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29782191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(3,4-Dimethylphenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C18H15NO2
2173410-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 C 11.9670 6.7116 0.0 0
M  V30 6 C 13.5070 4.0442 0.0 0
M  V30 7 C 2.6673 1.9406 0.0 0
M  V30 8 C 2.6673 3.4806 0.0 0
M  V30 9 C 4.1320 1.4647 0.0 0
M  V30 10 C 1.3336 1.1706 0.0 0
M  V30 11 C 4.1320 3.9564 0.0 0
M  V30 12 C 1.3336 4.2506 0.0 0
M  V30 13 N 5.0370 2.7106 0.0 0
M  V30 14 C 0.0000 1.9406 0.0 0
M  V30 15 C 0.0000 3.4806 0.0 0
M  V30 16 C 8.8870 4.0442 0.0 0
M  V30 17 C 9.6570 5.3778 0.0 0
M  V30 18 C 9.6570 2.7106 0.0 0
M  V30 19 C 11.1970 5.3778 0.0 0
M  V30 20 C 11.1970 2.7106 0.0 0
M  V30 21 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 5 19
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,4-Dimethylphenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoic acid
C19H17NO4
2173410-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 5.8172 6.2291 0.0 0
M  V30 5 O 8.4743 6.4615 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 C 11.9670 1.3768 0.0 0
M  V30 9 C 13.5070 4.0442 0.0 0
M  V30 10 N 5.0370 2.7104 0.0 0
M  V30 11 C 4.1320 3.9564 0.0 0
M  V30 12 C 4.1320 1.4645 0.0 0
M  V30 13 C 2.6673 3.4804 0.0 0
M  V30 14 C 2.6673 1.9404 0.0 0
M  V30 15 C 1.3336 4.2504 0.0 0
M  V30 16 C 1.3336 1.1704 0.0 0
M  V30 17 C 0.0000 3.4804 0.0 0
M  V30 18 C 0.0000 1.9404 0.0 0
M  V30 19 C 8.8870 4.0442 0.0 0
M  V30 20 C 9.6570 2.7104 0.0 0
M  V30 21 C 9.6570 5.3778 0.0 0
M  V30 22 C 11.1970 2.7104 0.0 0
M  V30 23 C 11.1970 5.3778 0.0 0
M  V30 24 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 11
M  V30 8 2 7 12
M  V30 9 1 8 22
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173410-93-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173410-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Cyclohexylamino)-N-(cyclopropylmethyl)-2-hydroxybutanamide
C14H26N2O2
2211037-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 N 9.3360 3.0801 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 12.0033 3.0801 0.0 0
M  V30 17 C 12.7733 4.4137 0.0 0
M  V30 18 C 13.5434 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Cyclohexylformylamino)-N-(cyclopropylmethyl)-2-hydroxybutanamide
C15H26N2O3
2211039-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 N 9.3360 2.3101 0.0 0
M  V30 10 O 8.0022 4.6201 0.0 0
M  V30 11 C 10.6697 3.0801 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 12.7733 0.9764 0.0 0
M  V30 20 C 13.5434 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 18
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211037-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-(2-methylpropyl)-3-[(2,2,2-trifluoroethyl)amino]butanamide
C10H19F3N2O2
2211037-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 N 4.0010 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 N 9.3360 2.3101 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 F 0.0000 3.0801 0.0 0
M  V30 14 F 2.1037 3.6437 0.0 0
M  V30 15 F 0.5637 0.9764 0.0 0
M  V30 16 C 12.0033 3.8501 0.0 0
M  V30 17 C 13.3370 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Formyl(2,2,2-trifluoroethyl)amino]-2-hydroxy-N-(2-methylpropyl)butanamide
C11H19F3N2O3
2211039-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.6674 0.0 0
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 3.0800 1.3336 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 O 3.8500 0.0000 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 O 5.3900 5.3347 0.0 0
M  V30 11 F 0.0000 4.0011 0.0 0
M  V30 12 F 1.5400 2.4611 0.0 0
M  V30 13 F 1.5400 5.5411 0.0 0
M  V30 14 N 8.4700 5.3347 0.0 0
M  V30 15 O 8.4700 2.6674 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.7800 6.6685 0.0 0
M  V30 18 C 10.0100 8.0021 0.0 0
M  V30 19 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 14 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211037-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-41-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromo-3,4-pyridinediamine
C5H5Br2N3
221241-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6673 0.0 0
M  V30 4 Br 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-1,5-dihydro-4H-imidazo[4,5-c]pyridin-4-one
C6H4BrN3O
163452-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.7034 0.0 0
M  V30 2 O 6.1601 3.7034 0.0 0
M  V30 3 C 2.3100 2.3698 0.0 0
M  V30 4 C 3.8500 2.3698 0.0 0
M  V30 5 C 1.5400 3.7034 0.0 0
M  V30 6 N 1.8342 0.9051 0.0 0
M  V30 7 C 4.6201 3.7034 0.0 0
M  V30 8 N 4.3259 0.9051 0.0 0
M  V30 9 C 2.3100 5.0371 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 N 3.8500 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221241-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 163452-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-168-CAS-15937257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridinones as antifibrotic agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramphal, Johnnie Y.; Buckman, Brad Owen; Emayan, Kumaraswamy; Nicholas,
John Beamond; Seiwert, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015153683 A1 2015-10-08

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromo-3,4-pyridinediamine
C5H5Br2N3
221241-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6673 0.0 0
M  V30 4 Br 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-1,5-dihydro-4H-imidazo[4,5-c]pyridin-4-one
C6H4BrN3O
163452-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.7034 0.0 0
M  V30 2 O 6.1601 3.7034 0.0 0
M  V30 3 C 2.3100 2.3698 0.0 0
M  V30 4 C 3.8500 2.3698 0.0 0
M  V30 5 C 1.5400 3.7034 0.0 0
M  V30 6 N 1.8342 0.9051 0.0 0
M  V30 7 C 4.6201 3.7034 0.0 0
M  V30 8 N 4.3259 0.9051 0.0 0
M  V30 9 C 2.3100 5.0371 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 N 3.8500 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221241-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 163452-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-168-CAS-11556093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of anti-fibrotic pyridinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buckman, Brad Owen; Nicholas, John Beamond; Ramphal, Johnnie Y.; Emayan,
Kumaraswamy; Seiwert, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014055548 A1 2014-04-10

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromo-3,4-pyridinediamine
C5H5Br2N3
221241-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6673 0.0 0
M  V30 4 Br 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-1,5-dihydro-4H-imidazo[4,5-c]pyridin-4-one
C6H4BrN3O
163452-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.7034 0.0 0
M  V30 2 O 6.1601 3.7034 0.0 0
M  V30 3 C 2.3100 2.3698 0.0 0
M  V30 4 C 3.8500 2.3698 0.0 0
M  V30 5 C 1.5400 3.7034 0.0 0
M  V30 6 N 1.8342 0.9051 0.0 0
M  V30 7 C 4.6201 3.7034 0.0 0
M  V30 8 N 4.3259 0.9051 0.0 0
M  V30 9 C 2.3100 5.0371 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 N 3.8500 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221241-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 163452-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-168-CAS-7522010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of anti-fibrotic pyridinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buckman, Brad Owen; Nicholas, John Beamond; Ramphal, Johnnie Y.; Emayan,
Kumaraswamy; Seiwert, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20140094456 A1 2014-04-03

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-iso...
C22H26N4O6
2222114-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5893 2.6795 0.0 0
M  V30 2 O 6.5893 8.1006 0.0 0
M  V30 3 O 4.6201 8.0575 0.0 0
M  V30 4 O 0.0000 5.3901 0.0 0
M  V30 5 C 16.5323 1.5400 0.0 0
M  V30 6 O 17.8659 2.3101 0.0 0
M  V30 7 O 16.5323 0.0000 0.0 0
M  V30 8 C 19.1996 1.5400 0.0 0
M  V30 9 C 19.9696 2.8737 0.0 0
M  V30 10 C 20.5333 0.7700 0.0 0
M  V30 11 C 18.4296 0.2062 0.0 0
M  V30 12 N 6.1601 5.3901 0.0 0
M  V30 13 C 7.0654 4.1441 0.0 0
M  V30 14 C 7.0654 6.6360 0.0 0
M  V30 15 C 8.5299 4.6201 0.0 0
M  V30 16 C 8.5299 6.1601 0.0 0
M  V30 17 C 9.8636 3.8501 0.0 0
M  V30 18 C 9.8636 6.9302 0.0 0
M  V30 19 C 11.1974 4.6201 0.0 0
M  V30 20 C 11.1974 6.1601 0.0 0
M  V30 21 C 4.6201 5.3901 0.0 0
M  V30 22 C 3.8501 6.7238 0.0 0
M  V30 23 C 3.8501 4.0563 0.0 0
M  V30 24 N 2.3101 6.7238 0.0 0
M  V30 25 C 2.3101 4.0563 0.0 0
M  V30 26 C 1.5400 5.3901 0.0 0
M  V30 27 N 12.5311 3.8501 0.0 0
M  V30 28 C 13.8648 4.6201 0.0 0
M  V30 29 C 12.5311 2.3101 0.0 0
M  V30 30 C 15.1984 3.8501 0.0 0
M  V30 31 C 13.8648 1.5400 0.0 0
M  V30 32 N 15.1984 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 14
M  V30 3 2 3 22
M  V30 4 2 4 26
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 32
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 19 27
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(2,6-dioxo-3-piperidinyl)-5-(1-piperazinyl)-1H-iso...
C17H18N4O4.CH2O2
2682112-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.6089 3.4495 0.0 0
M  V30 2 O 8.6089 8.8704 0.0 0
M  V30 3 O 10.5783 8.8273 0.0 0
M  V30 4 O 15.1983 6.1600 0.0 0
M  V30 5 N 9.0383 6.1600 0.0 0
M  V30 6 C 8.1330 4.9140 0.0 0
M  V30 7 C 8.1330 7.4059 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 C 6.6684 6.9300 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 C 4.0011 5.3900 0.0 0
M  V30 13 C 4.0011 6.9300 0.0 0
M  V30 14 C 10.5783 6.1600 0.0 0
M  V30 15 C 11.3483 7.4937 0.0 0
M  V30 16 C 11.3483 4.8262 0.0 0
M  V30 17 N 12.8883 7.4937 0.0 0
M  V30 18 C 12.8883 4.8262 0.0 0
M  V30 19 C 13.6583 6.1600 0.0 0
M  V30 20 N 2.6674 4.6200 0.0 0
M  V30 21 C 2.6674 3.0800 0.0 0
M  V30 22 C 1.3336 5.3900 0.0 0
M  V30 23 C 1.3336 2.3100 0.0 0
M  V30 24 C 0.0000 4.6200 0.0 0
M  V30 25 N 0.0000 3.0800 0.0 0
M  V30 26 C 7.5991 0.0000 0.0 0
M  V30 27 O 6.2655 0.7700 0.0 0
M  V30 28 O 8.9328 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 7
M  V30 3 2 3 15
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 12 20
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2222114-64-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2682112-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24735058
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted hydroxyphenylpyridazinamines for treating BAF
complex-related disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Netherton, Matthew; Brucelle, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021207291 A1 2021-10-14

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-iso...
C22H26N4O6
2222114-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5893 2.6795 0.0 0
M  V30 2 O 6.5893 8.1006 0.0 0
M  V30 3 O 4.6201 8.0575 0.0 0
M  V30 4 O 0.0000 5.3901 0.0 0
M  V30 5 C 16.5323 1.5400 0.0 0
M  V30 6 O 17.8659 2.3101 0.0 0
M  V30 7 O 16.5323 0.0000 0.0 0
M  V30 8 C 19.1996 1.5400 0.0 0
M  V30 9 C 19.9696 2.8737 0.0 0
M  V30 10 C 20.5333 0.7700 0.0 0
M  V30 11 C 18.4296 0.2062 0.0 0
M  V30 12 N 6.1601 5.3901 0.0 0
M  V30 13 C 7.0654 4.1441 0.0 0
M  V30 14 C 7.0654 6.6360 0.0 0
M  V30 15 C 8.5299 4.6201 0.0 0
M  V30 16 C 8.5299 6.1601 0.0 0
M  V30 17 C 9.8636 3.8501 0.0 0
M  V30 18 C 9.8636 6.9302 0.0 0
M  V30 19 C 11.1974 4.6201 0.0 0
M  V30 20 C 11.1974 6.1601 0.0 0
M  V30 21 C 4.6201 5.3901 0.0 0
M  V30 22 C 3.8501 6.7238 0.0 0
M  V30 23 C 3.8501 4.0563 0.0 0
M  V30 24 N 2.3101 6.7238 0.0 0
M  V30 25 C 2.3101 4.0563 0.0 0
M  V30 26 C 1.5400 5.3901 0.0 0
M  V30 27 N 12.5311 3.8501 0.0 0
M  V30 28 C 13.8648 4.6201 0.0 0
M  V30 29 C 12.5311 2.3101 0.0 0
M  V30 30 C 15.1984 3.8501 0.0 0
M  V30 31 C 13.8648 1.5400 0.0 0
M  V30 32 N 15.1984 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 14
M  V30 3 2 3 22
M  V30 4 2 4 26
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 32
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 19 27
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(2,6-dioxo-3-piperidinyl)-5-(1-piperazinyl)-1H-iso...
C17H18N4O4.CH2O2
2682112-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.6089 3.4495 0.0 0
M  V30 2 O 8.6089 8.8704 0.0 0
M  V30 3 O 10.5783 8.8273 0.0 0
M  V30 4 O 15.1983 6.1600 0.0 0
M  V30 5 N 9.0383 6.1600 0.0 0
M  V30 6 C 8.1330 4.9140 0.0 0
M  V30 7 C 8.1330 7.4059 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 C 6.6684 6.9300 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 C 4.0011 5.3900 0.0 0
M  V30 13 C 4.0011 6.9300 0.0 0
M  V30 14 C 10.5783 6.1600 0.0 0
M  V30 15 C 11.3483 7.4937 0.0 0
M  V30 16 C 11.3483 4.8262 0.0 0
M  V30 17 N 12.8883 7.4937 0.0 0
M  V30 18 C 12.8883 4.8262 0.0 0
M  V30 19 C 13.6583 6.1600 0.0 0
M  V30 20 N 2.6674 4.6200 0.0 0
M  V30 21 C 2.6674 3.0800 0.0 0
M  V30 22 C 1.3336 5.3900 0.0 0
M  V30 23 C 1.3336 2.3100 0.0 0
M  V30 24 C 0.0000 4.6200 0.0 0
M  V30 25 N 0.0000 3.0800 0.0 0
M  V30 26 C 7.5991 0.0000 0.0 0
M  V30 27 O 6.2655 0.7700 0.0 0
M  V30 28 O 8.9328 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 7
M  V30 3 2 3 15
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 12 20
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2222114-64-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2682112-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24451049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic compounds for the treatment of BAF complex-related
diseases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Netherton, Matthew; Schiller, Shawn E.r; Deng, Jing; Anthony, Neville
John; Brucelle, Francois; Ruppel, Sabine K.; Voigt, Johannes H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021155321 A2 2021-08-05

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, 5-chloro-N-[(2,4-dimethoxyphenyl)methyl]-4-[[(1S,6S)-6-(d...
C26H30ClFN4O4S2
2222539-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 9.2400 3.7947 0.0 0
M  V30 5 O 9.2400 6.8747 0.0 0
M  V30 6 F 10.7800 2.6673 0.0 0
M  V30 7 O 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 Cl 13.8600 8.0021 0.0 0
M  V30 10 N 15.4000 5.3347 0.0 0
M  V30 11 O 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 13 N 18.4800 5.3347 0.0 0
M  V30 14 C 17.7100 6.6684 0.0 0
M  V30 15 C 20.0200 5.3347 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 N 7.5563 8.0753 0.0 0
M  V30 18 S 5.3985 6.8294 0.0 0
M  V30 19 C 6.4119 9.1057 0.0 0
M  V30 20 C 5.0783 8.3357 0.0 0
M  V30 21 C 10.7800 5.3347 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 11.5500 6.6684 0.0 0
M  V30 24 C 13.0900 4.0011 0.0 0
M  V30 25 C 13.0900 6.6684 0.0 0
M  V30 26 C 13.8600 5.3347 0.0 0
M  V30 27 C 5.3900 4.0011 0.0 0
M  V30 28 C 4.6200 2.6673 0.0 0
M  V30 29 C 4.6200 5.3347 0.0 0
M  V30 30 C 3.0800 2.6673 0.0 0
M  V30 31 C 3.0800 5.3347 0.0 0
M  V30 32 C 2.3100 4.0011 0.0 0
M  V30 33 C 16.1700 4.0011 0.0 0 CFG=1
M  V30 34 C 17.7100 4.0011 0.0 0 CFG=1
M  V30 35 C 15.4000 2.6673 0.0 0
M  V30 36 C 18.4800 2.6673 0.0 0
M  V30 37 C 16.1700 1.3336 0.0 0
M  V30 38 C 17.7100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 21
M  V30 7 1 3 27
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 7 28
M  V30 11 1 9 25
M  V30 12 1 10 26
M  V30 13 1 33 10 CFG=3
M  V30 14 1 11 12
M  V30 15 1 11 32
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 34 13 CFG=1
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-chloro-4-[[(1S,6S)-6-(dimethylamino)-3-cyclohexen-...
C17H20ClFN4O2S2.CH2O2
2222537-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.3217 6.3111 0.0 0
M  V30 2 N 13.4017 6.3111 0.0 0
M  V30 3 C 14.9417 6.3111 0.0 0
M  V30 4 C 12.6317 7.6447 0.0 0
M  V30 5 Cl 8.7817 8.9784 0.0 0
M  V30 6 F 5.7017 3.6437 0.0 0
M  V30 7 S 4.1617 6.3111 0.0 0 VAL=6
M  V30 8 N 2.6217 6.3111 0.0 0
M  V30 9 O 4.1617 4.7711 0.0 0
M  V30 10 O 4.1617 7.8511 0.0 0
M  V30 11 C 11.0917 4.9775 0.0 0 CFG=1
M  V30 12 C 12.6317 4.9775 0.0 0 CFG=1
M  V30 13 C 10.3217 3.6437 0.0 0
M  V30 14 C 13.4017 3.6437 0.0 0
M  V30 15 C 11.0917 2.3100 0.0 0
M  V30 16 C 12.6317 2.3100 0.0 0
M  V30 17 C 8.7817 6.3111 0.0 0
M  V30 18 C 8.0117 7.6447 0.0 0
M  V30 19 C 8.0117 4.9775 0.0 0
M  V30 20 C 6.4717 7.6447 0.0 0
M  V30 21 C 6.4717 4.9775 0.0 0
M  V30 22 C 5.7017 6.3111 0.0 0
M  V30 23 C 1.8517 7.6447 0.0 0
M  V30 24 N 2.4782 9.0517 0.0 0
M  V30 25 S 0.3202 7.8057 0.0 0
M  V30 26 C 1.3336 10.0821 0.0 0
M  V30 27 C 0.0000 9.3121 0.0 0
M  V30 28 C 7.4708 0.0000 0.0 0
M  V30 29 O 6.1372 0.7700 0.0 0
M  V30 30 O 8.8045 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 12 2 CFG=1
M  V30 6 1 5 18
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 7 22
M  V30 12 1 8 23
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222539-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222537-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-20681555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Heteroaryl benzenesulfonamides as voltage-dependent sodium channel
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutherlin, Daniel; McKerrall, Steven; Wilson, Michael Scott; Lai, Kwong
Wah; Bergeron, Philippe; Zhang, Birong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180105504 A1 2018-04-19

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, 5-chloro-N-[(2,4-dimethoxyphenyl)methyl]-4-[[(1R,6R)-6-(d...
C26H30ClFN4O4S2
2222539-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 9.2400 3.7947 0.0 0
M  V30 5 O 9.2400 6.8747 0.0 0
M  V30 6 F 10.7800 2.6673 0.0 0
M  V30 7 O 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 Cl 13.8600 8.0021 0.0 0
M  V30 10 N 15.4000 5.3347 0.0 0
M  V30 11 O 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 13 N 18.4800 5.3347 0.0 0
M  V30 14 C 17.7100 6.6684 0.0 0
M  V30 15 C 20.0200 5.3347 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 N 7.5563 8.0753 0.0 0
M  V30 18 S 5.3985 6.8294 0.0 0
M  V30 19 C 6.4119 9.1057 0.0 0
M  V30 20 C 5.0783 8.3357 0.0 0
M  V30 21 C 10.7800 5.3347 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 11.5500 6.6684 0.0 0
M  V30 24 C 13.0900 4.0011 0.0 0
M  V30 25 C 13.0900 6.6684 0.0 0
M  V30 26 C 13.8600 5.3347 0.0 0
M  V30 27 C 5.3900 4.0011 0.0 0
M  V30 28 C 4.6200 2.6673 0.0 0
M  V30 29 C 4.6200 5.3347 0.0 0
M  V30 30 C 3.0800 2.6673 0.0 0
M  V30 31 C 3.0800 5.3347 0.0 0
M  V30 32 C 2.3100 4.0011 0.0 0
M  V30 33 C 16.1700 4.0011 0.0 0 CFG=2
M  V30 34 C 17.7100 4.0011 0.0 0 CFG=2
M  V30 35 C 15.4000 2.6673 0.0 0
M  V30 36 C 18.4800 2.6673 0.0 0
M  V30 37 C 16.1700 1.3336 0.0 0
M  V30 38 C 17.7100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 21
M  V30 7 1 3 27
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 7 28
M  V30 11 1 9 25
M  V30 12 1 10 26
M  V30 13 1 33 10 CFG=1
M  V30 14 1 11 12
M  V30 15 1 11 32
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 34 13 CFG=3
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-chloro-4-[[(1R,6R)-6-(dimethylamino)-3-cyclohexen-...
C17H20ClFN4O2S2.CH2O2
2222537-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.3217 6.3111 0.0 0
M  V30 2 N 13.4017 6.3111 0.0 0
M  V30 3 C 14.9417 6.3111 0.0 0
M  V30 4 C 12.6317 7.6447 0.0 0
M  V30 5 Cl 8.7817 8.9784 0.0 0
M  V30 6 F 5.7017 3.6437 0.0 0
M  V30 7 S 4.1617 6.3111 0.0 0 VAL=6
M  V30 8 N 2.6217 6.3111 0.0 0
M  V30 9 O 4.1617 4.7711 0.0 0
M  V30 10 O 4.1617 7.8511 0.0 0
M  V30 11 C 11.0917 4.9775 0.0 0 CFG=2
M  V30 12 C 12.6317 4.9775 0.0 0 CFG=2
M  V30 13 C 10.3217 3.6437 0.0 0
M  V30 14 C 13.4017 3.6437 0.0 0
M  V30 15 C 11.0917 2.3100 0.0 0
M  V30 16 C 12.6317 2.3100 0.0 0
M  V30 17 C 8.7817 6.3111 0.0 0
M  V30 18 C 8.0117 7.6447 0.0 0
M  V30 19 C 8.0117 4.9775 0.0 0
M  V30 20 C 6.4717 7.6447 0.0 0
M  V30 21 C 6.4717 4.9775 0.0 0
M  V30 22 C 5.7017 6.3111 0.0 0
M  V30 23 C 1.8517 7.6447 0.0 0
M  V30 24 N 2.4782 9.0517 0.0 0
M  V30 25 S 0.3202 7.8057 0.0 0
M  V30 26 C 1.3336 10.0821 0.0 0
M  V30 27 C 0.0000 9.3121 0.0 0
M  V30 28 C 7.4708 0.0000 0.0 0
M  V30 29 O 6.1372 0.7700 0.0 0
M  V30 30 O 8.8045 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 12 2 CFG=3
M  V30 6 1 5 18
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 7 22
M  V30 12 1 8 23
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222539-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222537-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-20681556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Heteroaryl benzenesulfonamides as voltage-dependent sodium channel
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutherlin, Daniel; McKerrall, Steven; Wilson, Michael Scott; Lai, Kwong
Wah; Bergeron, Philippe; Zhang, Birong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180105504 A1 2018-04-19

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N3-(2-Chlorophenyl)[1,1′-biphenyl]-3,4-diamine
C18H15ClN2
2250088-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6200 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 Cl 0.0000 3.0800 0.0 0
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 C 5.3347 4.6200 0.0 0
M  V30 6 C 6.6684 6.9300 0.0 0
M  V30 7 C 4.0011 5.3900 0.0 0
M  V30 8 C 5.3347 7.7000 0.0 0
M  V30 9 C 4.0011 6.9300 0.0 0
M  V30 10 C 8.0021 4.6200 0.0 0
M  V30 11 C 8.0021 3.0800 0.0 0
M  V30 12 C 9.3358 5.3900 0.0 0
M  V30 13 C 9.3358 2.3100 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 10.6694 3.0800 0.0 0
M  V30 16 C 2.6673 3.0800 0.0 0
M  V30 17 C 1.3336 2.3100 0.0 0
M  V30 18 C 4.0011 2.3100 0.0 0
M  V30 19 C 1.3336 0.7700 0.0 0
M  V30 20 C 4.0011 0.7700 0.0 0
M  V30 21 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 1 2 9
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-6-phenyl-1H-benzimidazole
C19H13ClN2
2247908-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.7536 0.0 0
M  V30 2 C 4.4773 4.8698 0.0 0
M  V30 3 N 3.0127 4.3940 0.0 0
M  V30 4 C 4.4773 6.4098 0.0 0
M  V30 5 C 5.8109 4.0998 0.0 0
M  V30 6 C 2.1075 5.6398 0.0 0
M  V30 7 N 3.0127 6.8857 0.0 0
M  V30 8 C 5.8109 7.1798 0.0 0
M  V30 9 C 7.1447 4.8698 0.0 0
M  V30 10 C 7.1447 6.4098 0.0 0
M  V30 11 C 2.5367 2.9292 0.0 0
M  V30 12 C 1.0304 2.6091 0.0 0
M  V30 13 C 3.5673 1.7849 0.0 0
M  V30 14 C 0.5546 1.1445 0.0 0
M  V30 15 C 3.0914 0.3202 0.0 0
M  V30 16 C 1.5850 0.0000 0.0 0
M  V30 17 C 8.4784 4.0998 0.0 0
M  V30 18 C 8.4784 2.5598 0.0 0
M  V30 19 C 9.8120 4.8698 0.0 0
M  V30 20 C 9.8120 1.7898 0.0 0
M  V30 21 C 11.1457 4.0998 0.0 0
M  V30 22 C 11.1457 2.5598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 6 7
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 9 17
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2250088-20-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2247908-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19717411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A selective class of inhibitors for the CLC-Ka chloride ion channel
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koster, Anna K.; Wood, Chase A. P.; Thomas-Tran, Rhiannon; Chavan, Tanmay
S.; Almqvist, Jonas; Choi, Kee-Hyun; Bois, J. Du; Maduke, Merritt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2018), 115(21), E4900-E4909

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Benzofuranyl)-3-(3-methoxypropoxy)-α-(1-methylethyl)benzeneethanamine
C23H29NO3
2253887-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5772 6.6685 0.0 0
M  V30 2 C 7.3472 5.3348 0.0 0
M  V30 3 C 6.5772 4.0012 0.0 0
M  V30 4 C 7.3472 2.6673 0.0 0
M  V30 5 O 6.5772 1.3337 0.0 0
M  V30 6 C 7.3472 0.0000 0.0 0
M  V30 7 C 11.1973 9.3360 0.0 0
M  V30 8 C 11.9673 10.6697 0.0 0
M  V30 9 C 13.5073 10.6697 0.0 0
M  V30 10 N 11.1973 12.0033 0.0 0
M  V30 11 C 14.2773 12.0033 0.0 0
M  V30 12 C 14.2773 9.3360 0.0 0
M  V30 13 C 5.0371 9.3360 0.0 0
M  V30 14 C 4.1321 8.0900 0.0 0
M  V30 15 O 4.1321 10.5819 0.0 0
M  V30 16 C 2.6673 8.5660 0.0 0
M  V30 17 C 2.6673 10.1060 0.0 0
M  V30 18 C 1.3337 7.7960 0.0 0
M  V30 19 C 1.3337 10.8760 0.0 0
M  V30 20 C 0.0000 8.5660 0.0 0
M  V30 21 C 0.0000 10.1060 0.0 0
M  V30 22 C 6.5772 9.3360 0.0 0
M  V30 23 C 7.3472 8.0022 0.0 0
M  V30 24 C 7.3472 10.6697 0.0 0
M  V30 25 C 8.8872 8.0022 0.0 0
M  V30 26 C 8.8872 10.6697 0.0 0
M  V30 27 C 9.6572 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-(2-Benzofuranyl)-3-(3-methoxypropoxy)phenyl]methyl]-2-methylpropyl]f...
C24H29NO4
2253887-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 6.5772 0.0 0
M  V30 2 C 9.3358 7.3472 0.0 0
M  V30 3 C 10.6697 6.5772 0.0 0
M  V30 4 C 12.0033 7.3472 0.0 0
M  V30 5 O 13.3370 6.5772 0.0 0
M  V30 6 C 14.6707 7.3472 0.0 0
M  V30 7 C 5.3348 11.1973 0.0 0
M  V30 8 C 4.0010 11.9673 0.0 0
M  V30 9 N 2.6673 11.1973 0.0 0
M  V30 10 C 4.0010 13.5073 0.0 0
M  V30 11 C 1.3337 11.9673 0.0 0
M  V30 12 C 2.6673 14.2773 0.0 0
M  V30 13 C 5.3348 14.2773 0.0 0
M  V30 14 O 0.0000 11.1973 0.0 0
M  V30 15 C 5.3348 5.0371 0.0 0
M  V30 16 C 6.5807 4.1321 0.0 0
M  V30 17 O 4.0888 4.1321 0.0 0
M  V30 18 C 6.1048 2.6673 0.0 0
M  V30 19 C 4.5648 2.6673 0.0 0
M  V30 20 C 6.8749 1.3337 0.0 0
M  V30 21 C 3.7948 1.3337 0.0 0
M  V30 22 C 6.1048 0.0000 0.0 0
M  V30 23 C 4.5648 0.0000 0.0 0
M  V30 24 C 5.3348 6.5772 0.0 0
M  V30 25 C 6.6685 7.3472 0.0 0
M  V30 26 C 4.0010 7.3472 0.0 0
M  V30 27 C 6.6685 8.8872 0.0 0
M  V30 28 C 4.0010 8.8872 0.0 0
M  V30 29 C 5.3348 9.6572 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 29
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-93-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786401
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Benzofuranyl)-3-(3-methoxypropoxy)-α-(1-methylethyl)benzeneethanamine
C23H29NO3
2253887-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5772 6.6685 0.0 0
M  V30 2 C 7.3472 5.3348 0.0 0
M  V30 3 C 6.5772 4.0012 0.0 0
M  V30 4 C 7.3472 2.6673 0.0 0
M  V30 5 O 6.5772 1.3337 0.0 0
M  V30 6 C 7.3472 0.0000 0.0 0
M  V30 7 C 11.1973 9.3360 0.0 0
M  V30 8 C 11.9673 10.6697 0.0 0
M  V30 9 C 13.5073 10.6697 0.0 0
M  V30 10 N 11.1973 12.0033 0.0 0
M  V30 11 C 14.2773 12.0033 0.0 0
M  V30 12 C 14.2773 9.3360 0.0 0
M  V30 13 C 5.0371 9.3360 0.0 0
M  V30 14 C 4.1321 8.0900 0.0 0
M  V30 15 O 4.1321 10.5819 0.0 0
M  V30 16 C 2.6673 8.5660 0.0 0
M  V30 17 C 2.6673 10.1060 0.0 0
M  V30 18 C 1.3337 7.7960 0.0 0
M  V30 19 C 1.3337 10.8760 0.0 0
M  V30 20 C 0.0000 8.5660 0.0 0
M  V30 21 C 0.0000 10.1060 0.0 0
M  V30 22 C 6.5772 9.3360 0.0 0
M  V30 23 C 7.3472 8.0022 0.0 0
M  V30 24 C 7.3472 10.6697 0.0 0
M  V30 25 C 8.8872 8.0022 0.0 0
M  V30 26 C 8.8872 10.6697 0.0 0
M  V30 27 C 9.6572 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-(2-Benzofuranyl)-3-(3-methoxypropoxy)phenyl]methyl]-2-methylpropyl]f...
C24H29NO4
2253887-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 6.5772 0.0 0
M  V30 2 C 9.3358 7.3472 0.0 0
M  V30 3 C 10.6697 6.5772 0.0 0
M  V30 4 C 12.0033 7.3472 0.0 0
M  V30 5 O 13.3370 6.5772 0.0 0
M  V30 6 C 14.6707 7.3472 0.0 0
M  V30 7 C 5.3348 11.1973 0.0 0
M  V30 8 C 4.0010 11.9673 0.0 0
M  V30 9 N 2.6673 11.1973 0.0 0
M  V30 10 C 4.0010 13.5073 0.0 0
M  V30 11 C 1.3337 11.9673 0.0 0
M  V30 12 C 2.6673 14.2773 0.0 0
M  V30 13 C 5.3348 14.2773 0.0 0
M  V30 14 O 0.0000 11.1973 0.0 0
M  V30 15 C 5.3348 5.0371 0.0 0
M  V30 16 C 6.5807 4.1321 0.0 0
M  V30 17 O 4.0888 4.1321 0.0 0
M  V30 18 C 6.1048 2.6673 0.0 0
M  V30 19 C 4.5648 2.6673 0.0 0
M  V30 20 C 6.8749 1.3337 0.0 0
M  V30 21 C 3.7948 1.3337 0.0 0
M  V30 22 C 6.1048 0.0000 0.0 0
M  V30 23 C 4.5648 0.0000 0.0 0
M  V30 24 C 5.3348 6.5772 0.0 0
M  V30 25 C 6.6685 7.3472 0.0 0
M  V30 26 C 4.0010 7.3472 0.0 0
M  V30 27 C 6.6685 8.8872 0.0 0
M  V30 28 C 4.0010 8.8872 0.0 0
M  V30 29 C 5.3348 9.6572 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 29
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253887-93-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2253887-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL

C44H58FN7O7
2254254-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6695 5.3900 0.0 0
M  V30 2 C 10.6695 3.8500 0.0 0
M  V30 3 O 9.3357 3.0800 0.0 0
M  V30 4 O 12.0031 3.0800 0.0 0
M  V30 5 C 9.3357 1.5400 0.0 0
M  V30 6 C 7.7957 1.5400 0.0 0
M  V30 7 C 9.3357 0.0000 0.0 0
M  V30 8 C 10.8757 1.5400 0.0 0
M  V30 9 C 16.0042 3.8500 0.0 0
M  V30 10 C 17.3379 3.0800 0.0 0
M  V30 11 N 5.3347 8.4700 0.0 0
M  V30 12 C 5.3347 10.0101 0.0 0
M  V30 13 C 4.0009 7.7000 0.0 0
M  V30 14 O 4.0009 10.7801 0.0 0
M  V30 15 O 6.6684 10.7801 0.0 0
M  V30 16 O 2.6673 8.4700 0.0 0
M  V30 17 O 4.0009 6.1600 0.0 0
M  V30 18 C 4.0009 12.3201 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 5.5409 12.3201 0.0 0
M  V30 21 C 4.0009 13.8601 0.0 0
M  V30 22 C 2.4609 12.3201 0.0 0
M  V30 23 C 2.1037 6.3662 0.0 0
M  V30 24 C 0.0000 6.9300 0.0 0
M  V30 25 C 0.5636 9.0337 0.0 0
M  V30 26 C 17.6881 11.0320 0.0 0
M  V30 27 N 22.6404 8.8270 0.0 0
M  V30 28 C 23.5456 10.0730 0.0 0
M  V30 29 C 25.0772 9.9120 0.0 0
M  V30 30 O 22.9193 11.4798 0.0 0
M  V30 31 C 29.9507 12.0818 0.0 0
M  V30 32 F 25.6348 15.2174 0.0 0
M  V30 33 C 12.0031 6.1600 0.0 0
M  V30 34 N 13.3368 5.3900 0.0 0
M  V30 35 N 12.0031 7.7000 0.0 0
M  V30 36 C 14.6704 6.1600 0.0 0
M  V30 37 C 13.3368 8.4700 0.0 0
M  V30 38 C 14.6704 7.7000 0.0 0
M  V30 39 C 16.0042 5.3900 0.0 0
M  V30 40 C 16.0042 8.4700 0.0 0
M  V30 41 C 17.3379 6.1600 0.0 0
M  V30 42 C 17.3379 7.7000 0.0 0
M  V30 43 C 9.3357 6.1600 0.0 0 CFG=1
M  V30 44 C 8.0020 5.3900 0.0 0
M  V30 45 C 9.3357 7.7000 0.0 0
M  V30 46 C 6.6684 6.1600 0.0 0
M  V30 47 C 8.0020 8.4700 0.0 0
M  V30 48 C 6.6684 7.7000 0.0 0 CFG=1
M  V30 49 C 18.6715 8.4700 0.0 0
M  V30 50 C 20.0785 7.8436 0.0 0
M  V30 51 N 18.8324 10.0016 0.0 0
M  V30 52 C 21.1089 8.9881 0.0 0
M  V30 53 N 20.3389 10.3217 0.0 0
M  V30 54 C 25.9824 11.1578 0.0 0
M  V30 55 C 27.5139 10.9969 0.0 0
M  V30 56 C 25.3561 12.5648 0.0 0
M  V30 57 C 28.4192 12.2428 0.0 0
M  V30 58 C 26.2613 13.8106 0.0 0
M  V30 59 C 27.7928 13.6497 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 33
M  V30 3 1 43 1 CFG=3
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 39
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 48 11 CFG=1
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 19 24
M  V30 26 1 19 25
M  V30 27 1 26 51
M  V30 28 1 27 28
M  V30 29 1 27 52
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 32 1 29 54
M  V30 33 1 31 57
M  V30 34 1 32 58
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 36 39
M  V30 41 1 37 38
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 46 1 42 49
M  V30 47 1 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 1 47 48
M  V30 53 2 49 50
M  V30 54 1 49 51
M  V30 55 1 50 52
M  V30 56 1 51 53
M  V30 57 2 52 53
M  V30 58 2 54 55
M  V30 59 1 54 56
M  V30 60 1 55 57
M  V30 61 2 56 58
M  V30 62 2 57 59
M  V30 63 1 58 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 43 48)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[5-[2-[(trans-4-aminocyclohexyl)amino]-8-ethyl-6-q...
C29H34FN7O.xCH2O2
2254253-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.2628 6.4955 0.0 0
M  V30 2 C 13.9468 13.6776 0.0 0
M  V30 3 C 12.6131 14.4476 0.0 0
M  V30 4 N 7.3103 8.7005 0.0 0
M  V30 5 C 6.4051 7.4545 0.0 0
M  V30 6 C 4.8736 7.6156 0.0 0
M  V30 7 O 7.0316 6.0477 0.0 0
M  V30 8 N 19.2816 12.1375 0.0 0
M  V30 9 C 4.3159 2.3100 0.0 0
M  V30 10 F 0.0000 5.4457 0.0 0
M  V30 11 N 24.6164 9.0576 0.0 0
M  V30 12 C 12.6131 9.8275 0.0 0
M  V30 13 C 13.9468 9.0575 0.0 0
M  V30 14 C 12.6131 11.3675 0.0 0
M  V30 15 C 15.2804 9.8275 0.0 0
M  V30 16 C 13.9468 12.1375 0.0 0
M  V30 17 C 15.2804 11.3675 0.0 0
M  V30 18 C 16.6141 9.0575 0.0 0
M  V30 19 N 16.6141 12.1375 0.0 0
M  V30 20 N 17.9479 9.8275 0.0 0
M  V30 21 C 17.9479 11.3675 0.0 0
M  V30 22 C 11.2793 9.0575 0.0 0
M  V30 23 C 9.8725 9.6840 0.0 0
M  V30 24 N 11.1184 7.5259 0.0 0
M  V30 25 C 8.8420 8.5394 0.0 0
M  V30 26 N 9.6121 7.2058 0.0 0
M  V30 27 C 3.9683 6.3697 0.0 0
M  V30 28 C 4.5948 4.9627 0.0 0
M  V30 29 C 2.4368 6.5306 0.0 0
M  V30 30 C 3.6896 3.7168 0.0 0
M  V30 31 C 1.5316 5.2847 0.0 0
M  V30 32 C 2.1580 3.8778 0.0 0
M  V30 33 C 20.6152 11.3675 0.0 0 CFG=1
M  V30 34 C 21.9489 12.1375 0.0 0
M  V30 35 C 20.6152 9.8275 0.0 0
M  V30 36 C 23.2827 11.3675 0.0 0
M  V30 37 C 21.9489 9.0575 0.0 0
M  V30 38 C 23.2827 9.8275 0.0 0 CFG=1
M  V30 39 C 12.3082 0.0000 0.0 0
M  V30 40 O 10.9745 0.7700 0.0 0
M  V30 41 O 13.6419 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 27
M  V30 9 1 8 21
M  V30 10 1 33 8 CFG=3
M  V30 11 1 9 30
M  V30 12 1 10 31
M  V30 13 1 38 11 CFG=1
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 22
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 2 39 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 33 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2254254-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254253-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-23816737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives and related heterocycles as IRE1
small molecule inhibitors for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vacca, Joseph P.; Li, Dansu; Bettigole, Sarah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018222917 A1 2018-12-06

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H32N2
2281870-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.3899 2.6198 0.0 0
M  V30 2 C 9.3714 4.3166 0.0 0
M  V30 3 C 10.1414 5.6502 0.0 0
M  V30 4 C 8.7138 3.0545 0.0 0
M  V30 5 C 3.5814 8.6658 0.0 0
M  V30 6 C 5.5242 8.2880 0.0 0
M  V30 7 C 3.7865 0.0000 0.0 0
M  V30 8 C 2.2445 1.1688 0.0 0
M  V30 9 C 5.1917 4.7849 0.0 0 CFG=2
M  V30 10 C 3.7140 4.3052 0.0 0
M  V30 11 C 6.3966 3.7967 0.0 0 CFG=1
M  V30 12 C 5.4910 6.3090 0.0 0 CFG=2
M  V30 13 C 2.6067 5.3137 0.0 0
M  V30 14 C 3.0586 2.9297 0.0 0
M  V30 15 C 7.8314 4.3166 0.0 0 CFG=1
M  V30 16 C 6.4077 2.2773 0.0 0
M  V30 17 C 4.3277 7.3186 0.0 0
M  V30 18 C 6.9285 6.8244 0.0 0
M  V30 19 C 2.8525 6.8121 0.0 0
M  V30 20 C 1.2361 4.6826 0.0 0
M  V30 21 N 1.5127 3.1322 0.0 0
M  V30 22 C 3.7392 1.5394 0.0 0
M  V30 23 C 8.0969 5.8288 0.0 0
M  V30 24 C 5.2600 1.2600 0.0 0
M  V30 25 C 1.6073 7.7463 0.0 0
M  V30 26 C 0.0000 5.6319 0.0 0
M  V30 27 C 0.1785 7.1641 0.0 0
M  V30 28 H 4.9061 3.2715 0.0 0
M  V30 29 H 5.7746 7.8226 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 2 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 15 4 CFG=1
M  V30 5 1 5 17
M  V30 6 1 6 17
M  V30 7 1 7 22
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 28 CFG=1
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 29 CFG=3
M  V30 20 2 13 19
M  V30 21 1 13 20
M  V30 22 1 14 21
M  V30 23 1 14 22
M  V30 24 1 15 23
M  V30 25 2 16 24
M  V30 26 1 17 19
M  V30 27 1 18 23
M  V30 28 1 19 25
M  V30 29 1 20 21
M  V30 30 2 20 26
M  V30 31 1 22 24
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 11 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H32N2O
2281870-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1244 4.0573 0.0 0
M  V30 2 C 8.8944 5.3909 0.0 0
M  V30 3 O 10.4344 5.3909 0.0 0
M  V30 4 C 8.1060 1.4487 0.0 0
M  V30 5 C 7.5836 0.0000 0.0 0
M  V30 6 C 8.4434 3.4003 0.0 0
M  V30 7 C 1.0477 3.0677 0.0 0
M  V30 8 C 2.5894 1.8268 0.0 0
M  V30 9 C 7.8018 8.5008 0.0 0
M  V30 10 C 5.9141 8.9252 0.0 0
M  V30 11 C 5.0520 4.3407 0.0 0 CFG=1
M  V30 12 C 6.5844 4.0573 0.0 0 CFG=1
M  V30 13 C 4.4654 5.7792 0.0 0
M  V30 14 C 4.0802 3.1287 0.0 0 CFG=2
M  V30 15 C 7.1127 2.6254 0.0 0 CFG=1
M  V30 16 C 7.7525 5.0289 0.0 0
M  V30 17 C 2.9804 5.9747 0.0 0
M  V30 18 C 5.0937 7.1673 0.0 0
M  V30 19 C 2.5584 3.3664 0.0 0
M  V30 20 C 4.6137 1.6977 0.0 0
M  V30 21 C 6.1283 1.4471 0.0 0
M  V30 22 C 7.7895 6.5621 0.0 0
M  V30 23 C 1.9940 4.8204 0.0 0
M  V30 24 C 2.5786 7.4291 0.0 0
M  V30 25 N 3.9418 8.2179 0.0 0
M  V30 26 C 6.5952 7.5440 0.0 0
M  V30 27 C 0.4768 5.1693 0.0 0
M  V30 28 C 1.0558 7.7615 0.0 0
M  V30 29 C 0.0000 6.6366 0.0 0
M  V30 30 H 6.0242 5.5349 0.0 0
M  V30 31 H 3.1066 1.9356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 15 4 CFG=1
M  V30 6 1 15 6 CFG=3
M  V30 7 1 7 19
M  V30 8 1 8 19
M  V30 9 1 9 26
M  V30 10 1 10 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 30 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 14 31 CFG=1
M  V30 22 1 15 21
M  V30 23 2 16 22
M  V30 24 2 17 23
M  V30 25 1 17 24
M  V30 26 1 18 25
M  V30 27 1 18 26
M  V30 28 1 19 23
M  V30 29 1 20 21
M  V30 30 1 22 26
M  V30 31 1 23 27
M  V30 32 1 24 25
M  V30 33 2 24 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2281870-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2281870-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19800876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Pentacyclic (-)-Ambiguine P Using Sequential Indole
Functionalizations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Rebecca E.; Ree, Hwisoo; Hartmann, Marco; Lang, Laura; Sawano,
Shota; Sarpong, Richmond
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2019), 141(6), 2233-2237

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS,βS)-β-Amino-α-phenylbenzeneethanol
C14H15NO
23190-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=2
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=2
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2S)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
301191-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23190-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 301191-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4316493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM mixed anhydride solution (prepared in stage 1) added in stage 2, 36.5 g
scale
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales, Marvin R.; Mellem, Kevin T.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(19), 4568-4571,
S4568/1-S4568/112

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diphenyl-p-phenylenediamine
C18H16N2
2350-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 N 9.3359 7.7001 0.0 0
M  V30 3 C 5.3348 5.3901 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 6.6684 7.7001 0.0 0
M  V30 7 C 8.0022 5.3901 0.0 0
M  V30 8 C 8.0022 6.9301 0.0 0
M  V30 9 C 2.6675 5.3901 0.0 0
M  V30 10 C 2.6675 6.9301 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 1.3337 7.7001 0.0 0
M  V30 13 C 0.0000 5.3901 0.0 0
M  V30 14 C 0.0000 6.9301 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 5.3348 2.3100 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 8
M  V30 5 2 3 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Diphenylamino)phenyl]formamide
C19H16N2O
2089149-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 N 9.3360 7.7002 0.0 0
M  V30 3 C 10.6697 6.9302 0.0 0
M  V30 4 O 12.0033 7.7002 0.0 0
M  V30 5 C 5.3348 5.3901 0.0 0
M  V30 6 C 5.3348 6.9302 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 6.6685 7.7002 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 C 8.0022 6.9302 0.0 0
M  V30 11 C 2.6673 5.3901 0.0 0
M  V30 12 C 2.6673 6.9302 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 7.7002 0.0 0
M  V30 15 C 0.0000 5.3901 0.0 0
M  V30 16 C 0.0000 6.9302 0.0 0
M  V30 17 C 4.0012 3.0801 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 2.6673 0.7700 0.0 0
M  V30 22 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 2 10
M  V30 6 2 3 4
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2350-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089149-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17127087
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process of changing the refractive index of a composite containing a
polymer and a compound having large dipole moment and polarizability and
applications thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marder, Seth R.; Peyghambarian, Nasser; Kippelen, Bernard; Volodin,
Boris; Hendrickx, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6090332 A 2000-07-18

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzylamine
C8H11NO
2393-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methyl]formamide
C9H11NO2
17061-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2393-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17061-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23015910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-83-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1610891-42-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, catalyst prepared and used,
reusable catalyst, 90% isolated yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalysed efficient N-formylation of amines with a recyclable
polyoxometalate-supported green catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dan, Demin; Chen, Fubo; Zhao, Whenshu; Yu, Han; Han, Sheng; Wei, Yongge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2021), 50(1), 90-94

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
(OC-6-21)-[3-(Aminothioxomethyl)-5-iodophenyl]pentafluorosulfur
C7H5F5INS2
2396495-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3336 4.6200 0.0 0 VAL=6
M  V30 2 F 0.0000 5.3900 0.0 0
M  V30 3 F 2.6674 5.3900 0.0 0
M  V30 4 F 0.0000 3.8500 0.0 0
M  V30 5 F 1.3336 6.1600 0.0 0
M  V30 6 F 1.3336 3.0800 0.0 0
M  V30 7 C 6.6685 4.6200 0.0 0
M  V30 8 N 6.6685 6.1600 0.0 0
M  V30 9 S 8.0021 3.8500 0.0 0
M  V30 10 I 4.0011 0.0000 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentafluoro[3-iodo-5-(1H-1,2,4-triazol-3-yl)phenyl]sulfur
C8H5F5IN3S
2396495-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 4.6201 0.0 0 VAL=6
M  V30 2 F 0.0000 5.3901 0.0 0
M  V30 3 F 2.6673 5.3901 0.0 0
M  V30 4 F 0.0000 3.8501 0.0 0
M  V30 5 F 1.3337 6.1601 0.0 0
M  V30 6 F 1.3337 3.0800 0.0 0
M  V30 7 I 4.0011 0.0000 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 6.6684 4.6201 0.0 0
M  V30 15 N 6.8295 6.1516 0.0 0
M  V30 16 N 8.0754 3.9936 0.0 0
M  V30 17 C 8.3358 6.4718 0.0 0
M  V30 18 N 9.1058 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 8
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2396495-70-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2396495-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-21687619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7803-57-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N'-substituted
pentafluorosulfanyltrifluoromethylphenyl-1H-1,2,4-triazolylacroylhydrazides
as nuclear transport modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Jia-Ning; Qi, Zude; Liu, Xianbo; Ning, Dezheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019233447 A1 2019-12-12

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
(OC-6-21)-[3-(Aminothioxomethyl)-5-iodophenyl]pentafluorosulfur
C7H5F5INS2
2396495-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3336 4.6200 0.0 0 VAL=6
M  V30 2 F 0.0000 5.3900 0.0 0
M  V30 3 F 2.6674 5.3900 0.0 0
M  V30 4 F 0.0000 3.8500 0.0 0
M  V30 5 F 1.3336 6.1600 0.0 0
M  V30 6 F 1.3336 3.0800 0.0 0
M  V30 7 C 6.6685 4.6200 0.0 0
M  V30 8 N 6.6685 6.1600 0.0 0
M  V30 9 S 8.0021 3.8500 0.0 0
M  V30 10 I 4.0011 0.0000 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentafluoro[3-iodo-5-(1H-1,2,4-triazol-3-yl)phenyl]sulfur
C8H5F5IN3S
2396495-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 4.6201 0.0 0 VAL=6
M  V30 2 F 0.0000 5.3901 0.0 0
M  V30 3 F 2.6673 5.3901 0.0 0
M  V30 4 F 0.0000 3.8501 0.0 0
M  V30 5 F 1.3337 6.1601 0.0 0
M  V30 6 F 1.3337 3.0800 0.0 0
M  V30 7 I 4.0011 0.0000 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 6.6684 4.6201 0.0 0
M  V30 15 N 6.8295 6.1516 0.0 0
M  V30 16 N 8.0754 3.9936 0.0 0
M  V30 17 C 8.3358 6.4718 0.0 0
M  V30 18 N 9.1058 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 8
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2396495-70-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2396495-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-22240822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7803-57-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N'-substituted
pentafluorosulfanyltrifluoromethylphenyl-1H-1,2,4-triazolylacroylhydrazides
as nuclear transport modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Jia-Ning; Qi, Zude; Liu, Xianbo; Ning, Dezheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019232724 A1 2019-12-12

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Methano-3aH-pyrrolo[3,2-b]pyridine-3a-carboxamide, 1-[[4-(1,1-dimethyleth...
C34H41N3O2
2411666-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0159 6.5497 0.0 0
M  V30 2 N 6.9226 5.3049 0.0 0
M  V30 3 O 4.4845 6.3869 0.0 0
M  V30 4 C 6.2979 3.8973 0.0 0
M  V30 5 C 4.1533 7.1181 0.0 0
M  V30 6 C 10.1436 6.7301 0.0 0
M  V30 7 O 15.4783 9.8102 0.0 0
M  V30 8 C 16.8120 9.0402 0.0 0
M  V30 9 C 17.5820 10.3738 0.0 0
M  V30 10 C 18.1456 8.2702 0.0 0
M  V30 11 C 16.0420 7.7064 0.0 0
M  V30 12 C 6.6407 7.9572 0.0 0 CFG=2
M  V30 13 C 7.5594 6.9421 0.0 0 CFG=1
M  V30 14 C 7.3292 9.1501 0.0 0 CFG=1
M  V30 15 N 5.2631 7.9575 0.0 0
M  V30 16 C 6.1928 8.0818 0.0 0 CFG=2
M  V30 17 N 8.8099 7.5002 0.0 0
M  V30 18 C 8.6679 8.8620 0.0 0
M  V30 19 C 6.6407 10.3430 0.0 0
M  V30 20 C 4.5746 9.1504 0.0 0
M  V30 21 C 5.2634 10.3432 0.0 0 CFG=2
M  V30 22 C 2.7688 7.7926 0.0 0
M  V30 23 C 1.4924 6.9310 0.0 0
M  V30 24 C 2.6607 9.3289 0.0 0
M  V30 25 C 0.1080 7.6055 0.0 0
M  V30 26 C 1.2764 10.0034 0.0 0
M  V30 27 C 0.0000 9.1418 0.0 0
M  V30 28 C 11.4772 7.5002 0.0 0
M  V30 29 C 11.4772 9.0402 0.0 0
M  V30 30 C 12.8109 6.7301 0.0 0
M  V30 31 C 12.8109 9.8102 0.0 0
M  V30 32 C 14.1447 7.5002 0.0 0
M  V30 33 C 14.1447 9.0402 0.0 0
M  V30 34 C 7.2045 2.6524 0.0 0
M  V30 35 C 8.7359 2.8151 0.0 0
M  V30 36 C 6.5798 1.2448 0.0 0
M  V30 37 C 9.6426 1.5703 0.0 0
M  V30 38 C 7.4864 0.0000 0.0 0
M  V30 39 C 9.0178 0.1628 0.0 0
M  V30 40 H 7.5336 5.4022 0.0 0
M  V30 41 H 8.2361 10.3949 0.0 0
M  V30 42 H 4.4936 11.6770 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 34
M  V30 6 1 16 5 CFG=3
M  V30 7 1 5 22
M  V30 8 1 6 17
M  V30 9 1 6 28
M  V30 10 1 7 8
M  V30 11 1 7 33
M  V30 12 1 8 9
M  V30 13 1 8 10
M  V30 14 1 8 11
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 13 17 CFG=1
M  V30 20 1 13 40 CFG=3
M  V30 21 1 14 18
M  V30 22 1 14 19
M  V30 23 1 14 41 CFG=3
M  V30 24 1 15 20
M  V30 25 1 16 21
M  V30 26 1 17 18
M  V30 27 1 19 21
M  V30 28 1 21 20 CFG=3
M  V30 29 1 21 42 CFG=1
M  V30 30 2 22 23
M  V30 31 1 22 24
M  V30 32 1 23 25
M  V30 33 2 24 26
M  V30 34 2 25 27
M  V30 35 1 26 27
M  V30 36 2 28 29
M  V30 37 1 28 30
M  V30 38 1 29 31
M  V30 39 2 30 32
M  V30 40 2 31 33
M  V30 41 1 32 33
M  V30 42 2 34 35
M  V30 43 1 34 36
M  V30 44 1 35 37
M  V30 45 2 36 38
M  V30 46 2 37 39
M  V30 47 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 12 13 14 16 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H33N3O2.2CH2O2
2411666-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0160 8.8597 0.0 0
M  V30 2 N 6.9226 7.6149 0.0 0
M  V30 3 O 4.4847 8.6969 0.0 0
M  V30 4 C 6.2979 6.2073 0.0 0
M  V30 5 C 4.1533 9.4281 0.0 0
M  V30 6 C 10.1436 9.0402 0.0 0
M  V30 7 O 15.4783 12.1202 0.0 0
M  V30 8 C 6.6407 10.2672 0.0 0 CFG=2
M  V30 9 C 7.5594 9.2521 0.0 0 CFG=1
M  V30 10 C 7.3294 11.4601 0.0 0 CFG=1
M  V30 11 N 5.2631 10.2676 0.0 0
M  V30 12 C 6.1928 10.3918 0.0 0 CFG=2
M  V30 13 N 8.8099 9.8102 0.0 0
M  V30 14 C 8.6679 11.1720 0.0 0
M  V30 15 C 6.6407 12.6530 0.0 0
M  V30 16 C 4.5746 11.4604 0.0 0
M  V30 17 C 5.2634 12.6532 0.0 0 CFG=2
M  V30 18 C 2.7688 10.1026 0.0 0
M  V30 19 C 2.6608 11.6389 0.0 0
M  V30 20 C 1.4924 9.2410 0.0 0
M  V30 21 C 1.2764 12.3135 0.0 0
M  V30 22 C 0.1080 9.9155 0.0 0
M  V30 23 C 0.0000 11.4518 0.0 0
M  V30 24 C 11.4772 9.8102 0.0 0
M  V30 25 C 12.8110 9.0402 0.0 0
M  V30 26 C 11.4772 11.3502 0.0 0
M  V30 27 C 14.1447 9.8102 0.0 0
M  V30 28 C 12.8110 12.1202 0.0 0
M  V30 29 C 14.1447 11.3502 0.0 0
M  V30 30 C 7.2045 4.9624 0.0 0
M  V30 31 C 8.7359 5.1252 0.0 0
M  V30 32 C 6.5798 3.5548 0.0 0
M  V30 33 C 9.6426 3.8804 0.0 0
M  V30 34 C 7.4864 2.3100 0.0 0
M  V30 35 C 9.0178 2.4728 0.0 0
M  V30 36 H 7.5336 7.7122 0.0 0
M  V30 37 H 8.2361 12.7049 0.0 0
M  V30 38 H 4.4936 13.9870 0.0 0
M  V30 39 C 7.7392 0.0000 0.0 0
M  V30 40 O 6.4055 0.7700 0.0 0
M  V30 41 O 9.0728 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 30
M  V30 6 1 12 5 CFG=3
M  V30 7 1 5 18
M  V30 8 1 6 13
M  V30 9 1 6 24
M  V30 10 1 7 29
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 1 8 11
M  V30 14 1 9 12
M  V30 15 1 9 13 CFG=1
M  V30 16 1 9 36 CFG=3
M  V30 17 1 10 14
M  V30 18 1 10 15
M  V30 19 1 10 37 CFG=3
M  V30 20 1 11 16
M  V30 21 1 12 17
M  V30 22 1 13 14
M  V30 23 1 15 17
M  V30 24 1 17 16 CFG=3
M  V30 25 1 17 38 CFG=1
M  V30 26 2 18 19
M  V30 27 1 18 20
M  V30 28 1 19 21
M  V30 29 2 20 22
M  V30 30 2 21 23
M  V30 31 1 22 23
M  V30 32 2 24 25
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 2 26 28
M  V30 36 2 27 29
M  V30 37 1 28 29
M  V30 38 2 30 31
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 2 32 34
M  V30 42 2 33 35
M  V30 43 1 34 35
M  V30 44 1 39 40
M  V30 45 2 39 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 8 9 10 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411666-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411666-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24742589
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of octahydro-3,6-methanopyrrolo[3,2-b]pyridine-3a-carboxamide
and octahydro-3,6-methanopyrrolo[3,2-c]pyridine-6-carboxamide derivatives
for treatment of rabies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kouji, Hiroyuki; Yamada, Kentaro; Kato, Akira; Ishizaki, Toshimasa;
Matsuoka, Shigeru; Nishizono, Akira; Mishina, Tadashi; Yoshimori, Atsushi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210214356 A1 2021-07-15

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Bromo-3,4-dihydro-8-methoxy-1-isoquinolinyl)methyl]-1H-isoindole-1,3(2H...
C19H15BrN2O3
2416863-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.8501 0.0 0
M  V30 2 O 7.4148 1.5400 0.0 0
M  V30 3 C 7.4148 0.0000 0.0 0
M  V30 4 Br 12.7496 4.6201 0.0 0
M  V30 5 O 5.7309 7.1821 0.0 0
M  V30 6 O 3.0203 2.4873 0.0 0
M  V30 7 C 8.7484 3.8501 0.0 0
M  V30 8 C 7.4148 4.6201 0.0 0
M  V30 9 C 10.0823 4.6201 0.0 0
M  V30 10 C 8.7484 2.3100 0.0 0
M  V30 11 N 7.4148 6.1601 0.0 0
M  V30 12 C 11.4159 3.8501 0.0 0
M  V30 13 C 10.0823 6.1601 0.0 0
M  V30 14 C 10.0823 1.5400 0.0 0
M  V30 15 C 8.7484 6.9301 0.0 0
M  V30 16 C 11.4159 2.3100 0.0 0
M  V30 17 N 4.7474 4.6201 0.0 0
M  V30 18 C 4.5864 6.1516 0.0 0
M  V30 19 C 3.3405 3.9936 0.0 0
M  V30 20 C 3.0801 6.4718 0.0 0
M  V30 21 C 2.3100 5.1381 0.0 0
M  V30 22 C 2.3100 7.8055 0.0 0
M  V30 23 C 0.7700 5.1381 0.0 0
M  V30 24 C 0.7700 7.8055 0.0 0
M  V30 25 C 0.0000 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 4 12
M  V30 6 2 5 18
M  V30 7 2 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-5-Bromo-1-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihydro-8...
C20H17BrN2O4
2416863-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 4.9672 0.0 0
M  V30 2 O 5.3348 7.2772 0.0 0
M  V30 3 C 5.3348 8.8172 0.0 0
M  V30 4 C 6.2181 1.3957 0.0 0
M  V30 5 O 5.5673 0.0000 0.0 0
M  V30 6 Br 0.0000 4.1972 0.0 0
M  V30 7 O 8.3942 2.0954 0.0 0
M  V30 8 O 8.8667 7.4959 0.0 0
M  V30 9 C 4.0011 4.9672 0.0 0
M  V30 10 C 5.3348 4.1972 0.0 0 CFG=1
M  V30 11 C 2.6675 4.1972 0.0 0
M  V30 12 C 4.0011 6.5072 0.0 0
M  V30 13 N 5.3348 2.6572 0.0 0
M  V30 14 C 2.6675 2.6572 0.0 0
M  V30 15 C 1.3338 4.9672 0.0 0
M  V30 16 C 2.6675 7.2772 0.0 0
M  V30 17 C 4.0011 1.8871 0.0 0
M  V30 18 C 1.3338 6.5072 0.0 0
M  V30 19 N 8.2026 4.8331 0.0 0
M  V30 20 C 8.9959 3.5129 0.0 0
M  V30 21 C 9.2130 5.9953 0.0 0
M  V30 22 C 10.4965 3.8595 0.0 0
M  V30 23 C 10.6306 5.3936 0.0 0
M  V30 24 C 11.7579 2.9761 0.0 0
M  V30 25 C 12.0263 6.0444 0.0 0
M  V30 26 C 13.1536 3.6269 0.0 0
M  V30 27 C 13.2879 5.1611 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 2 4 5
M  V30 6 1 4 13
M  V30 7 1 6 15
M  V30 8 2 7 20
M  V30 9 2 8 21
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2416863-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416863-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25556052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 37366-09-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 167316-27-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted isoquinolines as Nrf2 activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blaney, Emma Louise; Crick, Duncan James; Crumpler, Simon Ross; Hynd,
George; Lucas, Cathy Louise; Martin, Barrie Phillip; Ray, Nick Charles;
Seward, Eileen Mary; Evans, David Gareth; Le Bozec, Lucille; Nowak,
Thorsten; Russell, Michael Geoffrey Neil; Yeap, Siew Kuen; Roussel,
Fabien Jean Ghislain; Sehmi, Sanjeet Singh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020084300 A1 2020-04-30

$RFMT $RIREG SCHEME420 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzylamine
C7H8FN
89-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2-fluorophenyl)methyl]-N-formylcarbamate
C13H16FNO3
1293328-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 O 7.7000 4.0011 0.0 0
M  V30 6 O 7.7000 1.3338 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 C 9.2400 2.4611 0.0 0
M  V30 10 C 10.7800 4.0011 0.0 0
M  V30 11 C 9.2400 5.5411 0.0 0
M  V30 12 F 3.0800 6.6685 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 14
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-99-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1293328-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-4571019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
tert-Butyl formylcarbamates and N-Formyl pivalamides A) Formylation
Acetic anhydride (102 mmol 3.3 equiv) was given into an oven-dried
round-bottomed flask and cooled down to 0 °C, formic acid (102 mmol, 3.3
equiv) was added dropwise and the mixture was warmed up to rt and then to
60 °C for 1.5 h subsequently. After cooling down to rt THF (56 mL) was
added and the solution was cooled down to 0 °C before the amine (30.9
mmol, 1.00 equiv) in THF (32 mL) was added dropwise. The mixture was
warmed up to rt and stirred for 1 h. The remaining acid was neutralized
with K2CO3 and solvent was removed under vacuum. The remaining residue
was extracted with DCM (2 x 50 mL), washed with water (2 x 50 mL) and
dried over MgSO4. The solvent was removed under vacuum and the isolated
product was used without further purification for the next step of the
reaction sequence. B) Boc Group Protection Boc2O (10.0 mmol, 1.00 equiv),
the amide (10.0 mmol, 1.00 equiv) and DMAP (0.5 mmol, 0.05 equiv) were
placed into round-bottomed flask and dissolved in acetonitrile (20 mL, 2
mL/mmol). The mixture was stirred at rt for 14 h. After removal of the
solvent the residue was redissolved in DCM and H2O was added for
extraction. The collected organic layers were washed with brine, dried
over MgSO4 and dried under vacuum. tert-Butyl formyl(phenyl)carbamate
(AA) tert-Butyl 2-fluorobenzyl(formyl)carbamate (AG) Synthesized
according to the general procedure using (2-fluorophenyl)methanamine (63
mg, 0.5 mmol). The crude product was purified by column chromatography
(10–25 % ethyl acetate in pentane) to yield the product as white solid
(125 mg, 99 %). M.P. 38–40 °C; 1H-NMR δ (CDCl3, 400 MHz) 9.32 (s, 1H),
7.27–7.16 (m, 2H), 7.10–7.01 (m, 2H), 4.85 (s, 2H), 1.46 (s, 9H); 13C-NMR
δ (CDCl3, 100 MHz) 163.0, 160.5 (d, 1 J CF = 247 Hz), 152.4, 129.1 (d,J
CF = 8 Hz), 129.0 (d, J CF = 4 Hz), 124.1 (d, J CF = 4 Hz), 115.4 (d, J
CF = 22 Hz), 84.4, 37.6, 27.9; IR νmax/cm-1 (CHCl3) 2982, 2940, 1732,
1701, 1686, 1589, 1489, 1458, 1370, 1339, 1296, 1234, 1150, 1096, 1034,
964, 887, 849; HRMS m/z (EI) calcd. for C13H16FNO3: 253.1114, found
253.1117.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-Oxazolones and α-Aminoketones via Palladium-Catalyzed
Reaction of β,β-Dibromoenamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chai, David I.; Hoffmeister, Laura; Lautens, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2011), 13(1), 106-109

$RFMT $RIREG SCHEME420 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzylamine
C7H8FN
89-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2-fluorophenyl)methyl]-N-formylcarbamate
C13H16FNO3
1293328-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 O 7.7000 4.0011 0.0 0
M  V30 6 O 7.7000 1.3338 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 C 9.2400 2.4611 0.0 0
M  V30 10 C 10.7800 4.0011 0.0 0
M  V30 11 C 9.2400 5.5411 0.0 0
M  V30 12 F 3.0800 6.6685 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 14
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-99-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1293328-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-6846967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM t-Butyl 2-fluorobenzyl(formyl)carbamate (AG): General procedure for the
synthesis of t-butyl formylcarbamates and N-formyl pivalamides. A)
Formylation: Acetic anhydride (102 mmol 3.3 equiv.) was given into an
oven-dried round-bottomed flask and cooled down to 0 degC, formic acid
(102 mmol, 3.3 equiv.) was added dropwise and the mixture was warmed up
to rt and then to 60 degC for 1.5 hr subsequently. After cooling down to
rt, THF (56 mL) was added and the solution was cooled down to 0 degC
before the amine (30.9 mmol, 1.00 equiv.) in THF (32 mL) was added
dropwise. The mixture was warmed up to rt and stirred for 1 hr. The
remaining acid was neutralized with K2CO3 and solvent was removed under
vacuum. The remaining residue was extracted with DCM (2 x 50 mL), washed
with water (2 x 50 mL) and dried over MgSO4. The solvent was removed
under vacuum and the isolated product was used without further
purification for the next step of the reaction sequence. B) Boc group
protection: BOC2O (10.0 mmol, 1.00 equiv.), the amide (10.0 mmol, 1.00
equiv.) and DMAP (0.5 mmol, 0.05 equiv.) were placed into round-bottomed
flask and dissolved in acetonitrile (20 mL, 2 mL/mmol). The mixture was
stirred at rt for 14 hr. After removal of the solvent the residue was
redissolved in DCM and H2O was added for extraction. The collected
organic layers were washed with brine, dried over MgSO4 and dried under
vacuum. Synthesized according to the general procedure using
(2-fluorophenyl)methanamine (63 mg, 0.5 mmol). The crude product was
purified by column chromatography (10-25 % ethyl acetate in pentane) to
yield the product as a white solid (125 mg, 99 %). mp 38-40 degC.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocycles and carbocycles through tandem and domino
palladium-catalyzed reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chai, David Ingoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2011), 73(5), 605 pages

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)-6-phenyl-3-pyridinemethanamine
C18H15IN2
2445188-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 I 3.0800 0.0000 0.0 0
M  V30 4 C 10.0100 4.0011 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 N 9.2400 5.3349 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 7.7000 5.3349 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 11.5500 4.0011 0.0 0
M  V30 11 C 12.3200 5.3349 0.0 0
M  V30 12 C 12.3200 2.6674 0.0 0
M  V30 13 C 13.8600 5.3349 0.0 0
M  V30 14 C 13.8600 2.6674 0.0 0
M  V30 15 C 14.6300 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 16
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)-N-[(6-phenyl-3-pyridinyl)methyl]formamide
C19H15IN2O
2445187-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 C 5.3900 1.3338 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 I 3.0800 5.3349 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 9.2400 2.6674 0.0 0
M  V30 9 C 7.7000 5.3349 0.0 0
M  V30 10 C 7.7000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 11.5500 4.0011 0.0 0
M  V30 13 C 12.3200 5.3349 0.0 0
M  V30 14 C 12.3200 2.6674 0.0 0
M  V30 15 C 13.8600 5.3349 0.0 0
M  V30 16 C 13.8600 2.6674 0.0 0
M  V30 17 C 14.6300 4.0011 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3338 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 1.3338 0.0 0
M  V30 23 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 2 3 4
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445188-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445187-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31074268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phenylethynylpyridinecarboxylic and
phenylethynylbenzoic acids for use in combination products for the
treatment of cancer diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Czauderna, Frank; Ferretti, Roberta; Lindemann, Ralph; Ramaswamy,
Shivapriya; Sala-Hojman, Ada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021249969 A1 2021-12-16

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)-6-phenyl-3-pyridinemethanamine
C18H15IN2
2445188-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 I 3.0800 0.0000 0.0 0
M  V30 4 C 10.0100 4.0011 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 N 9.2400 5.3349 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 7.7000 5.3349 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 11.5500 4.0011 0.0 0
M  V30 11 C 12.3200 5.3349 0.0 0
M  V30 12 C 12.3200 2.6674 0.0 0
M  V30 13 C 13.8600 5.3349 0.0 0
M  V30 14 C 13.8600 2.6674 0.0 0
M  V30 15 C 14.6300 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 16
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)-N-[(6-phenyl-3-pyridinyl)methyl]formamide
C19H15IN2O
2445187-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 C 5.3900 1.3338 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 I 3.0800 5.3349 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 9.2400 2.6674 0.0 0
M  V30 9 C 7.7000 5.3349 0.0 0
M  V30 10 C 7.7000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 11.5500 4.0011 0.0 0
M  V30 13 C 12.3200 5.3349 0.0 0
M  V30 14 C 12.3200 2.6674 0.0 0
M  V30 15 C 13.8600 5.3349 0.0 0
M  V30 16 C 13.8600 2.6674 0.0 0
M  V30 17 C 14.6300 4.0011 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3338 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 1.3338 0.0 0
M  V30 23 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 2 3 4
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445188-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445187-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23014539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of disubstituted alkyne derivatives as monocarboxylate
transporter inhibitors for treatment of hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heinrich, Timo; Petersson, Carl; Krier, Mireille; Gondela, Andrzej;
Galezowski, Michal Mikolaj; Fabritius, Charles-Henry Robert Yves; Nowak,
Mateusz Oktawian; Krol, Marcin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020127960 A1 2020-06-25

$RFMT $RIREG SCHEME422 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorophenol
C6H5FO
371-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thianthrenium, 5-(4-methoxyphenyl)-, 1,1,1-trifluoromethanesulfonate (1:1)
C19H15OS2.CF3O3S
2489620-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 12.3200 0.0 0
M  V30 2 C 10.6694 11.5500 0.0 0
M  V30 3 S 4.0011 9.2400 0.0 0 CHG=1 VAL=3
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 2.6673 10.0100 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 1.3336 9.2400 0.0 0
M  V30 9 C 2.6673 11.5500 0.0 0
M  V30 10 S 1.3336 7.7000 0.0 0
M  V30 11 C 2.6673 5.3900 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 0.0000 10.0100 0.0 0
M  V30 14 C 1.3336 12.3200 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 0.0000 11.5500 0.0 0
M  V30 17 C 5.3347 10.0100 0.0 0
M  V30 18 C 6.6684 9.2400 0.0 0
M  V30 19 C 5.3347 11.5500 0.0 0
M  V30 20 C 8.0021 10.0100 0.0 0
M  V30 21 C 6.6684 12.3200 0.0 0
M  V30 22 C 8.0021 11.5500 0.0 0
M  V30 23 C 4.5647 1.5400 0.0 0
M  V30 24 S 6.1047 1.5400 0.0 0 VAL=6
M  V30 25 F 3.7947 2.8736 0.0 0
M  V30 26 F 3.0247 1.5400 0.0 0
M  V30 27 F 3.7947 0.2064 0.0 0
M  V30 28 O 6.1047 3.0800 0.0 0
M  V30 29 O 6.1047 0.0000 0.0 0
M  V30 30 O 7.6447 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 2 24 28
M  V30 31 2 24 29
M  V30 32 1 24 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorophenyl 4-methoxybenzoate
C14H11FO3
729-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 O 6.1601 4.0010 0.0 0
M  V30 4 O 13.0903 2.6673 0.0 0
M  V30 5 C 13.8603 4.0010 0.0 0
M  V30 6 F 0.0000 1.3337 0.0 0
M  V30 7 C 8.4702 2.6673 0.0 0
M  V30 8 C 9.2402 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 10.7802 4.0010 0.0 0
M  V30 11 C 10.7802 1.3337 0.0 0
M  V30 12 C 11.5503 2.6673 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 3.8501 2.6673 0.0 0
M  V30 15 C 3.8501 0.0000 0.0 0
M  V30 16 C 2.3101 2.6673 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-41-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2489620-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 729-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33647066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective in stage 3, Schlenk tube used in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of Esters from Arenes through C-H
Thianthrenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Mengning; Zhang, Xiaomei; Ma, Mengtao; Zhao, Binlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(32), 6031-6036

$RFMT $RIREG SCHEME423 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)phenol
C7H5F3O
402-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thianthrenium, 5-(4-methoxyphenyl)-, 1,1,1-trifluoromethanesulfonate (1:1)
C19H15OS2.CF3O3S
2489620-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 12.3200 0.0 0
M  V30 2 C 10.6694 11.5500 0.0 0
M  V30 3 S 4.0011 9.2400 0.0 0 CHG=1 VAL=3
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 2.6673 10.0100 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 1.3336 9.2400 0.0 0
M  V30 9 C 2.6673 11.5500 0.0 0
M  V30 10 S 1.3336 7.7000 0.0 0
M  V30 11 C 2.6673 5.3900 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 0.0000 10.0100 0.0 0
M  V30 14 C 1.3336 12.3200 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 0.0000 11.5500 0.0 0
M  V30 17 C 5.3347 10.0100 0.0 0
M  V30 18 C 6.6684 9.2400 0.0 0
M  V30 19 C 5.3347 11.5500 0.0 0
M  V30 20 C 8.0021 10.0100 0.0 0
M  V30 21 C 6.6684 12.3200 0.0 0
M  V30 22 C 8.0021 11.5500 0.0 0
M  V30 23 C 4.5647 1.5400 0.0 0
M  V30 24 S 6.1047 1.5400 0.0 0 VAL=6
M  V30 25 F 3.7947 2.8736 0.0 0
M  V30 26 F 3.0247 1.5400 0.0 0
M  V30 27 F 3.7947 0.2064 0.0 0
M  V30 28 O 6.1047 3.0800 0.0 0
M  V30 29 O 6.1047 0.0000 0.0 0
M  V30 30 O 7.6447 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 2 24 28
M  V30 31 2 24 29
M  V30 32 1 24 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)phenyl 4-methoxybenzoate
C15H11F3O3
207691-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 1.5400 0.0 0
M  V30 2 C 8.4700 2.8736 0.0 0
M  V30 3 O 7.7000 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 F 0.0000 1.5400 0.0 0
M  V30 7 F 1.5400 3.0800 0.0 0
M  V30 8 O 14.6300 2.8736 0.0 0
M  V30 9 C 15.4000 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 5.3900 0.2062 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 3.8500 0.2062 0.0 0
M  V30 14 C 3.8500 2.8736 0.0 0
M  V30 15 C 3.0800 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 15
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-45-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2489620-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207691-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33647054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective in stage 3, Schlenk tube used in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of Esters from Arenes through C-H
Thianthrenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Mengning; Zhang, Xiaomei; Ma, Mengtao; Zhao, Binlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(32), 6031-6036

$RFMT $RIREG SCHEME424 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylparaben
C8H8O3
99-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 O 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thianthrenium, 5-(4-methoxyphenyl)-, 1,1,1-trifluoromethanesulfonate (1:1)
C19H15OS2.CF3O3S
2489620-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 12.3200 0.0 0
M  V30 2 C 10.6694 11.5500 0.0 0
M  V30 3 S 4.0011 9.2400 0.0 0 CHG=1 VAL=3
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 2.6673 10.0100 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 1.3336 9.2400 0.0 0
M  V30 9 C 2.6673 11.5500 0.0 0
M  V30 10 S 1.3336 7.7000 0.0 0
M  V30 11 C 2.6673 5.3900 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 0.0000 10.0100 0.0 0
M  V30 14 C 1.3336 12.3200 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 0.0000 11.5500 0.0 0
M  V30 17 C 5.3347 10.0100 0.0 0
M  V30 18 C 6.6684 9.2400 0.0 0
M  V30 19 C 5.3347 11.5500 0.0 0
M  V30 20 C 8.0021 10.0100 0.0 0
M  V30 21 C 6.6684 12.3200 0.0 0
M  V30 22 C 8.0021 11.5500 0.0 0
M  V30 23 C 4.5647 1.5400 0.0 0
M  V30 24 S 6.1047 1.5400 0.0 0 VAL=6
M  V30 25 F 3.7947 2.8736 0.0 0
M  V30 26 F 3.0247 1.5400 0.0 0
M  V30 27 F 3.7947 0.2064 0.0 0
M  V30 28 O 6.1047 3.0800 0.0 0
M  V30 29 O 6.1047 0.0000 0.0 0
M  V30 30 O 7.6447 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 2 24 28
M  V30 31 2 24 29
M  V30 32 1 24 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-methoxy-, 4-(methoxycarbonyl)phenyl ester
C16H14O5
50649-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 1.3337 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 2.6673 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 15.4003 2.6673 0.0 0
M  V30 9 C 16.1704 4.0010 0.0 0
M  V30 10 C 6.9302 1.3337 0.0 0
M  V30 11 C 6.1601 0.0000 0.0 0
M  V30 12 C 6.1601 2.6673 0.0 0
M  V30 13 C 4.6201 0.0000 0.0 0
M  V30 14 C 4.6201 2.6673 0.0 0
M  V30 15 C 3.8501 1.3337 0.0 0
M  V30 16 C 10.7802 2.6673 0.0 0
M  V30 17 C 11.5503 1.3337 0.0 0
M  V30 18 C 11.5503 4.0010 0.0 0
M  V30 19 C 13.0903 1.3337 0.0 0
M  V30 20 C 13.0903 4.0010 0.0 0
M  V30 21 C 13.8603 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 15
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-76-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2489620-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50649-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33647070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective in stage 3, Schlenk tube used in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of Esters from Arenes through C-H
Thianthrenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Mengning; Zhang, Xiaomei; Ma, Mengtao; Zhao, Binlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(32), 6031-6036

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL

C38H33NO6
2495094-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 6.5336 0.0 0
M  V30 2 C 1.5400 5.1999 0.0 0
M  V30 3 C 2.3100 3.8663 0.0 0
M  V30 4 O 0.0000 5.1999 0.0 0
M  V30 5 O 9.6813 2.6642 0.0 0
M  V30 6 C 10.5143 1.3689 0.0 0
M  V30 7 C 12.0526 1.4427 0.0 0
M  V30 8 O 9.8091 0.0000 0.0 0
M  V30 9 O 14.9968 8.5069 0.0 0
M  V30 10 C 16.2408 9.4148 0.0 0
M  V30 11 C 17.6490 8.7914 0.0 0
M  V30 12 O 16.0765 10.9460 0.0 0
M  V30 13 C 6.9300 9.2010 0.0 0
M  V30 14 C 7.5041 10.5012 0.0 0
M  V30 15 C 5.3980 9.3572 0.0 0
M  V30 16 C 7.7619 8.0485 0.0 0
M  V30 17 N 9.0351 10.7707 0.0 0
M  V30 18 C 6.4044 11.6367 0.0 0
M  V30 19 C 5.0730 10.8625 0.0 0
M  V30 20 C 4.2567 8.3232 0.0 0
M  V30 21 C 9.3156 8.1031 0.0 0
M  V30 22 C 9.8806 9.5112 0.0 0
M  V30 23 C 9.6656 12.3418 0.0 0
M  V30 24 C 3.6070 11.3339 0.0 0
M  V30 25 C 2.7906 8.7946 0.0 0
M  V30 26 C 10.2588 6.6976 0.0 0
M  V30 27 C 11.2575 12.6012 0.0 0
M  V30 28 C 2.4657 10.2999 0.0 0
M  V30 29 C 11.7971 6.7714 0.0 0
M  V30 30 C 9.5537 5.3285 0.0 0
M  V30 31 C 12.1164 11.2455 0.0 0
M  V30 32 C 12.4282 8.2793 0.0 0
M  V30 33 C 12.6301 5.4761 0.0 0
M  V30 34 C 10.3866 4.0332 0.0 0
M  V30 35 C 13.4284 10.6546 0.0 0
M  V30 36 C 10.8620 10.2956 0.0 0
M  V30 37 C 13.5886 9.1302 0.0 0
M  V30 38 C 11.0037 8.9478 0.0 0
M  V30 39 C 11.9248 4.1070 0.0 0
M  V30 40 C 6.1600 7.8674 0.0 0
M  V30 41 C 4.6200 7.8674 0.0 0
M  V30 42 C 6.9300 6.5336 0.0 0
M  V30 43 C 3.8500 6.5336 0.0 0
M  V30 44 C 6.1600 5.1999 0.0 0
M  V30 45 C 4.6200 5.1999 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 43
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 37
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 40
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 17 23
M  V30 24 1 18 19
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 1 21 22
M  V30 28 1 21 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 2 25 28
M  V30 32 1 26 29
M  V30 33 2 26 30
M  V30 34 1 27 31
M  V30 35 1 29 32
M  V30 36 2 29 33
M  V30 37 1 30 34
M  V30 38 1 31 35
M  V30 39 2 31 36
M  V30 40 1 32 37
M  V30 41 2 32 38
M  V30 42 1 33 39
M  V30 43 2 34 39
M  V30 44 2 35 37
M  V30 45 1 36 38
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H27NO3.CH2O2
2495094-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.1794 0.0 0
M  V30 2 O 7.3714 2.3100 0.0 0
M  V30 3 O 12.6868 8.1526 0.0 0
M  V30 4 C 4.6200 8.8467 0.0 0
M  V30 5 C 5.1941 10.1471 0.0 0
M  V30 6 C 3.0879 9.0030 0.0 0
M  V30 7 C 5.4519 7.6943 0.0 0
M  V30 8 N 6.7252 10.4166 0.0 0
M  V30 9 C 4.0944 11.2825 0.0 0
M  V30 10 C 2.7631 10.5084 0.0 0
M  V30 11 C 1.9467 7.9691 0.0 0
M  V30 12 C 7.0055 7.7490 0.0 0
M  V30 13 C 7.5706 9.1569 0.0 0
M  V30 14 C 7.3557 11.9877 0.0 0
M  V30 15 C 1.2970 10.9798 0.0 0
M  V30 16 C 0.4806 8.4403 0.0 0
M  V30 17 C 7.9489 6.3433 0.0 0
M  V30 18 C 8.9476 12.2470 0.0 0
M  V30 19 C 0.1557 9.9456 0.0 0
M  V30 20 C 9.4872 6.4170 0.0 0
M  V30 21 C 7.2437 4.9744 0.0 0
M  V30 22 C 9.8064 10.8914 0.0 0
M  V30 23 C 10.1181 7.9252 0.0 0
M  V30 24 C 10.3202 5.1217 0.0 0
M  V30 25 C 8.0767 3.6791 0.0 0
M  V30 26 C 11.1185 10.3005 0.0 0
M  V30 27 C 8.5521 9.9415 0.0 0
M  V30 28 C 11.2787 8.7760 0.0 0
M  V30 29 C 8.6938 8.5935 0.0 0
M  V30 30 C 9.6148 3.7528 0.0 0
M  V30 31 C 3.8500 7.5131 0.0 0
M  V30 32 C 2.3100 7.5131 0.0 0
M  V30 33 C 4.6200 6.1794 0.0 0
M  V30 34 C 1.5400 6.1794 0.0 0
M  V30 35 C 3.8500 4.8458 0.0 0
M  V30 36 C 2.3100 4.8458 0.0 0
M  V30 37 C 6.3434 0.0000 0.0 0
M  V30 38 O 5.0097 0.7700 0.0 0
M  V30 39 O 7.6771 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 34
M  V30 2 1 2 25
M  V30 3 1 3 28
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 31
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 10
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 12 13
M  V30 19 1 12 17
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 2 17 21
M  V30 25 1 18 22
M  V30 26 1 20 23
M  V30 27 2 20 24
M  V30 28 1 21 25
M  V30 29 1 22 26
M  V30 30 2 22 27
M  V30 31 1 23 28
M  V30 32 2 23 29
M  V30 33 1 24 30
M  V30 34 2 25 30
M  V30 35 2 26 28
M  V30 36 1 27 29
M  V30 37 2 31 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 2 33 35
M  V30 41 2 34 36
M  V30 42 1 35 36
M  V30 43 1 37 38
M  V30 44 2 37 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2495094-75-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2495094-71-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-23029950
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as HCO2H salt using preparative TLC eluting with 17%
MeOH/CHCl3 containing 5% HCO2H
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable Total Syntheses and Structure-Activity Relationships of
Haouamines A, B, and Their Derivatives as Stable Formate Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsukamoto, Hirokazu; Nakamura, Saki; Tomida, Akito; Doi, Takayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(55), 12528-12532

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl-3-phenoxybenzenamine
C14H15NO
2588236-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 6.6684 0.0000 0.0 0
M  V30 3 C 4.0011 4.6200 0.0 0
M  V30 4 N 9.3358 1.5400 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 6.6684 1.5400 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 8.0021 2.3100 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 6
M  V30 4 1 3 7
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethyl-3-phenoxyphenyl)formamide
C15H15NO2
2581117-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 12.0033 1.5400 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2588236-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2581117-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36058953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of rotamers with 1:1 ratio,reaction in a
sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cell-based optimization of covalent reversible ketoamide inhibitors
bridging the unprimed to the primed site of the proteasome β5 subunit
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stubba, Daniel; Bensinger, Dennis; Steinbacher, Janika; Proskurjakov,
Lilia; Salcedo Gomez, Alvaro; Schmidt, Uwe; Roth, Stefan; Schmitz, Katja;
Schmidt, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2019), 14(23), 2005-2022

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H38ClN5O6
2650491-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 15.5085 4.6213 0.0 0
M  V30 2 C 14.2626 3.7162 0.0 0
M  V30 3 O 12.8558 4.3425 0.0 0
M  V30 4 O 14.4236 2.1845 0.0 0
M  V30 5 N 22.3015 1.5968 0.0 0
M  V30 6 C 23.5473 2.5021 0.0 0
M  V30 7 O 24.9543 1.8757 0.0 0
M  V30 8 O 23.3864 4.0336 0.0 0
M  V30 9 C 26.2002 2.7809 0.0 0
M  V30 10 C 25.2949 4.0268 0.0 0
M  V30 11 C 27.4460 3.6862 0.0 0
M  V30 12 C 27.1054 1.5351 0.0 0
M  V30 13 Cl 7.7000 0.0000 0.0 0
M  V30 14 O 4.6200 0.0000 0.0 0
M  V30 15 C 18.9050 3.1091 0.0 0
M  V30 16 C 17.4672 2.5572 0.0 0
M  V30 17 C 18.3530 4.5469 0.0 0
M  V30 18 C 20.3427 3.6611 0.0 0
M  V30 19 C 19.4569 1.6714 0.0 0
M  V30 20 C 16.9154 3.9949 0.0 0
M  V30 21 C 20.8947 2.2233 0.0 0
M  V30 22 C 11.6098 3.4373 0.0 0
M  V30 23 C 10.1453 3.9132 0.0 0
M  V30 24 C 11.6098 1.8973 0.0 0
M  V30 25 N 9.2400 2.6673 0.0 0
M  V30 26 C 10.1453 1.4214 0.0 0
M  V30 27 C 7.7000 2.6673 0.0 0
M  V30 28 C 6.9300 1.3336 0.0 0
M  V30 29 C 6.9300 4.0009 0.0 0
M  V30 30 C 5.3900 1.3336 0.0 0
M  V30 31 N 5.3900 4.0009 0.0 0
M  V30 32 N 4.6200 2.6673 0.0 0
M  V30 33 C 3.0800 2.6673 0.0 0
M  V30 34 C 2.3100 1.3336 0.0 0
M  V30 35 O 2.3100 4.0009 0.0 0
M  V30 36 C 0.7700 1.3336 0.0 0
M  V30 37 C 0.7700 4.0009 0.0 0
M  V30 38 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 22
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 28
M  V30 15 2 14 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 32 33
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H30ClN5O4.CH2O2
2650491-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 15.5085 6.9313 0.0 0
M  V30 2 C 14.2626 6.0262 0.0 0
M  V30 3 O 12.8558 6.6525 0.0 0
M  V30 4 O 14.4236 4.4945 0.0 0
M  V30 5 N 22.3015 3.9069 0.0 0
M  V30 6 Cl 7.7000 2.3100 0.0 0
M  V30 7 O 4.6200 2.3100 0.0 0
M  V30 8 C 18.9050 5.4191 0.0 0
M  V30 9 C 18.3530 6.8569 0.0 0
M  V30 10 C 17.4672 4.8672 0.0 0
M  V30 11 C 19.4569 3.9814 0.0 0
M  V30 12 C 20.3427 5.9711 0.0 0
M  V30 13 C 16.9154 6.3050 0.0 0
M  V30 14 C 20.8947 4.5333 0.0 0
M  V30 15 C 11.6098 5.7473 0.0 0
M  V30 16 C 10.1453 6.2232 0.0 0
M  V30 17 C 11.6098 4.2073 0.0 0
M  V30 18 N 9.2400 4.9773 0.0 0
M  V30 19 C 10.1453 3.7314 0.0 0
M  V30 20 C 7.7000 4.9773 0.0 0
M  V30 21 C 6.9300 3.6437 0.0 0
M  V30 22 C 6.9300 6.3110 0.0 0
M  V30 23 C 5.3900 3.6437 0.0 0
M  V30 24 N 5.3900 6.3110 0.0 0
M  V30 25 N 4.6200 4.9773 0.0 0
M  V30 26 C 3.0800 4.9773 0.0 0
M  V30 27 C 2.3100 3.6437 0.0 0
M  V30 28 O 2.3100 6.3110 0.0 0
M  V30 29 C 0.7700 3.6437 0.0 0
M  V30 30 C 0.7700 6.3110 0.0 0
M  V30 31 C 0.0000 4.9773 0.0 0
M  V30 32 C 11.1507 0.0000 0.0 0
M  V30 33 O 9.8171 0.7700 0.0 0
M  V30 34 O 12.4844 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 15
M  V30 6 1 5 14
M  V30 7 1 6 21
M  V30 8 2 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2650491-52-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2650491-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31183041
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds that modulate CD73 for disease therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vander Wal, Mark; Buell, John; Han, Xinping; Jin, Yongil; Wu, Guoxian;
Shi, Songyuan; Spevak, Wayne; Walleshauser, Jack; Zhang, Jiazhong; Zhang,
Ying; Guo, Zuojun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021113625 A1 2021-06-10

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H19N5O6
2713998-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.1372 3.2094 0.0 0
M  V30 2 O 15.0424 4.4553 0.0 0
M  V30 3 O 14.7635 1.8026 0.0 0
M  V30 4 C 16.5740 4.2944 0.0 0
M  V30 5 C 16.4131 2.7628 0.0 0
M  V30 6 C 18.1056 4.1335 0.0 0
M  V30 7 C 16.7349 5.8259 0.0 0
M  V30 8 O 7.0187 5.6421 0.0 0
M  V30 9 O 0.0000 3.0801 0.0 0
M  V30 10 C 10.4396 3.5981 0.0 0
M  V30 11 C 9.4091 2.4536 0.0 0
M  V30 12 C 11.6365 4.5673 0.0 0
M  V30 13 C 11.4087 2.4012 0.0 0
M  V30 14 O 9.6696 4.9318 0.0 0
M  V30 15 N 8.0022 3.0801 0.0 0
M  V30 16 N 12.6056 3.3705 0.0 0
M  V30 17 C 8.1633 4.6116 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 N 5.3348 3.0801 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0012 2.3101 0.0 0
M  V30 22 N 5.3348 0.0000 0.0 0
M  V30 23 C 4.0012 0.7700 0.0 0
M  V30 24 N 2.6673 3.0801 0.0 0
M  V30 25 O 2.6673 0.0000 0.0 0
M  V30 26 C 1.3337 2.3101 0.0 0
M  V30 27 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 2 9 26
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C11H11N5O4.CH2O2
2713998-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3780 8.2843 0.0 0
M  V30 2 O 11.1073 6.1515 0.0 0
M  V30 3 C 1.4378 4.2997 0.0 0
M  V30 4 C 2.9441 4.6199 0.0 0
M  V30 5 O 0.6678 5.6334 0.0 0
M  V30 6 C 1.9896 2.8620 0.0 0
M  V30 7 C 0.0000 3.7478 0.0 0
M  V30 8 N 3.1052 6.1515 0.0 0
M  V30 9 C 1.6982 6.7778 0.0 0
M  V30 10 N 0.5519 2.3100 0.0 0
M  V30 11 C 4.4388 6.9215 0.0 0
M  V30 12 N 5.7725 6.1515 0.0 0
M  V30 13 C 4.4388 8.4615 0.0 0
M  V30 14 C 7.1062 6.9215 0.0 0
M  V30 15 N 5.7725 9.2315 0.0 0
M  V30 16 C 7.1062 8.4615 0.0 0
M  V30 17 N 8.4400 6.1515 0.0 0
M  V30 18 O 8.4400 9.2315 0.0 0
M  V30 19 C 9.7737 6.9215 0.0 0
M  V30 20 C 9.7737 8.4615 0.0 0
M  V30 21 C 5.5537 0.0000 0.0 0
M  V30 22 O 4.2200 0.7700 0.0 0
M  V30 23 O 6.8873 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713998-83-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713998-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24584038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and their use in the treatment of
bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cumming, John G.; Kramer, Christian; Kreis, Lukas; Kuehne, Holger;
Schnider, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021190727 A1 2021-09-30

$RFMT $RIREG SCHEME429 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxyaniline
C8H11NO2
2735-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethoxyphenyl)formamide
C9H11NO3
6639-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3349 0.0 0
M  V30 3 O 9.2400 5.3349 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2735-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6639-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7449576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of 4-bromoaniline (17.1 g, 100
mmol) and 98 % formic acid (7.7 ml, 200 mmol) in 60 ml toluene is
refluxed under a condenser attached to a water separator. After the
reaction was complete, volatile materials were removed by evaporation.
Intermediate product of 1i, Yield: Quantitative yield..
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multicomponent Cascade Cycloaddition Involving Tropone, Allenoate, and
Isocyanide: A Rapid Access to a 7,6,5-Fused Tricyclic Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Shuanglong; Su, Shikuan; Li, Chunju; Jia, Xueshun; Li, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(21), 5604-5607

$RFMT $RIREG SCHEME430 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenemethanamine
C5H7NS
27757-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Thienylmethyl)formamide
C6H7NOS
1490137-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 O 7.7722 1.8517 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 C 1.0304 2.4782 0.0 0
M  V30 7 S 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27757-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1490137-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23018630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-83-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1610891-42-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, catalyst prepared and used,
reusable catalyst, 92% isolated yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalysed efficient N-formylation of amines with a recyclable
polyoxometalate-supported green catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dan, Demin; Chen, Fubo; Zhao, Whenshu; Yu, Han; Han, Sheng; Wei, Yongge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2021), 50(1), 90-94

